data_2mam_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mam _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.486 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 27.7 t80 . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.419 ' HB2' ' CE2' ' A' ' 86' ' ' TYR . 95.9 mt -123.24 -160.26 0.89 Allowed 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 167.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.468 HG22 ' OG1' ' A' ' 11' ' ' THR . 1.4 t -122.45 150.96 41.77 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 118.189 0.45 . . . . 0.0 111.908 -169.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -91.59 145.39 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.289 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.34 -13.13 67.9 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.468 ' OG1' HG22 ' A' ' 8' ' ' THR . 13.7 m -73.43 141.42 46.9 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 123.344 0.658 . . . . 0.0 111.174 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -89.71 131.29 35.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.71 175.8 9.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.595 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.5 m -117.08 144.82 44.23 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -121.28 139.09 53.86 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -75.87 136.11 40.15 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.329 0.585 . . . . 0.0 112.077 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -133.95 105.27 6.65 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.845 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 60.37 26.59 16.14 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 173.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.85 8.1 60.83 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.856 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.45 164.32 17.33 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -102.33 135.96 43.02 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.081 0.238 . . . . 0.0 111.003 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.5 t -122.33 146.86 46.92 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -88.04 151.24 22.9 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.384 -0.927 . . . . 0.0 109.502 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.438 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -152.79 162.32 41.42 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.8 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -126.61 126.29 43.37 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.462 ' HA ' HG13 ' A' ' 88' ' ' VAL . 52.3 mt -66.64 111.53 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -87.8 -44.43 11.12 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 124.858 1.263 . . . . 0.0 110.325 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 m -139.59 145.29 38.38 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -116.95 126.54 74.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -130.55 116.31 17.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.91 108.53 21.24 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.411 ' N ' HD23 ' A' ' 32' ' ' LEU . 2.0 pt? -139.14 158.78 43.57 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.738 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 14.5 p -125.27 137.27 58.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -90.29 101.06 13.79 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 122.128 0.966 . . . . 0.0 108.852 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.405 HG13 HG13 ' A' ' 37' ' ' VAL . 20.8 t -83.8 120.95 35.73 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.122 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -85.34 107.86 17.54 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 173.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.455 HG22 ' OE1' ' A' ' 46' ' ' GLN . 1.7 m -112.71 157.08 13.55 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.111 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -135.41 121.57 20.18 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.584 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 73.1 mt -69.8 129.33 39.26 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.005 -176.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.1 ptpt -68.71 -32.4 72.18 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.546 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 23.2 tt0 -81.1 -59.95 2.47 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 120.924 0.392 . . . . 0.0 110.956 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -85.57 -4.3 59.12 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 9.6 p30 56.38 18.62 3.53 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.729 1.612 . . . . 0.0 113.543 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.53 137.51 32.25 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-O 120.965 0.412 . . . . 0.0 111.165 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 m -101.11 148.16 25.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.455 ' OE1' HG22 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -152.44 163.39 39.62 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 123.133 0.573 . . . . 0.0 110.236 175.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.8 tp -128.99 103.13 6.83 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.53 162.52 37.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.518 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.9 pm0 -77.23 161.5 28.1 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -62.98 -6.02 3.48 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.618 1.167 . . . . 0.0 113.617 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -82.21 -27.63 32.45 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.776 0.798 . . . . 0.0 108.988 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -87.05 -22.51 25.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.223 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.8 117.21 48.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.47 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -102.8 105.37 15.77 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.315 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.405 ' HA3' HG13 ' A' ' 63' ' ' VAL . . . 149.63 -179.39 26.45 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.638 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.79 141.1 93.87 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.336 2.691 . . . . 0.0 113.562 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.27 83.45 3.87 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.467 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 47.2 ttp180 -139.13 135.9 34.56 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.57 122.79 18.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.87 12.18 59.46 Favored Glycine 0 N--CA 1.423 -2.214 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.422 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 58' ' ' ARG . . . -97.2 157.73 15.8 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 118.161 0.981 . . . . 0.0 110.789 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.9 mm -97.36 121.74 48.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.405 HG13 ' HA3' ' A' ' 55' ' ' GLY . 29.6 m -136.4 -173.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 122.927 0.491 . . . . 0.0 109.893 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -128.88 132.25 47.71 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 t -133.79 158.56 43.03 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-O 120.792 0.329 . . . . 0.0 110.369 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.4 ttm-85 -83.94 115.37 22.27 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.309 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 71' ' ' SER . 5.1 t -81.72 167.2 19.38 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.7 p -67.7 -2.35 6.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.927 0.87 . . . . 0.0 112.219 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -85.93 -16.31 38.85 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.067 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.5 -2.94 71.23 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 67' ' ' THR . 8.2 m -92.26 159.97 15.37 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -109.74 115.73 30.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.584 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 7.2 tt0 -113.37 148.35 35.95 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.618 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 35.3 tt0 -70.4 125.17 26.05 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.91 173.92 11.18 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.358 -173.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.67 139.99 48.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -75.5 126.2 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.2 m -108.33 -17.32 14.03 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.336 0.112 . . . . 0.0 110.892 177.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -166.65 151.69 7.8 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.0 mt -124.36 112.87 17.46 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 169.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.8 m . . . . . 0 C--N 1.279 -2.469 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.814 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 99' ' ' ARG . 75.2 m . . . . . 0 CA--C 1.498 -1.032 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.488 ' CE3' ' HB ' ' A' ' 97' ' ' THR . 46.1 m95 -107.61 107.92 18.95 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.079 0.466 . . . . 0.0 110.05 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.486 ' OH ' ' HB3' ' A' ' 6' ' ' TYR . 96.5 m-85 -101.64 103.45 14.25 Favored 'General case' 0 N--CA 1.404 -2.742 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.4 m -76.16 104.09 6.52 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 25.4 m -112.28 141.14 28.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-O 121.261 0.553 . . . . 0.0 111.172 -175.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.7 t -97.36 118.16 43.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.095 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -84.44 168.47 15.49 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -61.36 -21.27 63.89 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.12 0.486 . . . . 0.0 111.218 -175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.1 -16.87 63.18 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 123.666 0.786 . . . . 0.0 111.113 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.62 1.94 58.79 Favored Glycine 0 CA--C 1.507 -0.468 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.4 138.85 33.38 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 9.6 pt-20 -120.58 128.57 53.18 Favored 'General case' 0 C--N 1.284 -2.245 0 O-C-N 123.522 0.514 . . . . 0.0 110.413 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -131.54 149.61 52.45 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.488 ' HB ' ' CE3' ' A' ' 85' ' ' TRP . 2.3 p -79.75 112.72 17.29 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 122.383 0.273 . . . . 0.0 111.048 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.83 137.73 48.11 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.195 0.522 . . . . 0.0 110.682 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -76.34 143.62 40.66 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 175.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.473 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 2.5 tmm_? -44.07 -33.13 1.37 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.619 1.167 . . . . 0.0 113.265 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.3 m -55.31 -32.91 62.83 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.016 0.926 . . . . 0.0 112.047 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 35.1 m -82.69 -16.59 47.56 Favored 'General case' 0 N--CA 1.433 -1.306 0 O-C-N 122.063 -0.398 . . . . 0.0 110.849 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 mp -86.87 128.97 35.06 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.79 0.805 . . . . 0.0 111.462 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 20.0 m . . . . . 0 C--N 1.283 -2.284 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.902 -175.866 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.695 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 39.6 p90 . . . . . 0 N--CA 1.409 -2.491 0 CA-C-O 122.605 1.193 . . . . 0.0 109.948 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.8 mt -76.88 177.32 7.78 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 112.82 -1.991 . . . . 0.0 109.801 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.422 ' HA ' HG21 ' A' ' 29' ' ' VAL . 10.6 p -133.4 166.57 22.22 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.374 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.4 111.41 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.98 -26.52 2.2 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 m -71.64 137.93 48.27 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -116.33 125.68 52.46 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.461 ' CG2' HD22 ' A' ' 103' ' ' LEU . 33.9 m -144.79 -178.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 9.4 t -99.26 147.46 25.14 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 175.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -137.75 128.8 27.42 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 123.324 0.65 . . . . 0.0 109.396 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 51.1 mtpt -70.54 121.09 17.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.955 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -148.46 138.55 22.44 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 60.65 26.13 15.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.167 0.587 . . . . 0.0 111.46 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.55 3.05 72.1 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.184 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.06 145.53 44.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 117.652 0.726 . . . . 0.0 110.157 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 21.7 p90 -93.58 120.61 34.07 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.987 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.7 m -123.63 173.63 7.96 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.11 146.5 41.35 Favored 'General case' 0 C--O 1.253 1.242 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.21 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -152.12 147.78 26.86 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.416 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -116.6 128.36 55.32 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.428 ' HA ' HG11 ' A' ' 88' ' ' VAL . 28.4 mt -62.36 116.09 2.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -90.37 -40.32 12.15 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.601 1.16 . . . . 0.0 110.118 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.4 m -144.41 145.98 32.23 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.278 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 8' ' ' THR . 96.0 t -129.29 128.75 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.086 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 84' ' ' SER . 21.8 mmmt -118.29 102.66 9.14 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.637 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -77.15 88.0 3.62 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 pp -111.09 153.58 25.47 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.958 0.885 . . . . 0.0 112.437 -172.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.521 ' CG1' ' HB3' ' A' ' 80' ' ' LEU . 60.3 t -115.81 120.61 65.3 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.365 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 26.4 mtpp -85.59 99.02 10.99 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.407 HG12 HG11 ' A' ' 37' ' ' VAL . 21.4 t -84.41 123.8 39.31 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.928 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 87.7 tttt -87.99 115.41 25.44 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 171.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 45' ' ' THR . 1.7 m -118.46 143.38 29.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.427 0.632 . . . . 0.0 112.077 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.538 HD21 ' O ' ' A' ' 44' ' ' THR . 1.9 tm? -107.21 116.89 32.72 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.8 mt -74.7 124.6 27.04 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HB3' HD12 ' A' ' 76' ' ' ILE . 22.2 pttp -72.82 -29.29 63.12 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -78.2 -38.92 42.11 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.947 0.403 . . . . 0.0 111.595 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.543 ' OD1' ' HB ' ' A' ' 44' ' ' THR . 14.6 t70 -93.33 -25.55 17.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.864 0.364 . . . . 0.0 110.948 -176.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 70.26 22.31 5.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.29 1.036 . . . . 0.0 111.24 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.543 ' HB ' ' OD1' ' A' ' 42' ' ' ASP . 5.6 t -101.23 -174.8 2.69 Favored 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 121.475 0.655 . . . . 0.0 110.049 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.7 m -136.24 139.65 42.9 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.25 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.01 156.93 44.29 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.1 tt -140.96 103.8 4.55 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 25.6 m -126.03 -178.49 2.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.746 -172.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -100.7 173.06 6.7 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -43.03 -29.86 0.38 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 128.657 2.783 . . . . 0.0 114.754 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.35 -28.01 31.84 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.121 -174.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.478 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 8.0 mm-40 -90.19 -16.48 29.39 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.421 0.629 . . . . 0.0 109.443 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -97.57 109.37 23.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.509 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -99.03 106.88 19.17 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.525 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 139.18 -171.3 23.73 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.406 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.32 137.58 23.58 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.136 2.558 . . . . 0.0 113.495 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.5 mt -90.03 81.98 6.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.61 128.63 23.64 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.629 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 t -65.97 116.27 5.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.37 6.19 51.16 Favored Glycine 0 N--CA 1.431 -1.699 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.836 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.39 165.2 12.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.391 0.596 . . . . 0.0 111.228 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.5 mm -96.14 124.27 48.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 O-C-N 123.6 0.563 . . . . 0.0 109.935 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.401 ' CG1' HD12 ' A' ' 77' ' ' ILE . 19.7 m -131.61 178.08 6.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -121.6 121.4 37.32 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 t -116.37 158.04 24.1 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.816 -175.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.478 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 23.1 mtt180 -79.15 143.55 35.34 Favored 'General case' 0 CA--C 1.479 -1.782 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.037 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.1 p -97.92 175.25 6.2 Favored 'General case' 0 N--CA 1.404 -2.727 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.205 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.4 m -76.7 -17.92 58.82 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.252 0.549 . . . . 0.0 111.095 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -84.11 -21.12 31.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.819 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.8 6.01 23.37 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.368 -0.92 . . . . 0.0 114.424 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.9 p -99.3 177.27 5.25 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 117.619 0.71 . . . . 0.0 110.387 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 66' ' ' ARG . 60.6 m-85 -108.46 137.26 46.71 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.119 0.485 . . . . 0.0 110.792 175.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -122.43 141.75 51.27 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.28 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -74.36 118.69 17.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.715 0.769 . . . . 0.0 109.004 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.25 166.82 21.91 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.322 -175.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 3.5 mp -112.14 141.89 26.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.401 HD12 ' CG1' ' A' ' 63' ' ' VAL . 3.2 mp -74.26 122.57 27.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -101.18 -27.3 13.3 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.264 0.554 . . . . 0.0 110.241 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 53.7 tptt -162.72 142.24 9.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.521 ' HB3' ' CG1' ' A' ' 33' ' ' VAL . 25.3 mt -119.0 127.09 53.13 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 171.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 3.7 m . . . . . 0 C--N 1.279 -2.49 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 49.2 m . . . . . 0 N--CA 1.441 -0.904 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -118.59 145.25 45.54 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.695 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 55.5 m-85 -124.69 121.9 35.97 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 124.152 0.907 . . . . 0.0 109.115 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 70.5 m -95.09 107.73 19.8 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 26' ' ' ILE . 30.3 m -109.64 147.16 14.25 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.884 -176.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.92 128.48 57.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -90.49 179.06 5.94 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.915 -172.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -52.0 -39.71 59.83 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.488 1.515 . . . . 0.0 112.809 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.39 -13.73 58.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.421 0.629 . . . . 0.0 111.866 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.49 -0.44 43.06 Favored Glycine 0 C--N 1.292 -1.884 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.84 175.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -87.56 154.08 20.9 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -130.42 137.61 49.92 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 120.861 0.362 . . . . 0.0 110.084 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 87' ' ' THR . 0.6 OUTLIER -139.21 158.64 43.8 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.886 -177.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.1 m -101.57 117.22 34.47 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.444 0.465 . . . . 0.0 110.235 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.2 165.1 26.52 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.078 0.951 . . . . 0.0 111.909 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -100.12 -171.3 2.01 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -75.93 -5.34 45.69 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.654 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 p -71.27 -21.13 62.14 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.671 0.748 . . . . 0.0 110.11 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 23.3 m -106.64 -16.17 14.58 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.053 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 14' ' ' SER . 87.6 mt -93.05 127.33 38.54 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.612 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 18.8 m . . . . . 0 C--N 1.29 -1.995 0 CA-C-O 121.168 0.508 . . . . 0.0 110.431 -176.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.2 p90 . . . . . 0 N--CA 1.42 -1.965 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.473 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 22.1 mt -85.88 178.71 7.2 Favored 'General case' 0 C--N 1.277 -2.571 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.586 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 p -133.0 168.34 18.65 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.264 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.29 148.66 11.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 123.853 0.861 . . . . 0.0 111.562 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.23 -5.94 81.17 Favored Glycine 0 CA--C 1.505 -0.531 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.963 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.425 ' HB ' HD11 ' A' ' 26' ' ' ILE . 8.6 m -82.62 139.82 33.55 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 122.346 0.258 . . . . 0.0 110.532 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -104.93 111.06 23.69 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 104' ' ' CYS . 29.3 m -127.24 171.97 14.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 21.2 m -95.11 142.81 27.13 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.598 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.78 129.36 36.48 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.027 0.531 . . . . 0.0 109.701 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -94.83 120.31 34.84 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.706 0.765 . . . . 0.0 110.379 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -119.97 120.97 37.9 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? 63.78 26.28 14.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.53 0.681 . . . . 0.0 110.729 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.85 -14.88 63.09 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.501 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.31 130.17 52.15 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . 0.289 6.6 p90 -105.0 123.96 48.7 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.2 t -115.06 160.61 19.42 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -90.69 148.94 22.28 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-O 121.887 0.851 . . . . 0.0 110.08 178.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.484 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . . . -144.54 149.34 35.71 Favored 'General case' 0 C--N 1.259 -3.334 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.699 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.76 126.26 51.65 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.583 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.425 HD11 ' HB ' ' A' ' 11' ' ' THR . 30.8 mt -68.95 119.45 14.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 123.526 0.73 . . . . 0.0 112.268 -175.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -91.29 -53.38 4.37 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.057 0.932 . . . . 0.0 109.455 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 m -129.71 143.41 50.8 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.463 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.71 123.66 61.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.301 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -112.71 117.98 33.72 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 171.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -72.05 108.31 5.2 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 84' ' ' SER . 6.6 tt -129.34 136.76 50.43 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-O 121.544 0.688 . . . . 0.0 109.34 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.4 t -115.59 132.97 63.41 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.126 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.088 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -84.69 101.54 12.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 170.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.3 t -91.8 118.27 36.86 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.07 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.779 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 87.7 tttt -80.52 103.71 10.56 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 45' ' ' THR . 3.9 m -111.55 143.52 21.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-O 121.689 0.757 . . . . 0.0 111.21 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.04 117.13 32.46 Favored 'General case' 0 C--N 1.267 -3.018 0 CA-C-N 113.149 -1.841 . . . . 0.0 106.91 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.481 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 75.7 mt -73.72 108.5 6.59 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -62.25 -30.32 71.03 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -80.22 -40.15 27.69 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.241 0.543 . . . . 0.0 111.697 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -95.05 -25.38 16.49 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.242 0.544 . . . . 0.0 111.384 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 74.42 22.67 2.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.524 1.53 . . . . 0.0 113.12 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.97 150.17 24.47 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.655 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.9 m -119.03 151.87 37.44 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -157.85 161.88 38.35 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 123.451 0.7 . . . . 0.0 109.619 177.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 mt -113.11 102.31 10.27 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.7 m -117.94 172.51 5.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.597 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -84.9 161.5 19.82 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.058 0.456 . . . . 0.0 111.963 -174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -64.44 -20.15 65.99 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.271 1.029 . . . . 0.0 111.06 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.58 -21.92 47.88 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.783 0.801 . . . . 0.0 109.533 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -98.31 -11.57 22.41 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.656 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.88 111.51 27.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.569 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -98.4 103.75 15.72 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.227 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.466 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 140.71 178.87 17.63 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.505 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.53 140.32 80.98 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.346 2.697 . . . . 0.0 113.93 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -89.35 82.27 6.51 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.525 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 73.5 mtp180 -140.11 134.47 31.32 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.455 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.79 118.61 10.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.17 53.86 Favored Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.43 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -96.33 155.84 16.59 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.704 0.752 . . . . 0.0 110.619 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.09 116.92 39.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.426 0.632 . . . . 0.0 109.334 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.466 HG12 ' HA3' ' A' ' 55' ' ' GLY . 30.4 m -126.82 170.61 16.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.565 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -112.84 121.46 44.75 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 9.2 t -119.68 157.59 28.2 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.956 -174.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -81.93 126.17 31.61 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.759 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.7 p -90.31 -176.07 4.7 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.0 m -67.26 -26.31 66.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -79.85 -6.9 58.25 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.387 0.613 . . . . 0.0 110.56 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.27 -18.57 56.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.51 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 m -72.78 141.75 48.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 122.786 0.434 . . . . 0.0 110.081 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 65' ' ' THR . 45.0 m-85 -89.88 133.23 34.87 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.481 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 32.0 tt0 -124.09 146.52 48.55 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.05 117.31 19.24 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 122.484 1.135 . . . . 0.0 110.754 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.93 174.03 8.25 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 113.494 -1.685 . . . . 0.0 110.987 -174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 10.9 mt -117.15 144.34 25.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.525 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -77.88 125.85 37.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 175.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 t -102.64 -20.89 14.25 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -173.92 153.32 2.12 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.4 OUTLIER -129.77 115.39 17.22 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.759 0.79 . . . . 0.0 111.437 172.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.9 m . . . . . 0 C--N 1.298 -1.667 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.083 -176.71 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.468 ' HA ' ' HB3' ' A' ' 32' ' ' LEU . 31.2 m . . . . . 0 N--CA 1.437 -1.082 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -95.81 134.11 39.15 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.155 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 91.0 m-85 -125.89 104.42 8.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 55.2 m -83.53 106.9 15.64 Favored 'General case' 0 N--CA 1.408 -2.553 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.8 m -113.45 142.74 24.92 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.758 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 9.9 p -99.39 125.29 52.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.78 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CD1' ' HB3' ' A' ' 24' ' ' ALA . 72.4 m-85 -88.24 178.72 6.53 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.183 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.44 -31.85 56.29 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.015 0.926 . . . . 0.0 111.66 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.74 -17.09 64.37 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.894 0.877 . . . . 0.0 111.503 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.46 6.9 83.13 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.335 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -97.15 136.53 37.54 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 11.6 pt-20 -107.02 126.93 52.97 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.585 0.707 . . . . 0.0 110.06 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -122.5 145.35 48.39 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 44.4 m -87.65 119.86 28.38 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -109.69 166.21 11.08 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.226 0.536 . . . . 0.0 111.389 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -94.47 152.03 18.9 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.519 -1.219 . . . . 0.0 107.968 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -50.79 -49.53 58.18 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.888 1.275 . . . . 0.0 111.759 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 p -79.83 11.16 3.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.289 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 m -120.12 5.87 10.8 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 tp -117.95 165.87 13.19 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.764 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 43.5 t . . . . . 0 N--CA 1.433 -1.31 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.5 p90 . . . . . 0 N--CA 1.394 -3.267 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.411 ' HB2' ' CE2' ' A' ' 86' ' ' TYR . 89.9 mt -94.03 174.82 6.96 Favored 'General case' 0 C--N 1.263 -3.193 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.5 p -133.33 161.1 35.42 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -69.73 149.39 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-O 121.429 0.633 . . . . 0.0 111.998 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.81 -7.77 55.61 Favored Glycine 0 C--N 1.289 -2.058 0 CA-C-N 114.547 -1.206 . . . . 0.0 113.722 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 t -102.65 164.42 11.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.16 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 17.3 t70 -117.25 128.48 55.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -172.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.78 173.88 12.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.844 0.83 . . . . 0.0 110.415 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.504 ' HB2' ' SG ' ' A' ' 104' ' ' CYS . 13.6 m -110.04 121.89 46.3 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 106.851 -1.536 . . . . 0.0 106.851 172.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.42 144.44 34.34 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -96.28 126.88 41.8 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.054 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -131.62 122.25 25.7 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? 59.44 26.67 15.64 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.224 0.535 . . . . 0.0 111.894 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.52 0.2 88.17 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.721 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.88 148.88 29.96 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -96.98 133.09 42.1 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.1 m -129.05 139.85 51.86 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.92 132.81 40.5 Favored 'General case' 0 N--CA 1.398 -3.056 0 C-N-CA 123.52 0.728 . . . . 0.0 109.341 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.53 144.36 21.68 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.52 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HZ1' ' HB2' ' A' ' 25' ' ' LYS . 4.4 ttmp? -106.12 133.37 50.93 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -176.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.414 ' HA ' HG13 ' A' ' 88' ' ' VAL . 24.1 mt -64.95 110.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.301 0.572 . . . . 0.0 111.201 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -94.72 -40.72 9.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.298 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -133.24 143.24 48.98 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.866 0.365 . . . . 0.0 110.063 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.63 124.6 69.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.864 0.866 . . . . 0.0 109.159 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -118.22 112.47 20.15 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.089 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.407 ' HE ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -77.18 96.57 4.54 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.045 178.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.6 mp -122.59 114.74 21.04 Favored 'General case' 0 CA--C 1.462 -2.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.022 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.8 t -115.73 114.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.38 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 94.2 mttt -79.25 106.01 10.98 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.978 0.894 . . . . 0.0 109.19 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.8 t -91.8 127.32 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.041 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.099 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 35.6 ttpt -97.36 127.73 43.57 Favored 'General case' 0 N--CA 1.406 -2.659 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.84 160.85 21.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.59 0 O-C-N 123.449 0.468 . . . . 0.0 109.764 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -122.74 118.35 27.86 Favored 'General case' 0 C--N 1.274 -2.674 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.75 121.94 17.55 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.477 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -55.9 -44.27 78.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.396 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -80.85 -61.27 2.01 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.024 -173.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.94 -22.31 39.71 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.25 -0.887 . . . . 0.0 112.878 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.26 19.21 2.91 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.329 0.652 . . . . 0.0 112.743 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.7 142.22 31.82 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.2 m -109.18 137.44 47.06 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 3.6 tp60 -136.03 140.81 44.13 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -172.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.4 tp -119.67 101.96 8.28 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.6 t -135.71 152.9 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -175.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 5.3 pm0 -71.57 153.45 42.13 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.516 0.674 . . . . 0.0 112.523 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -55.8 -11.83 1.12 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.899 2.079 . . . . 0.0 114.234 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -77.82 -25.93 49.17 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.629 0.728 . . . . 0.0 110.557 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -106.97 -2.68 20.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.918 0.866 . . . . 0.0 110.144 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.44 113.27 37.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.953 174.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -94.1 97.99 10.68 Favored 'General case' 0 C--N 1.276 -2.605 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.278 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.412 ' HA3' HG13 ' A' ' 63' ' ' VAL . . . 153.78 -166.48 31.89 Favored Glycine 0 N--CA 1.429 -1.797 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.042 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.46 146.49 19.41 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.971 2.447 . . . . 0.0 112.293 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.25 82.21 2.89 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.847 1.308 . . . . 0.0 108.421 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 77' ' ' ILE . 19.4 tpt180 -140.78 117.97 11.3 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.723 -2.035 . . . . 0.0 107.26 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.428 ' HA ' ' CG2' ' A' ' 77' ' ' ILE . 47.1 t -56.54 123.44 7.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-N 118.439 0.563 . . . . 0.0 109.868 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.407 ' H ' ' HB ' ' A' ' 77' ' ' ILE . . . 98.43 7.83 55.45 Favored Glycine 0 N--CA 1.42 -2.406 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.84 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.484 ' O ' HG12 ' A' ' 77' ' ' ILE . . . -96.21 153.11 17.98 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 118.743 1.271 . . . . 0.0 109.575 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.407 HG12 HD13 ' A' ' 76' ' ' ILE . 65.2 mt -94.74 119.53 42.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.412 HG13 ' HA3' ' A' ' 55' ' ' GLY . 27.5 m -133.13 169.68 21.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.0 -175.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -111.97 120.17 41.0 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.9 m -106.56 146.53 30.54 Favored 'General case' 0 N--CA 1.396 -3.17 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -68.68 119.61 13.36 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.55 0.691 . . . . 0.0 111.058 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -92.21 161.84 14.56 Favored 'General case' 0 N--CA 1.403 -2.787 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.0 m -74.32 6.54 3.54 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.713 0.768 . . . . 0.0 111.688 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.6 -8.2 57.69 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.09 -22.08 39.35 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.03 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 m -99.27 -175.62 3.07 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 120.648 0.261 . . . . 0.0 110.726 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -111.55 136.74 50.31 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -124.05 154.49 39.85 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.23 123.08 20.19 Favored 'General case' 0 C--O 1.246 0.909 0 O-C-N 124.172 0.92 . . . . 0.0 111.645 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.19 170.89 14.88 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.475 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.407 HD13 HG12 ' A' ' 62' ' ' ILE . 9.8 mm -113.96 143.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 58' ' ' ARG . 11.4 mm -66.77 125.62 24.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.5 p -107.44 -25.91 11.2 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.152 0.501 . . . . 0.0 110.914 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -163.09 165.27 24.87 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.99 129.61 18.05 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.672 0.789 . . . . 0.0 108.976 172.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.3 m . . . . . 0 C--N 1.297 -1.69 0 C-N-CA 123.412 0.685 . . . . 0.0 109.341 -176.832 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.443 -0.799 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -88.45 120.4 29.79 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.132 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 7' ' ' LEU . 90.6 m-85 -113.35 110.52 20.47 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 27.7 m -89.33 108.21 19.5 Favored 'General case' 0 N--CA 1.389 -3.497 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.414 HG13 ' HA ' ' A' ' 26' ' ' ILE . 17.1 m -105.92 140.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.455 -176.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.21 139.98 29.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.597 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -91.27 172.75 8.32 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.63 -12.26 57.32 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.485 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -75.75 -17.92 59.73 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.174 175.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.18 -10.66 67.63 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.831 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -97.21 161.8 13.64 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.405 ' C ' ' HD2' ' A' ' 96' ' ' ARG . 9.3 pt-20 -137.6 157.47 46.44 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -171.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 87' ' ' THR . 4.2 mpt_? -129.54 151.4 50.19 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.895 0.878 . . . . 0.0 110.061 173.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.9 m -102.27 113.95 27.7 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 3.7 mm? -113.86 168.31 9.9 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.673 0.789 . . . . 0.0 110.946 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -89.31 157.31 18.25 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 173.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.459 ' C ' ' HD3' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -50.22 -38.1 38.65 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.518 0.599 . . . . 0.0 111.513 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.5 m -79.04 -3.66 46.31 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 15.7 m -98.56 5.75 47.64 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 121.114 -0.991 . . . . 0.0 108.376 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.7 mp -112.9 145.13 41.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.467 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 14' ' ' SER . 5.9 p . . . . . 0 C--N 1.281 -2.384 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.209 172.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.525 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 40.4 p90 . . . . . 0 N--CA 1.418 -2.062 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.588 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 21.3 mt -90.83 -176.0 4.54 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.656 0.597 . . . . 0.0 109.619 173.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -125.16 156.64 38.07 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.559 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -85.19 139.67 17.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -174.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.94 -5.65 83.17 Favored Glycine 0 CA--C 1.505 -0.586 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 96.8 m -79.68 133.89 36.39 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-O 121.491 0.662 . . . . 0.0 110.538 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -92.19 129.12 38.22 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.0 m -137.1 -178.88 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.763 0.792 . . . . 0.0 112.006 -173.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 m -125.69 135.79 52.49 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 172.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -127.65 135.35 50.12 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.546 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 19.6 pttp -93.06 143.21 26.47 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 118.62 -1.232 . . . . 0.0 113.599 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -134.78 124.93 25.94 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 58.11 25.47 12.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.552 1.141 . . . . 0.0 110.935 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.33 -9.42 76.17 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.327 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.74 131.43 50.93 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.546 ' CD2' ' HB3' ' A' ' 16' ' ' LYS . 76.6 m-85 -84.78 122.38 29.04 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.753 0.311 . . . . 0.0 110.704 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -106.98 149.0 27.98 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -80.5 143.38 33.36 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.32 148.51 16.63 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -115.49 132.52 56.6 Favored 'General case' 0 C--N 1.274 -2.709 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.712 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.2 mt -61.07 107.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.891 0.853 . . . . 0.0 111.681 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HG2' ' OE1' ' A' ' 95' ' ' GLU . 24.0 tptm -83.85 -44.99 13.74 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 125.517 1.527 . . . . 0.0 109.662 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 m -138.9 144.91 39.33 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.39 118.09 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 123.645 0.778 . . . . 0.0 109.808 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -123.14 107.85 12.19 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.015 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -77.43 105.47 8.58 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -132.88 120.5 21.59 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.219 0.533 . . . . 0.0 110.658 -175.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.61 129.35 37.83 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 32.9 mmtp -83.02 104.93 13.6 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.56 125.5 48.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.964 -174.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -99.74 105.73 17.56 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.8 m -117.07 156.1 18.47 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-O 121.151 0.501 . . . . 0.0 111.486 -175.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -113.93 114.67 26.53 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 173.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.8 mt -68.93 113.54 6.43 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.309 0.0 OUTLIER -72.98 -19.04 61.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -90.08 -27.02 19.95 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.909 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -112.22 -8.85 13.95 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.277 0.56 . . . . 0.0 111.804 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 p30 58.7 16.55 4.46 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.554 1.942 . . . . 0.0 113.986 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -98.6 150.72 21.45 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 121.994 -0.441 . . . . 0.0 111.107 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 m -99.56 144.77 28.26 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -142.89 142.3 31.72 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -174.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.5 tp -125.42 102.62 7.49 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.16 178.73 4.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.921 -173.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.484 ' HG3' ' HB3' ' A' ' 51' ' ' ASP . 14.1 pt20 -92.02 154.53 18.71 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -174.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -54.63 -28.39 46.52 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 126.352 1.861 . . . . 0.0 111.515 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.484 ' HB3' ' HG3' ' A' ' 49' ' ' GLN . 8.2 t70 -63.38 -27.89 69.62 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.306 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -108.32 -9.54 15.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.985 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -100.38 127.29 53.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.233 0.54 . . . . 0.0 111.648 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -106.75 127.14 53.14 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.111 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.21 -173.28 17.93 Favored Glycine 0 C--N 1.296 -1.661 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.497 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -82.66 138.03 9.28 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.279 2.653 . . . . 0.0 112.311 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.7 83.03 4.79 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.79 0.805 . . . . 0.0 110.51 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.526 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 23.0 mtp180 -135.2 133.63 39.27 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.807 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.58 120.99 11.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.68 58.98 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.597 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.71 164.11 12.54 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 117.488 0.644 . . . . 0.0 111.46 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.6 mm -95.86 118.41 42.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.49 ' CG1' HD11 ' A' ' 77' ' ' ILE . 15.7 m -126.18 175.57 8.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -128.66 120.66 26.96 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 t -118.27 158.7 24.68 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.14 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 67' ' ' THR . 37.2 ttm180 -76.87 139.48 40.28 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.334 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 16.9 p -94.1 171.82 8.61 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.8 m -55.7 -34.28 64.94 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -82.65 -4.92 58.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.96 3.93 56.83 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.483 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 58.1 m -87.53 168.75 12.79 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -121.7 139.85 53.05 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.111 0.482 . . . . 0.0 110.648 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -140.72 143.9 35.27 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.4 142.56 53.87 Favored 'General case' 0 C--O 1.254 1.326 0 CA-C-O 121.335 0.588 . . . . 0.0 110.946 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.97 164.66 33.9 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.87 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 5.4 mm -110.19 137.17 43.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.5 mp -72.84 122.9 26.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.5 m -103.82 -19.85 14.13 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.114 0.483 . . . . 0.0 109.825 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -168.68 156.46 7.85 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.18 139.67 37.6 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 172.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 85.6 m . . . . . 0 C--N 1.283 -2.305 0 CA-C-O 121.042 0.449 . . . . 0.0 110.475 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.409 -2.486 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -97.58 116.32 29.56 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-O 121.405 0.621 . . . . 0.0 110.621 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.588 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 53.3 m-85 -104.75 102.88 12.43 Favored 'General case' 0 N--CA 1.395 -3.205 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.4 m -79.91 105.61 11.32 Favored 'General case' 0 N--CA 1.384 -3.739 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.4 m -105.42 140.39 23.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 p -111.52 130.27 65.37 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.045 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.511 -174.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -83.24 163.97 20.41 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.76 -7.56 45.83 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.365 0.602 . . . . 0.0 110.617 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -72.18 -17.56 61.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.978 173.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.4 -9.31 60.84 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.298 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.06 144.72 25.64 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.517 ' OE1' ' HG2' ' A' ' 27' ' ' LYS . 2.8 pt-20 -124.37 131.72 53.51 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.407 0.622 . . . . 0.0 110.542 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -115.78 151.16 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 m -103.11 108.58 19.82 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 120.738 0.304 . . . . 0.0 110.22 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.27 156.21 31.69 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.705 0.402 . . . . 0.0 111.188 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -99.55 169.92 8.96 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -56.54 -23.4 39.7 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.7 m -60.31 -39.55 87.42 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.771 0.829 . . . . 0.0 111.679 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 15.0 m -90.27 -6.88 54.67 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 mp -102.5 153.9 19.62 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.511 -175.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 C--N 1.311 -1.083 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.066 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.453 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 18.9 p90 . . . . . 0 N--CA 1.433 -1.292 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.8 mt -93.78 -161.54 0.86 Allowed 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 p -131.54 162.43 30.3 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -171.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.3 t -64.91 142.18 17.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.902 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.92 -32.97 6.0 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.9 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.444 ' HB ' HD11 ' A' ' 26' ' ' ILE . 4.0 m -56.97 138.95 53.49 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.993 0.917 . . . . 0.0 110.564 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -111.3 113.67 26.31 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.9 m -135.43 -179.15 2.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 123.102 0.561 . . . . 0.0 109.708 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 m -105.24 142.81 34.36 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.475 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.81 119.3 29.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.414 ' HE2' ' HA2' ' A' ' 19' ' ' GLY . 13.7 tmtt? -88.43 107.22 18.74 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -129.12 139.53 51.92 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 59.6 25.07 13.91 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 122.018 0.913 . . . . 0.0 110.427 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.414 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . 91.0 1.73 72.5 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.28 -0.962 . . . . 0.0 114.325 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.51 145.54 43.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 117.916 0.858 . . . . 0.0 109.905 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -106.1 133.9 50.07 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.033 0.92 . . . . 0.0 113.473 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.6 t -122.75 158.25 30.57 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -72.92 147.42 45.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 89' ' ' VAL . . . -149.82 142.33 24.4 Favored 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.57 -174.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -110.12 131.14 55.33 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.774 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.518 HD13 ' CD1' ' A' ' 86' ' ' TYR . 36.6 mt -66.39 115.67 4.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -101.24 -36.24 8.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.136 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.2 m -140.14 144.73 36.84 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.1 t -116.57 120.18 64.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 31' ' ' ARG . 1.5 tmtp? -113.93 140.59 48.26 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.436 ' N ' ' HD3' ' A' ' 30' ' ' LYS . 10.9 mmt180 -75.03 118.36 17.9 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.728 0.775 . . . . 0.0 111.688 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.506 ' HB3' ' N ' ' A' ' 84' ' ' SER . 58.7 tp -91.51 164.5 13.77 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 127.01 2.124 . . . . 0.0 107.256 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.56 124.27 63.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 118.142 -1.423 . . . . 0.0 110.844 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -94.79 104.22 16.12 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 122.557 1.17 . . . . 0.0 108.202 172.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.8 t -87.35 128.69 39.72 Favored 'Isoleucine or valine' 1 C--N 1.244 -4.002 0 CA-C-N 112.753 -2.022 . . . . 0.0 109.648 -174.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.408 ' CB ' ' HB3' ' A' ' 79' ' ' LYS . 86.9 tttt -98.77 112.15 24.31 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 m -115.78 153.98 17.3 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 121.386 0.612 . . . . 0.0 111.727 -175.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -116.97 114.75 24.25 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.6 mt -75.35 120.52 20.93 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -67.81 -30.24 69.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -79.53 -41.51 27.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.381 0.61 . . . . 0.0 111.725 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.85 -15.15 21.39 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.021 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.279 0.0 OUTLIER 63.21 16.93 9.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.664 1.985 . . . . 0.0 112.222 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -93.27 145.24 24.59 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.244 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -96.45 142.53 28.44 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -144.48 141.31 29.47 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.9 mt -100.87 113.25 26.02 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.78 179.72 2.84 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.033 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.528 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -117.08 165.09 13.78 Favored 'General case' 0 C--N 1.27 -2.866 0 O-C-N 122.29 -0.256 . . . . 0.0 110.527 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -59.35 -18.76 41.04 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.637 1.575 . . . . 0.0 111.86 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.539 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 12.0 t70 -70.93 -34.43 71.49 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.118 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 26.4 mt-30 -95.54 -10.54 29.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.181 -175.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.6 t -105.23 134.94 45.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.714 -177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.66 118.07 24.87 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.263 0.554 . . . . 0.0 110.73 168.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.411 ' HA3' HG13 ' A' ' 63' ' ' VAL . . . 142.77 -165.07 26.96 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.563 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.91 137.0 12.19 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.865 2.377 . . . . 0.0 113.131 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -96.51 81.57 3.25 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.553 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 42.5 ttp180 -140.85 139.49 34.47 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.109 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.3 t -67.21 122.39 18.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.55 4.18 59.43 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.753 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.08 161.65 14.19 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.947 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.6 mm -107.4 119.29 56.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.517 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.411 HG13 ' HA3' ' A' ' 55' ' ' GLY . 28.0 m -130.47 176.58 8.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -119.85 131.46 55.28 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.8 t -145.1 155.99 43.64 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.182 -171.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.605 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 46.7 ttt180 -89.26 122.42 32.5 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.483 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.8 t -84.62 168.02 15.72 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.2 p -70.78 -5.01 26.87 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.504 0.669 . . . . 0.0 111.611 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.66 -10.24 59.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.968 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.75 -22.2 36.25 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.98 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.5 p -87.75 144.81 26.43 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 66' ' ' ARG . 87.1 m-85 -94.26 120.43 34.49 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -135.84 160.18 39.38 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -76.72 132.04 39.1 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.03 173.68 11.25 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 122.153 -0.342 . . . . 0.0 111.591 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.45 140.69 42.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.1 mp -79.52 128.44 38.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 120.658 0.266 . . . . 0.0 110.564 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 m -107.2 -17.25 14.2 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.992 0.517 . . . . 0.0 110.871 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 36' ' ' LYS . 50.3 tptt -171.87 156.48 4.19 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.17 143.4 50.58 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.423 -1.812 0 C-N-CA 122.693 0.397 . . . . 0.0 110.485 178.733 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.506 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 1.3 p . . . . . 0 CA--C 1.552 1.035 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 30' ' ' LYS 0.265 75.6 m95 -95.98 155.87 16.57 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 168.202 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.518 ' CD1' HD13 ' A' ' 26' ' ' ILE . 89.5 m-85 -134.58 117.85 16.6 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.558 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 17.8 m -84.03 104.37 14.04 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.8 m -109.92 141.62 24.71 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.837 0 CA-C-O 121.502 0.668 . . . . 0.0 110.462 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 6.3 t -97.9 116.72 41.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -72.89 159.92 32.96 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -57.2 -20.78 28.93 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.772 0.796 . . . . 0.0 111.072 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.65 -16.76 64.32 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.944 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.28 -6.88 59.77 Favored Glycine 0 C--O 1.241 0.555 0 CA-C-O 121.478 0.488 . . . . 0.0 112.402 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -96.8 141.34 30.13 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.56 128.29 54.81 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -136.32 147.5 47.46 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 18.6 m -99.38 107.43 19.68 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.24 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.85 170.41 8.16 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.539 ' HD3' ' OD1' ' A' ' 51' ' ' ASP . 2.2 mpt_? -94.9 175.2 6.74 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -72.6 -3.05 22.4 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.453 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 m -71.48 -41.29 69.52 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -109.82 22.63 15.43 Favored 'General case' 0 C--O 1.252 1.217 0 CA-C-O 121.761 0.791 . . . . 0.0 110.171 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.6 tp -112.67 142.72 44.94 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.478 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.431 -1.386 0 CA-C-O 121.695 0.759 . . . . 0.0 110.249 -177.338 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.737 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 45.2 p90 . . . . . 0 N--CA 1.413 -2.278 0 CA-C-O 121.14 0.495 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt -106.21 -175.68 2.86 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.645 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.9 p -131.33 158.53 40.43 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.33 130.59 28.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.66 38.19 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.043 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.432 ' HB ' HD12 ' A' ' 26' ' ' ILE . 33.2 m -81.23 139.47 35.47 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 120.821 0.343 . . . . 0.0 110.401 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.07 104.87 17.4 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.202 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -113.5 -179.28 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.836 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.542 ' OG ' ' HB3' ' A' ' 104' ' ' CYS . 3.0 p -131.14 135.34 47.38 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 21' ' ' PHE . . . -111.92 125.64 54.26 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 124.476 1.11 . . . . 0.0 109.672 -171.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -77.03 117.73 18.9 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.571 0.7 . . . . 0.0 109.569 173.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -129.62 135.95 49.17 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 59.4 25.65 14.41 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 121.521 0.677 . . . . 0.0 110.483 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.91 10.59 75.24 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.705 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.65 136.54 37.55 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 117.525 0.663 . . . . 0.0 110.437 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 35.4 p90 -98.79 129.59 45.21 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.47 -0.892 . . . . 0.0 113.127 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -129.26 157.39 42.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 10.5 pt-20 -74.01 146.25 43.92 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 121.779 0.8 . . . . 0.0 112.646 -174.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -151.99 145.8 25.1 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -105.07 133.75 49.32 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.673 -174.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.432 HD12 ' HB ' ' A' ' 11' ' ' THR . 39.3 mt -65.96 112.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.106 0.479 . . . . 0.0 110.451 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -94.72 -39.25 10.4 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.109 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 m -137.9 144.5 41.34 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 79.8 t -123.61 118.55 54.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -112.22 96.95 6.32 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -83.27 108.38 16.45 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.494 ' HA ' ' OD1' ' A' ' 50' ' ' ASP . 2.4 pt? -144.05 107.61 4.62 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.048 0.928 . . . . 0.0 109.286 176.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 p -100.53 123.22 53.32 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.856 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 52.3 mtpt -85.12 100.64 11.85 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 122.066 0.936 . . . . 0.0 109.237 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 t -84.82 132.7 31.03 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 113.754 -1.566 . . . . 0.0 109.336 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -89.53 112.91 24.22 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 76' ' ' ILE . 3.7 m -123.64 153.46 29.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.216 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.323 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.2 tt -121.8 122.58 39.8 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -73.4 110.71 7.9 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HB3' HD11 ' A' ' 76' ' ' ILE . 12.4 ptmm? -64.35 -20.19 65.96 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.228 0.537 . . . . 0.0 112.436 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -79.29 -46.66 17.3 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.817 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -98.51 -17.84 18.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.435 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 71.67 25.64 3.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.077 1.351 . . . . 0.0 111.593 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -104.68 155.74 18.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.751 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -100.18 154.65 18.28 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -149.32 143.94 26.13 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 tp -128.11 102.15 6.59 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 10.6 m -137.66 168.12 21.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.297 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -74.68 164.96 25.98 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.139 -174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.494 ' OD1' ' HA ' ' A' ' 32' ' ' LEU . 7.7 p-10 -71.8 -5.6 35.38 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.849 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -73.85 -23.6 59.64 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 65' ' ' THR . 8.9 mm-40 -92.58 -34.45 14.02 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.048 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 89.3 t -79.24 111.05 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.198 0.999 . . . . 0.0 112.7 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -111.63 103.06 11.34 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.27 -159.85 28.16 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.1 128.59 6.5 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.901 1.734 . . . . 0.0 112.123 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 mp -88.8 81.6 6.94 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.523 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 22.6 mmt180 -139.17 135.8 34.39 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.695 -175.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.0 t -66.76 117.83 8.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.53 3.93 55.05 Favored Glycine 0 C--N 1.303 -1.261 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.532 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.19 164.01 12.67 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.027 0.414 . . . . 0.0 110.652 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.3 mm -105.48 124.89 60.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.15 -177.63 2.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 123.028 0.531 . . . . 0.0 109.999 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -118.25 136.1 53.88 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.066 -1.828 . . . . 0.0 106.066 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 13.4 t -140.11 156.63 46.48 Favored 'General case' 0 C--N 1.275 -2.643 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.794 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -83.85 108.77 17.07 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 t -81.09 178.86 8.15 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 m -64.23 -16.33 61.82 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.241 0.543 . . . . 0.0 112.051 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.82 -26.01 60.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.347 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.95 -18.83 36.32 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.49 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -84.32 154.69 22.77 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 65' ' ' THR . 90.1 m-85 -89.36 115.36 26.76 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -108.84 143.86 37.48 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.78 136.85 38.18 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.423 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.23 168.1 21.22 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.428 -172.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 1.6 mp -112.45 144.13 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.3 mp -83.5 129.38 37.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.2 m -110.97 -19.32 12.82 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 122.617 0.367 . . . . 0.0 110.885 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -168.52 159.54 10.32 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 mp -127.63 139.87 52.46 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 167.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.5 m . . . . . 0 C--N 1.29 -1.989 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.602 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.447 ' HA ' HD21 ' A' ' 32' ' ' LEU . 19.5 m . . . . . 0 N--CA 1.437 -1.102 0 CA-C-O 122.078 0.942 . . . . 0.0 112.5 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.507 ' HB3' ' OG1' ' A' ' 97' ' ' THR . 74.7 m95 -95.82 116.98 29.7 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.555 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.737 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 82.6 m-85 -105.56 105.06 14.92 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.2 m -84.37 104.13 14.13 Favored 'General case' 0 N--CA 1.398 -3.06 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.59 142.12 22.04 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.575 -175.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.53 124.03 53.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.463 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -85.78 -179.89 6.93 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.814 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -68.57 -26.56 65.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.119 0.485 . . . . 0.0 110.78 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -68.87 -11.86 60.98 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.536 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.56 14.43 68.14 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -94.47 131.77 39.83 Favored 'General case' 0 CA--C 1.473 -2.01 0 CA-C-N 114.865 -0.668 . . . . 0.0 109.215 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.52 127.27 49.66 Favored 'General case' 0 C--N 1.268 -2.96 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.28 138.96 54.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.507 ' OG1' ' HB3' ' A' ' 85' ' ' TRP . 4.9 t -113.59 113.51 25.17 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.197 -1.401 . . . . 0.0 110.884 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.49 172.2 10.91 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.618 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -98.7 173.21 7.01 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.15 -39.72 87.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.417 1.087 . . . . 0.0 111.283 -173.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.3 p -72.41 0.89 8.99 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.3 t -116.05 7.48 14.29 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.18 132.96 53.7 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.561 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.542 ' HB3' ' OG ' ' A' ' 14' ' ' SER . 22.3 t . . . . . 0 C--N 1.304 -1.373 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.038 -176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.3 p90 . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.63 -172.47 3.58 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.4 p -128.36 156.63 42.8 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -169.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.65 126.65 29.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.011 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.55 -19.31 42.44 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 121.245 -0.503 . . . . 0.0 112.275 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.446 ' HB ' HD11 ' A' ' 26' ' ' ILE . 30.9 m -69.29 137.39 52.98 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.062 0.458 . . . . 0.0 110.669 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -86.44 131.83 34.09 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.8 m -137.22 -179.44 2.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-O 121.446 0.641 . . . . 0.0 111.494 -173.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.48 ' OG ' ' HB2' ' A' ' 104' ' ' CYS . 1.9 p -137.96 137.54 38.06 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.464 ' CB ' HD12 ' A' ' 98' ' ' LEU . . . -116.04 139.38 50.34 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -176.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -85.59 134.72 34.0 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.285 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -120.84 102.11 8.15 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 123.858 0.863 . . . . 0.0 109.146 172.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 58.77 28.09 16.87 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 170.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.51 9.71 57.5 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.777 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.05 151.39 41.99 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -106.73 137.12 45.36 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 119.031 0.832 . . . . 0.0 111.752 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.483 ' SG ' ' HD2' ' A' ' 90' ' ' PHE . 19.9 t -123.78 143.42 50.32 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.82 149.96 24.88 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.856 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.89 173.2 14.04 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.312 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -137.64 132.21 32.64 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.492 ' HA ' HG11 ' A' ' 88' ' ' VAL . 60.5 mt -65.45 116.33 4.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 121.407 0.622 . . . . 0.0 111.166 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -95.03 -41.64 9.03 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.66 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.425 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 86.8 m -137.91 142.47 40.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.473 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -117.72 107.34 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.898 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' SER . 65.1 mttm -91.39 90.41 7.67 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -94.77 106.07 18.04 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.38 144.0 37.98 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -175.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 11.4 p -118.41 124.34 72.98 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.718 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.267 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 97.9 mttt -82.65 100.7 10.36 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.716 0.769 . . . . 0.0 109.415 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.403 HG21 HD13 ' A' ' 57' ' ' LEU . 29.9 t -88.07 130.7 37.26 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.62 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.159 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -98.22 109.54 22.28 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.61 149.5 15.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 CA-C-O 121.38 0.609 . . . . 0.0 110.498 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.8 tp -111.69 118.11 34.73 Favored 'General case' 0 C--N 1.269 -2.934 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.469 HD11 ' OG1' ' A' ' 44' ' ' THR . 43.3 mt -70.35 126.12 28.73 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -72.82 -35.88 67.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.217 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -83.24 -36.15 24.82 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -107.42 -7.86 16.48 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.762 -0.775 . . . . 0.0 113.077 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.276 10.7 p30 59.76 21.06 9.85 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 125.679 1.592 . . . . 0.0 113.46 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.469 ' OG1' HD11 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -93.14 147.53 22.8 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.866 176.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -108.28 142.95 37.8 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.08 144.03 48.38 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -175.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.2 tp -126.88 101.76 6.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -142.27 162.89 18.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 5.2 pm0 -83.38 166.6 18.28 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.02 -12.31 2.0 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 125.967 1.707 . . . . 0.0 115.441 -173.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -89.19 -10.18 48.05 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 118.789 -1.165 . . . . 0.0 110.412 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -101.99 -7.82 22.04 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.9 t -103.16 118.46 50.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.407 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -98.03 97.31 8.8 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.67 -176.5 25.53 Favored Glycine 0 N--CA 1.427 -1.901 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.061 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -65.02 142.38 74.52 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.462 2.775 . . . . 0.0 112.696 176.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.403 HD13 HG21 ' A' ' 35' ' ' VAL . 1.5 mm? -96.75 84.16 3.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.513 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 7.0 tpt180 -137.98 126.37 23.29 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.773 -172.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.26 121.38 12.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.15 59.54 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.055 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -96.89 155.47 16.76 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.022 0.911 . . . . 0.0 110.937 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.7 mm -93.8 119.38 41.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.62 -179.12 2.48 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 122.768 0.427 . . . . 0.0 110.018 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -121.81 121.17 36.6 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.3 m -113.99 146.96 39.42 Favored 'General case' 0 N--CA 1.4 -2.974 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -83.57 127.23 33.58 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.7 p -92.17 175.28 6.91 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.9 m -68.63 -5.38 19.72 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.344 0.593 . . . . 0.0 111.919 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.04 -14.93 52.91 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 121.63 0.728 . . . . 0.0 109.302 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.01 -16.37 61.04 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 p -93.88 157.31 16.19 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 123.19 0.596 . . . . 0.0 110.561 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -94.95 146.89 23.93 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.455 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.02 143.73 42.89 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -80.45 130.62 35.27 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.24 173.88 11.06 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.6 -169.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 2.1 mp -119.57 139.19 47.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.7 mp -73.55 127.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.95 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.3 m -108.41 -23.33 11.93 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 122.463 0.305 . . . . 0.0 111.415 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -163.98 154.81 15.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . 2.9 mp -130.45 133.62 46.46 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 3.4 m . . . . . 0 C--N 1.287 -2.117 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 4.2 p . . . . . 0 N--CA 1.426 -1.664 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.486 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 92.8 m95 -97.35 121.22 39.0 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.284 -175.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -105.1 110.73 23.23 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.425 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 24.5 m -79.72 108.74 13.51 Favored 'General case' 0 N--CA 1.401 -2.876 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.492 HG11 ' HA ' ' A' ' 26' ' ' ILE . 28.9 m -113.54 145.16 19.8 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.447 -173.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 p -100.94 121.29 51.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.483 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 11.1 m-85 -88.76 -177.49 5.54 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.07 -172.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.75 -15.04 63.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.84 -17.4 63.99 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.529 173.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.42 -4.61 71.89 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -98.41 167.19 10.99 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 13.2 pt-20 -121.57 128.64 52.21 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.411 0.624 . . . . 0.0 111.304 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.432 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -125.62 150.92 47.15 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 44.5 m -105.21 118.11 35.72 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 120.824 0.345 . . . . 0.0 110.298 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.464 HD12 ' CB ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -141.97 152.49 43.52 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.106 0.562 . . . . 0.0 109.772 178.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -100.48 -173.76 2.49 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.055 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -53.97 -26.9 28.14 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.123 0.969 . . . . 0.0 112.836 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -58.02 -28.77 64.75 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 122.956 0.503 . . . . 0.0 112.306 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.4 p -125.96 10.51 7.61 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.336 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.9 tp -111.86 128.05 56.01 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.48 ' HB2' ' OG ' ' A' ' 14' ' ' SER . 24.8 m . . . . . 0 C--N 1.312 -1.031 0 C-N-CA 122.691 0.396 . . . . 0.0 111.955 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.484 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 21.4 p90 . . . . . 0 N--CA 1.425 -1.718 0 CA-C-O 122.247 1.022 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.36 -167.51 1.87 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.965 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.9 p -130.55 173.73 10.59 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.46 141.84 16.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 123.936 0.895 . . . . 0.0 110.102 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.13 -11.32 58.64 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.291 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.446 ' HB ' HD12 ' A' ' 26' ' ' ILE . 6.6 m -74.49 141.27 44.93 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.407 ' OD2' ' HG3' ' A' ' 25' ' ' LYS . 10.7 t70 -107.01 117.5 34.24 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -121.96 -179.86 2.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 120.861 0.362 . . . . 0.0 110.182 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.0 m -111.31 124.39 52.14 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.29 139.1 46.96 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.547 ' HD2' ' O ' ' A' ' 16' ' ' LYS 0.264 0.0 OUTLIER -94.01 129.69 40.42 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -178.631 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 34.0 m-85 -98.6 101.82 13.37 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 170.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 10.0 ptm180 49.21 35.95 8.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 173.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.26 10.4 57.2 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.932 -0.576 . . . . 0.0 114.074 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.72 124.79 34.37 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -91.91 141.95 28.09 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.465 0.65 . . . . 0.0 112.555 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.9 t -127.53 145.32 50.89 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -71.73 143.43 49.62 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.4 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.405 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -141.44 139.63 33.43 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.192 -176.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HG3' ' OD2' ' A' ' 12' ' ' ASP . 5.1 mttp -103.12 126.6 50.37 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.487 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.446 HD12 ' HB ' ' A' ' 11' ' ' THR . 25.1 mt -70.24 116.63 11.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.788 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.15 -45.09 6.67 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 109.424 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.406 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 7.6 m -128.6 143.63 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.635 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 81.6 t -126.59 119.29 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 57.0 mtpt -104.07 97.86 7.77 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -83.38 100.74 10.88 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -133.22 161.32 34.76 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.02 140.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.641 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 98.9 mttt -91.74 101.57 14.18 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.743 0.783 . . . . 0.0 109.682 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.49 121.48 40.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.182 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -85.5 111.63 20.17 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 m -112.61 146.44 17.35 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.269 0 CA-C-O 121.124 0.488 . . . . 0.0 110.606 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -112.96 114.1 26.43 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 73' ' ' GLN . 31.9 tp -75.62 111.64 11.16 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -56.05 -43.1 77.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -170.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -76.69 -50.86 12.66 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.371 0.605 . . . . 0.0 111.875 -174.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -84.95 -9.22 58.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.568 -171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.289 0.0 OUTLIER 56.33 24.06 7.91 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.377 2.271 . . . . 0.0 112.955 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.91 153.57 17.69 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.979 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.6 m -120.31 142.83 48.75 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.37 163.63 33.98 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.978 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 14.8 tp -128.02 104.31 7.72 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 -177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.2 m -121.05 174.36 5.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -173.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -87.4 162.34 17.37 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.488 0.661 . . . . 0.0 112.201 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -44.16 -28.46 0.51 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 127.7 2.4 . . . . 0.0 113.275 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -85.97 -24.76 26.37 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.385 0.674 . . . . 0.0 110.886 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -84.14 -17.79 38.91 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.78 116.29 32.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.399 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -106.06 101.48 10.96 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.431 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.42 -162.85 27.92 Favored Glycine 0 C--N 1.309 -0.922 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.17 135.46 12.2 Favored 'Trans proline' 0 CA--C 1.517 -0.371 0 C-N-CA 122.477 2.118 . . . . 0.0 112.299 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.78 82.33 3.56 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 122.049 0.928 . . . . 0.0 109.619 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.548 ' HD3' ' N ' ' A' ' 59' ' ' VAL . 1.1 tmt_? -140.08 138.65 35.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.548 ' N ' ' HD3' ' A' ' 58' ' ' ARG . 22.2 t -61.74 119.1 5.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.44 6.31 57.56 Favored Glycine 0 C--N 1.298 -1.563 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.937 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.416 ' HB3' HD13 ' A' ' 77' ' ' ILE . . . -90.53 152.87 20.73 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 117.396 0.598 . . . . 0.0 110.844 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.1 mm -89.65 117.65 33.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.64 177.66 6.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -122.52 121.53 36.76 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 172.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -115.67 158.43 22.76 Favored 'General case' 0 C--N 1.263 -3.161 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 71' ' ' SER . 40.7 ttt180 -79.93 125.59 29.94 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p -84.12 177.34 8.27 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.9 m -75.78 -2.99 32.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.803 0.811 . . . . 0.0 110.296 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -93.83 -1.03 55.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.537 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.23 -5.63 83.78 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.521 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 17.7 t -94.76 172.49 8.13 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -177.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -110.34 120.2 41.68 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.531 ' NE2' ' H ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -131.05 150.78 51.99 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -176.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.531 ' H ' ' NE2' ' A' ' 73' ' ' GLN . 32.8 tt0 -73.57 122.98 23.09 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.562 0.745 . . . . 0.0 111.56 -174.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.11 173.97 11.11 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.448 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mp -122.31 141.47 42.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.2 mp -72.26 122.22 24.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.9 t -99.91 -18.28 17.19 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -175.89 143.8 0.59 Allowed 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.377 0.0 OUTLIER -117.57 118.93 33.48 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.471 0.653 . . . . 0.0 109.737 165.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.8 m . . . . . 0 C--N 1.298 -1.638 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.971 -171.327 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 CA--C 1.511 -0.521 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.572 ' HB3' ' OG1' ' A' ' 97' ' ' THR . 99.6 m95 -97.37 123.02 41.06 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.484 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 73.4 m-85 -111.41 106.79 15.81 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 5.6 m -82.42 104.02 12.4 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.405 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 15.8 m -106.46 154.49 7.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.578 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 11.9 p -104.31 135.46 42.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -100.86 -177.84 3.59 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.327 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.09 -26.88 68.53 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.502 1.121 . . . . 0.0 109.993 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.43 -16.87 64.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.827 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.14 14.17 72.53 Favored Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 26.5 t70 -97.43 137.26 36.66 Favored 'General case' 0 CA--C 1.469 -2.138 0 CA-C-N 113.953 -1.123 . . . . 0.0 108.407 -174.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.77 126.55 50.98 Favored 'General case' 0 C--N 1.269 -2.894 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -141.83 139.37 32.68 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.572 ' OG1' ' HB3' ' A' ' 85' ' ' TRP . 10.9 t -100.16 122.45 43.01 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.083 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 20.0 mt -110.9 166.26 11.18 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.197 0.522 . . . . 0.0 110.065 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.433 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -78.98 164.06 24.71 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -68.19 -17.97 64.47 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.3 p -87.78 14.32 8.88 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.958 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 14.7 m -129.5 1.95 5.04 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.5 mt -128.33 147.31 50.61 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.486 -174.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 50.2 t . . . . . 0 C--N 1.294 -1.837 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.011 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.29 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 65.9 mt -70.39 -174.71 0.88 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.869 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 p -132.67 161.07 34.9 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.1 t -72.85 130.04 35.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.856 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.19 -24.11 4.52 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.25 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.6 m -83.49 142.26 31.05 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -99.91 135.2 41.7 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.0 m -127.01 161.21 34.45 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 C-N-CA 123.237 0.615 . . . . 0.0 109.516 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.7 m -100.61 123.97 45.56 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 21' ' ' PHE . . . -107.05 121.24 44.09 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -175.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 83.5 tttt -81.0 105.99 12.65 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.544 ' CE2' ' HB3' ' A' ' 22' ' ' CYS . 38.6 p90 -121.51 125.15 46.12 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.528 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 62.36 31.84 17.15 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.356 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.2 -3.25 69.4 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 115.16 0.824 . . . . 0.0 115.16 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.73 134.74 37.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.338 1.069 . . . . 0.0 110.27 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 28.5 p90 -91.17 136.17 33.28 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.544 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 52.3 t -134.96 163.03 30.78 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.95 147.11 45.54 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.59 0.709 . . . . 0.0 110.445 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -148.39 148.32 30.21 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.95 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -112.71 130.62 55.99 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.325 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.436 ' HA ' HG12 ' A' ' 88' ' ' VAL . 53.2 mt -64.84 119.58 9.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.952 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -95.85 -51.24 4.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.3 m -132.63 145.03 50.76 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.257 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.2 t -122.23 112.92 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.302 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 84' ' ' SER . 65.1 tttp -98.79 97.92 9.09 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -79.61 94.28 5.64 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 pp -103.14 160.63 14.48 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-O 121.127 0.489 . . . . 0.0 111.263 -178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.21 118.36 57.24 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.064 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 47' ' ' LEU . 50.4 mtpt -82.85 100.96 10.66 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 21.4 t -84.98 117.34 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.841 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.953 -177.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.95 107.46 13.78 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 45' ' ' THR . 12.5 m -112.91 149.41 15.38 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.003 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.43 -175.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -117.53 111.13 18.82 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.512 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 44.9 mt -71.78 123.93 23.7 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 17.9 ptpt -62.54 -31.01 71.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -175.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HB3' ' CD ' ' A' ' 73' ' ' GLN . 44.9 tt0 -84.95 -55.72 3.93 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 120.897 0.379 . . . . 0.0 111.474 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.6 -22.51 40.57 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 64.45 32.29 11.97 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.47 0.708 . . . . 0.0 112.279 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -92.87 138.86 31.12 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.8 m -107.35 130.11 54.83 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -157.19 156.75 33.15 Favored 'General case' 0 C--N 1.257 -3.434 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.2 mp -113.14 107.88 16.54 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.9 m -114.31 166.87 7.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.89 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -86.73 165.38 16.11 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.639 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.22 -34.19 56.0 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 124.584 1.154 . . . . 0.0 110.532 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.12 -22.8 66.99 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.686 -173.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -99.79 -17.83 17.49 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.6 t -98.09 116.63 41.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.944 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -110.33 114.47 27.95 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.797 176.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 143.97 -163.83 27.63 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.02 137.36 7.39 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.072 2.515 . . . . 0.0 113.647 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.9 mt -95.03 82.89 3.84 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.345 0.593 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.451 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 3.0 mpt_? -139.14 142.25 38.04 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.75 112.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.26 6.99 35.81 Favored Glycine 0 N--CA 1.428 -1.883 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.435 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.19 152.95 18.31 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.4 mt -99.95 125.92 53.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-O 121.111 0.482 . . . . 0.0 110.124 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.2 m -127.96 -177.78 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.51 128.22 38.9 Favored 'General case' 0 C--N 1.272 -2.761 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.9 t -139.96 159.64 41.72 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.99 -168.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -69.02 132.01 45.97 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.66 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 t -90.51 168.97 11.43 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 m -64.53 -23.0 67.13 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.088 0.555 . . . . 0.0 110.987 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -64.97 -26.19 68.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.288 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.8 -22.08 17.27 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.226 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.6 t -77.43 179.59 6.38 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.803 0.841 . . . . 0.0 109.504 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -119.19 136.13 54.34 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.512 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 30.3 tt0 -137.86 153.25 49.6 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 39.0 tt0 -77.44 137.19 38.54 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.426 0.631 . . . . 0.0 109.407 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.13 173.61 11.31 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.87 -174.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.19 143.74 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.0 mp -75.55 122.82 30.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 t -99.77 -24.2 14.76 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -169.22 151.55 4.68 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.3 OUTLIER -127.77 118.54 23.94 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 118.327 0.512 . . . . 0.0 110.805 172.291 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.306 -1.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.967 -174.758 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.5 p . . . . . 0 N--CA 1.425 -1.695 0 CA-C-O 121.14 0.495 . . . . 0.0 111.618 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.482 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 87.0 m95 -114.93 146.31 41.3 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.47 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 27.7 m-85 -124.03 112.96 17.79 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 m -85.49 107.15 17.31 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 26' ' ' ILE . 24.8 m -110.56 146.76 15.32 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.617 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.995 -175.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.11 121.5 53.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -74.0 173.58 9.8 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.469 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.98 -27.13 61.1 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.469 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.51 -15.92 61.79 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.241 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.89 75.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.807 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -98.26 141.87 30.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -104.42 127.93 52.2 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.25 148.36 49.55 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.482 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 30.5 m -104.75 113.2 26.63 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.356 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -140.54 159.6 41.84 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.064 0.546 . . . . 0.0 111.404 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.538 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 95.8 mtt180 -99.75 -172.47 2.25 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 122.964 0.506 . . . . 0.0 109.987 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.432 ' HA ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.08 -14.57 63.07 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.107 0.48 . . . . 0.0 110.964 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 p -73.27 -2.39 21.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 123.872 0.869 . . . . 0.0 111.234 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.6 m -137.6 9.53 2.89 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 99' ' ' ARG . 93.1 mt -113.69 137.69 51.26 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.853 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 C--N 1.295 -1.779 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.172 -177.651 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 N--CA 1.416 -2.15 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.525 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 6.6 mp -78.26 177.38 8.46 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.231 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 p -131.47 152.26 50.85 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.62 112.5 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.209 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.02 -24.15 3.45 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 46.2 m -73.68 138.67 44.87 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 120.937 0.398 . . . . 0.0 109.93 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -99.02 126.11 44.66 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -136.37 -178.91 2.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 123.249 0.62 . . . . 0.0 109.906 -176.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 15.8 m -130.9 146.06 52.21 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 174.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -119.38 127.4 53.1 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.87 138.98 36.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.168 0.509 . . . . 0.0 111.582 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -125.69 101.17 6.75 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 123.871 0.868 . . . . 0.0 108.898 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 57.63 37.8 27.55 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.385 0.428 . . . . 0.0 111.174 171.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.27 -6.06 71.68 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.982 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.56 123.8 43.76 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . 0.258 0.5 OUTLIER -107.62 131.28 54.54 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -174.102 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.7 m -105.14 144.51 31.83 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.386 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -85.9 147.55 26.2 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.452 ' HB2' ' CE2' ' A' ' 90' ' ' PHE . . . -150.55 154.58 37.83 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.528 0.68 . . . . 0.0 110.672 -175.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.99 126.81 55.19 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.411 ' HA ' HG12 ' A' ' 88' ' ' VAL . 32.0 mt -61.26 120.44 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -95.4 -43.9 7.79 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.927 0.891 . . . . 0.0 110.08 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.1 m -140.63 146.12 37.52 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.8 t -121.6 114.99 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 O-C-N 123.603 0.564 . . . . 0.0 109.599 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -112.35 91.13 3.54 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.748 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -84.09 87.48 7.15 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -91.15 111.23 22.62 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.564 -174.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.5 t -86.62 114.63 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.026 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 14.5 mmmm -80.05 99.49 7.71 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.8 t -89.38 129.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.071 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.286 -175.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 83.8 tttt -91.52 103.13 15.78 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.6 155.19 13.91 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.786 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 44' ' ' THR . 8.4 tt -129.14 118.31 22.24 Favored 'General case' 0 N--CA 1.387 -3.625 0 CA-C-N 114.445 -1.252 . . . . 0.0 107.638 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.444 HD22 ' HB3' ' A' ' 75' ' ' ALA . 86.5 mt -68.79 122.56 18.84 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.95 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 21.7 ptmt -59.94 -29.54 68.47 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 120.903 0.382 . . . . 0.0 111.415 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -59.84 -55.17 37.51 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 124.606 1.162 . . . . 0.0 113.226 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -120.23 -0.08 10.54 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.442 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 68.35 23.73 7.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.167 0.987 . . . . 0.0 112.334 -176.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -78.73 133.3 37.16 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 m -106.37 148.18 28.37 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 2.6 pt20 -159.72 160.07 33.62 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 123.031 0.207 . . . . 0.0 110.444 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 mt -115.8 102.17 9.47 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 27.9 m -124.28 170.13 14.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -177.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -91.26 170.78 9.71 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.956 -175.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -55.96 -21.08 18.93 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.097 1.759 . . . . 0.0 112.151 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -78.18 -35.39 48.78 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.307 0.575 . . . . 0.0 109.942 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -82.67 -15.14 53.12 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.081 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -109.17 135.17 48.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.162 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.419 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -125.46 139.75 53.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 172.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.94 -166.93 13.94 Favored Glycine 0 C--N 1.31 -0.867 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.57 132.34 10.97 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.77 2.313 . . . . 0.0 113.086 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.38 81.99 6.53 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.549 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 8.8 tpt180 -140.49 135.95 32.46 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.64 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.24 116.28 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.74 2.77 46.43 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.238 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.35 149.44 22.1 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.5 mt -95.69 117.12 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-O 121.882 0.849 . . . . 0.0 109.961 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 16.4 m -116.84 -172.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.273 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 72' ' ' PHE . 40.3 mt-10 -129.01 124.27 34.53 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.0 m -112.66 144.95 41.3 Favored 'General case' 0 N--CA 1.385 -3.678 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -74.05 117.69 16.14 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -89.06 -179.8 5.99 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 t -60.35 -29.86 69.17 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.218 1.007 . . . . 0.0 111.478 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.98 -25.18 67.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.845 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.56 -20.58 22.64 Favored Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.625 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 p -89.4 164.03 15.04 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.069 0.548 . . . . 0.0 111.052 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 96.5 m-85 -96.05 123.31 39.61 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 122.854 0.461 . . . . 0.0 110.746 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -114.03 150.86 33.3 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 45.6 mt-10 -68.87 127.73 34.15 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.113 0.959 . . . . 0.0 111.897 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HB3' HD22 ' A' ' 39' ' ' LEU . . . -135.84 161.49 35.47 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.85 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -116.89 139.49 43.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -73.05 124.45 30.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.9 176.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 t -103.9 -26.24 12.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.434 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 23.0 tptm -167.57 159.21 11.92 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mp -135.01 141.43 46.19 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.436 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 5.0 m . . . . . 0 C--N 1.278 -2.529 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.426 -1.646 0 CA-C-O 121.317 0.579 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.413 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 57.7 m95 -95.55 122.05 37.88 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.973 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.525 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 92.8 m-85 -109.35 109.43 20.31 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 73.0 m -85.17 104.18 14.81 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 174.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.411 HG12 ' HA ' ' A' ' 26' ' ' ILE . 28.5 m -106.2 141.46 21.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.868 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.27 130.41 59.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.022 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 24' ' ' ALA . 52.0 m-85 -91.02 167.89 12.06 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -62.18 -19.66 63.33 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.007 0.908 . . . . 0.0 109.993 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.16 -11.36 48.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.462 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.83 -3.78 82.23 Favored Glycine 0 C--O 1.227 -0.336 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -96.18 142.48 28.3 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -117.14 143.9 45.31 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 123.442 0.464 . . . . 0.0 110.994 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -129.61 143.8 50.99 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 85.7 m -104.16 113.05 26.33 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.0 OUTLIER -133.91 163.47 29.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.571 0.748 . . . . 0.0 112.109 -177.314 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -99.36 177.56 5.15 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 122.821 0.448 . . . . 0.0 110.013 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -60.9 -33.03 72.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.064 0.546 . . . . 0.0 111.428 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.4 m -57.86 -32.29 67.51 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.736 0.814 . . . . 0.0 110.921 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 17.5 m -91.45 7.4 41.39 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.019 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.7 170.48 7.91 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.554 0.692 . . . . 0.0 111.321 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 14' ' ' SER . 53.1 t . . . . . 0 C--N 1.292 -1.905 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.664 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.418 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 45.7 p90 . . . . . 0 N--CA 1.412 -2.374 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.435 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 90.2 mt -99.84 175.25 5.85 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.9 p -122.17 161.21 23.58 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 120.614 0.245 . . . . 0.0 111.521 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.57 144.05 14.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.521 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.35 -25.97 26.32 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.653 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.424 ' HB ' HD13 ' A' ' 26' ' ' ILE . 9.7 m -58.08 133.23 55.37 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 122.162 0.982 . . . . 0.0 112.65 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -84.49 113.91 21.55 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 113.491 -1.686 . . . . 0.0 109.165 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.48 -177.81 2.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.455 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -140.11 147.22 39.91 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 173.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -126.16 131.69 51.98 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 22.3 pttp -82.51 133.35 35.2 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -112.92 112.58 24.16 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 170.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 61.09 31.06 19.76 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.343 0.592 . . . . 0.0 110.897 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.33 -8.45 72.2 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.885 -0.598 . . . . 0.0 114.192 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.76 124.44 50.59 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.537 0.669 . . . . 0.0 110.126 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 73.7 m-85 -87.99 120.47 29.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -99.82 143.74 29.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 172.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -75.25 148.52 39.37 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.719 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 89' ' ' VAL . . . -154.34 143.66 21.34 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.449 0.643 . . . . 0.0 111.227 -175.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -115.73 128.29 55.76 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.424 HD13 ' HB ' ' A' ' 11' ' ' THR . 17.6 mt -68.94 113.82 5.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 120.716 0.293 . . . . 0.0 111.554 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HD2' ' HB ' ' A' ' 89' ' ' VAL . 43.9 mtpt -88.17 -38.09 15.61 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.8 m -146.54 141.95 27.53 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.067 -175.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.37 131.06 73.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -123.79 97.82 5.54 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -78.63 86.52 4.61 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.684 1.23 . . . . 0.0 108.607 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.456 ' HA ' ' OD1' ' A' ' 50' ' ' ASP . 2.0 pt? -107.29 134.47 50.32 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.967 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.3 t -108.06 132.27 56.22 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.971 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -86.04 101.53 13.01 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.5 t -91.78 127.08 44.3 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.836 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -92.21 106.94 18.84 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.79 143.71 23.93 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.96 0 CA-C-O 121.682 0.753 . . . . 0.0 112.022 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.1 tp -111.14 118.02 34.83 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.7 -1.591 . . . . 0.0 107.639 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.549 HD11 ' OG1' ' A' ' 44' ' ' THR . 94.3 mt -67.29 111.37 3.96 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -15.2 61.43 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.183 0.516 . . . . 0.0 112.214 -176.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -88.76 -51.09 5.84 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.654 0.74 . . . . 0.0 109.621 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 15.0 t70 -89.98 -33.12 16.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.445 -170.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 35.3 m-80 83.64 15.89 0.28 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.101 1.36 . . . . 0.0 113.402 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.549 ' OG1' HD11 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -95.85 150.52 20.33 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.91 0.386 . . . . 0.0 110.368 174.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -118.03 144.83 45.25 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -151.4 157.84 42.94 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.939 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.3 tp -119.36 101.48 7.99 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.1 m -126.62 175.53 8.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.48 -170.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -88.57 154.23 20.5 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.426 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.456 ' OD1' ' HA ' ' A' ' 32' ' ' LEU . 6.4 p-10 -65.88 -12.98 58.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.061 0.944 . . . . 0.0 111.507 -176.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.83 -28.89 63.88 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.664 0.745 . . . . 0.0 109.68 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.413 ' OE1' ' HD3' ' A' ' 66' ' ' ARG . 43.3 mt-30 -108.24 8.94 28.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.979 0.895 . . . . 0.0 109.333 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 78.4 t -108.03 110.06 30.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.909 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.27 103.58 16.22 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.024 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.478 ' HA3' HG11 ' A' ' 63' ' ' VAL . . . 145.1 -171.36 26.25 Favored Glycine 0 C--N 1.292 -1.88 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.339 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.81 144.28 19.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.209 2.606 . . . . 0.0 113.194 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -93.22 82.36 4.52 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.493 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 50.6 mtm180 -139.5 131.89 28.49 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.771 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.53 117.95 7.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.06 10.75 51.3 Favored Glycine 0 C--N 1.299 -1.477 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.291 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.85 162.46 13.24 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 117.313 0.556 . . . . 0.0 110.062 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.8 mm -102.54 121.53 53.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 123.559 0.537 . . . . 0.0 110.113 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.478 HG11 ' HA3' ' A' ' 55' ' ' GLY . 29.9 m -130.12 177.2 7.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.039 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -126.22 121.68 33.42 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.9 t -122.21 154.67 37.19 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-O 121.151 0.5 . . . . 0.0 111.067 -173.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.413 ' HD3' ' OE1' ' A' ' 52' ' ' GLN . 34.8 ttt180 -85.4 132.09 34.29 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.375 177.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.9 p -95.74 163.78 13.04 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.5 m -57.18 -23.68 49.23 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -80.5 -3.22 49.22 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 122.247 -0.283 . . . . 0.0 111.599 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.52 6.19 59.85 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.9 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.2 m -97.59 152.37 19.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 122.504 -0.409 . . . . 0.0 110.48 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 65' ' ' THR . 56.0 m-85 -110.88 121.01 44.28 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -128.39 153.7 46.78 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.918 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -73.52 127.88 33.95 Favored 'General case' 0 C--O 1.256 1.444 0 CA-C-O 121.716 0.769 . . . . 0.0 110.788 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HB2' HD21 ' A' ' 39' ' ' LEU . . . -135.73 168.54 19.09 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.177 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 8.9 mt -118.01 145.84 23.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.2 mp -77.98 115.13 19.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 175.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 m -97.93 -17.31 19.3 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.025 0.44 . . . . 0.0 109.964 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -169.64 156.73 6.67 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.65 111.18 6.8 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.799 0.809 . . . . 0.0 110.588 173.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 C--N 1.297 -1.685 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.787 -178.132 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 CA--C 1.552 1.033 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -102.7 141.6 35.25 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.498 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.435 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 50.6 m-85 -127.79 106.83 9.39 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 54.1 m -87.15 107.81 18.63 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 23.6 m -112.06 147.56 15.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.096 -173.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 7.2 p -105.09 125.08 60.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 123.687 0.795 . . . . 0.0 109.887 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.436 ' CE1' HG21 ' A' ' 88' ' ' VAL . 57.3 m-85 -92.79 -176.86 4.36 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.295 -174.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -47.61 -41.59 22.2 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.145 1.378 . . . . 0.0 112.664 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.08 -16.72 60.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.099 0.476 . . . . 0.0 111.893 -175.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.58 5.74 56.67 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.643 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -96.61 149.92 21.24 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.5 144.12 43.86 Favored 'General case' 0 C--O 1.253 1.287 0 CA-C-O 121.474 0.655 . . . . 0.0 112.177 -175.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.4 mmt-85 -136.77 151.27 49.0 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.466 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 63.5 m -99.42 109.27 21.87 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.278 0.561 . . . . 0.0 109.604 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.25 159.4 17.95 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.691 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -99.66 161.72 13.44 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 ttp85 -61.57 -23.43 65.98 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 m -59.01 -25.08 63.35 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 123.556 0.742 . . . . 0.0 110.93 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 18.9 m -96.12 -8.24 33.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.041 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.9 mp -92.9 133.18 36.36 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -171.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.445 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 19.3 t . . . . . 0 C--N 1.289 -2.062 0 CA-C-N 112.682 -2.053 . . . . 0.0 110.324 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.428 -1.564 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.517 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 48.6 mt -113.18 -174.92 2.55 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -131.17 160.63 34.23 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.81 144.84 10.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.49 -6.52 74.72 Favored Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.87 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.42 ' HB ' HD13 ' A' ' 26' ' ' ILE . 25.3 m -89.16 133.5 34.38 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 120.965 0.412 . . . . 0.0 110.19 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -96.88 124.18 40.79 Favored 'General case' 0 CA--C 1.476 -1.875 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.909 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.404 HG22 ' HB3' ' A' ' 103' ' ' LEU . 28.2 m -131.59 160.77 42.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.216 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.448 ' OG ' ' HB3' ' A' ' 104' ' ' CYS . 2.4 p -94.58 117.02 29.47 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -106.52 127.68 53.5 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.393 -173.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 22.6 pttp -84.76 134.9 34.31 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.453 0.644 . . . . 0.0 112.378 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CZ ' ' HZ ' ' A' ' 90' ' ' PHE . 80.7 m-85 -132.98 136.23 45.95 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.68 26.28 0.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.05 2.9 64.07 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.159 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.15 146.35 51.1 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 16' ' ' LYS 0.262 18.4 p90 -106.76 146.41 30.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 116.026 1.862 . . . . 0.0 116.026 -175.467 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 66.1 m -131.53 138.23 48.84 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.745 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 38.2 tt0 -79.92 137.35 36.86 Favored 'General case' 0 N--CA 1.406 -2.649 0 CA-C-O 121.225 0.536 . . . . 0.0 111.297 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.431 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . . . -147.41 158.75 44.1 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.048 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -106.55 129.26 54.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.42 HD13 ' HB ' ' A' ' 11' ' ' THR . 72.1 mt -61.0 117.27 2.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.196 0.522 . . . . 0.0 110.311 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -99.41 -40.5 7.85 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.983 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 m -127.48 141.83 51.56 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.413 HG11 ' CE1' ' A' ' 86' ' ' TYR . 55.8 t -120.17 124.06 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 C-N-CA 123.179 0.592 . . . . 0.0 109.601 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -131.4 90.62 2.89 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -83.54 92.43 7.62 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 117.766 -1.574 . . . . 0.0 108.211 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -112.33 133.97 54.13 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.278 0.561 . . . . 0.0 109.869 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.6 123.09 48.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -96.03 109.91 22.23 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 122.086 0.946 . . . . 0.0 109.225 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.59 129.26 45.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.323 -172.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.46 ' HB2' HD13 ' A' ' 47' ' ' LEU . 83.6 tttt -88.89 105.84 18.01 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 175.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.27 143.93 21.95 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.279 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.359 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.6 115.01 29.29 Favored 'General case' 0 C--N 1.266 -3.033 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.415 HD22 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -66.67 118.19 9.89 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -64.53 -43.43 94.02 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 124.65 1.18 . . . . 0.0 113.221 -171.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -88.42 -25.34 22.71 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.571 0.701 . . . . 0.0 111.717 -174.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.55 -32.01 11.67 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.565 -175.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 76.78 21.87 1.18 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -102.45 149.61 24.21 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.402 HG21 ' HE2' ' A' ' 36' ' ' LYS . 2.2 m -101.58 138.68 38.26 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -140.16 144.86 36.87 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 36' ' ' LYS . 10.5 tt -124.92 106.67 10.16 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.9 m -135.68 -178.02 2.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.517 -173.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -64.51 150.59 46.4 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -18.29 63.25 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.275 171.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.48 -24.41 61.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.5 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 65' ' ' THR . 12.3 mm100 -85.54 -19.05 31.71 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.2 t -91.5 112.12 24.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.659 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -97.82 98.47 9.86 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.98 175.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.51 179.11 26.01 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.596 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.53 141.26 72.84 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.242 2.628 . . . . 0.0 114.246 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.96 81.97 7.36 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.472 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 97.5 mtt180 -139.57 132.98 30.11 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.02 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.9 t -72.69 110.31 5.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.543 0.687 . . . . 0.0 109.538 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.97 7.19 27.44 Favored Glycine 0 N--CA 1.428 -1.858 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.364 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -93.54 147.46 22.97 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.258 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.3 mm -86.07 117.0 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.76 179.04 4.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.23 125.92 48.31 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 14.5 t -132.48 159.6 38.88 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -76.05 114.19 14.41 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 123.606 0.566 . . . . 0.0 109.853 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.508 HG21 ' O ' ' A' ' 71' ' ' SER . 9.2 t -85.38 -179.47 6.96 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.357 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.7 m -64.9 -18.1 64.9 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.629 1.172 . . . . 0.0 111.038 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.69 -21.51 57.53 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.448 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.61 -14.85 58.99 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.508 ' O ' HG21 ' A' ' 67' ' ' THR . 21.3 m -90.88 159.77 16.06 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -92.33 127.42 37.81 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -140.24 165.21 28.0 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.72 136.47 54.33 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.108 0.48 . . . . 0.0 111.91 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.415 ' HB2' HD22 ' A' ' 39' ' ' LEU . . . -145.62 164.6 31.2 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.8 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 3.1 mp -118.51 136.45 55.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -69.71 122.61 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 m -111.14 -17.03 13.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.212 0.529 . . . . 0.0 110.68 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -166.55 143.43 4.91 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.78 111.58 13.81 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.502 0.668 . . . . 0.0 109.705 172.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.288 -2.082 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.93 -169.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.0 m . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.527 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 34.5 m95 -90.04 132.62 35.29 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.799 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.517 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 97.6 m-85 -128.27 112.61 14.67 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.811 176.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 26.1 m -84.81 107.15 16.83 Favored 'General case' 0 N--CA 1.39 -3.469 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 17.2 m -105.63 141.43 20.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.195 -177.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.6 p -114.71 132.13 64.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.837 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 24' ' ' ALA . 76.3 m-85 -86.35 166.32 15.69 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.24 -21.86 66.74 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 122.283 1.039 . . . . 0.0 108.588 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.67 -17.27 64.48 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.06 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.93 0.16 64.1 Favored Glycine 0 C--O 1.218 -0.876 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.156 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -96.88 144.61 26.66 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 9.3 pt-20 -122.27 133.31 54.69 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.066 0.46 . . . . 0.0 111.088 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -129.67 142.18 50.78 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.527 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 31.9 m -105.47 111.41 24.11 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 120.769 0.318 . . . . 0.0 110.913 -177.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.2 mt -118.62 171.77 7.96 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -79.73 162.54 25.11 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -56.73 -30.12 63.21 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.153 0.502 . . . . 0.0 111.209 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.6 p -81.27 -2.66 49.78 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.809 0.844 . . . . 0.0 112.641 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.6 t -107.34 9.66 29.85 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' A' ' 86' ' ' TYR . 70.8 mt -122.27 134.92 54.67 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.448 ' HB3' ' OG ' ' A' ' 14' ' ' SER . 47.0 t . . . . . 0 C--N 1.285 -2.218 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -175.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.643 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 24.2 p90 . . . . . 0 N--CA 1.407 -2.583 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.6 mt -98.44 178.41 5.04 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.738 -178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.7 p -134.96 169.27 17.66 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.379 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.55 123.26 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 122.776 0.43 . . . . 0.0 111.09 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.0 -33.64 3.01 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.447 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.411 ' HB ' HD13 ' A' ' 26' ' ' ILE . 15.6 m -59.41 138.64 57.59 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.176 0.59 . . . . 0.0 111.332 -177.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -100.53 116.83 33.39 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.5 m -128.43 -179.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 122.871 0.468 . . . . 0.0 110.396 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 16.8 m -129.23 137.28 51.01 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.474 ' CB ' HD11 ' A' ' 98' ' ' LEU . . . -107.27 128.53 54.52 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -85.72 120.14 26.82 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.85 0.357 . . . . 0.0 111.144 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -125.88 109.91 13.04 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 61.86 26.77 16.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.831 0.852 . . . . 0.0 112.557 172.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.73 25.39 42.12 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.921 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.52 144.78 50.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -106.61 120.1 41.06 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.353 0.597 . . . . 0.0 111.117 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.6 m -103.73 128.73 51.07 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 175.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 9.8 pt-20 -93.62 140.49 29.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.536 -1.265 . . . . 0.0 109.852 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.502 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . . . -145.47 156.68 43.89 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.319 -173.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -112.23 132.78 54.73 Favored 'General case' 0 C--N 1.266 -3.029 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.411 HD13 ' HB ' ' A' ' 11' ' ' THR . 43.2 mt -59.41 121.81 7.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.332 0.587 . . . . 0.0 111.907 -176.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -97.31 -46.97 5.9 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 125.025 1.33 . . . . 0.0 109.994 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 16.6 m -137.77 146.18 43.3 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.16 124.24 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -110.75 91.07 3.52 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -78.15 122.9 26.25 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 121.974 0.892 . . . . 0.0 111.515 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 84' ' ' SER . 1.8 pt? -155.7 148.56 24.26 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -135.75 143.91 35.09 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.943 0 N-CA-C 104.34 -2.467 . . . . 0.0 104.34 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.559 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 94.4 mttt -85.05 101.19 12.21 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.46 118.06 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.52 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.575 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -86.55 107.82 18.3 Favored 'General case' 0 N--CA 1.413 -2.286 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 76' ' ' ILE . 3.7 m -112.53 150.03 14.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -126.53 117.66 23.31 Favored 'General case' 0 C--N 1.26 -3.314 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 mt -72.84 106.35 4.75 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -57.96 -34.36 69.85 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -72.13 -45.8 59.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 120.98 0.419 . . . . 0.0 111.403 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -91.84 -8.89 45.3 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.492 -175.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.2 p30 53.31 28.09 6.92 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.302 1.841 . . . . 0.0 113.256 -177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -104.14 145.74 29.75 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.309 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 m -97.7 154.44 17.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -151.15 138.93 19.8 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 mt -109.72 102.33 11.15 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.428 HG23 ' HG1' ' A' ' 65' ' ' THR . 27.4 m -116.58 176.43 2.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.29 -174.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -101.56 160.02 14.8 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.4 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -47.18 -33.9 5.75 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 126.405 1.882 . . . . 0.0 112.237 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -72.81 -28.76 62.76 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.29 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -92.72 -3.53 54.67 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.548 0.69 . . . . 0.0 109.222 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.8 t -99.37 123.02 51.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.076 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -103.46 95.83 6.34 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.59 -173.82 28.44 Favored Glycine 0 N--CA 1.423 -2.231 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.132 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.14 148.35 44.24 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.096 2.531 . . . . 0.0 113.478 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.27 82.64 6.5 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 62.8 ttt180 -139.35 119.59 13.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.818 -174.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.66 115.69 6.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.11 0.481 . . . . 0.0 109.862 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.5 5.51 42.44 Favored Glycine 0 N--CA 1.418 -2.543 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.122 -177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.13 155.78 16.98 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.413 0.606 . . . . 0.0 110.393 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.2 mt -97.24 124.8 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.18 179.19 4.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -113.49 125.51 54.29 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.428 ' HG1' HG23 ' A' ' 48' ' ' VAL . 9.7 t -127.61 152.39 47.72 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-O 120.777 0.323 . . . . 0.0 110.17 -174.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -83.25 123.9 30.05 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.041 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.2 p -85.6 177.13 7.83 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -71.33 -20.6 62.16 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.033 0.444 . . . . 0.0 109.815 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.91 -25.0 66.95 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.968 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.91 -20.27 24.47 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.077 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.2 p -92.2 159.43 15.64 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 120.942 0.401 . . . . 0.0 110.97 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 65' ' ' THR . 51.1 m-85 -92.73 138.89 31.1 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.013 0.435 . . . . 0.0 110.244 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -132.14 149.73 52.33 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.67 129.81 34.74 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.024 0.916 . . . . 0.0 109.741 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.86 173.38 11.59 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.403 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 5.7 mm -110.92 143.94 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -79.75 111.26 16.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -90.65 -24.77 20.4 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 120.922 0.391 . . . . 0.0 109.963 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -165.17 146.16 7.39 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.0 111.23 17.64 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.854 0.835 . . . . 0.0 109.119 168.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 8.2 m . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -173.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.463 ' HA ' HD23 ' A' ' 32' ' ' LEU . 50.5 m . . . . . 0 CA--C 1.507 -0.698 0 CA-C-O 121.883 0.849 . . . . 0.0 111.726 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -99.65 134.06 43.08 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.161 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.643 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 82.2 m-85 -121.2 107.94 13.17 Favored 'General case' 0 N--CA 1.422 -1.872 0 O-C-N 123.753 0.658 . . . . 0.0 109.315 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 33.3 m -90.08 106.47 18.5 Favored 'General case' 0 N--CA 1.398 -3.073 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.2 m -105.74 141.65 20.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.164 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.5 137.95 42.03 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.366 -174.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.502 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 87.4 m-85 -94.23 163.74 13.32 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.46 -26.74 65.48 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.615 0.722 . . . . 0.0 111.52 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.84 -17.14 64.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.089 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.1 1.92 58.21 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.75 138.31 31.58 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -125.86 133.91 51.8 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.465 0.65 . . . . 0.0 111.048 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.62 142.3 50.26 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.039 -176.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 43.4 m -104.89 110.16 22.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.519 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.474 HD11 ' CB ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -132.9 170.39 15.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.322 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -98.97 170.6 8.61 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -58.06 -31.38 67.01 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 123.699 0.8 . . . . 0.0 111.93 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 m -70.91 -9.14 57.19 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 121.498 0.666 . . . . 0.0 111.465 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.5 m -109.01 1.22 20.43 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 14' ' ' SER . 89.6 mt -107.22 129.43 54.87 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.788 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 14.2 t . . . . . 0 C--N 1.306 -1.291 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.079 -177.198 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.4 p90 . . . . . 0 N--CA 1.404 -2.752 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 29.5 mt -88.49 173.52 8.63 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.9 p -123.51 162.1 23.58 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -173.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -65.61 133.27 30.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.671 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.94 -16.57 42.89 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.944 177.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.455 ' HB ' HD11 ' A' ' 26' ' ' ILE . 13.4 m -66.54 132.08 47.42 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.498 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -96.75 115.36 27.3 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.9 m -128.61 -179.56 3.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 121.435 0.636 . . . . 0.0 110.361 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 19.4 m -133.43 136.45 45.21 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -107.18 138.83 42.63 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -89.91 129.93 36.19 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.879 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.447 ' HH ' HD21 ' A' ' 98' ' ' LEU . 99.5 m-85 -127.7 108.14 10.49 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.344 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.497 ' HD2' ' N ' ' A' ' 18' ' ' ARG . 2.9 mpt_? 59.57 32.82 21.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.67 0.788 . . . . 0.0 111.659 175.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.44 -2.63 68.0 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.787 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.36 147.97 36.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 117.184 0.492 . . . . 0.0 109.738 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -93.41 138.79 31.38 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.017 0.437 . . . . 0.0 110.833 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.0 m -125.36 128.03 47.53 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 170.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 6.8 pt-20 -90.08 138.38 31.56 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 118.417 -1.313 . . . . 0.0 110.771 -173.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -148.67 151.01 34.2 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.02 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.6 tttp -108.92 128.98 55.4 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.455 HD11 ' HB ' ' A' ' 11' ' ' THR . 19.0 mt -66.63 118.67 10.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 120.646 0.26 . . . . 0.0 110.709 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -97.13 -46.85 6.0 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.259 0.552 . . . . 0.0 110.129 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 m -127.06 139.2 53.17 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.2 t -121.57 107.17 19.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.028 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 84' ' ' SER . 95.5 mttt -99.3 90.49 4.57 Favored 'General case' 0 C--N 1.264 -3.115 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -86.21 108.12 18.21 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -132.78 129.46 38.61 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 8.5 p -97.39 116.38 39.63 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.826 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -88.92 100.56 13.28 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.411 HG21 HD12 ' A' ' 57' ' ' LEU . 25.7 t -84.75 137.05 21.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.862 -174.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 39.8 ttmt -91.43 105.43 17.76 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 175.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 45' ' ' THR . 3.5 m -112.6 143.13 22.93 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.328 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.3 118.75 34.78 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.4 mp -69.4 122.59 19.25 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.851 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.74 -31.43 72.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.153 0.501 . . . . 0.0 111.017 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -89.4 -58.82 2.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.529 0.68 . . . . 0.0 110.982 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.37 -17.37 45.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.599 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 t30 71.68 7.12 5.87 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.069 0.937 . . . . 0.0 113.385 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -86.64 159.75 19.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 110.789 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.6 m -119.4 140.35 50.54 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -134.09 142.51 47.56 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.44 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.75 101.22 10.53 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.2 149.62 28.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.424 0.631 . . . . 0.0 111.764 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 15.1 pt20 -69.81 160.98 30.73 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.37 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -63.4 -7.2 6.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.611 0.764 . . . . 0.0 112.523 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -73.58 -34.63 65.2 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.519 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 25.7 mm-40 -86.33 -28.99 23.35 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.076 -177.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.7 t -91.06 121.74 41.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.474 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -105.74 108.73 20.4 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.01 -173.79 22.76 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.059 177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.9 139.2 46.7 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 123.139 2.559 . . . . 0.0 112.859 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.411 HD12 HG21 ' A' ' 35' ' ' VAL . 1.7 mm? -97.12 81.44 3.05 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.535 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 42.8 ttp85 -141.1 138.6 33.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.835 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.92 124.7 19.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.34 9.07 63.7 Favored Glycine 0 N--CA 1.427 -1.952 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.349 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.93 153.18 18.05 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.926 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -89.81 119.24 36.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.0 m -134.55 175.04 12.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.034 0.445 . . . . 0.0 110.807 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -126.3 128.19 46.74 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 11.8 t -131.13 157.92 41.85 Favored 'General case' 0 C--N 1.277 -2.55 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.042 -174.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.519 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 37.0 ttm-85 -82.54 128.59 34.45 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 105.221 -2.141 . . . . 0.0 105.221 170.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.2 p -84.98 176.79 8.23 Favored 'General case' 0 C--N 1.276 -2.615 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.199 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.1 m -66.17 -19.72 65.92 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.004 0.431 . . . . 0.0 110.044 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -75.55 -25.43 57.14 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.84 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.33 -17.33 16.71 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.702 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.6 m -90.09 151.97 21.36 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.648 0.261 . . . . 0.0 111.416 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 65' ' ' THR . 62.4 m-85 -87.46 126.76 35.09 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.87 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -140.96 145.54 36.15 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.363 1.065 . . . . 0.0 108.983 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -76.13 131.05 39.17 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 121.812 0.815 . . . . 0.0 111.253 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.8 170.12 16.29 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.382 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.1 mm -119.83 142.46 35.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -74.42 129.06 36.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.3 m -114.47 -17.11 11.82 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 121.227 0.537 . . . . 0.0 111.025 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -168.82 156.23 7.48 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.76 135.15 53.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 87.1 m . . . . . 0 C--N 1.278 -2.516 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.769 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.7 p . . . . . 0 N--CA 1.425 -1.692 0 CA-C-O 121.111 0.481 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.536 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 87.6 m95 -107.75 113.87 27.43 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.108 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 94.5 m-85 -101.47 110.59 22.62 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.1 m -89.93 104.14 16.73 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.4 m -106.9 140.59 24.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.273 0.559 . . . . 0.0 111.301 -174.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.79 128.69 54.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 124.239 1.015 . . . . 0.0 109.979 -173.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -87.71 174.02 8.65 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.31 -17.82 55.55 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.96 -17.81 62.04 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.045 0.538 . . . . 0.0 110.326 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.21 -0.48 68.85 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.96 131.48 40.85 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 123.325 0.65 . . . . 0.0 109.548 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.45 ' C ' ' HD2' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -111.74 137.25 49.92 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.354 0.597 . . . . 0.0 111.911 -179.139 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.45 ' HD2' ' C ' ' A' ' 95' ' ' GLU . 4.3 mpt_? -121.67 158.18 29.25 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.395 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 24.0 m -101.84 119.69 39.19 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.251 0.548 . . . . 0.0 110.771 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.447 HD21 ' HH ' ' A' ' 17' ' ' TYR . 4.0 mm? -122.09 174.5 6.9 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.484 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -98.86 166.58 11.23 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.89 -21.61 63.3 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.572 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.6 m -74.19 -9.78 58.96 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.521 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 5.3 m -98.95 -11.8 21.26 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 70.1 mt -101.68 128.35 48.02 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.073 -171.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 30.3 t . . . . . 0 C--N 1.311 -1.082 0 C-N-CA 124.749 1.219 . . . . 0.0 110.75 -178.405 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.767 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 38.2 p90 . . . . . 0 N--CA 1.421 -1.885 0 CA-C-O 120.901 0.382 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.55 -173.58 3.07 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.716 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.5 p -128.61 157.91 39.96 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -171.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 m -74.35 148.96 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 CA-C-O 121.122 0.487 . . . . 0.0 111.834 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.15 -12.59 67.36 Favored Glycine 0 C--N 1.301 -1.378 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.071 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.437 ' HB ' HD13 ' A' ' 26' ' ' ILE . 13.6 m -79.59 135.92 36.71 Favored 'General case' 0 N--CA 1.403 -2.809 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -99.78 121.04 40.68 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 104' ' ' CYS . 17.4 m -135.37 -177.33 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 121.474 0.654 . . . . 0.0 110.307 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 m -123.07 141.62 51.76 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.54 139.76 41.57 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.344 0.0 OUTLIER -99.98 136.61 39.63 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -177.815 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -131.62 121.72 24.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.668 -1.605 . . . . 0.0 107.355 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 61.53 31.7 18.85 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.028 0.931 . . . . 0.0 110.428 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.89 28.8 70.04 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.5 -177.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.75 152.29 50.16 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -102.39 144.84 30.36 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.686 -173.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -127.58 139.73 52.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 172.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.53 152.38 26.04 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.482 -175.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -162.37 145.36 11.39 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -106.51 128.75 54.34 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.437 HD13 ' HB ' ' A' ' 11' ' ' THR . 30.4 mt -63.75 114.42 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 121.185 0.517 . . . . 0.0 111.23 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.42 -42.39 6.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.757 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 5.8 m -130.05 137.35 50.18 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.1 t -116.61 116.4 52.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.279 0.562 . . . . 0.0 109.949 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HB3' HD22 ' A' ' 32' ' ' LEU . 46.7 mmtt -109.57 91.03 3.48 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.185 174.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -83.25 87.69 6.94 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.549 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.3 pt? -135.07 116.53 14.69 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.291 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.8 t -108.5 115.23 48.74 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 171.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -82.64 108.35 15.95 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.244 1.021 . . . . 0.0 109.755 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.04 133.75 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.455 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.244 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -88.86 107.08 18.79 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.59 148.49 15.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.305 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.75 117.87 30.51 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.3 mt -73.92 106.55 5.68 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.41 -29.05 67.46 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -87.69 -24.47 23.86 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.765 -177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -115.53 -13.97 11.54 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.177 -173.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 68.33 15.98 9.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.508 1.523 . . . . 0.0 113.112 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -99.99 158.28 15.94 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.377 0.132 . . . . 0.0 111.088 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -125.57 140.4 52.78 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.1 160.61 42.7 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.359 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.56 100.88 7.39 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 m -128.28 163.88 31.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.434 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 17.1 pm0 -80.78 160.05 24.98 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.47 -25.11 2.38 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 127.076 2.15 . . . . 0.0 112.51 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.42 -29.1 67.69 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.718 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 65' ' ' THR . 71.7 mt-30 -100.21 -15.17 18.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.463 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.08 110.82 22.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 122.523 1.154 . . . . 0.0 111.586 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -99.19 106.13 18.26 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 113.974 -1.466 . . . . 0.0 108.001 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 139.68 -169.65 24.53 Favored Glycine 0 C--N 1.302 -1.325 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.172 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.56 134.86 11.34 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.884 2.39 . . . . 0.0 112.544 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -88.53 82.26 6.97 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.532 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 35.0 mtp180 -139.26 132.59 30.01 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.744 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.32 120.07 10.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.34 5.81 61.74 Favored Glycine 0 N--CA 1.433 -1.556 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.867 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -96.39 169.21 10.07 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.894 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.5 mm -99.02 115.74 40.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.113 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.485 ' CG1' HD13 ' A' ' 77' ' ' ILE . 16.0 m -123.78 -173.05 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.8 135.87 35.07 Favored 'General case' 1 N--CA 1.374 -4.238 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 174.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 11.6 t -141.56 158.91 43.24 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.056 -175.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -80.49 126.39 31.16 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -99.09 179.7 4.53 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.135 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.7 t -66.82 -21.06 66.04 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.205 1.002 . . . . 0.0 110.242 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.18 -18.34 62.49 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.53 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.88 -13.44 60.67 Favored Glycine 0 C--O 1.241 0.584 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.976 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.9 p -91.68 165.06 13.5 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 123.136 0.574 . . . . 0.0 110.727 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -98.38 124.68 43.18 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -119.6 146.91 45.1 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -72.7 127.74 33.46 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.55 168.35 18.39 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 7.0 mm -115.45 149.23 17.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.7 mp -89.92 130.47 39.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.0 m -107.35 -16.96 14.26 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.002 0.429 . . . . 0.0 110.583 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -173.53 147.47 1.45 Allowed 'General case' 0 C--O 1.212 -0.888 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.321 0.0 OUTLIER -129.92 115.89 17.84 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.546 0.688 . . . . 0.0 110.781 171.61 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.4 m . . . . . 0 C--N 1.288 -2.108 0 CA-C-O 121.456 0.646 . . . . 0.0 109.341 -177.02 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.447 -0.616 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.506 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 78.8 m95 -100.97 129.98 46.9 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.526 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.767 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 74.6 m-85 -123.11 108.73 13.19 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 26.0 m -84.25 103.8 13.74 Favored 'General case' 0 N--CA 1.391 -3.38 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 26' ' ' ILE . 17.3 m -106.09 141.29 21.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.845 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.79 122.77 56.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.864 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -88.51 173.43 8.68 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.41 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -55.28 -33.45 63.25 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.262 1.025 . . . . 0.0 111.589 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.82 -17.84 62.75 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.987 0.422 . . . . 0.0 111.608 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.56 6.76 56.28 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -90.47 134.83 34.09 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -111.04 128.32 55.82 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-O 121.221 0.534 . . . . 0.0 109.937 177.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -123.45 140.97 52.47 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.506 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 32.3 m -103.66 108.82 20.26 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 120.725 0.298 . . . . 0.0 111.104 -176.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.8 mt -117.34 178.03 4.52 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -98.74 165.25 11.88 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -62.06 -25.38 67.65 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.13 0.49 . . . . 0.0 110.816 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.93 1.21 9.21 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.18 0.992 . . . . 0.0 112.213 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.5 t -127.61 11.24 6.74 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.9 mp -122.26 161.0 24.09 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.291 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . 0.407 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 37.5 t . . . . . 0 N--CA 1.416 -2.156 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.6 p90 . . . . . 0 C--O 1.225 -0.197 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.418 ' O ' ' HE2' ' A' ' 86' ' ' TYR . 3.0 pp -151.43 166.47 30.96 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.462 ' HB ' ' OG1' ' A' ' 11' ' ' THR 0.539 54.2 p 115.17 71.88 0.0 OUTLIER 'General case' 0 C--O 1.193 -1.882 0 C-N-CA 130.201 3.401 . . . . 0.0 115.516 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.2 t -92.41 140.21 16.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.83 -13.57 58.68 Favored Glycine 0 C--N 1.313 -0.743 0 N-CA-C 112.238 -0.345 . . . . 0.0 112.238 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.462 ' OG1' ' HB ' ' A' ' 8' ' ' THR . 3.6 m -68.8 133.18 47.97 Favored 'General case' 0 N--CA 1.411 -2.38 0 C-N-CA 123.501 0.72 . . . . 0.0 110.067 -177.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.79 110.32 22.94 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.32 173.49 13.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 122.305 0.242 . . . . 0.0 110.719 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.9 p -95.38 132.06 40.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 98' ' ' LEU . . . -119.6 120.78 37.69 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 123.675 0.79 . . . . 0.0 109.802 -177.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -82.81 106.23 14.48 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.906 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -138.41 145.87 41.5 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 62.99 25.19 14.93 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 122.762 1.268 . . . . 0.0 108.899 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.53 16.04 75.61 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.263 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.17 142.67 42.18 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 26.2 p90 -98.45 114.09 26.33 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.089 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -100.6 143.17 31.08 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -71.64 132.78 45.08 Favored 'General case' 0 N--CA 1.38 -3.963 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -146.27 164.48 32.17 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.175 -173.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -117.44 126.84 53.32 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.423 HG12 HG11 ' A' ' 88' ' ' VAL . 18.6 mt -69.58 109.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -87.49 -41.2 13.68 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.344 0.592 . . . . 0.0 110.174 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.8 m -137.95 141.53 40.55 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.775 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.6 t -118.94 108.54 24.27 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 84' ' ' SER . 31.2 mmmt -82.33 101.29 10.47 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -84.49 99.39 10.67 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.6 pt? -138.88 126.09 21.44 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.655 0.74 . . . . 0.0 111.031 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 60.1 t -104.07 124.83 58.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -84.36 104.42 14.36 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.2 t -93.4 126.41 45.83 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.806 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.157 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -95.6 110.5 22.59 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 m -117.51 154.53 19.34 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.952 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.338 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tt -122.03 113.73 19.95 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.435 HD21 ' HB1' ' A' ' 75' ' ' ALA . 43.2 mt -64.72 118.14 8.5 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.356 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.41 ' HD2' ' OE1' ' A' ' 74' ' ' GLU . 18.8 ptpt -75.51 -23.04 56.66 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.409 -176.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -85.46 -42.45 14.47 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.268 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -91.66 -22.84 20.05 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.383 0.611 . . . . 0.0 110.653 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 73.1 22.31 2.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.109 1.364 . . . . 0.0 113.614 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 p -104.81 150.73 24.56 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.744 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -97.96 144.48 27.45 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -142.57 142.82 32.24 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.7 tp -121.57 102.63 8.36 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.28 164.49 29.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.767 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.446 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 4.5 pm0 -84.29 168.05 16.02 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -46.39 -21.47 0.17 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 128.584 2.754 . . . . 0.0 114.306 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.26 -23.03 23.61 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 122.084 0.945 . . . . 0.0 110.446 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -91.16 -20.13 22.33 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.876 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.9 t -105.24 127.04 60.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.354 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -110.93 110.06 20.47 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.419 ' HA3' HG13 ' A' ' 63' ' ' VAL . . . 141.54 -164.04 26.73 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.506 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.07 136.18 16.1 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.824 2.349 . . . . 0.0 113.117 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.8 mt -93.2 83.0 4.56 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.492 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 28.5 tpt180 -140.38 131.01 25.59 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.4 t -63.64 119.66 8.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.8 3.58 55.99 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.401 -176.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.44 168.76 10.19 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.471 0.635 . . . . 0.0 110.758 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.31 128.37 60.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.766 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.453 ' CG1' HD13 ' A' ' 77' ' ' ILE . 21.0 m -137.47 172.68 14.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.75 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -116.92 130.12 56.49 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.3 t -128.45 158.44 38.33 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.6 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -70.11 123.84 22.62 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.307 0.575 . . . . 0.0 111.023 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 71' ' ' SER . 14.2 t -95.11 169.83 9.83 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 p -63.83 -20.52 65.86 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.683 0.793 . . . . 0.0 112.524 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.61 -25.73 64.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.511 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.5 -22.27 12.09 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.672 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.461 ' O ' HG23 ' A' ' 67' ' ' THR . 23.3 m -87.19 170.09 11.78 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.856 0.36 . . . . 0.0 110.642 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -100.69 137.27 39.31 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -133.29 155.85 48.66 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.41 ' OE1' ' HD2' ' A' ' 40' ' ' LYS . 38.1 tt0 -69.15 128.67 37.45 Favored 'General case' 0 C--O 1.253 1.237 0 O-C-N 124.227 0.954 . . . . 0.0 112.288 -177.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.435 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -139.7 171.03 14.82 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.211 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.86 141.87 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.3 mp -76.35 122.22 30.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -106.35 -18.93 13.85 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -163.78 150.0 11.52 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.3 OUTLIER -135.95 117.16 14.49 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.683 0.754 . . . . 0.0 110.838 171.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.3 m . . . . . 0 C--N 1.295 -1.781 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.072 -175.19 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 56.0 m . . . . . 0 C--O 1.237 0.398 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -103.37 108.31 19.49 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.583 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.418 ' HE2' ' O ' ' A' ' 7' ' ' LEU . 48.1 m-85 -90.39 111.56 22.84 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 m -87.98 105.19 17.29 Favored 'General case' 0 N--CA 1.405 -2.69 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.423 HG11 HG12 ' A' ' 26' ' ' ILE . 21.8 m -105.68 141.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.995 -176.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.88 125.72 59.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.92 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -87.19 170.12 11.76 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -57.15 -24.62 55.56 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 123.39 0.432 . . . . 0.0 112.057 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -72.4 -16.88 61.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.267 0.556 . . . . 0.0 111.846 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.84 -1.75 63.7 Favored Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.984 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.54 150.16 20.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.97 154.4 50.52 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 118.313 0.506 . . . . 0.0 111.521 -175.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -149.14 147.6 28.65 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.271 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.37 113.17 23.7 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 123.544 0.738 . . . . 0.0 110.899 174.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.475 HD12 ' HB1' ' A' ' 15' ' ' ALA 0.315 0.2 OUTLIER -129.83 146.87 51.55 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.141 0.496 . . . . 0.0 111.858 174.229 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.1 158.84 34.05 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.171 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.05 -38.25 56.42 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.902 1.281 . . . . 0.0 110.54 -175.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.5 m -62.72 -10.12 11.59 Favored 'General case' 0 CA--C 1.576 1.944 0 C-N-CA 123.834 0.854 . . . . 0.0 112.875 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.0 m -111.49 6.38 20.15 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 120.937 -1.102 . . . . 0.0 111.448 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 mp -108.81 139.61 43.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.8 t . . . . . 0 C--N 1.298 -1.648 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -175.977 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.557 ' HA ' ' OH ' ' A' ' 86' ' ' TYR 0.29 28.4 p90 . . . . . 0 N--CA 1.463 0.189 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.51 173.67 7.95 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 173.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.4 p -127.74 169.04 14.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -172.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.6 t -72.49 134.69 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.306 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.91 -22.22 14.77 Favored Glycine 0 N--CA 1.432 -1.596 0 C-N-CA 119.816 -1.183 . . . . 0.0 113.419 175.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -93.43 167.74 11.51 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.719 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 5.0 p-10 -118.17 139.27 51.52 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 m -132.18 162.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.83 -177.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.4 m -101.13 127.95 47.44 Favored 'General case' 0 N--CA 1.405 -2.715 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.506 ' CB ' HD13 ' A' ' 98' ' ' LEU . . . -106.91 120.78 42.98 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 22.2 ptmt -93.59 138.07 32.22 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.721 -177.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -134.81 130.9 36.78 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.7 mmt-85 61.21 25.2 15.22 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.85 1.26 . . . . 0.0 110.243 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.23 2.55 83.06 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.206 -0.521 . . . . 0.0 113.093 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.25 145.97 45.63 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 16' ' ' LYS . 74.1 m-85 -95.1 132.92 39.48 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.982 -175.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.2 m -116.54 132.67 56.62 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -86.12 145.16 27.15 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.105 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.96 153.3 34.95 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 64.6 tttm -108.94 126.72 53.39 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -175.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.41 HG12 HG13 ' A' ' 88' ' ' VAL . 23.3 mt -65.31 114.14 2.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.936 0.398 . . . . 0.0 111.732 -175.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -97.18 -45.8 6.39 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.091 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 4.9 m -127.04 139.76 52.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -175.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.9 t -125.44 122.88 63.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -110.75 91.79 3.8 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 172.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.383 0.0 OUTLIER -85.71 86.94 7.34 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.06 177.362 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.5 pt? -116.46 105.27 12.3 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.449 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 7.3 p -91.45 127.23 43.92 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.492 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 68.4 mttm -79.78 105.11 10.83 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.314 0.578 . . . . 0.0 109.706 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.7 t -89.4 122.83 41.19 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.196 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.462 ' CB ' ' HB3' ' A' ' 79' ' ' LYS . 2.9 tmtm? -89.64 108.35 19.62 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.02 153.3 18.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 121.475 0.655 . . . . 0.0 112.472 -174.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -123.34 120.03 31.84 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.18 127.07 31.4 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.962 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.2 ptpt -64.28 -34.66 78.63 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -80.74 -58.77 2.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.001 0.429 . . . . 0.0 111.889 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.71 -4.42 55.11 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.7 p30 52.12 29.4 6.39 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.664 1.185 . . . . 0.0 112.595 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.3 145.77 24.22 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.734 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -113.27 147.73 37.0 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -158.7 164.46 35.9 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.918 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 31.5 tp -129.5 102.3 6.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.68 162.37 31.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 5.4 pm0 -90.99 166.73 12.86 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.32 -0.952 . . . . 0.0 113.538 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -42.68 -32.19 0.55 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 127.268 2.227 . . . . 0.0 113.253 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -68.25 -34.9 77.06 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 123.691 0.796 . . . . 0.0 111.238 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -90.39 -12.43 37.56 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.349 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.7 t -93.81 115.7 33.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.602 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -108.38 124.34 50.22 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.292 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.26 -161.38 22.07 Favored Glycine 0 C--N 1.288 -2.108 0 CA-C-O 119.445 -0.642 . . . . 0.0 111.921 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -86.13 133.23 4.02 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.848 2.365 . . . . 0.0 112.833 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.88 82.55 3.87 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 122.085 0.945 . . . . 0.0 110.808 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.581 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 25.6 mmt180 -140.02 141.11 36.34 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.371 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.05 126.34 22.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.23 3.85 67.06 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.308 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.55 157.5 15.99 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.408 HG12 ' CD1' ' A' ' 76' ' ' ILE . 56.8 mt -101.76 124.43 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 121.383 0.611 . . . . 0.0 110.796 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.445 ' CG1' HD13 ' A' ' 77' ' ' ILE . 14.6 m -125.64 -178.65 2.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.814 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 73' ' ' GLN . 39.0 mt-10 -126.69 120.89 30.55 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.9 p -116.37 150.28 37.99 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.725 -174.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -76.67 130.41 37.75 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.1 p -87.91 -177.16 5.71 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.0 t -78.35 -0.88 30.72 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 110.033 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -94.68 -14.45 24.83 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.3 5.61 60.44 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.455 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 m -97.15 160.86 14.1 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.34 119.31 37.86 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 121.05 0.452 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 46.7 mt-30 -119.19 153.54 34.76 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.083 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 44.9 mt-10 -69.09 122.75 19.38 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 124.056 0.847 . . . . 0.0 109.563 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.42 162.28 34.05 Favored 'General case' 0 C--N 1.267 -3.011 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.572 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.408 ' CD1' HG12 ' A' ' 62' ' ' ILE . 9.2 mm -107.48 137.52 38.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.581 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -70.89 120.02 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.417 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . 13.6 m -109.58 -15.77 14.11 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.301 -178.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 36' ' ' LYS . 15.3 tppt? -172.77 150.13 2.08 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.4 123.82 32.63 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 171.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 C--N 1.305 -1.365 0 C-N-CA 123.455 0.702 . . . . 0.0 109.954 -177.853 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m . . . . . 0 C--O 1.245 0.843 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.568 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 89.5 m95 -101.37 136.73 40.74 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.836 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.557 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 56.0 m-85 -122.81 114.36 20.41 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 16.0 m -91.74 105.54 17.8 Favored 'General case' 0 N--CA 1.401 -2.908 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.41 HG13 HG12 ' A' ' 26' ' ' ILE . 21.4 m -105.81 141.7 20.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.925 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.9 p -105.73 135.65 43.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.091 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -97.4 173.04 7.39 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.424 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -54.61 -42.64 71.4 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.674 1.189 . . . . 0.0 111.14 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.81 -14.02 62.61 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.925 0.89 . . . . 0.0 112.731 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.61 9.13 55.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.83 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -89.73 140.65 29.36 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -124.82 138.67 54.26 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -133.92 142.17 47.63 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.568 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 67.1 m -99.79 118.85 37.16 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.013 0.435 . . . . 0.0 110.872 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.506 HD13 ' CB ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -136.54 162.97 31.63 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.361 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.413 ' O ' HD11 ' A' ' 103' ' ' LEU . 28.7 ptt180 -99.32 166.32 11.26 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.738 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.423 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 72.0 mtm180 -56.47 -25.57 51.39 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 m -57.67 -22.37 45.53 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.35 1.06 . . . . 0.0 111.798 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.5 m -118.72 12.98 13.19 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.086 0.47 . . . . 0.0 111.634 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 99' ' ' ARG . 8.6 mp -103.12 146.16 28.81 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.633 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 34.6 t . . . . . 0 C--N 1.296 -1.737 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.215 -178.48 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.3 t80 . . . . . 0 N--CA 1.432 -1.348 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.6 mt -127.54 -164.15 1.33 Allowed 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.037 173.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.9 p -87.86 133.48 33.89 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -160.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.6 t -92.1 135.47 27.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.181 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.85 -11.39 52.86 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.887 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.433 ' HB ' HD11 ' A' ' 26' ' ' ILE . 24.6 m -75.52 143.1 42.66 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 123.068 0.547 . . . . 0.0 110.805 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -96.8 131.68 43.28 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.05 -179.63 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.192 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 3.3 p -118.75 136.82 53.76 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.37 125.63 51.44 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 125.196 1.398 . . . . 0.0 107.57 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -88.6 142.25 27.85 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.387 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -134.0 100.29 4.69 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 58.74 39.74 23.93 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.851 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.6 -11.36 70.13 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.534 -0.757 . . . . 0.0 114.243 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.78 131.05 54.34 Favored 'General case' 0 C--O 1.205 -1.238 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -106.68 132.44 52.67 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.842 -174.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.4 m -110.76 148.97 31.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -84.18 143.24 29.77 Favored 'General case' 0 C--O 1.249 1.069 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.638 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.32 149.61 27.1 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.327 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.426 ' O ' HG11 ' A' ' 89' ' ' VAL . 3.9 tmmm? -113.37 129.26 56.58 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.433 HD11 ' HB ' ' A' ' 11' ' ' THR . 53.8 mt -64.73 119.35 8.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 123.582 0.753 . . . . 0.0 112.657 -175.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -90.53 -49.21 6.63 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 122.154 0.978 . . . . 0.0 109.549 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.0 m -142.89 147.72 35.8 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.096 -175.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' A' ' 86' ' ' TYR . 53.2 t -114.27 133.52 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 171.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 23.7 tptm -121.82 120.82 35.68 Favored 'General case' 0 C--N 1.263 -3.156 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -70.56 144.32 51.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.611 -1.236 . . . . 0.0 111.026 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.526 HD21 ' CD1' ' A' ' 85' ' ' TRP . 73.5 mt -123.7 157.7 33.3 Favored 'General case' 0 C--N 1.265 -3.106 0 CA-C-N 114.046 -1.433 . . . . 0.0 107.457 175.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 80' ' ' LEU . 60.7 t -119.86 110.65 29.8 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.361 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 42.9 mtpt -85.53 108.1 17.78 Favored 'General case' 0 CA--C 1.471 -2.065 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.4 HG12 HG13 ' A' ' 77' ' ' ILE . 14.9 t -91.61 132.43 36.07 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.229 -173.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -90.4 111.91 23.32 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -112.96 144.33 20.85 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.103 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.056 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -112.76 115.36 28.4 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.9 122.03 17.81 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.385 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -66.74 -38.93 87.64 Favored 'General case' 0 N--CA 1.41 -2.464 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -170.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -86.31 -45.77 10.93 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -86.27 -25.12 25.68 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -173.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 74.02 19.65 2.97 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.07 150.8 24.19 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -112.06 145.02 40.46 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -151.4 147.8 27.33 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -174.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.4 tp -123.48 101.49 7.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.0 m -134.62 165.08 32.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.406 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 5.6 pm0 -85.66 161.03 19.42 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -173.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -43.49 -28.12 0.34 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 127.294 2.238 . . . . 0.0 113.977 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.87 -37.34 87.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.941 0.401 . . . . 0.0 110.789 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -100.53 -6.94 24.69 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.324 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.0 t -101.14 113.27 36.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.601 0.715 . . . . 0.0 110.035 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -98.63 100.28 11.49 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.041 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.483 ' HA3' HG13 ' A' ' 63' ' ' VAL . . . 152.33 -163.34 30.22 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.424 176.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -81.7 146.38 14.94 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.763 2.975 . . . . 0.0 113.903 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.93 82.09 6.21 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 49.1 mtm105 -139.89 123.75 17.51 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.674 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.3 t -61.08 118.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.525 0.679 . . . . 0.0 109.64 176.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.76 11.05 51.63 Favored Glycine 0 C--N 1.299 -1.515 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.532 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.11 168.9 10.17 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.414 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.8 mm -101.45 120.33 50.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.483 HG13 ' HA3' ' A' ' 55' ' ' GLY . 27.4 m -131.32 176.96 7.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -122.82 123.09 40.22 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 8.5 t -114.96 154.36 28.91 Favored 'General case' 0 C--N 1.265 -3.08 0 CA-C-O 121.052 0.453 . . . . 0.0 110.402 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 -85.69 147.62 26.27 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.2 p -99.94 172.68 7.07 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.9 t -67.84 -6.98 24.22 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.298 0.57 . . . . 0.0 109.801 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.31 -25.47 27.15 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.411 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.98 -11.77 34.45 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.357 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 m -87.48 158.12 19.03 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 122.184 0.193 . . . . 0.0 110.706 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 65' ' ' THR . 54.5 m-85 -111.13 145.26 38.92 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 122.538 0.335 . . . . 0.0 110.415 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -147.69 151.72 36.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.95 126.52 30.04 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.804 0.841 . . . . 0.0 109.554 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.65 167.74 21.42 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.812 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.0 mm -115.81 144.71 22.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.43 HD11 ' CG1' ' A' ' 63' ' ' VAL . 3.5 mp -77.55 123.65 34.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -111.87 -16.71 13.08 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.546 0.689 . . . . 0.0 111.582 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -161.1 150.8 17.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.411 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -141.25 111.51 6.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.067 0.937 . . . . 0.0 110.654 175.39 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.464 -170.718 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.249 1.035 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.526 ' CD1' HD21 ' A' ' 32' ' ' LEU . 64.8 m95 -94.09 151.08 19.76 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 167.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.475 ' CD2' HG21 ' A' ' 29' ' ' VAL . 53.2 m-85 -127.37 116.9 21.21 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 42.5 m -86.29 105.85 16.95 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 m -109.06 141.47 24.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.345 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 25' ' ' LYS . 14.8 p -107.78 134.22 50.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.436 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -80.27 169.71 17.4 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -63.33 -20.78 65.8 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.41 0.624 . . . . 0.0 109.905 175.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -68.74 -17.81 64.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.246 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.99 0.1 68.74 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.669 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.55 142.5 28.54 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 9.4 pt-20 -117.98 138.64 52.05 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -124.3 142.71 51.05 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.0 m -102.57 117.79 35.44 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.046 0.451 . . . . 0.0 111.222 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.54 173.4 11.58 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 123.168 0.587 . . . . 0.0 109.991 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.454 ' O ' HD13 ' A' ' 103' ' ' LEU . 3.7 ptm180 -95.38 173.8 7.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.569 0.622 . . . . 0.0 112.277 -173.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 53.8 ttp85 -58.37 -40.79 83.22 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.809 0.444 . . . . 0.0 111.535 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.13 12.06 7.06 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.7 p -115.75 5.65 14.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.587 1.184 . . . . 0.0 108.477 170.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 99' ' ' ARG . 9.5 mp -112.21 153.06 27.66 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.104 175.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 C--N 1.285 -2.222 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.211 179.357 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.626 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 25.6 p90 . . . . . 0 N--CA 1.438 -1.058 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.441 ' O ' ' HB ' ' A' ' 8' ' ' THR . 4.1 pp -145.23 134.87 23.38 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 9.2 t 176.41 25.3 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 O-C-N 124.13 0.894 . . . . 0.0 111.127 174.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 p -75.9 132.48 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 O-C-N 121.173 -0.954 . . . . 0.0 109.475 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.8 -3.77 74.61 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.403 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.418 ' HB ' ' HG1' ' A' ' 8' ' ' THR . 11.3 m -91.76 153.45 19.6 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-O 121.093 0.473 . . . . 0.0 109.978 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -103.7 111.44 23.94 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -119.14 173.22 5.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.181 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -95.26 135.18 37.17 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.05 127.06 39.15 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.493 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 21.5 ptmt -88.75 117.35 27.67 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.742 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.556 ' CE2' ' HB2' ' A' ' 22' ' ' CYS . 50.7 p90 -133.5 138.0 45.91 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 70.3 ttt180 64.2 25.77 13.68 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 122.326 1.06 . . . . 0.0 108.666 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.17 18.09 77.75 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.552 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.69 130.72 47.57 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.493 ' CD2' ' HB3' ' A' ' 16' ' ' LYS . 33.9 m-85 -86.53 110.38 19.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.556 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 73.1 m -126.64 155.37 42.68 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.82 149.4 32.57 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.246 -1.381 . . . . 0.0 111.756 -176.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.88 149.35 35.19 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.475 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -104.0 126.95 51.51 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.993 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.4 mt -69.27 121.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.954 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -111.56 -37.55 5.18 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.387 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 9.3 m -129.06 145.26 51.32 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.6 t -135.66 133.07 51.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 123.674 0.79 . . . . 0.0 108.955 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -122.92 111.09 16.22 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . 0.626 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 46.1 mtm-85 -86.65 107.0 17.99 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.127 0.489 . . . . 0.0 109.891 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -124.65 137.62 54.35 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 43.3 t -92.56 129.16 43.54 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.001 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.859 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -90.73 101.17 13.92 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.2 t -93.51 130.97 41.75 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.942 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.484 -170.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 88.0 tttt -98.36 106.26 18.52 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 m -112.7 143.37 22.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 CA-C-O 121.396 0.617 . . . . 0.0 111.217 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.0 tp -111.09 120.85 43.71 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.032 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.4 HD22 ' HB2' ' A' ' 75' ' ' ALA . 68.1 mt -73.13 116.81 14.11 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -68.47 -26.79 65.67 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.613 0.721 . . . . 0.0 110.083 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -70.83 -36.51 72.93 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.054 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -128.03 -19.6 3.95 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -171.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 78.43 15.19 1.3 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.274 1.03 . . . . 0.0 112.829 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.59 142.18 28.05 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -115.07 132.52 56.57 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.641 0.734 . . . . 0.0 109.434 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 2.2 mp0 -120.49 147.06 45.62 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.687 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.4 mt -122.29 101.65 7.64 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.72 -178.04 2.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -175.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -96.02 165.98 11.99 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.739 178.366 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.68 -4.66 3.2 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.103 0.961 . . . . 0.0 113.162 -177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.66 -30.59 41.27 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.427 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 79.7 mm-40 -82.46 -23.38 34.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.832 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.71 131.42 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.317 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -112.78 104.59 12.62 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.8 -176.0 21.16 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.597 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.23 144.39 99.49 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 123.742 2.961 . . . . 0.0 113.447 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.01 82.35 2.55 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.004 0.907 . . . . 0.0 108.587 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.548 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 79.3 ttt180 -139.86 133.61 30.51 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.627 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.01 119.36 12.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.23 4.0 53.76 Favored Glycine 0 C--N 1.292 -1.883 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.962 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.73 143.67 27.45 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.921 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.2 mt -93.74 124.05 46.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.489 0.662 . . . . 0.0 109.278 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.31 -172.54 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.881 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.71 148.27 44.17 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 8.8 t -145.38 152.88 40.56 Favored 'General case' 0 C--N 1.276 -2.61 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.939 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.427 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 40.3 ttm180 -78.73 126.88 31.32 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 174.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 71' ' ' SER . 7.2 t -98.87 159.05 15.23 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 174.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.2 m -66.05 -2.79 4.41 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.83 -22.43 61.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.75 -22.8 16.01 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.595 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 67' ' ' THR . 24.8 m -99.12 161.46 13.61 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.025 0.44 . . . . 0.0 111.964 -177.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 65' ' ' THR . 53.3 m-85 -93.09 124.11 36.83 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.039 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -122.26 162.08 22.1 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -78.05 128.1 33.33 Favored 'General case' 0 C--O 1.254 1.311 0 C-N-CA 123.387 0.675 . . . . 0.0 109.238 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB2' HD22 ' A' ' 39' ' ' LEU . . . -143.02 171.96 13.35 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.699 -175.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.59 139.01 51.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -70.63 122.13 21.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.3 m -102.22 -23.36 14.03 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.236 0.541 . . . . 0.0 110.109 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -163.7 144.41 8.8 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -120.9 116.06 24.41 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 167.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 N--CA 1.411 -2.385 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.506 -167.231 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TRP . . . . . 0.478 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 46.9 m95 -99.09 131.42 45.14 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -122.15 120.29 33.79 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . 0.452 ' CG2' ' HB3' ' A' ' 95' ' ' GLU . 89.2 m -98.16 109.38 22.14 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 17.5 m -106.25 148.25 10.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.314 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.24 123.72 54.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.566 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -92.33 -175.33 3.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.521 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.5 -33.0 13.4 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.382 1.873 . . . . 0.0 112.643 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -78.74 -16.95 56.58 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.414 0.626 . . . . 0.0 111.648 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.09 16.05 59.95 Favored Glycine 0 C--N 1.31 -0.865 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -172.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.79 135.83 38.18 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 114.039 -1.08 . . . . 0.0 108.855 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.452 ' HB3' ' CG2' ' A' ' 87' ' ' THR . 42.9 mt-10 -102.84 128.69 49.5 Favored 'General case' 0 C--N 1.277 -2.571 0 O-C-N 124.309 1.006 . . . . 0.0 110.144 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -136.29 140.64 43.55 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.478 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 26.7 m -89.68 111.92 23.03 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 122.524 0.33 . . . . 0.0 110.643 -177.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.0 mt -110.54 172.41 6.88 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.111 0.482 . . . . 0.0 110.973 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -99.27 169.04 9.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.783 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -68.19 -25.11 65.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.276 0.56 . . . . 0.0 110.521 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.0 m -83.18 4.04 28.36 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.934 0.873 . . . . 0.0 109.81 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.4 m -120.56 -0.47 10.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.32 162.18 28.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.102 -174.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 N--CA 1.42 -1.955 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.432 174.785 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -83.03 34.98 0.47 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.928 1.347 . . . . 0.0 108.629 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.31 177.0 1.73 Allowed Pre-proline 0 C--N 1.287 -2.113 0 C-N-CA 124.875 1.27 . . . . 0.0 109.037 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 25.9 Cg_exo -66.91 88.19 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.55 1.5 . . . . 0.0 109.689 168.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.44 -15.04 19.79 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.957 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.486 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 27.7 t80 -153.91 -58.07 0.12 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.633 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 95.9 mt -123.24 -160.26 0.89 Allowed 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 167.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.468 HG22 ' OG1' ' A' ' 11' ' ' THR . 1.4 t -122.45 150.96 41.77 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 118.189 0.45 . . . . 0.0 111.908 -169.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -91.59 145.39 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.289 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.34 -13.13 67.9 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.468 ' OG1' HG22 ' A' ' 8' ' ' THR . 13.7 m -73.43 141.42 46.9 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 123.344 0.658 . . . . 0.0 111.174 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -89.71 131.29 35.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.657 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 26.8 m -135.71 175.8 9.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.595 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.5 m -117.08 144.82 44.23 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -121.28 139.09 53.86 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -75.87 136.11 40.15 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.329 0.585 . . . . 0.0 112.077 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -133.95 105.27 6.65 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.845 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 60.37 26.59 16.14 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 173.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.85 8.1 60.83 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.856 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.45 164.32 17.33 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -102.33 135.96 43.02 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.081 0.238 . . . . 0.0 111.003 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.5 t -122.33 146.86 46.92 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -88.04 151.24 22.9 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.384 -0.927 . . . . 0.0 109.502 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.438 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -152.79 162.32 41.42 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.8 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -126.61 126.29 43.37 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.462 ' HA ' HG13 ' A' ' 88' ' ' VAL . 52.3 mt -66.64 111.53 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -87.8 -44.43 11.12 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 124.858 1.263 . . . . 0.0 110.325 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 m -139.59 145.29 38.38 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -116.95 126.54 74.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -130.55 116.31 17.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.91 108.53 21.24 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.411 ' N ' HD23 ' A' ' 32' ' ' LEU . 2.0 pt? -139.14 158.78 43.57 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.738 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 14.5 p -125.27 137.27 58.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -90.29 101.06 13.79 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 122.128 0.966 . . . . 0.0 108.852 178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.405 HG13 HG13 ' A' ' 37' ' ' VAL . 20.8 t -83.8 120.95 35.73 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.122 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -85.34 107.86 17.54 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 173.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.455 HG22 ' OE1' ' A' ' 46' ' ' GLN . 1.7 m -112.71 157.08 13.55 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.111 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -135.41 121.57 20.18 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.584 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 73.1 mt -69.8 129.33 39.26 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.005 -176.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.475 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.1 ptpt -68.71 -32.4 72.18 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.546 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 23.2 tt0 -81.1 -59.95 2.47 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 120.924 0.392 . . . . 0.0 110.956 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -85.57 -4.3 59.12 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 39' ' ' LEU . 9.6 p30 56.38 18.62 3.53 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.729 1.612 . . . . 0.0 113.543 178.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.53 137.51 32.25 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-O 120.965 0.412 . . . . 0.0 111.165 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 m -101.11 148.16 25.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.455 ' OE1' HG22 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -152.44 163.39 39.62 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 123.133 0.573 . . . . 0.0 110.236 175.418 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.8 tp -128.99 103.13 6.83 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.53 162.52 37.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.518 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.9 pm0 -77.23 161.5 28.1 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -62.98 -6.02 3.48 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.618 1.167 . . . . 0.0 113.617 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -82.21 -27.63 32.45 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.776 0.798 . . . . 0.0 108.988 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -87.05 -22.51 25.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.223 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.8 117.21 48.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.47 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -102.8 105.37 15.77 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.315 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.405 ' HA3' HG13 ' A' ' 63' ' ' VAL . . . 149.63 -179.39 26.45 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.638 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.79 141.1 93.87 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.336 2.691 . . . . 0.0 113.562 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.27 83.45 3.87 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.467 ' HB3' ' HB1' ' A' ' 61' ' ' ALA . 47.2 ttp180 -139.13 135.9 34.56 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.57 122.79 18.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.87 12.18 59.46 Favored Glycine 0 N--CA 1.423 -2.214 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.422 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' A' ' 58' ' ' ARG . . . -97.2 157.73 15.8 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 118.161 0.981 . . . . 0.0 110.789 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.9 mm -97.36 121.74 48.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.405 HG13 ' HA3' ' A' ' 55' ' ' GLY . 29.6 m -136.4 -173.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 122.927 0.491 . . . . 0.0 109.893 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -128.88 132.25 47.71 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.1 t -133.79 158.56 43.03 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-O 120.792 0.329 . . . . 0.0 110.369 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.4 ttm-85 -83.94 115.37 22.27 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.309 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.434 HG23 ' O ' ' A' ' 71' ' ' SER . 5.1 t -81.72 167.2 19.38 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.7 p -67.7 -2.35 6.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.927 0.87 . . . . 0.0 112.219 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -85.93 -16.31 38.85 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.067 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.5 -2.94 71.23 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.434 ' O ' HG23 ' A' ' 67' ' ' THR . 8.2 m -92.26 159.97 15.37 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -109.74 115.73 30.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.584 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 7.2 tt0 -113.37 148.35 35.95 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.618 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.475 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 35.3 tt0 -70.4 125.17 26.05 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -136.91 173.92 11.18 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.358 -173.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.4 mp -123.67 139.99 48.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -75.5 126.2 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.2 m -108.33 -17.32 14.03 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.336 0.112 . . . . 0.0 110.892 177.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -166.65 151.69 7.8 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.0 mt -124.36 112.87 17.46 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 169.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.8 m -95.52 122.18 37.99 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -59.72 142.04 53.95 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.96 0.41 . . . . 0.0 111.01 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -151.88 165.07 35.68 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 99' ' ' ARG . 75.2 m -170.42 135.47 1.23 Allowed 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.488 ' CE3' ' HB ' ' A' ' 97' ' ' THR . 46.1 m95 -107.61 107.92 18.95 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.079 0.466 . . . . 0.0 110.05 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.486 ' OH ' ' HB3' ' A' ' 6' ' ' TYR . 96.5 m-85 -101.64 103.45 14.25 Favored 'General case' 0 N--CA 1.404 -2.742 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.4 m -76.16 104.09 6.52 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 25.4 m -112.28 141.14 28.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-O 121.261 0.553 . . . . 0.0 111.172 -175.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 9.7 t -97.36 118.16 43.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.095 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -84.44 168.47 15.49 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -61.36 -21.27 63.89 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.12 0.486 . . . . 0.0 111.218 -175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.1 -16.87 63.18 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 123.666 0.786 . . . . 0.0 111.113 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.62 1.94 58.79 Favored Glycine 0 CA--C 1.507 -0.468 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.4 138.85 33.38 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 9.6 pt-20 -120.58 128.57 53.18 Favored 'General case' 0 C--N 1.284 -2.245 0 O-C-N 123.522 0.514 . . . . 0.0 110.413 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -131.54 149.61 52.45 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.488 ' HB ' ' CE3' ' A' ' 85' ' ' TRP . 2.3 p -79.75 112.72 17.29 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 122.383 0.273 . . . . 0.0 111.048 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.83 137.73 48.11 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.195 0.522 . . . . 0.0 110.682 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.54 ' HA ' ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -76.34 143.62 40.66 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 175.272 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.473 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 2.5 tmm_? -44.07 -33.13 1.37 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.619 1.167 . . . . 0.0 113.265 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 24.3 m -55.31 -32.91 62.83 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.016 0.926 . . . . 0.0 112.047 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.472 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 35.1 m -82.69 -16.59 47.56 Favored 'General case' 0 N--CA 1.433 -1.306 0 O-C-N 122.063 -0.398 . . . . 0.0 110.849 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 mp -86.87 128.97 35.06 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.79 0.805 . . . . 0.0 111.462 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 20.0 m -105.16 1.19 28.08 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.902 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.657 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 82.9 mt 59.46 -88.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.971 0.908 . . . . 0.0 112.602 -176.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.419 ' HB3' ' OE1' ' A' ' 108' ' ' GLU . 40.4 ttmt -88.44 -43.15 11.68 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.43 21.99 4.58 Favored Glycine 0 N--CA 1.432 -1.596 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.829 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.419 ' OE1' ' HB3' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -69.21 144.13 53.8 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 178.055 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 mtm-85 -77.56 73.33 4.13 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -172.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -129.23 14.07 6.16 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 169.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -131.15 171.21 13.55 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 112.826 -1.988 . . . . 0.0 106.124 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 73.9 -53.56 0.69 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.28 1.432 . . . . 0.0 111.357 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.37 -70.24 0.74 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.7 m -73.34 150.32 41.94 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.636 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 170.93 109.28 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 125.582 1.553 . . . . 0.0 108.336 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.6 p -108.81 11.38 26.26 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.183 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 mp 73.39 22.76 2.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.324 1.05 . . . . 0.0 110.302 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 . . . . . 0 C--N 1.307 -1.263 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 176.482 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.418 ' H3 ' ' CG ' ' A' ' 82' ' ' ASP . . . . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 120.782 0.325 . . . . 0.0 110.293 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.493 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 27.9 t70 -95.38 -34.93 11.95 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.47 ' OE1' ' HA ' ' A' ' 83' ' ' ALA . 30.9 mt-10 -104.56 97.69 12.9 Favored Pre-proline 0 N--CA 1.442 -0.828 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 175.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 2' ' ' ASP . 12.8 Cg_exo -73.86 -9.29 22.25 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.187 2.591 . . . . 0.0 112.046 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.49 27.57 0.5 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.815 1.246 . . . . 0.0 111.324 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.695 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 39.6 p90 -76.81 99.45 5.15 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-O 122.605 1.193 . . . . 0.0 109.948 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.8 mt -76.88 177.32 7.78 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 112.82 -1.991 . . . . 0.0 109.801 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.422 ' HA ' HG21 ' A' ' 29' ' ' VAL . 10.6 p -133.4 166.57 22.22 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.374 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.4 111.41 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.98 -26.52 2.2 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.6 m -71.64 137.93 48.27 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -116.33 125.68 52.46 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.461 ' CG2' HD22 ' A' ' 103' ' ' LEU . 33.9 m -144.79 -178.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 9.4 t -99.26 147.46 25.14 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 175.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -137.75 128.8 27.42 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 123.324 0.65 . . . . 0.0 109.396 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 51.1 mtpt -70.54 121.09 17.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.955 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -148.46 138.55 22.44 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 60.65 26.13 15.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.167 0.587 . . . . 0.0 111.46 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.55 3.05 72.1 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.184 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.06 145.53 44.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 117.652 0.726 . . . . 0.0 110.157 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 21.7 p90 -93.58 120.61 34.07 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.987 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 83.7 m -123.63 173.63 7.96 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.11 146.5 41.35 Favored 'General case' 0 C--O 1.253 1.242 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.21 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -152.12 147.78 26.86 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.416 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -116.6 128.36 55.32 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.428 ' HA ' HG11 ' A' ' 88' ' ' VAL . 28.4 mt -62.36 116.09 2.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -90.37 -40.32 12.15 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.601 1.16 . . . . 0.0 110.118 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 87.4 m -144.41 145.98 32.23 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.278 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 8' ' ' THR . 96.0 t -129.29 128.75 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.086 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 84' ' ' SER . 21.8 mmmt -118.29 102.66 9.14 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.637 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -77.15 88.0 3.62 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.403 HD13 ' HB3' ' A' ' 83' ' ' ALA . 3.5 pp -111.09 153.58 25.47 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.958 0.885 . . . . 0.0 112.437 -172.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.521 ' CG1' ' HB3' ' A' ' 80' ' ' LEU . 60.3 t -115.81 120.61 65.3 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.365 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 26.4 mtpp -85.59 99.02 10.99 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.407 HG12 HG11 ' A' ' 37' ' ' VAL . 21.4 t -84.41 123.8 39.31 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.928 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 87.7 tttt -87.99 115.41 25.44 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 171.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 45' ' ' THR . 1.7 m -118.46 143.38 29.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.427 0.632 . . . . 0.0 112.077 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.538 HD21 ' O ' ' A' ' 44' ' ' THR . 1.9 tm? -107.21 116.89 32.72 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 44.8 mt -74.7 124.6 27.04 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.434 ' HB3' HD12 ' A' ' 76' ' ' ILE . 22.2 pttp -72.82 -29.29 63.12 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -78.2 -38.92 42.11 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.947 0.403 . . . . 0.0 111.595 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.543 ' OD1' ' HB ' ' A' ' 44' ' ' THR . 14.6 t70 -93.33 -25.55 17.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.864 0.364 . . . . 0.0 110.948 -176.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 70.26 22.31 5.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.29 1.036 . . . . 0.0 111.24 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.543 ' HB ' ' OD1' ' A' ' 42' ' ' ASP . 5.6 t -101.23 -174.8 2.69 Favored 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 121.475 0.655 . . . . 0.0 110.049 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.7 m -136.24 139.65 42.9 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.25 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.01 156.93 44.29 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.1 tt -140.96 103.8 4.55 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 25.6 m -126.03 -178.49 2.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.746 -172.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -100.7 173.06 6.7 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -43.03 -29.86 0.38 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 128.657 2.783 . . . . 0.0 114.754 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.35 -28.01 31.84 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.121 -174.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.478 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 8.0 mm-40 -90.19 -16.48 29.39 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.421 0.629 . . . . 0.0 109.443 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -97.57 109.37 23.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.509 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -99.03 106.88 19.17 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.525 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 139.18 -171.3 23.73 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.406 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.32 137.58 23.58 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.136 2.558 . . . . 0.0 113.495 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.5 mt -90.03 81.98 6.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.61 128.63 23.64 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.629 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 t -65.97 116.27 5.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.37 6.19 51.16 Favored Glycine 0 N--CA 1.431 -1.699 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.836 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.39 165.2 12.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.391 0.596 . . . . 0.0 111.228 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.5 mm -96.14 124.27 48.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 O-C-N 123.6 0.563 . . . . 0.0 109.935 178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.401 ' CG1' HD12 ' A' ' 77' ' ' ILE . 19.7 m -131.61 178.08 6.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -121.6 121.4 37.32 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 8.4 t -116.37 158.04 24.1 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.816 -175.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.478 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 23.1 mtt180 -79.15 143.55 35.34 Favored 'General case' 0 CA--C 1.479 -1.782 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.037 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.1 p -97.92 175.25 6.2 Favored 'General case' 0 N--CA 1.404 -2.727 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.205 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.4 m -76.7 -17.92 58.82 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.252 0.549 . . . . 0.0 111.095 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -84.11 -21.12 31.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.819 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.8 6.01 23.37 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.368 -0.92 . . . . 0.0 114.424 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.9 p -99.3 177.27 5.25 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 117.619 0.71 . . . . 0.0 110.387 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.435 ' CE1' ' HG3' ' A' ' 66' ' ' ARG . 60.6 m-85 -108.46 137.26 46.71 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.119 0.485 . . . . 0.0 110.792 175.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -122.43 141.75 51.27 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.28 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -74.36 118.69 17.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.715 0.769 . . . . 0.0 109.004 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -134.25 166.82 21.91 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.322 -175.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 3.5 mp -112.14 141.89 26.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.401 HD12 ' CG1' ' A' ' 63' ' ' VAL . 3.2 mp -74.26 122.57 27.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -101.18 -27.3 13.3 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.264 0.554 . . . . 0.0 110.241 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 53.7 tptt -162.72 142.24 9.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.521 ' HB3' ' CG1' ' A' ' 33' ' ' VAL . 25.3 mt -119.0 127.09 53.13 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 171.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.532 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 3.7 m -106.49 104.3 13.96 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.418 ' CG ' ' H3 ' ' A' ' 1' ' ' ALA . 25.9 t70 -67.59 120.26 13.71 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.47 ' HA ' ' OE1' ' A' ' 3' ' ' GLU . . . -143.73 -176.91 5.16 Favored 'General case' 0 N--CA 1.432 -1.331 0 O-C-N 123.852 0.72 . . . . 0.0 110.433 -174.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 49.2 m -163.22 135.95 5.45 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -118.59 145.25 45.54 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.695 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 55.5 m-85 -124.69 121.9 35.97 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 124.152 0.907 . . . . 0.0 109.115 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 70.5 m -95.09 107.73 19.8 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.428 HG11 ' HA ' ' A' ' 26' ' ' ILE . 30.3 m -109.64 147.16 14.25 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.884 -176.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.92 128.48 57.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -90.49 179.06 5.94 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.915 -172.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -52.0 -39.71 59.83 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.488 1.515 . . . . 0.0 112.809 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.39 -13.73 58.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.421 0.629 . . . . 0.0 111.866 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.49 -0.44 43.06 Favored Glycine 0 C--N 1.292 -1.884 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.84 175.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -87.56 154.08 20.9 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -130.42 137.61 49.92 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 120.861 0.362 . . . . 0.0 110.084 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 87' ' ' THR . 0.6 OUTLIER -139.21 158.64 43.8 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.886 -177.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.1 m -101.57 117.22 34.47 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.444 0.465 . . . . 0.0 110.235 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.2 165.1 26.52 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.078 0.951 . . . . 0.0 111.909 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -100.12 -171.3 2.01 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.6 mpt_? -75.93 -5.34 45.69 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.654 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 p -71.27 -21.13 62.14 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.671 0.748 . . . . 0.0 110.11 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.523 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 23.3 m -106.64 -16.17 14.58 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.053 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 14' ' ' SER . 87.6 mt -93.05 127.33 38.54 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.612 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 18.8 m -96.67 90.71 5.41 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 121.168 0.508 . . . . 0.0 110.431 -176.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 61.1 mt -83.28 -26.2 30.89 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 171.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.61 -173.73 3.95 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.04 130.16 5.99 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.981 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.32 147.61 36.63 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 72.88 -56.99 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.533 1.133 . . . . 0.0 110.699 -171.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -135.88 155.65 49.99 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -124.78 125.92 44.81 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.528 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 115' ' ' GLU . . . 69.13 -51.58 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.973 1.709 . . . . 0.0 111.839 177.148 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.13 6.34 3.57 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 125.578 1.551 . . . . 0.0 110.692 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.6 m -64.18 -19.46 65.34 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.571 1.149 . . . . 0.0 109.032 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.411 ' HG3' ' O ' ' A' ' 112' ' ' ALA . 44.8 mt-10 -66.31 -23.95 66.46 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.975 175.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.7 m -99.46 97.52 8.53 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -151.0 -63.04 0.19 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 C--N 1.307 -1.265 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.218 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -1.009 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -104.19 -30.68 10.04 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -73.68 115.76 45.03 Favored Pre-proline 0 N--CA 1.423 -1.808 0 CA-C-N 112.72 -2.036 . . . . 0.0 109.766 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -95.55 -4.7 1.94 Allowed 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.085 1.857 . . . . 0.0 113.438 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.46 -19.53 23.77 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 121.895 -0.503 . . . . 0.0 110.751 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -167.96 136.97 2.49 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.473 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 22.1 mt -85.88 178.71 7.2 Favored 'General case' 0 C--N 1.277 -2.571 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.586 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 p -133.0 168.34 18.65 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.264 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.29 148.66 11.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 123.853 0.861 . . . . 0.0 111.562 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.23 -5.94 81.17 Favored Glycine 0 CA--C 1.505 -0.531 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.963 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.425 ' HB ' HD11 ' A' ' 26' ' ' ILE . 8.6 m -82.62 139.82 33.55 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 122.346 0.258 . . . . 0.0 110.532 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -104.93 111.06 23.69 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.461 ' HB ' ' O ' ' A' ' 104' ' ' CYS . 29.3 m -127.24 171.97 14.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 21.2 m -95.11 142.81 27.13 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.598 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.78 129.36 36.48 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.027 0.531 . . . . 0.0 109.701 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.569 ' CD ' ' HA ' ' A' ' 111' ' ' PHE . 21.1 ptmt -94.83 120.31 34.84 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.706 0.765 . . . . 0.0 110.379 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -119.97 120.97 37.9 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? 63.78 26.28 14.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.53 0.681 . . . . 0.0 110.729 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.85 -14.88 63.09 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.501 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.31 130.17 52.15 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . 0.289 6.6 p90 -105.0 123.96 48.7 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -177.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.2 t -115.06 160.61 19.42 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -90.69 148.94 22.28 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-O 121.887 0.851 . . . . 0.0 110.08 178.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.484 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . . . -144.54 149.34 35.71 Favored 'General case' 0 C--N 1.259 -3.334 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.699 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.76 126.26 51.65 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.583 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.425 HD11 ' HB ' ' A' ' 11' ' ' THR . 30.8 mt -68.95 119.45 14.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 123.526 0.73 . . . . 0.0 112.268 -175.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -91.29 -53.38 4.37 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.057 0.932 . . . . 0.0 109.455 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 m -129.71 143.41 50.8 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.463 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.71 123.66 61.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.301 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -112.71 117.98 33.72 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 171.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -72.05 108.31 5.2 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 84' ' ' SER . 6.6 tt -129.34 136.76 50.43 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-O 121.544 0.688 . . . . 0.0 109.34 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.4 t -115.59 132.97 63.41 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.126 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.088 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -84.69 101.54 12.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 170.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.3 t -91.8 118.27 36.86 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.07 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.779 -176.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.455 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 87.7 tttt -80.52 103.71 10.56 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 45' ' ' THR . 3.9 m -111.55 143.52 21.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-O 121.689 0.757 . . . . 0.0 111.21 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.04 117.13 32.46 Favored 'General case' 0 C--N 1.267 -3.018 0 CA-C-N 113.149 -1.841 . . . . 0.0 106.91 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.481 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 75.7 mt -73.72 108.5 6.59 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -62.25 -30.32 71.03 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -80.22 -40.15 27.69 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.241 0.543 . . . . 0.0 111.697 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -95.05 -25.38 16.49 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.242 0.544 . . . . 0.0 111.384 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 74.42 22.67 2.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.524 1.53 . . . . 0.0 113.12 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.97 150.17 24.47 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.655 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.9 m -119.03 151.87 37.44 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -157.85 161.88 38.35 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 123.451 0.7 . . . . 0.0 109.619 177.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 mt -113.11 102.31 10.27 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.7 m -117.94 172.51 5.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.597 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -84.9 161.5 19.82 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.058 0.456 . . . . 0.0 111.963 -174.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -64.44 -20.15 65.99 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.271 1.029 . . . . 0.0 111.06 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.58 -21.92 47.88 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.783 0.801 . . . . 0.0 109.533 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -98.31 -11.57 22.41 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.656 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.88 111.51 27.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.569 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -98.4 103.75 15.72 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.227 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.466 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 140.71 178.87 17.63 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.505 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.53 140.32 80.98 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.346 2.697 . . . . 0.0 113.93 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -89.35 82.27 6.51 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.525 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 73.5 mtp180 -140.11 134.47 31.32 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.455 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.79 118.61 10.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.17 53.86 Favored Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.43 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -96.33 155.84 16.59 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.704 0.752 . . . . 0.0 110.619 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.09 116.92 39.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.426 0.632 . . . . 0.0 109.334 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.466 HG12 ' HA3' ' A' ' 55' ' ' GLY . 30.4 m -126.82 170.61 16.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.565 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -112.84 121.46 44.75 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.485 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 9.2 t -119.68 157.59 28.2 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.956 -174.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -81.93 126.17 31.61 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.759 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.7 p -90.31 -176.07 4.7 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.0 m -67.26 -26.31 66.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -79.85 -6.9 58.25 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.387 0.613 . . . . 0.0 110.56 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.27 -18.57 56.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.51 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 m -72.78 141.75 48.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 122.786 0.434 . . . . 0.0 110.081 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.485 ' HA ' ' O ' ' A' ' 65' ' ' THR . 45.0 m-85 -89.88 133.23 34.87 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.481 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 32.0 tt0 -124.09 146.52 48.55 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.05 117.31 19.24 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 122.484 1.135 . . . . 0.0 110.754 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -124.93 174.03 8.25 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 113.494 -1.685 . . . . 0.0 110.987 -174.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.481 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 10.9 mt -117.15 144.34 25.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.525 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -77.88 125.85 37.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 175.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 t -102.64 -20.89 14.25 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -173.92 153.32 2.12 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.4 OUTLIER -129.77 115.39 17.22 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.759 0.79 . . . . 0.0 111.437 172.609 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.9 m -105.53 124.42 49.52 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.083 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.88 130.56 38.72 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.422 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.7 -67.95 0.94 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.468 ' HA ' ' HB3' ' A' ' 32' ' ' LEU . 31.2 m 67.87 145.35 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 124.848 1.259 . . . . 0.0 113.37 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -95.81 134.11 39.15 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.155 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.473 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 91.0 m-85 -125.89 104.42 8.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 55.2 m -83.53 106.9 15.64 Favored 'General case' 0 N--CA 1.408 -2.553 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.8 m -113.45 142.74 24.92 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.758 -174.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 9.9 p -99.39 125.29 52.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.78 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.484 ' CD1' ' HB3' ' A' ' 24' ' ' ALA . 72.4 m-85 -88.24 178.72 6.53 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.183 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.44 -31.85 56.29 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.015 0.926 . . . . 0.0 111.66 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.74 -17.09 64.37 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.894 0.877 . . . . 0.0 111.503 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.46 6.9 83.13 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.335 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -97.15 136.53 37.54 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 11.6 pt-20 -107.02 126.93 52.97 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.585 0.707 . . . . 0.0 110.06 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -122.5 145.35 48.39 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 44.4 m -87.65 119.86 28.38 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -109.69 166.21 11.08 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.226 0.536 . . . . 0.0 111.389 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -94.47 152.03 18.9 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.519 -1.219 . . . . 0.0 107.968 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -50.79 -49.53 58.18 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.888 1.275 . . . . 0.0 111.759 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 p -79.83 11.16 3.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.289 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 m -120.12 5.87 10.8 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 tp -117.95 165.87 13.19 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.764 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.461 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 43.5 t -133.76 108.61 8.6 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.5 tt -169.51 -50.81 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 167.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -157.35 144.87 18.73 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 168.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.11 30.57 9.21 Favored Glycine 0 C--N 1.301 -1.375 0 N-CA-C 106.291 -2.724 . . . . 0.0 106.291 -166.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.57 -10.38 57.92 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 126.369 1.868 . . . . 0.0 112.188 -172.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 18.1 mmt180 -72.18 134.49 45.72 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.255 -179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 86.68 -37.74 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 125.939 1.695 . . . . 0.0 109.691 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.569 ' HA ' ' CD ' ' A' ' 16' ' ' LYS . 59.5 t80 -64.33 -63.15 1.21 Allowed 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 171.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -98.42 89.49 4.45 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 172.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 105.35 2.49 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.76 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.2 t -101.56 -35.17 9.23 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -112.37 -9.86 13.82 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 171.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.1 m 77.54 -57.36 0.5 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.157 1.383 . . . . 0.0 109.627 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -96.32 47.31 1.08 Allowed 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 . . . . . 0 C--O 1.245 0.822 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.661 177.844 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.658 0.266 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.72 -34.98 79.04 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.974 0.892 . . . . 0.0 108.85 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.51 110.22 57.82 Favored Pre-proline 0 N--CA 1.428 -1.56 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.334 172.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -88.42 -159.9 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.346 2.031 . . . . 0.0 112.754 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.84 20.22 3.15 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.494 0.664 . . . . 0.0 110.724 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -152.75 148.94 27.83 Favored 'General case' 0 N--CA 1.394 -3.267 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.411 ' HB2' ' CE2' ' A' ' 86' ' ' TYR . 89.9 mt -94.03 174.82 6.96 Favored 'General case' 0 C--N 1.263 -3.193 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.5 p -133.33 161.1 35.42 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -69.73 149.39 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-O 121.429 0.633 . . . . 0.0 111.998 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.81 -7.77 55.61 Favored Glycine 0 C--N 1.289 -2.058 0 CA-C-N 114.547 -1.206 . . . . 0.0 113.722 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 t -102.65 164.42 11.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.16 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 17.3 t70 -117.25 128.48 55.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -172.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.78 173.88 12.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.844 0.83 . . . . 0.0 110.415 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.504 ' HB2' ' SG ' ' A' ' 104' ' ' CYS . 13.6 m -110.04 121.89 46.3 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 106.851 -1.536 . . . . 0.0 106.851 172.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.42 144.44 34.34 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -96.28 126.88 41.8 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.054 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -131.62 122.25 25.7 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? 59.44 26.67 15.64 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.224 0.535 . . . . 0.0 111.894 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.52 0.2 88.17 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.721 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.88 148.88 29.96 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -96.98 133.09 42.1 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.1 m -129.05 139.85 51.86 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.92 132.81 40.5 Favored 'General case' 0 N--CA 1.398 -3.056 0 C-N-CA 123.52 0.728 . . . . 0.0 109.341 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.53 144.36 21.68 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.52 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.488 ' HB2' ' HZ1' ' A' ' 25' ' ' LYS . 4.4 ttmp? -106.12 133.37 50.93 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -176.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.414 ' HA ' HG13 ' A' ' 88' ' ' VAL . 24.1 mt -64.95 110.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.301 0.572 . . . . 0.0 111.201 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -94.72 -40.72 9.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.298 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -133.24 143.24 48.98 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.866 0.365 . . . . 0.0 110.063 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.63 124.6 69.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.864 0.866 . . . . 0.0 109.159 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -118.22 112.47 20.15 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.089 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.407 ' HE ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -77.18 96.57 4.54 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.045 178.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 8.6 mp -122.59 114.74 21.04 Favored 'General case' 0 CA--C 1.462 -2.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.022 178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.8 t -115.73 114.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.38 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 94.2 mttt -79.25 106.01 10.98 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.978 0.894 . . . . 0.0 109.19 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.8 t -91.8 127.32 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.041 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.099 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 35.6 ttpt -97.36 127.73 43.57 Favored 'General case' 0 N--CA 1.406 -2.659 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.84 160.85 21.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.59 0 O-C-N 123.449 0.468 . . . . 0.0 109.764 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -122.74 118.35 27.86 Favored 'General case' 0 C--N 1.274 -2.674 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.1 mt -68.75 121.94 17.55 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.477 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -55.9 -44.27 78.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.396 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -80.85 -61.27 2.01 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.024 -173.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.94 -22.31 39.71 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.25 -0.887 . . . . 0.0 112.878 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.26 19.21 2.91 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.329 0.652 . . . . 0.0 112.743 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.7 142.22 31.82 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.2 m -109.18 137.44 47.06 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.483 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 3.6 tp60 -136.03 140.81 44.13 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -172.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 41.4 tp -119.67 101.96 8.28 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.6 t -135.71 152.9 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -175.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.524 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 5.3 pm0 -71.57 153.45 42.13 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.516 0.674 . . . . 0.0 112.523 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -55.8 -11.83 1.12 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.899 2.079 . . . . 0.0 114.234 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -77.82 -25.93 49.17 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.629 0.728 . . . . 0.0 110.557 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -106.97 -2.68 20.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.918 0.866 . . . . 0.0 110.144 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.1 t -101.44 113.27 37.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.953 174.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -94.1 97.99 10.68 Favored 'General case' 0 C--N 1.276 -2.605 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.278 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.412 ' HA3' HG13 ' A' ' 63' ' ' VAL . . . 153.78 -166.48 31.89 Favored Glycine 0 N--CA 1.429 -1.797 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.042 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.46 146.49 19.41 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.971 2.447 . . . . 0.0 112.293 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -98.25 82.21 2.89 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.847 1.308 . . . . 0.0 108.421 176.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 77' ' ' ILE . 19.4 tpt180 -140.78 117.97 11.3 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.723 -2.035 . . . . 0.0 107.26 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.428 ' HA ' ' CG2' ' A' ' 77' ' ' ILE . 47.1 t -56.54 123.44 7.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-N 118.439 0.563 . . . . 0.0 109.868 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.407 ' H ' ' HB ' ' A' ' 77' ' ' ILE . . . 98.43 7.83 55.45 Favored Glycine 0 N--CA 1.42 -2.406 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.84 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.484 ' O ' HG12 ' A' ' 77' ' ' ILE . . . -96.21 153.11 17.98 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 118.743 1.271 . . . . 0.0 109.575 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.407 HG12 HD13 ' A' ' 76' ' ' ILE . 65.2 mt -94.74 119.53 42.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.412 HG13 ' HA3' ' A' ' 55' ' ' GLY . 27.5 m -133.13 169.68 21.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.0 -175.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -111.97 120.17 41.0 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 18.9 m -106.56 146.53 30.54 Favored 'General case' 0 N--CA 1.396 -3.17 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -68.68 119.61 13.36 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.55 0.691 . . . . 0.0 111.058 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -92.21 161.84 14.56 Favored 'General case' 0 N--CA 1.403 -2.787 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.0 m -74.32 6.54 3.54 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.713 0.768 . . . . 0.0 111.688 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.6 -8.2 57.69 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.09 -22.08 39.35 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.03 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 m -99.27 -175.62 3.07 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 120.648 0.261 . . . . 0.0 110.726 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -111.55 136.74 50.31 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -124.05 154.49 39.85 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 177.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.23 123.08 20.19 Favored 'General case' 0 C--O 1.246 0.909 0 O-C-N 124.172 0.92 . . . . 0.0 111.645 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.19 170.89 14.88 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.475 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.407 HD13 HG12 ' A' ' 62' ' ' ILE . 9.8 mm -113.96 143.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 58' ' ' ARG . 11.4 mm -66.77 125.62 24.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.5 p -107.44 -25.91 11.2 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.152 0.501 . . . . 0.0 110.914 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -163.09 165.27 24.87 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.99 129.61 18.05 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.672 0.789 . . . . 0.0 108.976 172.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.3 m -127.77 125.65 40.29 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 123.412 0.685 . . . . 0.0 109.341 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -81.05 135.33 35.82 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.39 -66.3 1.09 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.1 m 53.33 104.92 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 124.812 1.32 . . . . 0.0 113.998 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -88.45 120.4 29.79 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.132 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.411 ' CE2' ' HB2' ' A' ' 7' ' ' LEU . 90.6 m-85 -113.35 110.52 20.47 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.479 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 27.7 m -89.33 108.21 19.5 Favored 'General case' 0 N--CA 1.389 -3.497 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.414 HG13 ' HA ' ' A' ' 26' ' ' ILE . 17.1 m -105.92 140.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.455 -176.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.21 139.98 29.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.597 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -91.27 172.75 8.32 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.63 -12.26 57.32 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.485 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -75.75 -17.92 59.73 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.174 175.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.18 -10.66 67.63 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.831 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -97.21 161.8 13.64 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' C ' ' HD2' ' A' ' 96' ' ' ARG . 9.3 pt-20 -137.6 157.47 46.44 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -171.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 87' ' ' THR . 4.2 mpt_? -129.54 151.4 50.19 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.895 0.878 . . . . 0.0 110.061 173.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.9 m -102.27 113.95 27.7 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 3.7 mm? -113.86 168.31 9.9 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.673 0.789 . . . . 0.0 110.946 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -89.31 157.31 18.25 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 173.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.459 ' C ' ' HD3' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -50.22 -38.1 38.65 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.518 0.599 . . . . 0.0 111.513 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.5 m -79.04 -3.66 46.31 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.459 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 15.7 m -98.56 5.75 47.64 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 121.114 -0.991 . . . . 0.0 108.376 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.7 mp -112.9 145.13 41.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.467 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 110' ' ' HIS . 5.9 p -133.57 97.15 3.86 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.209 172.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.01 -64.22 1.01 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.346 -178.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -159.41 -49.33 0.06 Allowed 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.573 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.24 -26.64 73.19 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -68.35 -31.72 71.32 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 56.52 45.89 21.56 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.737 0.815 . . . . 0.0 112.024 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.579 ' HA ' ' SG ' ' A' ' 104' ' ' CYS . 47.6 m80 65.62 98.68 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.09 0.869 . . . . 0.0 109.506 -178.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.438 ' CZ ' ' HA ' ' A' ' 102' ' ' SER . 15.1 p90 -75.09 121.19 21.66 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.51 45.46 1.83 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.98 -62.47 0.81 Allowed 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 113.785 -1.552 . . . . 0.0 114.074 -172.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 t 64.17 -64.18 0.14 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.036 1.334 . . . . 0.0 111.537 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -129.62 -179.41 5.16 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.6 m 71.27 107.66 0.06 Allowed 'General case' 0 CA--C 1.544 0.738 0 O-C-N 124.133 0.895 . . . . 0.0 110.05 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.61 103.42 15.55 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--N 1.3 -1.569 0 CA-C-O 118.27 -0.871 . . . . 0.0 109.511 172.915 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.578 0 CA-C-O 120.356 0.122 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.575 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 33.1 t70 -74.2 -37.62 63.83 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.265 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -92.69 106.54 19.07 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.407 178.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.575 ' HD3' ' O ' ' A' ' 2' ' ' ASP . 5.6 Cg_exo -79.21 -76.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.167 0 N-CA-C 108.343 -1.445 . . . . 0.0 108.343 172.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.83 7.77 11.03 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.525 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 40.4 p90 -159.26 149.08 18.83 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -174.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.588 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 21.3 mt -90.83 -176.0 4.54 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.656 0.597 . . . . 0.0 109.619 173.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -125.16 156.64 38.07 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.559 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -85.19 139.67 17.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -174.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.94 -5.65 83.17 Favored Glycine 0 CA--C 1.505 -0.586 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 96.8 m -79.68 133.89 36.39 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-O 121.491 0.662 . . . . 0.0 110.538 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -92.19 129.12 38.22 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.0 m -137.1 -178.88 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.763 0.792 . . . . 0.0 112.006 -173.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 m -125.69 135.79 52.49 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 172.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -127.65 135.35 50.12 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.546 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 19.6 pttp -93.06 143.21 26.47 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 118.62 -1.232 . . . . 0.0 113.599 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -134.78 124.93 25.94 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 58.11 25.47 12.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.552 1.141 . . . . 0.0 110.935 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.33 -9.42 76.17 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.327 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.74 131.43 50.93 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.546 ' CD2' ' HB3' ' A' ' 16' ' ' LYS . 76.6 m-85 -84.78 122.38 29.04 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.753 0.311 . . . . 0.0 110.704 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -106.98 149.0 27.98 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -80.5 143.38 33.36 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.32 148.51 16.63 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -115.49 132.52 56.6 Favored 'General case' 0 C--N 1.274 -2.709 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.712 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 63.2 mt -61.07 107.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.891 0.853 . . . . 0.0 111.681 -179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HG2' ' OE1' ' A' ' 95' ' ' GLU . 24.0 tptm -83.85 -44.99 13.74 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 125.517 1.527 . . . . 0.0 109.662 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 m -138.9 144.91 39.33 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.39 118.09 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 123.645 0.778 . . . . 0.0 109.808 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -123.14 107.85 12.19 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.015 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -77.43 105.47 8.58 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.507 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 1.3 pt? -132.88 120.5 21.59 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.219 0.533 . . . . 0.0 110.658 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.61 129.35 37.83 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.464 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 32.9 mmtp -83.02 104.93 13.6 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 t -95.56 125.5 48.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.964 -174.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.0 tttm -99.74 105.73 17.56 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.8 m -117.07 156.1 18.47 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-O 121.151 0.501 . . . . 0.0 111.486 -175.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -113.93 114.67 26.53 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 173.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.8 mt -68.93 113.54 6.43 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.309 0.0 OUTLIER -72.98 -19.04 61.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -90.08 -27.02 19.95 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.909 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -112.22 -8.85 13.95 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.277 0.56 . . . . 0.0 111.804 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 p30 58.7 16.55 4.46 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.554 1.942 . . . . 0.0 113.986 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -98.6 150.72 21.45 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 121.994 -0.441 . . . . 0.0 111.107 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 m -99.56 144.77 28.26 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -142.89 142.3 31.72 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -174.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.5 tp -125.42 102.62 7.49 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 176.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.16 178.73 4.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.921 -173.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.484 ' HG3' ' HB3' ' A' ' 51' ' ' ASP . 14.1 pt20 -92.02 154.53 18.71 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -174.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -54.63 -28.39 46.52 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 126.352 1.861 . . . . 0.0 111.515 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.484 ' HB3' ' HG3' ' A' ' 49' ' ' GLN . 8.2 t70 -63.38 -27.89 69.62 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.306 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -108.32 -9.54 15.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.985 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -100.38 127.29 53.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.233 0.54 . . . . 0.0 111.648 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -106.75 127.14 53.14 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.111 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.21 -173.28 17.93 Favored Glycine 0 C--N 1.296 -1.661 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.497 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -82.66 138.03 9.28 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.279 2.653 . . . . 0.0 112.311 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.7 83.03 4.79 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.79 0.805 . . . . 0.0 110.51 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.526 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 23.0 mtp180 -135.2 133.63 39.27 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.807 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.58 120.99 11.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.68 58.98 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.597 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.71 164.11 12.54 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 117.488 0.644 . . . . 0.0 111.46 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.6 mm -95.86 118.41 42.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.49 ' CG1' HD11 ' A' ' 77' ' ' ILE . 15.7 m -126.18 175.57 8.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -128.66 120.66 26.96 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.8 t -118.27 158.7 24.68 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.14 -174.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 67' ' ' THR . 37.2 ttm180 -76.87 139.48 40.28 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.334 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.469 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 16.9 p -94.1 171.82 8.61 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.8 m -55.7 -34.28 64.94 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -82.65 -4.92 58.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.96 3.93 56.83 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.483 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 58.1 m -87.53 168.75 12.79 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -121.7 139.85 53.05 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.111 0.482 . . . . 0.0 110.648 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -140.72 143.9 35.27 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.4 142.56 53.87 Favored 'General case' 0 C--O 1.254 1.326 0 CA-C-O 121.335 0.588 . . . . 0.0 110.946 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -148.97 164.66 33.9 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.87 -177.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.485 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 5.4 mm -110.19 137.17 43.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.526 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.5 mp -72.84 122.9 26.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.5 m -103.82 -19.85 14.13 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.114 0.483 . . . . 0.0 109.825 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -168.68 156.46 7.85 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.18 139.67 37.6 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 172.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.464 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 85.6 m -124.58 127.09 46.86 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.042 0.449 . . . . 0.0 110.475 -176.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -57.12 122.9 13.49 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.869 1.267 . . . . 0.0 110.604 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.507 ' HB1' ' O ' ' A' ' 32' ' ' LEU . . . -149.81 146.85 27.38 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-O 121.502 0.667 . . . . 0.0 109.775 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m -155.62 127.69 7.59 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 171.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -97.58 116.32 29.56 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-O 121.405 0.621 . . . . 0.0 110.621 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.588 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 53.3 m-85 -104.75 102.88 12.43 Favored 'General case' 0 N--CA 1.395 -3.205 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.4 m -79.91 105.61 11.32 Favored 'General case' 0 N--CA 1.384 -3.739 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.4 m -105.42 140.39 23.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 p -111.52 130.27 65.37 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.045 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.511 -174.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -83.24 163.97 20.41 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.76 -7.56 45.83 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.365 0.602 . . . . 0.0 110.617 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -72.18 -17.56 61.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.978 173.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.4 -9.31 60.84 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.298 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.06 144.72 25.64 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.517 ' OE1' ' HG2' ' A' ' 27' ' ' LYS . 2.8 pt-20 -124.37 131.72 53.51 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.407 0.622 . . . . 0.0 110.542 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -115.78 151.16 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 m -103.11 108.58 19.82 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 120.738 0.304 . . . . 0.0 110.22 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.27 156.21 31.69 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.705 0.402 . . . . 0.0 111.188 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -99.55 169.92 8.96 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -56.54 -23.4 39.7 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.7 m -60.31 -39.55 87.42 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.771 0.829 . . . . 0.0 111.679 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.447 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 15.0 m -90.27 -6.88 54.67 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 mp -102.5 153.9 19.62 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.511 -175.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.449 ' HB3' ' O ' ' A' ' 109' ' ' ARG . 72.8 m -135.26 18.44 3.4 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 44.1 tp 47.44 -90.78 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -119.02 -49.58 2.41 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 163.27 2.43 0.05 OUTLIER Glycine 0 C--N 1.303 -1.255 0 C-N-CA 119.951 -1.119 . . . . 0.0 112.855 -176.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -69.43 -34.87 75.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 104' ' ' CYS . 1.9 ptm180 -121.88 138.45 54.39 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 173.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -146.16 37.48 1.04 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.71 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 t80 62.4 81.11 0.21 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.273 1.429 . . . . 0.0 111.593 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 179.44 -60.84 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.43 ' CD ' ' HE ' ' A' ' 109' ' ' ARG . 36.4 mt-10 41.61 -90.01 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 127.279 2.232 . . . . 0.0 117.014 168.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.3 t -152.14 -159.88 1.07 Allowed 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -168.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -71.12 153.78 42.26 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 124.128 0.971 . . . . 0.0 110.053 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.4 p -89.78 160.46 16.51 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -147.96 136.94 22.01 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 . . . . . 0 C--O 1.256 1.436 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.267 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.518 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 6.8 m-20 -86.18 1.81 49.28 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -172.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -104.5 90.85 3.57 Favored Pre-proline 0 C--O 1.248 0.984 0 CA-C-O 121.799 0.809 . . . . 0.0 109.32 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 2' ' ' ASP . 10.1 Cg_endo -88.49 67.84 2.98 Favored 'Trans proline' 0 N--CA 1.423 -2.639 0 C-N-CA 121.945 1.764 . . . . 0.0 113.203 -174.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.08 -78.14 0.58 Allowed 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 171.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.453 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 18.9 p90 -178.94 131.98 0.12 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.8 mt -93.78 -161.54 0.86 Allowed 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 p -131.54 162.43 30.3 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -171.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.3 t -64.91 142.18 17.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.902 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.92 -32.97 6.0 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.9 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.444 ' HB ' HD11 ' A' ' 26' ' ' ILE . 4.0 m -56.97 138.95 53.49 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.993 0.917 . . . . 0.0 110.564 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -111.3 113.67 26.31 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.9 m -135.43 -179.15 2.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 123.102 0.561 . . . . 0.0 109.708 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 m -105.24 142.81 34.36 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.475 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.81 119.3 29.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.414 ' HE2' ' HA2' ' A' ' 19' ' ' GLY . 13.7 tmtt? -88.43 107.22 18.74 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -129.12 139.53 51.92 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 59.6 25.07 13.91 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 122.018 0.913 . . . . 0.0 110.427 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.414 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . 91.0 1.73 72.5 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.28 -0.962 . . . . 0.0 114.325 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.51 145.54 43.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 117.916 0.858 . . . . 0.0 109.905 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -106.1 133.9 50.07 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.033 0.92 . . . . 0.0 113.473 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.6 t -122.75 158.25 30.57 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -72.92 147.42 45.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 89' ' ' VAL . . . -149.82 142.33 24.4 Favored 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.57 -174.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 44.4 tttp -110.12 131.14 55.33 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.774 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.518 HD13 ' CD1' ' A' ' 86' ' ' TYR . 36.6 mt -66.39 115.67 4.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -101.24 -36.24 8.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.136 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.2 m -140.14 144.73 36.84 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.1 t -116.57 120.18 64.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.436 ' HD3' ' N ' ' A' ' 31' ' ' ARG . 1.5 tmtp? -113.93 140.59 48.26 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.436 ' N ' ' HD3' ' A' ' 30' ' ' LYS . 10.9 mmt180 -75.03 118.36 17.9 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.728 0.775 . . . . 0.0 111.688 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.506 ' HB3' ' N ' ' A' ' 84' ' ' SER . 58.7 tp -91.51 164.5 13.77 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 127.01 2.124 . . . . 0.0 107.256 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.56 124.27 63.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 118.142 -1.423 . . . . 0.0 110.844 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -94.79 104.22 16.12 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 122.557 1.17 . . . . 0.0 108.202 172.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.8 t -87.35 128.69 39.72 Favored 'Isoleucine or valine' 1 C--N 1.244 -4.002 0 CA-C-N 112.753 -2.022 . . . . 0.0 109.648 -174.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.408 ' CB ' ' HB3' ' A' ' 79' ' ' LYS . 86.9 tttt -98.77 112.15 24.31 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 15.9 m -115.78 153.98 17.3 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 121.386 0.612 . . . . 0.0 111.727 -175.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -116.97 114.75 24.25 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 62.6 mt -75.35 120.52 20.93 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -67.81 -30.24 69.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -79.53 -41.51 27.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.381 0.61 . . . . 0.0 111.725 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.85 -15.15 21.39 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.021 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.279 0.0 OUTLIER 63.21 16.93 9.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.664 1.985 . . . . 0.0 112.222 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -93.27 145.24 24.59 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.244 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -96.45 142.53 28.44 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -144.48 141.31 29.47 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.9 mt -100.87 113.25 26.02 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.78 179.72 2.84 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.033 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.528 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -117.08 165.09 13.78 Favored 'General case' 0 C--N 1.27 -2.866 0 O-C-N 122.29 -0.256 . . . . 0.0 110.527 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -59.35 -18.76 41.04 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.637 1.575 . . . . 0.0 111.86 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.539 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 12.0 t70 -70.93 -34.43 71.49 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.118 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 26.4 mt-30 -95.54 -10.54 29.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.181 -175.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.6 t -105.23 134.94 45.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.714 -177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -125.66 118.07 24.87 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.263 0.554 . . . . 0.0 110.73 168.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.411 ' HA3' HG13 ' A' ' 63' ' ' VAL . . . 142.77 -165.07 26.96 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.563 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.91 137.0 12.19 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.865 2.377 . . . . 0.0 113.131 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -96.51 81.57 3.25 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.553 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 42.5 ttp180 -140.85 139.49 34.47 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.109 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.3 t -67.21 122.39 18.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.55 4.18 59.43 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.753 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.08 161.65 14.19 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.947 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.6 mm -107.4 119.29 56.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.517 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.411 HG13 ' HA3' ' A' ' 55' ' ' GLY . 28.0 m -130.47 176.58 8.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -119.85 131.46 55.28 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.8 t -145.1 155.99 43.64 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.182 -171.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.605 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 46.7 ttt180 -89.26 122.42 32.5 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.483 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.8 t -84.62 168.02 15.72 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.2 p -70.78 -5.01 26.87 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.504 0.669 . . . . 0.0 111.611 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.66 -10.24 59.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.968 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.75 -22.2 36.25 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.98 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.5 p -87.75 144.81 26.43 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.605 ' CE1' ' HB2' ' A' ' 66' ' ' ARG . 87.1 m-85 -94.26 120.43 34.49 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -135.84 160.18 39.38 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -76.72 132.04 39.1 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.03 173.68 11.25 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 122.153 -0.342 . . . . 0.0 111.591 -175.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.45 140.69 42.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.1 mp -79.52 128.44 38.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 120.658 0.266 . . . . 0.0 110.564 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 m -107.2 -17.25 14.2 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.992 0.517 . . . . 0.0 110.871 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.408 ' HB3' ' CB ' ' A' ' 36' ' ' LYS . 50.3 tptt -171.87 156.48 4.19 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.17 143.4 50.58 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.0 p -134.76 159.53 41.04 Favored 'General case' 0 N--CA 1.423 -1.812 0 C-N-CA 122.693 0.397 . . . . 0.0 110.485 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.04 115.93 7.29 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 123.983 0.913 . . . . 0.0 111.168 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -118.94 -164.52 1.05 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.506 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 1.3 p -141.04 129.6 22.65 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -172.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.419 ' HB2' ' HB3' ' A' ' 30' ' ' LYS 0.265 75.6 m95 -95.98 155.87 16.57 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 168.202 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.518 ' CD1' HD13 ' A' ' 26' ' ' ILE . 89.5 m-85 -134.58 117.85 16.6 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.558 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 17.8 m -84.03 104.37 14.04 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.8 m -109.92 141.62 24.71 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.837 0 CA-C-O 121.502 0.668 . . . . 0.0 110.462 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 6.3 t -97.9 116.72 41.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -72.89 159.92 32.96 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -57.2 -20.78 28.93 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.772 0.796 . . . . 0.0 111.072 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.65 -16.76 64.32 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.944 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.28 -6.88 59.77 Favored Glycine 0 C--O 1.241 0.555 0 CA-C-O 121.478 0.488 . . . . 0.0 112.402 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -96.8 141.34 30.13 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.56 128.29 54.81 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -136.32 147.5 47.46 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 18.6 m -99.38 107.43 19.68 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.24 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.85 170.41 8.16 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.539 ' HD3' ' OD1' ' A' ' 51' ' ' ASP . 2.2 mpt_? -94.9 175.2 6.74 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -72.6 -3.05 22.4 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.453 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 m -71.48 -41.29 69.52 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -109.82 22.63 15.43 Favored 'General case' 0 C--O 1.252 1.217 0 CA-C-O 121.761 0.791 . . . . 0.0 110.171 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.6 tp -112.67 142.72 44.94 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.478 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 15.4 t -91.42 83.09 5.39 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 121.695 0.759 . . . . 0.0 110.249 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 92.1 mt -104.52 55.87 0.71 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.814 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 74.24 98.5 0.07 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.236 1.414 . . . . 0.0 111.021 -176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -144.63 130.56 3.97 Favored Glycine 0 N--CA 1.422 -2.291 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.829 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.493 ' C ' ' H ' ' A' ' 110' ' ' HIS . 0.2 OUTLIER -90.11 101.86 14.57 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 70.8 -30.54 0.21 Allowed 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 124.536 1.134 . . . . 0.0 111.484 -173.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.493 ' H ' ' C ' ' A' ' 108' ' ' GLU . 7.1 t-160 -65.9 89.02 0.11 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.771 1.628 . . . . 0.0 110.059 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 52.72 72.88 0.38 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.825 1.25 . . . . 0.0 111.724 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -163.89 -169.36 1.85 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.435 -1.257 . . . . 0.0 107.637 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -61.9 -19.36 62.6 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.299 7.7 p 60.66 83.25 0.15 Allowed 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.488 1.137 . . . . 0.0 111.949 -175.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -55.0 146.97 16.58 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 112.926 -1.943 . . . . 0.0 113.417 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.4 m -59.32 -29.12 67.4 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 124.912 1.285 . . . . 0.0 111.585 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.8 mt -85.77 9.3 16.89 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 C--O 1.243 0.741 0 CA-C-O 117.783 -1.103 . . . . 0.0 108.593 175.073 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.638 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.13 -36.31 35.46 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.2 mp0 -68.64 134.52 90.47 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 173.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.431 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 46.8 Cg_endo -71.05 84.72 0.85 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.787 1.658 . . . . 0.0 111.467 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.84 -29.71 16.59 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.673 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.737 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 45.2 p90 -127.2 127.29 44.25 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.688 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt -106.21 -175.68 2.86 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.645 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.9 p -131.33 158.53 40.43 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.33 130.59 28.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.66 38.19 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.043 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.432 ' HB ' HD12 ' A' ' 26' ' ' ILE . 33.2 m -81.23 139.47 35.47 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 120.821 0.343 . . . . 0.0 110.401 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.07 104.87 17.4 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.202 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 31.4 m -113.5 -179.28 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.836 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.542 ' OG ' ' HB3' ' A' ' 104' ' ' CYS . 3.0 p -131.14 135.34 47.38 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 21' ' ' PHE . . . -111.92 125.64 54.26 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 124.476 1.11 . . . . 0.0 109.672 -171.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -77.03 117.73 18.9 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.571 0.7 . . . . 0.0 109.569 173.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -129.62 135.95 49.17 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 59.4 25.65 14.41 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 121.521 0.677 . . . . 0.0 110.483 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.91 10.59 75.24 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.705 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.65 136.54 37.55 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 117.525 0.663 . . . . 0.0 110.437 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 35.4 p90 -98.79 129.59 45.21 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.47 -0.892 . . . . 0.0 113.127 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -129.26 157.39 42.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 10.5 pt-20 -74.01 146.25 43.92 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 121.779 0.8 . . . . 0.0 112.646 -174.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -151.99 145.8 25.1 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -105.07 133.75 49.32 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.673 -174.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.432 HD12 ' HB ' ' A' ' 11' ' ' THR . 39.3 mt -65.96 112.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.106 0.479 . . . . 0.0 110.451 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -94.72 -39.25 10.4 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.109 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 m -137.9 144.5 41.34 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 79.8 t -123.61 118.55 54.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -112.22 96.95 6.32 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -83.27 108.38 16.45 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.494 ' HA ' ' OD1' ' A' ' 50' ' ' ASP . 2.4 pt? -144.05 107.61 4.62 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.048 0.928 . . . . 0.0 109.286 176.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 p -100.53 123.22 53.32 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.856 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 52.3 mtpt -85.12 100.64 11.85 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 122.066 0.936 . . . . 0.0 109.237 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 31.1 t -84.82 132.7 31.03 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 113.754 -1.566 . . . . 0.0 109.336 -178.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -89.53 112.91 24.22 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 76' ' ' ILE . 3.7 m -123.64 153.46 29.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.216 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.323 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 8.2 tt -121.8 122.58 39.8 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -73.4 110.71 7.9 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.422 ' HB3' HD11 ' A' ' 76' ' ' ILE . 12.4 ptmm? -64.35 -20.19 65.96 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.228 0.537 . . . . 0.0 112.436 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -79.29 -46.66 17.3 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.817 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -98.51 -17.84 18.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.435 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 71.67 25.64 3.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.077 1.351 . . . . 0.0 111.593 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -104.68 155.74 18.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.751 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.9 m -100.18 154.65 18.28 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -149.32 143.94 26.13 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 tp -128.11 102.15 6.59 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 10.6 m -137.66 168.12 21.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.297 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -74.68 164.96 25.98 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.139 -174.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.494 ' OD1' ' HA ' ' A' ' 32' ' ' LEU . 7.7 p-10 -71.8 -5.6 35.38 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.849 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -73.85 -23.6 59.64 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 65' ' ' THR . 8.9 mm-40 -92.58 -34.45 14.02 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.048 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 89.3 t -79.24 111.05 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.198 0.999 . . . . 0.0 112.7 -176.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -111.63 103.06 11.34 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.27 -159.85 28.16 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.1 128.59 6.5 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.901 1.734 . . . . 0.0 112.123 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 mp -88.8 81.6 6.94 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.523 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 22.6 mmt180 -139.17 135.8 34.39 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.695 -175.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.0 t -66.76 117.83 8.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.53 3.93 55.05 Favored Glycine 0 C--N 1.303 -1.261 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.532 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.19 164.01 12.67 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.027 0.414 . . . . 0.0 110.652 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.3 mm -105.48 124.89 60.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.7 m -130.15 -177.63 2.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 123.028 0.531 . . . . 0.0 109.999 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -118.25 136.1 53.88 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.066 -1.828 . . . . 0.0 106.066 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 13.4 t -140.11 156.63 46.48 Favored 'General case' 0 C--N 1.275 -2.643 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.794 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 12.1 ttm180 -83.85 108.77 17.07 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 12.7 t -81.09 178.86 8.15 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 m -64.23 -16.33 61.82 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.241 0.543 . . . . 0.0 112.051 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -73.82 -26.01 60.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.347 177.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.95 -18.83 36.32 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.49 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -84.32 154.69 22.77 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.489 ' HA ' ' O ' ' A' ' 65' ' ' THR . 90.1 m-85 -89.36 115.36 26.76 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -108.84 143.86 37.48 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.78 136.85 38.18 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.423 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -145.23 168.1 21.22 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.428 -172.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 1.6 mp -112.45 144.13 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.3 mp -83.5 129.38 37.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.2 m -110.97 -19.32 12.82 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 122.617 0.367 . . . . 0.0 110.885 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -168.52 159.54 10.32 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.1 mp -127.63 139.87 52.46 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 167.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.5 m -126.0 116.5 21.55 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -69.07 126.42 29.74 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.109 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.411 ' HA ' ' NE ' ' A' ' 99' ' ' ARG . . . -130.38 9.69 5.18 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.602 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.447 ' HA ' HD21 ' A' ' 32' ' ' LEU . 19.5 m -55.67 121.95 10.29 Favored 'General case' 0 N--CA 1.437 -1.102 0 O-C-N 124.406 1.066 . . . . 0.0 112.5 -176.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.507 ' HB3' ' OG1' ' A' ' 97' ' ' THR . 74.7 m95 -95.82 116.98 29.7 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.555 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.737 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 82.6 m-85 -105.56 105.06 14.92 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.2 m -84.37 104.13 14.13 Favored 'General case' 0 N--CA 1.398 -3.06 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.5 m -108.59 142.12 22.04 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.575 -175.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.53 124.03 53.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.463 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -85.78 -179.89 6.93 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.814 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -68.57 -26.56 65.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.119 0.485 . . . . 0.0 110.78 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -68.87 -11.86 60.98 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.536 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.56 14.43 68.14 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -94.47 131.77 39.83 Favored 'General case' 0 CA--C 1.473 -2.01 0 CA-C-N 114.865 -0.668 . . . . 0.0 109.215 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.52 127.27 49.66 Favored 'General case' 0 C--N 1.268 -2.96 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.28 138.96 54.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.507 ' OG1' ' HB3' ' A' ' 85' ' ' TRP . 4.9 t -113.59 113.51 25.17 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.197 -1.401 . . . . 0.0 110.884 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.49 172.2 10.91 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.618 -177.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.411 ' NE ' ' HA ' ' A' ' 83' ' ' ALA . 95.9 mtt180 -98.7 173.21 7.01 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -60.15 -39.72 87.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.417 1.087 . . . . 0.0 111.283 -173.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.3 p -72.41 0.89 8.99 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.3 t -116.05 7.48 14.29 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.18 132.96 53.7 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.561 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.542 ' HB3' ' OG ' ' A' ' 14' ' ' SER . 22.3 t -96.55 -59.47 1.81 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.038 -176.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 7.1 tt 95.88 137.6 0.02 OUTLIER 'General case' 0 C--O 1.241 0.621 0 C-N-CA 127.602 2.361 . . . . 0.0 109.814 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -40.01 111.1 0.17 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.381 1.473 . . . . 0.0 113.8 -174.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.14 174.08 34.43 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . 0.29 0.0 OUTLIER -67.65 -62.32 1.47 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -132.46 81.58 1.96 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.872 -0.518 . . . . 0.0 109.888 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.475 ' HB2' ' SG ' ' A' ' 104' ' ' CYS . 21.9 m80 -91.93 -14.97 28.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.076 0.941 . . . . 0.0 109.149 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -107.29 45.49 0.99 Allowed 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.94 95.51 1.99 Allowed 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.43 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.42 104.96 6.2 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.8 m -112.93 117.1 31.15 Favored 'General case' 0 N--CA 1.402 -2.843 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.57 136.28 57.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.366 0.603 . . . . 0.0 110.795 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.5 m -116.1 93.32 4.19 Favored 'General case' 0 N--CA 1.406 -2.657 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -87.37 -42.66 12.7 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 C--N 1.303 -1.456 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.431 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.16 -23.94 64.01 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -103.03 124.61 37.9 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 119.32 -0.952 . . . . 0.0 111.127 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.01 14.73 2.33 Favored 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.936 2.424 . . . . 0.0 111.783 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.48 -57.77 9.16 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -178.38 135.99 0.16 Allowed 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 124.489 1.118 . . . . 0.0 109.736 174.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.63 -172.47 3.58 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.4 p -128.36 156.63 42.8 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -169.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.65 126.65 29.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.011 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.55 -19.31 42.44 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 121.245 -0.503 . . . . 0.0 112.275 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.446 ' HB ' HD11 ' A' ' 26' ' ' ILE . 30.9 m -69.29 137.39 52.98 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.062 0.458 . . . . 0.0 110.669 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 13.4 m-20 -86.44 131.83 34.09 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 30.8 m -137.22 -179.44 2.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-O 121.446 0.641 . . . . 0.0 111.494 -173.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.48 ' OG ' ' HB2' ' A' ' 104' ' ' CYS . 1.9 p -137.96 137.54 38.06 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.464 ' CB ' HD12 ' A' ' 98' ' ' LEU . . . -116.04 139.38 50.34 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -176.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -85.59 134.72 34.0 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.285 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -120.84 102.11 8.15 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 123.858 0.863 . . . . 0.0 109.146 172.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 58.77 28.09 16.87 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 170.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.51 9.71 57.5 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.777 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.05 151.39 41.99 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -106.73 137.12 45.36 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 119.031 0.832 . . . . 0.0 111.752 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.483 ' SG ' ' HD2' ' A' ' 90' ' ' PHE . 19.9 t -123.78 143.42 50.32 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.82 149.96 24.88 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.856 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -149.89 173.2 14.04 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.312 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -137.64 132.21 32.64 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.492 ' HA ' HG11 ' A' ' 88' ' ' VAL . 60.5 mt -65.45 116.33 4.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 121.407 0.622 . . . . 0.0 111.166 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -95.03 -41.64 9.03 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.66 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.425 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 86.8 m -137.91 142.47 40.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.473 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -117.72 107.34 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.898 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 84' ' ' SER . 65.1 mttm -91.39 90.41 7.67 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -94.77 106.07 18.04 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.556 ' O ' ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -139.38 144.0 37.98 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -175.284 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 11.4 p -118.41 124.34 72.98 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.718 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.267 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.444 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 97.9 mttt -82.65 100.7 10.36 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.716 0.769 . . . . 0.0 109.415 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.403 HG21 HD13 ' A' ' 57' ' ' LEU . 29.9 t -88.07 130.7 37.26 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.62 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.159 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -98.22 109.54 22.28 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.61 149.5 15.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 CA-C-O 121.38 0.609 . . . . 0.0 110.498 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.8 tp -111.69 118.11 34.73 Favored 'General case' 0 C--N 1.269 -2.934 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.469 HD11 ' OG1' ' A' ' 44' ' ' THR . 43.3 mt -70.35 126.12 28.73 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -72.82 -35.88 67.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.217 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -83.24 -36.15 24.82 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -107.42 -7.86 16.48 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.762 -0.775 . . . . 0.0 113.077 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.276 10.7 p30 59.76 21.06 9.85 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 125.679 1.592 . . . . 0.0 113.46 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.469 ' OG1' HD11 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -93.14 147.53 22.8 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.866 176.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -108.28 142.95 37.8 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.08 144.03 48.38 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -175.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.2 tp -126.88 101.76 6.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -142.27 162.89 18.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.53 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 5.2 pm0 -83.38 166.6 18.28 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.02 -12.31 2.0 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 125.967 1.707 . . . . 0.0 115.441 -173.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -89.19 -10.18 48.05 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 118.789 -1.165 . . . . 0.0 110.412 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -101.99 -7.82 22.04 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.9 t -103.16 118.46 50.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.407 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -98.03 97.31 8.8 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.67 -176.5 25.53 Favored Glycine 0 N--CA 1.427 -1.901 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.061 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -65.02 142.38 74.52 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.462 2.775 . . . . 0.0 112.696 176.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.403 HD13 HG21 ' A' ' 35' ' ' VAL . 1.5 mm? -96.75 84.16 3.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.513 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 7.0 tpt180 -137.98 126.37 23.29 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.773 -172.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.26 121.38 12.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.15 59.54 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.055 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.419 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -96.89 155.47 16.76 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.022 0.911 . . . . 0.0 110.937 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.7 mm -93.8 119.38 41.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.62 -179.12 2.48 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 122.768 0.427 . . . . 0.0 110.018 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -121.81 121.17 36.6 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.3 m -113.99 146.96 39.42 Favored 'General case' 0 N--CA 1.4 -2.974 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -83.57 127.23 33.58 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.7 p -92.17 175.28 6.91 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.9 m -68.63 -5.38 19.72 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.344 0.593 . . . . 0.0 111.919 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.04 -14.93 52.91 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 121.63 0.728 . . . . 0.0 109.302 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.01 -16.37 61.04 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 p -93.88 157.31 16.19 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 123.19 0.596 . . . . 0.0 110.561 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -94.95 146.89 23.93 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.455 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -137.02 143.73 42.89 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -80.45 130.62 35.27 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.24 173.88 11.06 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.6 -169.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 2.1 mp -119.57 139.19 47.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.513 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.7 mp -73.55 127.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.95 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.3 m -108.41 -23.33 11.93 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 122.463 0.305 . . . . 0.0 111.415 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 51.7 tttp -163.98 154.81 15.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -176.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.404 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . 2.9 mp -130.45 133.62 46.46 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.444 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 3.4 m -104.52 123.12 46.95 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -66.49 119.75 12.19 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 123.541 0.526 . . . . 0.0 110.944 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.556 ' HB1' ' O ' ' A' ' 32' ' ' LEU . . . -138.78 145.85 40.66 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-O 121.438 0.637 . . . . 0.0 109.601 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 4.2 p -169.69 101.8 0.32 Allowed 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 124.821 1.248 . . . . 0.0 107.992 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.486 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 92.8 m95 -97.35 121.22 39.0 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.284 -175.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -105.1 110.73 23.23 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.425 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 24.5 m -79.72 108.74 13.51 Favored 'General case' 0 N--CA 1.401 -2.876 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.492 HG11 ' HA ' ' A' ' 26' ' ' ILE . 28.9 m -113.54 145.16 19.8 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.447 -173.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 p -100.94 121.29 51.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.483 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 11.1 m-85 -88.76 -177.49 5.54 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.07 -172.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.75 -15.04 63.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.84 -17.4 63.99 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.529 173.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.42 -4.61 71.89 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -98.41 167.19 10.99 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.435 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 13.2 pt-20 -121.57 128.64 52.21 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.411 0.624 . . . . 0.0 111.304 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.432 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -125.62 150.92 47.15 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 44.5 m -105.21 118.11 35.72 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 120.824 0.345 . . . . 0.0 110.298 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.464 HD12 ' CB ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -141.97 152.49 43.52 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.106 0.562 . . . . 0.0 109.772 178.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -100.48 -173.76 2.49 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.055 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -53.97 -26.9 28.14 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.123 0.969 . . . . 0.0 112.836 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -58.02 -28.77 64.75 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 122.956 0.503 . . . . 0.0 112.306 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.4 p -125.96 10.51 7.61 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.336 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.9 tp -111.86 128.05 56.01 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 111' ' ' PHE . 24.8 m -96.96 -63.25 1.15 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 122.691 0.396 . . . . 0.0 111.955 -172.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 12' ' ' ASP . 5.5 tt 77.52 -66.14 0.24 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.706 1.203 . . . . 0.0 110.635 177.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -94.77 -81.84 0.38 Allowed 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.199 -176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 166.65 64.03 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.864 0 C-N-CA 118.537 -1.792 . . . . 0.0 112.452 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.68 124.1 33.21 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -74.96 36.67 0.11 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -168.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -163.0 93.72 0.81 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.567 0.699 . . . . 0.0 111.527 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.486 ' CZ ' ' HA ' ' A' ' 104' ' ' CYS . 20.7 m-85 -126.45 21.47 7.19 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.805 173.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 69.22 71.47 0.26 Allowed 'General case' 0 C--O 1.243 0.719 0 C-N-CA 124.339 1.056 . . . . 0.0 109.691 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -77.27 153.76 33.63 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.518 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.2 m -92.16 -175.92 4.21 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.23 85.68 5.07 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 122.086 0.946 . . . . 0.0 110.569 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.2 m -116.67 25.05 10.84 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.216 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.3 mt -73.5 -33.24 64.69 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.176 0.989 . . . . 0.0 108.678 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 C--N 1.301 -1.519 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.641 175.307 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 120.628 0.252 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -118.34 -37.87 3.27 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.77 144.4 82.89 Favored Pre-proline 0 N--CA 1.429 -1.521 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.606 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -87.46 36.54 0.45 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.691 2.26 . . . . 0.0 111.873 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.96 -58.99 5.08 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 122.655 0.382 . . . . 0.0 110.388 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.484 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 21.4 p90 -145.51 96.99 2.91 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-O 122.247 1.022 . . . . 0.0 109.415 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.36 -167.51 1.87 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.965 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.9 p -130.55 173.73 10.59 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -176.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.46 141.84 16.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 123.936 0.895 . . . . 0.0 110.102 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.13 -11.32 58.64 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.291 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.446 ' HB ' HD12 ' A' ' 26' ' ' ILE . 6.6 m -74.49 141.27 44.93 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.407 ' OD2' ' HG3' ' A' ' 25' ' ' LYS . 10.7 t70 -107.01 117.5 34.24 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.426 HG12 HD22 ' A' ' 105' ' ' LEU . 34.7 m -121.96 -179.86 2.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 120.861 0.362 . . . . 0.0 110.182 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.0 m -111.31 124.39 52.14 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.29 139.1 46.96 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.547 ' HD2' ' O ' ' A' ' 16' ' ' LYS 0.264 0.0 OUTLIER -94.01 129.69 40.42 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -178.631 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 34.0 m-85 -98.6 101.82 13.37 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 170.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 10.0 ptm180 49.21 35.95 8.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 173.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.26 10.4 57.2 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.932 -0.576 . . . . 0.0 114.074 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.72 124.79 34.37 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -91.91 141.95 28.09 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.465 0.65 . . . . 0.0 112.555 -172.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.9 t -127.53 145.32 50.89 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -71.73 143.43 49.62 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.4 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.405 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -141.44 139.63 33.43 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.192 -176.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HG3' ' OD2' ' A' ' 12' ' ' ASP . 5.1 mttp -103.12 126.6 50.37 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.487 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.446 HD12 ' HB ' ' A' ' 11' ' ' THR . 25.1 mt -70.24 116.63 11.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.788 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.15 -45.09 6.67 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 109.424 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.406 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 7.6 m -128.6 143.63 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.635 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 81.6 t -126.59 119.29 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 57.0 mtpt -104.07 97.86 7.77 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.364 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -83.38 100.74 10.88 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -133.22 161.32 34.76 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.4 p -130.02 140.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.641 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 98.9 mttt -91.74 101.57 14.18 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.743 0.783 . . . . 0.0 109.682 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.49 121.48 40.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.182 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -85.5 111.63 20.17 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 174.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.9 m -112.61 146.44 17.35 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.269 0 CA-C-O 121.124 0.488 . . . . 0.0 110.606 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -112.96 114.1 26.43 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.434 HD12 ' HB3' ' A' ' 73' ' ' GLN . 31.9 tp -75.62 111.64 11.16 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -56.05 -43.1 77.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -170.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -76.69 -50.86 12.66 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.371 0.605 . . . . 0.0 111.875 -174.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -84.95 -9.22 58.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.568 -171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.289 0.0 OUTLIER 56.33 24.06 7.91 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.377 2.271 . . . . 0.0 112.955 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.91 153.57 17.69 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.979 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.6 m -120.31 142.83 48.75 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.37 163.63 33.98 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.978 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.413 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 14.8 tp -128.02 104.31 7.72 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 -177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.2 m -121.05 174.36 5.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -173.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -87.4 162.34 17.37 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.488 0.661 . . . . 0.0 112.201 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -44.16 -28.46 0.51 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 127.7 2.4 . . . . 0.0 113.275 176.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -85.97 -24.76 26.37 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.385 0.674 . . . . 0.0 110.886 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -84.14 -17.79 38.91 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.78 116.29 32.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.399 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -106.06 101.48 10.96 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.431 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.42 -162.85 27.92 Favored Glycine 0 C--N 1.309 -0.922 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.17 135.46 12.2 Favored 'Trans proline' 0 CA--C 1.517 -0.371 0 C-N-CA 122.477 2.118 . . . . 0.0 112.299 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.78 82.33 3.56 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 122.049 0.928 . . . . 0.0 109.619 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.548 ' HD3' ' N ' ' A' ' 59' ' ' VAL . 1.1 tmt_? -140.08 138.65 35.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.548 ' N ' ' HD3' ' A' ' 58' ' ' ARG . 22.2 t -61.74 119.1 5.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.44 6.31 57.56 Favored Glycine 0 C--N 1.298 -1.563 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.937 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.416 ' HB3' HD13 ' A' ' 77' ' ' ILE . . . -90.53 152.87 20.73 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 117.396 0.598 . . . . 0.0 110.844 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.1 mm -89.65 117.65 33.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.64 177.66 6.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -122.52 121.53 36.76 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 172.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.7 t -115.67 158.43 22.76 Favored 'General case' 0 C--N 1.263 -3.161 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -174.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.46 ' HA ' ' O ' ' A' ' 71' ' ' SER . 40.7 ttt180 -79.93 125.59 29.94 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p -84.12 177.34 8.27 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.9 m -75.78 -2.99 32.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.803 0.811 . . . . 0.0 110.296 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -93.83 -1.03 55.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.537 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.23 -5.63 83.78 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.521 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.46 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 17.7 t -94.76 172.49 8.13 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -177.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -110.34 120.2 41.68 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.531 ' NE2' ' H ' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -131.05 150.78 51.99 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -176.235 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.531 ' H ' ' NE2' ' A' ' 73' ' ' GLN . 32.8 tt0 -73.57 122.98 23.09 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.562 0.745 . . . . 0.0 111.56 -174.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.11 173.97 11.11 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.448 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.0 mp -122.31 141.47 42.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.2 mp -72.26 122.22 24.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.9 t -99.91 -18.28 17.19 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -175.89 143.8 0.59 Allowed 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.377 0.0 OUTLIER -117.57 118.93 33.48 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.471 0.653 . . . . 0.0 109.737 165.709 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.8 m -101.59 130.56 47.94 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.971 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.01 122.34 12.09 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 124.375 1.047 . . . . 0.0 111.035 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.85 154.05 40.87 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 m -176.64 121.62 0.14 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 126.429 1.892 . . . . 0.0 107.513 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.572 ' HB3' ' OG1' ' A' ' 97' ' ' THR . 99.6 m95 -97.37 123.02 41.06 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.484 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 73.4 m-85 -111.41 106.79 15.81 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 5.6 m -82.42 104.02 12.4 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.405 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 15.8 m -106.46 154.49 7.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.578 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 11.9 p -104.31 135.46 42.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -100.86 -177.84 3.59 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.327 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.09 -26.88 68.53 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.502 1.121 . . . . 0.0 109.993 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.43 -16.87 64.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.827 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.14 14.17 72.53 Favored Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 26.5 t70 -97.43 137.26 36.66 Favored 'General case' 0 CA--C 1.469 -2.138 0 CA-C-N 113.953 -1.123 . . . . 0.0 108.407 -174.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.77 126.55 50.98 Favored 'General case' 0 C--N 1.269 -2.894 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -141.83 139.37 32.68 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.572 ' OG1' ' HB3' ' A' ' 85' ' ' TRP . 10.9 t -100.16 122.45 43.01 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.083 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.442 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 20.0 mt -110.9 166.26 11.18 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.197 0.522 . . . . 0.0 110.065 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.433 ' N ' ' HD3' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -78.98 164.06 24.71 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -68.19 -17.97 64.47 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.3 p -87.78 14.32 8.88 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.958 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 14.7 m -129.5 1.95 5.04 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.5 mt -128.33 147.31 50.61 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.486 -174.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 50.2 t -154.54 126.33 7.61 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.426 HD22 HG12 ' A' ' 13' ' ' VAL . 55.2 mt -49.62 -69.65 0.11 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.855 0.462 . . . . 0.0 109.812 173.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HE3' ' HA ' ' A' ' 106' ' ' LYS . 1.3 tpmt? -167.27 103.72 0.53 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -170.77 71.24 0.12 Allowed Glycine 0 C--N 1.301 -1.391 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.427 ' O ' ' HB3' ' A' ' 112' ' ' ALA . 11.9 pt-20 -73.82 -24.19 59.76 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -175.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -88.93 66.14 7.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.1 t60 170.81 -59.08 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.0 92.81 4.31 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.155 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.427 ' HB3' ' O ' ' A' ' 108' ' ' GLU . . . -133.93 -48.18 0.8 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 64.88 22.6 12.52 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.542 1.163 . . . . 0.0 111.122 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 t -141.03 117.33 10.7 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 101.88 -3.378 . . . . 0.0 101.88 174.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 68.14 96.65 0.06 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -167.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.1 m -89.09 1.49 55.51 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -170.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -78.84 -87.38 0.06 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.814 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 C--N 1.315 -0.897 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.315 -177.068 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.516 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -97.15 -30.58 12.94 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.097 0.475 . . . . 0.0 110.054 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -107.28 107.01 59.84 Favored Pre-proline 0 C--N 1.308 -1.201 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.9 -11.6 12.38 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.441 2.094 . . . . 0.0 114.308 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.91 -21.85 20.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.505 0.669 . . . . 0.0 110.234 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.63 105.6 2.44 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.956 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.47 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 65.9 mt -70.39 -174.71 0.88 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.869 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 p -132.67 161.07 34.9 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.1 t -72.85 130.04 35.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.856 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.19 -24.11 4.52 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.25 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.6 m -83.49 142.26 31.05 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -99.91 135.2 41.7 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.659 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 18.0 m -127.01 161.21 34.45 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 C-N-CA 123.237 0.615 . . . . 0.0 109.516 -176.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.7 m -100.61 123.97 45.56 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 21' ' ' PHE . . . -107.05 121.24 44.09 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -175.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.516 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 83.5 tttt -81.0 105.99 12.65 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.544 ' CE2' ' HB3' ' A' ' 22' ' ' CYS . 38.6 p90 -121.51 125.15 46.12 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.528 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 62.36 31.84 17.15 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.356 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.2 -3.25 69.4 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 115.16 0.824 . . . . 0.0 115.16 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.73 134.74 37.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.338 1.069 . . . . 0.0 110.27 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 28.5 p90 -91.17 136.17 33.28 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.544 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 52.3 t -134.96 163.03 30.78 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.95 147.11 45.54 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.59 0.709 . . . . 0.0 110.445 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -148.39 148.32 30.21 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.95 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -112.71 130.62 55.99 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.325 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.436 ' HA ' HG12 ' A' ' 88' ' ' VAL . 53.2 mt -64.84 119.58 9.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.952 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -95.85 -51.24 4.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.3 m -132.63 145.03 50.76 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.257 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 95.2 t -122.23 112.92 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.302 176.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 84' ' ' SER . 65.1 tttp -98.79 97.92 9.09 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -79.61 94.28 5.64 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.467 HD12 ' HB1' ' A' ' 83' ' ' ALA . 2.7 pp -103.14 160.63 14.48 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-O 121.127 0.489 . . . . 0.0 111.263 -178.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.21 118.36 57.24 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.064 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 47' ' ' LEU . 50.4 mtpt -82.85 100.96 10.66 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 21.4 t -84.98 117.34 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.841 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.953 -177.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -80.95 107.46 13.78 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 45' ' ' THR . 12.5 m -112.91 149.41 15.38 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.003 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.43 -175.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -117.53 111.13 18.82 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.512 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 44.9 mt -71.78 123.93 23.7 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 17.9 ptpt -62.54 -31.01 71.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -175.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.448 ' HB3' ' CD ' ' A' ' 73' ' ' GLN . 44.9 tt0 -84.95 -55.72 3.93 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 120.897 0.379 . . . . 0.0 111.474 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.6 -22.51 40.57 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 64.45 32.29 11.97 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.47 0.708 . . . . 0.0 112.279 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -92.87 138.86 31.12 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.5 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.8 m -107.35 130.11 54.83 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -157.19 156.75 33.15 Favored 'General case' 0 C--N 1.257 -3.434 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.443 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.2 mp -113.14 107.88 16.54 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.9 m -114.31 166.87 7.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.89 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -86.73 165.38 16.11 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.639 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.22 -34.19 56.0 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 124.584 1.154 . . . . 0.0 110.532 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.12 -22.8 66.99 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.686 -173.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -99.79 -17.83 17.49 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.6 t -98.09 116.63 41.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.944 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.418 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -110.33 114.47 27.95 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.797 176.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 143.97 -163.83 27.63 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.02 137.36 7.39 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.072 2.515 . . . . 0.0 113.647 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.9 mt -95.03 82.89 3.84 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.345 0.593 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.451 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 3.0 mpt_? -139.14 142.25 38.04 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.75 112.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.26 6.99 35.81 Favored Glycine 0 N--CA 1.428 -1.883 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.435 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.19 152.95 18.31 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.4 mt -99.95 125.92 53.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-O 121.111 0.482 . . . . 0.0 110.124 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 25.2 m -127.96 -177.78 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -131.51 128.22 38.9 Favored 'General case' 0 C--N 1.272 -2.761 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 9.9 t -139.96 159.64 41.72 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.99 -168.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -69.02 132.01 45.97 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.66 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 7.0 t -90.51 168.97 11.43 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 m -64.53 -23.0 67.13 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.088 0.555 . . . . 0.0 110.987 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -64.97 -26.19 68.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.288 176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.8 -22.08 17.27 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.226 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.6 t -77.43 179.59 6.38 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.803 0.841 . . . . 0.0 109.504 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -119.19 136.13 54.34 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.512 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 30.3 tt0 -137.86 153.25 49.6 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 39.0 tt0 -77.44 137.19 38.54 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.426 0.631 . . . . 0.0 109.407 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -141.13 173.61 11.31 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.87 -174.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.19 143.74 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.0 mp -75.55 122.82 30.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 t -99.77 -24.2 14.76 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -169.22 151.55 4.68 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.3 OUTLIER -127.77 118.54 23.94 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 118.327 0.512 . . . . 0.0 110.805 172.291 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.0 m -107.86 125.42 51.44 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.967 -174.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.9 121.49 24.22 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.06 0.457 . . . . 0.0 109.839 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.467 ' HB1' HD12 ' A' ' 32' ' ' LEU . . . -128.36 -179.44 5.03 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.5 p -164.41 145.9 8.4 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.14 0.495 . . . . 0.0 111.618 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.482 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 87.0 m95 -114.93 146.31 41.3 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.47 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 27.7 m-85 -124.03 112.96 17.79 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 m -85.49 107.15 17.31 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.436 HG12 ' HA ' ' A' ' 26' ' ' ILE . 24.8 m -110.56 146.76 15.32 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.617 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.995 -175.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.11 121.5 53.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -74.0 173.58 9.8 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.469 -176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.98 -27.13 61.1 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.469 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.51 -15.92 61.79 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.241 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.89 75.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.807 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -98.26 141.87 30.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -104.42 127.93 52.2 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -135.25 148.36 49.55 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.482 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 30.5 m -104.75 113.2 26.63 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.356 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.426 HD12 ' HB3' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -140.54 159.6 41.84 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.064 0.546 . . . . 0.0 111.404 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.538 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 95.8 mtt180 -99.75 -172.47 2.25 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 122.964 0.506 . . . . 0.0 109.987 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.432 ' HA ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.08 -14.57 63.07 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.107 0.48 . . . . 0.0 110.964 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 p -73.27 -2.39 21.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 123.872 0.869 . . . . 0.0 111.234 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.6 m -137.6 9.53 2.89 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 99' ' ' ARG . 93.1 mt -113.69 137.69 51.26 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.853 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.2 t -110.28 6.59 22.62 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.172 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.659 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 93.7 mt 62.95 -74.43 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.154 0 C-N-CA 124.083 0.953 . . . . 0.0 110.644 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -138.6 132.75 31.52 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.49 45.31 1.8 Allowed Glycine 0 C--N 1.315 -0.589 0 O-C-N 123.445 0.465 . . . . 0.0 114.176 -175.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -82.55 -33.55 28.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 175.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -108.53 170.96 7.69 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.72 168.03 15.59 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -85.85 -69.15 0.68 Allowed 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.59 22.22 1.99 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.735 0.779 . . . . 0.0 109.423 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -82.89 177.6 8.57 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.573 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.8 t -77.46 164.19 25.67 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -73.84 -64.82 0.92 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.0 m -146.34 131.42 18.3 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -76.88 132.48 39.14 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 118.696 -0.668 . . . . 0.0 110.14 -177.531 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.592 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -71.94 -33.55 68.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.59 106.1 58.03 Favored Pre-proline 0 N--CA 1.434 -1.24 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -78.96 169.84 18.79 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.68 1.587 . . . . 0.0 110.278 174.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.32 -4.04 56.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.903 0.858 . . . . 0.0 109.525 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -170.78 125.74 0.7 Allowed 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.525 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 6.6 mp -78.26 177.38 8.46 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.231 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 p -131.47 152.26 50.85 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.62 112.5 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.209 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.02 -24.15 3.45 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 46.2 m -73.68 138.67 44.87 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 120.937 0.398 . . . . 0.0 109.93 179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -99.02 126.11 44.66 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -136.37 -178.91 2.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 123.249 0.62 . . . . 0.0 109.906 -176.078 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.425 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 15.8 m -130.9 146.06 52.21 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 174.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -119.38 127.4 53.1 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.444 ' HE3' ' CD2' ' A' ' 111' ' ' PHE . 0.0 OUTLIER -80.87 138.98 36.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.168 0.509 . . . . 0.0 111.582 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -125.69 101.17 6.75 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 123.871 0.868 . . . . 0.0 108.898 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 57.63 37.8 27.55 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.385 0.428 . . . . 0.0 111.174 171.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.27 -6.06 71.68 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.982 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.56 123.8 43.76 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . 0.258 0.5 OUTLIER -107.62 131.28 54.54 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -174.102 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.7 m -105.14 144.51 31.83 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.386 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.425 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -85.9 147.55 26.2 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.884 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.452 ' HB2' ' CE2' ' A' ' 90' ' ' PHE . . . -150.55 154.58 37.83 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.528 0.68 . . . . 0.0 110.672 -175.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.99 126.81 55.19 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.411 ' HA ' HG12 ' A' ' 88' ' ' VAL . 32.0 mt -61.26 120.44 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -95.4 -43.9 7.79 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.927 0.891 . . . . 0.0 110.08 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.1 m -140.63 146.12 37.52 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.8 t -121.6 114.99 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 O-C-N 123.603 0.564 . . . . 0.0 109.599 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -112.35 91.13 3.54 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.748 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -84.09 87.48 7.15 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -91.15 111.23 22.62 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.564 -174.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.5 t -86.62 114.63 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.026 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.461 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 14.5 mmmm -80.05 99.49 7.71 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.8 t -89.38 129.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.071 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.286 -175.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 83.8 tttt -91.52 103.13 15.78 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.7 m -112.6 155.19 13.91 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.786 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 44' ' ' THR . 8.4 tt -129.14 118.31 22.24 Favored 'General case' 0 N--CA 1.387 -3.625 0 CA-C-N 114.445 -1.252 . . . . 0.0 107.638 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.444 HD22 ' HB3' ' A' ' 75' ' ' ALA . 86.5 mt -68.79 122.56 18.84 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.95 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.496 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 21.7 ptmt -59.94 -29.54 68.47 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 120.903 0.382 . . . . 0.0 111.415 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -59.84 -55.17 37.51 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 124.606 1.162 . . . . 0.0 113.226 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -120.23 -0.08 10.54 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.442 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 68.35 23.73 7.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.167 0.987 . . . . 0.0 112.334 -176.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -78.73 133.3 37.16 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 m -106.37 148.18 28.37 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 2.6 pt20 -159.72 160.07 33.62 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 123.031 0.207 . . . . 0.0 110.444 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 mt -115.8 102.17 9.47 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.461 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 27.9 m -124.28 170.13 14.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -177.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -91.26 170.78 9.71 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.956 -175.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -55.96 -21.08 18.93 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.097 1.759 . . . . 0.0 112.151 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -78.18 -35.39 48.78 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.307 0.575 . . . . 0.0 109.942 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -82.67 -15.14 53.12 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.081 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -109.17 135.17 48.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.162 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.419 ' O ' ' HB ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -125.46 139.75 53.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 172.64 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.94 -166.93 13.94 Favored Glycine 0 C--N 1.31 -0.867 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.57 132.34 10.97 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.77 2.313 . . . . 0.0 113.086 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.38 81.99 6.53 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.549 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 8.8 tpt180 -140.49 135.95 32.46 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.64 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.24 116.28 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.74 2.77 46.43 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.238 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.35 149.44 22.1 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.5 mt -95.69 117.12 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-O 121.882 0.849 . . . . 0.0 109.961 177.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.419 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 16.4 m -116.84 -172.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.273 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 72' ' ' PHE . 40.3 mt-10 -129.01 124.27 34.53 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.0 m -112.66 144.95 41.3 Favored 'General case' 0 N--CA 1.385 -3.678 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -74.05 117.69 16.14 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -89.06 -179.8 5.99 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 t -60.35 -29.86 69.17 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.218 1.007 . . . . 0.0 111.478 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.98 -25.18 67.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.845 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.56 -20.58 22.64 Favored Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.625 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 p -89.4 164.03 15.04 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.069 0.548 . . . . 0.0 111.052 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.423 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 96.5 m-85 -96.05 123.31 39.61 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 122.854 0.461 . . . . 0.0 110.746 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -114.03 150.86 33.3 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.496 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 45.6 mt-10 -68.87 127.73 34.15 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.113 0.959 . . . . 0.0 111.897 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.444 ' HB3' HD22 ' A' ' 39' ' ' LEU . . . -135.84 161.49 35.47 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.85 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.8 mp -116.89 139.49 43.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.549 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -73.05 124.45 30.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.9 176.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 t -103.9 -26.24 12.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.434 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 23.0 tptm -167.57 159.21 11.92 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mp -135.01 141.43 46.19 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.436 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 5.0 m -127.58 104.13 7.71 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.93 133.23 41.81 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.713 0.768 . . . . 0.0 111.591 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.19 160.25 39.55 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 177.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -153.89 121.83 6.02 Favored 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 119.896 -0.721 . . . . 0.0 112.465 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.413 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 57.7 m95 -95.55 122.05 37.88 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.973 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.525 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 92.8 m-85 -109.35 109.43 20.31 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 73.0 m -85.17 104.18 14.81 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 174.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.411 HG12 ' HA ' ' A' ' 26' ' ' ILE . 28.5 m -106.2 141.46 21.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.868 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.27 130.41 59.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.022 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.452 ' CE2' ' HB2' ' A' ' 24' ' ' ALA . 52.0 m-85 -91.02 167.89 12.06 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -62.18 -19.66 63.33 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.007 0.908 . . . . 0.0 109.993 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.16 -11.36 48.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.462 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.83 -3.78 82.23 Favored Glycine 0 C--O 1.227 -0.336 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -96.18 142.48 28.3 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -117.14 143.9 45.31 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 123.442 0.464 . . . . 0.0 110.994 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -129.61 143.8 50.99 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.413 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 85.7 m -104.16 113.05 26.33 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.421 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.0 OUTLIER -133.91 163.47 29.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.571 0.748 . . . . 0.0 112.109 -177.314 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -99.36 177.56 5.15 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 122.821 0.448 . . . . 0.0 110.013 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -60.9 -33.03 72.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.064 0.546 . . . . 0.0 111.428 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.4 m -57.86 -32.29 67.51 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.736 0.814 . . . . 0.0 110.921 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.421 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 17.5 m -91.45 7.4 41.39 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.019 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.7 170.48 7.91 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.554 0.692 . . . . 0.0 111.321 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.409 ' HB3' ' HB2' ' A' ' 14' ' ' SER . 53.1 t -116.66 -19.62 9.9 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.664 176.142 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? 62.7 -81.39 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -173.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -148.69 138.9 22.4 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 125.557 1.543 . . . . 0.0 107.209 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 166.45 157.52 10.35 Favored Glycine 0 N--CA 1.423 -2.183 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.78 -54.45 2.49 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -118.6 -8.93 10.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.317 0.58 . . . . 0.0 110.259 174.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.507 ' CB ' ' HB3' ' A' ' 113' ' ' GLU . 33.2 m170 -102.26 153.25 20.15 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.444 ' CD2' ' HE3' ' A' ' 16' ' ' LYS . 48.7 m-85 -114.42 109.36 18.19 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 58.88 74.79 0.42 Allowed 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 124.374 1.07 . . . . 0.0 108.685 -174.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.507 ' HB3' ' CB ' ' A' ' 110' ' ' HIS . 15.0 pt-20 -83.14 120.12 25.37 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -171.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.4 m -114.63 136.53 52.94 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 70.21 178.93 0.25 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.554 0.693 . . . . 0.0 111.568 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.2 p -108.63 24.97 12.29 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.24 117.13 20.75 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.708 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.6 t70 . . . . . 0 C--N 1.31 -1.151 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.407 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.659 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -73.28 -55.14 6.82 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -75.2 122.82 88.18 Favored Pre-proline 0 N--CA 1.434 -1.227 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.093 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -91.14 38.32 0.31 Allowed 'Trans proline' 0 N--CA 1.438 -1.766 0 C-N-CA 122.728 2.285 . . . . 0.0 108.939 172.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.55 86.24 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.704 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.418 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 45.7 p90 -153.22 150.1 28.66 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 173.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.435 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 90.2 mt -99.84 175.25 5.85 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.9 p -122.17 161.21 23.58 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 120.614 0.245 . . . . 0.0 111.521 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.57 144.05 14.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.521 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.35 -25.97 26.32 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.653 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.424 ' HB ' HD13 ' A' ' 26' ' ' ILE . 9.7 m -58.08 133.23 55.37 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 122.162 0.982 . . . . 0.0 112.65 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.414 ' HB3' ' NZ ' ' A' ' 106' ' ' LYS . 18.8 t70 -84.49 113.91 21.55 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 113.491 -1.686 . . . . 0.0 109.165 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.48 -177.81 2.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.455 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -140.11 147.22 39.91 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 173.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -126.16 131.69 51.98 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 22.3 pttp -82.51 133.35 35.2 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -112.92 112.58 24.16 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 170.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 61.09 31.06 19.76 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.343 0.592 . . . . 0.0 110.897 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.33 -8.45 72.2 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.885 -0.598 . . . . 0.0 114.192 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.76 124.44 50.59 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.537 0.669 . . . . 0.0 110.126 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 73.7 m-85 -87.99 120.47 29.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -99.82 143.74 29.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 172.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -75.25 148.52 39.37 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.719 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 89' ' ' VAL . . . -154.34 143.66 21.34 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.449 0.643 . . . . 0.0 111.227 -175.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -115.73 128.29 55.76 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.424 HD13 ' HB ' ' A' ' 11' ' ' THR . 17.6 mt -68.94 113.82 5.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 120.716 0.293 . . . . 0.0 111.554 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.464 ' HD2' ' HB ' ' A' ' 89' ' ' VAL . 43.9 mtpt -88.17 -38.09 15.61 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.8 m -146.54 141.95 27.53 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.067 -175.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.37 131.06 73.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -123.79 97.82 5.54 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -78.63 86.52 4.61 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.684 1.23 . . . . 0.0 108.607 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.456 ' HA ' ' OD1' ' A' ' 50' ' ' ASP . 2.0 pt? -107.29 134.47 50.32 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.967 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.3 t -108.06 132.27 56.22 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.971 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -86.04 101.53 13.01 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.5 t -91.78 127.08 44.3 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.836 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -92.21 106.94 18.84 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -114.79 143.71 23.93 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.96 0 CA-C-O 121.682 0.753 . . . . 0.0 112.022 -177.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.1 tp -111.14 118.02 34.83 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.7 -1.591 . . . . 0.0 107.639 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.549 HD11 ' OG1' ' A' ' 44' ' ' THR . 94.3 mt -67.29 111.37 3.96 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -15.2 61.43 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.183 0.516 . . . . 0.0 112.214 -176.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -88.76 -51.09 5.84 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.654 0.74 . . . . 0.0 109.621 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 15.0 t70 -89.98 -33.12 16.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.445 -170.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 35.3 m-80 83.64 15.89 0.28 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.101 1.36 . . . . 0.0 113.402 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.549 ' OG1' HD11 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -95.85 150.52 20.33 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.91 0.386 . . . . 0.0 110.368 174.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -118.03 144.83 45.25 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -151.4 157.84 42.94 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.939 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.3 tp -119.36 101.48 7.99 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.1 m -126.62 175.53 8.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.48 -170.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -88.57 154.23 20.5 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.426 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.456 ' OD1' ' HA ' ' A' ' 32' ' ' LEU . 6.4 p-10 -65.88 -12.98 58.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.061 0.944 . . . . 0.0 111.507 -176.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.83 -28.89 63.88 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.664 0.745 . . . . 0.0 109.68 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.413 ' OE1' ' HD3' ' A' ' 66' ' ' ARG . 43.3 mt-30 -108.24 8.94 28.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.979 0.895 . . . . 0.0 109.333 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.433 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 78.4 t -108.03 110.06 30.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.909 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.27 103.58 16.22 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.024 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.478 ' HA3' HG11 ' A' ' 63' ' ' VAL . . . 145.1 -171.36 26.25 Favored Glycine 0 C--N 1.292 -1.88 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.339 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.81 144.28 19.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.209 2.606 . . . . 0.0 113.194 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -93.22 82.36 4.52 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.493 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 50.6 mtm180 -139.5 131.89 28.49 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.771 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.53 117.95 7.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.06 10.75 51.3 Favored Glycine 0 C--N 1.299 -1.477 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.291 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.429 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.85 162.46 13.24 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 117.313 0.556 . . . . 0.0 110.062 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.8 mm -102.54 121.53 53.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 123.559 0.537 . . . . 0.0 110.113 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.478 HG11 ' HA3' ' A' ' 55' ' ' GLY . 29.9 m -130.12 177.2 7.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.039 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -126.22 121.68 33.42 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.9 t -122.21 154.67 37.19 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-O 121.151 0.5 . . . . 0.0 111.067 -173.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.413 ' HD3' ' OE1' ' A' ' 52' ' ' GLN . 34.8 ttt180 -85.4 132.09 34.29 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.375 177.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.9 p -95.74 163.78 13.04 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.5 m -57.18 -23.68 49.23 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -80.5 -3.22 49.22 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 122.247 -0.283 . . . . 0.0 111.599 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.52 6.19 59.85 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.9 175.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.2 m -97.59 152.37 19.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 122.504 -0.409 . . . . 0.0 110.48 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 65' ' ' THR . 56.0 m-85 -110.88 121.01 44.28 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -128.39 153.7 46.78 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.918 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -73.52 127.88 33.95 Favored 'General case' 0 C--O 1.256 1.444 0 CA-C-O 121.716 0.769 . . . . 0.0 110.788 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.472 ' HB2' HD21 ' A' ' 39' ' ' LEU . . . -135.73 168.54 19.09 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.177 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.429 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 8.9 mt -118.01 145.84 23.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.2 mp -77.98 115.13 19.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 175.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 m -97.93 -17.31 19.3 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.025 0.44 . . . . 0.0 109.964 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -169.64 156.73 6.67 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.65 111.18 6.8 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.799 0.809 . . . . 0.0 110.588 173.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.7 m -103.28 108.06 19.13 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.787 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -67.67 135.09 52.26 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -175.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.4 -63.84 1.39 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m 58.49 112.3 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -102.7 141.6 35.25 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.498 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.435 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 50.6 m-85 -127.79 106.83 9.39 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 54.1 m -87.15 107.81 18.63 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 24' ' ' ALA . 23.6 m -112.06 147.56 15.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.096 -173.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 7.2 p -105.09 125.08 60.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 123.687 0.795 . . . . 0.0 109.887 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.436 ' CE1' HG21 ' A' ' 88' ' ' VAL . 57.3 m-85 -92.79 -176.86 4.36 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.295 -174.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -47.61 -41.59 22.2 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.145 1.378 . . . . 0.0 112.664 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.08 -16.72 60.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.099 0.476 . . . . 0.0 111.893 -175.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.58 5.74 56.67 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.643 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -96.61 149.92 21.24 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.5 144.12 43.86 Favored 'General case' 0 C--O 1.253 1.287 0 CA-C-O 121.474 0.655 . . . . 0.0 112.177 -175.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.4 mmt-85 -136.77 151.27 49.0 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.466 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 63.5 m -99.42 109.27 21.87 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.278 0.561 . . . . 0.0 109.604 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.25 159.4 17.95 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.691 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -99.66 161.72 13.44 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 ttp85 -61.57 -23.43 65.98 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 m -59.01 -25.08 63.35 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 123.556 0.742 . . . . 0.0 110.93 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.41 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 18.9 m -96.12 -8.24 33.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.041 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.9 mp -92.9 133.18 36.36 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -171.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.482 ' O ' ' HB3' ' A' ' 108' ' ' GLU . 19.3 t -77.1 -48.89 16.57 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 112.682 -2.053 . . . . 0.0 110.324 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 66.03 94.37 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.135 -172.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.414 ' NZ ' ' HB3' ' A' ' 12' ' ' ASP . 74.3 mmtt 63.24 -95.38 0.05 OUTLIER 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.995 -177.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -138.97 67.38 0.51 Allowed Glycine 0 CA--C 1.485 -1.784 0 C-N-CA 120.018 -1.086 . . . . 0.0 112.527 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' A' ' 104' ' ' CYS . 21.6 tp10 -127.64 56.43 1.57 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -75.94 82.37 2.83 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -130.49 9.41 5.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.254 -168.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -126.93 109.7 12.23 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.306 -174.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.59 -38.73 62.55 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 170.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -137.61 -62.04 0.62 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 170.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.8 t -179.76 147.73 0.3 Allowed 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 102.162 -3.273 . . . . 0.0 102.162 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -80.12 153.15 28.88 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.254 -0.979 . . . . 0.0 110.634 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.8 m -61.75 109.31 1.19 Allowed 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.1 135.15 51.38 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.069 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 . . . . . 0 C--N 1.31 -1.141 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.062 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.193 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -90.71 6.97 41.87 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.438 0.637 . . . . 0.0 110.9 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -104.16 167.83 9.45 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.76 99.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.817 2.345 . . . . 0.0 111.704 177.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.67 -70.23 0.8 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.961 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -74.98 -63.92 1.16 Allowed 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 119.221 -0.992 . . . . 0.0 108.898 -176.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.517 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 48.6 mt -113.18 -174.92 2.55 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -131.17 160.63 34.23 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -171.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.81 144.84 10.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.49 -6.52 74.72 Favored Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.87 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.42 ' HB ' HD13 ' A' ' 26' ' ' ILE . 25.3 m -89.16 133.5 34.38 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 120.965 0.412 . . . . 0.0 110.19 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -96.88 124.18 40.79 Favored 'General case' 0 CA--C 1.476 -1.875 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.909 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.404 HG22 ' HB3' ' A' ' 103' ' ' LEU . 28.2 m -131.59 160.77 42.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.216 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.448 ' OG ' ' HB3' ' A' ' 104' ' ' CYS . 2.4 p -94.58 117.02 29.47 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -106.52 127.68 53.5 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.393 -173.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 22.6 pttp -84.76 134.9 34.31 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.453 0.644 . . . . 0.0 112.378 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CZ ' ' HZ ' ' A' ' 90' ' ' PHE . 80.7 m-85 -132.98 136.23 45.95 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.68 26.28 0.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.05 2.9 64.07 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.159 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.15 146.35 51.1 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 16' ' ' LYS 0.262 18.4 p90 -106.76 146.41 30.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 116.026 1.862 . . . . 0.0 116.026 -175.467 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 66.1 m -131.53 138.23 48.84 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.745 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 38.2 tt0 -79.92 137.35 36.86 Favored 'General case' 0 N--CA 1.406 -2.649 0 CA-C-O 121.225 0.536 . . . . 0.0 111.297 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.431 ' HB3' ' CD1' ' A' ' 90' ' ' PHE . . . -147.41 158.75 44.1 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.048 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -106.55 129.26 54.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.42 HD13 ' HB ' ' A' ' 11' ' ' THR . 72.1 mt -61.0 117.27 2.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.196 0.522 . . . . 0.0 110.311 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -99.41 -40.5 7.85 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.983 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 m -127.48 141.83 51.56 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.413 HG11 ' CE1' ' A' ' 86' ' ' TYR . 55.8 t -120.17 124.06 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 C-N-CA 123.179 0.592 . . . . 0.0 109.601 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -131.4 90.62 2.89 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -83.54 92.43 7.62 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 117.766 -1.574 . . . . 0.0 108.211 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -112.33 133.97 54.13 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.278 0.561 . . . . 0.0 109.869 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.6 123.09 48.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -96.03 109.91 22.23 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 122.086 0.946 . . . . 0.0 109.225 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.4 t -94.59 129.26 45.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.323 -172.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.46 ' HB2' HD13 ' A' ' 47' ' ' LEU . 83.6 tttt -88.89 105.84 18.01 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 175.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -113.27 143.93 21.95 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.279 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.359 -177.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.6 115.01 29.29 Favored 'General case' 0 C--N 1.266 -3.033 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.415 HD22 ' HB2' ' A' ' 75' ' ' ALA . 0.4 OUTLIER -66.67 118.19 9.89 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -64.53 -43.43 94.02 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 124.65 1.18 . . . . 0.0 113.221 -171.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -88.42 -25.34 22.71 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.571 0.701 . . . . 0.0 111.717 -174.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -98.55 -32.01 11.67 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.565 -175.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 76.78 21.87 1.18 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -102.45 149.61 24.21 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.402 HG21 ' HE2' ' A' ' 36' ' ' LYS . 2.2 m -101.58 138.68 38.26 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -140.16 144.86 36.87 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.46 HD13 ' HB2' ' A' ' 36' ' ' LYS . 10.5 tt -124.92 106.67 10.16 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.9 m -135.68 -178.02 2.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.517 -173.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -64.51 150.59 46.4 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -18.29 63.25 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.275 171.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.48 -24.41 61.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.5 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 65' ' ' THR . 12.3 mm100 -85.54 -19.05 31.71 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.2 t -91.5 112.12 24.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.659 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -97.82 98.47 9.86 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.98 175.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 150.51 179.11 26.01 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.596 178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.53 141.26 72.84 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.242 2.628 . . . . 0.0 114.246 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.96 81.97 7.36 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.472 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 97.5 mtt180 -139.57 132.98 30.11 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.02 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.9 t -72.69 110.31 5.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.543 0.687 . . . . 0.0 109.538 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.97 7.19 27.44 Favored Glycine 0 N--CA 1.428 -1.858 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.364 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -93.54 147.46 22.97 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.258 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.3 mm -86.07 117.0 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.76 179.04 4.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.23 125.92 48.31 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 14.5 t -132.48 159.6 38.88 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -76.05 114.19 14.41 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 123.606 0.566 . . . . 0.0 109.853 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.508 HG21 ' O ' ' A' ' 71' ' ' SER . 9.2 t -85.38 -179.47 6.96 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.357 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.7 m -64.9 -18.1 64.9 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.629 1.172 . . . . 0.0 111.038 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -75.69 -21.51 57.53 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.448 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.61 -14.85 58.99 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.508 ' O ' HG21 ' A' ' 67' ' ' THR . 21.3 m -90.88 159.77 16.06 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -92.33 127.42 37.81 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -140.24 165.21 28.0 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -67.72 136.47 54.33 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.108 0.48 . . . . 0.0 111.91 -175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.415 ' HB2' HD22 ' A' ' 39' ' ' LEU . . . -145.62 164.6 31.2 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.8 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 3.1 mp -118.51 136.45 55.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.472 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -69.71 122.61 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 m -111.14 -17.03 13.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.212 0.529 . . . . 0.0 110.68 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.1 tttp -166.55 143.43 4.91 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.78 111.58 13.81 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.502 0.668 . . . . 0.0 109.705 172.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 m -103.56 127.8 50.91 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.93 -169.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -78.75 103.22 8.55 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.53 -64.06 1.22 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 44.0 m 55.81 100.86 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.408 -1.269 . . . . 0.0 113.302 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.527 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 34.5 m95 -90.04 132.62 35.29 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.799 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.517 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 97.6 m-85 -128.27 112.61 14.67 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.811 176.451 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 26.1 m -84.81 107.15 16.83 Favored 'General case' 0 N--CA 1.39 -3.469 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 17.2 m -105.63 141.43 20.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.195 -177.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.6 p -114.71 132.13 64.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.837 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.431 ' CD1' ' HB3' ' A' ' 24' ' ' ALA . 76.3 m-85 -86.35 166.32 15.69 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.24 -21.86 66.74 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 122.283 1.039 . . . . 0.0 108.588 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.67 -17.27 64.48 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.06 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.93 0.16 64.1 Favored Glycine 0 C--O 1.218 -0.876 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.156 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -96.88 144.61 26.66 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 9.3 pt-20 -122.27 133.31 54.69 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.066 0.46 . . . . 0.0 111.088 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -129.67 142.18 50.78 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.527 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 31.9 m -105.47 111.41 24.11 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 120.769 0.318 . . . . 0.0 110.913 -177.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 25.2 mt -118.62 171.77 7.96 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -79.73 162.54 25.11 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -56.73 -30.12 63.21 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.153 0.502 . . . . 0.0 111.209 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.6 p -81.27 -2.66 49.78 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.809 0.844 . . . . 0.0 112.641 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 27.6 t -107.34 9.66 29.85 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.461 HD13 ' HB2' ' A' ' 86' ' ' TYR . 70.8 mt -122.27 134.92 54.67 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.448 ' HB3' ' OG ' ' A' ' 14' ' ' SER . 47.0 t -86.52 82.6 7.87 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -175.158 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 67.8 mt -115.52 -64.87 1.25 Allowed 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 162.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -118.59 138.52 52.51 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.325 176.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.18 -41.77 0.45 Allowed Glycine 0 C--N 1.307 -1.051 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 67.39 -68.91 0.14 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.374 1.47 . . . . 0.0 114.713 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -53.66 96.62 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -173.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 73.51 19.72 3.3 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.991 1.317 . . . . 0.0 111.101 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.424 ' HB3' ' SG ' ' A' ' 104' ' ' CYS . 95.5 m-85 -106.16 164.38 12.04 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 71.49 -71.73 0.13 Allowed 'General case' 0 C--O 1.245 0.824 0 C-N-CA 125.774 1.63 . . . . 0.0 113.729 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -137.21 153.99 50.29 Favored 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -173.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.4 t 74.01 102.48 0.07 Allowed 'General case' 0 C--O 1.242 0.686 0 C-N-CA 125.004 1.322 . . . . 0.0 110.627 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.449 ' CD ' ' H ' ' A' ' 116' ' ' THR . 0.2 OUTLIER -158.12 -179.54 8.22 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 -178.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.449 ' H ' ' CD ' ' A' ' 115' ' ' GLU . 10.7 m -56.94 113.81 1.84 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.68 -57.26 6.68 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 120.671 0.272 . . . . 0.0 110.485 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 t70 . . . . . 0 C--N 1.312 -1.035 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.965 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.943 0.401 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -90.87 34.54 0.91 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -51.7 114.14 4.86 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 125.937 1.695 . . . . 0.0 112.733 -173.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -77.26 29.35 0.42 Allowed 'Trans proline' 0 N--CA 1.48 0.705 0 C-N-CA 123.683 2.922 . . . . 0.0 112.908 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.27 -33.49 67.5 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.643 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 24.2 p90 -122.8 113.26 18.92 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.6 mt -98.44 178.41 5.04 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.738 -178.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.7 p -134.96 169.27 17.66 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.379 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.55 123.26 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 122.776 0.43 . . . . 0.0 111.09 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.0 -33.64 3.01 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.447 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.411 ' HB ' HD13 ' A' ' 26' ' ' ILE . 15.6 m -59.41 138.64 57.59 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.176 0.59 . . . . 0.0 111.332 -177.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -100.53 116.83 33.39 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.5 m -128.43 -179.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 122.871 0.468 . . . . 0.0 110.396 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 16.8 m -129.23 137.28 51.01 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.474 ' CB ' HD11 ' A' ' 98' ' ' LEU . . . -107.27 128.53 54.52 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -85.72 120.14 26.82 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.85 0.357 . . . . 0.0 111.144 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -125.88 109.91 13.04 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 61.86 26.77 16.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.831 0.852 . . . . 0.0 112.557 172.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.73 25.39 42.12 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.921 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.52 144.78 50.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -106.61 120.1 41.06 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.353 0.597 . . . . 0.0 111.117 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.6 m -103.73 128.73 51.07 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 175.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 9.8 pt-20 -93.62 140.49 29.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.536 -1.265 . . . . 0.0 109.852 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.502 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . . . -145.47 156.68 43.89 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.319 -173.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -112.23 132.78 54.73 Favored 'General case' 0 C--N 1.266 -3.029 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.411 HD13 ' HB ' ' A' ' 11' ' ' THR . 43.2 mt -59.41 121.81 7.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.332 0.587 . . . . 0.0 111.907 -176.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -97.31 -46.97 5.9 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 125.025 1.33 . . . . 0.0 109.994 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 16.6 m -137.77 146.18 43.3 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 98.4 t -131.16 124.24 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -110.75 91.07 3.52 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 48.3 mtm180 -78.15 122.9 26.25 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 121.974 0.892 . . . . 0.0 111.515 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.463 HD23 ' HA ' ' A' ' 84' ' ' SER . 1.8 pt? -155.7 148.56 24.26 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -135.75 143.91 35.09 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.943 0 N-CA-C 104.34 -2.467 . . . . 0.0 104.34 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.559 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 94.4 mttt -85.05 101.19 12.21 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.46 118.06 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.52 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.575 -176.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -86.55 107.82 18.3 Favored 'General case' 0 N--CA 1.413 -2.286 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 76' ' ' ILE . 3.7 m -112.53 150.03 14.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -126.53 117.66 23.31 Favored 'General case' 0 C--N 1.26 -3.314 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 20.3 mt -72.84 106.35 4.75 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -178.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -57.96 -34.36 69.85 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -72.13 -45.8 59.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 120.98 0.419 . . . . 0.0 111.403 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -91.84 -8.89 45.3 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.492 -175.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.2 p30 53.31 28.09 6.92 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.302 1.841 . . . . 0.0 113.256 -177.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -104.14 145.74 29.75 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.309 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 m -97.7 154.44 17.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -151.15 138.93 19.8 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 mt -109.72 102.33 11.15 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.428 HG23 ' HG1' ' A' ' 65' ' ' THR . 27.4 m -116.58 176.43 2.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.29 -174.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -101.56 160.02 14.8 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.4 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -47.18 -33.9 5.75 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 126.405 1.882 . . . . 0.0 112.237 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -72.81 -28.76 62.76 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.29 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -92.72 -3.53 54.67 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.548 0.69 . . . . 0.0 109.222 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.8 t -99.37 123.02 51.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.076 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -103.46 95.83 6.34 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.59 -173.82 28.44 Favored Glycine 0 N--CA 1.423 -2.231 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.132 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.14 148.35 44.24 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.096 2.531 . . . . 0.0 113.478 -179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.27 82.64 6.5 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 62.8 ttt180 -139.35 119.59 13.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.818 -174.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.66 115.69 6.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.11 0.481 . . . . 0.0 109.862 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.5 5.51 42.44 Favored Glycine 0 N--CA 1.418 -2.543 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.122 -177.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.13 155.78 16.98 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.413 0.606 . . . . 0.0 110.393 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.2 mt -97.24 124.8 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.0 m -132.18 179.19 4.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -113.49 125.51 54.29 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.428 ' HG1' HG23 ' A' ' 48' ' ' VAL . 9.7 t -127.61 152.39 47.72 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-O 120.777 0.323 . . . . 0.0 110.17 -174.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -83.25 123.9 30.05 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.041 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.2 p -85.6 177.13 7.83 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -71.33 -20.6 62.16 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.033 0.444 . . . . 0.0 109.815 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.91 -25.0 66.95 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.968 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.91 -20.27 24.47 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.077 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.2 p -92.2 159.43 15.64 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 120.942 0.401 . . . . 0.0 110.97 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.412 ' HA ' ' O ' ' A' ' 65' ' ' THR . 51.1 m-85 -92.73 138.89 31.1 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.013 0.435 . . . . 0.0 110.244 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -132.14 149.73 52.33 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.67 129.81 34.74 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.024 0.916 . . . . 0.0 109.741 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.86 173.38 11.59 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.403 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 5.7 mm -110.92 143.94 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -79.75 111.26 16.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -90.65 -24.77 20.4 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 120.922 0.391 . . . . 0.0 109.963 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -165.17 146.16 7.39 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.0 111.23 17.64 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.854 0.835 . . . . 0.0 109.119 168.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.559 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 8.2 m -96.09 126.62 41.45 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -173.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -56.84 141.59 44.1 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 124.323 1.014 . . . . 0.0 112.679 -171.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 32' ' ' LEU . . . -159.82 -144.32 0.11 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.463 ' HA ' HD23 ' A' ' 32' ' ' LEU . 50.5 m 87.63 121.83 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 125.396 1.478 . . . . 0.0 111.726 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -99.65 134.06 43.08 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.161 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.643 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 82.2 m-85 -121.2 107.94 13.17 Favored 'General case' 0 N--CA 1.422 -1.872 0 O-C-N 123.753 0.658 . . . . 0.0 109.315 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.419 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 33.3 m -90.08 106.47 18.5 Favored 'General case' 0 N--CA 1.398 -3.073 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.2 m -105.74 141.65 20.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.164 -176.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.5 137.95 42.03 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.366 -174.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.502 ' CE1' ' HB3' ' A' ' 24' ' ' ALA . 87.4 m-85 -94.23 163.74 13.32 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.46 -26.74 65.48 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.615 0.722 . . . . 0.0 111.52 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.84 -17.14 64.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.089 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.1 1.92 58.21 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.75 138.31 31.58 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -125.86 133.91 51.8 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.465 0.65 . . . . 0.0 111.048 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.62 142.3 50.26 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.039 -176.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.409 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 43.4 m -104.89 110.16 22.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.519 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.474 HD11 ' CB ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -132.9 170.39 15.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.322 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -98.97 170.6 8.61 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -58.06 -31.38 67.01 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 123.699 0.8 . . . . 0.0 111.93 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 m -70.91 -9.14 57.19 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 121.498 0.666 . . . . 0.0 111.465 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.5 m -109.01 1.22 20.43 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 14' ' ' SER . 89.6 mt -107.22 129.43 54.87 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.788 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 14.2 t -71.24 -55.73 7.49 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.079 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.2 tp 67.95 173.62 0.27 Allowed 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 123.847 0.859 . . . . 0.0 111.797 175.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.7 tptp 75.31 -20.74 0.33 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.603 1.561 . . . . 0.0 112.94 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.13 1.89 59.4 Favored Glycine 0 C--N 1.307 -1.069 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -86.74 153.73 21.48 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.427 ' O ' ' HB3' ' A' ' 110' ' ' HIS . 53.0 ttp180 -134.22 87.48 2.37 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 120.925 0.393 . . . . 0.0 111.063 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' A' ' 109' ' ' ARG . 4.5 p-80 174.93 -28.59 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 125.684 1.594 . . . . 0.0 107.319 172.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 73.97 -74.74 0.08 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.674 1.189 . . . . 0.0 109.42 173.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.83 -62.31 0.1 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -103.33 128.72 50.32 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.558 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.0 m -132.57 -52.62 0.94 Allowed 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -124.06 -170.62 2.17 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 116' ' ' THR . 9.2 t -77.42 104.61 8.04 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.1 mp 66.08 -174.23 0.18 Allowed 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.642 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 . . . . . 0 CA--C 1.485 -1.544 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.166 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.5 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -76.04 -36.53 59.03 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -114.5 142.68 28.56 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 173.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.68 106.04 0.3 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.463 2.109 . . . . 0.0 111.894 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.63 -8.25 54.96 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.956 0.884 . . . . 0.0 109.781 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -154.8 156.69 36.71 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.564 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 29.5 mt -88.49 173.52 8.63 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.9 p -123.51 162.1 23.58 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -173.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -65.61 133.27 30.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.671 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.94 -16.57 42.89 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.944 177.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.455 ' HB ' HD11 ' A' ' 26' ' ' ILE . 13.4 m -66.54 132.08 47.42 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.498 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -96.75 115.36 27.3 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.9 m -128.61 -179.56 3.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 121.435 0.636 . . . . 0.0 110.361 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 19.4 m -133.43 136.45 45.21 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -107.18 138.83 42.63 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -89.91 129.93 36.19 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.879 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.447 ' HH ' HD21 ' A' ' 98' ' ' LEU . 99.5 m-85 -127.7 108.14 10.49 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.344 175.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.497 ' HD2' ' N ' ' A' ' 18' ' ' ARG . 2.9 mpt_? 59.57 32.82 21.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.67 0.788 . . . . 0.0 111.659 175.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.44 -2.63 68.0 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.787 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.36 147.97 36.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 117.184 0.492 . . . . 0.0 109.738 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -93.41 138.79 31.38 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.017 0.437 . . . . 0.0 110.833 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.0 m -125.36 128.03 47.53 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 170.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 6.8 pt-20 -90.08 138.38 31.56 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 118.417 -1.313 . . . . 0.0 110.771 -173.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -148.67 151.01 34.2 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.02 -174.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.6 tttp -108.92 128.98 55.4 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.455 HD11 ' HB ' ' A' ' 11' ' ' THR . 19.0 mt -66.63 118.67 10.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 120.646 0.26 . . . . 0.0 110.709 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -97.13 -46.85 6.0 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.259 0.552 . . . . 0.0 110.129 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 m -127.06 139.2 53.17 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.2 t -121.57 107.17 19.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.028 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 84' ' ' SER . 95.5 mttt -99.3 90.49 4.57 Favored 'General case' 0 C--N 1.264 -3.115 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -86.21 108.12 18.21 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -132.78 129.46 38.61 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -175.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 8.5 p -97.39 116.38 39.63 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.826 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -88.92 100.56 13.28 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.411 HG21 HD12 ' A' ' 57' ' ' LEU . 25.7 t -84.75 137.05 21.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.862 -174.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.49 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 39.8 ttmt -91.43 105.43 17.76 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 175.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 45' ' ' THR . 3.5 m -112.6 143.13 22.93 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.328 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.3 118.75 34.78 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 10.4 mp -69.4 122.59 19.25 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.851 -179.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.74 -31.43 72.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.153 0.501 . . . . 0.0 111.017 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -89.4 -58.82 2.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.529 0.68 . . . . 0.0 110.982 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.37 -17.37 45.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.599 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 t30 71.68 7.12 5.87 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.069 0.937 . . . . 0.0 113.385 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -86.64 159.75 19.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 110.789 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.6 m -119.4 140.35 50.54 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -134.09 142.51 47.56 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.44 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.75 101.22 10.53 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.2 149.62 28.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.424 0.631 . . . . 0.0 111.764 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 15.1 pt20 -69.81 160.98 30.73 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.37 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -63.4 -7.2 6.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.611 0.764 . . . . 0.0 112.523 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -73.58 -34.63 65.2 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.519 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 25.7 mm-40 -86.33 -28.99 23.35 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.076 -177.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.7 t -91.06 121.74 41.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.474 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -105.74 108.73 20.4 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.01 -173.79 22.76 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.059 177.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.9 139.2 46.7 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 123.139 2.559 . . . . 0.0 112.859 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.411 HD12 HG21 ' A' ' 35' ' ' VAL . 1.7 mm? -97.12 81.44 3.05 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.535 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 42.8 ttp85 -141.1 138.6 33.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.835 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.92 124.7 19.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.34 9.07 63.7 Favored Glycine 0 N--CA 1.427 -1.952 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.349 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.93 153.18 18.05 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.926 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -89.81 119.24 36.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.0 m -134.55 175.04 12.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.034 0.445 . . . . 0.0 110.807 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -126.3 128.19 46.74 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 11.8 t -131.13 157.92 41.85 Favored 'General case' 0 C--N 1.277 -2.55 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.042 -174.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.519 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 37.0 ttm-85 -82.54 128.59 34.45 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 105.221 -2.141 . . . . 0.0 105.221 170.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 34.2 p -84.98 176.79 8.23 Favored 'General case' 0 C--N 1.276 -2.615 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.199 178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.1 m -66.17 -19.72 65.92 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.004 0.431 . . . . 0.0 110.044 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -75.55 -25.43 57.14 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.84 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.33 -17.33 16.71 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.702 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.6 m -90.09 151.97 21.36 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.648 0.261 . . . . 0.0 111.416 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.436 ' HA ' ' O ' ' A' ' 65' ' ' THR . 62.4 m-85 -87.46 126.76 35.09 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.87 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -140.96 145.54 36.15 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.363 1.065 . . . . 0.0 108.983 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -76.13 131.05 39.17 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 121.812 0.815 . . . . 0.0 111.253 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.8 170.12 16.29 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.382 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.1 mm -119.83 142.46 35.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.535 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -74.42 129.06 36.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.3 m -114.47 -17.11 11.82 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 121.227 0.537 . . . . 0.0 111.025 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -168.82 156.23 7.48 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.76 135.15 53.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 87.1 m -114.37 111.71 21.89 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.39 122.74 17.85 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.107 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.55 153.34 43.79 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.7 p -161.78 122.38 2.64 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.111 0.481 . . . . 0.0 109.877 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.536 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 87.6 m95 -107.75 113.87 27.43 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.108 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 94.5 m-85 -101.47 110.59 22.62 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.1 m -89.93 104.14 16.73 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 24.4 m -106.9 140.59 24.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.273 0.559 . . . . 0.0 111.301 -174.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.5 t -101.79 128.69 54.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 124.239 1.015 . . . . 0.0 109.979 -173.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -87.71 174.02 8.65 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 174.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.31 -17.82 55.55 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.96 -17.81 62.04 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.045 0.538 . . . . 0.0 110.326 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.21 -0.48 68.85 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.96 131.48 40.85 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 123.325 0.65 . . . . 0.0 109.548 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.45 ' C ' ' HD2' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -111.74 137.25 49.92 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.354 0.597 . . . . 0.0 111.911 -179.139 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.45 ' HD2' ' C ' ' A' ' 95' ' ' GLU . 4.3 mpt_? -121.67 158.18 29.25 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.395 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 24.0 m -101.84 119.69 39.19 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.251 0.548 . . . . 0.0 110.771 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.447 HD21 ' HH ' ' A' ' 17' ' ' TYR . 4.0 mm? -122.09 174.5 6.9 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.484 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -98.86 166.58 11.23 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.89 -21.61 63.3 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.572 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.6 m -74.19 -9.78 58.96 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.521 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 5.3 m -98.95 -11.8 21.26 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 70.1 mt -101.68 128.35 48.02 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.073 -171.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.708 ' SG ' ' HA ' ' A' ' 110' ' ' HIS . 30.3 t -61.11 -41.93 97.59 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 124.749 1.219 . . . . 0.0 110.75 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.9 mt 68.86 127.77 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 176.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.8 tttm 71.39 -28.89 0.19 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.428 1.491 . . . . 0.0 113.04 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.52 -38.03 3.25 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -66.86 -43.9 82.35 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.94 0.896 . . . . 0.0 109.043 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -86.9 136.79 32.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.708 ' HA ' ' SG ' ' A' ' 104' ' ' CYS . 8.6 m170 -116.1 137.94 51.68 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.153 0.502 . . . . 0.0 110.628 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -86.53 130.48 34.48 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.018 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.03 134.4 44.35 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -84.05 -0.82 53.27 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.598 0.713 . . . . 0.0 110.081 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.3 p -153.84 85.75 1.17 Allowed 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -74.21 -25.63 59.79 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.006 0.431 . . . . 0.0 111.381 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.7 m -82.57 118.09 23.03 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -82.12 -31.41 30.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.094 0.474 . . . . 0.0 110.462 -177.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.4 t70 . . . . . 0 C--N 1.305 -1.367 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.373 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.178 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -134.58 -34.02 0.94 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.434 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -72.07 114.8 32.28 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.046 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -88.57 -175.34 1.25 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.291 1.994 . . . . 0.0 112.826 -178.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.22 -22.1 63.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.373 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.767 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 38.2 p90 -131.37 129.89 41.93 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 120.901 0.382 . . . . 0.0 110.353 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.55 -173.58 3.07 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.716 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.5 p -128.61 157.91 39.96 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -171.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 m -74.35 148.96 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 CA-C-O 121.122 0.487 . . . . 0.0 111.834 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.15 -12.59 67.36 Favored Glycine 0 C--N 1.301 -1.378 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.071 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.437 ' HB ' HD13 ' A' ' 26' ' ' ILE . 13.6 m -79.59 135.92 36.71 Favored 'General case' 0 N--CA 1.403 -2.809 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 106' ' ' LYS . 15.9 t70 -99.78 121.04 40.68 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' A' ' 104' ' ' CYS . 17.4 m -135.37 -177.33 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 121.474 0.654 . . . . 0.0 110.307 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 m -123.07 141.62 51.76 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.54 139.76 41.57 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' HZ1' ' CD ' ' A' ' 115' ' ' GLU 0.344 0.0 OUTLIER -99.98 136.61 39.63 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -177.815 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -131.62 121.72 24.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.668 -1.605 . . . . 0.0 107.355 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 61.53 31.7 18.85 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.028 0.931 . . . . 0.0 110.428 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.89 28.8 70.04 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.5 -177.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.75 152.29 50.16 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -102.39 144.84 30.36 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.686 -173.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -127.58 139.73 52.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 172.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.53 152.38 26.04 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.482 -175.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -162.37 145.36 11.39 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -106.51 128.75 54.34 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.437 HD13 ' HB ' ' A' ' 11' ' ' THR . 30.4 mt -63.75 114.42 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 121.185 0.517 . . . . 0.0 111.23 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.42 -42.39 6.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.757 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 5.8 m -130.05 137.35 50.18 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.1 t -116.61 116.4 52.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.279 0.562 . . . . 0.0 109.949 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.443 ' HB3' HD22 ' A' ' 32' ' ' LEU . 46.7 mmtt -109.57 91.03 3.48 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.185 174.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -83.25 87.69 6.94 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.549 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.3 pt? -135.07 116.53 14.69 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.291 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.502 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 62.8 t -108.5 115.23 48.74 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 171.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -82.64 108.35 15.95 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.244 1.021 . . . . 0.0 109.755 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.04 133.75 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.455 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.244 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -88.86 107.08 18.79 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 m -112.59 148.49 15.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.305 -176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.75 117.87 30.51 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 57.3 mt -73.92 106.55 5.68 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.41 -29.05 67.46 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -87.69 -24.47 23.86 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.765 -177.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -115.53 -13.97 11.54 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.177 -173.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 68.33 15.98 9.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.508 1.523 . . . . 0.0 113.112 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -99.99 158.28 15.94 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.377 0.132 . . . . 0.0 111.088 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -125.57 140.4 52.78 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.1 160.61 42.7 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.359 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.56 100.88 7.39 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 m -128.28 163.88 31.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.434 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.476 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 17.1 pm0 -80.78 160.05 24.98 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.47 -25.11 2.38 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 127.076 2.15 . . . . 0.0 112.51 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.42 -29.1 67.69 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.718 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.455 ' O ' ' HA ' ' A' ' 65' ' ' THR . 71.7 mt-30 -100.21 -15.17 18.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.463 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.08 110.82 22.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 122.523 1.154 . . . . 0.0 111.586 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -99.19 106.13 18.26 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 113.974 -1.466 . . . . 0.0 108.001 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 139.68 -169.65 24.53 Favored Glycine 0 C--N 1.302 -1.325 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.172 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.56 134.86 11.34 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.884 2.39 . . . . 0.0 112.544 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -88.53 82.26 6.97 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.532 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 35.0 mtp180 -139.26 132.59 30.01 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.744 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.32 120.07 10.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.34 5.81 61.74 Favored Glycine 0 N--CA 1.433 -1.556 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.867 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -96.39 169.21 10.07 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.894 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.5 mm -99.02 115.74 40.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.113 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.485 ' CG1' HD13 ' A' ' 77' ' ' ILE . 16.0 m -123.78 -173.05 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.8 135.87 35.07 Favored 'General case' 1 N--CA 1.374 -4.238 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 174.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.455 ' HA ' ' O ' ' A' ' 52' ' ' GLN . 11.6 t -141.56 158.91 43.24 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.056 -175.156 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -80.49 126.39 31.16 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -99.09 179.7 4.53 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.135 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.7 t -66.82 -21.06 66.04 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.205 1.002 . . . . 0.0 110.242 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.18 -18.34 62.49 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.53 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.88 -13.44 60.67 Favored Glycine 0 C--O 1.241 0.584 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.976 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.9 p -91.68 165.06 13.5 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 123.136 0.574 . . . . 0.0 110.727 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -98.38 124.68 43.18 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.5 tp-100 -119.6 146.91 45.1 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -176.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -72.7 127.74 33.46 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -132.55 168.35 18.39 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.45 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 7.0 mm -115.45 149.23 17.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.532 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.7 mp -89.92 130.47 39.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.0 m -107.35 -16.96 14.26 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.002 0.429 . . . . 0.0 110.583 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -173.53 147.47 1.45 Allowed 'General case' 0 C--O 1.212 -0.888 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.321 0.0 OUTLIER -129.92 115.89 17.84 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.546 0.688 . . . . 0.0 110.781 171.61 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.4 m -112.14 103.88 12.07 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.456 0.646 . . . . 0.0 109.341 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.502 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.9 p30 -75.4 141.77 43.18 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.108 -176.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.14 -60.25 1.71 Allowed 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.6 m 45.05 90.41 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.282 1.433 . . . . 0.0 113.546 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.506 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 78.8 m95 -100.97 129.98 46.9 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.526 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.767 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 74.6 m-85 -123.11 108.73 13.19 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 26.0 m -84.25 103.8 13.74 Favored 'General case' 0 N--CA 1.391 -3.38 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 26' ' ' ILE . 17.3 m -106.09 141.29 21.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.845 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.79 122.77 56.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.864 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -88.51 173.43 8.68 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.41 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -55.28 -33.45 63.25 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.262 1.025 . . . . 0.0 111.589 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.82 -17.84 62.75 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.987 0.422 . . . . 0.0 111.608 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.56 6.76 56.28 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -90.47 134.83 34.09 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -111.04 128.32 55.82 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-O 121.221 0.534 . . . . 0.0 109.937 177.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -123.45 140.97 52.47 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.506 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 32.3 m -103.66 108.82 20.26 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 120.725 0.298 . . . . 0.0 111.104 -176.051 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.8 mt -117.34 178.03 4.52 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -98.74 165.25 11.88 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -62.06 -25.38 67.65 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.13 0.49 . . . . 0.0 110.816 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.93 1.21 9.21 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.18 0.992 . . . . 0.0 112.213 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.5 t -127.61 11.24 6.74 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.9 mp -122.26 161.0 24.09 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.291 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.407 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 37.5 t -135.35 -143.94 0.2 Allowed 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.9 mt -141.11 164.16 31.03 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.51 ' HB2' ' O ' ' A' ' 12' ' ' ASP . 6.5 tmtt? -67.03 132.77 48.58 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.2 -15.82 8.17 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 65.33 96.62 0.05 OUTLIER 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.59 1.156 . . . . 0.0 109.827 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -104.68 167.81 9.48 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -80.32 79.71 6.87 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.907 0.861 . . . . 0.0 111.082 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -111.14 13.76 21.85 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.42 -171.25 2.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.821 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 56.98 77.43 0.26 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.683 1.23 . . . . 0.0 112.056 -173.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 75.7 m -157.16 -173.83 4.63 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.433 ' CD ' ' HZ1' ' A' ' 16' ' ' LYS . 0.5 OUTLIER 69.12 97.15 0.06 Allowed 'General case' 0 C--O 1.245 0.863 0 O-C-N 124.139 0.899 . . . . 0.0 109.74 -175.057 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.9 m -48.8 -50.16 35.56 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.594 1.558 . . . . 0.0 111.621 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.74 100.42 13.23 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 C--N 1.298 -1.673 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.036 -179.589 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 121.366 0.603 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -114.23 -37.88 4.28 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.483 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -36.22 96.45 0.11 Allowed Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 127.452 2.301 . . . . 0.0 115.605 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -110.66 39.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 124.736 3.624 . . . . 0.0 107.069 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.54 14.49 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 118.467 2.766 . . . . 0.0 118.467 -165.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -160.26 21.23 0.15 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 118.845 0.748 . . . . 0.0 112.085 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.418 ' O ' ' HE2' ' A' ' 86' ' ' TYR . 3.0 pp -151.43 166.47 30.96 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.462 ' HB ' ' OG1' ' A' ' 11' ' ' THR 0.539 54.2 p 115.17 71.88 0.0 OUTLIER 'General case' 0 C--O 1.193 -1.882 0 C-N-CA 130.201 3.401 . . . . 0.0 115.516 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.2 t -92.41 140.21 16.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.83 -13.57 58.68 Favored Glycine 0 C--N 1.313 -0.743 0 N-CA-C 112.238 -0.345 . . . . 0.0 112.238 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.462 ' OG1' ' HB ' ' A' ' 8' ' ' THR . 3.6 m -68.8 133.18 47.97 Favored 'General case' 0 N--CA 1.411 -2.38 0 C-N-CA 123.501 0.72 . . . . 0.0 110.067 -177.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.79 110.32 22.94 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.32 173.49 13.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 122.305 0.242 . . . . 0.0 110.719 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.9 p -95.38 132.06 40.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 98' ' ' LEU . . . -119.6 120.78 37.69 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 123.675 0.79 . . . . 0.0 109.802 -177.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -82.81 106.23 14.48 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.906 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -138.41 145.87 41.5 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 62.99 25.19 14.93 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 122.762 1.268 . . . . 0.0 108.899 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.53 16.04 75.61 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.263 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.17 142.67 42.18 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.406 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 26.2 p90 -98.45 114.09 26.33 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.089 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -100.6 143.17 31.08 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -71.64 132.78 45.08 Favored 'General case' 0 N--CA 1.38 -3.963 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -146.27 164.48 32.17 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.175 -173.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -117.44 126.84 53.32 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.423 HG12 HG11 ' A' ' 88' ' ' VAL . 18.6 mt -69.58 109.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -87.49 -41.2 13.68 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.344 0.592 . . . . 0.0 110.174 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.8 m -137.95 141.53 40.55 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.775 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.6 t -118.94 108.54 24.27 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 84' ' ' SER . 31.2 mmmt -82.33 101.29 10.47 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -84.49 99.39 10.67 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.6 pt? -138.88 126.09 21.44 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.655 0.74 . . . . 0.0 111.031 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.423 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 60.1 t -104.07 124.83 58.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -84.36 104.42 14.36 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 16.2 t -93.4 126.41 45.83 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.806 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.157 -177.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -95.6 110.5 22.59 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.6 m -117.51 154.53 19.34 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.952 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.338 -176.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tt -122.03 113.73 19.95 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.435 HD21 ' HB1' ' A' ' 75' ' ' ALA . 43.2 mt -64.72 118.14 8.5 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.356 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.41 ' HD2' ' OE1' ' A' ' 74' ' ' GLU . 18.8 ptpt -75.51 -23.04 56.66 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.409 -176.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -85.46 -42.45 14.47 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.268 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -91.66 -22.84 20.05 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.383 0.611 . . . . 0.0 110.653 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 73.1 22.31 2.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.109 1.364 . . . . 0.0 113.614 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 p -104.81 150.73 24.56 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.744 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -97.96 144.48 27.45 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -142.57 142.82 32.24 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.7 tp -121.57 102.63 8.36 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.28 164.49 29.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.767 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.446 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 4.5 pm0 -84.29 168.05 16.02 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.298 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -46.39 -21.47 0.17 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 128.584 2.754 . . . . 0.0 114.306 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.26 -23.03 23.61 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 122.084 0.945 . . . . 0.0 110.446 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -91.16 -20.13 22.33 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.876 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.9 t -105.24 127.04 60.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.354 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -110.93 110.06 20.47 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.419 ' HA3' HG13 ' A' ' 63' ' ' VAL . . . 141.54 -164.04 26.73 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.506 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.07 136.18 16.1 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.824 2.349 . . . . 0.0 113.117 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 39.8 mt -93.2 83.0 4.56 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.492 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 28.5 tpt180 -140.38 131.01 25.59 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.4 t -63.64 119.66 8.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.8 3.58 55.99 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.401 -176.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.44 168.76 10.19 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.471 0.635 . . . . 0.0 110.758 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.31 128.37 60.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.766 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.453 ' CG1' HD13 ' A' ' 77' ' ' ILE . 21.0 m -137.47 172.68 14.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.75 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -116.92 130.12 56.49 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.3 t -128.45 158.44 38.33 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.6 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -70.11 123.84 22.62 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.307 0.575 . . . . 0.0 111.023 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 71' ' ' SER . 14.2 t -95.11 169.83 9.83 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 p -63.83 -20.52 65.86 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.683 0.793 . . . . 0.0 112.524 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -69.61 -25.73 64.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.511 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.5 -22.27 12.09 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.672 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.461 ' O ' HG23 ' A' ' 67' ' ' THR . 23.3 m -87.19 170.09 11.78 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.856 0.36 . . . . 0.0 110.642 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -100.69 137.27 39.31 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -133.29 155.85 48.66 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.41 ' OE1' ' HD2' ' A' ' 40' ' ' LYS . 38.1 tt0 -69.15 128.67 37.45 Favored 'General case' 0 C--O 1.253 1.237 0 O-C-N 124.227 0.954 . . . . 0.0 112.288 -177.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.435 ' HB1' HD21 ' A' ' 39' ' ' LEU . . . -139.7 171.03 14.82 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.211 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.8 mp -120.86 141.87 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.492 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.3 mp -76.35 122.22 30.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -106.35 -18.93 13.85 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -163.78 150.0 11.52 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.3 OUTLIER -135.95 117.16 14.49 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.683 0.754 . . . . 0.0 110.838 171.811 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.3 m -112.16 104.85 13.08 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.072 -175.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -67.38 109.77 3.3 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.03 -73.17 0.58 Allowed 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.35 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.541 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 56.0 m 57.71 115.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 99.4 m95 -103.37 108.31 19.49 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.583 -179.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.418 ' HE2' ' O ' ' A' ' 7' ' ' LEU . 48.1 m-85 -90.39 111.56 22.84 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 m -87.98 105.19 17.29 Favored 'General case' 0 N--CA 1.405 -2.69 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.423 HG11 HG12 ' A' ' 26' ' ' ILE . 21.8 m -105.68 141.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.995 -176.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.88 125.72 59.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.92 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -87.19 170.12 11.76 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -57.15 -24.62 55.56 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 123.39 0.432 . . . . 0.0 112.057 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -72.4 -16.88 61.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.267 0.556 . . . . 0.0 111.846 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.84 -1.75 63.7 Favored Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.984 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.54 150.16 20.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.97 154.4 50.52 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 118.313 0.506 . . . . 0.0 111.521 -175.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -149.14 147.6 28.65 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.271 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.37 113.17 23.7 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 123.544 0.738 . . . . 0.0 110.899 174.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.475 HD12 ' HB1' ' A' ' 15' ' ' ALA 0.315 0.2 OUTLIER -129.83 146.87 51.55 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.141 0.496 . . . . 0.0 111.858 174.229 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.1 158.84 34.05 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.171 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.05 -38.25 56.42 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.902 1.281 . . . . 0.0 110.54 -175.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.5 m -62.72 -10.12 11.59 Favored 'General case' 0 CA--C 1.576 1.944 0 C-N-CA 123.834 0.854 . . . . 0.0 112.875 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.0 m -111.49 6.38 20.15 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 120.937 -1.102 . . . . 0.0 111.448 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 mp -108.81 139.61 43.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 110' ' ' HIS . 49.8 t -75.8 -48.83 20.04 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -175.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.3 tp 69.01 -70.66 0.13 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.394 1.078 . . . . 0.0 112.39 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -106.09 108.33 19.79 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.007 0.432 . . . . 0.0 110.163 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.69 -177.78 32.02 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -121.59 -40.16 2.58 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 117.805 0.803 . . . . 0.0 110.144 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -90.58 77.9 6.35 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.815 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.458 ' HB2' ' SG ' ' A' ' 104' ' ' CYS . 69.0 m-70 -137.63 159.07 42.99 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 74.65 7.18 4.46 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.251 1.42 . . . . 0.0 113.258 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.18 156.02 33.46 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 70.64 13.28 7.3 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 122.375 1.084 . . . . 0.0 110.448 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.2 t -178.91 105.59 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 66.45 178.45 0.22 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.844 1.307 . . . . 0.0 113.596 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.1 m -135.79 167.94 20.23 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 174.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -122.38 138.17 54.62 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 119.912 1.233 . . . . 0.0 113.034 -177.769 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.2 t70 . . . . . 0 C--N 1.307 -1.278 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.157 178.296 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.218 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -113.08 -5.66 13.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.031 0.443 . . . . 0.0 110.25 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.17 151.11 40.07 Favored Pre-proline 0 C--N 1.304 -1.387 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -82.42 76.53 4.13 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.086 1.857 . . . . 0.0 110.287 174.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.23 -41.34 77.13 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.858 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.557 ' HA ' ' OH ' ' A' ' 86' ' ' TYR 0.29 28.4 p90 60.95 134.26 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.759 2.024 . . . . 0.0 115.679 178.137 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.51 173.67 7.95 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 173.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.4 p -127.74 169.04 14.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -172.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.6 t -72.49 134.69 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.306 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.91 -22.22 14.77 Favored Glycine 0 N--CA 1.432 -1.596 0 C-N-CA 119.816 -1.183 . . . . 0.0 113.419 175.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -93.43 167.74 11.51 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.719 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 5.0 p-10 -118.17 139.27 51.52 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 m -132.18 162.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.83 -177.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.4 m -101.13 127.95 47.44 Favored 'General case' 0 N--CA 1.405 -2.715 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.506 ' CB ' HD13 ' A' ' 98' ' ' LEU . . . -106.91 120.78 42.98 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.453 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 22.2 ptmt -93.59 138.07 32.22 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.721 -177.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -134.81 130.9 36.78 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.7 mmt-85 61.21 25.2 15.22 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.85 1.26 . . . . 0.0 110.243 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.23 2.55 83.06 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.206 -0.521 . . . . 0.0 113.093 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.25 145.97 45.63 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.453 ' CD2' ' HB3' ' A' ' 16' ' ' LYS . 74.1 m-85 -95.1 132.92 39.48 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.982 -175.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.2 m -116.54 132.67 56.62 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -86.12 145.16 27.15 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.105 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.96 153.3 34.95 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 64.6 tttm -108.94 126.72 53.39 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -175.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.41 HG12 HG13 ' A' ' 88' ' ' VAL . 23.3 mt -65.31 114.14 2.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.936 0.398 . . . . 0.0 111.732 -175.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -97.18 -45.8 6.39 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.091 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 4.9 m -127.04 139.76 52.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -175.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.9 t -125.44 122.88 63.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -110.75 91.79 3.8 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 172.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.383 0.0 OUTLIER -85.71 86.94 7.34 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.06 177.362 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.47 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.5 pt? -116.46 105.27 12.3 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.449 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.414 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 7.3 p -91.45 127.23 43.92 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.492 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 68.4 mttm -79.78 105.11 10.83 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.314 0.578 . . . . 0.0 109.706 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.7 t -89.4 122.83 41.19 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.196 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.462 ' CB ' ' HB3' ' A' ' 79' ' ' LYS . 2.9 tmtm? -89.64 108.35 19.62 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.02 153.3 18.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 121.475 0.655 . . . . 0.0 112.472 -174.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -123.34 120.03 31.84 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.18 127.07 31.4 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.962 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.2 ptpt -64.28 -34.66 78.63 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -80.74 -58.77 2.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.001 0.429 . . . . 0.0 111.889 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.71 -4.42 55.11 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.7 p30 52.12 29.4 6.39 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.664 1.185 . . . . 0.0 112.595 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.3 145.77 24.22 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.734 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -113.27 147.73 37.0 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -158.7 164.46 35.9 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.918 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 31.5 tp -129.5 102.3 6.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.68 162.37 31.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 5.4 pm0 -90.99 166.73 12.86 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.32 -0.952 . . . . 0.0 113.538 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -42.68 -32.19 0.55 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 127.268 2.227 . . . . 0.0 113.253 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -68.25 -34.9 77.06 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 123.691 0.796 . . . . 0.0 111.238 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -90.39 -12.43 37.56 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.349 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 87.7 t -93.81 115.7 33.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.602 -177.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -108.38 124.34 50.22 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.292 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.26 -161.38 22.07 Favored Glycine 0 C--N 1.288 -2.108 0 CA-C-O 119.445 -0.642 . . . . 0.0 111.921 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -86.13 133.23 4.02 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.848 2.365 . . . . 0.0 112.833 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.88 82.55 3.87 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 122.085 0.945 . . . . 0.0 110.808 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.581 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 25.6 mmt180 -140.02 141.11 36.34 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.371 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.05 126.34 22.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.23 3.85 67.06 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.308 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.55 157.5 15.99 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.408 HG12 ' CD1' ' A' ' 76' ' ' ILE . 56.8 mt -101.76 124.43 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 121.383 0.611 . . . . 0.0 110.796 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.445 ' CG1' HD13 ' A' ' 77' ' ' ILE . 14.6 m -125.64 -178.65 2.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.814 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.484 ' HA ' ' O ' ' A' ' 73' ' ' GLN . 39.0 mt-10 -126.69 120.89 30.55 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 33.9 p -116.37 150.28 37.99 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.725 -174.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -76.67 130.41 37.75 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.1 p -87.91 -177.16 5.71 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.0 t -78.35 -0.88 30.72 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 110.033 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -94.68 -14.45 24.83 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.3 5.61 60.44 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.455 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 m -97.15 160.86 14.1 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.34 119.31 37.86 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 121.05 0.452 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.484 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 46.7 mt-30 -119.19 153.54 34.76 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.083 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 44.9 mt-10 -69.09 122.75 19.38 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 124.056 0.847 . . . . 0.0 109.563 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.42 162.28 34.05 Favored 'General case' 0 C--N 1.267 -3.011 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.572 178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.408 ' CD1' HG12 ' A' ' 62' ' ' ILE . 9.2 mm -107.48 137.52 38.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.581 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -70.89 120.02 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.417 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . 13.6 m -109.58 -15.77 14.11 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.301 -178.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.462 ' HB3' ' CB ' ' A' ' 36' ' ' LYS . 15.3 tppt? -172.77 150.13 2.08 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.4 123.82 32.63 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 171.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.4 m -118.77 115.5 24.59 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 123.455 0.702 . . . . 0.0 109.954 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -63.4 136.53 57.69 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.15 0.5 . . . . 0.0 111.798 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -139.02 13.34 2.65 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.994 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 50.5 m -49.3 123.74 7.96 Favored 'General case' 0 C--O 1.245 0.843 0 O-C-N 124.231 0.957 . . . . 0.0 113.57 -175.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.568 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 89.5 m95 -101.37 136.73 40.74 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.836 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.557 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 56.0 m-85 -122.81 114.36 20.41 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 16.0 m -91.74 105.54 17.8 Favored 'General case' 0 N--CA 1.401 -2.908 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.41 HG13 HG12 ' A' ' 26' ' ' ILE . 21.4 m -105.81 141.7 20.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.925 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.9 p -105.73 135.65 43.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.091 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -97.4 173.04 7.39 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.424 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -54.61 -42.64 71.4 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.674 1.189 . . . . 0.0 111.14 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.81 -14.02 62.61 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.925 0.89 . . . . 0.0 112.731 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.61 9.13 55.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.83 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -89.73 140.65 29.36 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -124.82 138.67 54.26 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -133.92 142.17 47.63 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.568 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 67.1 m -99.79 118.85 37.16 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.013 0.435 . . . . 0.0 110.872 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.506 HD13 ' CB ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -136.54 162.97 31.63 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.361 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.413 ' O ' HD11 ' A' ' 103' ' ' LEU . 28.7 ptt180 -99.32 166.32 11.26 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.738 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.423 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 72.0 mtm180 -56.47 -25.57 51.39 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 m -57.67 -22.37 45.53 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.35 1.06 . . . . 0.0 111.798 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.5 m -118.72 12.98 13.19 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.086 0.47 . . . . 0.0 111.634 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 99' ' ' ARG . 8.6 mp -103.12 146.16 28.81 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.633 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 34.6 t -79.75 -55.5 4.95 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.215 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.515 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 6.4 tt -64.1 101.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -167.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HG3' ' O ' ' A' ' 105' ' ' LEU . 1.9 mptt -174.14 -50.1 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 104.508 -2.405 . . . . 0.0 104.508 169.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.9 69.81 0.63 Allowed Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 113.436 -1.711 . . . . 0.0 110.147 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -133.16 138.46 46.61 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 48.85 -100.08 0.07 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 165.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -130.78 18.86 5.11 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.732 0.777 . . . . 0.0 109.94 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -85.71 -22.98 27.56 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 173.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.95 171.61 14.22 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 68.0 89.48 0.1 Allowed 'General case' 0 C--O 1.243 0.758 0 CA-C-O 122.475 1.131 . . . . 0.0 109.827 -177.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.0 t -78.56 87.54 4.52 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.342 -172.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -80.74 -43.15 20.69 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 168.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.8 p -118.58 173.63 6.73 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.043 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.2 mt -108.75 -66.78 1.02 Allowed 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--N 1.3 -1.57 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 174.814 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 121.36 0.6 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -113.04 20.39 16.37 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -62.66 119.49 51.34 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 113.513 -1.676 . . . . 0.0 112.61 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -65.87 143.31 72.81 Favored 'Trans proline' 0 N--CA 1.441 -1.607 0 N-CA-C 106.691 -2.08 . . . . 0.0 106.691 167.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -53.63 -43.35 68.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -151.07 -52.51 0.13 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 56.6 mt -127.54 -164.15 1.33 Allowed 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.037 173.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.9 p -87.86 133.48 33.89 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -160.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.6 t -92.1 135.47 27.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.181 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.85 -11.39 52.86 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.887 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.433 ' HB ' HD11 ' A' ' 26' ' ' ILE . 24.6 m -75.52 143.1 42.66 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 123.068 0.547 . . . . 0.0 110.805 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -96.8 131.68 43.28 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.05 -179.63 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.192 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 3.3 p -118.75 136.82 53.76 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.37 125.63 51.44 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 125.196 1.398 . . . . 0.0 107.57 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.414 ' HE2' ' N ' ' A' ' 112' ' ' ALA . 20.5 pttp -88.6 142.25 27.85 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.387 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -134.0 100.29 4.69 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 58.74 39.74 23.93 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.851 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.6 -11.36 70.13 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.534 -0.757 . . . . 0.0 114.243 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.78 131.05 54.34 Favored 'General case' 0 C--O 1.205 -1.238 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -106.68 132.44 52.67 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.842 -174.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.4 m -110.76 148.97 31.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -84.18 143.24 29.77 Favored 'General case' 0 C--O 1.249 1.069 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.638 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.32 149.61 27.1 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.327 -177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.426 ' O ' HG11 ' A' ' 89' ' ' VAL . 3.9 tmmm? -113.37 129.26 56.58 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.433 HD11 ' HB ' ' A' ' 11' ' ' THR . 53.8 mt -64.73 119.35 8.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 123.582 0.753 . . . . 0.0 112.657 -175.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -90.53 -49.21 6.63 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 122.154 0.978 . . . . 0.0 109.549 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.0 m -142.89 147.72 35.8 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.096 -175.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.475 HG21 ' CD2' ' A' ' 86' ' ' TYR . 53.2 t -114.27 133.52 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 171.683 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.445 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 23.7 tptm -121.82 120.82 35.68 Favored 'General case' 0 C--N 1.263 -3.156 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -70.56 144.32 51.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.611 -1.236 . . . . 0.0 111.026 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.526 HD21 ' CD1' ' A' ' 85' ' ' TRP . 73.5 mt -123.7 157.7 33.3 Favored 'General case' 0 C--N 1.265 -3.106 0 CA-C-N 114.046 -1.433 . . . . 0.0 107.457 175.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.411 ' CG1' ' HB2' ' A' ' 80' ' ' LEU . 60.7 t -119.86 110.65 29.8 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.361 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.415 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 42.9 mtpt -85.53 108.1 17.78 Favored 'General case' 0 CA--C 1.471 -2.065 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.4 HG12 HG13 ' A' ' 77' ' ' ILE . 14.9 t -91.61 132.43 36.07 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.229 -173.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -90.4 111.91 23.32 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.7 m -112.96 144.33 20.85 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.103 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.056 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -112.76 115.36 28.4 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.9 122.03 17.81 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.385 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -66.74 -38.93 87.64 Favored 'General case' 0 N--CA 1.41 -2.464 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -170.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -86.31 -45.77 10.93 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -86.27 -25.12 25.68 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -173.507 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 74.02 19.65 2.97 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.07 150.8 24.19 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -112.06 145.02 40.46 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -151.4 147.8 27.33 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -174.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.4 tp -123.48 101.49 7.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.0 m -134.62 165.08 32.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.406 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 5.6 pm0 -85.66 161.03 19.42 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -173.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -43.49 -28.12 0.34 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 127.294 2.238 . . . . 0.0 113.977 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.87 -37.34 87.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.941 0.401 . . . . 0.0 110.789 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -100.53 -6.94 24.69 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.324 -177.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.0 t -101.14 113.27 36.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.601 0.715 . . . . 0.0 110.035 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -98.63 100.28 11.49 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.041 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.483 ' HA3' HG13 ' A' ' 63' ' ' VAL . . . 152.33 -163.34 30.22 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.424 176.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -81.7 146.38 14.94 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.763 2.975 . . . . 0.0 113.903 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.93 82.09 6.21 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 49.1 mtm105 -139.89 123.75 17.51 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.674 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.3 t -61.08 118.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.525 0.679 . . . . 0.0 109.64 176.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.76 11.05 51.63 Favored Glycine 0 C--N 1.299 -1.515 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.532 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.11 168.9 10.17 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.414 178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.8 mm -101.45 120.33 50.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.483 HG13 ' HA3' ' A' ' 55' ' ' GLY . 27.4 m -131.32 176.96 7.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -122.82 123.09 40.22 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 8.5 t -114.96 154.36 28.91 Favored 'General case' 0 C--N 1.265 -3.08 0 CA-C-O 121.052 0.453 . . . . 0.0 110.402 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 ttt-85 -85.69 147.62 26.27 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 175.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.2 p -99.94 172.68 7.07 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.9 t -67.84 -6.98 24.22 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.298 0.57 . . . . 0.0 109.801 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.31 -25.47 27.15 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.411 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.98 -11.77 34.45 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.357 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 m -87.48 158.12 19.03 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 122.184 0.193 . . . . 0.0 110.706 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.467 ' HA ' ' O ' ' A' ' 65' ' ' THR . 54.5 m-85 -111.13 145.26 38.92 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 122.538 0.335 . . . . 0.0 110.415 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -147.69 151.72 36.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.95 126.52 30.04 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.804 0.841 . . . . 0.0 109.554 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -139.65 167.74 21.42 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.812 -176.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.0 mm -115.81 144.71 22.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.43 HD11 ' CG1' ' A' ' 63' ' ' VAL . 3.5 mp -77.55 123.65 34.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -111.87 -16.71 13.08 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.546 0.689 . . . . 0.0 111.582 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -161.1 150.8 17.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.411 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -141.25 111.51 6.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.067 0.937 . . . . 0.0 110.654 175.39 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.2 m -105.01 140.61 37.94 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.464 -170.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.49 127.03 32.04 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.322 0.582 . . . . 0.0 110.761 177.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -130.29 -170.05 2.25 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 176.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.8 p -166.1 142.53 5.06 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.526 ' CD1' HD21 ' A' ' 32' ' ' LEU . 64.8 m95 -94.09 151.08 19.76 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 167.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.475 ' CD2' HG21 ' A' ' 29' ' ' VAL . 53.2 m-85 -127.37 116.9 21.21 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 42.5 m -86.29 105.85 16.95 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 22.3 m -109.06 141.47 24.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.345 -176.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.426 HG11 ' O ' ' A' ' 25' ' ' LYS . 14.8 p -107.78 134.22 50.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.436 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -80.27 169.71 17.4 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -63.33 -20.78 65.8 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.41 0.624 . . . . 0.0 109.905 175.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -68.74 -17.81 64.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.246 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.99 0.1 68.74 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.669 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.55 142.5 28.54 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 9.4 pt-20 -117.98 138.64 52.05 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.0 mmp_? -124.3 142.71 51.05 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.0 m -102.57 117.79 35.44 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.046 0.451 . . . . 0.0 111.222 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.54 173.4 11.58 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 123.168 0.587 . . . . 0.0 109.991 179.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.454 ' O ' HD13 ' A' ' 103' ' ' LEU . 3.7 ptm180 -95.38 173.8 7.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.569 0.622 . . . . 0.0 112.277 -173.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 53.8 ttp85 -58.37 -40.79 83.22 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.809 0.444 . . . . 0.0 111.535 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.13 12.06 7.06 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.7 p -115.75 5.65 14.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.587 1.184 . . . . 0.0 108.477 170.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 99' ' ' ARG . 9.5 mp -112.21 153.06 27.66 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.104 175.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 55.7 m -89.91 -29.29 18.63 Favored 'General case' 0 C--N 1.285 -2.222 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.211 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 75.3 mt 62.76 -71.48 0.05 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.993 0.917 . . . . 0.0 111.386 -174.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? 175.22 -53.6 0.01 OUTLIER 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.495 1.118 . . . . 0.0 109.693 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -103.47 -3.4 47.15 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.38 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -89.04 135.12 33.72 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -139.98 68.11 1.37 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 122.328 1.061 . . . . 0.0 109.319 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -136.86 119.78 16.39 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.204 176.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -115.48 -169.35 1.56 Allowed 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.414 ' N ' ' HE2' ' A' ' 16' ' ' LYS . . . -164.34 82.35 0.41 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -173.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.07 108.5 19.94 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.703 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.5 p -100.41 -171.66 2.07 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -81.74 -57.05 3.61 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 39.2 p -96.77 130.0 44.1 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -89.74 104.63 17.17 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.482 -1.674 . . . . 0.0 106.482 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 . . . . . 0 C--N 1.306 -1.297 0 CA-C-O 118.698 -0.668 . . . . 0.0 109.848 -176.402 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.36 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -123.37 -5.68 8.25 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -65.33 129.18 94.34 Favored Pre-proline 0 C--O 1.252 1.197 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.016 179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -66.62 126.01 14.75 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.608 2.205 . . . . 0.0 110.657 177.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.434 ' HB2' ' NH1' ' A' ' 100' ' ' ARG . . . -112.83 -41.54 3.76 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.366 0.603 . . . . 0.0 110.688 -178.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.626 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 25.6 p90 -99.42 9.67 42.85 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -176.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.441 ' O ' ' HB ' ' A' ' 8' ' ' THR . 4.1 pp -145.23 134.87 23.38 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 9.2 t 176.41 25.3 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 O-C-N 124.13 0.894 . . . . 0.0 111.127 174.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 p -75.9 132.48 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 O-C-N 121.173 -0.954 . . . . 0.0 109.475 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.8 -3.77 74.61 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.403 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.418 ' HB ' ' HG1' ' A' ' 8' ' ' THR . 11.3 m -91.76 153.45 19.6 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-O 121.093 0.473 . . . . 0.0 109.978 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -103.7 111.44 23.94 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -119.14 173.22 5.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.181 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.9 m -95.26 135.18 37.17 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.05 127.06 39.15 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.493 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 21.5 ptmt -88.75 117.35 27.67 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.742 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.556 ' CE2' ' HB2' ' A' ' 22' ' ' CYS . 50.7 p90 -133.5 138.0 45.91 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 70.3 ttt180 64.2 25.77 13.68 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 122.326 1.06 . . . . 0.0 108.666 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.17 18.09 77.75 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.552 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.69 130.72 47.57 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.493 ' CD2' ' HB3' ' A' ' 16' ' ' LYS . 33.9 m-85 -86.53 110.38 19.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.556 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 73.1 m -126.64 155.37 42.68 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.82 149.4 32.57 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.246 -1.381 . . . . 0.0 111.756 -176.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -144.88 149.35 35.19 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.475 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -104.0 126.95 51.51 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.993 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 47.4 mt -69.27 121.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.954 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -111.56 -37.55 5.18 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.387 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.448 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 9.3 m -129.06 145.26 51.32 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.6 t -135.66 133.07 51.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 123.674 0.79 . . . . 0.0 108.955 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -122.92 111.09 16.22 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.626 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 46.1 mtm-85 -86.65 107.0 17.99 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.127 0.489 . . . . 0.0 109.891 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -124.65 137.62 54.35 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 43.3 t -92.56 129.16 43.54 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.001 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.859 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -90.73 101.17 13.92 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.2 t -93.51 130.97 41.75 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.942 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.484 -170.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.505 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 88.0 tttt -98.36 106.26 18.52 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.8 m -112.7 143.37 22.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 CA-C-O 121.396 0.617 . . . . 0.0 111.217 179.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.0 tp -111.09 120.85 43.71 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.032 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.4 HD22 ' HB2' ' A' ' 75' ' ' ALA . 68.1 mt -73.13 116.81 14.11 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -68.47 -26.79 65.67 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.613 0.721 . . . . 0.0 110.083 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -70.83 -36.51 72.93 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.054 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -128.03 -19.6 3.95 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -171.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 78.43 15.19 1.3 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.274 1.03 . . . . 0.0 112.829 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.59 142.18 28.05 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -115.07 132.52 56.57 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.641 0.734 . . . . 0.0 109.434 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.505 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 2.2 mp0 -120.49 147.06 45.62 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.687 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.4 mt -122.29 101.65 7.64 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.72 -178.04 2.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -175.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -96.02 165.98 11.99 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.739 178.366 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.68 -4.66 3.2 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.103 0.961 . . . . 0.0 113.162 -177.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.66 -30.59 41.27 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.427 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 79.7 mm-40 -82.46 -23.38 34.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.832 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.71 131.42 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.317 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -112.78 104.59 12.62 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.8 -176.0 21.16 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.597 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.23 144.39 99.49 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 123.742 2.961 . . . . 0.0 113.447 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.01 82.35 2.55 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.004 0.907 . . . . 0.0 108.587 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.548 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 79.3 ttt180 -139.86 133.61 30.51 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.627 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.01 119.36 12.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.23 4.0 53.76 Favored Glycine 0 C--N 1.292 -1.883 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.962 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.73 143.67 27.45 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.921 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.2 mt -93.74 124.05 46.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.489 0.662 . . . . 0.0 109.278 179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.31 -172.54 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.881 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.71 148.27 44.17 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 8.8 t -145.38 152.88 40.56 Favored 'General case' 0 C--N 1.276 -2.61 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.939 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.427 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 40.3 ttm180 -78.73 126.88 31.32 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 174.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 71' ' ' SER . 7.2 t -98.87 159.05 15.23 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 174.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.2 m -66.05 -2.79 4.41 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.83 -22.43 61.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.75 -22.8 16.01 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.595 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.408 ' O ' HG22 ' A' ' 67' ' ' THR . 24.8 m -99.12 161.46 13.61 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.025 0.44 . . . . 0.0 111.964 -177.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.415 ' HA ' ' O ' ' A' ' 65' ' ' THR . 53.3 m-85 -93.09 124.11 36.83 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.039 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -122.26 162.08 22.1 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -78.05 128.1 33.33 Favored 'General case' 0 C--O 1.254 1.311 0 C-N-CA 123.387 0.675 . . . . 0.0 109.238 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.4 ' HB2' HD22 ' A' ' 39' ' ' LEU . . . -143.02 171.96 13.35 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.699 -175.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.59 139.01 51.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -70.63 122.13 21.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.3 m -102.22 -23.36 14.03 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.236 0.541 . . . . 0.0 110.109 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -163.7 144.41 8.8 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -120.9 116.06 24.41 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 167.957 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 m -101.59 144.4 30.37 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.506 -167.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.592 ' HB3' ' NH1' ' A' ' 100' ' ' ARG . 1.7 m-20 -63.18 122.31 15.81 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.362 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.97 147.23 31.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.9 m -165.03 139.67 5.1 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TRP . . . . . 0.478 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 46.9 m95 -99.09 131.42 45.14 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -122.15 120.29 33.79 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . 0.452 ' CG2' ' HB3' ' A' ' 95' ' ' GLU . 89.2 m -98.16 109.38 22.14 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 17.5 m -106.25 148.25 10.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.314 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.24 123.72 54.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.566 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -92.33 -175.33 3.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.521 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.5 -33.0 13.4 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.382 1.873 . . . . 0.0 112.643 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -78.74 -16.95 56.58 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.414 0.626 . . . . 0.0 111.648 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.09 16.05 59.95 Favored Glycine 0 C--N 1.31 -0.865 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -172.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.79 135.83 38.18 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 114.039 -1.08 . . . . 0.0 108.855 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.452 ' HB3' ' CG2' ' A' ' 87' ' ' THR . 42.9 mt-10 -102.84 128.69 49.5 Favored 'General case' 0 C--N 1.277 -2.571 0 O-C-N 124.309 1.006 . . . . 0.0 110.144 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -136.29 140.64 43.55 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.478 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 26.7 m -89.68 111.92 23.03 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 122.524 0.33 . . . . 0.0 110.643 -177.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 17.0 mt -110.54 172.41 6.88 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.111 0.482 . . . . 0.0 110.973 -178.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -99.27 169.04 9.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.783 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.592 ' NH1' ' HB3' ' A' ' 82' ' ' ASP . 97.4 mtt180 -68.19 -25.11 65.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.276 0.56 . . . . 0.0 110.521 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.0 m -83.18 4.04 28.36 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.934 0.873 . . . . 0.0 109.81 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 7.4 m -120.56 -0.47 10.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.32 162.18 28.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.102 -174.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.3 t -138.58 104.54 5.15 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.432 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.6 tp -98.44 -82.82 0.42 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 170.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 46.31 -83.43 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.1 1.76 . . . . 0.0 113.945 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -160.79 -48.69 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -120.77 -178.87 3.83 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -87.06 17.61 4.09 Favored 'General case' 0 C--O 1.251 1.14 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -69.85 100.4 1.54 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 122.013 0.911 . . . . 0.0 109.074 -179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -178.81 -35.71 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.04 171.91 11.04 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.478 171.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -81.44 104.66 12.03 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.7 m -155.73 102.63 2.22 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -80.27 109.1 14.43 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.626 0.727 . . . . 0.0 111.195 -171.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.6 p -92.38 160.65 15.0 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.735 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.2 mp 68.79 91.08 0.09 Allowed 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.061 0.945 . . . . 0.0 111.716 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 C--N 1.303 -1.451 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.712 179.615 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.487 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 27.7 t80 . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 86' ' ' TYR . 95.9 mt -123.24 -160.26 0.89 Allowed 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 167.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.48 HG23 ' OG1' ' A' ' 11' ' ' THR . 1.4 t -122.45 150.96 41.77 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 118.189 0.45 . . . . 0.0 111.908 -169.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -91.59 145.39 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.289 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.34 -13.13 67.9 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.48 ' OG1' HG23 ' A' ' 8' ' ' THR . 13.7 m -73.43 141.42 46.9 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 123.344 0.658 . . . . 0.0 111.174 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -89.71 131.29 35.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.71 175.8 9.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.595 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 104' ' ' CYS . 51.5 m -117.08 144.82 44.23 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -121.28 139.09 53.86 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -75.87 136.11 40.15 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.329 0.585 . . . . 0.0 112.077 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -133.95 105.27 6.65 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.845 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 18' ' ' ARG . 2.9 mtp180 60.37 26.59 16.14 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 173.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.85 8.1 60.83 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.856 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.45 164.32 17.33 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -102.33 135.96 43.02 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.081 0.238 . . . . 0.0 111.003 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.5 t -122.33 146.86 46.92 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -88.04 151.24 22.9 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.384 -0.927 . . . . 0.0 109.502 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -152.79 162.32 41.42 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.8 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -126.61 126.29 43.37 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.584 ' HA ' HG12 ' A' ' 88' ' ' VAL . 52.3 mt -66.64 111.53 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -87.8 -44.43 11.12 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 124.858 1.263 . . . . 0.0 110.325 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 m -139.59 145.29 38.38 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -116.95 126.54 74.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 48.7 mttp -130.55 116.31 17.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.91 108.53 21.24 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.14 158.78 43.57 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.738 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 14.5 p -125.27 137.27 58.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 93.3 mttt -90.29 101.06 13.79 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 122.128 0.966 . . . . 0.0 108.852 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.602 HG12 HG13 ' A' ' 37' ' ' VAL . 20.8 t -83.8 120.95 35.73 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.122 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -85.34 107.86 17.54 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 173.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.602 HG13 HG12 ' A' ' 35' ' ' VAL . 1.7 m -112.71 157.08 13.55 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.111 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -135.41 121.57 20.18 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.597 HD23 ' HB2' ' A' ' 75' ' ' ALA . 73.1 mt -69.8 129.33 39.26 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.005 -176.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.1 ptpt -68.71 -32.4 72.18 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.555 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 23.2 tt0 -81.1 -59.95 2.47 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 120.924 0.392 . . . . 0.0 110.956 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -85.57 -4.3 59.12 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 p30 56.38 18.62 3.53 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.729 1.612 . . . . 0.0 113.543 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.53 137.51 32.25 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-O 120.965 0.412 . . . . 0.0 111.165 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 m -101.11 148.16 25.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.443 ' OE1' HG23 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -152.44 163.39 39.62 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 123.133 0.573 . . . . 0.0 110.236 175.418 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.416 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 20.8 tp -128.99 103.13 6.83 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.53 162.52 37.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.518 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.9 pm0 -77.23 161.5 28.1 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -62.98 -6.02 3.48 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.618 1.167 . . . . 0.0 113.617 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -82.21 -27.63 32.45 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.776 0.798 . . . . 0.0 108.988 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -87.05 -22.51 25.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.223 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.8 117.21 48.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.47 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -102.8 105.37 15.77 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.315 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.492 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 149.63 -179.39 26.45 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.638 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.79 141.1 93.87 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.336 2.691 . . . . 0.0 113.562 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.27 83.45 3.87 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.542 ' HB3' ' HB2' ' A' ' 61' ' ' ALA . 47.2 ttp180 -139.13 135.9 34.56 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.57 122.79 18.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.87 12.18 59.46 Favored Glycine 0 N--CA 1.423 -2.214 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.422 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . . . -97.2 157.73 15.8 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 118.161 0.981 . . . . 0.0 110.789 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.9 mm -97.36 121.74 48.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.492 HG12 ' HA3' ' A' ' 55' ' ' GLY . 29.6 m -136.4 -173.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 122.927 0.491 . . . . 0.0 109.893 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -128.88 132.25 47.71 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.481 HG21 HG21 ' A' ' 37' ' ' VAL . 9.1 t -133.79 158.56 43.03 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-O 120.792 0.329 . . . . 0.0 110.369 -174.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.4 ttm-85 -83.94 115.37 22.27 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.309 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 71' ' ' SER . 5.1 t -81.72 167.2 19.38 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.7 p -67.7 -2.35 6.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.927 0.87 . . . . 0.0 112.219 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -85.93 -16.31 38.85 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.067 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.5 -2.94 71.23 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.454 ' O ' HG22 ' A' ' 67' ' ' THR . 8.2 m -92.26 159.97 15.37 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -109.74 115.73 30.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.594 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 7.2 tt0 -113.37 148.35 35.95 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.618 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 35.3 tt0 -70.4 125.17 26.05 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -136.91 173.92 11.18 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.358 -173.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.406 HD11 ' HB3' ' A' ' 40' ' ' LYS . 2.4 mp -123.67 139.99 48.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -75.5 126.2 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.2 m -108.33 -17.32 14.03 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.336 0.112 . . . . 0.0 110.892 177.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -166.65 151.69 7.8 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.0 mt -124.36 112.87 17.46 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 169.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.8 m . . . . . 0 C--N 1.279 -2.469 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.814 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 99' ' ' ARG . 75.2 m . . . . . 0 CA--C 1.498 -1.032 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.494 ' CE3' ' HB ' ' A' ' 97' ' ' THR . 46.1 m95 -107.61 107.92 18.95 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.079 0.466 . . . . 0.0 110.05 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.487 ' OH ' ' HB3' ' A' ' 6' ' ' TYR . 96.5 m-85 -101.64 103.45 14.25 Favored 'General case' 0 N--CA 1.404 -2.742 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.4 m -76.16 104.09 6.52 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.597 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 25.4 m -112.28 141.14 28.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-O 121.261 0.553 . . . . 0.0 111.172 -175.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 95' ' ' GLU . 9.7 t -97.36 118.16 43.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.095 -176.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 93.0 m-85 -84.44 168.47 15.49 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -61.36 -21.27 63.89 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.12 0.486 . . . . 0.0 111.218 -175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.1 -16.87 63.18 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 123.666 0.786 . . . . 0.0 111.113 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.62 1.94 58.79 Favored Glycine 0 CA--C 1.507 -0.468 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.4 138.85 33.38 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 9.6 pt-20 -120.58 128.57 53.18 Favored 'General case' 0 C--N 1.284 -2.245 0 O-C-N 123.522 0.514 . . . . 0.0 110.413 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -131.54 149.61 52.45 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.494 ' HB ' ' CE3' ' A' ' 85' ' ' TRP . 2.3 p -79.75 112.72 17.29 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 122.383 0.273 . . . . 0.0 111.048 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.83 137.73 48.11 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.195 0.522 . . . . 0.0 110.682 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -76.34 143.62 40.66 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 175.272 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 100' ' ' ARG . 2.5 tmm_? -44.07 -33.13 1.37 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.619 1.167 . . . . 0.0 113.265 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' THR . . . . . 0.403 ' H ' ' HD2' ' A' ' 99' ' ' ARG . 24.3 m -55.31 -32.91 62.83 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.016 0.926 . . . . 0.0 112.047 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 35.1 m -82.69 -16.59 47.56 Favored 'General case' 0 N--CA 1.433 -1.306 0 O-C-N 122.063 -0.398 . . . . 0.0 110.849 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 mp -86.87 128.97 35.06 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.79 0.805 . . . . 0.0 111.462 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 20.0 m . . . . . 0 C--N 1.283 -2.284 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.902 -175.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.694 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 39.6 p90 . . . . . 0 N--CA 1.409 -2.491 0 CA-C-O 122.605 1.193 . . . . 0.0 109.948 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.8 mt -76.88 177.32 7.78 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 112.82 -1.991 . . . . 0.0 109.801 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.472 ' HA ' HG21 ' A' ' 29' ' ' VAL . 10.6 p -133.4 166.57 22.22 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.374 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.4 111.41 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.98 -26.52 2.2 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.483 ' HB ' HD12 ' A' ' 26' ' ' ILE . 5.6 m -71.64 137.93 48.27 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -116.33 125.68 52.46 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.451 ' CG2' HD22 ' A' ' 103' ' ' LEU . 33.9 m -144.79 -178.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 9.4 t -99.26 147.46 25.14 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 175.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -137.75 128.8 27.42 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 123.324 0.65 . . . . 0.0 109.396 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 51.1 mtpt -70.54 121.09 17.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.955 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.417 ' HE1' ' HB2' ' A' ' 22' ' ' CYS . 12.5 p90 -148.46 138.55 22.44 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 60.65 26.13 15.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.167 0.587 . . . . 0.0 111.46 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.55 3.05 72.1 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.184 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.06 145.53 44.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 117.652 0.726 . . . . 0.0 110.157 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 21.7 p90 -93.58 120.61 34.07 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.987 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.417 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 83.7 m -123.63 173.63 7.96 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.11 146.5 41.35 Favored 'General case' 0 C--O 1.253 1.242 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.21 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.572 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -152.12 147.78 26.86 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.416 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -116.6 128.36 55.32 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.541 ' HA ' HG12 ' A' ' 88' ' ' VAL . 28.4 mt -62.36 116.09 2.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -90.37 -40.32 12.15 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.601 1.16 . . . . 0.0 110.118 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 87.4 m -144.41 145.98 32.23 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.278 -177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 8' ' ' THR . 96.0 t -129.29 128.75 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.086 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 84' ' ' SER . 21.8 mmmt -118.29 102.66 9.14 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.637 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -77.15 88.0 3.62 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 pp -111.09 153.58 25.47 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.958 0.885 . . . . 0.0 112.437 -172.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 80' ' ' LEU . 60.3 t -115.81 120.61 65.3 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.365 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.621 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 26.4 mtpp -85.59 99.02 10.99 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.595 HG12 HG13 ' A' ' 37' ' ' VAL . 21.4 t -84.41 123.8 39.31 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.928 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 87.7 tttt -87.99 115.41 25.44 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 171.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.595 HG13 HG12 ' A' ' 35' ' ' VAL . 1.7 m -118.46 143.38 29.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.427 0.632 . . . . 0.0 112.077 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 44' ' ' THR . 1.9 tm? -107.21 116.89 32.72 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 75' ' ' ALA . 44.8 mt -74.7 124.6 27.04 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.486 ' HB3' HD11 ' A' ' 76' ' ' ILE . 22.2 pttp -72.82 -29.29 63.12 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -78.2 -38.92 42.11 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.947 0.403 . . . . 0.0 111.595 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.565 ' OD1' ' HB ' ' A' ' 44' ' ' THR . 14.6 t70 -93.33 -25.55 17.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.864 0.364 . . . . 0.0 110.948 -176.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 70.26 22.31 5.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.29 1.036 . . . . 0.0 111.24 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.565 ' HB ' ' OD1' ' A' ' 42' ' ' ASP . 5.6 t -101.23 -174.8 2.69 Favored 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 121.475 0.655 . . . . 0.0 110.049 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.7 m -136.24 139.65 42.9 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.25 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.01 156.93 44.29 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 8.1 tt -140.96 103.8 4.55 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 25.6 m -126.03 -178.49 2.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.746 -172.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -100.7 173.06 6.7 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 33' ' ' VAL . 1.4 t70 -43.03 -29.86 0.38 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 128.657 2.783 . . . . 0.0 114.754 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.35 -28.01 31.84 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.121 -174.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.494 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 8.0 mm-40 -90.19 -16.48 29.39 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.421 0.629 . . . . 0.0 109.443 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -97.57 109.37 23.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.509 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -99.03 106.88 19.17 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.525 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 139.18 -171.3 23.73 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.406 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.32 137.58 23.58 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.136 2.558 . . . . 0.0 113.495 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.5 mt -90.03 81.98 6.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.61 128.63 23.64 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.629 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 t -65.97 116.27 5.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.37 6.19 51.16 Favored Glycine 0 N--CA 1.431 -1.699 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.836 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.39 165.2 12.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.391 0.596 . . . . 0.0 111.228 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.414 HD13 HG13 ' A' ' 76' ' ' ILE . 48.5 mm -96.14 124.27 48.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 O-C-N 123.6 0.563 . . . . 0.0 109.935 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.421 ' CG1' HD11 ' A' ' 77' ' ' ILE . 19.7 m -131.61 178.08 6.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -121.6 121.4 37.32 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.442 HG21 HG21 ' A' ' 37' ' ' VAL . 8.4 t -116.37 158.04 24.1 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.816 -175.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 23.1 mtt180 -79.15 143.55 35.34 Favored 'General case' 0 CA--C 1.479 -1.782 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.037 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.1 p -97.92 175.25 6.2 Favored 'General case' 0 N--CA 1.404 -2.727 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.205 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.4 m -76.7 -17.92 58.82 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.252 0.549 . . . . 0.0 111.095 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -84.11 -21.12 31.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.819 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.8 6.01 23.37 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.368 -0.92 . . . . 0.0 114.424 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.9 p -99.3 177.27 5.25 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 117.619 0.71 . . . . 0.0 110.387 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.446 ' CE1' ' HG3' ' A' ' 66' ' ' ARG . 60.6 m-85 -108.46 137.26 46.71 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.119 0.485 . . . . 0.0 110.792 175.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -122.43 141.75 51.27 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.28 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -74.36 118.69 17.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.715 0.769 . . . . 0.0 109.004 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -134.25 166.82 21.91 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.322 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 40' ' ' LYS . 3.5 mp -112.14 141.89 26.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.421 HD11 ' CG1' ' A' ' 63' ' ' VAL . 3.2 mp -74.26 122.57 27.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -101.18 -27.3 13.3 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.264 0.554 . . . . 0.0 110.241 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 53.7 tptt -162.72 142.24 9.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.493 ' HB3' ' CG1' ' A' ' 33' ' ' VAL . 25.3 mt -119.0 127.09 53.13 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 171.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.621 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 3.7 m . . . . . 0 C--N 1.279 -2.49 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 49.2 m . . . . . 0 N--CA 1.441 -0.904 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -118.59 145.25 45.54 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.694 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 55.5 m-85 -124.69 121.9 35.97 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 124.152 0.907 . . . . 0.0 109.115 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 70.5 m -95.09 107.73 19.8 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.572 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 30.3 m -109.64 147.16 14.25 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.884 -176.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.92 128.48 57.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -90.49 179.06 5.94 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.915 -172.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -52.0 -39.71 59.83 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.488 1.515 . . . . 0.0 112.809 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.39 -13.73 58.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.421 0.629 . . . . 0.0 111.866 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.49 -0.44 43.06 Favored Glycine 0 C--N 1.292 -1.884 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.84 175.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -87.56 154.08 20.9 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 6.8 pt-20 -130.42 137.61 49.92 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 120.861 0.362 . . . . 0.0 110.084 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 87' ' ' THR . 0.6 OUTLIER -139.21 158.64 43.8 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.886 -177.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.1 m -101.57 117.22 34.47 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.444 0.465 . . . . 0.0 110.235 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.405 ' CD2' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -136.2 165.1 26.52 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.078 0.951 . . . . 0.0 111.909 -177.385 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -100.12 -171.3 2.01 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.407 HH21 ' HA ' ' A' ' 6' ' ' TYR . 3.6 mpt_? -75.93 -5.34 45.69 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.654 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 p -71.27 -21.13 62.14 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.671 0.748 . . . . 0.0 110.11 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 23.3 m -106.64 -16.17 14.58 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.053 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 14' ' ' SER . 87.6 mt -93.05 127.33 38.54 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.612 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 18.8 m . . . . . 0 C--N 1.29 -1.995 0 CA-C-O 121.168 0.508 . . . . 0.0 110.431 -176.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.2 p90 . . . . . 0 N--CA 1.42 -1.965 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.472 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 22.1 mt -85.88 178.71 7.2 Favored 'General case' 0 C--N 1.277 -2.571 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.586 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 p -133.0 168.34 18.65 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.264 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.29 148.66 11.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 123.853 0.861 . . . . 0.0 111.562 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.23 -5.94 81.17 Favored Glycine 0 CA--C 1.505 -0.531 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.963 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.527 ' HB ' HD12 ' A' ' 26' ' ' ILE . 8.6 m -82.62 139.82 33.55 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 122.346 0.258 . . . . 0.0 110.532 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -104.93 111.06 23.69 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 104' ' ' CYS . 29.3 m -127.24 171.97 14.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 21.2 m -95.11 142.81 27.13 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.598 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.78 129.36 36.48 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.027 0.531 . . . . 0.0 109.701 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 21.1 ptmt -94.83 120.31 34.84 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.706 0.765 . . . . 0.0 110.379 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -119.97 120.97 37.9 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? 63.78 26.28 14.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.53 0.681 . . . . 0.0 110.729 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.85 -14.88 63.09 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.501 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.31 130.17 52.15 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 16' ' ' LYS 0.289 6.6 p90 -105.0 123.96 48.7 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -177.195 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.2 t -115.06 160.61 19.42 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -90.69 148.94 22.28 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-O 121.887 0.851 . . . . 0.0 110.08 178.071 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -144.54 149.34 35.71 Favored 'General case' 0 C--N 1.259 -3.334 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.699 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.76 126.26 51.65 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.583 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.527 HD12 ' HB ' ' A' ' 11' ' ' THR . 30.8 mt -68.95 119.45 14.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 123.526 0.73 . . . . 0.0 112.268 -175.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -91.29 -53.38 4.37 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.057 0.932 . . . . 0.0 109.455 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 m -129.71 143.41 50.8 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.463 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.71 123.66 61.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.301 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -112.71 117.98 33.72 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 171.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -72.05 108.31 5.2 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 84' ' ' SER . 6.6 tt -129.34 136.76 50.43 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-O 121.544 0.688 . . . . 0.0 109.34 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.4 t -115.59 132.97 63.41 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.126 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.088 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -84.69 101.54 12.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 170.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.402 HG12 HG13 ' A' ' 37' ' ' VAL . 14.3 t -91.8 118.27 36.86 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.07 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.779 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 87.7 tttt -80.52 103.71 10.56 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 65' ' ' THR . 3.9 m -111.55 143.52 21.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-O 121.689 0.757 . . . . 0.0 111.21 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.04 117.13 32.46 Favored 'General case' 0 C--N 1.267 -3.018 0 CA-C-N 113.149 -1.841 . . . . 0.0 106.91 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.49 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 75.7 mt -73.72 108.5 6.59 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -62.25 -30.32 71.03 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -80.22 -40.15 27.69 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.241 0.543 . . . . 0.0 111.697 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -95.05 -25.38 16.49 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.242 0.544 . . . . 0.0 111.384 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 74.42 22.67 2.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.524 1.53 . . . . 0.0 113.12 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.97 150.17 24.47 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.655 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.9 m -119.03 151.87 37.44 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 1.4 pm0 -157.85 161.88 38.35 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 123.451 0.7 . . . . 0.0 109.619 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 mt -113.11 102.31 10.27 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.7 m -117.94 172.51 5.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.597 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -84.9 161.5 19.82 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.058 0.456 . . . . 0.0 111.963 -174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -64.44 -20.15 65.99 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.271 1.029 . . . . 0.0 111.06 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.58 -21.92 47.88 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.783 0.801 . . . . 0.0 109.533 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 65' ' ' THR . 96.6 mt-30 -98.31 -11.57 22.41 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.656 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.88 111.51 27.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.569 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -98.4 103.75 15.72 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.227 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 140.71 178.87 17.63 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.505 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.53 140.32 80.98 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.346 2.697 . . . . 0.0 113.93 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -89.35 82.27 6.51 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.523 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 73.5 mtp180 -140.11 134.47 31.32 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.455 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.79 118.61 10.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.17 53.86 Favored Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.43 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -96.33 155.84 16.59 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.704 0.752 . . . . 0.0 110.619 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.09 116.92 39.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.426 0.632 . . . . 0.0 109.334 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.523 HG12 ' HA3' ' A' ' 55' ' ' GLY . 30.4 m -126.82 170.61 16.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.565 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -112.84 121.46 44.75 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 9.2 t -119.68 157.59 28.2 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.956 -174.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -81.93 126.17 31.61 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.759 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.7 p -90.31 -176.07 4.7 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.0 m -67.26 -26.31 66.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -79.85 -6.9 58.25 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.387 0.613 . . . . 0.0 110.56 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.27 -18.57 56.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.51 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 m -72.78 141.75 48.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 122.786 0.434 . . . . 0.0 110.081 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 65' ' ' THR . 45.0 m-85 -89.88 133.23 34.87 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.49 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 32.0 tt0 -124.09 146.52 48.55 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.05 117.31 19.24 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 122.484 1.135 . . . . 0.0 110.754 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.455 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -124.93 174.03 8.25 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 113.494 -1.685 . . . . 0.0 110.987 -174.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 10.9 mt -117.15 144.34 25.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -77.88 125.85 37.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 175.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 t -102.64 -20.89 14.25 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -173.92 153.32 2.12 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.4 OUTLIER -129.77 115.39 17.22 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.759 0.79 . . . . 0.0 111.437 172.609 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.9 m . . . . . 0 C--N 1.298 -1.667 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.083 -176.71 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.48 ' HA ' ' HB3' ' A' ' 32' ' ' LEU . 31.2 m . . . . . 0 N--CA 1.437 -1.082 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -95.81 134.11 39.15 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.155 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 91.0 m-85 -125.89 104.42 8.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 55.2 m -83.53 106.9 15.64 Favored 'General case' 0 N--CA 1.408 -2.553 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.453 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 26.8 m -113.45 142.74 24.92 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.758 -174.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 9.9 p -99.39 125.29 52.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.78 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 72.4 m-85 -88.24 178.72 6.53 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.183 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.44 -31.85 56.29 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.015 0.926 . . . . 0.0 111.66 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.74 -17.09 64.37 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.894 0.877 . . . . 0.0 111.503 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.46 6.9 83.13 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.335 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -97.15 136.53 37.54 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 11.6 pt-20 -107.02 126.93 52.97 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.585 0.707 . . . . 0.0 110.06 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -122.5 145.35 48.39 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 44.4 m -87.65 119.86 28.38 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -109.69 166.21 11.08 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.226 0.536 . . . . 0.0 111.389 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -94.47 152.03 18.9 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.519 -1.219 . . . . 0.0 107.968 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -50.79 -49.53 58.18 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.888 1.275 . . . . 0.0 111.759 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 p -79.83 11.16 3.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.289 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 m -120.12 5.87 10.8 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 tp -117.95 165.87 13.19 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.764 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.453 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 43.5 t . . . . . 0 N--CA 1.433 -1.31 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.5 p90 . . . . . 0 N--CA 1.394 -3.267 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 86' ' ' TYR . 89.9 mt -94.03 174.82 6.96 Favored 'General case' 0 C--N 1.263 -3.193 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.5 p -133.33 161.1 35.42 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -69.73 149.39 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-O 121.429 0.633 . . . . 0.0 111.998 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.81 -7.77 55.61 Favored Glycine 0 C--N 1.289 -2.058 0 CA-C-N 114.547 -1.206 . . . . 0.0 113.722 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 t -102.65 164.42 11.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.16 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 17.3 t70 -117.25 128.48 55.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -172.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.78 173.88 12.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.844 0.83 . . . . 0.0 110.415 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.516 ' HB2' ' SG ' ' A' ' 104' ' ' CYS . 13.6 m -110.04 121.89 46.3 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 106.851 -1.536 . . . . 0.0 106.851 172.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.42 144.44 34.34 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -96.28 126.88 41.8 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.054 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -131.62 122.25 25.7 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? 59.44 26.67 15.64 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.224 0.535 . . . . 0.0 111.894 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.52 0.2 88.17 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.721 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.88 148.88 29.96 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -96.98 133.09 42.1 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.1 m -129.05 139.85 51.86 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.92 132.81 40.5 Favored 'General case' 0 N--CA 1.398 -3.056 0 C-N-CA 123.52 0.728 . . . . 0.0 109.341 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.53 144.36 21.68 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.52 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.468 ' HB2' ' NZ ' ' A' ' 25' ' ' LYS . 4.4 ttmp? -106.12 133.37 50.93 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -176.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.548 ' HA ' HG12 ' A' ' 88' ' ' VAL . 24.1 mt -64.95 110.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.301 0.572 . . . . 0.0 111.201 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -94.72 -40.72 9.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.298 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -133.24 143.24 48.98 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.866 0.365 . . . . 0.0 110.063 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.63 124.6 69.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.864 0.866 . . . . 0.0 109.159 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -118.22 112.47 20.15 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.089 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.435 ' HE ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -77.18 96.57 4.54 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.045 178.308 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' A' ' 85' ' ' TRP . 8.6 mp -122.59 114.74 21.04 Favored 'General case' 0 CA--C 1.462 -2.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.022 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.8 t -115.73 114.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.38 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 94.2 mttt -79.25 106.01 10.98 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.978 0.894 . . . . 0.0 109.19 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.8 t -91.8 127.32 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.041 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.099 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 35.6 ttpt -97.36 127.73 43.57 Favored 'General case' 0 N--CA 1.406 -2.659 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.84 160.85 21.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.59 0 O-C-N 123.449 0.468 . . . . 0.0 109.764 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -122.74 118.35 27.86 Favored 'General case' 0 C--N 1.274 -2.674 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 75' ' ' ALA . 81.1 mt -68.75 121.94 17.55 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.477 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -55.9 -44.27 78.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.396 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -80.85 -61.27 2.01 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.024 -173.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.94 -22.31 39.71 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.25 -0.887 . . . . 0.0 112.878 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.26 19.21 2.91 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.329 0.652 . . . . 0.0 112.743 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.403 ' OG1' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -82.7 142.22 31.82 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.098 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 36' ' ' LYS . 3.2 m -109.18 137.44 47.06 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 3.6 tp60 -136.03 140.81 44.13 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -172.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.455 HD13 ' HB2' ' A' ' 36' ' ' LYS . 41.4 tp -119.67 101.96 8.28 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.6 t -135.71 152.9 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -175.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 5.3 pm0 -71.57 153.45 42.13 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.516 0.674 . . . . 0.0 112.523 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -55.8 -11.83 1.12 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.899 2.079 . . . . 0.0 114.234 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -77.82 -25.93 49.17 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.629 0.728 . . . . 0.0 110.557 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -106.97 -2.68 20.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.918 0.866 . . . . 0.0 110.144 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.423 HG22 HG23 ' A' ' 65' ' ' THR . 53.1 t -101.44 113.27 37.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.953 174.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -94.1 97.99 10.68 Favored 'General case' 0 C--N 1.276 -2.605 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.278 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.519 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 153.78 -166.48 31.89 Favored Glycine 0 N--CA 1.429 -1.797 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.042 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.46 146.49 19.41 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.971 2.447 . . . . 0.0 112.293 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -98.25 82.21 2.89 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.847 1.308 . . . . 0.0 108.421 176.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.548 ' O ' HG13 ' A' ' 77' ' ' ILE . 19.4 tpt180 -140.78 117.97 11.3 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.723 -2.035 . . . . 0.0 107.26 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.439 ' HA ' ' CG2' ' A' ' 77' ' ' ILE . 47.1 t -56.54 123.44 7.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-N 118.439 0.563 . . . . 0.0 109.868 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.438 ' H ' ' HB ' ' A' ' 77' ' ' ILE . . . 98.43 7.83 55.45 Favored Glycine 0 N--CA 1.42 -2.406 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.84 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.496 ' O ' HG12 ' A' ' 77' ' ' ILE . . . -96.21 153.11 17.98 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 118.743 1.271 . . . . 0.0 109.575 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.444 HG12 HD12 ' A' ' 76' ' ' ILE . 65.2 mt -94.74 119.53 42.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.519 HG12 ' HA3' ' A' ' 55' ' ' GLY . 27.5 m -133.13 169.68 21.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.0 -175.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -111.97 120.17 41.0 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.423 HG23 HG22 ' A' ' 53' ' ' VAL . 18.9 m -106.56 146.53 30.54 Favored 'General case' 0 N--CA 1.396 -3.17 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -68.68 119.61 13.36 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.55 0.691 . . . . 0.0 111.058 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.416 ' HB ' ' HG2' ' A' ' 73' ' ' GLN . 9.8 t -92.21 161.84 14.56 Favored 'General case' 0 N--CA 1.403 -2.787 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.0 m -74.32 6.54 3.54 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.713 0.768 . . . . 0.0 111.688 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.6 -8.2 57.69 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.09 -22.08 39.35 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.03 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 m -99.27 -175.62 3.07 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 120.648 0.261 . . . . 0.0 110.726 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -111.55 136.74 50.31 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.416 ' HG2' ' HB ' ' A' ' 67' ' ' THR . 22.6 pt20 -124.05 154.49 39.85 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.23 123.08 20.19 Favored 'General case' 0 C--O 1.246 0.909 0 O-C-N 124.172 0.92 . . . . 0.0 111.645 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.19 170.89 14.88 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.475 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.444 HD12 HG12 ' A' ' 62' ' ' ILE . 9.8 mm -113.96 143.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 58' ' ' ARG . 11.4 mm -66.77 125.62 24.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.5 p -107.44 -25.91 11.2 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.152 0.501 . . . . 0.0 110.914 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 21.8 tptm -163.09 165.27 24.87 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.99 129.61 18.05 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.672 0.789 . . . . 0.0 108.976 172.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.3 m . . . . . 0 C--N 1.297 -1.69 0 C-N-CA 123.412 0.685 . . . . 0.0 109.341 -176.832 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.443 -0.799 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.42 ' CD1' HD22 ' A' ' 32' ' ' LEU . 95.4 m95 -88.45 120.4 29.79 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.132 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 7' ' ' LEU . 90.6 m-85 -113.35 110.52 20.47 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 27.7 m -89.33 108.21 19.5 Favored 'General case' 0 N--CA 1.389 -3.497 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 26' ' ' ILE . 17.1 m -105.92 140.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.455 -176.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.21 139.98 29.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.597 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.422 ' CE2' ' HD3' ' A' ' 96' ' ' ARG . 65.3 m-85 -91.27 172.75 8.32 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.63 -12.26 57.32 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.485 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -75.75 -17.92 59.73 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.174 175.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.18 -10.66 67.63 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.831 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -97.21 161.8 13.64 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.409 ' C ' ' HD2' ' A' ' 96' ' ' ARG . 9.3 pt-20 -137.6 157.47 46.44 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -171.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 87' ' ' THR . 4.2 mpt_? -129.54 151.4 50.19 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.895 0.878 . . . . 0.0 110.061 173.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.9 m -102.27 113.95 27.7 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 3.7 mm? -113.86 168.31 9.9 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.673 0.789 . . . . 0.0 110.946 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -89.31 157.31 18.25 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 173.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.461 ' HD3' ' C ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -50.22 -38.1 38.65 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.518 0.599 . . . . 0.0 111.513 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.5 m -79.04 -3.66 46.31 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.511 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 15.7 m -98.56 5.75 47.64 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 121.114 -0.991 . . . . 0.0 108.376 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.7 mp -112.9 145.13 41.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.467 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 14' ' ' SER . 5.9 p . . . . . 0 C--N 1.281 -2.384 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.209 172.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.533 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 40.4 p90 . . . . . 0 N--CA 1.418 -2.062 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.587 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 21.3 mt -90.83 -176.0 4.54 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.656 0.597 . . . . 0.0 109.619 173.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -125.16 156.64 38.07 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.559 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -85.19 139.67 17.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -174.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.94 -5.65 83.17 Favored Glycine 0 CA--C 1.505 -0.586 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 96.8 m -79.68 133.89 36.39 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-O 121.491 0.662 . . . . 0.0 110.538 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -92.19 129.12 38.22 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.0 m -137.1 -178.88 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.763 0.792 . . . . 0.0 112.006 -173.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 m -125.69 135.79 52.49 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 172.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -127.65 135.35 50.12 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 19.6 pttp -93.06 143.21 26.47 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 118.62 -1.232 . . . . 0.0 113.599 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -134.78 124.93 25.94 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 58.11 25.47 12.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.552 1.141 . . . . 0.0 110.935 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.33 -9.42 76.17 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.327 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.74 131.43 50.93 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 76.6 m-85 -84.78 122.38 29.04 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.753 0.311 . . . . 0.0 110.704 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -106.98 149.0 27.98 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -80.5 143.38 33.36 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.32 148.51 16.63 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -115.49 132.52 56.6 Favored 'General case' 0 C--N 1.274 -2.709 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.712 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.443 ' HA ' HG12 ' A' ' 88' ' ' VAL . 63.2 mt -61.07 107.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.891 0.853 . . . . 0.0 111.681 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.531 ' HG2' ' OE1' ' A' ' 95' ' ' GLU . 24.0 tptm -83.85 -44.99 13.74 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 125.517 1.527 . . . . 0.0 109.662 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 m -138.9 144.91 39.33 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.39 118.09 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 123.645 0.778 . . . . 0.0 109.808 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -123.14 107.85 12.19 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.015 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -77.43 105.47 8.58 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -132.88 120.5 21.59 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.219 0.533 . . . . 0.0 110.658 -175.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.61 129.35 37.83 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 32.9 mmtp -83.02 104.93 13.6 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 37' ' ' VAL . 2.8 t -95.56 125.5 48.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.964 -174.405 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.411 ' HB2' HD13 ' A' ' 47' ' ' LEU . 49.0 tttm -99.74 105.73 17.56 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.527 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 23.8 m -117.07 156.1 18.47 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-O 121.151 0.501 . . . . 0.0 111.486 -175.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -113.93 114.67 26.53 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 173.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.8 mt -68.93 113.54 6.43 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.309 0.0 OUTLIER -72.98 -19.04 61.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -90.08 -27.02 19.95 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.909 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -112.22 -8.85 13.95 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.277 0.56 . . . . 0.0 111.804 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 p30 58.7 16.55 4.46 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.554 1.942 . . . . 0.0 113.986 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -98.6 150.72 21.45 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 121.994 -0.441 . . . . 0.0 111.107 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 m -99.56 144.77 28.26 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -142.89 142.3 31.72 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -174.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 36' ' ' LYS . 43.5 tp -125.42 102.62 7.49 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.16 178.73 4.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.921 -173.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.507 ' HG3' ' HB3' ' A' ' 51' ' ' ASP . 14.1 pt20 -92.02 154.53 18.71 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -174.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -54.63 -28.39 46.52 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 126.352 1.861 . . . . 0.0 111.515 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.507 ' HB3' ' HG3' ' A' ' 49' ' ' GLN . 8.2 t70 -63.38 -27.89 69.62 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.306 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -108.32 -9.54 15.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.985 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -100.38 127.29 53.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.233 0.54 . . . . 0.0 111.648 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -106.75 127.14 53.14 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.111 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.21 -173.28 17.93 Favored Glycine 0 C--N 1.296 -1.661 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.497 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -82.66 138.03 9.28 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.279 2.653 . . . . 0.0 112.311 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.7 83.03 4.79 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.79 0.805 . . . . 0.0 110.51 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.522 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 23.0 mtp180 -135.2 133.63 39.27 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.807 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.58 120.99 11.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.68 58.98 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.597 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.71 164.11 12.54 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 117.488 0.644 . . . . 0.0 111.46 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.6 mm -95.86 118.41 42.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.546 HG13 HD11 ' A' ' 77' ' ' ILE . 15.7 m -126.18 175.57 8.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -128.66 120.66 26.96 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.425 HG21 HG21 ' A' ' 37' ' ' VAL . 9.8 t -118.27 158.7 24.68 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.14 -174.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 67' ' ' THR . 37.2 ttm180 -76.87 139.48 40.28 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.334 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 16.9 p -94.1 171.82 8.61 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.8 m -55.7 -34.28 64.94 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -82.65 -4.92 58.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.96 3.93 56.83 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.483 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 58.1 m -87.53 168.75 12.79 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -121.7 139.85 53.05 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.111 0.482 . . . . 0.0 110.648 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -140.72 143.9 35.27 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.4 142.56 53.87 Favored 'General case' 0 C--O 1.254 1.326 0 CA-C-O 121.335 0.588 . . . . 0.0 110.946 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -148.97 164.66 33.9 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.87 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 5.4 mm -110.19 137.17 43.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.546 HD11 HG13 ' A' ' 63' ' ' VAL . 3.5 mp -72.84 122.9 26.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.5 m -103.82 -19.85 14.13 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.114 0.483 . . . . 0.0 109.825 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -168.68 156.46 7.85 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.18 139.67 37.6 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 172.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 85.6 m . . . . . 0 C--N 1.283 -2.305 0 CA-C-O 121.042 0.449 . . . . 0.0 110.475 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.409 -2.486 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -97.58 116.32 29.56 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-O 121.405 0.621 . . . . 0.0 110.621 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.587 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 53.3 m-85 -104.75 102.88 12.43 Favored 'General case' 0 N--CA 1.395 -3.205 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.4 m -79.91 105.61 11.32 Favored 'General case' 0 N--CA 1.384 -3.739 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 26' ' ' ILE . 16.4 m -105.42 140.39 23.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 p -111.52 130.27 65.37 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.045 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.511 -174.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -83.24 163.97 20.41 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.76 -7.56 45.83 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.365 0.602 . . . . 0.0 110.617 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -72.18 -17.56 61.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.978 173.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.4 -9.31 60.84 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.298 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.06 144.72 25.64 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.531 ' OE1' ' HG2' ' A' ' 27' ' ' LYS . 2.8 pt-20 -124.37 131.72 53.51 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.407 0.622 . . . . 0.0 110.542 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -115.78 151.16 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 m -103.11 108.58 19.82 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 120.738 0.304 . . . . 0.0 110.22 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.27 156.21 31.69 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.705 0.402 . . . . 0.0 111.188 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -99.55 169.92 8.96 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -56.54 -23.4 39.7 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.7 m -60.31 -39.55 87.42 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.771 0.829 . . . . 0.0 111.679 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 15.0 m -90.27 -6.88 54.67 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 mp -102.5 153.9 19.62 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.511 -175.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 C--N 1.311 -1.083 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.066 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.47 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 18.9 p90 . . . . . 0 N--CA 1.433 -1.292 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.8 mt -93.78 -161.54 0.86 Allowed 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 p -131.54 162.43 30.3 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -171.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.3 t -64.91 142.18 17.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.902 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.92 -32.97 6.0 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.9 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.577 ' HB ' HD12 ' A' ' 26' ' ' ILE . 4.0 m -56.97 138.95 53.49 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.993 0.917 . . . . 0.0 110.564 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -111.3 113.67 26.31 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.9 m -135.43 -179.15 2.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 123.102 0.561 . . . . 0.0 109.708 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 m -105.24 142.81 34.36 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.475 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.81 119.3 29.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.46 ' HE2' ' HA2' ' A' ' 19' ' ' GLY . 13.7 tmtt? -88.43 107.22 18.74 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -129.12 139.53 51.92 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 59.6 25.07 13.91 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 122.018 0.913 . . . . 0.0 110.427 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . 91.0 1.73 72.5 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.28 -0.962 . . . . 0.0 114.325 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.51 145.54 43.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 117.916 0.858 . . . . 0.0 109.905 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -106.1 133.9 50.07 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.033 0.92 . . . . 0.0 113.473 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.6 t -122.75 158.25 30.57 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -72.92 147.42 45.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.67 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -149.82 142.33 24.4 Favored 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.57 -174.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 44.4 tttp -110.12 131.14 55.33 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.774 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.577 HD12 ' HB ' ' A' ' 11' ' ' THR . 36.6 mt -66.39 115.67 4.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -101.24 -36.24 8.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.136 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.2 m -140.14 144.73 36.84 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.1 t -116.57 120.18 64.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.444 ' HD3' ' N ' ' A' ' 31' ' ' ARG . 1.5 tmtp? -113.93 140.59 48.26 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.444 ' N ' ' HD3' ' A' ' 30' ' ' LYS . 10.9 mmt180 -75.03 118.36 17.9 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.728 0.775 . . . . 0.0 111.688 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.509 ' HB3' ' N ' ' A' ' 84' ' ' SER . 58.7 tp -91.51 164.5 13.77 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 127.01 2.124 . . . . 0.0 107.256 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.56 124.27 63.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 118.142 -1.423 . . . . 0.0 110.844 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -94.79 104.22 16.12 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 122.557 1.17 . . . . 0.0 108.202 172.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG12 HG13 ' A' ' 37' ' ' VAL . 15.8 t -87.35 128.69 39.72 Favored 'Isoleucine or valine' 1 C--N 1.244 -4.002 0 CA-C-N 112.753 -2.022 . . . . 0.0 109.648 -174.487 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 86.9 tttt -98.77 112.15 24.31 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 65' ' ' THR . 15.9 m -115.78 153.98 17.3 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 121.386 0.612 . . . . 0.0 111.727 -175.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -116.97 114.75 24.25 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.486 HD23 ' HB2' ' A' ' 75' ' ' ALA . 62.6 mt -75.35 120.52 20.93 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.3 ptpt -67.81 -30.24 69.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -79.53 -41.51 27.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.381 0.61 . . . . 0.0 111.725 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.85 -15.15 21.39 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.021 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.279 0.0 OUTLIER 63.21 16.93 9.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.664 1.985 . . . . 0.0 112.222 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -93.27 145.24 24.59 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.244 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -96.45 142.53 28.44 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -144.48 141.31 29.47 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.9 mt -100.87 113.25 26.02 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.78 179.72 2.84 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.033 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.528 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -117.08 165.09 13.78 Favored 'General case' 0 C--N 1.27 -2.866 0 O-C-N 122.29 -0.256 . . . . 0.0 110.527 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -59.35 -18.76 41.04 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.637 1.575 . . . . 0.0 111.86 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.54 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 12.0 t70 -70.93 -34.43 71.49 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.118 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 26.4 mt-30 -95.54 -10.54 29.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.181 -175.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.6 t -105.23 134.94 45.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.714 -177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.415 ' HE2' ' CD1' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -125.66 118.07 24.87 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.263 0.554 . . . . 0.0 110.73 168.79 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 142.77 -165.07 26.96 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.563 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.91 137.0 12.19 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.865 2.377 . . . . 0.0 113.131 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -96.51 81.57 3.25 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.55 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 42.5 ttp180 -140.85 139.49 34.47 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.109 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.3 t -67.21 122.39 18.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.55 4.18 59.43 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.753 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.08 161.65 14.19 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.947 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.6 mm -107.4 119.29 56.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.517 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.427 HG12 ' HA3' ' A' ' 55' ' ' GLY . 28.0 m -130.47 176.58 8.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -119.85 131.46 55.28 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.497 HG21 HG21 ' A' ' 37' ' ' VAL . 7.8 t -145.1 155.99 43.64 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.182 -171.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.622 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 46.7 ttt180 -89.26 122.42 32.5 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.483 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.8 t -84.62 168.02 15.72 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.2 p -70.78 -5.01 26.87 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.504 0.669 . . . . 0.0 111.611 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.66 -10.24 59.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.968 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.75 -22.2 36.25 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.98 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.5 p -87.75 144.81 26.43 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.622 ' CE1' ' HB2' ' A' ' 66' ' ' ARG . 87.1 m-85 -94.26 120.43 34.49 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -135.84 160.18 39.38 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 39.3 tt0 -76.72 132.04 39.1 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.486 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.03 173.68 11.25 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 122.153 -0.342 . . . . 0.0 111.591 -175.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.45 140.69 42.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.1 mp -79.52 128.44 38.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 120.658 0.266 . . . . 0.0 110.564 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 m -107.2 -17.25 14.2 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.992 0.517 . . . . 0.0 110.871 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 50.3 tptt -171.87 156.48 4.19 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.17 143.4 50.58 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.423 -1.812 0 C-N-CA 122.693 0.397 . . . . 0.0 110.485 178.733 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 1.3 p . . . . . 0 CA--C 1.552 1.035 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.443 ' HB2' ' HB3' ' A' ' 30' ' ' LYS 0.265 75.6 m95 -95.98 155.87 16.57 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 168.202 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.47 ' CD1' HD13 ' A' ' 26' ' ' ILE . 89.5 m-85 -134.58 117.85 16.6 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.558 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 17.8 m -84.03 104.37 14.04 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.67 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 22.8 m -109.92 141.62 24.71 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.837 0 CA-C-O 121.502 0.668 . . . . 0.0 110.462 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 6.3 t -97.9 116.72 41.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -72.89 159.92 32.96 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -57.2 -20.78 28.93 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.772 0.796 . . . . 0.0 111.072 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.65 -16.76 64.32 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.944 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.28 -6.88 59.77 Favored Glycine 0 C--O 1.241 0.555 0 CA-C-O 121.478 0.488 . . . . 0.0 112.402 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -96.8 141.34 30.13 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.56 128.29 54.81 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -136.32 147.5 47.46 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 18.6 m -99.38 107.43 19.68 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.24 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.85 170.41 8.16 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.54 ' HD3' ' OD1' ' A' ' 51' ' ' ASP . 2.2 mpt_? -94.9 175.2 6.74 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -72.6 -3.05 22.4 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.453 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 m -71.48 -41.29 69.52 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -109.82 22.63 15.43 Favored 'General case' 0 C--O 1.252 1.217 0 CA-C-O 121.761 0.791 . . . . 0.0 110.171 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.6 tp -112.67 142.72 44.94 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.478 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.431 -1.386 0 CA-C-O 121.695 0.759 . . . . 0.0 110.249 -177.338 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.756 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 45.2 p90 . . . . . 0 N--CA 1.413 -2.278 0 CA-C-O 121.14 0.495 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt -106.21 -175.68 2.86 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.645 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.9 p -131.33 158.53 40.43 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.33 130.59 28.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.66 38.19 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.043 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.531 ' HB ' HD12 ' A' ' 26' ' ' ILE . 33.2 m -81.23 139.47 35.47 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 120.821 0.343 . . . . 0.0 110.401 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.07 104.87 17.4 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.202 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -113.5 -179.28 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.836 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.532 ' OG ' ' HB3' ' A' ' 104' ' ' CYS . 3.0 p -131.14 135.34 47.38 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 21' ' ' PHE . . . -111.92 125.64 54.26 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 124.476 1.11 . . . . 0.0 109.672 -171.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -77.03 117.73 18.9 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.571 0.7 . . . . 0.0 109.569 173.451 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -129.62 135.95 49.17 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 59.4 25.65 14.41 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 121.521 0.677 . . . . 0.0 110.483 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.91 10.59 75.24 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.705 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.65 136.54 37.55 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 117.525 0.663 . . . . 0.0 110.437 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 35.4 p90 -98.79 129.59 45.21 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.47 -0.892 . . . . 0.0 113.127 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -129.26 157.39 42.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 10.5 pt-20 -74.01 146.25 43.92 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 121.779 0.8 . . . . 0.0 112.646 -174.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -151.99 145.8 25.1 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -105.07 133.75 49.32 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.673 -174.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.531 HD12 ' HB ' ' A' ' 11' ' ' THR . 39.3 mt -65.96 112.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.106 0.479 . . . . 0.0 110.451 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -94.72 -39.25 10.4 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.109 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 m -137.9 144.5 41.34 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 79.8 t -123.61 118.55 54.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 59.2 mtpt -112.22 96.95 6.32 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -83.27 108.38 16.45 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 84' ' ' SER . 2.4 pt? -144.05 107.61 4.62 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.048 0.928 . . . . 0.0 109.286 176.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 p -100.53 123.22 53.32 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.856 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 52.3 mtpt -85.12 100.64 11.85 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 122.066 0.936 . . . . 0.0 109.237 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 31.1 t -84.82 132.7 31.03 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 113.754 -1.566 . . . . 0.0 109.336 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 88.4 tttt -89.53 112.91 24.22 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.612 HG21 HG21 ' A' ' 65' ' ' THR . 3.7 m -123.64 153.46 29.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.216 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.323 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 8.2 tt -121.8 122.58 39.8 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.539 HD13 ' HB2' ' A' ' 75' ' ' ALA . 1.5 mm? -73.4 110.71 7.9 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.56 ' HB3' HD11 ' A' ' 76' ' ' ILE . 12.4 ptmm? -64.35 -20.19 65.96 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.228 0.537 . . . . 0.0 112.436 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -79.29 -46.66 17.3 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.817 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -98.51 -17.84 18.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.435 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 71.67 25.64 3.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.077 1.351 . . . . 0.0 111.593 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -104.68 155.74 18.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.751 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 38' ' ' LEU . 3.9 m -100.18 154.65 18.28 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -149.32 143.94 26.13 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 tp -128.11 102.15 6.59 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 10.6 m -137.66 168.12 21.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.297 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 29.7 pt20 -74.68 164.96 25.98 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.139 -174.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.47 ' OD1' ' HA ' ' A' ' 32' ' ' LEU . 7.7 p-10 -71.8 -5.6 35.38 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.849 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -73.85 -23.6 59.64 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 65' ' ' THR . 8.9 mm-40 -92.58 -34.45 14.02 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.048 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 89.3 t -79.24 111.05 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.198 0.999 . . . . 0.0 112.7 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -111.63 103.06 11.34 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.27 -159.85 28.16 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.1 128.59 6.5 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.901 1.734 . . . . 0.0 112.123 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 mp -88.8 81.6 6.94 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.521 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 22.6 mmt180 -139.17 135.8 34.39 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.695 -175.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.0 t -66.76 117.83 8.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.53 3.93 55.05 Favored Glycine 0 C--N 1.303 -1.261 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.532 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.19 164.01 12.67 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.027 0.414 . . . . 0.0 110.652 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.3 mm -105.48 124.89 60.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' A' ' 77' ' ' ILE . 19.7 m -130.15 -177.63 2.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 123.028 0.531 . . . . 0.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -118.25 136.1 53.88 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.066 -1.828 . . . . 0.0 106.066 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.612 HG21 HG21 ' A' ' 37' ' ' VAL . 13.4 t -140.11 156.63 46.48 Favored 'General case' 0 C--N 1.275 -2.643 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.794 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.476 ' H ' ' HB3' ' A' ' 52' ' ' GLN . 12.1 ttm180 -83.85 108.77 17.07 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 69' ' ' ASP . 12.7 t -81.09 178.86 8.15 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 m -64.23 -16.33 61.82 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.241 0.543 . . . . 0.0 112.051 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 67' ' ' THR . 20.7 t70 -73.82 -26.01 60.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.347 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.95 -18.83 36.32 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.49 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -84.32 154.69 22.77 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 65' ' ' THR . 90.1 m-85 -89.36 115.36 26.76 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.525 ' HB3' HD12 ' A' ' 39' ' ' LEU . 2.8 tp60 -108.84 143.86 37.48 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -174.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.78 136.85 38.18 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.423 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' ' 39' ' ' LEU . . . -145.23 168.1 21.22 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.428 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.56 HD11 ' HB3' ' A' ' 40' ' ' LYS . 1.6 mp -112.45 144.13 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.3 mp -83.5 129.38 37.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.2 m -110.97 -19.32 12.82 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 122.617 0.367 . . . . 0.0 110.885 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 54.0 tttm -168.52 159.54 10.32 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 4.1 mp -127.63 139.87 52.46 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 167.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.5 m . . . . . 0 C--N 1.29 -1.989 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.602 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.505 ' HA ' HD23 ' A' ' 32' ' ' LEU . 19.5 m . . . . . 0 N--CA 1.437 -1.102 0 CA-C-O 122.078 0.942 . . . . 0.0 112.5 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.516 ' HB3' ' OG1' ' A' ' 97' ' ' THR . 74.7 m95 -95.82 116.98 29.7 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.555 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.756 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 82.6 m-85 -105.56 105.06 14.92 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.2 m -84.37 104.13 14.13 Favored 'General case' 0 N--CA 1.398 -3.06 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 26' ' ' ILE . 28.5 m -108.59 142.12 22.04 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.575 -175.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.53 124.03 53.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.463 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -85.78 -179.89 6.93 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.814 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -68.57 -26.56 65.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.119 0.485 . . . . 0.0 110.78 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -68.87 -11.86 60.98 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.536 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.56 14.43 68.14 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -94.47 131.77 39.83 Favored 'General case' 0 CA--C 1.473 -2.01 0 CA-C-N 114.865 -0.668 . . . . 0.0 109.215 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.52 127.27 49.66 Favored 'General case' 0 C--N 1.268 -2.96 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.28 138.96 54.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.516 ' OG1' ' HB3' ' A' ' 85' ' ' TRP . 4.9 t -113.59 113.51 25.17 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.197 -1.401 . . . . 0.0 110.884 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.412 HD11 ' CB ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -127.49 172.2 10.91 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.618 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -98.7 173.21 7.01 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -60.15 -39.72 87.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.417 1.087 . . . . 0.0 111.283 -173.583 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.3 p -72.41 0.89 8.99 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.3 t -116.05 7.48 14.29 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.18 132.96 53.7 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.561 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.532 ' HB3' ' OG ' ' A' ' 14' ' ' SER . 22.3 t . . . . . 0 C--N 1.304 -1.373 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.038 -176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.3 p90 . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.63 -172.47 3.58 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.4 p -128.36 156.63 42.8 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -169.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.65 126.65 29.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.011 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.55 -19.31 42.44 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 121.245 -0.503 . . . . 0.0 112.275 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.459 ' HB ' HD12 ' A' ' 26' ' ' ILE . 30.9 m -69.29 137.39 52.98 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.062 0.458 . . . . 0.0 110.669 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -86.44 131.83 34.09 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.406 HG21 HG11 ' A' ' 88' ' ' VAL . 30.8 m -137.22 -179.44 2.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-O 121.446 0.641 . . . . 0.0 111.494 -173.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.491 ' OG ' ' HB2' ' A' ' 104' ' ' CYS . 1.9 p -137.96 137.54 38.06 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' CB ' HD11 ' A' ' 98' ' ' LEU . . . -116.04 139.38 50.34 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -176.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -85.59 134.72 34.0 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.285 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -120.84 102.11 8.15 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 123.858 0.863 . . . . 0.0 109.146 172.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 58.77 28.09 16.87 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 170.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.51 9.71 57.5 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.777 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.05 151.39 41.99 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -106.73 137.12 45.36 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 119.031 0.832 . . . . 0.0 111.752 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.482 ' SG ' ' HD2' ' A' ' 90' ' ' PHE . 19.9 t -123.78 143.42 50.32 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.82 149.96 24.88 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.856 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' PHE . . . -149.89 173.2 14.04 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.312 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -137.64 132.21 32.64 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.671 ' HA ' HG12 ' A' ' 88' ' ' VAL . 60.5 mt -65.45 116.33 4.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 121.407 0.622 . . . . 0.0 111.166 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -95.03 -41.64 9.03 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.66 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.446 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 86.8 m -137.91 142.47 40.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.473 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -117.72 107.34 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.898 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 84' ' ' SER . 65.1 mttm -91.39 90.41 7.67 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 31' ' ' ARG . 18.7 ptt180 -94.77 106.07 18.04 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.496 HD23 ' HB3' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -139.38 144.0 37.98 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -175.284 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 11.4 p -118.41 124.34 72.98 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.718 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.267 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 97.9 mttt -82.65 100.7 10.36 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.716 0.769 . . . . 0.0 109.415 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.587 HG21 HD12 ' A' ' 57' ' ' LEU . 29.9 t -88.07 130.7 37.26 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.62 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.159 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 61.4 tttp -98.22 109.54 22.28 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.61 149.5 15.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 CA-C-O 121.38 0.609 . . . . 0.0 110.498 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.8 tp -111.69 118.11 34.73 Favored 'General case' 0 C--N 1.269 -2.934 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 75' ' ' ALA . 43.3 mt -70.35 126.12 28.73 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -72.82 -35.88 67.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.217 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.404 ' HB3' ' NE2' ' A' ' 73' ' ' GLN . 35.6 tt0 -83.24 -36.15 24.82 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -175.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -107.42 -7.86 16.48 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.762 -0.775 . . . . 0.0 113.077 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.276 10.7 p30 59.76 21.06 9.85 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 125.679 1.592 . . . . 0.0 113.46 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.483 ' OG1' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -93.14 147.53 22.8 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.866 176.462 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -108.28 142.95 37.8 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.08 144.03 48.38 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -175.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.2 tp -126.88 101.76 6.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -142.27 162.89 18.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 5.2 pm0 -83.38 166.6 18.28 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.02 -12.31 2.0 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 125.967 1.707 . . . . 0.0 115.441 -173.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -89.19 -10.18 48.05 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 118.789 -1.165 . . . . 0.0 110.412 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -101.99 -7.82 22.04 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.9 t -103.16 118.46 50.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.407 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -98.03 97.31 8.8 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.67 -176.5 25.53 Favored Glycine 0 N--CA 1.427 -1.901 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.061 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -65.02 142.38 74.52 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.462 2.775 . . . . 0.0 112.696 176.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.587 HD12 HG21 ' A' ' 35' ' ' VAL . 1.5 mm? -96.75 84.16 3.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 7.0 tpt180 -137.98 126.37 23.29 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.773 -172.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.26 121.38 12.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.15 59.54 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.055 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.89 155.47 16.76 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.022 0.911 . . . . 0.0 110.937 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.7 mm -93.8 119.38 41.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.62 -179.12 2.48 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 122.768 0.427 . . . . 0.0 110.018 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -121.81 121.17 36.6 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.3 m -113.99 146.96 39.42 Favored 'General case' 0 N--CA 1.4 -2.974 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -83.57 127.23 33.58 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.7 p -92.17 175.28 6.91 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.9 m -68.63 -5.38 19.72 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.344 0.593 . . . . 0.0 111.919 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.04 -14.93 52.91 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 121.63 0.728 . . . . 0.0 109.302 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.01 -16.37 61.04 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 p -93.88 157.31 16.19 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 123.19 0.596 . . . . 0.0 110.561 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -94.95 146.89 23.93 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.455 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.404 ' NE2' ' HB3' ' A' ' 41' ' ' GLN . 7.3 tp60 -137.02 143.73 42.89 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -80.45 130.62 35.27 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.24 173.88 11.06 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.6 -169.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 mp -119.57 139.19 47.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.7 mp -73.55 127.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.95 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.3 m -108.41 -23.33 11.93 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 122.463 0.305 . . . . 0.0 111.415 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 51.7 tttp -163.98 154.81 15.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.434 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . 2.9 mp -130.45 133.62 46.46 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 3.4 m . . . . . 0 C--N 1.287 -2.117 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 4.2 p . . . . . 0 N--CA 1.426 -1.664 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.496 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 92.8 m95 -97.35 121.22 39.0 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.284 -175.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -105.1 110.73 23.23 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.446 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 24.5 m -79.72 108.74 13.51 Favored 'General case' 0 N--CA 1.401 -2.876 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 26' ' ' ILE . 28.9 m -113.54 145.16 19.8 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.447 -173.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 p -100.94 121.29 51.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.482 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 11.1 m-85 -88.76 -177.49 5.54 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.07 -172.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.75 -15.04 63.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.84 -17.4 63.99 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.529 173.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.42 -4.61 71.89 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -98.41 167.19 10.99 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 13.2 pt-20 -121.57 128.64 52.21 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.411 0.624 . . . . 0.0 111.304 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.461 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -125.62 150.92 47.15 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.367 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.496 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 44.5 m -105.21 118.11 35.72 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 120.824 0.345 . . . . 0.0 110.298 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.499 HD11 ' CB ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -141.97 152.49 43.52 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.106 0.562 . . . . 0.0 109.772 178.149 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -100.48 -173.76 2.49 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.055 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -53.97 -26.9 28.14 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.123 0.969 . . . . 0.0 112.836 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -58.02 -28.77 64.75 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 122.956 0.503 . . . . 0.0 112.306 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.4 p -125.96 10.51 7.61 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.336 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 103' ' ' LEU . 9.9 tp -111.86 128.05 56.01 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.491 ' HB2' ' OG ' ' A' ' 14' ' ' SER . 24.8 m . . . . . 0 C--N 1.312 -1.031 0 C-N-CA 122.691 0.396 . . . . 0.0 111.955 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.435 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 21.4 p90 . . . . . 0 N--CA 1.425 -1.718 0 CA-C-O 122.247 1.022 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.36 -167.51 1.87 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.965 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.9 p -130.55 173.73 10.59 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.46 141.84 16.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 123.936 0.895 . . . . 0.0 110.102 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.13 -11.32 58.64 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.291 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.631 ' HB ' HD12 ' A' ' 26' ' ' ILE . 6.6 m -74.49 141.27 44.93 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' OD2' ' HG3' ' A' ' 25' ' ' LYS . 10.7 t70 -107.01 117.5 34.24 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -121.96 -179.86 2.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 120.861 0.362 . . . . 0.0 110.182 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.0 m -111.31 124.39 52.14 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.29 139.1 46.96 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' A' ' 16' ' ' LYS 0.264 0.0 OUTLIER -94.01 129.69 40.42 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -178.631 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.484 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 34.0 m-85 -98.6 101.82 13.37 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 170.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 10.0 ptm180 49.21 35.95 8.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 173.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.26 10.4 57.2 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.932 -0.576 . . . . 0.0 114.074 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.72 124.79 34.37 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 17.0 m-85 -91.91 141.95 28.09 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.465 0.65 . . . . 0.0 112.555 -172.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.9 t -127.53 145.32 50.89 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -71.73 143.43 49.62 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.4 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.517 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -141.44 139.63 33.43 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.192 -176.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.418 ' HG3' ' OD2' ' A' ' 12' ' ' ASP . 5.1 mttp -103.12 126.6 50.37 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.487 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.631 HD12 ' HB ' ' A' ' 11' ' ' THR . 25.1 mt -70.24 116.63 11.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.788 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.15 -45.09 6.67 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 109.424 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.422 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 7.6 m -128.6 143.63 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.635 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 81.6 t -126.59 119.29 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 57.0 mtpt -104.07 97.86 7.77 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -83.38 100.74 10.88 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 32' ' ' LEU . 2.1 pt? -133.22 161.32 34.76 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.443 ' H ' ' HB2' ' A' ' 50' ' ' ASP . 10.4 p -130.02 140.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.641 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 98.9 mttt -91.74 101.57 14.18 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.743 0.783 . . . . 0.0 109.682 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.412 HG12 HG13 ' A' ' 37' ' ' VAL . 21.7 t -90.49 121.48 40.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.182 -173.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 85.3 tttt -85.5 111.63 20.17 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 174.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.451 HG21 HG21 ' A' ' 65' ' ' THR . 1.9 m -112.61 146.44 17.35 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.269 0 CA-C-O 121.124 0.488 . . . . 0.0 110.606 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -112.96 114.1 26.43 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.584 HD11 ' HB3' ' A' ' 73' ' ' GLN . 31.9 tp -75.62 111.64 11.16 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -56.05 -43.1 77.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -170.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -76.69 -50.86 12.66 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.371 0.605 . . . . 0.0 111.875 -174.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.457 ' HB3' HD23 ' A' ' 39' ' ' LEU . 30.6 t70 -84.95 -9.22 58.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.568 -171.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.289 0.0 OUTLIER 56.33 24.06 7.91 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.377 2.271 . . . . 0.0 112.955 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.91 153.57 17.69 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.979 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.6 m -120.31 142.83 48.75 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.37 163.63 33.98 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.978 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 14.8 tp -128.02 104.31 7.72 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 -177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.2 m -121.05 174.36 5.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -173.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -87.4 162.34 17.37 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.488 0.661 . . . . 0.0 112.201 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 33' ' ' VAL . 7.7 t70 -44.16 -28.46 0.51 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 127.7 2.4 . . . . 0.0 113.275 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -85.97 -24.76 26.37 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.385 0.674 . . . . 0.0 110.886 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -84.14 -17.79 38.91 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.78 116.29 32.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.399 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -106.06 101.48 10.96 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.431 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.42 -162.85 27.92 Favored Glycine 0 C--N 1.309 -0.922 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.17 135.46 12.2 Favored 'Trans proline' 0 CA--C 1.517 -0.371 0 C-N-CA 122.477 2.118 . . . . 0.0 112.299 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.78 82.33 3.56 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 122.049 0.928 . . . . 0.0 109.619 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.555 ' HD3' ' N ' ' A' ' 59' ' ' VAL . 1.1 tmt_? -140.08 138.65 35.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.555 ' N ' ' HD3' ' A' ' 58' ' ' ARG . 22.2 t -61.74 119.1 5.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.44 6.31 57.56 Favored Glycine 0 C--N 1.298 -1.563 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.937 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.479 ' HB3' HD13 ' A' ' 77' ' ' ILE . . . -90.53 152.87 20.73 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 117.396 0.598 . . . . 0.0 110.844 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.429 HD13 HG13 ' A' ' 76' ' ' ILE . 45.1 mm -89.65 117.65 33.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.64 177.66 6.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -122.52 121.53 36.76 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 172.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.451 HG21 HG21 ' A' ' 37' ' ' VAL . 9.7 t -115.67 158.43 22.76 Favored 'General case' 0 C--N 1.263 -3.161 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -174.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 71' ' ' SER . 40.7 ttt180 -79.93 125.59 29.94 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p -84.12 177.34 8.27 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.9 m -75.78 -2.99 32.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.803 0.811 . . . . 0.0 110.296 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -93.83 -1.03 55.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.537 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.23 -5.63 83.78 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.521 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 17.7 t -94.76 172.49 8.13 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -177.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 65' ' ' THR . 93.4 m-85 -110.34 120.2 41.68 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.584 ' HB3' HD11 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -131.05 150.78 51.99 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -176.235 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.57 122.98 23.09 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.562 0.745 . . . . 0.0 111.56 -174.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.11 173.97 11.11 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.448 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.429 HG13 HD13 ' A' ' 62' ' ' ILE . 4.0 mp -122.31 141.47 42.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.479 HD13 ' HB3' ' A' ' 61' ' ' ALA . 3.2 mp -72.26 122.22 24.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.9 t -99.91 -18.28 17.19 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 86.8 tttt -175.89 143.8 0.59 Allowed 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.377 0.0 OUTLIER -117.57 118.93 33.48 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.471 0.653 . . . . 0.0 109.737 165.709 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.8 m . . . . . 0 C--N 1.298 -1.638 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.971 -171.327 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 CA--C 1.511 -0.521 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.577 ' HB3' ' OG1' ' A' ' 97' ' ' THR . 99.6 m95 -97.37 123.02 41.06 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.435 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 73.4 m-85 -111.41 106.79 15.81 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 5.6 m -82.42 104.02 12.4 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.517 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 15.8 m -106.46 154.49 7.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.578 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 11.9 p -104.31 135.46 42.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -100.86 -177.84 3.59 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.327 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.09 -26.88 68.53 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.502 1.121 . . . . 0.0 109.993 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.43 -16.87 64.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.827 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.14 14.17 72.53 Favored Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 26.5 t70 -97.43 137.26 36.66 Favored 'General case' 0 CA--C 1.469 -2.138 0 CA-C-N 113.953 -1.123 . . . . 0.0 108.407 -174.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.77 126.55 50.98 Favored 'General case' 0 C--N 1.269 -2.894 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -141.83 139.37 32.68 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 85' ' ' TRP . 10.9 t -100.16 122.45 43.01 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.083 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 20.0 mt -110.9 166.26 11.18 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.197 0.522 . . . . 0.0 110.065 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.98 164.06 24.71 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -68.19 -17.97 64.47 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.3 p -87.78 14.32 8.88 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.958 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 14.7 m -129.5 1.95 5.04 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.5 mt -128.33 147.31 50.61 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.486 -174.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 50.2 t . . . . . 0 C--N 1.294 -1.837 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.011 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.29 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.474 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 65.9 mt -70.39 -174.71 0.88 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.869 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 p -132.67 161.07 34.9 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.1 t -72.85 130.04 35.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.856 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.19 -24.11 4.52 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.25 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.6 m -83.49 142.26 31.05 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -99.91 135.2 41.7 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.0 m -127.01 161.21 34.45 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 C-N-CA 123.237 0.615 . . . . 0.0 109.516 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.7 m -100.61 123.97 45.56 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -107.05 121.24 44.09 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -175.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 83.5 tttt -81.0 105.99 12.65 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 22' ' ' CYS . 38.6 p90 -121.51 125.15 46.12 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.528 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 62.36 31.84 17.15 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.356 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.2 -3.25 69.4 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 115.16 0.824 . . . . 0.0 115.16 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.73 134.74 37.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.338 1.069 . . . . 0.0 110.27 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.588 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 28.5 p90 -91.17 136.17 33.28 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.558 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 52.3 t -134.96 163.03 30.78 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.95 147.11 45.54 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.59 0.709 . . . . 0.0 110.445 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.475 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -148.39 148.32 30.21 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.95 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -112.71 130.62 55.99 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.325 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.571 ' HA ' HG12 ' A' ' 88' ' ' VAL . 53.2 mt -64.84 119.58 9.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.952 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -95.85 -51.24 4.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.3 m -132.63 145.03 50.76 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.257 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG22 ' HD1' ' A' ' 86' ' ' TYR . 95.2 t -122.23 112.92 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.302 176.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' SER . 65.1 tttp -98.79 97.92 9.09 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -79.61 94.28 5.64 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.506 HD23 ' HE3' ' A' ' 30' ' ' LYS . 2.7 pp -103.14 160.63 14.48 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-O 121.127 0.489 . . . . 0.0 111.263 -178.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.21 118.36 57.24 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.064 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 47' ' ' LEU . 50.4 mtpt -82.85 100.96 10.66 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 21.4 t -84.98 117.34 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.841 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.953 -177.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.425 ' HA ' ' HG ' ' A' ' 47' ' ' LEU . 88.5 tttt -80.95 107.46 13.78 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' THR . 12.5 m -112.91 149.41 15.38 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.003 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.43 -175.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -117.53 111.13 18.82 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.524 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 44.9 mt -71.78 123.93 23.7 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 17.9 ptpt -62.54 -31.01 71.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -175.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HB3' ' CD ' ' A' ' 73' ' ' GLN . 44.9 tt0 -84.95 -55.72 3.93 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 120.897 0.379 . . . . 0.0 111.474 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.6 -22.51 40.57 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 64.45 32.29 11.97 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.47 0.708 . . . . 0.0 112.279 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -92.87 138.86 31.12 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.8 m -107.35 130.11 54.83 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -157.19 156.75 33.15 Favored 'General case' 0 C--N 1.257 -3.434 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.2 mp -113.14 107.88 16.54 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.9 m -114.31 166.87 7.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.89 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -86.73 165.38 16.11 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.639 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.22 -34.19 56.0 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 124.584 1.154 . . . . 0.0 110.532 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.12 -22.8 66.99 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.686 -173.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -99.79 -17.83 17.49 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.6 t -98.09 116.63 41.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.944 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -110.33 114.47 27.95 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.797 176.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.408 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 143.97 -163.83 27.63 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.02 137.36 7.39 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.072 2.515 . . . . 0.0 113.647 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.9 mt -95.03 82.89 3.84 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.345 0.593 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.429 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 3.0 mpt_? -139.14 142.25 38.04 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.75 112.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.26 6.99 35.81 Favored Glycine 0 N--CA 1.428 -1.883 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.435 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.19 152.95 18.31 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.4 mt -99.95 125.92 53.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-O 121.111 0.482 . . . . 0.0 110.124 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.408 HG12 ' HA3' ' A' ' 55' ' ' GLY . 25.2 m -127.96 -177.78 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 8.7 pt-20 -131.51 128.22 38.9 Favored 'General case' 0 C--N 1.272 -2.761 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.445 HG21 HG21 ' A' ' 37' ' ' VAL . 9.9 t -139.96 159.64 41.72 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.99 -168.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -69.02 132.01 45.97 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.66 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.405 HG23 ' HB3' ' A' ' 69' ' ' ASP . 7.0 t -90.51 168.97 11.43 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 m -64.53 -23.0 67.13 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.088 0.555 . . . . 0.0 110.987 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.405 ' HB3' HG23 ' A' ' 67' ' ' THR . 7.7 t70 -64.97 -26.19 68.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.288 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.8 -22.08 17.27 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.226 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.6 t -77.43 179.59 6.38 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.803 0.841 . . . . 0.0 109.504 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -119.19 136.13 54.34 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.524 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 30.3 tt0 -137.86 153.25 49.6 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 39.0 tt0 -77.44 137.19 38.54 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.426 0.631 . . . . 0.0 109.407 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.13 173.61 11.31 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.87 -174.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.19 143.74 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.43 HG13 ' CG1' ' A' ' 35' ' ' VAL . 3.0 mp -75.55 122.82 30.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 t -99.77 -24.2 14.76 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -169.22 151.55 4.68 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.3 OUTLIER -127.77 118.54 23.94 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 118.327 0.512 . . . . 0.0 110.805 172.291 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.306 -1.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.967 -174.758 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.5 p . . . . . 0 N--CA 1.425 -1.695 0 CA-C-O 121.14 0.495 . . . . 0.0 111.618 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.493 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 87.0 m95 -114.93 146.31 41.3 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 27.7 m-85 -124.03 112.96 17.79 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 m -85.49 107.15 17.31 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 26' ' ' ILE . 24.8 m -110.56 146.76 15.32 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.617 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.995 -175.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.11 121.5 53.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.427 ' HD1' ' HB2' ' A' ' 24' ' ' ALA . 29.4 m-85 -74.0 173.58 9.8 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.469 -176.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.98 -27.13 61.1 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.469 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.51 -15.92 61.79 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.241 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.89 75.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.807 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -98.26 141.87 30.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -104.42 127.93 52.2 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.41 ' HB2' ' CE2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -135.25 148.36 49.55 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.217 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.493 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 30.5 m -104.75 113.2 26.63 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.356 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.708 HD11 ' HB1' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -140.54 159.6 41.84 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.064 0.546 . . . . 0.0 111.404 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.547 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 95.8 mtt180 -99.75 -172.47 2.25 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 122.964 0.506 . . . . 0.0 109.987 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.447 ' HA ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.08 -14.57 63.07 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.107 0.48 . . . . 0.0 110.964 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 p -73.27 -2.39 21.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 123.872 0.869 . . . . 0.0 111.234 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 19.6 m -137.6 9.53 2.89 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 99' ' ' ARG . 93.1 mt -113.69 137.69 51.26 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.853 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 C--N 1.295 -1.779 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.172 -177.651 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 N--CA 1.416 -2.15 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.533 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 6.6 mp -78.26 177.38 8.46 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.231 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 p -131.47 152.26 50.85 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.62 112.5 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.209 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.02 -24.15 3.45 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.519 ' HB ' HD12 ' A' ' 26' ' ' ILE . 46.2 m -73.68 138.67 44.87 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 120.937 0.398 . . . . 0.0 109.93 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -99.02 126.11 44.66 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -136.37 -178.91 2.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 123.249 0.62 . . . . 0.0 109.906 -176.078 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 15.8 m -130.9 146.06 52.21 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 174.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -119.38 127.4 53.1 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -80.87 138.98 36.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.168 0.509 . . . . 0.0 111.582 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -125.69 101.17 6.75 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 123.871 0.868 . . . . 0.0 108.898 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 57.63 37.8 27.55 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.385 0.428 . . . . 0.0 111.174 171.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.27 -6.06 71.68 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.982 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.56 123.8 43.76 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . 0.258 0.5 OUTLIER -107.62 131.28 54.54 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -174.102 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.7 m -105.14 144.51 31.83 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.386 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -85.9 147.55 26.2 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.884 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' A' ' 90' ' ' PHE . . . -150.55 154.58 37.83 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.528 0.68 . . . . 0.0 110.672 -175.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.99 126.81 55.19 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.521 ' HA ' HG12 ' A' ' 88' ' ' VAL . 32.0 mt -61.26 120.44 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -95.4 -43.9 7.79 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.927 0.891 . . . . 0.0 110.08 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.1 m -140.63 146.12 37.52 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.8 t -121.6 114.99 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 O-C-N 123.603 0.564 . . . . 0.0 109.599 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -112.35 91.13 3.54 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.748 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -84.09 87.48 7.15 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 32' ' ' LEU . 2.4 pt? -91.15 111.23 22.62 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.564 -174.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.5 t -86.62 114.63 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.026 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 14.5 mmmm -80.05 99.49 7.71 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.8 t -89.38 129.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.071 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.286 -175.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 83.8 tttt -91.52 103.13 15.78 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 3.7 m -112.6 155.19 13.91 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.786 -177.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 44' ' ' THR . 8.4 tt -129.14 118.31 22.24 Favored 'General case' 0 N--CA 1.387 -3.625 0 CA-C-N 114.445 -1.252 . . . . 0.0 107.638 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.711 HD23 ' HB2' ' A' ' 75' ' ' ALA . 86.5 mt -68.79 122.56 18.84 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.95 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 21.7 ptmt -59.94 -29.54 68.47 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 120.903 0.382 . . . . 0.0 111.415 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -59.84 -55.17 37.51 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 124.606 1.162 . . . . 0.0 113.226 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -120.23 -0.08 10.54 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.442 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 68.35 23.73 7.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.167 0.987 . . . . 0.0 112.334 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -78.73 133.3 37.16 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 m -106.37 148.18 28.37 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 13.0 pt20 -159.72 160.07 33.62 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 123.031 0.207 . . . . 0.0 110.444 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 mt -115.8 102.17 9.47 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 27.9 m -124.28 170.13 14.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -177.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 11.3 pt20 -91.26 170.78 9.71 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.956 -175.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -55.96 -21.08 18.93 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.097 1.759 . . . . 0.0 112.151 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -78.18 -35.39 48.78 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.307 0.575 . . . . 0.0 109.942 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -82.67 -15.14 53.12 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.081 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -109.17 135.17 48.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.162 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.451 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -125.46 139.75 53.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 172.64 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.94 -166.93 13.94 Favored Glycine 0 C--N 1.31 -0.867 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.57 132.34 10.97 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.77 2.313 . . . . 0.0 113.086 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.38 81.99 6.53 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.553 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 8.8 tpt180 -140.49 135.95 32.46 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.64 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.24 116.28 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.74 2.77 46.43 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.238 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.35 149.44 22.1 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.417 HG12 HG13 ' A' ' 76' ' ' ILE . 49.5 mt -95.69 117.12 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-O 121.882 0.849 . . . . 0.0 109.961 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 16.4 m -116.84 -172.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.273 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 72' ' ' PHE . 40.3 mt-10 -129.01 124.27 34.53 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.0 m -112.66 144.95 41.3 Favored 'General case' 0 N--CA 1.385 -3.678 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -74.05 117.69 16.14 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -89.06 -179.8 5.99 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 t -60.35 -29.86 69.17 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.218 1.007 . . . . 0.0 111.478 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.98 -25.18 67.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.845 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.56 -20.58 22.64 Favored Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.625 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 p -89.4 164.03 15.04 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.069 0.548 . . . . 0.0 111.052 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.479 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 96.5 m-85 -96.05 123.31 39.61 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 122.854 0.461 . . . . 0.0 110.746 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -114.03 150.86 33.3 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.508 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 45.6 mt-10 -68.87 127.73 34.15 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.113 0.959 . . . . 0.0 111.897 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.711 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -135.84 161.49 35.47 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.85 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.417 HG13 HG12 ' A' ' 62' ' ' ILE . 3.8 mp -116.89 139.49 43.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -73.05 124.45 30.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.9 176.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 t -103.9 -26.24 12.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.434 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 23.0 tptm -167.57 159.21 11.92 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mp -135.01 141.43 46.19 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 5.0 m . . . . . 0 C--N 1.278 -2.529 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.426 -1.646 0 CA-C-O 121.317 0.579 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.424 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 57.7 m95 -95.55 122.05 37.88 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.973 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 92.8 m-85 -109.35 109.43 20.31 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 73.0 m -85.17 104.18 14.81 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 174.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 26' ' ' ILE . 28.5 m -106.2 141.46 21.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.868 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.27 130.41 59.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.022 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' A' ' 24' ' ' ALA . 52.0 m-85 -91.02 167.89 12.06 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -62.18 -19.66 63.33 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.007 0.908 . . . . 0.0 109.993 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.16 -11.36 48.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.462 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.83 -3.78 82.23 Favored Glycine 0 C--O 1.227 -0.336 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -96.18 142.48 28.3 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -117.14 143.9 45.31 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 123.442 0.464 . . . . 0.0 110.994 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -129.61 143.8 50.99 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 85.7 m -104.16 113.05 26.33 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.0 OUTLIER -133.91 163.47 29.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.571 0.748 . . . . 0.0 112.109 -177.314 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -99.36 177.56 5.15 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 122.821 0.448 . . . . 0.0 110.013 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -60.9 -33.03 72.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.064 0.546 . . . . 0.0 111.428 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.4 m -57.86 -32.29 67.51 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.736 0.814 . . . . 0.0 110.921 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 17.5 m -91.45 7.4 41.39 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.019 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.7 170.48 7.91 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.554 0.692 . . . . 0.0 111.321 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 14' ' ' SER . 53.1 t . . . . . 0 C--N 1.292 -1.905 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.664 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.442 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 45.7 p90 . . . . . 0 N--CA 1.412 -2.374 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.438 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 90.2 mt -99.84 175.25 5.85 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.9 p -122.17 161.21 23.58 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 120.614 0.245 . . . . 0.0 111.521 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.57 144.05 14.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.521 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.35 -25.97 26.32 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.653 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.573 ' HB ' HD12 ' A' ' 26' ' ' ILE . 9.7 m -58.08 133.23 55.37 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 122.162 0.982 . . . . 0.0 112.65 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -84.49 113.91 21.55 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 113.491 -1.686 . . . . 0.0 109.165 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.48 -177.81 2.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.455 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -140.11 147.22 39.91 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 173.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -126.16 131.69 51.98 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 22.3 pttp -82.51 133.35 35.2 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -112.92 112.58 24.16 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 170.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 61.09 31.06 19.76 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.343 0.592 . . . . 0.0 110.897 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.33 -8.45 72.2 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.885 -0.598 . . . . 0.0 114.192 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.76 124.44 50.59 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.537 0.669 . . . . 0.0 110.126 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 73.7 m-85 -87.99 120.47 29.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -99.82 143.74 29.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 172.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -75.25 148.52 39.37 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.719 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -154.34 143.66 21.34 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.449 0.643 . . . . 0.0 111.227 -175.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -115.73 128.29 55.76 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.573 HD12 ' HB ' ' A' ' 11' ' ' THR . 17.6 mt -68.94 113.82 5.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 120.716 0.293 . . . . 0.0 111.554 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HD2' ' HB ' ' A' ' 89' ' ' VAL . 43.9 mtpt -88.17 -38.09 15.61 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.8 m -146.54 141.95 27.53 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.067 -175.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.37 131.06 73.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -123.79 97.82 5.54 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -78.63 86.52 4.61 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.684 1.23 . . . . 0.0 108.607 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.475 ' HA ' ' OD1' ' A' ' 50' ' ' ASP . 2.0 pt? -107.29 134.47 50.32 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.967 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.3 t -108.06 132.27 56.22 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.971 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -86.04 101.53 13.01 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.49 HG12 HG13 ' A' ' 37' ' ' VAL . 11.5 t -91.78 127.08 44.3 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.836 -174.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -92.21 106.94 18.84 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.498 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 2.4 m -114.79 143.71 23.93 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.96 0 CA-C-O 121.682 0.753 . . . . 0.0 112.022 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.1 tp -111.14 118.02 34.83 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.7 -1.591 . . . . 0.0 107.639 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.736 HD23 ' HB2' ' A' ' 75' ' ' ALA . 94.3 mt -67.29 111.37 3.96 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.428 ' HB3' HD11 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -73.25 -15.2 61.43 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.183 0.516 . . . . 0.0 112.214 -176.734 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -88.76 -51.09 5.84 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.654 0.74 . . . . 0.0 109.621 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 15.0 t70 -89.98 -33.12 16.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.445 -170.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 35.3 m-80 83.64 15.89 0.28 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.101 1.36 . . . . 0.0 113.402 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -95.85 150.52 20.33 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.91 0.386 . . . . 0.0 110.368 174.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -118.03 144.83 45.25 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.4 157.84 42.94 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.939 176.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.3 tp -119.36 101.48 7.99 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.1 m -126.62 175.53 8.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.48 -170.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -88.57 154.23 20.5 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.426 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 32' ' ' LEU . 6.4 p-10 -65.88 -12.98 58.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.061 0.944 . . . . 0.0 111.507 -176.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.83 -28.89 63.88 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.664 0.745 . . . . 0.0 109.68 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.43 ' OE1' ' HD3' ' A' ' 66' ' ' ARG . 43.3 mt-30 -108.24 8.94 28.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.979 0.895 . . . . 0.0 109.333 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 78.4 t -108.03 110.06 30.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.909 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.27 103.58 16.22 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.024 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.531 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 145.1 -171.36 26.25 Favored Glycine 0 C--N 1.292 -1.88 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.339 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.81 144.28 19.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.209 2.606 . . . . 0.0 113.194 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -93.22 82.36 4.52 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.49 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 50.6 mtm180 -139.5 131.89 28.49 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.771 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.53 117.95 7.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.06 10.75 51.3 Favored Glycine 0 C--N 1.299 -1.477 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.291 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB3' HD13 ' A' ' 77' ' ' ILE . . . -97.85 162.46 13.24 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 117.313 0.556 . . . . 0.0 110.062 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.8 mm -102.54 121.53 53.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 123.559 0.537 . . . . 0.0 110.113 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.531 HG12 ' HA3' ' A' ' 55' ' ' GLY . 29.9 m -130.12 177.2 7.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.039 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -126.22 121.68 33.42 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.9 t -122.21 154.67 37.19 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-O 121.151 0.5 . . . . 0.0 111.067 -173.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HD3' ' OE1' ' A' ' 52' ' ' GLN . 34.8 ttt180 -85.4 132.09 34.29 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.375 177.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.9 p -95.74 163.78 13.04 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.5 m -57.18 -23.68 49.23 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -80.5 -3.22 49.22 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 122.247 -0.283 . . . . 0.0 111.599 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.416 ' HA2' ' HE ' ' A' ' 66' ' ' ARG . . . 95.52 6.19 59.85 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.9 175.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.2 m -97.59 152.37 19.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 122.504 -0.409 . . . . 0.0 110.48 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' THR . 56.0 m-85 -110.88 121.01 44.28 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -128.39 153.7 46.78 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.918 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -73.52 127.88 33.95 Favored 'General case' 0 C--O 1.256 1.444 0 CA-C-O 121.716 0.769 . . . . 0.0 110.788 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.736 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -135.73 168.54 19.09 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.177 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.428 HD11 ' HB3' ' A' ' 40' ' ' LYS . 8.9 mt -118.01 145.84 23.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.2 mp -77.98 115.13 19.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 175.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 m -97.93 -17.31 19.3 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.025 0.44 . . . . 0.0 109.964 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -169.64 156.73 6.67 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.65 111.18 6.8 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.799 0.809 . . . . 0.0 110.588 173.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 C--N 1.297 -1.685 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.787 -178.132 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 CA--C 1.552 1.033 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -102.7 141.6 35.25 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.498 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.442 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 50.6 m-85 -127.79 106.83 9.39 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 54.1 m -87.15 107.81 18.63 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.675 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 23.6 m -112.06 147.56 15.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.096 -173.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.501 ' HB ' ' HD2' ' A' ' 27' ' ' LYS . 7.2 p -105.09 125.08 60.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 123.687 0.795 . . . . 0.0 109.887 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.457 ' CE1' HG23 ' A' ' 88' ' ' VAL . 57.3 m-85 -92.79 -176.86 4.36 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.295 -174.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -47.61 -41.59 22.2 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.145 1.378 . . . . 0.0 112.664 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.08 -16.72 60.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.099 0.476 . . . . 0.0 111.893 -175.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.58 5.74 56.67 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.643 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -96.61 149.92 21.24 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.5 144.12 43.86 Favored 'General case' 0 C--O 1.253 1.287 0 CA-C-O 121.474 0.655 . . . . 0.0 112.177 -175.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.4 mmt-85 -136.77 151.27 49.0 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.466 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 63.5 m -99.42 109.27 21.87 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.278 0.561 . . . . 0.0 109.604 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.25 159.4 17.95 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.691 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -99.66 161.72 13.44 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 ttp85 -61.57 -23.43 65.98 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 m -59.01 -25.08 63.35 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 123.556 0.742 . . . . 0.0 110.93 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 18.9 m -96.12 -8.24 33.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.041 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.9 mp -92.9 133.18 36.36 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -171.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.455 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 19.3 t . . . . . 0 C--N 1.289 -2.062 0 CA-C-N 112.682 -2.053 . . . . 0.0 110.324 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.418 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.428 -1.564 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.522 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 48.6 mt -113.18 -174.92 2.55 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -131.17 160.63 34.23 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.81 144.84 10.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.49 -6.52 74.72 Favored Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.87 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.417 ' HB ' HD12 ' A' ' 26' ' ' ILE . 25.3 m -89.16 133.5 34.38 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 120.965 0.412 . . . . 0.0 110.19 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -96.88 124.18 40.79 Favored 'General case' 0 CA--C 1.476 -1.875 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.909 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 103' ' ' LEU . 28.2 m -131.59 160.77 42.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.216 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 104' ' ' CYS . 2.4 p -94.58 117.02 29.47 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.447 ' HB1' HD12 ' A' ' 98' ' ' LEU . . . -106.52 127.68 53.5 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.393 -173.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 22.6 pttp -84.76 134.9 34.31 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.453 0.644 . . . . 0.0 112.378 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.413 ' CZ ' ' HZ ' ' A' ' 90' ' ' PHE . 80.7 m-85 -132.98 136.23 45.95 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HD3' ' C ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 44.68 26.28 0.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.021 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.05 2.9 64.07 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.159 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.15 146.35 51.1 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 16' ' ' LYS 0.262 18.4 p90 -106.76 146.41 30.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 116.026 1.862 . . . . 0.0 116.026 -175.467 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 66.1 m -131.53 138.23 48.84 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.745 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 38.2 tt0 -79.92 137.35 36.86 Favored 'General case' 0 N--CA 1.406 -2.649 0 CA-C-O 121.225 0.536 . . . . 0.0 111.297 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -147.41 158.75 44.1 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.048 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -106.55 129.26 54.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.417 HD12 ' HB ' ' A' ' 11' ' ' THR . 72.1 mt -61.0 117.27 2.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.196 0.522 . . . . 0.0 110.311 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -99.41 -40.5 7.85 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.983 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 m -127.48 141.83 51.56 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.514 HG13 ' CE1' ' A' ' 86' ' ' TYR . 55.8 t -120.17 124.06 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 C-N-CA 123.179 0.592 . . . . 0.0 109.601 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 46.9 tptt -131.4 90.62 2.89 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -83.54 92.43 7.62 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 117.766 -1.574 . . . . 0.0 108.211 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 32' ' ' LEU . 2.3 pt? -112.33 133.97 54.13 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.278 0.561 . . . . 0.0 109.869 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.6 123.09 48.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -96.03 109.91 22.23 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 122.086 0.946 . . . . 0.0 109.225 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 37' ' ' VAL . 21.4 t -94.59 129.26 45.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.323 -172.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 83.6 tttt -88.89 105.84 18.01 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 175.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.537 HG21 HG21 ' A' ' 65' ' ' THR . 0.4 OUTLIER -113.27 143.93 21.95 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.279 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.359 -177.821 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.6 115.01 29.29 Favored 'General case' 0 C--N 1.266 -3.033 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.541 HD12 ' H ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -66.67 118.19 9.89 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.552 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -64.53 -43.43 94.02 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 124.65 1.18 . . . . 0.0 113.221 -171.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -88.42 -25.34 22.71 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.571 0.701 . . . . 0.0 111.717 -174.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.541 ' H ' HD12 ' A' ' 39' ' ' LEU . 18.0 t70 -98.55 -32.01 11.67 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.565 -175.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 76.78 21.87 1.18 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -102.45 149.61 24.21 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.449 HG21 ' HE2' ' A' ' 36' ' ' LYS . 2.2 m -101.58 138.68 38.26 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -140.16 144.86 36.87 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 36' ' ' LYS . 10.5 tt -124.92 106.67 10.16 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.9 m -135.68 -178.02 2.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.517 -173.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.415 ' HB2' ' HG2' ' A' ' 52' ' ' GLN . 12.3 mt-30 -64.51 150.59 46.4 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -18.29 63.25 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.275 171.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.48 -24.41 61.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.5 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 65' ' ' THR . 12.3 mm100 -85.54 -19.05 31.71 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.2 t -91.5 112.12 24.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.659 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -97.82 98.47 9.86 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.98 175.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.442 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 150.51 179.11 26.01 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.596 178.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.53 141.26 72.84 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.242 2.628 . . . . 0.0 114.246 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.96 81.97 7.36 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 97.5 mtt180 -139.57 132.98 30.11 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.02 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.9 t -72.69 110.31 5.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.543 0.687 . . . . 0.0 109.538 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.97 7.19 27.44 Favored Glycine 0 N--CA 1.428 -1.858 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.364 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.54 147.46 22.97 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.258 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.404 HD13 HG13 ' A' ' 76' ' ' ILE . 48.3 mm -86.07 117.0 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.442 HG12 ' HA3' ' A' ' 55' ' ' GLY . 27.5 m -130.76 179.04 4.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.23 125.92 48.31 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 HG21 ' A' ' 37' ' ' VAL . 14.5 t -132.48 159.6 38.88 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -76.05 114.19 14.41 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 123.606 0.566 . . . . 0.0 109.853 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 71' ' ' SER . 9.2 t -85.38 -179.47 6.96 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.357 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.7 m -64.9 -18.1 64.9 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.629 1.172 . . . . 0.0 111.038 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.419 ' H ' HG23 ' A' ' 67' ' ' THR . 31.4 t70 -75.69 -21.51 57.53 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.448 177.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.61 -14.85 58.99 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 67' ' ' THR . 21.3 m -90.88 159.77 16.06 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -92.33 127.42 37.81 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -140.24 165.21 28.0 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.41 ' O ' HD13 ' A' ' 39' ' ' LEU . 60.3 mt-10 -67.72 136.47 54.33 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.108 0.48 . . . . 0.0 111.91 -175.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -145.62 164.6 31.2 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.8 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.404 HG13 HD13 ' A' ' 62' ' ' ILE . 3.1 mp -118.51 136.45 55.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -69.71 122.61 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 m -111.14 -17.03 13.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.212 0.529 . . . . 0.0 110.68 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 65.1 tttp -166.55 143.43 4.91 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.78 111.58 13.81 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.502 0.668 . . . . 0.0 109.705 172.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.288 -2.082 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.93 -169.995 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.419 ' HB3' ' CE2' ' A' ' 86' ' ' TYR . 44.0 m . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.536 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 34.5 m95 -90.04 132.62 35.29 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.799 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.588 ' HB2' HD11 ' A' ' 103' ' ' LEU . 97.6 m-85 -128.27 112.61 14.67 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.811 176.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 26.1 m -84.81 107.15 16.83 Favored 'General case' 0 N--CA 1.39 -3.469 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 17.2 m -105.63 141.43 20.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.195 -177.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.6 p -114.71 132.13 64.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.837 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 76.3 m-85 -86.35 166.32 15.69 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.24 -21.86 66.74 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 122.283 1.039 . . . . 0.0 108.588 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.67 -17.27 64.48 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.06 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.93 0.16 64.1 Favored Glycine 0 C--O 1.218 -0.876 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.156 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -96.88 144.61 26.66 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 9.3 pt-20 -122.27 133.31 54.69 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.066 0.46 . . . . 0.0 111.088 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -129.67 142.18 50.78 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 31.9 m -105.47 111.41 24.11 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 120.769 0.318 . . . . 0.0 110.913 -177.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.447 HD12 ' HB1' ' A' ' 15' ' ' ALA . 25.2 mt -118.62 171.77 7.96 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -79.73 162.54 25.11 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -56.73 -30.12 63.21 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.153 0.502 . . . . 0.0 111.209 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.6 p -81.27 -2.66 49.78 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.809 0.844 . . . . 0.0 112.641 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 27.6 t -107.34 9.66 29.85 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.588 HD11 ' HB2' ' A' ' 86' ' ' TYR . 70.8 mt -122.27 134.92 54.67 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.455 ' HB3' ' OG ' ' A' ' 14' ' ' SER . 47.0 t . . . . . 0 C--N 1.285 -2.218 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -175.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.642 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 24.2 p90 . . . . . 0 N--CA 1.407 -2.583 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 87.6 mt -98.44 178.41 5.04 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.738 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.7 p -134.96 169.27 17.66 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.379 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.55 123.26 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 122.776 0.43 . . . . 0.0 111.09 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.0 -33.64 3.01 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.447 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.576 ' HB ' HD12 ' A' ' 26' ' ' ILE . 15.6 m -59.41 138.64 57.59 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.176 0.59 . . . . 0.0 111.332 -177.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -100.53 116.83 33.39 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.5 m -128.43 -179.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 122.871 0.468 . . . . 0.0 110.396 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 16.8 m -129.23 137.28 51.01 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' CB ' HD11 ' A' ' 98' ' ' LEU . . . -107.27 128.53 54.52 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -85.72 120.14 26.82 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.85 0.357 . . . . 0.0 111.144 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -125.88 109.91 13.04 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 61.86 26.77 16.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.831 0.852 . . . . 0.0 112.557 172.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.73 25.39 42.12 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.921 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.52 144.78 50.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -106.61 120.1 41.06 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.353 0.597 . . . . 0.0 111.117 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.6 m -103.73 128.73 51.07 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 175.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 9.8 pt-20 -93.62 140.49 29.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.536 -1.265 . . . . 0.0 109.852 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -145.47 156.68 43.89 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.319 -173.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -112.23 132.78 54.73 Favored 'General case' 0 C--N 1.266 -3.029 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.576 HD12 ' HB ' ' A' ' 11' ' ' THR . 43.2 mt -59.41 121.81 7.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.332 0.587 . . . . 0.0 111.907 -176.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -97.31 -46.97 5.9 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 125.025 1.33 . . . . 0.0 109.994 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 16.6 m -137.77 146.18 43.3 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.412 HG12 ' HG3' ' A' ' 31' ' ' ARG . 98.4 t -131.16 124.24 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -110.75 91.07 3.52 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HG3' HG12 ' A' ' 29' ' ' VAL . 48.3 mtm180 -78.15 122.9 26.25 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 121.974 0.892 . . . . 0.0 111.515 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 84' ' ' SER . 1.8 pt? -155.7 148.56 24.26 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -135.75 143.91 35.09 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.943 0 N-CA-C 104.34 -2.467 . . . . 0.0 104.34 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 94.4 mttt -85.05 101.19 12.21 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.533 HG12 HG13 ' A' ' 37' ' ' VAL . 21.3 t -86.46 118.06 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.52 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.575 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -86.55 107.82 18.3 Favored 'General case' 0 N--CA 1.413 -2.286 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.567 HG21 HG21 ' A' ' 65' ' ' THR . 3.7 m -112.53 150.03 14.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -126.53 117.66 23.31 Favored 'General case' 0 C--N 1.26 -3.314 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 75' ' ' ALA . 20.3 mt -72.84 106.35 4.75 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -57.96 -34.36 69.85 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -72.13 -45.8 59.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 120.98 0.419 . . . . 0.0 111.403 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -91.84 -8.89 45.3 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.492 -175.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.2 p30 53.31 28.09 6.92 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.302 1.841 . . . . 0.0 113.256 -177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -104.14 145.74 29.75 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.309 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 m -97.7 154.44 17.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -151.15 138.93 19.8 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 mt -109.72 102.33 11.15 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.414 HG21 ' OG1' ' A' ' 65' ' ' THR . 27.4 m -116.58 176.43 2.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.29 -174.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -101.56 160.02 14.8 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.4 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -47.18 -33.9 5.75 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 126.405 1.882 . . . . 0.0 112.237 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -72.81 -28.76 62.76 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.29 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 85.6 mt-30 -92.72 -3.53 54.67 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.548 0.69 . . . . 0.0 109.222 -178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.8 t -99.37 123.02 51.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.076 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -103.46 95.83 6.34 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.424 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 148.59 -173.82 28.44 Favored Glycine 0 N--CA 1.423 -2.231 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.132 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.416 ' HD2' HG12 ' A' ' 63' ' ' VAL . 11.6 Cg_exo -73.14 148.35 44.24 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.096 2.531 . . . . 0.0 113.478 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.27 82.64 6.5 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 62.8 ttt180 -139.35 119.59 13.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.818 -174.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.66 115.69 6.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.11 0.481 . . . . 0.0 109.862 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.5 5.51 42.44 Favored Glycine 0 N--CA 1.418 -2.543 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.122 -177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.13 155.78 16.98 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.413 0.606 . . . . 0.0 110.393 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.2 mt -97.24 124.8 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.424 HG12 ' HA3' ' A' ' 55' ' ' GLY . 28.0 m -132.18 179.19 4.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -113.49 125.51 54.29 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.567 HG21 HG21 ' A' ' 37' ' ' VAL . 9.7 t -127.61 152.39 47.72 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-O 120.777 0.323 . . . . 0.0 110.17 -174.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . 58.2 ttt180 -83.25 123.9 30.05 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.041 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.2 p -85.6 177.13 7.83 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -71.33 -20.6 62.16 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.033 0.444 . . . . 0.0 109.815 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.91 -25.0 66.95 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.968 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.91 -20.27 24.47 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.077 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.2 p -92.2 159.43 15.64 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 120.942 0.401 . . . . 0.0 110.97 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 65' ' ' THR . 51.1 m-85 -92.73 138.89 31.1 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.013 0.435 . . . . 0.0 110.244 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -132.14 149.73 52.33 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.67 129.81 34.74 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.024 0.916 . . . . 0.0 109.741 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.514 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -142.86 173.38 11.59 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.403 -174.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 5.7 mm -110.92 143.94 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -79.75 111.26 16.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -90.65 -24.77 20.4 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 120.922 0.391 . . . . 0.0 109.963 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -165.17 146.16 7.39 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.0 111.23 17.64 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.854 0.835 . . . . 0.0 109.119 168.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 8.2 m . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -173.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.506 ' HA ' HD23 ' A' ' 32' ' ' LEU . 50.5 m . . . . . 0 CA--C 1.507 -0.698 0 CA-C-O 121.883 0.849 . . . . 0.0 111.726 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -99.65 134.06 43.08 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.161 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.642 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 82.2 m-85 -121.2 107.94 13.17 Favored 'General case' 0 N--CA 1.422 -1.872 0 O-C-N 123.753 0.658 . . . . 0.0 109.315 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 33.3 m -90.08 106.47 18.5 Favored 'General case' 0 N--CA 1.398 -3.073 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 26' ' ' ILE . 16.2 m -105.74 141.65 20.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.164 -176.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.5 137.95 42.03 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.366 -174.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 87.4 m-85 -94.23 163.74 13.32 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.46 -26.74 65.48 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.615 0.722 . . . . 0.0 111.52 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.84 -17.14 64.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.089 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.1 1.92 58.21 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.75 138.31 31.58 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -125.86 133.91 51.8 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.465 0.65 . . . . 0.0 111.048 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.62 142.3 50.26 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.039 -176.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 43.4 m -104.89 110.16 22.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.519 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.486 HD11 ' CB ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -132.9 170.39 15.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.322 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -98.97 170.6 8.61 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -58.06 -31.38 67.01 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 123.699 0.8 . . . . 0.0 111.93 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 m -70.91 -9.14 57.19 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 121.498 0.666 . . . . 0.0 111.465 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.477 ' HB2' HD12 ' A' ' 98' ' ' LEU . 21.5 m -109.01 1.22 20.43 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 14' ' ' SER . 89.6 mt -107.22 129.43 54.87 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.788 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 14.2 t . . . . . 0 C--N 1.306 -1.291 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.079 -177.198 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.4 p90 . . . . . 0 N--CA 1.404 -2.752 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 29.5 mt -88.49 173.52 8.63 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.9 p -123.51 162.1 23.58 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -173.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -65.61 133.27 30.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.671 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.94 -16.57 42.89 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.944 177.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.619 ' HB ' HD12 ' A' ' 26' ' ' ILE . 13.4 m -66.54 132.08 47.42 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.498 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -96.75 115.36 27.3 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.9 m -128.61 -179.56 3.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 121.435 0.636 . . . . 0.0 110.361 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 19.4 m -133.43 136.45 45.21 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -107.18 138.83 42.63 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -89.91 129.93 36.19 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.879 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -127.7 108.14 10.49 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.344 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.501 ' HD2' ' N ' ' A' ' 18' ' ' ARG . 2.9 mpt_? 59.57 32.82 21.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.67 0.788 . . . . 0.0 111.659 175.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.44 -2.63 68.0 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.787 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.36 147.97 36.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 117.184 0.492 . . . . 0.0 109.738 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -93.41 138.79 31.38 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.017 0.437 . . . . 0.0 110.833 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.0 m -125.36 128.03 47.53 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 170.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 6.8 pt-20 -90.08 138.38 31.56 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 118.417 -1.313 . . . . 0.0 110.771 -173.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.43 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -148.67 151.01 34.2 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.02 -174.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.6 tttp -108.92 128.98 55.4 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.619 HD12 ' HB ' ' A' ' 11' ' ' THR . 19.0 mt -66.63 118.67 10.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 120.646 0.26 . . . . 0.0 110.709 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -97.13 -46.85 6.0 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.259 0.552 . . . . 0.0 110.129 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 m -127.06 139.2 53.17 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.2 t -121.57 107.17 19.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.028 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 84' ' ' SER . 95.5 mttt -99.3 90.49 4.57 Favored 'General case' 0 C--N 1.264 -3.115 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -86.21 108.12 18.21 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.425 ' H ' HD23 ' A' ' 32' ' ' LEU . 1.9 pt? -132.78 129.46 38.61 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -175.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 8.5 p -97.39 116.38 39.63 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.826 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -88.92 100.56 13.28 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 57' ' ' LEU . 25.7 t -84.75 137.05 21.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.862 -174.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 39.8 ttmt -91.43 105.43 17.76 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 175.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 65' ' ' THR . 3.5 m -112.6 143.13 22.93 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.328 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.3 118.75 34.78 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 67' ' ' THR . 10.4 mp -69.4 122.59 19.25 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.851 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.74 -31.43 72.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.153 0.501 . . . . 0.0 111.017 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -89.4 -58.82 2.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.529 0.68 . . . . 0.0 110.982 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.37 -17.37 45.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.599 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 t30 71.68 7.12 5.87 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.069 0.937 . . . . 0.0 113.385 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -86.64 159.75 19.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 110.789 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.6 m -119.4 140.35 50.54 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 10.0 mp0 -134.09 142.51 47.56 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.44 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.75 101.22 10.53 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.2 149.62 28.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.424 0.631 . . . . 0.0 111.764 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 15.1 pt20 -69.81 160.98 30.73 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.37 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -63.4 -7.2 6.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.611 0.764 . . . . 0.0 112.523 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 49' ' ' GLN . 5.4 m-20 -73.58 -34.63 65.2 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.523 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 25.7 mm-40 -86.33 -28.99 23.35 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.076 -177.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.7 t -91.06 121.74 41.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.474 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -105.74 108.73 20.4 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.01 -173.79 22.76 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.059 177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.9 139.2 46.7 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 123.139 2.559 . . . . 0.0 112.859 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.474 HD12 HG21 ' A' ' 35' ' ' VAL . 1.7 mm? -97.12 81.44 3.05 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.537 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 42.8 ttp85 -141.1 138.6 33.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.835 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.92 124.7 19.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.34 9.07 63.7 Favored Glycine 0 N--CA 1.427 -1.952 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.349 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.93 153.18 18.05 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.926 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -89.81 119.24 36.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.0 m -134.55 175.04 12.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.034 0.445 . . . . 0.0 110.807 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -126.3 128.19 46.74 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.56 HG21 HG21 ' A' ' 37' ' ' VAL . 11.8 t -131.13 157.92 41.85 Favored 'General case' 0 C--N 1.277 -2.55 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.042 -174.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.523 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 37.0 ttm-85 -82.54 128.59 34.45 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 105.221 -2.141 . . . . 0.0 105.221 170.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.477 HG21 HD21 ' A' ' 39' ' ' LEU . 34.2 p -84.98 176.79 8.23 Favored 'General case' 0 C--N 1.276 -2.615 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.199 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.1 m -66.17 -19.72 65.92 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.004 0.431 . . . . 0.0 110.044 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -75.55 -25.43 57.14 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.84 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.33 -17.33 16.71 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.702 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.6 m -90.09 151.97 21.36 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.648 0.261 . . . . 0.0 111.416 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 65' ' ' THR . 62.4 m-85 -87.46 126.76 35.09 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.87 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -140.96 145.54 36.15 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.363 1.065 . . . . 0.0 108.983 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -76.13 131.05 39.17 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 121.812 0.815 . . . . 0.0 111.253 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.8 170.12 16.29 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.382 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.1 mm -119.83 142.46 35.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -74.42 129.06 36.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.3 m -114.47 -17.11 11.82 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 121.227 0.537 . . . . 0.0 111.025 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 57.4 tttm -168.82 156.23 7.48 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.76 135.15 53.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 87.1 m . . . . . 0 C--N 1.278 -2.516 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.769 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.7 p . . . . . 0 N--CA 1.425 -1.692 0 CA-C-O 121.111 0.481 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.542 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 87.6 m95 -107.75 113.87 27.43 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.108 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 94.5 m-85 -101.47 110.59 22.62 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.1 m -89.93 104.14 16.73 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.428 HG22 HD23 ' A' ' 98' ' ' LEU . 24.4 m -106.9 140.59 24.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.273 0.559 . . . . 0.0 111.301 -174.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 3.5 t -101.79 128.69 54.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 124.239 1.015 . . . . 0.0 109.979 -173.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 58.7 m-85 -87.71 174.02 8.65 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 174.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.31 -17.82 55.55 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.96 -17.81 62.04 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.045 0.538 . . . . 0.0 110.326 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.21 -0.48 68.85 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.96 131.48 40.85 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 123.325 0.65 . . . . 0.0 109.548 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.457 ' C ' ' HD2' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -111.74 137.25 49.92 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.354 0.597 . . . . 0.0 111.911 -179.139 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.457 ' HD2' ' C ' ' A' ' 95' ' ' GLU . 4.3 mpt_? -121.67 158.18 29.25 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.395 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.542 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 24.0 m -101.84 119.69 39.19 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.251 0.548 . . . . 0.0 110.771 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.428 HD23 HG22 ' A' ' 88' ' ' VAL . 4.0 mm? -122.09 174.5 6.9 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.484 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 22.5 mmt180 -98.86 166.58 11.23 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.89 -21.61 63.3 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.572 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.6 m -74.19 -9.78 58.96 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.521 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 5.3 m -98.95 -11.8 21.26 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 99' ' ' ARG . 70.1 mt -101.68 128.35 48.02 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.073 -171.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 30.3 t . . . . . 0 C--N 1.311 -1.082 0 C-N-CA 124.749 1.219 . . . . 0.0 110.75 -178.405 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.761 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 38.2 p90 . . . . . 0 N--CA 1.421 -1.885 0 CA-C-O 120.901 0.382 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.55 -173.58 3.07 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.716 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.5 p -128.61 157.91 39.96 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -171.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 m -74.35 148.96 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 CA-C-O 121.122 0.487 . . . . 0.0 111.834 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.15 -12.59 67.36 Favored Glycine 0 C--N 1.301 -1.378 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.071 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.479 ' HB ' HD12 ' A' ' 26' ' ' ILE . 13.6 m -79.59 135.92 36.71 Favored 'General case' 0 N--CA 1.403 -2.809 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -99.78 121.04 40.68 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 104' ' ' CYS . 17.4 m -135.37 -177.33 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 121.474 0.654 . . . . 0.0 110.307 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 m -123.07 141.62 51.76 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.54 139.76 41.57 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.344 0.0 OUTLIER -99.98 136.61 39.63 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -177.815 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -131.62 121.72 24.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.668 -1.605 . . . . 0.0 107.355 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 61.53 31.7 18.85 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.028 0.931 . . . . 0.0 110.428 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.89 28.8 70.04 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.5 -177.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.75 152.29 50.16 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -102.39 144.84 30.36 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.686 -173.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -127.58 139.73 52.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 172.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.53 152.38 26.04 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.482 -175.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -162.37 145.36 11.39 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -106.51 128.75 54.34 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.527 ' HA ' HG12 ' A' ' 88' ' ' VAL . 30.4 mt -63.75 114.42 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 121.185 0.517 . . . . 0.0 111.23 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.42 -42.39 6.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.757 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 5.8 m -130.05 137.35 50.18 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.1 t -116.61 116.4 52.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.279 0.562 . . . . 0.0 109.949 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.484 ' HB3' HD22 ' A' ' 32' ' ' LEU . 46.7 mmtt -109.57 91.03 3.48 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.185 174.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -83.25 87.69 6.94 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.549 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.629 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.3 pt? -135.07 116.53 14.69 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.291 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.8 t -108.5 115.23 48.74 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 171.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -82.64 108.35 15.95 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.244 1.021 . . . . 0.0 109.755 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.04 133.75 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.455 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.244 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -88.86 107.08 18.79 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 65' ' ' THR . 3.5 m -112.59 148.49 15.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.305 -176.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.75 117.87 30.51 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 75' ' ' ALA . 57.3 mt -73.92 106.55 5.68 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.41 -29.05 67.46 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -87.69 -24.47 23.86 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.765 -177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -115.53 -13.97 11.54 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.177 -173.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 68.33 15.98 9.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.508 1.523 . . . . 0.0 113.112 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -99.99 158.28 15.94 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.377 0.132 . . . . 0.0 111.088 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -125.57 140.4 52.78 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.1 160.61 42.7 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.359 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.56 100.88 7.39 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 m -128.28 163.88 31.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.434 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.629 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 17.1 pm0 -80.78 160.05 24.98 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.47 -25.11 2.38 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 127.076 2.15 . . . . 0.0 112.51 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.42 -29.1 67.69 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.718 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 65' ' ' THR . 71.7 mt-30 -100.21 -15.17 18.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.463 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.08 110.82 22.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 122.523 1.154 . . . . 0.0 111.586 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -99.19 106.13 18.26 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 113.974 -1.466 . . . . 0.0 108.001 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 139.68 -169.65 24.53 Favored Glycine 0 C--N 1.302 -1.325 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.172 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.56 134.86 11.34 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.884 2.39 . . . . 0.0 112.544 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -88.53 82.26 6.97 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.535 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 35.0 mtp180 -139.26 132.59 30.01 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.744 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.32 120.07 10.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.34 5.81 61.74 Favored Glycine 0 N--CA 1.433 -1.556 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.867 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -96.39 169.21 10.07 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.894 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.5 mm -99.02 115.74 40.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.113 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 77' ' ' ILE . 16.0 m -123.78 -173.05 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.8 135.87 35.07 Favored 'General case' 1 N--CA 1.374 -4.238 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 174.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.636 HG21 HG21 ' A' ' 37' ' ' VAL . 11.6 t -141.56 158.91 43.24 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.056 -175.156 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -80.49 126.39 31.16 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -99.09 179.7 4.53 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.135 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.7 t -66.82 -21.06 66.04 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.205 1.002 . . . . 0.0 110.242 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.18 -18.34 62.49 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.53 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.88 -13.44 60.67 Favored Glycine 0 C--O 1.241 0.584 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.976 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.9 p -91.68 165.06 13.5 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 123.136 0.574 . . . . 0.0 110.727 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -98.38 124.68 43.18 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.425 ' HB3' HD22 ' A' ' 39' ' ' LEU . 5.5 tp-100 -119.6 146.91 45.1 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -176.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -72.7 127.74 33.46 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.581 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -132.55 168.35 18.39 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 7.0 mm -115.45 149.23 17.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.561 HD11 HG13 ' A' ' 63' ' ' VAL . 3.7 mp -89.92 130.47 39.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.0 m -107.35 -16.96 14.26 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.002 0.429 . . . . 0.0 110.583 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -173.53 147.47 1.45 Allowed 'General case' 0 C--O 1.212 -0.888 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.321 0.0 OUTLIER -129.92 115.89 17.84 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.546 0.688 . . . . 0.0 110.781 171.61 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.4 m . . . . . 0 C--N 1.288 -2.108 0 CA-C-O 121.456 0.646 . . . . 0.0 109.341 -177.02 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.447 -0.616 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.517 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 78.8 m95 -100.97 129.98 46.9 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.526 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.761 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 74.6 m-85 -123.11 108.73 13.19 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 26.0 m -84.25 103.8 13.74 Favored 'General case' 0 N--CA 1.391 -3.38 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 26' ' ' ILE . 17.3 m -106.09 141.29 21.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.845 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.79 122.77 56.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.864 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -88.51 173.43 8.68 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.41 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -55.28 -33.45 63.25 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.262 1.025 . . . . 0.0 111.589 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.82 -17.84 62.75 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.987 0.422 . . . . 0.0 111.608 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.56 6.76 56.28 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -90.47 134.83 34.09 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -111.04 128.32 55.82 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-O 121.221 0.534 . . . . 0.0 109.937 177.51 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -123.45 140.97 52.47 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.517 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 32.3 m -103.66 108.82 20.26 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 120.725 0.298 . . . . 0.0 111.104 -176.051 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.8 mt -117.34 178.03 4.52 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -98.74 165.25 11.88 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -62.06 -25.38 67.65 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.13 0.49 . . . . 0.0 110.816 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.93 1.21 9.21 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.18 0.992 . . . . 0.0 112.213 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.5 t -127.61 11.24 6.74 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.9 mp -122.26 161.0 24.09 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.291 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.402 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 37.5 t . . . . . 0 N--CA 1.416 -2.156 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.6 p90 . . . . . 0 C--O 1.225 -0.197 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.42 ' O ' ' HE2' ' A' ' 86' ' ' TYR . 3.0 pp -151.43 166.47 30.96 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.464 ' HB ' ' OG1' ' A' ' 11' ' ' THR 0.539 54.2 p 115.17 71.88 0.0 OUTLIER 'General case' 0 C--O 1.193 -1.882 0 C-N-CA 130.201 3.401 . . . . 0.0 115.516 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.2 t -92.41 140.21 16.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.83 -13.57 58.68 Favored Glycine 0 C--N 1.313 -0.743 0 N-CA-C 112.238 -0.345 . . . . 0.0 112.238 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.5 ' HB ' HD12 ' A' ' 26' ' ' ILE . 3.6 m -68.8 133.18 47.97 Favored 'General case' 0 N--CA 1.411 -2.38 0 C-N-CA 123.501 0.72 . . . . 0.0 110.067 -177.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.79 110.32 22.94 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.32 173.49 13.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 122.305 0.242 . . . . 0.0 110.719 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.9 p -95.38 132.06 40.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.772 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -119.6 120.78 37.69 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 123.675 0.79 . . . . 0.0 109.802 -177.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 1.9 ttpm? -82.81 106.23 14.48 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.906 -177.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -138.41 145.87 41.5 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 62.99 25.19 14.93 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 122.762 1.268 . . . . 0.0 108.899 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.53 16.04 75.61 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.263 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.17 142.67 42.18 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 26.2 p90 -98.45 114.09 26.33 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.089 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -100.6 143.17 31.08 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -71.64 132.78 45.08 Favored 'General case' 0 N--CA 1.38 -3.963 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -146.27 164.48 32.17 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.175 -173.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -117.44 126.84 53.32 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.507 HG12 HG12 ' A' ' 88' ' ' VAL . 18.6 mt -69.58 109.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -87.49 -41.2 13.68 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.344 0.592 . . . . 0.0 110.174 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.8 m -137.95 141.53 40.55 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.775 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.6 t -118.94 108.54 24.27 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 84' ' ' SER . 31.2 mmmt -82.33 101.29 10.47 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -84.49 99.39 10.67 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.6 pt? -138.88 126.09 21.44 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.655 0.74 . . . . 0.0 111.031 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 60.1 t -104.07 124.83 58.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -84.36 104.42 14.36 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 57' ' ' LEU . 16.2 t -93.4 126.41 45.83 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.806 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.157 -177.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 81.5 tttt -95.6 110.5 22.59 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.417 HG13 HG12 ' A' ' 35' ' ' VAL . 3.6 m -117.51 154.53 19.34 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.952 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.338 -176.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tt -122.03 113.73 19.95 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 75' ' ' ALA . 43.2 mt -64.72 118.14 8.5 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.356 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.486 ' HB3' HD11 ' A' ' 76' ' ' ILE . 18.8 ptpt -75.51 -23.04 56.66 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.409 -176.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -85.46 -42.45 14.47 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.268 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -91.66 -22.84 20.05 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.383 0.611 . . . . 0.0 110.653 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 73.1 22.31 2.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.109 1.364 . . . . 0.0 113.614 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 p -104.81 150.73 24.56 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.744 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -97.96 144.48 27.45 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -142.57 142.82 32.24 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.7 tp -121.57 102.63 8.36 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.28 164.49 29.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.767 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 4.5 pm0 -84.29 168.05 16.02 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.298 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -46.39 -21.47 0.17 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 128.584 2.754 . . . . 0.0 114.306 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.26 -23.03 23.61 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 122.084 0.945 . . . . 0.0 110.446 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -91.16 -20.13 22.33 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.876 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.9 t -105.24 127.04 60.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.354 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -110.93 110.06 20.47 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.441 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 141.54 -164.04 26.73 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.506 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.07 136.18 16.1 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.824 2.349 . . . . 0.0 113.117 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.441 HD22 HG21 ' A' ' 35' ' ' VAL . 39.8 mt -93.2 83.0 4.56 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 28.5 tpt180 -140.38 131.01 25.59 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.4 t -63.64 119.66 8.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.8 3.58 55.99 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.401 -176.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . . . -97.44 168.76 10.19 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.471 0.635 . . . . 0.0 110.758 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.31 128.37 60.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.766 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.526 HG13 HD11 ' A' ' 77' ' ' ILE . 21.0 m -137.47 172.68 14.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.75 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -116.92 130.12 56.49 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.3 t -128.45 158.44 38.33 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.6 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -70.11 123.84 22.62 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.307 0.575 . . . . 0.0 111.023 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.482 HG23 ' H ' ' A' ' 69' ' ' ASP . 14.2 t -95.11 169.83 9.83 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 p -63.83 -20.52 65.86 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.683 0.793 . . . . 0.0 112.524 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.482 ' H ' HG23 ' A' ' 67' ' ' THR . 19.0 t70 -69.61 -25.73 64.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.511 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.5 -22.27 12.09 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.672 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 67' ' ' THR . 23.3 m -87.19 170.09 11.78 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.856 0.36 . . . . 0.0 110.642 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -100.69 137.27 39.31 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -133.29 155.85 48.66 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.412 ' OE1' ' HD2' ' A' ' 40' ' ' LYS . 38.1 tt0 -69.15 128.67 37.45 Favored 'General case' 0 C--O 1.253 1.237 0 O-C-N 124.227 0.954 . . . . 0.0 112.288 -177.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.519 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -139.7 171.03 14.82 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.211 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 40' ' ' LYS . 2.8 mp -120.86 141.87 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.526 HD11 HG13 ' A' ' 63' ' ' VAL . 3.3 mp -76.35 122.22 30.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -106.35 -18.93 13.85 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 86.7 tttt -163.78 150.0 11.52 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.3 OUTLIER -135.95 117.16 14.49 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.683 0.754 . . . . 0.0 110.838 171.811 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.3 m . . . . . 0 C--N 1.295 -1.781 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.072 -175.19 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 56.0 m . . . . . 0 C--O 1.237 0.398 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.49 ' CD1' HD21 ' A' ' 32' ' ' LEU . 99.4 m95 -103.37 108.31 19.49 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.583 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.42 ' HE2' ' O ' ' A' ' 7' ' ' LEU . 48.1 m-85 -90.39 111.56 22.84 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 m -87.98 105.19 17.29 Favored 'General case' 0 N--CA 1.405 -2.69 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.507 HG12 HG12 ' A' ' 26' ' ' ILE . 21.8 m -105.68 141.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.995 -176.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.88 125.72 59.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.92 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 42.9 m-85 -87.19 170.12 11.76 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -57.15 -24.62 55.56 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 123.39 0.432 . . . . 0.0 112.057 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -72.4 -16.88 61.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.267 0.556 . . . . 0.0 111.846 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.84 -1.75 63.7 Favored Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.984 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.54 150.16 20.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.97 154.4 50.52 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 118.313 0.506 . . . . 0.0 111.521 -175.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -149.14 147.6 28.65 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.271 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.37 113.17 23.7 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 123.544 0.738 . . . . 0.0 110.899 174.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.772 HD11 ' HB1' ' A' ' 15' ' ' ALA 0.315 0.2 OUTLIER -129.83 146.87 51.55 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.141 0.496 . . . . 0.0 111.858 174.229 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.1 158.84 34.05 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.171 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.05 -38.25 56.42 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.902 1.281 . . . . 0.0 110.54 -175.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.5 m -62.72 -10.12 11.59 Favored 'General case' 0 CA--C 1.576 1.944 0 C-N-CA 123.834 0.854 . . . . 0.0 112.875 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.0 m -111.49 6.38 20.15 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 120.937 -1.102 . . . . 0.0 111.448 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 mp -108.81 139.61 43.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.8 t . . . . . 0 C--N 1.298 -1.648 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -175.977 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.562 ' HA ' ' OH ' ' A' ' 86' ' ' TYR 0.29 28.4 p90 . . . . . 0 N--CA 1.463 0.189 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.51 173.67 7.95 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 173.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.4 p -127.74 169.04 14.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -172.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.6 t -72.49 134.69 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.306 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.91 -22.22 14.77 Favored Glycine 0 N--CA 1.432 -1.596 0 C-N-CA 119.816 -1.183 . . . . 0.0 113.419 175.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -93.43 167.74 11.51 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.719 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 5.0 p-10 -118.17 139.27 51.52 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 m -132.18 162.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.83 -177.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.477 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 14.4 m -101.13 127.95 47.44 Favored 'General case' 0 N--CA 1.405 -2.715 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.149 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.623 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -106.91 120.78 42.98 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 22.2 ptmt -93.59 138.07 32.22 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.721 -177.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HH ' ' HZ ' ' A' ' 90' ' ' PHE . 74.9 m-85 -134.81 130.9 36.78 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.7 mmt-85 61.21 25.2 15.22 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.85 1.26 . . . . 0.0 110.243 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.23 2.55 83.06 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.206 -0.521 . . . . 0.0 113.093 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.25 145.97 45.63 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 74.1 m-85 -95.1 132.92 39.48 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.982 -175.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.2 m -116.54 132.67 56.62 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -86.12 145.16 27.15 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.105 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.96 153.3 34.95 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 64.6 tttm -108.94 126.72 53.39 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -175.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.508 ' HA ' HG12 ' A' ' 88' ' ' VAL . 23.3 mt -65.31 114.14 2.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.936 0.398 . . . . 0.0 111.732 -175.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -97.18 -45.8 6.39 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.091 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.514 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 4.9 m -127.04 139.76 52.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -175.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.9 t -125.44 122.88 63.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 63.8 mttp -110.75 91.79 3.8 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 172.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.383 0.0 OUTLIER -85.71 86.94 7.34 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.06 177.362 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.5 pt? -116.46 105.27 12.3 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.449 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 7.3 p -91.45 127.23 43.92 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.529 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 68.4 mttm -79.78 105.11 10.83 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.314 0.578 . . . . 0.0 109.706 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.7 t -89.4 122.83 41.19 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.196 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.492 ' CB ' ' HB3' ' A' ' 79' ' ' LYS . 2.9 tmtm? -89.64 108.35 19.62 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.432 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 19.4 m -117.02 153.3 18.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 121.475 0.655 . . . . 0.0 112.472 -174.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -123.34 120.03 31.84 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.18 127.07 31.4 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.962 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.2 ptpt -64.28 -34.66 78.63 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -80.74 -58.77 2.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.001 0.429 . . . . 0.0 111.889 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.71 -4.42 55.11 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.7 p30 52.12 29.4 6.39 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.664 1.185 . . . . 0.0 112.595 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.3 145.77 24.22 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.734 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -113.27 147.73 37.0 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -158.7 164.46 35.9 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.918 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 31.5 tp -129.5 102.3 6.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.68 162.37 31.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 5.4 pm0 -90.99 166.73 12.86 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.32 -0.952 . . . . 0.0 113.538 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.408 ' HB2' HG12 ' A' ' 33' ' ' VAL . 4.9 t70 -42.68 -32.19 0.55 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 127.268 2.227 . . . . 0.0 113.253 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -68.25 -34.9 77.06 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 123.691 0.796 . . . . 0.0 111.238 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -90.39 -12.43 37.56 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.349 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 65' ' ' THR . 87.7 t -93.81 115.7 33.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.602 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -108.38 124.34 50.22 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.292 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.26 -161.38 22.07 Favored Glycine 0 C--N 1.288 -2.108 0 CA-C-O 119.445 -0.642 . . . . 0.0 111.921 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -86.13 133.23 4.02 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.848 2.365 . . . . 0.0 112.833 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.88 82.55 3.87 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 122.085 0.945 . . . . 0.0 110.808 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.583 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 25.6 mmt180 -140.02 141.11 36.34 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.371 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.05 126.34 22.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.23 3.85 67.06 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.308 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.55 157.5 15.99 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.422 HG12 ' CD1' ' A' ' 76' ' ' ILE . 56.8 mt -101.76 124.43 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 121.383 0.611 . . . . 0.0 110.796 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.489 HG13 HD11 ' A' ' 77' ' ' ILE . 14.6 m -125.64 -178.65 2.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.814 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 73' ' ' GLN . 39.0 mt-10 -126.69 120.89 30.55 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.513 HG22 HG22 ' A' ' 53' ' ' VAL . 33.9 p -116.37 150.28 37.99 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.725 -174.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -76.67 130.41 37.75 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.1 p -87.91 -177.16 5.71 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.0 t -78.35 -0.88 30.72 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 110.033 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -94.68 -14.45 24.83 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.3 5.61 60.44 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.455 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 m -97.15 160.86 14.1 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.34 119.31 37.86 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 121.05 0.452 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 46.7 mt-30 -119.19 153.54 34.76 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.083 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 44.9 mt-10 -69.09 122.75 19.38 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 124.056 0.847 . . . . 0.0 109.563 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.432 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -137.42 162.28 34.05 Favored 'General case' 0 C--N 1.267 -3.011 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.572 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.422 ' CD1' HG12 ' A' ' 62' ' ' ILE . 9.2 mm -107.48 137.52 38.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -70.89 120.02 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . 13.6 m -109.58 -15.77 14.11 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.301 -178.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HB3' ' CB ' ' A' ' 36' ' ' LYS . 15.3 tppt? -172.77 150.13 2.08 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.4 123.82 32.63 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 171.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 C--N 1.305 -1.365 0 C-N-CA 123.455 0.702 . . . . 0.0 109.954 -177.853 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.428 ' HA ' HD23 ' A' ' 32' ' ' LEU . 50.5 m . . . . . 0 C--O 1.245 0.843 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.576 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 89.5 m95 -101.37 136.73 40.74 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.836 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.562 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 56.0 m-85 -122.81 114.36 20.41 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.514 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 16.0 m -91.74 105.54 17.8 Favored 'General case' 0 N--CA 1.401 -2.908 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 26' ' ' ILE . 21.4 m -105.81 141.7 20.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.925 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.9 p -105.73 135.65 43.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.091 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.456 ' HZ ' ' HH ' ' A' ' 17' ' ' TYR . 44.8 m-85 -97.4 173.04 7.39 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.424 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -54.61 -42.64 71.4 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.674 1.189 . . . . 0.0 111.14 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.81 -14.02 62.61 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.925 0.89 . . . . 0.0 112.731 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.61 9.13 55.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.83 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -89.73 140.65 29.36 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -124.82 138.67 54.26 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -133.92 142.17 47.63 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.576 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 67.1 m -99.79 118.85 37.16 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.013 0.435 . . . . 0.0 110.872 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.623 HD11 ' HB1' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -136.54 162.97 31.63 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.361 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.418 ' O ' HD13 ' A' ' 103' ' ' LEU . 28.7 ptt180 -99.32 166.32 11.26 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.738 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.448 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 72.0 mtm180 -56.47 -25.57 51.39 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 m -57.67 -22.37 45.53 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.35 1.06 . . . . 0.0 111.798 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.5 m -118.72 12.98 13.19 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.086 0.47 . . . . 0.0 111.634 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 99' ' ' ARG . 8.6 mp -103.12 146.16 28.81 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.633 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' CYS . . . . . 0.41 ' CB ' ' HB2' ' A' ' 14' ' ' SER . 34.6 t . . . . . 0 C--N 1.296 -1.737 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.215 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.3 t80 . . . . . 0 N--CA 1.432 -1.348 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 7' ' ' LEU . 56.6 mt -127.54 -164.15 1.33 Allowed 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.037 173.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.9 p -87.86 133.48 33.89 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -160.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.6 t -92.1 135.47 27.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.181 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.85 -11.39 52.86 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.887 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.496 ' HB ' HD12 ' A' ' 26' ' ' ILE . 24.6 m -75.52 143.1 42.66 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 123.068 0.547 . . . . 0.0 110.805 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -96.8 131.68 43.28 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.05 -179.63 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.192 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 3.3 p -118.75 136.82 53.76 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.652 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -107.37 125.63 51.44 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 125.196 1.398 . . . . 0.0 107.57 -177.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HE3' ' HA ' ' A' ' 102' ' ' SER . 20.5 pttp -88.6 142.25 27.85 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.387 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -134.0 100.29 4.69 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 58.74 39.74 23.93 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.851 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.6 -11.36 70.13 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.534 -0.757 . . . . 0.0 114.243 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.78 131.05 54.34 Favored 'General case' 0 C--O 1.205 -1.238 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 1.6 m-85 -106.68 132.44 52.67 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.842 -174.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.4 m -110.76 148.97 31.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -84.18 143.24 29.77 Favored 'General case' 0 C--O 1.249 1.069 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.638 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.472 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -154.32 149.61 27.1 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.327 -177.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.449 ' O ' HG12 ' A' ' 89' ' ' VAL . 3.9 tmmm? -113.37 129.26 56.58 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.496 HD12 ' HB ' ' A' ' 11' ' ' THR . 53.8 mt -64.73 119.35 8.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 123.582 0.753 . . . . 0.0 112.657 -175.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -90.53 -49.21 6.63 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 122.154 0.978 . . . . 0.0 109.549 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.0 m -142.89 147.72 35.8 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.096 -175.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 86' ' ' TYR . 53.2 t -114.27 133.52 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 171.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 23.7 tptm -121.82 120.82 35.68 Favored 'General case' 0 C--N 1.263 -3.156 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -70.56 144.32 51.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.611 -1.236 . . . . 0.0 111.026 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.538 HD21 ' CD1' ' A' ' 85' ' ' TRP . 73.5 mt -123.7 157.7 33.3 Favored 'General case' 0 C--N 1.265 -3.106 0 CA-C-N 114.046 -1.433 . . . . 0.0 107.457 175.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.417 ' CG1' ' HB2' ' A' ' 80' ' ' LEU . 60.7 t -119.86 110.65 29.8 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.361 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 42.9 mtpt -85.53 108.1 17.78 Favored 'General case' 0 CA--C 1.471 -2.065 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.47 HG11 HG13 ' A' ' 77' ' ' ILE . 14.9 t -91.61 132.43 36.07 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.229 -173.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -90.4 111.91 23.32 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.448 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 2.7 m -112.96 144.33 20.85 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.103 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.056 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -112.76 115.36 28.4 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.9 122.03 17.81 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.385 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -66.74 -38.93 87.64 Favored 'General case' 0 N--CA 1.41 -2.464 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -170.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -86.31 -45.77 10.93 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.443 ' HB2' HE22 ' A' ' 73' ' ' GLN . 17.6 t70 -86.27 -25.12 25.68 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -173.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 74.02 19.65 2.97 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.07 150.8 24.19 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -112.06 145.02 40.46 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.546 HE22 ' H ' ' A' ' 68' ' ' SER . 12.7 tt0 -151.4 147.8 27.33 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -174.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.4 tp -123.48 101.49 7.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.0 m -134.62 165.08 32.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.406 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 5.6 pm0 -85.66 161.03 19.42 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -173.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -43.49 -28.12 0.34 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 127.294 2.238 . . . . 0.0 113.977 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.87 -37.34 87.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.941 0.401 . . . . 0.0 110.789 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.487 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 88.1 mt-30 -100.53 -6.94 24.69 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.324 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.0 t -101.14 113.27 36.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.601 0.715 . . . . 0.0 110.035 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -98.63 100.28 11.49 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.041 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.515 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 152.33 -163.34 30.22 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.424 176.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -81.7 146.38 14.94 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.763 2.975 . . . . 0.0 113.903 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.93 82.09 6.21 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 49.1 mtm105 -139.89 123.75 17.51 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.674 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.3 t -61.08 118.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.525 0.679 . . . . 0.0 109.64 176.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.76 11.05 51.63 Favored Glycine 0 C--N 1.299 -1.515 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.532 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.459 ' HB3' HD13 ' A' ' 77' ' ' ILE . . . -97.11 168.9 10.17 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.414 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.8 mm -101.45 120.33 50.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 77' ' ' ILE . 27.4 m -131.32 176.96 7.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -122.82 123.09 40.22 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 8.5 t -114.96 154.36 28.91 Favored 'General case' 0 C--N 1.265 -3.08 0 CA-C-O 121.052 0.453 . . . . 0.0 110.402 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.487 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . 59.9 ttt-85 -85.69 147.62 26.27 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.2 p -99.94 172.68 7.07 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.546 ' H ' HE22 ' A' ' 46' ' ' GLN . 25.9 t -67.84 -6.98 24.22 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.298 0.57 . . . . 0.0 109.801 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.31 -25.47 27.15 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.411 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.98 -11.77 34.45 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.357 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 m -87.48 158.12 19.03 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 122.184 0.193 . . . . 0.0 110.706 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 65' ' ' THR . 54.5 m-85 -111.13 145.26 38.92 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 122.538 0.335 . . . . 0.0 110.415 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.443 HE22 ' HB2' ' A' ' 42' ' ' ASP . 8.2 tt0 -147.69 151.72 36.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.95 126.52 30.04 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.804 0.841 . . . . 0.0 109.554 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.448 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -139.65 167.74 21.42 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.812 -176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.0 mm -115.81 144.71 22.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.547 HD11 HG13 ' A' ' 63' ' ' VAL . 3.5 mp -77.55 123.65 34.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -111.87 -16.71 13.08 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.546 0.689 . . . . 0.0 111.582 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -161.1 150.8 17.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.417 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -141.25 111.51 6.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.067 0.937 . . . . 0.0 110.654 175.39 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.464 -170.718 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.249 1.035 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.538 ' CD1' HD21 ' A' ' 32' ' ' LEU . 64.8 m95 -94.09 151.08 19.76 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 167.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.496 ' CD2' HG22 ' A' ' 29' ' ' VAL . 53.2 m-85 -127.37 116.9 21.21 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 42.5 m -86.29 105.85 16.95 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.472 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 22.3 m -109.06 141.47 24.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.345 -176.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 25' ' ' LYS . 14.8 p -107.78 134.22 50.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.436 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -80.27 169.71 17.4 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -63.33 -20.78 65.8 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.41 0.624 . . . . 0.0 109.905 175.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -68.74 -17.81 64.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.246 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.99 0.1 68.74 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.669 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.55 142.5 28.54 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 9.4 pt-20 -117.98 138.64 52.05 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.425 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 4.0 mmp_? -124.3 142.71 51.05 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.225 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.0 m -102.57 117.79 35.44 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.046 0.451 . . . . 0.0 111.222 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.652 HD11 ' HB1' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -139.54 173.4 11.58 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 123.168 0.587 . . . . 0.0 109.991 179.313 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.464 ' O ' HD13 ' A' ' 103' ' ' LEU . 3.7 ptm180 -95.38 173.8 7.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.569 0.622 . . . . 0.0 112.277 -173.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 53.8 ttp85 -58.37 -40.79 83.22 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.809 0.444 . . . . 0.0 111.535 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.13 12.06 7.06 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.496 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 10.7 p -115.75 5.65 14.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.587 1.184 . . . . 0.0 108.477 170.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 99' ' ' ARG . 9.5 mp -112.21 153.06 27.66 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.104 175.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 C--N 1.285 -2.222 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.211 179.357 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.639 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 25.6 p90 . . . . . 0 N--CA 1.438 -1.058 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.447 ' O ' ' HB ' ' A' ' 8' ' ' THR . 4.1 pp -145.23 134.87 23.38 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 9.2 t 176.41 25.3 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 O-C-N 124.13 0.894 . . . . 0.0 111.127 174.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 p -75.9 132.48 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 O-C-N 121.173 -0.954 . . . . 0.0 109.475 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.8 -3.77 74.61 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.403 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -91.76 153.45 19.6 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-O 121.093 0.473 . . . . 0.0 109.978 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -103.7 111.44 23.94 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -119.14 173.22 5.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.181 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 14.9 m -95.26 135.18 37.17 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.05 127.06 39.15 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 21.5 ptmt -88.75 117.35 27.67 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.742 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CE2' ' HB2' ' A' ' 22' ' ' CYS . 50.7 p90 -133.5 138.0 45.91 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 70.3 ttt180 64.2 25.77 13.68 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 122.326 1.06 . . . . 0.0 108.666 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.17 18.09 77.75 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.552 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.69 130.72 47.57 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.504 ' CD2' ' HB3' ' A' ' 16' ' ' LYS . 33.9 m-85 -86.53 110.38 19.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.573 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 73.1 m -126.64 155.37 42.68 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -78.82 149.4 32.57 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.246 -1.381 . . . . 0.0 111.756 -176.749 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.403 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -144.88 149.35 35.19 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.475 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -104.0 126.95 51.51 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.993 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.478 HG12 HG12 ' A' ' 88' ' ' VAL . 47.4 mt -69.27 121.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.954 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -111.56 -37.55 5.18 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.387 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 9.3 m -129.06 145.26 51.32 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.6 t -135.66 133.07 51.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 123.674 0.79 . . . . 0.0 108.955 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -122.92 111.09 16.22 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.639 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 46.1 mtm-85 -86.65 107.0 17.99 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.127 0.489 . . . . 0.0 109.891 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 32' ' ' LEU . 1.8 pt? -124.65 137.62 54.35 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 43.3 t -92.56 129.16 43.54 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.001 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.859 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -90.73 101.17 13.92 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.477 HG12 HG13 ' A' ' 37' ' ' VAL . 14.2 t -93.51 130.97 41.75 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.942 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.484 -170.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 88.0 tttt -98.36 106.26 18.52 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.52 HG21 HG21 ' A' ' 65' ' ' THR . 1.8 m -112.7 143.37 22.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 CA-C-O 121.396 0.617 . . . . 0.0 111.217 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.0 tp -111.09 120.85 43.71 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.032 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 75' ' ' ALA . 68.1 mt -73.13 116.81 14.11 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -68.47 -26.79 65.67 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.613 0.721 . . . . 0.0 110.083 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -70.83 -36.51 72.93 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.054 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -128.03 -19.6 3.95 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -171.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 78.43 15.19 1.3 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.274 1.03 . . . . 0.0 112.829 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.59 142.18 28.05 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -115.07 132.52 56.57 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.641 0.734 . . . . 0.0 109.434 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 2.2 mp0 -120.49 147.06 45.62 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.687 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.4 mt -122.29 101.65 7.64 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.72 -178.04 2.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -175.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -96.02 165.98 11.99 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.739 178.366 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.68 -4.66 3.2 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.103 0.961 . . . . 0.0 113.162 -177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.66 -30.59 41.27 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.424 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 79.7 mm-40 -82.46 -23.38 34.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.832 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.71 131.42 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.317 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -112.78 104.59 12.62 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.8 -176.0 21.16 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.597 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.23 144.39 99.49 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 123.742 2.961 . . . . 0.0 113.447 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.01 82.35 2.55 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.004 0.907 . . . . 0.0 108.587 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.537 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 79.3 ttt180 -139.86 133.61 30.51 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.627 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.01 119.36 12.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.23 4.0 53.76 Favored Glycine 0 C--N 1.292 -1.883 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.962 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.73 143.67 27.45 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.921 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.466 HG12 HG13 ' A' ' 76' ' ' ILE . 41.2 mt -93.74 124.05 46.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.489 0.662 . . . . 0.0 109.278 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.31 -172.54 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.881 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.71 148.27 44.17 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.52 HG21 HG21 ' A' ' 37' ' ' VAL . 8.8 t -145.38 152.88 40.56 Favored 'General case' 0 C--N 1.276 -2.61 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.939 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.424 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 40.3 ttm180 -78.73 126.88 31.32 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 174.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 71' ' ' SER . 7.2 t -98.87 159.05 15.23 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 174.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.2 m -66.05 -2.79 4.41 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.83 -22.43 61.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.75 -22.8 16.01 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.595 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 67' ' ' THR . 24.8 m -99.12 161.46 13.61 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.025 0.44 . . . . 0.0 111.964 -177.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 65' ' ' THR . 53.3 m-85 -93.09 124.11 36.83 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.039 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -122.26 162.08 22.1 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -78.05 128.1 33.33 Favored 'General case' 0 C--O 1.254 1.311 0 C-N-CA 123.387 0.675 . . . . 0.0 109.238 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.685 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -143.02 171.96 13.35 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.699 -175.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 62' ' ' ILE . 4.5 mp -123.59 139.01 51.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -70.63 122.13 21.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.3 m -102.22 -23.36 14.03 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.236 0.541 . . . . 0.0 110.109 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 87.0 tttt -163.7 144.41 8.8 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.404 ' HB2' ' CG1' ' A' ' 33' ' ' VAL 0.315 0.0 OUTLIER -120.9 116.06 24.41 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 167.957 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 N--CA 1.411 -2.385 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.506 -167.231 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TRP . . . . . 0.486 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 46.9 m95 -99.09 131.42 45.14 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' THR . 33.4 m-85 -122.15 120.29 33.79 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 89.2 m -98.16 109.38 22.14 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.478 HG12 HG12 ' A' ' 26' ' ' ILE . 17.5 m -106.25 148.25 10.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.314 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.24 123.72 54.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.566 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -92.33 -175.33 3.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.521 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.5 -33.0 13.4 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.382 1.873 . . . . 0.0 112.643 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -78.74 -16.95 56.58 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.414 0.626 . . . . 0.0 111.648 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.09 16.05 59.95 Favored Glycine 0 C--N 1.31 -0.865 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -172.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.79 135.83 38.18 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 114.039 -1.08 . . . . 0.0 108.855 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 87' ' ' THR . 42.9 mt-10 -102.84 128.69 49.5 Favored 'General case' 0 C--N 1.277 -2.571 0 O-C-N 124.309 1.006 . . . . 0.0 110.144 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -136.29 140.64 43.55 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 26.7 m -89.68 111.92 23.03 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 122.524 0.33 . . . . 0.0 110.643 -177.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 17.0 mt -110.54 172.41 6.88 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.111 0.482 . . . . 0.0 110.973 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -99.27 169.04 9.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.783 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -68.19 -25.11 65.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.276 0.56 . . . . 0.0 110.521 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.0 m -83.18 4.04 28.36 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.934 0.873 . . . . 0.0 109.81 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 7.4 m -120.56 -0.47 10.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.32 162.18 28.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.102 -174.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 N--CA 1.42 -1.955 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.432 174.785 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -83.03 34.98 0.47 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.928 1.347 . . . . 0.0 108.629 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.31 177.0 1.73 Allowed Pre-proline 0 C--N 1.287 -2.113 0 C-N-CA 124.875 1.27 . . . . 0.0 109.037 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 25.9 Cg_exo -66.91 88.19 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.55 1.5 . . . . 0.0 109.689 168.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.44 -15.04 19.79 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.957 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.487 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 27.7 t80 -153.91 -58.07 0.12 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.662 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 95.9 mt -123.24 -160.26 0.89 Allowed 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 167.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.48 HG23 ' OG1' ' A' ' 11' ' ' THR . 1.4 t -122.45 150.96 41.77 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 118.189 0.45 . . . . 0.0 111.908 -169.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -91.59 145.39 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.289 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.34 -13.13 67.9 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.48 ' OG1' HG23 ' A' ' 8' ' ' THR . 13.7 m -73.43 141.42 46.9 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 123.344 0.658 . . . . 0.0 111.174 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -89.71 131.29 35.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 26.8 m -135.71 175.8 9.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.595 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 104' ' ' CYS . 51.5 m -117.08 144.82 44.23 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -121.28 139.09 53.86 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -75.87 136.11 40.15 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.329 0.585 . . . . 0.0 112.077 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -133.95 105.27 6.65 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.845 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 18' ' ' ARG . 2.9 mtp180 60.37 26.59 16.14 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 173.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.85 8.1 60.83 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.856 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.45 164.32 17.33 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -102.33 135.96 43.02 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.081 0.238 . . . . 0.0 111.003 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.5 t -122.33 146.86 46.92 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -88.04 151.24 22.9 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.384 -0.927 . . . . 0.0 109.502 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -152.79 162.32 41.42 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.8 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -126.61 126.29 43.37 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.584 ' HA ' HG12 ' A' ' 88' ' ' VAL . 52.3 mt -66.64 111.53 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -87.8 -44.43 11.12 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 124.858 1.263 . . . . 0.0 110.325 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 m -139.59 145.29 38.38 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -116.95 126.54 74.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 48.7 mttp -130.55 116.31 17.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.91 108.53 21.24 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.14 158.78 43.57 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.738 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 14.5 p -125.27 137.27 58.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 93.3 mttt -90.29 101.06 13.79 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 122.128 0.966 . . . . 0.0 108.852 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.602 HG12 HG13 ' A' ' 37' ' ' VAL . 20.8 t -83.8 120.95 35.73 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.122 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -85.34 107.86 17.54 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 173.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.602 HG13 HG12 ' A' ' 35' ' ' VAL . 1.7 m -112.71 157.08 13.55 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.111 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -135.41 121.57 20.18 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.597 HD23 ' HB2' ' A' ' 75' ' ' ALA . 73.1 mt -69.8 129.33 39.26 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.005 -176.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.1 ptpt -68.71 -32.4 72.18 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.555 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 23.2 tt0 -81.1 -59.95 2.47 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 120.924 0.392 . . . . 0.0 110.956 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -85.57 -4.3 59.12 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 p30 56.38 18.62 3.53 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.729 1.612 . . . . 0.0 113.543 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.53 137.51 32.25 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-O 120.965 0.412 . . . . 0.0 111.165 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 m -101.11 148.16 25.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.443 ' OE1' HG23 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -152.44 163.39 39.62 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 123.133 0.573 . . . . 0.0 110.236 175.418 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.416 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 20.8 tp -128.99 103.13 6.83 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.53 162.52 37.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.518 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.9 pm0 -77.23 161.5 28.1 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -62.98 -6.02 3.48 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.618 1.167 . . . . 0.0 113.617 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -82.21 -27.63 32.45 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.776 0.798 . . . . 0.0 108.988 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -87.05 -22.51 25.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.223 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.8 117.21 48.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.47 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -102.8 105.37 15.77 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.315 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.492 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 149.63 -179.39 26.45 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.638 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.79 141.1 93.87 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.336 2.691 . . . . 0.0 113.562 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.27 83.45 3.87 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.542 ' HB3' ' HB2' ' A' ' 61' ' ' ALA . 47.2 ttp180 -139.13 135.9 34.56 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.57 122.79 18.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.87 12.18 59.46 Favored Glycine 0 N--CA 1.423 -2.214 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.422 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . . . -97.2 157.73 15.8 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 118.161 0.981 . . . . 0.0 110.789 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.9 mm -97.36 121.74 48.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.492 HG12 ' HA3' ' A' ' 55' ' ' GLY . 29.6 m -136.4 -173.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 122.927 0.491 . . . . 0.0 109.893 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -128.88 132.25 47.71 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.481 HG21 HG21 ' A' ' 37' ' ' VAL . 9.1 t -133.79 158.56 43.03 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-O 120.792 0.329 . . . . 0.0 110.369 -174.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.4 ttm-85 -83.94 115.37 22.27 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.309 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 71' ' ' SER . 5.1 t -81.72 167.2 19.38 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.7 p -67.7 -2.35 6.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.927 0.87 . . . . 0.0 112.219 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -85.93 -16.31 38.85 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.067 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.5 -2.94 71.23 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.454 ' O ' HG22 ' A' ' 67' ' ' THR . 8.2 m -92.26 159.97 15.37 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -109.74 115.73 30.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.594 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 7.2 tt0 -113.37 148.35 35.95 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.618 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 35.3 tt0 -70.4 125.17 26.05 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -136.91 173.92 11.18 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.358 -173.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.406 HD11 ' HB3' ' A' ' 40' ' ' LYS . 2.4 mp -123.67 139.99 48.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -75.5 126.2 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.2 m -108.33 -17.32 14.03 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.336 0.112 . . . . 0.0 110.892 177.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -166.65 151.69 7.8 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.0 mt -124.36 112.87 17.46 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 169.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.8 m -95.52 122.18 37.99 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -59.72 142.04 53.95 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.96 0.41 . . . . 0.0 111.01 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -151.88 165.07 35.68 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 99' ' ' ARG . 75.2 m -170.42 135.47 1.23 Allowed 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.494 ' CE3' ' HB ' ' A' ' 97' ' ' THR . 46.1 m95 -107.61 107.92 18.95 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.079 0.466 . . . . 0.0 110.05 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.487 ' OH ' ' HB3' ' A' ' 6' ' ' TYR . 96.5 m-85 -101.64 103.45 14.25 Favored 'General case' 0 N--CA 1.404 -2.742 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.4 m -76.16 104.09 6.52 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.597 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 25.4 m -112.28 141.14 28.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-O 121.261 0.553 . . . . 0.0 111.172 -175.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 95' ' ' GLU . 9.7 t -97.36 118.16 43.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.095 -176.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 93.0 m-85 -84.44 168.47 15.49 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -61.36 -21.27 63.89 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.12 0.486 . . . . 0.0 111.218 -175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.1 -16.87 63.18 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 123.666 0.786 . . . . 0.0 111.113 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.62 1.94 58.79 Favored Glycine 0 CA--C 1.507 -0.468 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.4 138.85 33.38 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 9.6 pt-20 -120.58 128.57 53.18 Favored 'General case' 0 C--N 1.284 -2.245 0 O-C-N 123.522 0.514 . . . . 0.0 110.413 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -131.54 149.61 52.45 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.494 ' HB ' ' CE3' ' A' ' 85' ' ' TRP . 2.3 p -79.75 112.72 17.29 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 122.383 0.273 . . . . 0.0 111.048 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.83 137.73 48.11 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.195 0.522 . . . . 0.0 110.682 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -76.34 143.62 40.66 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 175.272 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.472 ' HD2' ' O ' ' A' ' 100' ' ' ARG . 2.5 tmm_? -44.07 -33.13 1.37 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.619 1.167 . . . . 0.0 113.265 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' THR . . . . . 0.403 ' H ' ' HD2' ' A' ' 99' ' ' ARG . 24.3 m -55.31 -32.91 62.83 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.016 0.926 . . . . 0.0 112.047 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 35.1 m -82.69 -16.59 47.56 Favored 'General case' 0 N--CA 1.433 -1.306 0 O-C-N 122.063 -0.398 . . . . 0.0 110.849 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 mp -86.87 128.97 35.06 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.79 0.805 . . . . 0.0 111.462 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 20.0 m -105.16 1.19 28.08 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.902 -175.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 82.9 mt 59.46 -88.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.971 0.908 . . . . 0.0 112.602 -176.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.425 ' HB3' ' OE1' ' A' ' 108' ' ' GLU . 40.4 ttmt -88.44 -43.15 11.68 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.43 21.99 4.58 Favored Glycine 0 N--CA 1.432 -1.596 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.829 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.425 ' OE1' ' HB3' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -69.21 144.13 53.8 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 178.055 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 mtm-85 -77.56 73.33 4.13 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -172.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -129.23 14.07 6.16 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 169.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -131.15 171.21 13.55 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 112.826 -1.988 . . . . 0.0 106.124 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 73.9 -53.56 0.69 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.28 1.432 . . . . 0.0 111.357 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.37 -70.24 0.74 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.7 m -73.34 150.32 41.94 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.636 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 170.93 109.28 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 125.582 1.553 . . . . 0.0 108.336 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.6 p -108.81 11.38 26.26 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.183 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 mp 73.39 22.76 2.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.324 1.05 . . . . 0.0 110.302 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 . . . . . 0 C--N 1.307 -1.263 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 176.482 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 120.782 0.325 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.495 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 27.9 t70 -95.38 -34.93 11.95 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.476 ' OE1' ' HA ' ' A' ' 83' ' ' ALA . 30.9 mt-10 -104.56 97.69 12.9 Favored Pre-proline 0 N--CA 1.442 -0.828 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 175.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 2' ' ' ASP . 12.8 Cg_exo -73.86 -9.29 22.25 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.187 2.591 . . . . 0.0 112.046 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.49 27.57 0.5 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.815 1.246 . . . . 0.0 111.324 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.694 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 39.6 p90 -76.81 99.45 5.15 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-O 122.605 1.193 . . . . 0.0 109.948 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.8 mt -76.88 177.32 7.78 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 112.82 -1.991 . . . . 0.0 109.801 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.472 ' HA ' HG21 ' A' ' 29' ' ' VAL . 10.6 p -133.4 166.57 22.22 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.374 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.4 111.41 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.98 -26.52 2.2 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.483 ' HB ' HD12 ' A' ' 26' ' ' ILE . 5.6 m -71.64 137.93 48.27 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -116.33 125.68 52.46 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.451 ' CG2' HD22 ' A' ' 103' ' ' LEU . 33.9 m -144.79 -178.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 9.4 t -99.26 147.46 25.14 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 175.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -137.75 128.8 27.42 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 123.324 0.65 . . . . 0.0 109.396 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 51.1 mtpt -70.54 121.09 17.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.955 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.417 ' HE1' ' HB2' ' A' ' 22' ' ' CYS . 12.5 p90 -148.46 138.55 22.44 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 60.65 26.13 15.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.167 0.587 . . . . 0.0 111.46 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.55 3.05 72.1 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.184 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.06 145.53 44.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 117.652 0.726 . . . . 0.0 110.157 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 21.7 p90 -93.58 120.61 34.07 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.987 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.417 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 83.7 m -123.63 173.63 7.96 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.11 146.5 41.35 Favored 'General case' 0 C--O 1.253 1.242 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.21 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.572 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -152.12 147.78 26.86 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.416 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -116.6 128.36 55.32 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.541 ' HA ' HG12 ' A' ' 88' ' ' VAL . 28.4 mt -62.36 116.09 2.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -90.37 -40.32 12.15 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.601 1.16 . . . . 0.0 110.118 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 87.4 m -144.41 145.98 32.23 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.278 -177.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 8' ' ' THR . 96.0 t -129.29 128.75 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.086 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 84' ' ' SER . 21.8 mmmt -118.29 102.66 9.14 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.637 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -77.15 88.0 3.62 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 83' ' ' ALA . 3.5 pp -111.09 153.58 25.47 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.958 0.885 . . . . 0.0 112.437 -172.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 80' ' ' LEU . 60.3 t -115.81 120.61 65.3 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.365 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.621 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 26.4 mtpp -85.59 99.02 10.99 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.595 HG12 HG13 ' A' ' 37' ' ' VAL . 21.4 t -84.41 123.8 39.31 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.928 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 87.7 tttt -87.99 115.41 25.44 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 171.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.595 HG13 HG12 ' A' ' 35' ' ' VAL . 1.7 m -118.46 143.38 29.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.427 0.632 . . . . 0.0 112.077 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 44' ' ' THR . 1.9 tm? -107.21 116.89 32.72 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 75' ' ' ALA . 44.8 mt -74.7 124.6 27.04 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.486 ' HB3' HD11 ' A' ' 76' ' ' ILE . 22.2 pttp -72.82 -29.29 63.12 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -78.2 -38.92 42.11 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.947 0.403 . . . . 0.0 111.595 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.565 ' OD1' ' HB ' ' A' ' 44' ' ' THR . 14.6 t70 -93.33 -25.55 17.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.864 0.364 . . . . 0.0 110.948 -176.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 70.26 22.31 5.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.29 1.036 . . . . 0.0 111.24 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.565 ' HB ' ' OD1' ' A' ' 42' ' ' ASP . 5.6 t -101.23 -174.8 2.69 Favored 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 121.475 0.655 . . . . 0.0 110.049 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.7 m -136.24 139.65 42.9 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.25 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.01 156.93 44.29 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 8.1 tt -140.96 103.8 4.55 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 25.6 m -126.03 -178.49 2.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.746 -172.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -100.7 173.06 6.7 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 33' ' ' VAL . 1.4 t70 -43.03 -29.86 0.38 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 128.657 2.783 . . . . 0.0 114.754 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.35 -28.01 31.84 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.121 -174.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.494 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 8.0 mm-40 -90.19 -16.48 29.39 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.421 0.629 . . . . 0.0 109.443 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -97.57 109.37 23.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.509 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -99.03 106.88 19.17 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.525 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 139.18 -171.3 23.73 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.406 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.32 137.58 23.58 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.136 2.558 . . . . 0.0 113.495 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.5 mt -90.03 81.98 6.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.61 128.63 23.64 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.629 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 t -65.97 116.27 5.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.37 6.19 51.16 Favored Glycine 0 N--CA 1.431 -1.699 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.836 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.39 165.2 12.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.391 0.596 . . . . 0.0 111.228 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.414 HD13 HG13 ' A' ' 76' ' ' ILE . 48.5 mm -96.14 124.27 48.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 O-C-N 123.6 0.563 . . . . 0.0 109.935 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.421 ' CG1' HD11 ' A' ' 77' ' ' ILE . 19.7 m -131.61 178.08 6.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -121.6 121.4 37.32 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.442 HG21 HG21 ' A' ' 37' ' ' VAL . 8.4 t -116.37 158.04 24.1 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.816 -175.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 23.1 mtt180 -79.15 143.55 35.34 Favored 'General case' 0 CA--C 1.479 -1.782 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.037 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.1 p -97.92 175.25 6.2 Favored 'General case' 0 N--CA 1.404 -2.727 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.205 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.4 m -76.7 -17.92 58.82 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.252 0.549 . . . . 0.0 111.095 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -84.11 -21.12 31.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.819 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.8 6.01 23.37 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.368 -0.92 . . . . 0.0 114.424 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.9 p -99.3 177.27 5.25 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 117.619 0.71 . . . . 0.0 110.387 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.446 ' CE1' ' HG3' ' A' ' 66' ' ' ARG . 60.6 m-85 -108.46 137.26 46.71 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.119 0.485 . . . . 0.0 110.792 175.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -122.43 141.75 51.27 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.28 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -74.36 118.69 17.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.715 0.769 . . . . 0.0 109.004 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -134.25 166.82 21.91 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.322 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 40' ' ' LYS . 3.5 mp -112.14 141.89 26.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.421 HD11 ' CG1' ' A' ' 63' ' ' VAL . 3.2 mp -74.26 122.57 27.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -101.18 -27.3 13.3 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.264 0.554 . . . . 0.0 110.241 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 53.7 tptt -162.72 142.24 9.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.493 ' HB3' ' CG1' ' A' ' 33' ' ' VAL . 25.3 mt -119.0 127.09 53.13 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 171.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.621 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 3.7 m -106.49 104.3 13.96 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.59 120.26 13.71 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.477 ' HB3' HD12 ' A' ' 32' ' ' LEU . . . -143.73 -176.91 5.16 Favored 'General case' 0 N--CA 1.432 -1.331 0 O-C-N 123.852 0.72 . . . . 0.0 110.433 -174.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 49.2 m -163.22 135.95 5.45 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -118.59 145.25 45.54 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.694 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 55.5 m-85 -124.69 121.9 35.97 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 124.152 0.907 . . . . 0.0 109.115 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 70.5 m -95.09 107.73 19.8 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.572 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 30.3 m -109.64 147.16 14.25 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.884 -176.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.92 128.48 57.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -90.49 179.06 5.94 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.915 -172.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -52.0 -39.71 59.83 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.488 1.515 . . . . 0.0 112.809 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.39 -13.73 58.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.421 0.629 . . . . 0.0 111.866 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.49 -0.44 43.06 Favored Glycine 0 C--N 1.292 -1.884 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.84 175.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -87.56 154.08 20.9 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 6.8 pt-20 -130.42 137.61 49.92 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 120.861 0.362 . . . . 0.0 110.084 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 87' ' ' THR . 0.6 OUTLIER -139.21 158.64 43.8 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.886 -177.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.1 m -101.57 117.22 34.47 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.444 0.465 . . . . 0.0 110.235 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.405 ' CD2' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -136.2 165.1 26.52 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.078 0.951 . . . . 0.0 111.909 -177.385 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -100.12 -171.3 2.01 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.407 HH21 ' HA ' ' A' ' 6' ' ' TYR . 3.6 mpt_? -75.93 -5.34 45.69 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.654 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 p -71.27 -21.13 62.14 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.671 0.748 . . . . 0.0 110.11 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 23.3 m -106.64 -16.17 14.58 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.053 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 14' ' ' SER . 87.6 mt -93.05 127.33 38.54 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.612 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 18.8 m -96.67 90.71 5.41 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 121.168 0.508 . . . . 0.0 110.431 -176.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 61.1 mt -83.28 -26.2 30.89 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 171.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.61 -173.73 3.95 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.04 130.16 5.99 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.981 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.32 147.61 36.63 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 72.88 -56.99 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.533 1.133 . . . . 0.0 110.699 -171.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -135.88 155.65 49.99 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -124.78 125.92 44.81 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.528 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 115' ' ' GLU . . . 69.13 -51.58 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.973 1.709 . . . . 0.0 111.839 177.148 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.13 6.34 3.57 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 125.578 1.551 . . . . 0.0 110.692 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.6 m -64.18 -19.46 65.34 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.571 1.149 . . . . 0.0 109.032 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 112' ' ' ALA . 44.8 mt-10 -66.31 -23.95 66.46 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.975 175.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.7 m -99.46 97.52 8.53 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -151.0 -63.04 0.19 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 C--N 1.307 -1.265 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.218 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -1.009 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -104.19 -30.68 10.04 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -73.68 115.76 45.03 Favored Pre-proline 0 N--CA 1.423 -1.808 0 CA-C-N 112.72 -2.036 . . . . 0.0 109.766 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -95.55 -4.7 1.94 Allowed 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.085 1.857 . . . . 0.0 113.438 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.46 -19.53 23.77 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 121.895 -0.503 . . . . 0.0 110.751 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -167.96 136.97 2.49 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.472 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 22.1 mt -85.88 178.71 7.2 Favored 'General case' 0 C--N 1.277 -2.571 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.586 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 p -133.0 168.34 18.65 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.264 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.29 148.66 11.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 123.853 0.861 . . . . 0.0 111.562 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.23 -5.94 81.17 Favored Glycine 0 CA--C 1.505 -0.531 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.963 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.527 ' HB ' HD12 ' A' ' 26' ' ' ILE . 8.6 m -82.62 139.82 33.55 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 122.346 0.258 . . . . 0.0 110.532 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -104.93 111.06 23.69 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 104' ' ' CYS . 29.3 m -127.24 171.97 14.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 21.2 m -95.11 142.81 27.13 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.598 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.78 129.36 36.48 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.027 0.531 . . . . 0.0 109.701 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HD2' ' HA ' ' A' ' 111' ' ' PHE . 21.1 ptmt -94.83 120.31 34.84 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.706 0.765 . . . . 0.0 110.379 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -119.97 120.97 37.9 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? 63.78 26.28 14.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.53 0.681 . . . . 0.0 110.729 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.85 -14.88 63.09 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.501 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.31 130.17 52.15 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 16' ' ' LYS 0.289 6.6 p90 -105.0 123.96 48.7 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -177.195 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.2 t -115.06 160.61 19.42 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -90.69 148.94 22.28 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-O 121.887 0.851 . . . . 0.0 110.08 178.071 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -144.54 149.34 35.71 Favored 'General case' 0 C--N 1.259 -3.334 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.699 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.76 126.26 51.65 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.583 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.527 HD12 ' HB ' ' A' ' 11' ' ' THR . 30.8 mt -68.95 119.45 14.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 123.526 0.73 . . . . 0.0 112.268 -175.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -91.29 -53.38 4.37 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.057 0.932 . . . . 0.0 109.455 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 m -129.71 143.41 50.8 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.463 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.71 123.66 61.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.301 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -112.71 117.98 33.72 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 171.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -72.05 108.31 5.2 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 84' ' ' SER . 6.6 tt -129.34 136.76 50.43 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-O 121.544 0.688 . . . . 0.0 109.34 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.4 t -115.59 132.97 63.41 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.126 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.088 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -84.69 101.54 12.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 170.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.402 HG12 HG13 ' A' ' 37' ' ' VAL . 14.3 t -91.8 118.27 36.86 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.07 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.779 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 87.7 tttt -80.52 103.71 10.56 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 65' ' ' THR . 3.9 m -111.55 143.52 21.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-O 121.689 0.757 . . . . 0.0 111.21 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.04 117.13 32.46 Favored 'General case' 0 C--N 1.267 -3.018 0 CA-C-N 113.149 -1.841 . . . . 0.0 106.91 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.49 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 75.7 mt -73.72 108.5 6.59 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -62.25 -30.32 71.03 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -80.22 -40.15 27.69 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.241 0.543 . . . . 0.0 111.697 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -95.05 -25.38 16.49 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.242 0.544 . . . . 0.0 111.384 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 74.42 22.67 2.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.524 1.53 . . . . 0.0 113.12 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.97 150.17 24.47 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.655 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.9 m -119.03 151.87 37.44 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 1.4 pm0 -157.85 161.88 38.35 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 123.451 0.7 . . . . 0.0 109.619 177.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 mt -113.11 102.31 10.27 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.7 m -117.94 172.51 5.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.597 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -84.9 161.5 19.82 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.058 0.456 . . . . 0.0 111.963 -174.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -64.44 -20.15 65.99 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.271 1.029 . . . . 0.0 111.06 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.58 -21.92 47.88 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.783 0.801 . . . . 0.0 109.533 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 65' ' ' THR . 96.6 mt-30 -98.31 -11.57 22.41 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.656 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.88 111.51 27.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.569 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -98.4 103.75 15.72 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.227 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 140.71 178.87 17.63 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.505 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.53 140.32 80.98 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.346 2.697 . . . . 0.0 113.93 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -89.35 82.27 6.51 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.523 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 73.5 mtp180 -140.11 134.47 31.32 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.455 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.79 118.61 10.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.17 53.86 Favored Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.43 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -96.33 155.84 16.59 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.704 0.752 . . . . 0.0 110.619 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.09 116.92 39.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.426 0.632 . . . . 0.0 109.334 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.523 HG12 ' HA3' ' A' ' 55' ' ' GLY . 30.4 m -126.82 170.61 16.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.565 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -112.84 121.46 44.75 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 9.2 t -119.68 157.59 28.2 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.956 -174.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -81.93 126.17 31.61 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.759 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.7 p -90.31 -176.07 4.7 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.0 m -67.26 -26.31 66.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -79.85 -6.9 58.25 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.387 0.613 . . . . 0.0 110.56 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.27 -18.57 56.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.51 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 m -72.78 141.75 48.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 122.786 0.434 . . . . 0.0 110.081 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 65' ' ' THR . 45.0 m-85 -89.88 133.23 34.87 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.49 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 32.0 tt0 -124.09 146.52 48.55 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.05 117.31 19.24 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 122.484 1.135 . . . . 0.0 110.754 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.455 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -124.93 174.03 8.25 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 113.494 -1.685 . . . . 0.0 110.987 -174.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 10.9 mt -117.15 144.34 25.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -77.88 125.85 37.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 175.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 t -102.64 -20.89 14.25 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -173.92 153.32 2.12 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.4 OUTLIER -129.77 115.39 17.22 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.759 0.79 . . . . 0.0 111.437 172.609 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.9 m -105.53 124.42 49.52 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.083 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.88 130.56 38.72 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.422 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.7 -67.95 0.94 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.48 ' HA ' ' HB3' ' A' ' 32' ' ' LEU . 31.2 m 67.87 145.35 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 124.848 1.259 . . . . 0.0 113.37 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -95.81 134.11 39.15 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.155 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 91.0 m-85 -125.89 104.42 8.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 55.2 m -83.53 106.9 15.64 Favored 'General case' 0 N--CA 1.408 -2.553 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.453 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 26.8 m -113.45 142.74 24.92 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.758 -174.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 9.9 p -99.39 125.29 52.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.78 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 72.4 m-85 -88.24 178.72 6.53 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.183 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.44 -31.85 56.29 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.015 0.926 . . . . 0.0 111.66 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.74 -17.09 64.37 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.894 0.877 . . . . 0.0 111.503 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.46 6.9 83.13 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.335 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -97.15 136.53 37.54 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 11.6 pt-20 -107.02 126.93 52.97 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.585 0.707 . . . . 0.0 110.06 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -122.5 145.35 48.39 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 44.4 m -87.65 119.86 28.38 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -109.69 166.21 11.08 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.226 0.536 . . . . 0.0 111.389 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -94.47 152.03 18.9 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.519 -1.219 . . . . 0.0 107.968 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -50.79 -49.53 58.18 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.888 1.275 . . . . 0.0 111.759 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 p -79.83 11.16 3.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.289 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 m -120.12 5.87 10.8 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 tp -117.95 165.87 13.19 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.764 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.453 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 43.5 t -133.76 108.61 8.6 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.5 tt -169.51 -50.81 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 167.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -157.35 144.87 18.73 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 168.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.11 30.57 9.21 Favored Glycine 0 C--N 1.301 -1.375 0 N-CA-C 106.291 -2.724 . . . . 0.0 106.291 -166.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.57 -10.38 57.92 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 126.369 1.868 . . . . 0.0 112.188 -172.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 18.1 mmt180 -72.18 134.49 45.72 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.255 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 86.68 -37.74 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 125.939 1.695 . . . . 0.0 109.691 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.607 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 59.5 t80 -64.33 -63.15 1.21 Allowed 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 171.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -98.42 89.49 4.45 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 172.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 105.35 2.49 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.76 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.2 t -101.56 -35.17 9.23 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -112.37 -9.86 13.82 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 171.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.1 m 77.54 -57.36 0.5 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.157 1.383 . . . . 0.0 109.627 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.526 HD23 ' H ' ' A' ' 117' ' ' LEU . 2.3 pt? -96.32 47.31 1.08 Allowed 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.413 ' OD2' ' HD2' ' A' ' 109' ' ' ARG . 6.2 m-20 . . . . . 0 C--O 1.245 0.822 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.661 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.658 0.266 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.72 -34.98 79.04 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.974 0.892 . . . . 0.0 108.85 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.51 110.22 57.82 Favored Pre-proline 0 N--CA 1.428 -1.56 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.334 172.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -88.42 -159.9 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.346 2.031 . . . . 0.0 112.754 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.84 20.22 3.15 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.494 0.664 . . . . 0.0 110.724 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -152.75 148.94 27.83 Favored 'General case' 0 N--CA 1.394 -3.267 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 86' ' ' TYR . 89.9 mt -94.03 174.82 6.96 Favored 'General case' 0 C--N 1.263 -3.193 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.5 p -133.33 161.1 35.42 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -69.73 149.39 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-O 121.429 0.633 . . . . 0.0 111.998 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.81 -7.77 55.61 Favored Glycine 0 C--N 1.289 -2.058 0 CA-C-N 114.547 -1.206 . . . . 0.0 113.722 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 t -102.65 164.42 11.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.16 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 17.3 t70 -117.25 128.48 55.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -172.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.455 HG12 HD23 ' A' ' 105' ' ' LEU . 33.0 m -128.78 173.88 12.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.844 0.83 . . . . 0.0 110.415 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.516 ' HB2' ' SG ' ' A' ' 104' ' ' CYS . 13.6 m -110.04 121.89 46.3 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 106.851 -1.536 . . . . 0.0 106.851 172.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.42 144.44 34.34 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -96.28 126.88 41.8 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.054 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -131.62 122.25 25.7 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? 59.44 26.67 15.64 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.224 0.535 . . . . 0.0 111.894 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.52 0.2 88.17 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.721 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.88 148.88 29.96 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -96.98 133.09 42.1 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.1 m -129.05 139.85 51.86 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.92 132.81 40.5 Favored 'General case' 0 N--CA 1.398 -3.056 0 C-N-CA 123.52 0.728 . . . . 0.0 109.341 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.53 144.36 21.68 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.52 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' HB2' ' NZ ' ' A' ' 25' ' ' LYS . 4.4 ttmp? -106.12 133.37 50.93 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -176.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.548 ' HA ' HG12 ' A' ' 88' ' ' VAL . 24.1 mt -64.95 110.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.301 0.572 . . . . 0.0 111.201 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -94.72 -40.72 9.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.298 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -133.24 143.24 48.98 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.866 0.365 . . . . 0.0 110.063 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.63 124.6 69.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.864 0.866 . . . . 0.0 109.159 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -118.22 112.47 20.15 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.089 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.435 ' HE ' ' HA ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -77.18 96.57 4.54 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.045 178.308 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' A' ' 85' ' ' TRP . 8.6 mp -122.59 114.74 21.04 Favored 'General case' 0 CA--C 1.462 -2.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.022 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.8 t -115.73 114.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.38 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 94.2 mttt -79.25 106.01 10.98 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.978 0.894 . . . . 0.0 109.19 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.8 t -91.8 127.32 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.041 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.099 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 35.6 ttpt -97.36 127.73 43.57 Favored 'General case' 0 N--CA 1.406 -2.659 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.84 160.85 21.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.59 0 O-C-N 123.449 0.468 . . . . 0.0 109.764 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -122.74 118.35 27.86 Favored 'General case' 0 C--N 1.274 -2.674 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 75' ' ' ALA . 81.1 mt -68.75 121.94 17.55 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.477 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -55.9 -44.27 78.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.396 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -80.85 -61.27 2.01 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.024 -173.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.94 -22.31 39.71 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.25 -0.887 . . . . 0.0 112.878 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.26 19.21 2.91 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.329 0.652 . . . . 0.0 112.743 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.403 ' OG1' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -82.7 142.22 31.82 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.098 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 36' ' ' LYS . 3.2 m -109.18 137.44 47.06 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 3.6 tp60 -136.03 140.81 44.13 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -172.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.455 HD13 ' HB2' ' A' ' 36' ' ' LYS . 41.4 tp -119.67 101.96 8.28 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.6 t -135.71 152.9 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -175.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 5.3 pm0 -71.57 153.45 42.13 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.516 0.674 . . . . 0.0 112.523 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -55.8 -11.83 1.12 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.899 2.079 . . . . 0.0 114.234 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -77.82 -25.93 49.17 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.629 0.728 . . . . 0.0 110.557 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -106.97 -2.68 20.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.918 0.866 . . . . 0.0 110.144 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.423 HG22 HG23 ' A' ' 65' ' ' THR . 53.1 t -101.44 113.27 37.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.953 174.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -94.1 97.99 10.68 Favored 'General case' 0 C--N 1.276 -2.605 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.278 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.519 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 153.78 -166.48 31.89 Favored Glycine 0 N--CA 1.429 -1.797 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.042 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.46 146.49 19.41 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.971 2.447 . . . . 0.0 112.293 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.495 HD23 ' H ' ' A' ' 57' ' ' LEU . 1.0 OUTLIER -98.25 82.21 2.89 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.847 1.308 . . . . 0.0 108.421 176.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.548 ' O ' HG13 ' A' ' 77' ' ' ILE . 19.4 tpt180 -140.78 117.97 11.3 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.723 -2.035 . . . . 0.0 107.26 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.439 ' HA ' ' CG2' ' A' ' 77' ' ' ILE . 47.1 t -56.54 123.44 7.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-N 118.439 0.563 . . . . 0.0 109.868 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.438 ' H ' ' HB ' ' A' ' 77' ' ' ILE . . . 98.43 7.83 55.45 Favored Glycine 0 N--CA 1.42 -2.406 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.84 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.496 ' O ' HG12 ' A' ' 77' ' ' ILE . . . -96.21 153.11 17.98 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 118.743 1.271 . . . . 0.0 109.575 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.444 HG12 HD12 ' A' ' 76' ' ' ILE . 65.2 mt -94.74 119.53 42.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.519 HG12 ' HA3' ' A' ' 55' ' ' GLY . 27.5 m -133.13 169.68 21.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.0 -175.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -111.97 120.17 41.0 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.423 HG23 HG22 ' A' ' 53' ' ' VAL . 18.9 m -106.56 146.53 30.54 Favored 'General case' 0 N--CA 1.396 -3.17 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -68.68 119.61 13.36 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.55 0.691 . . . . 0.0 111.058 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.416 ' HB ' ' HG2' ' A' ' 73' ' ' GLN . 9.8 t -92.21 161.84 14.56 Favored 'General case' 0 N--CA 1.403 -2.787 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.0 m -74.32 6.54 3.54 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.713 0.768 . . . . 0.0 111.688 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.6 -8.2 57.69 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.09 -22.08 39.35 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.03 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 m -99.27 -175.62 3.07 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 120.648 0.261 . . . . 0.0 110.726 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -111.55 136.74 50.31 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.416 ' HG2' ' HB ' ' A' ' 67' ' ' THR . 22.6 pt20 -124.05 154.49 39.85 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.23 123.08 20.19 Favored 'General case' 0 C--O 1.246 0.909 0 O-C-N 124.172 0.92 . . . . 0.0 111.645 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.19 170.89 14.88 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.475 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.444 HD12 HG12 ' A' ' 62' ' ' ILE . 9.8 mm -113.96 143.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 58' ' ' ARG . 11.4 mm -66.77 125.62 24.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.5 p -107.44 -25.91 11.2 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.152 0.501 . . . . 0.0 110.914 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 21.8 tptm -163.09 165.27 24.87 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.99 129.61 18.05 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.672 0.789 . . . . 0.0 108.976 172.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.3 m -127.77 125.65 40.29 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 123.412 0.685 . . . . 0.0 109.341 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -81.05 135.33 35.82 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.39 -66.3 1.09 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.1 m 53.33 104.92 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 124.812 1.32 . . . . 0.0 113.998 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.42 ' CD1' HD22 ' A' ' 32' ' ' LEU . 95.4 m95 -88.45 120.4 29.79 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.132 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 7' ' ' LEU . 90.6 m-85 -113.35 110.52 20.47 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 27.7 m -89.33 108.21 19.5 Favored 'General case' 0 N--CA 1.389 -3.497 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 26' ' ' ILE . 17.1 m -105.92 140.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.455 -176.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.21 139.98 29.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.597 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.422 ' CE2' ' HD3' ' A' ' 96' ' ' ARG . 65.3 m-85 -91.27 172.75 8.32 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.63 -12.26 57.32 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.485 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -75.75 -17.92 59.73 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.174 175.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.18 -10.66 67.63 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.831 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -97.21 161.8 13.64 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.409 ' C ' ' HD2' ' A' ' 96' ' ' ARG . 9.3 pt-20 -137.6 157.47 46.44 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -171.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 87' ' ' THR . 4.2 mpt_? -129.54 151.4 50.19 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.895 0.878 . . . . 0.0 110.061 173.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.9 m -102.27 113.95 27.7 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 3.7 mm? -113.86 168.31 9.9 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.673 0.789 . . . . 0.0 110.946 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -89.31 157.31 18.25 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 173.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.461 ' HD3' ' C ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -50.22 -38.1 38.65 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.518 0.599 . . . . 0.0 111.513 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.5 m -79.04 -3.66 46.31 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.511 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 15.7 m -98.56 5.75 47.64 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 121.114 -0.991 . . . . 0.0 108.376 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.7 mp -112.9 145.13 41.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.467 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 110' ' ' HIS . 5.9 p -133.57 97.15 3.86 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.209 172.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 13' ' ' VAL . 2.9 tm? -73.01 -64.22 1.01 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.346 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -159.41 -49.33 0.06 Allowed 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.573 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.24 -26.64 73.19 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -68.35 -31.72 71.32 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 56.52 45.89 21.56 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.737 0.815 . . . . 0.0 112.024 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.579 ' HA ' ' SG ' ' A' ' 104' ' ' CYS . 47.6 m80 65.62 98.68 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.09 0.869 . . . . 0.0 109.506 -178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.451 ' CZ ' ' HA ' ' A' ' 102' ' ' SER . 15.1 p90 -75.09 121.19 21.66 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.51 45.46 1.83 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.98 -62.47 0.81 Allowed 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 113.785 -1.552 . . . . 0.0 114.074 -172.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 t 64.17 -64.18 0.14 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.036 1.334 . . . . 0.0 111.537 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -129.62 -179.41 5.16 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.6 m 71.27 107.66 0.06 Allowed 'General case' 0 CA--C 1.544 0.738 0 O-C-N 124.133 0.895 . . . . 0.0 110.05 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.61 103.42 15.55 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--N 1.3 -1.569 0 CA-C-O 118.27 -0.871 . . . . 0.0 109.511 172.915 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.578 0 CA-C-O 120.356 0.122 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.574 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 33.1 t70 -74.2 -37.62 63.83 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.265 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.519 ' HB3' HD23 ' A' ' 7' ' ' LEU . 8.6 pt-20 -92.69 106.54 19.07 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.407 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 2' ' ' ASP . 5.6 Cg_exo -79.21 -76.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.167 0 N-CA-C 108.343 -1.445 . . . . 0.0 108.343 172.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.83 7.77 11.03 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.533 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 40.4 p90 -159.26 149.08 18.83 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -174.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.587 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 21.3 mt -90.83 -176.0 4.54 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.656 0.597 . . . . 0.0 109.619 173.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -125.16 156.64 38.07 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.559 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -85.19 139.67 17.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -174.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.94 -5.65 83.17 Favored Glycine 0 CA--C 1.505 -0.586 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 96.8 m -79.68 133.89 36.39 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-O 121.491 0.662 . . . . 0.0 110.538 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -92.19 129.12 38.22 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 105' ' ' LEU . 32.0 m -137.1 -178.88 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.763 0.792 . . . . 0.0 112.006 -173.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 m -125.69 135.79 52.49 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 172.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -127.65 135.35 50.12 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 19.6 pttp -93.06 143.21 26.47 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 118.62 -1.232 . . . . 0.0 113.599 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -134.78 124.93 25.94 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 58.11 25.47 12.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.552 1.141 . . . . 0.0 110.935 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.33 -9.42 76.17 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.327 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.74 131.43 50.93 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 76.6 m-85 -84.78 122.38 29.04 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.753 0.311 . . . . 0.0 110.704 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -106.98 149.0 27.98 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -80.5 143.38 33.36 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.32 148.51 16.63 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -115.49 132.52 56.6 Favored 'General case' 0 C--N 1.274 -2.709 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.712 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.443 ' HA ' HG12 ' A' ' 88' ' ' VAL . 63.2 mt -61.07 107.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.891 0.853 . . . . 0.0 111.681 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.531 ' HG2' ' OE1' ' A' ' 95' ' ' GLU . 24.0 tptm -83.85 -44.99 13.74 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 125.517 1.527 . . . . 0.0 109.662 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 m -138.9 144.91 39.33 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.39 118.09 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 123.645 0.778 . . . . 0.0 109.808 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -123.14 107.85 12.19 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.015 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -77.43 105.47 8.58 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.49 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 1.3 pt? -132.88 120.5 21.59 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.219 0.533 . . . . 0.0 110.658 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.61 129.35 37.83 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 32.9 mmtp -83.02 104.93 13.6 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 37' ' ' VAL . 2.8 t -95.56 125.5 48.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.964 -174.405 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.411 ' HB2' HD13 ' A' ' 47' ' ' LEU . 49.0 tttm -99.74 105.73 17.56 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.527 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 23.8 m -117.07 156.1 18.47 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-O 121.151 0.501 . . . . 0.0 111.486 -175.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -113.93 114.67 26.53 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 173.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.8 mt -68.93 113.54 6.43 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.309 0.0 OUTLIER -72.98 -19.04 61.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -90.08 -27.02 19.95 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.909 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -112.22 -8.85 13.95 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.277 0.56 . . . . 0.0 111.804 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 p30 58.7 16.55 4.46 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.554 1.942 . . . . 0.0 113.986 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -98.6 150.72 21.45 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 121.994 -0.441 . . . . 0.0 111.107 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 m -99.56 144.77 28.26 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -142.89 142.3 31.72 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -174.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 36' ' ' LYS . 43.5 tp -125.42 102.62 7.49 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.16 178.73 4.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.921 -173.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.507 ' HG3' ' HB3' ' A' ' 51' ' ' ASP . 14.1 pt20 -92.02 154.53 18.71 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -174.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -54.63 -28.39 46.52 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 126.352 1.861 . . . . 0.0 111.515 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.507 ' HB3' ' HG3' ' A' ' 49' ' ' GLN . 8.2 t70 -63.38 -27.89 69.62 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.306 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -108.32 -9.54 15.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.985 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -100.38 127.29 53.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.233 0.54 . . . . 0.0 111.648 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -106.75 127.14 53.14 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.111 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.21 -173.28 17.93 Favored Glycine 0 C--N 1.296 -1.661 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.497 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -82.66 138.03 9.28 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.279 2.653 . . . . 0.0 112.311 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.7 83.03 4.79 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.79 0.805 . . . . 0.0 110.51 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.522 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 23.0 mtp180 -135.2 133.63 39.27 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.807 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.58 120.99 11.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.68 58.98 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.597 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.71 164.11 12.54 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 117.488 0.644 . . . . 0.0 111.46 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.6 mm -95.86 118.41 42.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.546 HG13 HD11 ' A' ' 77' ' ' ILE . 15.7 m -126.18 175.57 8.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -128.66 120.66 26.96 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.425 HG21 HG21 ' A' ' 37' ' ' VAL . 9.8 t -118.27 158.7 24.68 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.14 -174.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 67' ' ' THR . 37.2 ttm180 -76.87 139.48 40.28 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.334 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 16.9 p -94.1 171.82 8.61 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.8 m -55.7 -34.28 64.94 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -82.65 -4.92 58.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.96 3.93 56.83 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.483 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 58.1 m -87.53 168.75 12.79 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -121.7 139.85 53.05 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.111 0.482 . . . . 0.0 110.648 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -140.72 143.9 35.27 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.4 142.56 53.87 Favored 'General case' 0 C--O 1.254 1.326 0 CA-C-O 121.335 0.588 . . . . 0.0 110.946 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -148.97 164.66 33.9 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.87 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 5.4 mm -110.19 137.17 43.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.546 HD11 HG13 ' A' ' 63' ' ' VAL . 3.5 mp -72.84 122.9 26.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.5 m -103.82 -19.85 14.13 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.114 0.483 . . . . 0.0 109.825 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -168.68 156.46 7.85 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.18 139.67 37.6 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 172.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 85.6 m -124.58 127.09 46.86 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.042 0.449 . . . . 0.0 110.475 -176.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -57.12 122.9 13.49 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.869 1.267 . . . . 0.0 110.604 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 32' ' ' LEU . . . -149.81 146.85 27.38 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-O 121.502 0.667 . . . . 0.0 109.775 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m -155.62 127.69 7.59 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 171.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -97.58 116.32 29.56 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-O 121.405 0.621 . . . . 0.0 110.621 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.587 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 53.3 m-85 -104.75 102.88 12.43 Favored 'General case' 0 N--CA 1.395 -3.205 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.4 m -79.91 105.61 11.32 Favored 'General case' 0 N--CA 1.384 -3.739 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 26' ' ' ILE . 16.4 m -105.42 140.39 23.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 p -111.52 130.27 65.37 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.045 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.511 -174.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -83.24 163.97 20.41 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.76 -7.56 45.83 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.365 0.602 . . . . 0.0 110.617 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -72.18 -17.56 61.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.978 173.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.4 -9.31 60.84 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.298 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.06 144.72 25.64 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.531 ' OE1' ' HG2' ' A' ' 27' ' ' LYS . 2.8 pt-20 -124.37 131.72 53.51 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.407 0.622 . . . . 0.0 110.542 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -115.78 151.16 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 m -103.11 108.58 19.82 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 120.738 0.304 . . . . 0.0 110.22 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.27 156.21 31.69 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.705 0.402 . . . . 0.0 111.188 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -99.55 169.92 8.96 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -56.54 -23.4 39.7 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.7 m -60.31 -39.55 87.42 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.771 0.829 . . . . 0.0 111.679 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 15.0 m -90.27 -6.88 54.67 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 mp -102.5 153.9 19.62 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.511 -175.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 109' ' ' ARG . 72.8 m -135.26 18.44 3.4 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.424 ' HA ' HG12 ' A' ' 13' ' ' VAL . 44.1 tp 47.44 -90.78 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -119.02 -49.58 2.41 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.413 ' H ' ' H ' ' A' ' 108' ' ' GLU . . . 163.27 2.43 0.05 OUTLIER Glycine 0 C--N 1.303 -1.255 0 C-N-CA 119.951 -1.119 . . . . 0.0 112.855 -176.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' A' ' 108' ' ' GLU . 0.8 OUTLIER -69.43 -34.87 75.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.258 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 1.9 ptm180 -121.88 138.45 54.39 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 173.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -146.16 37.48 1.04 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.71 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 t80 62.4 81.11 0.21 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.273 1.429 . . . . 0.0 111.593 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 179.44 -60.84 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 109' ' ' ARG . 36.4 mt-10 41.61 -90.01 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 127.279 2.232 . . . . 0.0 117.014 168.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.3 t -152.14 -159.88 1.07 Allowed 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -168.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -71.12 153.78 42.26 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 124.128 0.971 . . . . 0.0 110.053 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.4 p -89.78 160.46 16.51 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.406 HD13 ' N ' ' A' ' 118' ' ' ASP . 1.9 tm? -147.96 136.94 22.01 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.406 ' N ' HD13 ' A' ' 117' ' ' LEU . 11.9 m-20 . . . . . 0 C--O 1.256 1.436 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' A' ' 105' ' ' LEU . . . . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.514 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 6.8 m-20 -86.18 1.81 49.28 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -172.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -104.5 90.85 3.57 Favored Pre-proline 0 C--O 1.248 0.984 0 CA-C-O 121.799 0.809 . . . . 0.0 109.32 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 2' ' ' ASP . 10.1 Cg_endo -88.49 67.84 2.98 Favored 'Trans proline' 0 N--CA 1.423 -2.639 0 C-N-CA 121.945 1.764 . . . . 0.0 113.203 -174.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.08 -78.14 0.58 Allowed 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 171.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.47 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 18.9 p90 -178.94 131.98 0.12 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.8 mt -93.78 -161.54 0.86 Allowed 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 p -131.54 162.43 30.3 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -171.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.3 t -64.91 142.18 17.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.902 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.92 -32.97 6.0 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.9 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.577 ' HB ' HD12 ' A' ' 26' ' ' ILE . 4.0 m -56.97 138.95 53.49 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.993 0.917 . . . . 0.0 110.564 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -111.3 113.67 26.31 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.569 HG11 HD23 ' A' ' 105' ' ' LEU . 31.9 m -135.43 -179.15 2.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 123.102 0.561 . . . . 0.0 109.708 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 m -105.24 142.81 34.36 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.475 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.81 119.3 29.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.46 ' HE2' ' HA2' ' A' ' 19' ' ' GLY . 13.7 tmtt? -88.43 107.22 18.74 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -129.12 139.53 51.92 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 59.6 25.07 13.91 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 122.018 0.913 . . . . 0.0 110.427 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . 91.0 1.73 72.5 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.28 -0.962 . . . . 0.0 114.325 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.51 145.54 43.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 117.916 0.858 . . . . 0.0 109.905 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -106.1 133.9 50.07 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.033 0.92 . . . . 0.0 113.473 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.6 t -122.75 158.25 30.57 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -72.92 147.42 45.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.67 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -149.82 142.33 24.4 Favored 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.57 -174.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 44.4 tttp -110.12 131.14 55.33 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.774 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.577 HD12 ' HB ' ' A' ' 11' ' ' THR . 36.6 mt -66.39 115.67 4.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -101.24 -36.24 8.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.136 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.2 m -140.14 144.73 36.84 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.1 t -116.57 120.18 64.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.444 ' HD3' ' N ' ' A' ' 31' ' ' ARG . 1.5 tmtp? -113.93 140.59 48.26 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.444 ' N ' ' HD3' ' A' ' 30' ' ' LYS . 10.9 mmt180 -75.03 118.36 17.9 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.728 0.775 . . . . 0.0 111.688 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.509 ' HB3' ' N ' ' A' ' 84' ' ' SER . 58.7 tp -91.51 164.5 13.77 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 127.01 2.124 . . . . 0.0 107.256 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.56 124.27 63.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 118.142 -1.423 . . . . 0.0 110.844 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 6.6 ttpm? -94.79 104.22 16.12 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 122.557 1.17 . . . . 0.0 108.202 172.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG12 HG13 ' A' ' 37' ' ' VAL . 15.8 t -87.35 128.69 39.72 Favored 'Isoleucine or valine' 1 C--N 1.244 -4.002 0 CA-C-N 112.753 -2.022 . . . . 0.0 109.648 -174.487 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 86.9 tttt -98.77 112.15 24.31 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 65' ' ' THR . 15.9 m -115.78 153.98 17.3 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 121.386 0.612 . . . . 0.0 111.727 -175.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -116.97 114.75 24.25 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.486 HD23 ' HB2' ' A' ' 75' ' ' ALA . 62.6 mt -75.35 120.52 20.93 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.3 ptpt -67.81 -30.24 69.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -79.53 -41.51 27.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.381 0.61 . . . . 0.0 111.725 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.85 -15.15 21.39 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.021 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.279 0.0 OUTLIER 63.21 16.93 9.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.664 1.985 . . . . 0.0 112.222 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -93.27 145.24 24.59 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.244 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -96.45 142.53 28.44 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -144.48 141.31 29.47 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.9 mt -100.87 113.25 26.02 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.78 179.72 2.84 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.033 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.528 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -117.08 165.09 13.78 Favored 'General case' 0 C--N 1.27 -2.866 0 O-C-N 122.29 -0.256 . . . . 0.0 110.527 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -59.35 -18.76 41.04 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.637 1.575 . . . . 0.0 111.86 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.54 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 12.0 t70 -70.93 -34.43 71.49 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.118 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 26.4 mt-30 -95.54 -10.54 29.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.181 -175.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.6 t -105.23 134.94 45.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.714 -177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.415 ' HE2' ' CD1' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -125.66 118.07 24.87 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.263 0.554 . . . . 0.0 110.73 168.79 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 142.77 -165.07 26.96 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.563 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.91 137.0 12.19 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.865 2.377 . . . . 0.0 113.131 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -96.51 81.57 3.25 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.55 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 42.5 ttp180 -140.85 139.49 34.47 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.109 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.3 t -67.21 122.39 18.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.55 4.18 59.43 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.753 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.08 161.65 14.19 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.947 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.6 mm -107.4 119.29 56.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.517 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.427 HG12 ' HA3' ' A' ' 55' ' ' GLY . 28.0 m -130.47 176.58 8.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -119.85 131.46 55.28 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.497 HG21 HG21 ' A' ' 37' ' ' VAL . 7.8 t -145.1 155.99 43.64 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.182 -171.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.622 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 46.7 ttt180 -89.26 122.42 32.5 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.483 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.8 t -84.62 168.02 15.72 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.2 p -70.78 -5.01 26.87 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.504 0.669 . . . . 0.0 111.611 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.66 -10.24 59.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.968 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.75 -22.2 36.25 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.98 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.5 p -87.75 144.81 26.43 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.622 ' CE1' ' HB2' ' A' ' 66' ' ' ARG . 87.1 m-85 -94.26 120.43 34.49 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -135.84 160.18 39.38 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 39.3 tt0 -76.72 132.04 39.1 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.486 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.03 173.68 11.25 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 122.153 -0.342 . . . . 0.0 111.591 -175.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.45 140.69 42.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.1 mp -79.52 128.44 38.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 120.658 0.266 . . . . 0.0 110.564 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 m -107.2 -17.25 14.2 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.992 0.517 . . . . 0.0 110.871 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 50.3 tptt -171.87 156.48 4.19 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.17 143.4 50.58 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.0 p -134.76 159.53 41.04 Favored 'General case' 0 N--CA 1.423 -1.812 0 C-N-CA 122.693 0.397 . . . . 0.0 110.485 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.04 115.93 7.29 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 123.983 0.913 . . . . 0.0 111.168 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . . . -118.94 -164.52 1.05 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 1.3 p -141.04 129.6 22.65 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -172.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.443 ' HB2' ' HB3' ' A' ' 30' ' ' LYS 0.265 75.6 m95 -95.98 155.87 16.57 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 168.202 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.47 ' CD1' HD13 ' A' ' 26' ' ' ILE . 89.5 m-85 -134.58 117.85 16.6 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.558 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 17.8 m -84.03 104.37 14.04 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.67 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 22.8 m -109.92 141.62 24.71 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.837 0 CA-C-O 121.502 0.668 . . . . 0.0 110.462 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 6.3 t -97.9 116.72 41.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -72.89 159.92 32.96 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -57.2 -20.78 28.93 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.772 0.796 . . . . 0.0 111.072 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.65 -16.76 64.32 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.944 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.28 -6.88 59.77 Favored Glycine 0 C--O 1.241 0.555 0 CA-C-O 121.478 0.488 . . . . 0.0 112.402 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -96.8 141.34 30.13 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.56 128.29 54.81 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -136.32 147.5 47.46 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 18.6 m -99.38 107.43 19.68 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.24 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.85 170.41 8.16 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.54 ' HD3' ' OD1' ' A' ' 51' ' ' ASP . 2.2 mpt_? -94.9 175.2 6.74 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -72.6 -3.05 22.4 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.453 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 m -71.48 -41.29 69.52 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -109.82 22.63 15.43 Favored 'General case' 0 C--O 1.252 1.217 0 CA-C-O 121.761 0.791 . . . . 0.0 110.171 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.6 tp -112.67 142.72 44.94 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.478 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 15.4 t -91.42 83.09 5.39 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 121.695 0.759 . . . . 0.0 110.249 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.569 HD23 HG11 ' A' ' 13' ' ' VAL . 92.1 mt -104.52 55.87 0.71 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.814 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 74.24 98.5 0.07 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.236 1.414 . . . . 0.0 111.021 -176.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -144.63 130.56 3.97 Favored Glycine 0 N--CA 1.422 -2.291 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.829 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 110' ' ' HIS . 0.2 OUTLIER -90.11 101.86 14.57 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.473 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 70.8 -30.54 0.21 Allowed 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 124.536 1.134 . . . . 0.0 111.484 -173.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.454 ' H ' ' C ' ' A' ' 108' ' ' GLU . 7.1 t-160 -65.9 89.02 0.11 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.771 1.628 . . . . 0.0 110.059 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 52.72 72.88 0.38 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.825 1.25 . . . . 0.0 111.724 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -163.89 -169.36 1.85 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.435 -1.257 . . . . 0.0 107.637 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -61.9 -19.36 62.6 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.299 7.7 p 60.66 83.25 0.15 Allowed 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.488 1.137 . . . . 0.0 111.949 -175.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -55.0 146.97 16.58 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 112.926 -1.943 . . . . 0.0 113.417 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.4 m -59.32 -29.12 67.4 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 124.912 1.285 . . . . 0.0 111.585 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.8 mt -85.77 9.3 16.89 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 C--O 1.243 0.741 0 CA-C-O 117.783 -1.103 . . . . 0.0 108.593 175.073 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.638 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.13 -36.31 35.46 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.2 mp0 -68.64 134.52 90.47 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 173.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 46.8 Cg_endo -71.05 84.72 0.85 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.787 1.658 . . . . 0.0 111.467 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.84 -29.71 16.59 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.673 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.756 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 45.2 p90 -127.2 127.29 44.25 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.688 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt -106.21 -175.68 2.86 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.645 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.9 p -131.33 158.53 40.43 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.33 130.59 28.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.66 38.19 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.043 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.531 ' HB ' HD12 ' A' ' 26' ' ' ILE . 33.2 m -81.23 139.47 35.47 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 120.821 0.343 . . . . 0.0 110.401 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.07 104.87 17.4 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.202 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 31.4 m -113.5 -179.28 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.836 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.532 ' OG ' ' HB3' ' A' ' 104' ' ' CYS . 3.0 p -131.14 135.34 47.38 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 21' ' ' PHE . . . -111.92 125.64 54.26 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 124.476 1.11 . . . . 0.0 109.672 -171.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -77.03 117.73 18.9 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.571 0.7 . . . . 0.0 109.569 173.451 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -129.62 135.95 49.17 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 59.4 25.65 14.41 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 121.521 0.677 . . . . 0.0 110.483 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.91 10.59 75.24 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.705 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.65 136.54 37.55 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 117.525 0.663 . . . . 0.0 110.437 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 35.4 p90 -98.79 129.59 45.21 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.47 -0.892 . . . . 0.0 113.127 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -129.26 157.39 42.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 10.5 pt-20 -74.01 146.25 43.92 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 121.779 0.8 . . . . 0.0 112.646 -174.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -151.99 145.8 25.1 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -105.07 133.75 49.32 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.673 -174.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.531 HD12 ' HB ' ' A' ' 11' ' ' THR . 39.3 mt -65.96 112.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.106 0.479 . . . . 0.0 110.451 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -94.72 -39.25 10.4 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.109 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 m -137.9 144.5 41.34 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 79.8 t -123.61 118.55 54.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 59.2 mtpt -112.22 96.95 6.32 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -83.27 108.38 16.45 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 84' ' ' SER . 2.4 pt? -144.05 107.61 4.62 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.048 0.928 . . . . 0.0 109.286 176.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 p -100.53 123.22 53.32 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.856 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 52.3 mtpt -85.12 100.64 11.85 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 122.066 0.936 . . . . 0.0 109.237 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 31.1 t -84.82 132.7 31.03 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 113.754 -1.566 . . . . 0.0 109.336 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 88.4 tttt -89.53 112.91 24.22 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.612 HG21 HG21 ' A' ' 65' ' ' THR . 3.7 m -123.64 153.46 29.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.216 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.323 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 8.2 tt -121.8 122.58 39.8 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.539 HD13 ' HB2' ' A' ' 75' ' ' ALA . 1.5 mm? -73.4 110.71 7.9 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.56 ' HB3' HD11 ' A' ' 76' ' ' ILE . 12.4 ptmm? -64.35 -20.19 65.96 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.228 0.537 . . . . 0.0 112.436 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -79.29 -46.66 17.3 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.817 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -98.51 -17.84 18.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.435 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 71.67 25.64 3.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.077 1.351 . . . . 0.0 111.593 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -104.68 155.74 18.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.751 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 38' ' ' LEU . 3.9 m -100.18 154.65 18.28 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -149.32 143.94 26.13 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 tp -128.11 102.15 6.59 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 10.6 m -137.66 168.12 21.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.297 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 29.7 pt20 -74.68 164.96 25.98 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.139 -174.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.47 ' OD1' ' HA ' ' A' ' 32' ' ' LEU . 7.7 p-10 -71.8 -5.6 35.38 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.849 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -73.85 -23.6 59.64 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 65' ' ' THR . 8.9 mm-40 -92.58 -34.45 14.02 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.048 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 89.3 t -79.24 111.05 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.198 0.999 . . . . 0.0 112.7 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -111.63 103.06 11.34 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.27 -159.85 28.16 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.1 128.59 6.5 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.901 1.734 . . . . 0.0 112.123 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 mp -88.8 81.6 6.94 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.521 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 22.6 mmt180 -139.17 135.8 34.39 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.695 -175.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.0 t -66.76 117.83 8.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.53 3.93 55.05 Favored Glycine 0 C--N 1.303 -1.261 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.532 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.19 164.01 12.67 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.027 0.414 . . . . 0.0 110.652 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.3 mm -105.48 124.89 60.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' A' ' 77' ' ' ILE . 19.7 m -130.15 -177.63 2.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 123.028 0.531 . . . . 0.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -118.25 136.1 53.88 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.066 -1.828 . . . . 0.0 106.066 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.612 HG21 HG21 ' A' ' 37' ' ' VAL . 13.4 t -140.11 156.63 46.48 Favored 'General case' 0 C--N 1.275 -2.643 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.794 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.476 ' H ' ' HB3' ' A' ' 52' ' ' GLN . 12.1 ttm180 -83.85 108.77 17.07 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 69' ' ' ASP . 12.7 t -81.09 178.86 8.15 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 m -64.23 -16.33 61.82 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.241 0.543 . . . . 0.0 112.051 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 67' ' ' THR . 20.7 t70 -73.82 -26.01 60.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.347 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.95 -18.83 36.32 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.49 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -84.32 154.69 22.77 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 65' ' ' THR . 90.1 m-85 -89.36 115.36 26.76 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.525 ' HB3' HD12 ' A' ' 39' ' ' LEU . 2.8 tp60 -108.84 143.86 37.48 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -174.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.78 136.85 38.18 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.423 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' ' 39' ' ' LEU . . . -145.23 168.1 21.22 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.428 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.56 HD11 ' HB3' ' A' ' 40' ' ' LYS . 1.6 mp -112.45 144.13 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.3 mp -83.5 129.38 37.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.2 m -110.97 -19.32 12.82 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 122.617 0.367 . . . . 0.0 110.885 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 54.0 tttm -168.52 159.54 10.32 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 4.1 mp -127.63 139.87 52.46 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 167.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.5 m -126.0 116.5 21.55 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -69.07 126.42 29.74 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.109 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.428 ' HA ' ' NE ' ' A' ' 99' ' ' ARG . . . -130.38 9.69 5.18 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.602 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.505 ' HA ' HD23 ' A' ' 32' ' ' LEU . 19.5 m -55.67 121.95 10.29 Favored 'General case' 0 N--CA 1.437 -1.102 0 O-C-N 124.406 1.066 . . . . 0.0 112.5 -176.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.516 ' HB3' ' OG1' ' A' ' 97' ' ' THR . 74.7 m95 -95.82 116.98 29.7 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.555 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.756 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 82.6 m-85 -105.56 105.06 14.92 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.2 m -84.37 104.13 14.13 Favored 'General case' 0 N--CA 1.398 -3.06 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 26' ' ' ILE . 28.5 m -108.59 142.12 22.04 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.575 -175.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.53 124.03 53.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.463 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -85.78 -179.89 6.93 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.814 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -68.57 -26.56 65.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.119 0.485 . . . . 0.0 110.78 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -68.87 -11.86 60.98 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.536 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.56 14.43 68.14 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -94.47 131.77 39.83 Favored 'General case' 0 CA--C 1.473 -2.01 0 CA-C-N 114.865 -0.668 . . . . 0.0 109.215 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.52 127.27 49.66 Favored 'General case' 0 C--N 1.268 -2.96 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.28 138.96 54.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.516 ' OG1' ' HB3' ' A' ' 85' ' ' TRP . 4.9 t -113.59 113.51 25.17 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.197 -1.401 . . . . 0.0 110.884 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.412 HD11 ' CB ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -127.49 172.2 10.91 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.618 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.428 ' NE ' ' HA ' ' A' ' 83' ' ' ALA . 95.9 mtt180 -98.7 173.21 7.01 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -60.15 -39.72 87.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.417 1.087 . . . . 0.0 111.283 -173.583 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.3 p -72.41 0.89 8.99 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.3 t -116.05 7.48 14.29 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.18 132.96 53.7 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.561 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.532 ' HB3' ' OG ' ' A' ' 14' ' ' SER . 22.3 t -96.55 -59.47 1.81 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.038 -176.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 7.1 tt 95.88 137.6 0.02 OUTLIER 'General case' 0 C--O 1.241 0.621 0 C-N-CA 127.602 2.361 . . . . 0.0 109.814 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -40.01 111.1 0.17 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.381 1.473 . . . . 0.0 113.8 -174.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.14 174.08 34.43 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . 0.29 0.0 OUTLIER -67.65 -62.32 1.47 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -132.46 81.58 1.96 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.872 -0.518 . . . . 0.0 109.888 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.494 ' HB2' ' SG ' ' A' ' 104' ' ' CYS . 21.9 m80 -91.93 -14.97 28.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.076 0.941 . . . . 0.0 109.149 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -107.29 45.49 0.99 Allowed 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.94 95.51 1.99 Allowed 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.43 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.42 104.96 6.2 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.8 m -112.93 117.1 31.15 Favored 'General case' 0 N--CA 1.402 -2.843 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.57 136.28 57.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.366 0.603 . . . . 0.0 110.795 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.5 m -116.1 93.32 4.19 Favored 'General case' 0 N--CA 1.406 -2.657 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -87.37 -42.66 12.7 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 C--N 1.303 -1.456 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.431 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.16 -23.94 64.01 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -103.03 124.61 37.9 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 119.32 -0.952 . . . . 0.0 111.127 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.01 14.73 2.33 Favored 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.936 2.424 . . . . 0.0 111.783 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.48 -57.77 9.16 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -178.38 135.99 0.16 Allowed 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 124.489 1.118 . . . . 0.0 109.736 174.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.63 -172.47 3.58 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.4 p -128.36 156.63 42.8 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -169.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.65 126.65 29.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.011 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.55 -19.31 42.44 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 121.245 -0.503 . . . . 0.0 112.275 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.459 ' HB ' HD12 ' A' ' 26' ' ' ILE . 30.9 m -69.29 137.39 52.98 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.062 0.458 . . . . 0.0 110.669 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.47 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 13.4 m-20 -86.44 131.83 34.09 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 30.8 m -137.22 -179.44 2.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-O 121.446 0.641 . . . . 0.0 111.494 -173.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.491 ' OG ' ' HB2' ' A' ' 104' ' ' CYS . 1.9 p -137.96 137.54 38.06 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' CB ' HD11 ' A' ' 98' ' ' LEU . . . -116.04 139.38 50.34 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -176.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -85.59 134.72 34.0 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.285 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -120.84 102.11 8.15 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 123.858 0.863 . . . . 0.0 109.146 172.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 58.77 28.09 16.87 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 170.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.51 9.71 57.5 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.777 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.05 151.39 41.99 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -106.73 137.12 45.36 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 119.031 0.832 . . . . 0.0 111.752 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.482 ' SG ' ' HD2' ' A' ' 90' ' ' PHE . 19.9 t -123.78 143.42 50.32 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.82 149.96 24.88 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.856 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' PHE . . . -149.89 173.2 14.04 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.312 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -137.64 132.21 32.64 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.671 ' HA ' HG12 ' A' ' 88' ' ' VAL . 60.5 mt -65.45 116.33 4.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 121.407 0.622 . . . . 0.0 111.166 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -95.03 -41.64 9.03 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.66 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.446 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 86.8 m -137.91 142.47 40.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.473 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -117.72 107.34 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.898 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 84' ' ' SER . 65.1 mttm -91.39 90.41 7.67 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 31' ' ' ARG . 18.7 ptt180 -94.77 106.07 18.04 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.548 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -139.38 144.0 37.98 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -175.284 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 11.4 p -118.41 124.34 72.98 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.718 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.267 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 97.9 mttt -82.65 100.7 10.36 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.716 0.769 . . . . 0.0 109.415 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.587 HG21 HD12 ' A' ' 57' ' ' LEU . 29.9 t -88.07 130.7 37.26 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.62 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.159 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 61.4 tttp -98.22 109.54 22.28 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.61 149.5 15.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 CA-C-O 121.38 0.609 . . . . 0.0 110.498 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.8 tp -111.69 118.11 34.73 Favored 'General case' 0 C--N 1.269 -2.934 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 75' ' ' ALA . 43.3 mt -70.35 126.12 28.73 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -72.82 -35.88 67.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.217 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.404 ' HB3' ' NE2' ' A' ' 73' ' ' GLN . 35.6 tt0 -83.24 -36.15 24.82 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -175.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -107.42 -7.86 16.48 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.762 -0.775 . . . . 0.0 113.077 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.276 10.7 p30 59.76 21.06 9.85 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 125.679 1.592 . . . . 0.0 113.46 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.483 ' OG1' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -93.14 147.53 22.8 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.866 176.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -108.28 142.95 37.8 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.08 144.03 48.38 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -175.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.2 tp -126.88 101.76 6.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -142.27 162.89 18.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 5.2 pm0 -83.38 166.6 18.28 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.02 -12.31 2.0 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 125.967 1.707 . . . . 0.0 115.441 -173.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -89.19 -10.18 48.05 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 118.789 -1.165 . . . . 0.0 110.412 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -101.99 -7.82 22.04 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.9 t -103.16 118.46 50.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.407 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -98.03 97.31 8.8 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.67 -176.5 25.53 Favored Glycine 0 N--CA 1.427 -1.901 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.061 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -65.02 142.38 74.52 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.462 2.775 . . . . 0.0 112.696 176.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.587 HD12 HG21 ' A' ' 35' ' ' VAL . 1.5 mm? -96.75 84.16 3.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 7.0 tpt180 -137.98 126.37 23.29 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.773 -172.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.26 121.38 12.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.15 59.54 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.055 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.89 155.47 16.76 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.022 0.911 . . . . 0.0 110.937 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.7 mm -93.8 119.38 41.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.62 -179.12 2.48 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 122.768 0.427 . . . . 0.0 110.018 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -121.81 121.17 36.6 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.3 m -113.99 146.96 39.42 Favored 'General case' 0 N--CA 1.4 -2.974 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -83.57 127.23 33.58 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.7 p -92.17 175.28 6.91 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.9 m -68.63 -5.38 19.72 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.344 0.593 . . . . 0.0 111.919 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.04 -14.93 52.91 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 121.63 0.728 . . . . 0.0 109.302 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.01 -16.37 61.04 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 p -93.88 157.31 16.19 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 123.19 0.596 . . . . 0.0 110.561 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -94.95 146.89 23.93 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.455 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.404 ' NE2' ' HB3' ' A' ' 41' ' ' GLN . 7.3 tp60 -137.02 143.73 42.89 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -80.45 130.62 35.27 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.24 173.88 11.06 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.6 -169.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 mp -119.57 139.19 47.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.7 mp -73.55 127.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.95 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.3 m -108.41 -23.33 11.93 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 122.463 0.305 . . . . 0.0 111.415 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 51.7 tttp -163.98 154.81 15.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.434 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . 2.9 mp -130.45 133.62 46.46 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 3.4 m -104.52 123.12 46.95 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -66.49 119.75 12.19 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 123.541 0.526 . . . . 0.0 110.944 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 32' ' ' LEU . . . -138.78 145.85 40.66 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-O 121.438 0.637 . . . . 0.0 109.601 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 4.2 p -169.69 101.8 0.32 Allowed 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 124.821 1.248 . . . . 0.0 107.992 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.496 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 92.8 m95 -97.35 121.22 39.0 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.284 -175.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -105.1 110.73 23.23 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.446 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 24.5 m -79.72 108.74 13.51 Favored 'General case' 0 N--CA 1.401 -2.876 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 26' ' ' ILE . 28.9 m -113.54 145.16 19.8 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.447 -173.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 p -100.94 121.29 51.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.482 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 11.1 m-85 -88.76 -177.49 5.54 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.07 -172.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.75 -15.04 63.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.84 -17.4 63.99 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.529 173.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.42 -4.61 71.89 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -98.41 167.19 10.99 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 13.2 pt-20 -121.57 128.64 52.21 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.411 0.624 . . . . 0.0 111.304 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.461 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -125.62 150.92 47.15 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.367 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.496 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 44.5 m -105.21 118.11 35.72 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 120.824 0.345 . . . . 0.0 110.298 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.499 HD11 ' CB ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -141.97 152.49 43.52 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.106 0.562 . . . . 0.0 109.772 178.149 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -100.48 -173.76 2.49 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.055 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -53.97 -26.9 28.14 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.123 0.969 . . . . 0.0 112.836 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -58.02 -28.77 64.75 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 122.956 0.503 . . . . 0.0 112.306 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.4 p -125.96 10.51 7.61 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.336 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 103' ' ' LEU . 9.9 tp -111.86 128.05 56.01 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.491 ' HB2' ' OG ' ' A' ' 14' ' ' SER . 24.8 m -96.96 -63.25 1.15 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 122.691 0.396 . . . . 0.0 111.955 -172.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 5.5 tt 77.52 -66.14 0.24 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.706 1.203 . . . . 0.0 110.635 177.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -94.77 -81.84 0.38 Allowed 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.199 -176.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 166.65 64.03 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.864 0 C-N-CA 118.537 -1.792 . . . . 0.0 112.452 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.68 124.1 33.21 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -74.96 36.67 0.11 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -168.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -163.0 93.72 0.81 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.567 0.699 . . . . 0.0 111.527 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 104' ' ' CYS . 20.7 m-85 -126.45 21.47 7.19 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.805 173.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 69.22 71.47 0.26 Allowed 'General case' 0 C--O 1.243 0.719 0 C-N-CA 124.339 1.056 . . . . 0.0 109.691 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -77.27 153.76 33.63 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.518 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.2 m -92.16 -175.92 4.21 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.23 85.68 5.07 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 122.086 0.946 . . . . 0.0 110.569 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.2 m -116.67 25.05 10.84 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.216 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.3 mt -73.5 -33.24 64.69 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.176 0.989 . . . . 0.0 108.678 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 C--N 1.301 -1.519 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.641 175.307 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 120.628 0.252 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -118.34 -37.87 3.27 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 0.7 OUTLIER -73.77 144.4 82.89 Favored Pre-proline 0 N--CA 1.429 -1.521 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.606 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -87.46 36.54 0.45 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.691 2.26 . . . . 0.0 111.873 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.96 -58.99 5.08 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 122.655 0.382 . . . . 0.0 110.388 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.435 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 21.4 p90 -145.51 96.99 2.91 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-O 122.247 1.022 . . . . 0.0 109.415 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.36 -167.51 1.87 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.965 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.9 p -130.55 173.73 10.59 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.46 141.84 16.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 123.936 0.895 . . . . 0.0 110.102 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.13 -11.32 58.64 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.291 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.631 ' HB ' HD12 ' A' ' 26' ' ' ILE . 6.6 m -74.49 141.27 44.93 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' OD2' ' HG3' ' A' ' 25' ' ' LYS . 10.7 t70 -107.01 117.5 34.24 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.585 HG12 HD23 ' A' ' 105' ' ' LEU . 34.7 m -121.96 -179.86 2.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 120.861 0.362 . . . . 0.0 110.182 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.0 m -111.31 124.39 52.14 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.29 139.1 46.96 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' A' ' 16' ' ' LYS 0.264 0.0 OUTLIER -94.01 129.69 40.42 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -178.631 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.484 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 34.0 m-85 -98.6 101.82 13.37 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 170.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 10.0 ptm180 49.21 35.95 8.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 173.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.26 10.4 57.2 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.932 -0.576 . . . . 0.0 114.074 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.72 124.79 34.37 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 17.0 m-85 -91.91 141.95 28.09 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.465 0.65 . . . . 0.0 112.555 -172.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.9 t -127.53 145.32 50.89 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -71.73 143.43 49.62 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.4 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.517 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -141.44 139.63 33.43 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.192 -176.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.418 ' HG3' ' OD2' ' A' ' 12' ' ' ASP . 5.1 mttp -103.12 126.6 50.37 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.487 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.631 HD12 ' HB ' ' A' ' 11' ' ' THR . 25.1 mt -70.24 116.63 11.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.788 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.15 -45.09 6.67 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 109.424 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.422 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 7.6 m -128.6 143.63 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.635 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 81.6 t -126.59 119.29 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 57.0 mtpt -104.07 97.86 7.77 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -83.38 100.74 10.88 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 32' ' ' LEU . 2.1 pt? -133.22 161.32 34.76 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.443 ' H ' ' HB2' ' A' ' 50' ' ' ASP . 10.4 p -130.02 140.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.641 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 98.9 mttt -91.74 101.57 14.18 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.743 0.783 . . . . 0.0 109.682 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.412 HG12 HG13 ' A' ' 37' ' ' VAL . 21.7 t -90.49 121.48 40.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.182 -173.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 85.3 tttt -85.5 111.63 20.17 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 174.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.451 HG21 HG21 ' A' ' 65' ' ' THR . 1.9 m -112.61 146.44 17.35 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.269 0 CA-C-O 121.124 0.488 . . . . 0.0 110.606 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -112.96 114.1 26.43 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.584 HD11 ' HB3' ' A' ' 73' ' ' GLN . 31.9 tp -75.62 111.64 11.16 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -56.05 -43.1 77.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -170.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -76.69 -50.86 12.66 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.371 0.605 . . . . 0.0 111.875 -174.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.457 ' HB3' HD23 ' A' ' 39' ' ' LEU . 30.6 t70 -84.95 -9.22 58.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.568 -171.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.289 0.0 OUTLIER 56.33 24.06 7.91 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.377 2.271 . . . . 0.0 112.955 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.91 153.57 17.69 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.979 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.6 m -120.31 142.83 48.75 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.37 163.63 33.98 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.978 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 14.8 tp -128.02 104.31 7.72 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 -177.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.2 m -121.05 174.36 5.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -173.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -87.4 162.34 17.37 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.488 0.661 . . . . 0.0 112.201 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 33' ' ' VAL . 7.7 t70 -44.16 -28.46 0.51 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 127.7 2.4 . . . . 0.0 113.275 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -85.97 -24.76 26.37 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.385 0.674 . . . . 0.0 110.886 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -84.14 -17.79 38.91 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.78 116.29 32.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.399 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -106.06 101.48 10.96 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.431 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.42 -162.85 27.92 Favored Glycine 0 C--N 1.309 -0.922 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.17 135.46 12.2 Favored 'Trans proline' 0 CA--C 1.517 -0.371 0 C-N-CA 122.477 2.118 . . . . 0.0 112.299 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.78 82.33 3.56 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 122.049 0.928 . . . . 0.0 109.619 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.555 ' HD3' ' N ' ' A' ' 59' ' ' VAL . 1.1 tmt_? -140.08 138.65 35.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.555 ' N ' ' HD3' ' A' ' 58' ' ' ARG . 22.2 t -61.74 119.1 5.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.44 6.31 57.56 Favored Glycine 0 C--N 1.298 -1.563 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.937 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.479 ' HB3' HD13 ' A' ' 77' ' ' ILE . . . -90.53 152.87 20.73 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 117.396 0.598 . . . . 0.0 110.844 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.429 HD13 HG13 ' A' ' 76' ' ' ILE . 45.1 mm -89.65 117.65 33.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.64 177.66 6.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -122.52 121.53 36.76 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 172.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.451 HG21 HG21 ' A' ' 37' ' ' VAL . 9.7 t -115.67 158.43 22.76 Favored 'General case' 0 C--N 1.263 -3.161 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -174.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 71' ' ' SER . 40.7 ttt180 -79.93 125.59 29.94 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p -84.12 177.34 8.27 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.9 m -75.78 -2.99 32.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.803 0.811 . . . . 0.0 110.296 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -93.83 -1.03 55.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.537 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.23 -5.63 83.78 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.521 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 17.7 t -94.76 172.49 8.13 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -177.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 65' ' ' THR . 93.4 m-85 -110.34 120.2 41.68 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.584 ' HB3' HD11 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -131.05 150.78 51.99 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -176.235 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.57 122.98 23.09 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.562 0.745 . . . . 0.0 111.56 -174.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.11 173.97 11.11 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.448 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.429 HG13 HD13 ' A' ' 62' ' ' ILE . 4.0 mp -122.31 141.47 42.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.479 HD13 ' HB3' ' A' ' 61' ' ' ALA . 3.2 mp -72.26 122.22 24.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.9 t -99.91 -18.28 17.19 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 86.8 tttt -175.89 143.8 0.59 Allowed 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.377 0.0 OUTLIER -117.57 118.93 33.48 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.471 0.653 . . . . 0.0 109.737 165.709 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.8 m -101.59 130.56 47.94 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.971 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.01 122.34 12.09 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 124.375 1.047 . . . . 0.0 111.035 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.85 154.05 40.87 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 m -176.64 121.62 0.14 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 126.429 1.892 . . . . 0.0 107.513 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.577 ' HB3' ' OG1' ' A' ' 97' ' ' THR . 99.6 m95 -97.37 123.02 41.06 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.435 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 73.4 m-85 -111.41 106.79 15.81 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 5.6 m -82.42 104.02 12.4 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.517 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 15.8 m -106.46 154.49 7.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.578 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 11.9 p -104.31 135.46 42.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -100.86 -177.84 3.59 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.327 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.09 -26.88 68.53 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.502 1.121 . . . . 0.0 109.993 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.43 -16.87 64.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.827 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.14 14.17 72.53 Favored Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 26.5 t70 -97.43 137.26 36.66 Favored 'General case' 0 CA--C 1.469 -2.138 0 CA-C-N 113.953 -1.123 . . . . 0.0 108.407 -174.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.77 126.55 50.98 Favored 'General case' 0 C--N 1.269 -2.894 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -141.83 139.37 32.68 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 85' ' ' TRP . 10.9 t -100.16 122.45 43.01 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.083 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 20.0 mt -110.9 166.26 11.18 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.197 0.522 . . . . 0.0 110.065 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.98 164.06 24.71 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -68.19 -17.97 64.47 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.3 p -87.78 14.32 8.88 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.958 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 14.7 m -129.5 1.95 5.04 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.5 mt -128.33 147.31 50.61 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.486 -174.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 50.2 t -154.54 126.33 7.61 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.585 HD23 HG12 ' A' ' 13' ' ' VAL . 55.2 mt -49.62 -69.65 0.11 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.855 0.462 . . . . 0.0 109.812 173.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.545 ' HA ' ' HE3' ' A' ' 106' ' ' LYS . 1.3 tpmt? -167.27 103.72 0.53 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -170.77 71.24 0.12 Allowed Glycine 0 C--N 1.301 -1.391 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 112' ' ' ALA . 11.9 pt-20 -73.82 -24.19 59.76 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -175.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -88.93 66.14 7.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.1 t60 170.81 -59.08 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.0 92.81 4.31 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.155 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 108' ' ' GLU . . . -133.93 -48.18 0.8 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 64.88 22.6 12.52 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.542 1.163 . . . . 0.0 111.122 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 t -141.03 117.33 10.7 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 101.88 -3.378 . . . . 0.0 101.88 174.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 68.14 96.65 0.06 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -167.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.1 m -89.09 1.49 55.51 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -170.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -78.84 -87.38 0.06 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.814 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 C--N 1.315 -0.897 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.315 -177.068 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.516 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -97.15 -30.58 12.94 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.097 0.475 . . . . 0.0 110.054 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -107.28 107.01 59.84 Favored Pre-proline 0 C--N 1.308 -1.201 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.9 -11.6 12.38 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.441 2.094 . . . . 0.0 114.308 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.91 -21.85 20.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.505 0.669 . . . . 0.0 110.234 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.63 105.6 2.44 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.956 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.474 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 65.9 mt -70.39 -174.71 0.88 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.869 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 p -132.67 161.07 34.9 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.1 t -72.85 130.04 35.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.856 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.19 -24.11 4.52 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.25 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.6 m -83.49 142.26 31.05 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -99.91 135.2 41.7 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 18.0 m -127.01 161.21 34.45 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 C-N-CA 123.237 0.615 . . . . 0.0 109.516 -176.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.7 m -100.61 123.97 45.56 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -107.05 121.24 44.09 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -175.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 83.5 tttt -81.0 105.99 12.65 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 22' ' ' CYS . 38.6 p90 -121.51 125.15 46.12 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.528 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 62.36 31.84 17.15 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.356 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.2 -3.25 69.4 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 115.16 0.824 . . . . 0.0 115.16 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.73 134.74 37.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.338 1.069 . . . . 0.0 110.27 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.588 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 28.5 p90 -91.17 136.17 33.28 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.558 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 52.3 t -134.96 163.03 30.78 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.95 147.11 45.54 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.59 0.709 . . . . 0.0 110.445 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.475 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -148.39 148.32 30.21 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.95 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -112.71 130.62 55.99 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.325 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.571 ' HA ' HG12 ' A' ' 88' ' ' VAL . 53.2 mt -64.84 119.58 9.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.952 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -95.85 -51.24 4.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.3 m -132.63 145.03 50.76 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.257 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG22 ' HD1' ' A' ' 86' ' ' TYR . 95.2 t -122.23 112.92 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.302 176.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' SER . 65.1 tttp -98.79 97.92 9.09 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -79.61 94.28 5.64 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.655 HD12 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pp -103.14 160.63 14.48 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-O 121.127 0.489 . . . . 0.0 111.263 -178.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.21 118.36 57.24 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.064 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 47' ' ' LEU . 50.4 mtpt -82.85 100.96 10.66 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 21.4 t -84.98 117.34 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.841 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.953 -177.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.425 ' HA ' ' HG ' ' A' ' 47' ' ' LEU . 88.5 tttt -80.95 107.46 13.78 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' THR . 12.5 m -112.91 149.41 15.38 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.003 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.43 -175.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -117.53 111.13 18.82 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.524 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 44.9 mt -71.78 123.93 23.7 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 17.9 ptpt -62.54 -31.01 71.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -175.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HB3' ' CD ' ' A' ' 73' ' ' GLN . 44.9 tt0 -84.95 -55.72 3.93 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 120.897 0.379 . . . . 0.0 111.474 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.6 -22.51 40.57 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 64.45 32.29 11.97 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.47 0.708 . . . . 0.0 112.279 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -92.87 138.86 31.12 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.8 m -107.35 130.11 54.83 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -157.19 156.75 33.15 Favored 'General case' 0 C--N 1.257 -3.434 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.2 mp -113.14 107.88 16.54 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.9 m -114.31 166.87 7.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.89 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -86.73 165.38 16.11 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.639 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.22 -34.19 56.0 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 124.584 1.154 . . . . 0.0 110.532 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.12 -22.8 66.99 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.686 -173.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -99.79 -17.83 17.49 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.6 t -98.09 116.63 41.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.944 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -110.33 114.47 27.95 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.797 176.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.408 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 143.97 -163.83 27.63 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.02 137.36 7.39 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.072 2.515 . . . . 0.0 113.647 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.9 mt -95.03 82.89 3.84 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.345 0.593 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.429 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 3.0 mpt_? -139.14 142.25 38.04 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.75 112.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.26 6.99 35.81 Favored Glycine 0 N--CA 1.428 -1.883 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.435 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.19 152.95 18.31 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.4 mt -99.95 125.92 53.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-O 121.111 0.482 . . . . 0.0 110.124 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.408 HG12 ' HA3' ' A' ' 55' ' ' GLY . 25.2 m -127.96 -177.78 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 8.7 pt-20 -131.51 128.22 38.9 Favored 'General case' 0 C--N 1.272 -2.761 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.445 HG21 HG21 ' A' ' 37' ' ' VAL . 9.9 t -139.96 159.64 41.72 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.99 -168.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -69.02 132.01 45.97 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.66 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.405 HG23 ' HB3' ' A' ' 69' ' ' ASP . 7.0 t -90.51 168.97 11.43 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 m -64.53 -23.0 67.13 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.088 0.555 . . . . 0.0 110.987 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.405 ' HB3' HG23 ' A' ' 67' ' ' THR . 7.7 t70 -64.97 -26.19 68.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.288 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.8 -22.08 17.27 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.226 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.6 t -77.43 179.59 6.38 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.803 0.841 . . . . 0.0 109.504 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -119.19 136.13 54.34 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.524 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 30.3 tt0 -137.86 153.25 49.6 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 39.0 tt0 -77.44 137.19 38.54 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.426 0.631 . . . . 0.0 109.407 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.13 173.61 11.31 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.87 -174.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.19 143.74 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.43 HG13 ' CG1' ' A' ' 35' ' ' VAL . 3.0 mp -75.55 122.82 30.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 t -99.77 -24.2 14.76 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -169.22 151.55 4.68 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.3 OUTLIER -127.77 118.54 23.94 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 118.327 0.512 . . . . 0.0 110.805 172.291 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.0 m -107.86 125.42 51.44 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.967 -174.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.9 121.49 24.22 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.06 0.457 . . . . 0.0 109.839 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB3' HD12 ' A' ' 32' ' ' LEU . . . -128.36 -179.44 5.03 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.5 p -164.41 145.9 8.4 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.14 0.495 . . . . 0.0 111.618 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.493 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 87.0 m95 -114.93 146.31 41.3 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 27.7 m-85 -124.03 112.96 17.79 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 m -85.49 107.15 17.31 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 26' ' ' ILE . 24.8 m -110.56 146.76 15.32 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.617 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.995 -175.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.11 121.5 53.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.427 ' HD1' ' HB2' ' A' ' 24' ' ' ALA . 29.4 m-85 -74.0 173.58 9.8 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.469 -176.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.98 -27.13 61.1 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.469 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.51 -15.92 61.79 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.241 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.89 75.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.807 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -98.26 141.87 30.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -104.42 127.93 52.2 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.41 ' HB2' ' CE2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -135.25 148.36 49.55 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.217 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.493 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 30.5 m -104.75 113.2 26.63 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.356 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.708 HD11 ' HB1' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -140.54 159.6 41.84 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.064 0.546 . . . . 0.0 111.404 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.547 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 95.8 mtt180 -99.75 -172.47 2.25 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 122.964 0.506 . . . . 0.0 109.987 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.447 ' HA ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.08 -14.57 63.07 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.107 0.48 . . . . 0.0 110.964 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 p -73.27 -2.39 21.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 123.872 0.869 . . . . 0.0 111.234 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 19.6 m -137.6 9.53 2.89 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 99' ' ' ARG . 93.1 mt -113.69 137.69 51.26 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.853 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.2 t -110.28 6.59 22.62 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.172 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 93.7 mt 62.95 -74.43 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.154 0 C-N-CA 124.083 0.953 . . . . 0.0 110.644 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -138.6 132.75 31.52 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.49 45.31 1.8 Allowed Glycine 0 C--N 1.315 -0.589 0 O-C-N 123.445 0.465 . . . . 0.0 114.176 -175.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 109' ' ' ARG . 37.9 mm-40 -82.55 -33.55 28.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 175.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.438 ' HD2' ' HB2' ' A' ' 108' ' ' GLU . 5.7 mpt_? -108.53 170.96 7.69 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.72 168.03 15.59 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -85.85 -69.15 0.68 Allowed 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.59 22.22 1.99 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.735 0.779 . . . . 0.0 109.423 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -82.89 177.6 8.57 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.573 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.8 t -77.46 164.19 25.67 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -73.84 -64.82 0.92 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.0 m -146.34 131.42 18.3 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -76.88 132.48 39.14 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 118.696 -0.668 . . . . 0.0 110.14 -177.531 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.592 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -71.94 -33.55 68.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.59 106.1 58.03 Favored Pre-proline 0 N--CA 1.434 -1.24 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HB2' ' O ' ' A' ' 6' ' ' TYR . 2.9 Cg_exo -78.96 169.84 18.79 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.68 1.587 . . . . 0.0 110.278 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.32 -4.04 56.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.903 0.858 . . . . 0.0 109.525 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.409 ' O ' ' HB2' ' A' ' 4' ' ' PRO . 47.9 p90 -170.78 125.74 0.7 Allowed 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.533 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 6.6 mp -78.26 177.38 8.46 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.231 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 p -131.47 152.26 50.85 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.62 112.5 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.209 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.02 -24.15 3.45 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.519 ' HB ' HD12 ' A' ' 26' ' ' ILE . 46.2 m -73.68 138.67 44.87 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 120.937 0.398 . . . . 0.0 109.93 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -99.02 126.11 44.66 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -136.37 -178.91 2.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 123.249 0.62 . . . . 0.0 109.906 -176.078 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 15.8 m -130.9 146.06 52.21 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 174.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -119.38 127.4 53.1 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -80.87 138.98 36.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.168 0.509 . . . . 0.0 111.582 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -125.69 101.17 6.75 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 123.871 0.868 . . . . 0.0 108.898 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 57.63 37.8 27.55 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.385 0.428 . . . . 0.0 111.174 171.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.27 -6.06 71.68 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.982 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.56 123.8 43.76 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . 0.258 0.5 OUTLIER -107.62 131.28 54.54 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -174.102 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.7 m -105.14 144.51 31.83 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.386 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -85.9 147.55 26.2 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.884 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' A' ' 90' ' ' PHE . . . -150.55 154.58 37.83 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.528 0.68 . . . . 0.0 110.672 -175.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.99 126.81 55.19 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.521 ' HA ' HG12 ' A' ' 88' ' ' VAL . 32.0 mt -61.26 120.44 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -95.4 -43.9 7.79 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.927 0.891 . . . . 0.0 110.08 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.1 m -140.63 146.12 37.52 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.8 t -121.6 114.99 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 O-C-N 123.603 0.564 . . . . 0.0 109.599 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -112.35 91.13 3.54 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.748 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -84.09 87.48 7.15 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 32' ' ' LEU . 2.4 pt? -91.15 111.23 22.62 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.564 -174.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.5 t -86.62 114.63 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.026 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 14.5 mmmm -80.05 99.49 7.71 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.8 t -89.38 129.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.071 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.286 -175.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 83.8 tttt -91.52 103.13 15.78 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 3.7 m -112.6 155.19 13.91 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.786 -177.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 44' ' ' THR . 8.4 tt -129.14 118.31 22.24 Favored 'General case' 0 N--CA 1.387 -3.625 0 CA-C-N 114.445 -1.252 . . . . 0.0 107.638 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.711 HD23 ' HB2' ' A' ' 75' ' ' ALA . 86.5 mt -68.79 122.56 18.84 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.95 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 21.7 ptmt -59.94 -29.54 68.47 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 120.903 0.382 . . . . 0.0 111.415 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -59.84 -55.17 37.51 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 124.606 1.162 . . . . 0.0 113.226 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -120.23 -0.08 10.54 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.442 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 68.35 23.73 7.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.167 0.987 . . . . 0.0 112.334 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -78.73 133.3 37.16 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 m -106.37 148.18 28.37 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 13.0 pt20 -159.72 160.07 33.62 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 123.031 0.207 . . . . 0.0 110.444 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 mt -115.8 102.17 9.47 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 27.9 m -124.28 170.13 14.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -177.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 11.3 pt20 -91.26 170.78 9.71 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.956 -175.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -55.96 -21.08 18.93 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.097 1.759 . . . . 0.0 112.151 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -78.18 -35.39 48.78 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.307 0.575 . . . . 0.0 109.942 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -82.67 -15.14 53.12 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.081 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -109.17 135.17 48.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.162 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.451 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -125.46 139.75 53.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 172.64 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.94 -166.93 13.94 Favored Glycine 0 C--N 1.31 -0.867 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.57 132.34 10.97 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.77 2.313 . . . . 0.0 113.086 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.38 81.99 6.53 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.553 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 8.8 tpt180 -140.49 135.95 32.46 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.64 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.24 116.28 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.74 2.77 46.43 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.238 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.35 149.44 22.1 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.417 HG12 HG13 ' A' ' 76' ' ' ILE . 49.5 mt -95.69 117.12 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-O 121.882 0.849 . . . . 0.0 109.961 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 16.4 m -116.84 -172.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.273 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 72' ' ' PHE . 40.3 mt-10 -129.01 124.27 34.53 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.0 m -112.66 144.95 41.3 Favored 'General case' 0 N--CA 1.385 -3.678 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -74.05 117.69 16.14 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -89.06 -179.8 5.99 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 t -60.35 -29.86 69.17 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.218 1.007 . . . . 0.0 111.478 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.98 -25.18 67.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.845 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.56 -20.58 22.64 Favored Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.625 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 p -89.4 164.03 15.04 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.069 0.548 . . . . 0.0 111.052 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.479 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 96.5 m-85 -96.05 123.31 39.61 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 122.854 0.461 . . . . 0.0 110.746 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -114.03 150.86 33.3 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.508 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 45.6 mt-10 -68.87 127.73 34.15 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.113 0.959 . . . . 0.0 111.897 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.711 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -135.84 161.49 35.47 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.85 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.417 HG13 HG12 ' A' ' 62' ' ' ILE . 3.8 mp -116.89 139.49 43.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -73.05 124.45 30.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.9 176.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 t -103.9 -26.24 12.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.434 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 23.0 tptm -167.57 159.21 11.92 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mp -135.01 141.43 46.19 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 5.0 m -127.58 104.13 7.71 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.93 133.23 41.81 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.713 0.768 . . . . 0.0 111.591 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.19 160.25 39.55 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 177.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -153.89 121.83 6.02 Favored 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 119.896 -0.721 . . . . 0.0 112.465 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.424 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 57.7 m95 -95.55 122.05 37.88 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.973 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 92.8 m-85 -109.35 109.43 20.31 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 73.0 m -85.17 104.18 14.81 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 174.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 26' ' ' ILE . 28.5 m -106.2 141.46 21.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.868 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.27 130.41 59.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.022 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' A' ' 24' ' ' ALA . 52.0 m-85 -91.02 167.89 12.06 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -62.18 -19.66 63.33 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.007 0.908 . . . . 0.0 109.993 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.16 -11.36 48.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.462 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.83 -3.78 82.23 Favored Glycine 0 C--O 1.227 -0.336 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -96.18 142.48 28.3 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -117.14 143.9 45.31 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 123.442 0.464 . . . . 0.0 110.994 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -129.61 143.8 50.99 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 85.7 m -104.16 113.05 26.33 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.0 OUTLIER -133.91 163.47 29.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.571 0.748 . . . . 0.0 112.109 -177.314 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -99.36 177.56 5.15 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 122.821 0.448 . . . . 0.0 110.013 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -60.9 -33.03 72.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.064 0.546 . . . . 0.0 111.428 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.4 m -57.86 -32.29 67.51 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.736 0.814 . . . . 0.0 110.921 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 17.5 m -91.45 7.4 41.39 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.019 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.7 170.48 7.91 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.554 0.692 . . . . 0.0 111.321 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 14' ' ' SER . 53.1 t -116.66 -19.62 9.9 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.664 176.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? 62.7 -81.39 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -173.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -148.69 138.9 22.4 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 125.557 1.543 . . . . 0.0 107.209 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 166.45 157.52 10.35 Favored Glycine 0 N--CA 1.423 -2.183 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.78 -54.45 2.49 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -118.6 -8.93 10.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.317 0.58 . . . . 0.0 110.259 174.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.518 ' CB ' ' HB3' ' A' ' 113' ' ' GLU . 33.2 m170 -102.26 153.25 20.15 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.45 ' CD2' ' HE3' ' A' ' 16' ' ' LYS . 48.7 m-85 -114.42 109.36 18.19 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 58.88 74.79 0.42 Allowed 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 124.374 1.07 . . . . 0.0 108.685 -174.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.518 ' HB3' ' CB ' ' A' ' 110' ' ' HIS . 15.0 pt-20 -83.14 120.12 25.37 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -171.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.4 m -114.63 136.53 52.94 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 70.21 178.93 0.25 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.554 0.693 . . . . 0.0 111.568 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.2 p -108.63 24.97 12.29 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.24 117.13 20.75 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.708 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.6 t70 . . . . . 0 C--N 1.31 -1.151 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.407 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.659 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -73.28 -55.14 6.82 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -75.2 122.82 88.18 Favored Pre-proline 0 N--CA 1.434 -1.227 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.093 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -91.14 38.32 0.31 Allowed 'Trans proline' 0 N--CA 1.438 -1.766 0 C-N-CA 122.728 2.285 . . . . 0.0 108.939 172.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.55 86.24 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.704 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.442 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 45.7 p90 -153.22 150.1 28.66 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 173.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.438 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 90.2 mt -99.84 175.25 5.85 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.9 p -122.17 161.21 23.58 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 120.614 0.245 . . . . 0.0 111.521 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.57 144.05 14.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.521 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.35 -25.97 26.32 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.653 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.573 ' HB ' HD12 ' A' ' 26' ' ' ILE . 9.7 m -58.08 133.23 55.37 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 122.162 0.982 . . . . 0.0 112.65 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.423 ' HB3' ' NZ ' ' A' ' 106' ' ' LYS . 18.8 t70 -84.49 113.91 21.55 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 113.491 -1.686 . . . . 0.0 109.165 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.48 -177.81 2.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.455 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -140.11 147.22 39.91 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 173.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -126.16 131.69 51.98 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 22.3 pttp -82.51 133.35 35.2 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -112.92 112.58 24.16 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 170.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 61.09 31.06 19.76 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.343 0.592 . . . . 0.0 110.897 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.33 -8.45 72.2 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.885 -0.598 . . . . 0.0 114.192 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.76 124.44 50.59 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.537 0.669 . . . . 0.0 110.126 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 73.7 m-85 -87.99 120.47 29.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -99.82 143.74 29.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 172.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -75.25 148.52 39.37 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.719 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -154.34 143.66 21.34 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.449 0.643 . . . . 0.0 111.227 -175.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -115.73 128.29 55.76 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.573 HD12 ' HB ' ' A' ' 11' ' ' THR . 17.6 mt -68.94 113.82 5.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 120.716 0.293 . . . . 0.0 111.554 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HD2' ' HB ' ' A' ' 89' ' ' VAL . 43.9 mtpt -88.17 -38.09 15.61 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.8 m -146.54 141.95 27.53 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.067 -175.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.37 131.06 73.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -123.79 97.82 5.54 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -78.63 86.52 4.61 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.684 1.23 . . . . 0.0 108.607 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.475 ' HA ' ' OD1' ' A' ' 50' ' ' ASP . 2.0 pt? -107.29 134.47 50.32 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.967 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.3 t -108.06 132.27 56.22 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.971 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -86.04 101.53 13.01 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.49 HG12 HG13 ' A' ' 37' ' ' VAL . 11.5 t -91.78 127.08 44.3 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.836 -174.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -92.21 106.94 18.84 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.498 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 2.4 m -114.79 143.71 23.93 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.96 0 CA-C-O 121.682 0.753 . . . . 0.0 112.022 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.1 tp -111.14 118.02 34.83 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.7 -1.591 . . . . 0.0 107.639 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.736 HD23 ' HB2' ' A' ' 75' ' ' ALA . 94.3 mt -67.29 111.37 3.96 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.428 ' HB3' HD11 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -73.25 -15.2 61.43 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.183 0.516 . . . . 0.0 112.214 -176.734 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -88.76 -51.09 5.84 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.654 0.74 . . . . 0.0 109.621 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 15.0 t70 -89.98 -33.12 16.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.445 -170.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 35.3 m-80 83.64 15.89 0.28 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.101 1.36 . . . . 0.0 113.402 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -95.85 150.52 20.33 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.91 0.386 . . . . 0.0 110.368 174.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -118.03 144.83 45.25 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.4 157.84 42.94 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.939 176.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.3 tp -119.36 101.48 7.99 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.1 m -126.62 175.53 8.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.48 -170.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -88.57 154.23 20.5 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.426 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 32' ' ' LEU . 6.4 p-10 -65.88 -12.98 58.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.061 0.944 . . . . 0.0 111.507 -176.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.83 -28.89 63.88 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.664 0.745 . . . . 0.0 109.68 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.43 ' OE1' ' HD3' ' A' ' 66' ' ' ARG . 43.3 mt-30 -108.24 8.94 28.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.979 0.895 . . . . 0.0 109.333 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 78.4 t -108.03 110.06 30.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.909 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.27 103.58 16.22 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.024 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.531 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 145.1 -171.36 26.25 Favored Glycine 0 C--N 1.292 -1.88 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.339 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.81 144.28 19.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.209 2.606 . . . . 0.0 113.194 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -93.22 82.36 4.52 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.49 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 50.6 mtm180 -139.5 131.89 28.49 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.771 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.53 117.95 7.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.06 10.75 51.3 Favored Glycine 0 C--N 1.299 -1.477 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.291 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB3' HD13 ' A' ' 77' ' ' ILE . . . -97.85 162.46 13.24 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 117.313 0.556 . . . . 0.0 110.062 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.8 mm -102.54 121.53 53.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 123.559 0.537 . . . . 0.0 110.113 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.531 HG12 ' HA3' ' A' ' 55' ' ' GLY . 29.9 m -130.12 177.2 7.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.039 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -126.22 121.68 33.42 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.9 t -122.21 154.67 37.19 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-O 121.151 0.5 . . . . 0.0 111.067 -173.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HD3' ' OE1' ' A' ' 52' ' ' GLN . 34.8 ttt180 -85.4 132.09 34.29 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.375 177.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.9 p -95.74 163.78 13.04 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.5 m -57.18 -23.68 49.23 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -80.5 -3.22 49.22 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 122.247 -0.283 . . . . 0.0 111.599 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.416 ' HA2' ' HE ' ' A' ' 66' ' ' ARG . . . 95.52 6.19 59.85 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.9 175.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.2 m -97.59 152.37 19.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 122.504 -0.409 . . . . 0.0 110.48 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' THR . 56.0 m-85 -110.88 121.01 44.28 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -128.39 153.7 46.78 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.918 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -73.52 127.88 33.95 Favored 'General case' 0 C--O 1.256 1.444 0 CA-C-O 121.716 0.769 . . . . 0.0 110.788 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.736 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -135.73 168.54 19.09 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.177 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.428 HD11 ' HB3' ' A' ' 40' ' ' LYS . 8.9 mt -118.01 145.84 23.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.2 mp -77.98 115.13 19.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 175.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 m -97.93 -17.31 19.3 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.025 0.44 . . . . 0.0 109.964 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -169.64 156.73 6.67 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.65 111.18 6.8 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.799 0.809 . . . . 0.0 110.588 173.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.7 m -103.28 108.06 19.13 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.787 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -67.67 135.09 52.26 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -175.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.4 -63.84 1.39 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m 58.49 112.3 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -102.7 141.6 35.25 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.498 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.442 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 50.6 m-85 -127.79 106.83 9.39 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 54.1 m -87.15 107.81 18.63 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.675 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 23.6 m -112.06 147.56 15.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.096 -173.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.501 ' HB ' ' HD2' ' A' ' 27' ' ' LYS . 7.2 p -105.09 125.08 60.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 123.687 0.795 . . . . 0.0 109.887 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.457 ' CE1' HG23 ' A' ' 88' ' ' VAL . 57.3 m-85 -92.79 -176.86 4.36 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.295 -174.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -47.61 -41.59 22.2 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.145 1.378 . . . . 0.0 112.664 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.08 -16.72 60.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.099 0.476 . . . . 0.0 111.893 -175.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.58 5.74 56.67 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.643 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -96.61 149.92 21.24 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.5 144.12 43.86 Favored 'General case' 0 C--O 1.253 1.287 0 CA-C-O 121.474 0.655 . . . . 0.0 112.177 -175.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.4 mmt-85 -136.77 151.27 49.0 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.466 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 63.5 m -99.42 109.27 21.87 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.278 0.561 . . . . 0.0 109.604 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.25 159.4 17.95 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.691 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -99.66 161.72 13.44 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 ttp85 -61.57 -23.43 65.98 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 m -59.01 -25.08 63.35 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 123.556 0.742 . . . . 0.0 110.93 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 18.9 m -96.12 -8.24 33.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.041 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.9 mp -92.9 133.18 36.36 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -171.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 108' ' ' GLU . 19.3 t -77.1 -48.89 16.57 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 112.682 -2.053 . . . . 0.0 110.324 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 66.03 94.37 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.135 -172.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.423 ' NZ ' ' HB3' ' A' ' 12' ' ' ASP . 74.3 mmtt 63.24 -95.38 0.05 OUTLIER 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.995 -177.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -138.97 67.38 0.51 Allowed Glycine 0 CA--C 1.485 -1.784 0 C-N-CA 120.018 -1.086 . . . . 0.0 112.527 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 104' ' ' CYS . 21.6 tp10 -127.64 56.43 1.57 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -75.94 82.37 2.83 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -130.49 9.41 5.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.254 -168.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -126.93 109.7 12.23 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.306 -174.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.59 -38.73 62.55 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 170.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -137.61 -62.04 0.62 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 170.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.8 t -179.76 147.73 0.3 Allowed 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 102.162 -3.273 . . . . 0.0 102.162 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -80.12 153.15 28.88 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.254 -0.979 . . . . 0.0 110.634 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.8 m -61.75 109.31 1.19 Allowed 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.1 135.15 51.38 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.069 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 . . . . . 0 C--N 1.31 -1.141 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.062 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.193 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -90.71 6.97 41.87 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.438 0.637 . . . . 0.0 110.9 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -104.16 167.83 9.45 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.565 ' HA ' HG11 ' A' ' 29' ' ' VAL . 52.4 Cg_exo -55.76 99.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.817 2.345 . . . . 0.0 111.704 177.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.67 -70.23 0.8 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.961 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.418 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -74.98 -63.92 1.16 Allowed 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 119.221 -0.992 . . . . 0.0 108.898 -176.309 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.522 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 48.6 mt -113.18 -174.92 2.55 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -131.17 160.63 34.23 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -171.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.81 144.84 10.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.49 -6.52 74.72 Favored Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.87 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.417 ' HB ' HD12 ' A' ' 26' ' ' ILE . 25.3 m -89.16 133.5 34.38 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 120.965 0.412 . . . . 0.0 110.19 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -96.88 124.18 40.79 Favored 'General case' 0 CA--C 1.476 -1.875 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.909 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 103' ' ' LEU . 28.2 m -131.59 160.77 42.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.216 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 104' ' ' CYS . 2.4 p -94.58 117.02 29.47 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.447 ' HB1' HD12 ' A' ' 98' ' ' LEU . . . -106.52 127.68 53.5 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.393 -173.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 22.6 pttp -84.76 134.9 34.31 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.453 0.644 . . . . 0.0 112.378 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.413 ' CZ ' ' HZ ' ' A' ' 90' ' ' PHE . 80.7 m-85 -132.98 136.23 45.95 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HD3' ' C ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 44.68 26.28 0.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.021 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.05 2.9 64.07 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.159 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.15 146.35 51.1 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 16' ' ' LYS 0.262 18.4 p90 -106.76 146.41 30.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 116.026 1.862 . . . . 0.0 116.026 -175.467 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 66.1 m -131.53 138.23 48.84 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.745 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 38.2 tt0 -79.92 137.35 36.86 Favored 'General case' 0 N--CA 1.406 -2.649 0 CA-C-O 121.225 0.536 . . . . 0.0 111.297 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -147.41 158.75 44.1 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.048 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -106.55 129.26 54.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.417 HD12 ' HB ' ' A' ' 11' ' ' THR . 72.1 mt -61.0 117.27 2.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.196 0.522 . . . . 0.0 110.311 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -99.41 -40.5 7.85 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.983 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 m -127.48 141.83 51.56 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 4' ' ' PRO . 55.8 t -120.17 124.06 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 C-N-CA 123.179 0.592 . . . . 0.0 109.601 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 46.9 tptt -131.4 90.62 2.89 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -83.54 92.43 7.62 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 117.766 -1.574 . . . . 0.0 108.211 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 32' ' ' LEU . 2.3 pt? -112.33 133.97 54.13 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.278 0.561 . . . . 0.0 109.869 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.6 123.09 48.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -96.03 109.91 22.23 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 122.086 0.946 . . . . 0.0 109.225 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 37' ' ' VAL . 21.4 t -94.59 129.26 45.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.323 -172.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 83.6 tttt -88.89 105.84 18.01 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 175.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.537 HG21 HG21 ' A' ' 65' ' ' THR . 0.4 OUTLIER -113.27 143.93 21.95 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.279 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.359 -177.821 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.6 115.01 29.29 Favored 'General case' 0 C--N 1.266 -3.033 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.541 HD12 ' H ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -66.67 118.19 9.89 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -64.53 -43.43 94.02 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 124.65 1.18 . . . . 0.0 113.221 -171.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -88.42 -25.34 22.71 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.571 0.701 . . . . 0.0 111.717 -174.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.541 ' H ' HD12 ' A' ' 39' ' ' LEU . 18.0 t70 -98.55 -32.01 11.67 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.565 -175.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 76.78 21.87 1.18 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -102.45 149.61 24.21 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.449 HG21 ' HE2' ' A' ' 36' ' ' LYS . 2.2 m -101.58 138.68 38.26 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -140.16 144.86 36.87 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 36' ' ' LYS . 10.5 tt -124.92 106.67 10.16 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.9 m -135.68 -178.02 2.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.517 -173.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.415 ' HB2' ' HG2' ' A' ' 52' ' ' GLN . 12.3 mt-30 -64.51 150.59 46.4 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -18.29 63.25 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.275 171.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.48 -24.41 61.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.5 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 65' ' ' THR . 12.3 mm100 -85.54 -19.05 31.71 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.2 t -91.5 112.12 24.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.659 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -97.82 98.47 9.86 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.98 175.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.442 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 150.51 179.11 26.01 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.596 178.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.53 141.26 72.84 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.242 2.628 . . . . 0.0 114.246 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.96 81.97 7.36 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 97.5 mtt180 -139.57 132.98 30.11 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.02 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.9 t -72.69 110.31 5.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.543 0.687 . . . . 0.0 109.538 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.97 7.19 27.44 Favored Glycine 0 N--CA 1.428 -1.858 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.364 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.54 147.46 22.97 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.258 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.404 HD13 HG13 ' A' ' 76' ' ' ILE . 48.3 mm -86.07 117.0 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.442 HG12 ' HA3' ' A' ' 55' ' ' GLY . 27.5 m -130.76 179.04 4.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.23 125.92 48.31 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 HG21 ' A' ' 37' ' ' VAL . 14.5 t -132.48 159.6 38.88 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -76.05 114.19 14.41 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 123.606 0.566 . . . . 0.0 109.853 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 71' ' ' SER . 9.2 t -85.38 -179.47 6.96 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.357 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.7 m -64.9 -18.1 64.9 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.629 1.172 . . . . 0.0 111.038 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.419 ' H ' HG23 ' A' ' 67' ' ' THR . 31.4 t70 -75.69 -21.51 57.53 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.448 177.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.61 -14.85 58.99 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 67' ' ' THR . 21.3 m -90.88 159.77 16.06 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -92.33 127.42 37.81 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -140.24 165.21 28.0 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.41 ' O ' HD13 ' A' ' 39' ' ' LEU . 60.3 mt-10 -67.72 136.47 54.33 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.108 0.48 . . . . 0.0 111.91 -175.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -145.62 164.6 31.2 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.8 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.404 HG13 HD13 ' A' ' 62' ' ' ILE . 3.1 mp -118.51 136.45 55.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -69.71 122.61 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 m -111.14 -17.03 13.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.212 0.529 . . . . 0.0 110.68 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 65.1 tttp -166.55 143.43 4.91 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.78 111.58 13.81 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.502 0.668 . . . . 0.0 109.705 172.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 m -103.56 127.8 50.91 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.93 -169.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -78.75 103.22 8.55 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.53 -64.06 1.22 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.419 ' HB3' ' CE2' ' A' ' 86' ' ' TYR . 44.0 m 55.81 100.86 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.408 -1.269 . . . . 0.0 113.302 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.536 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 34.5 m95 -90.04 132.62 35.29 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.799 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.588 ' HB2' HD11 ' A' ' 103' ' ' LEU . 97.6 m-85 -128.27 112.61 14.67 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.811 176.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 26.1 m -84.81 107.15 16.83 Favored 'General case' 0 N--CA 1.39 -3.469 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 17.2 m -105.63 141.43 20.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.195 -177.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.6 p -114.71 132.13 64.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.837 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 76.3 m-85 -86.35 166.32 15.69 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.24 -21.86 66.74 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 122.283 1.039 . . . . 0.0 108.588 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.67 -17.27 64.48 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.06 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.93 0.16 64.1 Favored Glycine 0 C--O 1.218 -0.876 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.156 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -96.88 144.61 26.66 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 9.3 pt-20 -122.27 133.31 54.69 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.066 0.46 . . . . 0.0 111.088 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -129.67 142.18 50.78 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 31.9 m -105.47 111.41 24.11 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 120.769 0.318 . . . . 0.0 110.913 -177.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.447 HD12 ' HB1' ' A' ' 15' ' ' ALA . 25.2 mt -118.62 171.77 7.96 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -79.73 162.54 25.11 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -56.73 -30.12 63.21 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.153 0.502 . . . . 0.0 111.209 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.6 p -81.27 -2.66 49.78 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.809 0.844 . . . . 0.0 112.641 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 27.6 t -107.34 9.66 29.85 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.588 HD11 ' HB2' ' A' ' 86' ' ' TYR . 70.8 mt -122.27 134.92 54.67 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.455 ' HB3' ' OG ' ' A' ' 14' ' ' SER . 47.0 t -86.52 82.6 7.87 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -175.158 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 67.8 mt -115.52 -64.87 1.25 Allowed 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 162.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -118.59 138.52 52.51 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.325 176.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.18 -41.77 0.45 Allowed Glycine 0 C--N 1.307 -1.051 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 67.39 -68.91 0.14 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.374 1.47 . . . . 0.0 114.713 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -53.66 96.62 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -173.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 73.51 19.72 3.3 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.991 1.317 . . . . 0.0 111.101 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.434 ' HB3' ' SG ' ' A' ' 104' ' ' CYS . 95.5 m-85 -106.16 164.38 12.04 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 71.49 -71.73 0.13 Allowed 'General case' 0 C--O 1.245 0.824 0 C-N-CA 125.774 1.63 . . . . 0.0 113.729 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -137.21 153.99 50.29 Favored 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -173.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.4 t 74.01 102.48 0.07 Allowed 'General case' 0 C--O 1.242 0.686 0 C-N-CA 125.004 1.322 . . . . 0.0 110.627 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 116' ' ' THR . 0.2 OUTLIER -158.12 -179.54 8.22 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 -178.578 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.454 ' H ' ' CD ' ' A' ' 115' ' ' GLU . 10.7 m -56.94 113.81 1.84 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.68 -57.26 6.68 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 120.671 0.272 . . . . 0.0 110.485 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 t70 . . . . . 0 C--N 1.312 -1.035 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.965 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.943 0.401 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -90.87 34.54 0.91 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -51.7 114.14 4.86 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 125.937 1.695 . . . . 0.0 112.733 -173.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -77.26 29.35 0.42 Allowed 'Trans proline' 0 N--CA 1.48 0.705 0 C-N-CA 123.683 2.922 . . . . 0.0 112.908 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.27 -33.49 67.5 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.642 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 24.2 p90 -122.8 113.26 18.92 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 87.6 mt -98.44 178.41 5.04 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.738 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.7 p -134.96 169.27 17.66 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.379 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.55 123.26 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 122.776 0.43 . . . . 0.0 111.09 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.0 -33.64 3.01 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.447 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.576 ' HB ' HD12 ' A' ' 26' ' ' ILE . 15.6 m -59.41 138.64 57.59 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.176 0.59 . . . . 0.0 111.332 -177.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -100.53 116.83 33.39 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.5 m -128.43 -179.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 122.871 0.468 . . . . 0.0 110.396 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 16.8 m -129.23 137.28 51.01 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' CB ' HD11 ' A' ' 98' ' ' LEU . . . -107.27 128.53 54.52 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -85.72 120.14 26.82 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.85 0.357 . . . . 0.0 111.144 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -125.88 109.91 13.04 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 61.86 26.77 16.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.831 0.852 . . . . 0.0 112.557 172.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.73 25.39 42.12 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.921 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.52 144.78 50.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -106.61 120.1 41.06 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.353 0.597 . . . . 0.0 111.117 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.6 m -103.73 128.73 51.07 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 175.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 9.8 pt-20 -93.62 140.49 29.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.536 -1.265 . . . . 0.0 109.852 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -145.47 156.68 43.89 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.319 -173.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -112.23 132.78 54.73 Favored 'General case' 0 C--N 1.266 -3.029 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.576 HD12 ' HB ' ' A' ' 11' ' ' THR . 43.2 mt -59.41 121.81 7.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.332 0.587 . . . . 0.0 111.907 -176.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -97.31 -46.97 5.9 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 125.025 1.33 . . . . 0.0 109.994 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 16.6 m -137.77 146.18 43.3 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.412 HG12 ' HG3' ' A' ' 31' ' ' ARG . 98.4 t -131.16 124.24 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -110.75 91.07 3.52 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HG3' HG12 ' A' ' 29' ' ' VAL . 48.3 mtm180 -78.15 122.9 26.25 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 121.974 0.892 . . . . 0.0 111.515 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 84' ' ' SER . 1.8 pt? -155.7 148.56 24.26 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -135.75 143.91 35.09 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.943 0 N-CA-C 104.34 -2.467 . . . . 0.0 104.34 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 94.4 mttt -85.05 101.19 12.21 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.533 HG12 HG13 ' A' ' 37' ' ' VAL . 21.3 t -86.46 118.06 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.52 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.575 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -86.55 107.82 18.3 Favored 'General case' 0 N--CA 1.413 -2.286 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.567 HG21 HG21 ' A' ' 65' ' ' THR . 3.7 m -112.53 150.03 14.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -126.53 117.66 23.31 Favored 'General case' 0 C--N 1.26 -3.314 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 75' ' ' ALA . 20.3 mt -72.84 106.35 4.75 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -57.96 -34.36 69.85 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -72.13 -45.8 59.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 120.98 0.419 . . . . 0.0 111.403 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -91.84 -8.89 45.3 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.492 -175.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.2 p30 53.31 28.09 6.92 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.302 1.841 . . . . 0.0 113.256 -177.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -104.14 145.74 29.75 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.309 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 m -97.7 154.44 17.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -151.15 138.93 19.8 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 mt -109.72 102.33 11.15 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.414 HG21 ' OG1' ' A' ' 65' ' ' THR . 27.4 m -116.58 176.43 2.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.29 -174.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -101.56 160.02 14.8 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.4 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -47.18 -33.9 5.75 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 126.405 1.882 . . . . 0.0 112.237 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -72.81 -28.76 62.76 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.29 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 85.6 mt-30 -92.72 -3.53 54.67 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.548 0.69 . . . . 0.0 109.222 -178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.8 t -99.37 123.02 51.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.076 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -103.46 95.83 6.34 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.424 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 148.59 -173.82 28.44 Favored Glycine 0 N--CA 1.423 -2.231 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.132 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.416 ' HD2' HG12 ' A' ' 63' ' ' VAL . 11.6 Cg_exo -73.14 148.35 44.24 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.096 2.531 . . . . 0.0 113.478 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.27 82.64 6.5 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 62.8 ttt180 -139.35 119.59 13.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.818 -174.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.66 115.69 6.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.11 0.481 . . . . 0.0 109.862 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.5 5.51 42.44 Favored Glycine 0 N--CA 1.418 -2.543 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.122 -177.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.13 155.78 16.98 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.413 0.606 . . . . 0.0 110.393 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.2 mt -97.24 124.8 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.424 HG12 ' HA3' ' A' ' 55' ' ' GLY . 28.0 m -132.18 179.19 4.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -113.49 125.51 54.29 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.567 HG21 HG21 ' A' ' 37' ' ' VAL . 9.7 t -127.61 152.39 47.72 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-O 120.777 0.323 . . . . 0.0 110.17 -174.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . 58.2 ttt180 -83.25 123.9 30.05 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.041 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.2 p -85.6 177.13 7.83 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -71.33 -20.6 62.16 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.033 0.444 . . . . 0.0 109.815 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.91 -25.0 66.95 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.968 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.91 -20.27 24.47 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.077 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.2 p -92.2 159.43 15.64 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 120.942 0.401 . . . . 0.0 110.97 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 65' ' ' THR . 51.1 m-85 -92.73 138.89 31.1 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.013 0.435 . . . . 0.0 110.244 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -132.14 149.73 52.33 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.67 129.81 34.74 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.024 0.916 . . . . 0.0 109.741 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.514 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -142.86 173.38 11.59 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.403 -174.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 5.7 mm -110.92 143.94 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -79.75 111.26 16.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -90.65 -24.77 20.4 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 120.922 0.391 . . . . 0.0 109.963 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -165.17 146.16 7.39 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.0 111.23 17.64 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.854 0.835 . . . . 0.0 109.119 168.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 8.2 m -96.09 126.62 41.45 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -173.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -56.84 141.59 44.1 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 124.323 1.014 . . . . 0.0 112.679 -171.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 32' ' ' LEU . . . -159.82 -144.32 0.11 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.506 ' HA ' HD23 ' A' ' 32' ' ' LEU . 50.5 m 87.63 121.83 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 125.396 1.478 . . . . 0.0 111.726 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -99.65 134.06 43.08 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.161 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.642 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 82.2 m-85 -121.2 107.94 13.17 Favored 'General case' 0 N--CA 1.422 -1.872 0 O-C-N 123.753 0.658 . . . . 0.0 109.315 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 33.3 m -90.08 106.47 18.5 Favored 'General case' 0 N--CA 1.398 -3.073 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 26' ' ' ILE . 16.2 m -105.74 141.65 20.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.164 -176.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.5 137.95 42.03 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.366 -174.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 87.4 m-85 -94.23 163.74 13.32 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.46 -26.74 65.48 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.615 0.722 . . . . 0.0 111.52 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.84 -17.14 64.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.089 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.1 1.92 58.21 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.75 138.31 31.58 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -125.86 133.91 51.8 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.465 0.65 . . . . 0.0 111.048 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.62 142.3 50.26 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.039 -176.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 43.4 m -104.89 110.16 22.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.519 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.486 HD11 ' CB ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -132.9 170.39 15.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.322 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -98.97 170.6 8.61 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -58.06 -31.38 67.01 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 123.699 0.8 . . . . 0.0 111.93 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 m -70.91 -9.14 57.19 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 121.498 0.666 . . . . 0.0 111.465 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.477 ' HB2' HD12 ' A' ' 98' ' ' LEU . 21.5 m -109.01 1.22 20.43 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 14' ' ' SER . 89.6 mt -107.22 129.43 54.87 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.788 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 14.2 t -71.24 -55.73 7.49 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.079 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.2 tp 67.95 173.62 0.27 Allowed 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 123.847 0.859 . . . . 0.0 111.797 175.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.7 tptp 75.31 -20.74 0.33 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.603 1.561 . . . . 0.0 112.94 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.13 1.89 59.4 Favored Glycine 0 C--N 1.307 -1.069 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -175.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -86.74 153.73 21.48 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 110' ' ' HIS . 53.0 ttp180 -134.22 87.48 2.37 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 120.925 0.393 . . . . 0.0 111.063 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.43 ' HB3' ' O ' ' A' ' 109' ' ' ARG . 4.5 p-80 174.93 -28.59 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 125.684 1.594 . . . . 0.0 107.319 172.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 73.97 -74.74 0.08 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.674 1.189 . . . . 0.0 109.42 173.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.83 -62.31 0.1 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -103.33 128.72 50.32 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.558 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.0 m -132.57 -52.62 0.94 Allowed 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -124.06 -170.62 2.17 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.2 t -77.42 104.61 8.04 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.1 mp 66.08 -174.23 0.18 Allowed 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.642 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 . . . . . 0 CA--C 1.485 -1.544 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.166 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.5 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -76.04 -36.53 59.03 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -114.5 142.68 28.56 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 173.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.68 106.04 0.3 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.463 2.109 . . . . 0.0 111.894 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.63 -8.25 54.96 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.956 0.884 . . . . 0.0 109.781 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -154.8 156.69 36.71 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 29.5 mt -88.49 173.52 8.63 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.9 p -123.51 162.1 23.58 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -173.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -65.61 133.27 30.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.671 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.94 -16.57 42.89 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.944 177.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.619 ' HB ' HD12 ' A' ' 26' ' ' ILE . 13.4 m -66.54 132.08 47.42 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.498 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -96.75 115.36 27.3 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.9 m -128.61 -179.56 3.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 121.435 0.636 . . . . 0.0 110.361 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 19.4 m -133.43 136.45 45.21 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -107.18 138.83 42.63 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -89.91 129.93 36.19 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.879 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -127.7 108.14 10.49 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.344 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.501 ' HD2' ' N ' ' A' ' 18' ' ' ARG . 2.9 mpt_? 59.57 32.82 21.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.67 0.788 . . . . 0.0 111.659 175.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.44 -2.63 68.0 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.787 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.36 147.97 36.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 117.184 0.492 . . . . 0.0 109.738 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -93.41 138.79 31.38 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.017 0.437 . . . . 0.0 110.833 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.0 m -125.36 128.03 47.53 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 170.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 6.8 pt-20 -90.08 138.38 31.56 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 118.417 -1.313 . . . . 0.0 110.771 -173.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.43 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -148.67 151.01 34.2 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.02 -174.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.6 tttp -108.92 128.98 55.4 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.619 HD12 ' HB ' ' A' ' 11' ' ' THR . 19.0 mt -66.63 118.67 10.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 120.646 0.26 . . . . 0.0 110.709 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -97.13 -46.85 6.0 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.259 0.552 . . . . 0.0 110.129 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 m -127.06 139.2 53.17 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.2 t -121.57 107.17 19.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.028 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 84' ' ' SER . 95.5 mttt -99.3 90.49 4.57 Favored 'General case' 0 C--N 1.264 -3.115 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -86.21 108.12 18.21 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.425 ' H ' HD23 ' A' ' 32' ' ' LEU . 1.9 pt? -132.78 129.46 38.61 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -175.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 8.5 p -97.39 116.38 39.63 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.826 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -88.92 100.56 13.28 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 57' ' ' LEU . 25.7 t -84.75 137.05 21.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.862 -174.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 39.8 ttmt -91.43 105.43 17.76 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 175.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 65' ' ' THR . 3.5 m -112.6 143.13 22.93 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.328 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.3 118.75 34.78 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 67' ' ' THR . 10.4 mp -69.4 122.59 19.25 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.851 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.74 -31.43 72.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.153 0.501 . . . . 0.0 111.017 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -89.4 -58.82 2.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.529 0.68 . . . . 0.0 110.982 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.37 -17.37 45.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.599 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 t30 71.68 7.12 5.87 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.069 0.937 . . . . 0.0 113.385 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -86.64 159.75 19.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 110.789 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.6 m -119.4 140.35 50.54 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 10.0 mp0 -134.09 142.51 47.56 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.44 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.75 101.22 10.53 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.2 149.62 28.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.424 0.631 . . . . 0.0 111.764 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 15.1 pt20 -69.81 160.98 30.73 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.37 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -63.4 -7.2 6.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.611 0.764 . . . . 0.0 112.523 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 49' ' ' GLN . 5.4 m-20 -73.58 -34.63 65.2 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.523 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 25.7 mm-40 -86.33 -28.99 23.35 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.076 -177.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.7 t -91.06 121.74 41.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.474 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -105.74 108.73 20.4 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.01 -173.79 22.76 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.059 177.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.9 139.2 46.7 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 123.139 2.559 . . . . 0.0 112.859 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.474 HD12 HG21 ' A' ' 35' ' ' VAL . 1.7 mm? -97.12 81.44 3.05 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.537 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 42.8 ttp85 -141.1 138.6 33.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.835 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.92 124.7 19.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.34 9.07 63.7 Favored Glycine 0 N--CA 1.427 -1.952 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.349 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.93 153.18 18.05 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.926 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -89.81 119.24 36.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.0 m -134.55 175.04 12.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.034 0.445 . . . . 0.0 110.807 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -126.3 128.19 46.74 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.56 HG21 HG21 ' A' ' 37' ' ' VAL . 11.8 t -131.13 157.92 41.85 Favored 'General case' 0 C--N 1.277 -2.55 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.042 -174.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.523 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 37.0 ttm-85 -82.54 128.59 34.45 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 105.221 -2.141 . . . . 0.0 105.221 170.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.477 HG21 HD21 ' A' ' 39' ' ' LEU . 34.2 p -84.98 176.79 8.23 Favored 'General case' 0 C--N 1.276 -2.615 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.199 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.1 m -66.17 -19.72 65.92 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.004 0.431 . . . . 0.0 110.044 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -75.55 -25.43 57.14 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.84 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.33 -17.33 16.71 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.702 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.6 m -90.09 151.97 21.36 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.648 0.261 . . . . 0.0 111.416 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 65' ' ' THR . 62.4 m-85 -87.46 126.76 35.09 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.87 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -140.96 145.54 36.15 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.363 1.065 . . . . 0.0 108.983 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -76.13 131.05 39.17 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 121.812 0.815 . . . . 0.0 111.253 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.8 170.12 16.29 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.382 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.1 mm -119.83 142.46 35.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -74.42 129.06 36.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.3 m -114.47 -17.11 11.82 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 121.227 0.537 . . . . 0.0 111.025 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 57.4 tttm -168.82 156.23 7.48 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.76 135.15 53.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 87.1 m -114.37 111.71 21.89 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.39 122.74 17.85 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.107 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.55 153.34 43.79 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.7 p -161.78 122.38 2.64 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.111 0.481 . . . . 0.0 109.877 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.542 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 87.6 m95 -107.75 113.87 27.43 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.108 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 94.5 m-85 -101.47 110.59 22.62 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.1 m -89.93 104.14 16.73 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.428 HG22 HD23 ' A' ' 98' ' ' LEU . 24.4 m -106.9 140.59 24.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.273 0.559 . . . . 0.0 111.301 -174.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 3.5 t -101.79 128.69 54.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 124.239 1.015 . . . . 0.0 109.979 -173.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 58.7 m-85 -87.71 174.02 8.65 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 174.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.31 -17.82 55.55 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.96 -17.81 62.04 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.045 0.538 . . . . 0.0 110.326 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.21 -0.48 68.85 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.96 131.48 40.85 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 123.325 0.65 . . . . 0.0 109.548 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.457 ' C ' ' HD2' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -111.74 137.25 49.92 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.354 0.597 . . . . 0.0 111.911 -179.139 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.457 ' HD2' ' C ' ' A' ' 95' ' ' GLU . 4.3 mpt_? -121.67 158.18 29.25 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.395 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.542 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 24.0 m -101.84 119.69 39.19 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.251 0.548 . . . . 0.0 110.771 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.428 HD23 HG22 ' A' ' 88' ' ' VAL . 4.0 mm? -122.09 174.5 6.9 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.484 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 22.5 mmt180 -98.86 166.58 11.23 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.89 -21.61 63.3 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.572 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.6 m -74.19 -9.78 58.96 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.521 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 5.3 m -98.95 -11.8 21.26 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 99' ' ' ARG . 70.1 mt -101.68 128.35 48.02 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.073 -171.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.718 ' SG ' ' HA ' ' A' ' 110' ' ' HIS . 30.3 t -61.11 -41.93 97.59 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 124.749 1.219 . . . . 0.0 110.75 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.9 mt 68.86 127.77 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 176.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.8 tttm 71.39 -28.89 0.19 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.428 1.491 . . . . 0.0 113.04 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.52 -38.03 3.25 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -66.86 -43.9 82.35 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.94 0.896 . . . . 0.0 109.043 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -86.9 136.79 32.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.718 ' HA ' ' SG ' ' A' ' 104' ' ' CYS . 8.6 m170 -116.1 137.94 51.68 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.153 0.502 . . . . 0.0 110.628 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -86.53 130.48 34.48 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.018 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.03 134.4 44.35 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -84.05 -0.82 53.27 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.598 0.713 . . . . 0.0 110.081 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.3 p -153.84 85.75 1.17 Allowed 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -74.21 -25.63 59.79 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.006 0.431 . . . . 0.0 111.381 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.7 m -82.57 118.09 23.03 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -82.12 -31.41 30.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.094 0.474 . . . . 0.0 110.462 -177.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.4 t70 . . . . . 0 C--N 1.305 -1.367 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.373 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.178 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -134.58 -34.02 0.94 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.434 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 27.9 mt-10 -72.07 114.8 32.28 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.046 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 10.6 Cg_endo -88.57 -175.34 1.25 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.291 1.994 . . . . 0.0 112.826 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.22 -22.1 63.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.373 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.761 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 38.2 p90 -131.37 129.89 41.93 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 120.901 0.382 . . . . 0.0 110.353 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.55 -173.58 3.07 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.716 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.5 p -128.61 157.91 39.96 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -171.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 m -74.35 148.96 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 CA-C-O 121.122 0.487 . . . . 0.0 111.834 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.15 -12.59 67.36 Favored Glycine 0 C--N 1.301 -1.378 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.071 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.479 ' HB ' HD12 ' A' ' 26' ' ' ILE . 13.6 m -79.59 135.92 36.71 Favored 'General case' 0 N--CA 1.403 -2.809 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 106' ' ' LYS . 15.9 t70 -99.78 121.04 40.68 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 104' ' ' CYS . 17.4 m -135.37 -177.33 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 121.474 0.654 . . . . 0.0 110.307 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 m -123.07 141.62 51.76 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.54 139.76 41.57 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.344 0.0 OUTLIER -99.98 136.61 39.63 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -177.815 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -131.62 121.72 24.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.668 -1.605 . . . . 0.0 107.355 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 61.53 31.7 18.85 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.028 0.931 . . . . 0.0 110.428 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.89 28.8 70.04 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.5 -177.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.75 152.29 50.16 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -102.39 144.84 30.36 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.686 -173.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -127.58 139.73 52.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 172.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.53 152.38 26.04 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.482 -175.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -162.37 145.36 11.39 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -106.51 128.75 54.34 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.527 ' HA ' HG12 ' A' ' 88' ' ' VAL . 30.4 mt -63.75 114.42 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 121.185 0.517 . . . . 0.0 111.23 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.42 -42.39 6.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.757 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 5.8 m -130.05 137.35 50.18 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.1 t -116.61 116.4 52.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.279 0.562 . . . . 0.0 109.949 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.484 ' HB3' HD22 ' A' ' 32' ' ' LEU . 46.7 mmtt -109.57 91.03 3.48 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.185 174.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -83.25 87.69 6.94 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.549 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.629 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.3 pt? -135.07 116.53 14.69 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.291 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 62.8 t -108.5 115.23 48.74 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 171.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -82.64 108.35 15.95 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.244 1.021 . . . . 0.0 109.755 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.04 133.75 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.455 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.244 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -88.86 107.08 18.79 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 65' ' ' THR . 3.5 m -112.59 148.49 15.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.305 -176.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.75 117.87 30.51 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 75' ' ' ALA . 57.3 mt -73.92 106.55 5.68 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.41 -29.05 67.46 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -87.69 -24.47 23.86 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.765 -177.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -115.53 -13.97 11.54 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.177 -173.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 68.33 15.98 9.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.508 1.523 . . . . 0.0 113.112 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -99.99 158.28 15.94 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.377 0.132 . . . . 0.0 111.088 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -125.57 140.4 52.78 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.1 160.61 42.7 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.359 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.56 100.88 7.39 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 m -128.28 163.88 31.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.434 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.629 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 17.1 pm0 -80.78 160.05 24.98 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.47 -25.11 2.38 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 127.076 2.15 . . . . 0.0 112.51 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.42 -29.1 67.69 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.718 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 65' ' ' THR . 71.7 mt-30 -100.21 -15.17 18.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.463 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.08 110.82 22.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 122.523 1.154 . . . . 0.0 111.586 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -99.19 106.13 18.26 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 113.974 -1.466 . . . . 0.0 108.001 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 139.68 -169.65 24.53 Favored Glycine 0 C--N 1.302 -1.325 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.172 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.56 134.86 11.34 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.884 2.39 . . . . 0.0 112.544 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -88.53 82.26 6.97 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.535 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 35.0 mtp180 -139.26 132.59 30.01 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.744 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.32 120.07 10.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.34 5.81 61.74 Favored Glycine 0 N--CA 1.433 -1.556 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.867 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -96.39 169.21 10.07 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.894 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.5 mm -99.02 115.74 40.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.113 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 77' ' ' ILE . 16.0 m -123.78 -173.05 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.8 135.87 35.07 Favored 'General case' 1 N--CA 1.374 -4.238 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 174.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.636 HG21 HG21 ' A' ' 37' ' ' VAL . 11.6 t -141.56 158.91 43.24 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.056 -175.156 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -80.49 126.39 31.16 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -99.09 179.7 4.53 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.135 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.7 t -66.82 -21.06 66.04 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.205 1.002 . . . . 0.0 110.242 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.18 -18.34 62.49 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.53 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.88 -13.44 60.67 Favored Glycine 0 C--O 1.241 0.584 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.976 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.9 p -91.68 165.06 13.5 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 123.136 0.574 . . . . 0.0 110.727 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -98.38 124.68 43.18 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.425 ' HB3' HD22 ' A' ' 39' ' ' LEU . 5.5 tp-100 -119.6 146.91 45.1 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -176.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -72.7 127.74 33.46 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.581 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -132.55 168.35 18.39 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 7.0 mm -115.45 149.23 17.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.561 HD11 HG13 ' A' ' 63' ' ' VAL . 3.7 mp -89.92 130.47 39.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.0 m -107.35 -16.96 14.26 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.002 0.429 . . . . 0.0 110.583 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -173.53 147.47 1.45 Allowed 'General case' 0 C--O 1.212 -0.888 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.321 0.0 OUTLIER -129.92 115.89 17.84 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.546 0.688 . . . . 0.0 110.781 171.61 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.4 m -112.14 103.88 12.07 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.456 0.646 . . . . 0.0 109.341 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.9 p30 -75.4 141.77 43.18 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.108 -176.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.14 -60.25 1.71 Allowed 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.6 m 45.05 90.41 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.282 1.433 . . . . 0.0 113.546 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.517 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 78.8 m95 -100.97 129.98 46.9 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.526 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.761 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 74.6 m-85 -123.11 108.73 13.19 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 26.0 m -84.25 103.8 13.74 Favored 'General case' 0 N--CA 1.391 -3.38 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 26' ' ' ILE . 17.3 m -106.09 141.29 21.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.845 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.79 122.77 56.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.864 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -88.51 173.43 8.68 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.41 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -55.28 -33.45 63.25 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.262 1.025 . . . . 0.0 111.589 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.82 -17.84 62.75 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.987 0.422 . . . . 0.0 111.608 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.56 6.76 56.28 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -90.47 134.83 34.09 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -111.04 128.32 55.82 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-O 121.221 0.534 . . . . 0.0 109.937 177.51 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -123.45 140.97 52.47 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.517 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 32.3 m -103.66 108.82 20.26 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 120.725 0.298 . . . . 0.0 111.104 -176.051 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.8 mt -117.34 178.03 4.52 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -98.74 165.25 11.88 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -62.06 -25.38 67.65 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.13 0.49 . . . . 0.0 110.816 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.93 1.21 9.21 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.18 0.992 . . . . 0.0 112.213 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.5 t -127.61 11.24 6.74 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.9 mp -122.26 161.0 24.09 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.291 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.402 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 37.5 t -135.35 -143.94 0.2 Allowed 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.9 mt -141.11 164.16 31.03 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 12' ' ' ASP . 6.5 tmtt? -67.03 132.77 48.58 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.2 -15.82 8.17 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 65.33 96.62 0.05 OUTLIER 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.59 1.156 . . . . 0.0 109.827 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -104.68 167.81 9.48 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -80.32 79.71 6.87 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.907 0.861 . . . . 0.0 111.082 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -111.14 13.76 21.85 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.42 -171.25 2.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.821 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 56.98 77.43 0.26 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.683 1.23 . . . . 0.0 112.056 -173.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 75.7 m -157.16 -173.83 4.63 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 69.12 97.15 0.06 Allowed 'General case' 0 C--O 1.245 0.863 0 O-C-N 124.139 0.899 . . . . 0.0 109.74 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.9 m -48.8 -50.16 35.56 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.594 1.558 . . . . 0.0 111.621 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.74 100.42 13.23 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 C--N 1.298 -1.673 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.036 -179.589 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 121.366 0.603 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -114.23 -37.88 4.28 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.483 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.4 mp0 -36.22 96.45 0.11 Allowed Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 127.452 2.301 . . . . 0.0 115.605 -172.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -110.66 39.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 124.736 3.624 . . . . 0.0 107.069 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.54 14.49 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 118.467 2.766 . . . . 0.0 118.467 -165.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -160.26 21.23 0.15 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 118.845 0.748 . . . . 0.0 112.085 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.42 ' O ' ' HE2' ' A' ' 86' ' ' TYR . 3.0 pp -151.43 166.47 30.96 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.464 ' HB ' ' OG1' ' A' ' 11' ' ' THR 0.539 54.2 p 115.17 71.88 0.0 OUTLIER 'General case' 0 C--O 1.193 -1.882 0 C-N-CA 130.201 3.401 . . . . 0.0 115.516 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.2 t -92.41 140.21 16.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.83 -13.57 58.68 Favored Glycine 0 C--N 1.313 -0.743 0 N-CA-C 112.238 -0.345 . . . . 0.0 112.238 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.5 ' HB ' HD12 ' A' ' 26' ' ' ILE . 3.6 m -68.8 133.18 47.97 Favored 'General case' 0 N--CA 1.411 -2.38 0 C-N-CA 123.501 0.72 . . . . 0.0 110.067 -177.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.79 110.32 22.94 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.32 173.49 13.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 122.305 0.242 . . . . 0.0 110.719 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.9 p -95.38 132.06 40.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.772 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -119.6 120.78 37.69 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 123.675 0.79 . . . . 0.0 109.802 -177.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 1.9 ttpm? -82.81 106.23 14.48 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.906 -177.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -138.41 145.87 41.5 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 62.99 25.19 14.93 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 122.762 1.268 . . . . 0.0 108.899 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.53 16.04 75.61 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.263 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.17 142.67 42.18 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 26.2 p90 -98.45 114.09 26.33 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.089 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -100.6 143.17 31.08 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -71.64 132.78 45.08 Favored 'General case' 0 N--CA 1.38 -3.963 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -146.27 164.48 32.17 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.175 -173.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -117.44 126.84 53.32 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.507 HG12 HG12 ' A' ' 88' ' ' VAL . 18.6 mt -69.58 109.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -87.49 -41.2 13.68 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.344 0.592 . . . . 0.0 110.174 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.8 m -137.95 141.53 40.55 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.775 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.6 t -118.94 108.54 24.27 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 84' ' ' SER . 31.2 mmmt -82.33 101.29 10.47 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -84.49 99.39 10.67 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.6 pt? -138.88 126.09 21.44 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.655 0.74 . . . . 0.0 111.031 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 60.1 t -104.07 124.83 58.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -84.36 104.42 14.36 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 57' ' ' LEU . 16.2 t -93.4 126.41 45.83 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.806 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.157 -177.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 81.5 tttt -95.6 110.5 22.59 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.417 HG13 HG12 ' A' ' 35' ' ' VAL . 3.6 m -117.51 154.53 19.34 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.952 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.338 -176.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tt -122.03 113.73 19.95 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 75' ' ' ALA . 43.2 mt -64.72 118.14 8.5 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.356 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.486 ' HB3' HD11 ' A' ' 76' ' ' ILE . 18.8 ptpt -75.51 -23.04 56.66 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.409 -176.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -85.46 -42.45 14.47 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.268 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -91.66 -22.84 20.05 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.383 0.611 . . . . 0.0 110.653 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 73.1 22.31 2.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.109 1.364 . . . . 0.0 113.614 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 p -104.81 150.73 24.56 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.744 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -97.96 144.48 27.45 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -142.57 142.82 32.24 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.7 tp -121.57 102.63 8.36 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.28 164.49 29.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.767 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 4.5 pm0 -84.29 168.05 16.02 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.298 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -46.39 -21.47 0.17 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 128.584 2.754 . . . . 0.0 114.306 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.26 -23.03 23.61 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 122.084 0.945 . . . . 0.0 110.446 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -91.16 -20.13 22.33 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.876 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.9 t -105.24 127.04 60.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.354 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -110.93 110.06 20.47 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.441 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 141.54 -164.04 26.73 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.506 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.07 136.18 16.1 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.824 2.349 . . . . 0.0 113.117 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.441 HD22 HG21 ' A' ' 35' ' ' VAL . 39.8 mt -93.2 83.0 4.56 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 28.5 tpt180 -140.38 131.01 25.59 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.4 t -63.64 119.66 8.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.8 3.58 55.99 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.401 -176.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . . . -97.44 168.76 10.19 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.471 0.635 . . . . 0.0 110.758 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.31 128.37 60.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.766 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.526 HG13 HD11 ' A' ' 77' ' ' ILE . 21.0 m -137.47 172.68 14.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.75 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -116.92 130.12 56.49 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.3 t -128.45 158.44 38.33 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.6 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -70.11 123.84 22.62 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.307 0.575 . . . . 0.0 111.023 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.482 HG23 ' H ' ' A' ' 69' ' ' ASP . 14.2 t -95.11 169.83 9.83 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 p -63.83 -20.52 65.86 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.683 0.793 . . . . 0.0 112.524 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.482 ' H ' HG23 ' A' ' 67' ' ' THR . 19.0 t70 -69.61 -25.73 64.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.511 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.5 -22.27 12.09 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.672 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 67' ' ' THR . 23.3 m -87.19 170.09 11.78 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.856 0.36 . . . . 0.0 110.642 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -100.69 137.27 39.31 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -133.29 155.85 48.66 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.412 ' OE1' ' HD2' ' A' ' 40' ' ' LYS . 38.1 tt0 -69.15 128.67 37.45 Favored 'General case' 0 C--O 1.253 1.237 0 O-C-N 124.227 0.954 . . . . 0.0 112.288 -177.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.519 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -139.7 171.03 14.82 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.211 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 40' ' ' LYS . 2.8 mp -120.86 141.87 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.526 HD11 HG13 ' A' ' 63' ' ' VAL . 3.3 mp -76.35 122.22 30.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -106.35 -18.93 13.85 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 86.7 tttt -163.78 150.0 11.52 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.3 OUTLIER -135.95 117.16 14.49 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.683 0.754 . . . . 0.0 110.838 171.811 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.3 m -112.16 104.85 13.08 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.072 -175.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -67.38 109.77 3.3 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.03 -73.17 0.58 Allowed 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.35 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 56.0 m 57.71 115.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.49 ' CD1' HD21 ' A' ' 32' ' ' LEU . 99.4 m95 -103.37 108.31 19.49 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.583 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.42 ' HE2' ' O ' ' A' ' 7' ' ' LEU . 48.1 m-85 -90.39 111.56 22.84 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 m -87.98 105.19 17.29 Favored 'General case' 0 N--CA 1.405 -2.69 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.507 HG12 HG12 ' A' ' 26' ' ' ILE . 21.8 m -105.68 141.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.995 -176.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.88 125.72 59.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.92 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 42.9 m-85 -87.19 170.12 11.76 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -57.15 -24.62 55.56 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 123.39 0.432 . . . . 0.0 112.057 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -72.4 -16.88 61.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.267 0.556 . . . . 0.0 111.846 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.84 -1.75 63.7 Favored Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.984 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.54 150.16 20.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.97 154.4 50.52 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 118.313 0.506 . . . . 0.0 111.521 -175.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -149.14 147.6 28.65 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.271 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.37 113.17 23.7 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 123.544 0.738 . . . . 0.0 110.899 174.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.772 HD11 ' HB1' ' A' ' 15' ' ' ALA 0.315 0.2 OUTLIER -129.83 146.87 51.55 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.141 0.496 . . . . 0.0 111.858 174.229 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.1 158.84 34.05 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.171 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.05 -38.25 56.42 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.902 1.281 . . . . 0.0 110.54 -175.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.5 m -62.72 -10.12 11.59 Favored 'General case' 0 CA--C 1.576 1.944 0 C-N-CA 123.834 0.854 . . . . 0.0 112.875 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.0 m -111.49 6.38 20.15 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 120.937 -1.102 . . . . 0.0 111.448 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 mp -108.81 139.61 43.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 110' ' ' HIS . 49.8 t -75.8 -48.83 20.04 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -175.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.3 tp 69.01 -70.66 0.13 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.394 1.078 . . . . 0.0 112.39 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -106.09 108.33 19.79 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.007 0.432 . . . . 0.0 110.163 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.69 -177.78 32.02 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -121.59 -40.16 2.58 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 117.805 0.803 . . . . 0.0 110.144 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -90.58 77.9 6.35 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.815 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.45 ' HB2' ' SG ' ' A' ' 104' ' ' CYS . 69.0 m-70 -137.63 159.07 42.99 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 74.65 7.18 4.46 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.251 1.42 . . . . 0.0 113.258 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.18 156.02 33.46 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 70.64 13.28 7.3 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 122.375 1.084 . . . . 0.0 110.448 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.2 t -178.91 105.59 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 66.45 178.45 0.22 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.844 1.307 . . . . 0.0 113.596 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.1 m -135.79 167.94 20.23 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 174.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.401 ' H ' HD13 ' A' ' 117' ' ' LEU 0.259 0.0 OUTLIER -122.38 138.17 54.62 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 119.912 1.233 . . . . 0.0 113.034 -177.769 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.2 t70 . . . . . 0 C--N 1.307 -1.278 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.157 178.296 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.218 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -113.08 -5.66 13.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.031 0.443 . . . . 0.0 110.25 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.17 151.11 40.07 Favored Pre-proline 0 C--N 1.304 -1.387 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -82.42 76.53 4.13 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.086 1.857 . . . . 0.0 110.287 174.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.23 -41.34 77.13 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.858 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.562 ' HA ' ' OH ' ' A' ' 86' ' ' TYR 0.29 28.4 p90 60.95 134.26 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.759 2.024 . . . . 0.0 115.679 178.137 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.51 173.67 7.95 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 173.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.4 p -127.74 169.04 14.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -172.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.6 t -72.49 134.69 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.306 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.91 -22.22 14.77 Favored Glycine 0 N--CA 1.432 -1.596 0 C-N-CA 119.816 -1.183 . . . . 0.0 113.419 175.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -93.43 167.74 11.51 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.719 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 5.0 p-10 -118.17 139.27 51.52 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 m -132.18 162.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.83 -177.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.477 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 14.4 m -101.13 127.95 47.44 Favored 'General case' 0 N--CA 1.405 -2.715 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.149 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.623 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -106.91 120.78 42.98 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 22.2 ptmt -93.59 138.07 32.22 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.721 -177.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HH ' ' HZ ' ' A' ' 90' ' ' PHE . 74.9 m-85 -134.81 130.9 36.78 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.7 mmt-85 61.21 25.2 15.22 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.85 1.26 . . . . 0.0 110.243 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.23 2.55 83.06 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.206 -0.521 . . . . 0.0 113.093 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.25 145.97 45.63 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 74.1 m-85 -95.1 132.92 39.48 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.982 -175.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.2 m -116.54 132.67 56.62 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -86.12 145.16 27.15 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.105 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.96 153.3 34.95 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 64.6 tttm -108.94 126.72 53.39 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -175.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.508 ' HA ' HG12 ' A' ' 88' ' ' VAL . 23.3 mt -65.31 114.14 2.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.936 0.398 . . . . 0.0 111.732 -175.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -97.18 -45.8 6.39 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.091 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.514 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 4.9 m -127.04 139.76 52.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -175.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.9 t -125.44 122.88 63.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 63.8 mttp -110.75 91.79 3.8 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 172.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.383 0.0 OUTLIER -85.71 86.94 7.34 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.06 177.362 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.5 pt? -116.46 105.27 12.3 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.449 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 7.3 p -91.45 127.23 43.92 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.529 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 68.4 mttm -79.78 105.11 10.83 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.314 0.578 . . . . 0.0 109.706 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.7 t -89.4 122.83 41.19 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.196 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.492 ' CB ' ' HB3' ' A' ' 79' ' ' LYS . 2.9 tmtm? -89.64 108.35 19.62 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.432 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 19.4 m -117.02 153.3 18.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 121.475 0.655 . . . . 0.0 112.472 -174.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -123.34 120.03 31.84 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.18 127.07 31.4 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.962 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.2 ptpt -64.28 -34.66 78.63 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -80.74 -58.77 2.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.001 0.429 . . . . 0.0 111.889 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.71 -4.42 55.11 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.7 p30 52.12 29.4 6.39 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.664 1.185 . . . . 0.0 112.595 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.3 145.77 24.22 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.734 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -113.27 147.73 37.0 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -158.7 164.46 35.9 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.918 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 31.5 tp -129.5 102.3 6.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.68 162.37 31.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 5.4 pm0 -90.99 166.73 12.86 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.32 -0.952 . . . . 0.0 113.538 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.408 ' HB2' HG12 ' A' ' 33' ' ' VAL . 4.9 t70 -42.68 -32.19 0.55 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 127.268 2.227 . . . . 0.0 113.253 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -68.25 -34.9 77.06 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 123.691 0.796 . . . . 0.0 111.238 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -90.39 -12.43 37.56 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.349 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 65' ' ' THR . 87.7 t -93.81 115.7 33.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.602 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -108.38 124.34 50.22 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.292 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.26 -161.38 22.07 Favored Glycine 0 C--N 1.288 -2.108 0 CA-C-O 119.445 -0.642 . . . . 0.0 111.921 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -86.13 133.23 4.02 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.848 2.365 . . . . 0.0 112.833 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.88 82.55 3.87 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 122.085 0.945 . . . . 0.0 110.808 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.583 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 25.6 mmt180 -140.02 141.11 36.34 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.371 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.05 126.34 22.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.23 3.85 67.06 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.308 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.55 157.5 15.99 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.422 HG12 ' CD1' ' A' ' 76' ' ' ILE . 56.8 mt -101.76 124.43 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 121.383 0.611 . . . . 0.0 110.796 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.489 HG13 HD11 ' A' ' 77' ' ' ILE . 14.6 m -125.64 -178.65 2.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.814 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 73' ' ' GLN . 39.0 mt-10 -126.69 120.89 30.55 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.513 HG22 HG22 ' A' ' 53' ' ' VAL . 33.9 p -116.37 150.28 37.99 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.725 -174.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -76.67 130.41 37.75 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.1 p -87.91 -177.16 5.71 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.0 t -78.35 -0.88 30.72 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 110.033 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -94.68 -14.45 24.83 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.3 5.61 60.44 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.455 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 m -97.15 160.86 14.1 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.34 119.31 37.86 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 121.05 0.452 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 46.7 mt-30 -119.19 153.54 34.76 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.083 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 44.9 mt-10 -69.09 122.75 19.38 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 124.056 0.847 . . . . 0.0 109.563 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.432 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -137.42 162.28 34.05 Favored 'General case' 0 C--N 1.267 -3.011 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.572 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.422 ' CD1' HG12 ' A' ' 62' ' ' ILE . 9.2 mm -107.48 137.52 38.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -70.89 120.02 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . 13.6 m -109.58 -15.77 14.11 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.301 -178.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HB3' ' CB ' ' A' ' 36' ' ' LYS . 15.3 tppt? -172.77 150.13 2.08 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.4 123.82 32.63 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 171.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.4 m -118.77 115.5 24.59 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 123.455 0.702 . . . . 0.0 109.954 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -63.4 136.53 57.69 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.15 0.5 . . . . 0.0 111.798 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -139.02 13.34 2.65 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.994 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.428 ' HA ' HD23 ' A' ' 32' ' ' LEU . 50.5 m -49.3 123.74 7.96 Favored 'General case' 0 C--O 1.245 0.843 0 O-C-N 124.231 0.957 . . . . 0.0 113.57 -175.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.576 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 89.5 m95 -101.37 136.73 40.74 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.836 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.562 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 56.0 m-85 -122.81 114.36 20.41 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.514 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 16.0 m -91.74 105.54 17.8 Favored 'General case' 0 N--CA 1.401 -2.908 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 26' ' ' ILE . 21.4 m -105.81 141.7 20.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.925 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.9 p -105.73 135.65 43.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.091 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.456 ' HZ ' ' HH ' ' A' ' 17' ' ' TYR . 44.8 m-85 -97.4 173.04 7.39 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.424 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -54.61 -42.64 71.4 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.674 1.189 . . . . 0.0 111.14 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.81 -14.02 62.61 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.925 0.89 . . . . 0.0 112.731 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.61 9.13 55.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.83 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -89.73 140.65 29.36 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -124.82 138.67 54.26 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -133.92 142.17 47.63 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.576 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 67.1 m -99.79 118.85 37.16 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.013 0.435 . . . . 0.0 110.872 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.623 HD11 ' HB1' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -136.54 162.97 31.63 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.361 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.418 ' O ' HD13 ' A' ' 103' ' ' LEU . 28.7 ptt180 -99.32 166.32 11.26 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.738 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.448 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 72.0 mtm180 -56.47 -25.57 51.39 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 m -57.67 -22.37 45.53 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.35 1.06 . . . . 0.0 111.798 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.5 m -118.72 12.98 13.19 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.086 0.47 . . . . 0.0 111.634 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 99' ' ' ARG . 8.6 mp -103.12 146.16 28.81 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.633 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' CYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 111' ' ' PHE . 34.6 t -79.75 -55.5 4.95 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.215 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.501 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 6.4 tt -64.1 101.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -167.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 105' ' ' LEU . 1.9 mptt -174.14 -50.1 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 104.508 -2.405 . . . . 0.0 104.508 169.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.9 69.81 0.63 Allowed Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 113.436 -1.711 . . . . 0.0 110.147 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -133.16 138.46 46.61 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 48.85 -100.08 0.07 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 165.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -130.78 18.86 5.11 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.732 0.777 . . . . 0.0 109.94 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 104' ' ' CYS . 98.9 m-85 -85.71 -22.98 27.56 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 173.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.95 171.61 14.22 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 68.0 89.48 0.1 Allowed 'General case' 0 C--O 1.243 0.758 0 CA-C-O 122.475 1.131 . . . . 0.0 109.827 -177.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.0 t -78.56 87.54 4.52 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.342 -172.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -80.74 -43.15 20.69 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 168.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.8 p -118.58 173.63 6.73 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.043 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.2 mt -108.75 -66.78 1.02 Allowed 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--N 1.3 -1.57 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 174.814 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 121.36 0.6 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -113.04 20.39 16.37 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -62.66 119.49 51.34 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 113.513 -1.676 . . . . 0.0 112.61 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -65.87 143.31 72.81 Favored 'Trans proline' 0 N--CA 1.441 -1.607 0 N-CA-C 106.691 -2.08 . . . . 0.0 106.691 167.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.465 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . . . -53.63 -43.35 68.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -175.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -151.07 -52.51 0.13 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 7' ' ' LEU . 56.6 mt -127.54 -164.15 1.33 Allowed 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.037 173.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.9 p -87.86 133.48 33.89 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -160.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.6 t -92.1 135.47 27.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.181 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.85 -11.39 52.86 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.887 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.496 ' HB ' HD12 ' A' ' 26' ' ' ILE . 24.6 m -75.52 143.1 42.66 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 123.068 0.547 . . . . 0.0 110.805 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -96.8 131.68 43.28 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 105' ' ' LEU . 31.3 m -141.05 -179.63 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.192 -176.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 3.3 p -118.75 136.82 53.76 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.652 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -107.37 125.63 51.44 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 125.196 1.398 . . . . 0.0 107.57 -177.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HE3' ' HA ' ' A' ' 102' ' ' SER . 20.5 pttp -88.6 142.25 27.85 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.387 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -134.0 100.29 4.69 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 58.74 39.74 23.93 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.851 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.6 -11.36 70.13 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.534 -0.757 . . . . 0.0 114.243 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.78 131.05 54.34 Favored 'General case' 0 C--O 1.205 -1.238 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 1.6 m-85 -106.68 132.44 52.67 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.842 -174.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.4 m -110.76 148.97 31.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -84.18 143.24 29.77 Favored 'General case' 0 C--O 1.249 1.069 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.638 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.472 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -154.32 149.61 27.1 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.327 -177.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.449 ' O ' HG12 ' A' ' 89' ' ' VAL . 3.9 tmmm? -113.37 129.26 56.58 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.496 HD12 ' HB ' ' A' ' 11' ' ' THR . 53.8 mt -64.73 119.35 8.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 123.582 0.753 . . . . 0.0 112.657 -175.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -90.53 -49.21 6.63 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 122.154 0.978 . . . . 0.0 109.549 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.0 m -142.89 147.72 35.8 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.096 -175.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 86' ' ' TYR . 53.2 t -114.27 133.52 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 171.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 23.7 tptm -121.82 120.82 35.68 Favored 'General case' 0 C--N 1.263 -3.156 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -70.56 144.32 51.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.611 -1.236 . . . . 0.0 111.026 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.538 HD21 ' CD1' ' A' ' 85' ' ' TRP . 73.5 mt -123.7 157.7 33.3 Favored 'General case' 0 C--N 1.265 -3.106 0 CA-C-N 114.046 -1.433 . . . . 0.0 107.457 175.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.417 ' CG1' ' HB2' ' A' ' 80' ' ' LEU . 60.7 t -119.86 110.65 29.8 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.361 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 42.9 mtpt -85.53 108.1 17.78 Favored 'General case' 0 CA--C 1.471 -2.065 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.47 HG11 HG13 ' A' ' 77' ' ' ILE . 14.9 t -91.61 132.43 36.07 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.229 -173.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -90.4 111.91 23.32 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.448 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 2.7 m -112.96 144.33 20.85 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.103 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.056 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -112.76 115.36 28.4 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.9 122.03 17.81 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.385 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -66.74 -38.93 87.64 Favored 'General case' 0 N--CA 1.41 -2.464 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -170.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -86.31 -45.77 10.93 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.443 ' HB2' HE22 ' A' ' 73' ' ' GLN . 17.6 t70 -86.27 -25.12 25.68 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -173.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 74.02 19.65 2.97 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.07 150.8 24.19 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -112.06 145.02 40.46 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.546 HE22 ' H ' ' A' ' 68' ' ' SER . 12.7 tt0 -151.4 147.8 27.33 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -174.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.4 tp -123.48 101.49 7.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.0 m -134.62 165.08 32.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.406 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 5.6 pm0 -85.66 161.03 19.42 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -173.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -43.49 -28.12 0.34 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 127.294 2.238 . . . . 0.0 113.977 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.87 -37.34 87.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.941 0.401 . . . . 0.0 110.789 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.487 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 88.1 mt-30 -100.53 -6.94 24.69 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.324 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.0 t -101.14 113.27 36.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.601 0.715 . . . . 0.0 110.035 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -98.63 100.28 11.49 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.041 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.515 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 152.33 -163.34 30.22 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.424 176.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -81.7 146.38 14.94 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.763 2.975 . . . . 0.0 113.903 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.93 82.09 6.21 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 49.1 mtm105 -139.89 123.75 17.51 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.674 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.3 t -61.08 118.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.525 0.679 . . . . 0.0 109.64 176.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.76 11.05 51.63 Favored Glycine 0 C--N 1.299 -1.515 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.532 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.459 ' HB3' HD13 ' A' ' 77' ' ' ILE . . . -97.11 168.9 10.17 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.414 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.8 mm -101.45 120.33 50.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 77' ' ' ILE . 27.4 m -131.32 176.96 7.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -122.82 123.09 40.22 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 8.5 t -114.96 154.36 28.91 Favored 'General case' 0 C--N 1.265 -3.08 0 CA-C-O 121.052 0.453 . . . . 0.0 110.402 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.487 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . 59.9 ttt-85 -85.69 147.62 26.27 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 59.2 p -99.94 172.68 7.07 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.546 ' H ' HE22 ' A' ' 46' ' ' GLN . 25.9 t -67.84 -6.98 24.22 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.298 0.57 . . . . 0.0 109.801 175.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.31 -25.47 27.15 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.411 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.98 -11.77 34.45 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.357 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 m -87.48 158.12 19.03 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 122.184 0.193 . . . . 0.0 110.706 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 65' ' ' THR . 54.5 m-85 -111.13 145.26 38.92 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 122.538 0.335 . . . . 0.0 110.415 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.443 HE22 ' HB2' ' A' ' 42' ' ' ASP . 8.2 tt0 -147.69 151.72 36.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.95 126.52 30.04 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.804 0.841 . . . . 0.0 109.554 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.448 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -139.65 167.74 21.42 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.812 -176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.0 mm -115.81 144.71 22.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.547 HD11 HG13 ' A' ' 63' ' ' VAL . 3.5 mp -77.55 123.65 34.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -111.87 -16.71 13.08 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.546 0.689 . . . . 0.0 111.582 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -161.1 150.8 17.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.417 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -141.25 111.51 6.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.067 0.937 . . . . 0.0 110.654 175.39 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.2 m -105.01 140.61 37.94 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.464 -170.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.49 127.03 32.04 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.322 0.582 . . . . 0.0 110.761 177.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . . . -130.29 -170.05 2.25 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.8 p -166.1 142.53 5.06 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.538 ' CD1' HD21 ' A' ' 32' ' ' LEU . 64.8 m95 -94.09 151.08 19.76 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 167.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.496 ' CD2' HG22 ' A' ' 29' ' ' VAL . 53.2 m-85 -127.37 116.9 21.21 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 42.5 m -86.29 105.85 16.95 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.472 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 22.3 m -109.06 141.47 24.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.345 -176.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 25' ' ' LYS . 14.8 p -107.78 134.22 50.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.436 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -80.27 169.71 17.4 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -63.33 -20.78 65.8 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.41 0.624 . . . . 0.0 109.905 175.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -68.74 -17.81 64.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.246 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.99 0.1 68.74 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.669 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.55 142.5 28.54 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 9.4 pt-20 -117.98 138.64 52.05 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.425 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 4.0 mmp_? -124.3 142.71 51.05 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.0 m -102.57 117.79 35.44 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.046 0.451 . . . . 0.0 111.222 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.652 HD11 ' HB1' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -139.54 173.4 11.58 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 123.168 0.587 . . . . 0.0 109.991 179.313 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.464 ' O ' HD13 ' A' ' 103' ' ' LEU . 3.7 ptm180 -95.38 173.8 7.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.569 0.622 . . . . 0.0 112.277 -173.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 53.8 ttp85 -58.37 -40.79 83.22 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.809 0.444 . . . . 0.0 111.535 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.13 12.06 7.06 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.496 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 10.7 p -115.75 5.65 14.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.587 1.184 . . . . 0.0 108.477 170.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 99' ' ' ARG . 9.5 mp -112.21 153.06 27.66 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.104 175.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 55.7 m -89.91 -29.29 18.63 Favored 'General case' 0 C--N 1.285 -2.222 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.211 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.413 ' HA ' HG12 ' A' ' 13' ' ' VAL . 75.3 mt 62.76 -71.48 0.05 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.993 0.917 . . . . 0.0 111.386 -174.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? 175.22 -53.6 0.01 OUTLIER 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.495 1.118 . . . . 0.0 109.693 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -103.47 -3.4 47.15 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.38 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -89.04 135.12 33.72 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -139.98 68.11 1.37 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 122.328 1.061 . . . . 0.0 109.319 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -136.86 119.78 16.39 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.204 176.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -115.48 -169.35 1.56 Allowed 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.438 ' H ' ' HE2' ' A' ' 16' ' ' LYS . . . -164.34 82.35 0.41 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -173.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.07 108.5 19.94 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.703 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.5 p -100.41 -171.66 2.07 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -81.74 -57.05 3.61 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 39.2 p -96.77 130.0 44.1 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -89.74 104.63 17.17 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.482 -1.674 . . . . 0.0 106.482 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 . . . . . 0 C--N 1.306 -1.297 0 CA-C-O 118.698 -0.668 . . . . 0.0 109.848 -176.402 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.36 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -123.37 -5.68 8.25 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.8 mp0 -65.33 129.18 94.34 Favored Pre-proline 0 C--O 1.252 1.197 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.016 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 22.0 Cg_exo -66.62 126.01 14.75 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.608 2.205 . . . . 0.0 110.657 177.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.448 ' HB1' ' NH1' ' A' ' 100' ' ' ARG . . . -112.83 -41.54 3.76 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.366 0.603 . . . . 0.0 110.688 -178.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.639 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 25.6 p90 -99.42 9.67 42.85 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -176.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.447 ' O ' ' HB ' ' A' ' 8' ' ' THR . 4.1 pp -145.23 134.87 23.38 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 9.2 t 176.41 25.3 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 O-C-N 124.13 0.894 . . . . 0.0 111.127 174.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 p -75.9 132.48 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 O-C-N 121.173 -0.954 . . . . 0.0 109.475 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.8 -3.77 74.61 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.403 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -91.76 153.45 19.6 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-O 121.093 0.473 . . . . 0.0 109.978 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -103.7 111.44 23.94 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -119.14 173.22 5.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.181 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 14.9 m -95.26 135.18 37.17 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.05 127.06 39.15 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 21.5 ptmt -88.75 117.35 27.67 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.742 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CE2' ' HB2' ' A' ' 22' ' ' CYS . 50.7 p90 -133.5 138.0 45.91 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 70.3 ttt180 64.2 25.77 13.68 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 122.326 1.06 . . . . 0.0 108.666 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.17 18.09 77.75 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.552 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.69 130.72 47.57 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.504 ' CD2' ' HB3' ' A' ' 16' ' ' LYS . 33.9 m-85 -86.53 110.38 19.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.573 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 73.1 m -126.64 155.37 42.68 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -78.82 149.4 32.57 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.246 -1.381 . . . . 0.0 111.756 -176.749 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.403 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -144.88 149.35 35.19 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.475 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -104.0 126.95 51.51 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.993 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.478 HG12 HG12 ' A' ' 88' ' ' VAL . 47.4 mt -69.27 121.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.954 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -111.56 -37.55 5.18 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.387 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 9.3 m -129.06 145.26 51.32 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.6 t -135.66 133.07 51.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 123.674 0.79 . . . . 0.0 108.955 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -122.92 111.09 16.22 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.639 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 46.1 mtm-85 -86.65 107.0 17.99 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.127 0.489 . . . . 0.0 109.891 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 32' ' ' LEU . 1.8 pt? -124.65 137.62 54.35 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 43.3 t -92.56 129.16 43.54 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.001 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.859 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -90.73 101.17 13.92 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.477 HG12 HG13 ' A' ' 37' ' ' VAL . 14.2 t -93.51 130.97 41.75 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.942 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.484 -170.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 88.0 tttt -98.36 106.26 18.52 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.52 HG21 HG21 ' A' ' 65' ' ' THR . 1.8 m -112.7 143.37 22.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 CA-C-O 121.396 0.617 . . . . 0.0 111.217 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.0 tp -111.09 120.85 43.71 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.032 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 75' ' ' ALA . 68.1 mt -73.13 116.81 14.11 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -68.47 -26.79 65.67 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.613 0.721 . . . . 0.0 110.083 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -70.83 -36.51 72.93 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.054 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -128.03 -19.6 3.95 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -171.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 78.43 15.19 1.3 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.274 1.03 . . . . 0.0 112.829 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.59 142.18 28.05 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -115.07 132.52 56.57 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.641 0.734 . . . . 0.0 109.434 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 2.2 mp0 -120.49 147.06 45.62 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.687 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.4 mt -122.29 101.65 7.64 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.72 -178.04 2.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -175.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -96.02 165.98 11.99 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.739 178.366 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.68 -4.66 3.2 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.103 0.961 . . . . 0.0 113.162 -177.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.66 -30.59 41.27 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.424 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 79.7 mm-40 -82.46 -23.38 34.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.832 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.71 131.42 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.317 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -112.78 104.59 12.62 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.8 -176.0 21.16 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.597 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.23 144.39 99.49 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 123.742 2.961 . . . . 0.0 113.447 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.01 82.35 2.55 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.004 0.907 . . . . 0.0 108.587 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.537 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 79.3 ttt180 -139.86 133.61 30.51 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.627 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.01 119.36 12.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.23 4.0 53.76 Favored Glycine 0 C--N 1.292 -1.883 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.962 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.73 143.67 27.45 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.921 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.466 HG12 HG13 ' A' ' 76' ' ' ILE . 41.2 mt -93.74 124.05 46.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.489 0.662 . . . . 0.0 109.278 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.31 -172.54 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.881 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.71 148.27 44.17 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.52 HG21 HG21 ' A' ' 37' ' ' VAL . 8.8 t -145.38 152.88 40.56 Favored 'General case' 0 C--N 1.276 -2.61 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.939 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.424 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 40.3 ttm180 -78.73 126.88 31.32 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 174.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 71' ' ' SER . 7.2 t -98.87 159.05 15.23 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 174.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.2 m -66.05 -2.79 4.41 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.83 -22.43 61.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.75 -22.8 16.01 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.595 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 67' ' ' THR . 24.8 m -99.12 161.46 13.61 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.025 0.44 . . . . 0.0 111.964 -177.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 65' ' ' THR . 53.3 m-85 -93.09 124.11 36.83 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.039 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -122.26 162.08 22.1 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -78.05 128.1 33.33 Favored 'General case' 0 C--O 1.254 1.311 0 C-N-CA 123.387 0.675 . . . . 0.0 109.238 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.685 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -143.02 171.96 13.35 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.699 -175.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 62' ' ' ILE . 4.5 mp -123.59 139.01 51.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -70.63 122.13 21.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.3 m -102.22 -23.36 14.03 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.236 0.541 . . . . 0.0 110.109 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 87.0 tttt -163.7 144.41 8.8 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.404 ' HB2' ' CG1' ' A' ' 33' ' ' VAL 0.315 0.0 OUTLIER -120.9 116.06 24.41 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 167.957 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 m -101.59 144.4 30.37 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.506 -167.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.601 ' HB3' ' NH1' ' A' ' 100' ' ' ARG . 1.7 m-20 -63.18 122.31 15.81 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.362 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.97 147.23 31.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.9 m -165.03 139.67 5.1 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TRP . . . . . 0.486 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 46.9 m95 -99.09 131.42 45.14 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' THR . 33.4 m-85 -122.15 120.29 33.79 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 89.2 m -98.16 109.38 22.14 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.478 HG12 HG12 ' A' ' 26' ' ' ILE . 17.5 m -106.25 148.25 10.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.314 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.24 123.72 54.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.566 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -92.33 -175.33 3.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.521 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.5 -33.0 13.4 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.382 1.873 . . . . 0.0 112.643 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -78.74 -16.95 56.58 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.414 0.626 . . . . 0.0 111.648 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.09 16.05 59.95 Favored Glycine 0 C--N 1.31 -0.865 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -172.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.79 135.83 38.18 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 114.039 -1.08 . . . . 0.0 108.855 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 87' ' ' THR . 42.9 mt-10 -102.84 128.69 49.5 Favored 'General case' 0 C--N 1.277 -2.571 0 O-C-N 124.309 1.006 . . . . 0.0 110.144 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -136.29 140.64 43.55 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 26.7 m -89.68 111.92 23.03 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 122.524 0.33 . . . . 0.0 110.643 -177.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 17.0 mt -110.54 172.41 6.88 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.111 0.482 . . . . 0.0 110.973 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -99.27 169.04 9.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.783 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.601 ' NH1' ' HB3' ' A' ' 82' ' ' ASP . 97.4 mtt180 -68.19 -25.11 65.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.276 0.56 . . . . 0.0 110.521 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.0 m -83.18 4.04 28.36 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.934 0.873 . . . . 0.0 109.81 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 7.4 m -120.56 -0.47 10.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.32 162.18 28.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.102 -174.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.3 t -138.58 104.54 5.15 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.432 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.6 tp -98.44 -82.82 0.42 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 170.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 46.31 -83.43 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.1 1.76 . . . . 0.0 113.945 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -160.79 -48.69 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' A' ' 110' ' ' HIS . 10.4 pt-20 -120.77 -178.87 3.83 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -87.06 17.61 4.09 Favored 'General case' 0 C--O 1.251 1.14 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.411 ' H ' ' HG3' ' A' ' 108' ' ' GLU . 14.9 t-80 -69.85 100.4 1.54 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 122.013 0.911 . . . . 0.0 109.074 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -178.81 -35.71 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.04 171.91 11.04 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.478 171.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -81.44 104.66 12.03 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.7 m -155.73 102.63 2.22 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -80.27 109.1 14.43 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.626 0.727 . . . . 0.0 111.195 -171.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.6 p -92.38 160.65 15.0 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.735 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.2 mp 68.79 91.08 0.09 Allowed 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.061 0.945 . . . . 0.0 111.716 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 C--N 1.303 -1.451 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.712 179.615 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.487 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 27.7 t80 . . . . . 0 N--CA 1.44 -0.96 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.429 ' HB2' ' CE2' ' A' ' 86' ' ' TYR . 95.9 mt -123.24 -160.26 0.89 Allowed 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 167.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.48 HG23 ' OG1' ' A' ' 11' ' ' THR . 1.4 t -122.45 150.96 41.77 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 118.189 0.45 . . . . 0.0 111.908 -169.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -91.59 145.39 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.289 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.34 -13.13 67.9 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.48 ' OG1' HG23 ' A' ' 8' ' ' THR . 13.7 m -73.43 141.42 46.9 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 123.344 0.658 . . . . 0.0 111.174 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -89.71 131.29 35.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.8 m -135.71 175.8 9.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.595 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 104' ' ' CYS . 51.5 m -117.08 144.82 44.23 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -121.28 139.09 53.86 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -75.87 136.11 40.15 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.329 0.585 . . . . 0.0 112.077 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -133.95 105.27 6.65 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.845 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 18' ' ' ARG . 2.9 mtp180 60.37 26.59 16.14 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 173.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.85 8.1 60.83 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.856 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.45 164.32 17.33 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -102.33 135.96 43.02 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.081 0.238 . . . . 0.0 111.003 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.5 t -122.33 146.86 46.92 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -88.04 151.24 22.9 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.384 -0.927 . . . . 0.0 109.502 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -152.79 162.32 41.42 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.8 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -126.61 126.29 43.37 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.584 ' HA ' HG12 ' A' ' 88' ' ' VAL . 52.3 mt -66.64 111.53 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -87.8 -44.43 11.12 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 124.858 1.263 . . . . 0.0 110.325 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 m -139.59 145.29 38.38 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -116.95 126.54 74.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 48.7 mttp -130.55 116.31 17.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.91 108.53 21.24 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.14 158.78 43.57 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.738 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 14.5 p -125.27 137.27 58.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 93.3 mttt -90.29 101.06 13.79 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 122.128 0.966 . . . . 0.0 108.852 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.602 HG12 HG13 ' A' ' 37' ' ' VAL . 20.8 t -83.8 120.95 35.73 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.122 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -85.34 107.86 17.54 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 173.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.602 HG13 HG12 ' A' ' 35' ' ' VAL . 1.7 m -112.71 157.08 13.55 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.111 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -135.41 121.57 20.18 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.597 HD23 ' HB2' ' A' ' 75' ' ' ALA . 73.1 mt -69.8 129.33 39.26 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.005 -176.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.1 ptpt -68.71 -32.4 72.18 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.555 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 23.2 tt0 -81.1 -59.95 2.47 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 120.924 0.392 . . . . 0.0 110.956 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -85.57 -4.3 59.12 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 p30 56.38 18.62 3.53 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.729 1.612 . . . . 0.0 113.543 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.53 137.51 32.25 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-O 120.965 0.412 . . . . 0.0 111.165 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 m -101.11 148.16 25.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.443 ' OE1' HG23 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -152.44 163.39 39.62 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 123.133 0.573 . . . . 0.0 110.236 175.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.416 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 20.8 tp -128.99 103.13 6.83 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.53 162.52 37.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.518 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.9 pm0 -77.23 161.5 28.1 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -62.98 -6.02 3.48 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.618 1.167 . . . . 0.0 113.617 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -82.21 -27.63 32.45 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.776 0.798 . . . . 0.0 108.988 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -87.05 -22.51 25.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.223 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.8 117.21 48.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.47 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -102.8 105.37 15.77 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.315 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.492 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 149.63 -179.39 26.45 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.638 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.79 141.1 93.87 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.336 2.691 . . . . 0.0 113.562 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.27 83.45 3.87 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.542 ' HB3' ' HB2' ' A' ' 61' ' ' ALA . 47.2 ttp180 -139.13 135.9 34.56 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.57 122.79 18.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.87 12.18 59.46 Favored Glycine 0 N--CA 1.423 -2.214 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.422 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . . . -97.2 157.73 15.8 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 118.161 0.981 . . . . 0.0 110.789 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.9 mm -97.36 121.74 48.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.492 HG12 ' HA3' ' A' ' 55' ' ' GLY . 29.6 m -136.4 -173.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 122.927 0.491 . . . . 0.0 109.893 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -128.88 132.25 47.71 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.481 HG21 HG21 ' A' ' 37' ' ' VAL . 9.1 t -133.79 158.56 43.03 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-O 120.792 0.329 . . . . 0.0 110.369 -174.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.4 ttm-85 -83.94 115.37 22.27 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.309 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 71' ' ' SER . 5.1 t -81.72 167.2 19.38 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.7 p -67.7 -2.35 6.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.927 0.87 . . . . 0.0 112.219 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -85.93 -16.31 38.85 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.067 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.5 -2.94 71.23 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.454 ' O ' HG22 ' A' ' 67' ' ' THR . 8.2 m -92.26 159.97 15.37 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -109.74 115.73 30.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.594 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 7.2 tt0 -113.37 148.35 35.95 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.618 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 35.3 tt0 -70.4 125.17 26.05 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -136.91 173.92 11.18 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.358 -173.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.406 HD11 ' HB3' ' A' ' 40' ' ' LYS . 2.4 mp -123.67 139.99 48.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -75.5 126.2 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.2 m -108.33 -17.32 14.03 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.336 0.112 . . . . 0.0 110.892 177.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -166.65 151.69 7.8 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.0 mt -124.36 112.87 17.46 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 169.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.8 m . . . . . 0 C--N 1.279 -2.469 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.814 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 99' ' ' ARG . 75.2 m . . . . . 0 CA--C 1.498 -1.032 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.494 ' CE3' ' HB ' ' A' ' 97' ' ' THR . 46.1 m95 -107.61 107.92 18.95 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.079 0.466 . . . . 0.0 110.05 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.487 ' OH ' ' HB3' ' A' ' 6' ' ' TYR . 96.5 m-85 -101.64 103.45 14.25 Favored 'General case' 0 N--CA 1.404 -2.742 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.4 m -76.16 104.09 6.52 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.597 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 25.4 m -112.28 141.14 28.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-O 121.261 0.553 . . . . 0.0 111.172 -175.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 95' ' ' GLU . 9.7 t -97.36 118.16 43.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.095 -176.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 93.0 m-85 -84.44 168.47 15.49 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -61.36 -21.27 63.89 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.12 0.486 . . . . 0.0 111.218 -175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.1 -16.87 63.18 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 123.666 0.786 . . . . 0.0 111.113 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.62 1.94 58.79 Favored Glycine 0 CA--C 1.507 -0.468 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.4 138.85 33.38 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 9.6 pt-20 -120.58 128.57 53.18 Favored 'General case' 0 C--N 1.284 -2.245 0 O-C-N 123.522 0.514 . . . . 0.0 110.413 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -131.54 149.61 52.45 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.494 ' HB ' ' CE3' ' A' ' 85' ' ' TRP . 2.3 p -79.75 112.72 17.29 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 122.383 0.273 . . . . 0.0 111.048 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.83 137.73 48.11 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.195 0.522 . . . . 0.0 110.682 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -76.34 143.62 40.66 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 175.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.472 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 2.5 tmm_? -44.07 -33.13 1.37 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.619 1.167 . . . . 0.0 113.265 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . 0.403 ' H ' ' HD2' ' A' ' 99' ' ' ARG . 24.3 m -55.31 -32.91 62.83 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.016 0.926 . . . . 0.0 112.047 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 35.1 m -82.69 -16.59 47.56 Favored 'General case' 0 N--CA 1.433 -1.306 0 O-C-N 122.063 -0.398 . . . . 0.0 110.849 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 mp -86.87 128.97 35.06 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.79 0.805 . . . . 0.0 111.462 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 20.0 m . . . . . 0 C--N 1.283 -2.284 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.902 -175.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.694 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 39.6 p90 . . . . . 0 N--CA 1.409 -2.491 0 CA-C-O 122.605 1.193 . . . . 0.0 109.948 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.8 mt -76.88 177.32 7.78 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 112.82 -1.991 . . . . 0.0 109.801 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.472 ' HA ' HG21 ' A' ' 29' ' ' VAL . 10.6 p -133.4 166.57 22.22 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.374 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.4 111.41 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.98 -26.52 2.2 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.483 ' HB ' HD12 ' A' ' 26' ' ' ILE . 5.6 m -71.64 137.93 48.27 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -116.33 125.68 52.46 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.451 ' CG2' HD22 ' A' ' 103' ' ' LEU . 33.9 m -144.79 -178.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 9.4 t -99.26 147.46 25.14 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 175.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -137.75 128.8 27.42 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 123.324 0.65 . . . . 0.0 109.396 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 51.1 mtpt -70.54 121.09 17.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.955 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.417 ' HE1' ' HB2' ' A' ' 22' ' ' CYS . 12.5 p90 -148.46 138.55 22.44 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 60.65 26.13 15.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.167 0.587 . . . . 0.0 111.46 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.55 3.05 72.1 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.184 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.06 145.53 44.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 117.652 0.726 . . . . 0.0 110.157 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 21.7 p90 -93.58 120.61 34.07 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.987 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.417 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 83.7 m -123.63 173.63 7.96 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.11 146.5 41.35 Favored 'General case' 0 C--O 1.253 1.242 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.21 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.572 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -152.12 147.78 26.86 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.416 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -116.6 128.36 55.32 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.541 ' HA ' HG12 ' A' ' 88' ' ' VAL . 28.4 mt -62.36 116.09 2.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -90.37 -40.32 12.15 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.601 1.16 . . . . 0.0 110.118 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 87.4 m -144.41 145.98 32.23 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.278 -177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 8' ' ' THR . 96.0 t -129.29 128.75 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.086 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 84' ' ' SER . 21.8 mmmt -118.29 102.66 9.14 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.637 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -77.15 88.0 3.62 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.5 pp -111.09 153.58 25.47 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.958 0.885 . . . . 0.0 112.437 -172.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 80' ' ' LEU . 60.3 t -115.81 120.61 65.3 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.365 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.621 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 26.4 mtpp -85.59 99.02 10.99 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.595 HG12 HG13 ' A' ' 37' ' ' VAL . 21.4 t -84.41 123.8 39.31 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.928 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 87.7 tttt -87.99 115.41 25.44 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 171.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.595 HG13 HG12 ' A' ' 35' ' ' VAL . 1.7 m -118.46 143.38 29.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.427 0.632 . . . . 0.0 112.077 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 44' ' ' THR . 1.9 tm? -107.21 116.89 32.72 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 75' ' ' ALA . 44.8 mt -74.7 124.6 27.04 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.486 ' HB3' HD11 ' A' ' 76' ' ' ILE . 22.2 pttp -72.82 -29.29 63.12 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -78.2 -38.92 42.11 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.947 0.403 . . . . 0.0 111.595 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.565 ' OD1' ' HB ' ' A' ' 44' ' ' THR . 14.6 t70 -93.33 -25.55 17.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.864 0.364 . . . . 0.0 110.948 -176.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 70.26 22.31 5.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.29 1.036 . . . . 0.0 111.24 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.565 ' HB ' ' OD1' ' A' ' 42' ' ' ASP . 5.6 t -101.23 -174.8 2.69 Favored 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 121.475 0.655 . . . . 0.0 110.049 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.7 m -136.24 139.65 42.9 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.25 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.01 156.93 44.29 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 8.1 tt -140.96 103.8 4.55 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 25.6 m -126.03 -178.49 2.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.746 -172.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -100.7 173.06 6.7 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 33' ' ' VAL . 1.4 t70 -43.03 -29.86 0.38 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 128.657 2.783 . . . . 0.0 114.754 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.35 -28.01 31.84 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.121 -174.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.494 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 8.0 mm-40 -90.19 -16.48 29.39 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.421 0.629 . . . . 0.0 109.443 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -97.57 109.37 23.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.509 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -99.03 106.88 19.17 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.525 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 139.18 -171.3 23.73 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.406 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.32 137.58 23.58 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.136 2.558 . . . . 0.0 113.495 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.5 mt -90.03 81.98 6.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.61 128.63 23.64 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.629 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 t -65.97 116.27 5.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.37 6.19 51.16 Favored Glycine 0 N--CA 1.431 -1.699 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.836 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.39 165.2 12.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.391 0.596 . . . . 0.0 111.228 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.414 HD13 HG13 ' A' ' 76' ' ' ILE . 48.5 mm -96.14 124.27 48.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 O-C-N 123.6 0.563 . . . . 0.0 109.935 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.421 ' CG1' HD11 ' A' ' 77' ' ' ILE . 19.7 m -131.61 178.08 6.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -121.6 121.4 37.32 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.442 HG21 HG21 ' A' ' 37' ' ' VAL . 8.4 t -116.37 158.04 24.1 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.816 -175.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 23.1 mtt180 -79.15 143.55 35.34 Favored 'General case' 0 CA--C 1.479 -1.782 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.037 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.1 p -97.92 175.25 6.2 Favored 'General case' 0 N--CA 1.404 -2.727 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.205 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.4 m -76.7 -17.92 58.82 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.252 0.549 . . . . 0.0 111.095 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -84.11 -21.12 31.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.819 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.8 6.01 23.37 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.368 -0.92 . . . . 0.0 114.424 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.9 p -99.3 177.27 5.25 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 117.619 0.71 . . . . 0.0 110.387 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.446 ' CE1' ' HG3' ' A' ' 66' ' ' ARG . 60.6 m-85 -108.46 137.26 46.71 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.119 0.485 . . . . 0.0 110.792 175.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -122.43 141.75 51.27 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.28 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -74.36 118.69 17.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.715 0.769 . . . . 0.0 109.004 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -134.25 166.82 21.91 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.322 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 40' ' ' LYS . 3.5 mp -112.14 141.89 26.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.421 HD11 ' CG1' ' A' ' 63' ' ' VAL . 3.2 mp -74.26 122.57 27.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -101.18 -27.3 13.3 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.264 0.554 . . . . 0.0 110.241 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 53.7 tptt -162.72 142.24 9.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.493 ' HB3' ' CG1' ' A' ' 33' ' ' VAL . 25.3 mt -119.0 127.09 53.13 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 171.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.621 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 3.7 m . . . . . 0 C--N 1.279 -2.49 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 49.2 m . . . . . 0 N--CA 1.441 -0.904 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -118.59 145.25 45.54 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.694 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 55.5 m-85 -124.69 121.9 35.97 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 124.152 0.907 . . . . 0.0 109.115 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 70.5 m -95.09 107.73 19.8 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.572 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 30.3 m -109.64 147.16 14.25 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.884 -176.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.92 128.48 57.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -90.49 179.06 5.94 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.915 -172.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -52.0 -39.71 59.83 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.488 1.515 . . . . 0.0 112.809 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.39 -13.73 58.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.421 0.629 . . . . 0.0 111.866 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.49 -0.44 43.06 Favored Glycine 0 C--N 1.292 -1.884 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.84 175.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -87.56 154.08 20.9 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 6.8 pt-20 -130.42 137.61 49.92 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 120.861 0.362 . . . . 0.0 110.084 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 87' ' ' THR . 0.6 OUTLIER -139.21 158.64 43.8 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.886 -177.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.1 m -101.57 117.22 34.47 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.444 0.465 . . . . 0.0 110.235 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.405 ' CD2' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -136.2 165.1 26.52 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.078 0.951 . . . . 0.0 111.909 -177.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -100.12 -171.3 2.01 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.407 HH21 ' HA ' ' A' ' 6' ' ' TYR . 3.6 mpt_? -75.93 -5.34 45.69 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.654 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 p -71.27 -21.13 62.14 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.671 0.748 . . . . 0.0 110.11 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 23.3 m -106.64 -16.17 14.58 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.053 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 14' ' ' SER . 87.6 mt -93.05 127.33 38.54 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.612 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 18.8 m . . . . . 0 C--N 1.29 -1.995 0 CA-C-O 121.168 0.508 . . . . 0.0 110.431 -176.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.2 p90 . . . . . 0 N--CA 1.42 -1.965 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.472 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 22.1 mt -85.88 178.71 7.2 Favored 'General case' 0 C--N 1.277 -2.571 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.586 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 p -133.0 168.34 18.65 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.264 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.29 148.66 11.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 123.853 0.861 . . . . 0.0 111.562 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.23 -5.94 81.17 Favored Glycine 0 CA--C 1.505 -0.531 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.963 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.527 ' HB ' HD12 ' A' ' 26' ' ' ILE . 8.6 m -82.62 139.82 33.55 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 122.346 0.258 . . . . 0.0 110.532 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -104.93 111.06 23.69 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 104' ' ' CYS . 29.3 m -127.24 171.97 14.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 21.2 m -95.11 142.81 27.13 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.598 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.78 129.36 36.48 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.027 0.531 . . . . 0.0 109.701 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 21.1 ptmt -94.83 120.31 34.84 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.706 0.765 . . . . 0.0 110.379 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -119.97 120.97 37.9 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? 63.78 26.28 14.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.53 0.681 . . . . 0.0 110.729 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.85 -14.88 63.09 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.501 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.31 130.17 52.15 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 16' ' ' LYS 0.289 6.6 p90 -105.0 123.96 48.7 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -177.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.2 t -115.06 160.61 19.42 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -90.69 148.94 22.28 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-O 121.887 0.851 . . . . 0.0 110.08 178.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -144.54 149.34 35.71 Favored 'General case' 0 C--N 1.259 -3.334 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.699 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.76 126.26 51.65 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.583 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.527 HD12 ' HB ' ' A' ' 11' ' ' THR . 30.8 mt -68.95 119.45 14.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 123.526 0.73 . . . . 0.0 112.268 -175.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -91.29 -53.38 4.37 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.057 0.932 . . . . 0.0 109.455 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 m -129.71 143.41 50.8 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.463 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.71 123.66 61.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.301 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -112.71 117.98 33.72 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 171.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -72.05 108.31 5.2 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 84' ' ' SER . 6.6 tt -129.34 136.76 50.43 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-O 121.544 0.688 . . . . 0.0 109.34 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.4 t -115.59 132.97 63.41 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.126 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.088 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -84.69 101.54 12.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 170.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.402 HG12 HG13 ' A' ' 37' ' ' VAL . 14.3 t -91.8 118.27 36.86 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.07 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.779 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 87.7 tttt -80.52 103.71 10.56 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 65' ' ' THR . 3.9 m -111.55 143.52 21.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-O 121.689 0.757 . . . . 0.0 111.21 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.04 117.13 32.46 Favored 'General case' 0 C--N 1.267 -3.018 0 CA-C-N 113.149 -1.841 . . . . 0.0 106.91 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.49 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 75.7 mt -73.72 108.5 6.59 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -62.25 -30.32 71.03 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -80.22 -40.15 27.69 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.241 0.543 . . . . 0.0 111.697 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -95.05 -25.38 16.49 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.242 0.544 . . . . 0.0 111.384 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 74.42 22.67 2.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.524 1.53 . . . . 0.0 113.12 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.97 150.17 24.47 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.655 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.9 m -119.03 151.87 37.44 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -157.85 161.88 38.35 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 123.451 0.7 . . . . 0.0 109.619 177.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 mt -113.11 102.31 10.27 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.7 m -117.94 172.51 5.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.597 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -84.9 161.5 19.82 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.058 0.456 . . . . 0.0 111.963 -174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -64.44 -20.15 65.99 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.271 1.029 . . . . 0.0 111.06 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.58 -21.92 47.88 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.783 0.801 . . . . 0.0 109.533 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 65' ' ' THR . 96.6 mt-30 -98.31 -11.57 22.41 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.656 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.88 111.51 27.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.569 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -98.4 103.75 15.72 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.227 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 140.71 178.87 17.63 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.505 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.53 140.32 80.98 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.346 2.697 . . . . 0.0 113.93 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -89.35 82.27 6.51 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.523 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 73.5 mtp180 -140.11 134.47 31.32 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.455 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.79 118.61 10.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.17 53.86 Favored Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.43 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -96.33 155.84 16.59 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.704 0.752 . . . . 0.0 110.619 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.09 116.92 39.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.426 0.632 . . . . 0.0 109.334 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.523 HG12 ' HA3' ' A' ' 55' ' ' GLY . 30.4 m -126.82 170.61 16.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.565 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -112.84 121.46 44.75 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 9.2 t -119.68 157.59 28.2 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.956 -174.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -81.93 126.17 31.61 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.759 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.7 p -90.31 -176.07 4.7 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.0 m -67.26 -26.31 66.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -79.85 -6.9 58.25 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.387 0.613 . . . . 0.0 110.56 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.27 -18.57 56.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.51 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 m -72.78 141.75 48.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 122.786 0.434 . . . . 0.0 110.081 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 65' ' ' THR . 45.0 m-85 -89.88 133.23 34.87 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.49 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 32.0 tt0 -124.09 146.52 48.55 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.05 117.31 19.24 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 122.484 1.135 . . . . 0.0 110.754 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.455 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -124.93 174.03 8.25 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 113.494 -1.685 . . . . 0.0 110.987 -174.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 10.9 mt -117.15 144.34 25.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -77.88 125.85 37.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 175.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 t -102.64 -20.89 14.25 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -173.92 153.32 2.12 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.4 OUTLIER -129.77 115.39 17.22 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.759 0.79 . . . . 0.0 111.437 172.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.9 m . . . . . 0 C--N 1.298 -1.667 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.083 -176.71 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.48 ' HA ' ' HB3' ' A' ' 32' ' ' LEU . 31.2 m . . . . . 0 N--CA 1.437 -1.082 0 N-CA-C 113.37 0.878 . . . . 0.0 113.37 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -95.81 134.11 39.15 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.155 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 91.0 m-85 -125.89 104.42 8.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 55.2 m -83.53 106.9 15.64 Favored 'General case' 0 N--CA 1.408 -2.553 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.453 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 26.8 m -113.45 142.74 24.92 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.758 -174.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 9.9 p -99.39 125.29 52.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.78 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 72.4 m-85 -88.24 178.72 6.53 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.183 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.44 -31.85 56.29 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.015 0.926 . . . . 0.0 111.66 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.74 -17.09 64.37 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.894 0.877 . . . . 0.0 111.503 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.46 6.9 83.13 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.335 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -97.15 136.53 37.54 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 11.6 pt-20 -107.02 126.93 52.97 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.585 0.707 . . . . 0.0 110.06 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -122.5 145.35 48.39 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 44.4 m -87.65 119.86 28.38 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -109.69 166.21 11.08 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.226 0.536 . . . . 0.0 111.389 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -94.47 152.03 18.9 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.519 -1.219 . . . . 0.0 107.968 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -50.79 -49.53 58.18 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.888 1.275 . . . . 0.0 111.759 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 p -79.83 11.16 3.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.289 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 m -120.12 5.87 10.8 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 tp -117.95 165.87 13.19 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.764 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.453 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 43.5 t . . . . . 0 N--CA 1.433 -1.31 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.5 p90 . . . . . 0 N--CA 1.394 -3.267 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 86' ' ' TYR . 89.9 mt -94.03 174.82 6.96 Favored 'General case' 0 C--N 1.263 -3.193 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.5 p -133.33 161.1 35.42 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -69.73 149.39 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-O 121.429 0.633 . . . . 0.0 111.998 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.81 -7.77 55.61 Favored Glycine 0 C--N 1.289 -2.058 0 CA-C-N 114.547 -1.206 . . . . 0.0 113.722 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 t -102.65 164.42 11.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.16 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 17.3 t70 -117.25 128.48 55.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -172.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.0 m -128.78 173.88 12.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.844 0.83 . . . . 0.0 110.415 -175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.516 ' HB2' ' SG ' ' A' ' 104' ' ' CYS . 13.6 m -110.04 121.89 46.3 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 106.851 -1.536 . . . . 0.0 106.851 172.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.42 144.44 34.34 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -96.28 126.88 41.8 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.054 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -131.62 122.25 25.7 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? 59.44 26.67 15.64 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.224 0.535 . . . . 0.0 111.894 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.52 0.2 88.17 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.721 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.88 148.88 29.96 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -96.98 133.09 42.1 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.1 m -129.05 139.85 51.86 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.92 132.81 40.5 Favored 'General case' 0 N--CA 1.398 -3.056 0 C-N-CA 123.52 0.728 . . . . 0.0 109.341 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.53 144.36 21.68 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.52 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.468 ' HB2' ' NZ ' ' A' ' 25' ' ' LYS . 4.4 ttmp? -106.12 133.37 50.93 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -176.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.548 ' HA ' HG12 ' A' ' 88' ' ' VAL . 24.1 mt -64.95 110.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.301 0.572 . . . . 0.0 111.201 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -94.72 -40.72 9.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.298 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -133.24 143.24 48.98 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.866 0.365 . . . . 0.0 110.063 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.63 124.6 69.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.864 0.866 . . . . 0.0 109.159 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -118.22 112.47 20.15 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.089 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -77.18 96.57 4.54 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.045 178.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' A' ' 85' ' ' TRP . 8.6 mp -122.59 114.74 21.04 Favored 'General case' 0 CA--C 1.462 -2.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.022 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.8 t -115.73 114.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.38 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 94.2 mttt -79.25 106.01 10.98 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.978 0.894 . . . . 0.0 109.19 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.8 t -91.8 127.32 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.041 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.099 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 35.6 ttpt -97.36 127.73 43.57 Favored 'General case' 0 N--CA 1.406 -2.659 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.84 160.85 21.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.59 0 O-C-N 123.449 0.468 . . . . 0.0 109.764 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -122.74 118.35 27.86 Favored 'General case' 0 C--N 1.274 -2.674 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 75' ' ' ALA . 81.1 mt -68.75 121.94 17.55 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.477 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -55.9 -44.27 78.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.396 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -80.85 -61.27 2.01 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.024 -173.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.94 -22.31 39.71 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.25 -0.887 . . . . 0.0 112.878 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.26 19.21 2.91 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.329 0.652 . . . . 0.0 112.743 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.403 ' OG1' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -82.7 142.22 31.82 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 36' ' ' LYS . 3.2 m -109.18 137.44 47.06 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 3.6 tp60 -136.03 140.81 44.13 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -172.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.455 HD13 ' HB2' ' A' ' 36' ' ' LYS . 41.4 tp -119.67 101.96 8.28 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.6 t -135.71 152.9 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -175.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 5.3 pm0 -71.57 153.45 42.13 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.516 0.674 . . . . 0.0 112.523 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -55.8 -11.83 1.12 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.899 2.079 . . . . 0.0 114.234 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -77.82 -25.93 49.17 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.629 0.728 . . . . 0.0 110.557 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -106.97 -2.68 20.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.918 0.866 . . . . 0.0 110.144 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.423 HG22 HG23 ' A' ' 65' ' ' THR . 53.1 t -101.44 113.27 37.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.953 174.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -94.1 97.99 10.68 Favored 'General case' 0 C--N 1.276 -2.605 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.278 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.519 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 153.78 -166.48 31.89 Favored Glycine 0 N--CA 1.429 -1.797 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.042 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.46 146.49 19.41 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.971 2.447 . . . . 0.0 112.293 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.495 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -98.25 82.21 2.89 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.847 1.308 . . . . 0.0 108.421 176.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.548 ' O ' HG13 ' A' ' 77' ' ' ILE . 19.4 tpt180 -140.78 117.97 11.3 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.723 -2.035 . . . . 0.0 107.26 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.439 ' HA ' ' CG2' ' A' ' 77' ' ' ILE . 47.1 t -56.54 123.44 7.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-N 118.439 0.563 . . . . 0.0 109.868 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.438 ' H ' ' HB ' ' A' ' 77' ' ' ILE . . . 98.43 7.83 55.45 Favored Glycine 0 N--CA 1.42 -2.406 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.84 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.496 ' O ' HG12 ' A' ' 77' ' ' ILE . . . -96.21 153.11 17.98 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 118.743 1.271 . . . . 0.0 109.575 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.444 HG12 HD12 ' A' ' 76' ' ' ILE . 65.2 mt -94.74 119.53 42.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.519 HG12 ' HA3' ' A' ' 55' ' ' GLY . 27.5 m -133.13 169.68 21.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.0 -175.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -111.97 120.17 41.0 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.423 HG23 HG22 ' A' ' 53' ' ' VAL . 18.9 m -106.56 146.53 30.54 Favored 'General case' 0 N--CA 1.396 -3.17 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -68.68 119.61 13.36 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.55 0.691 . . . . 0.0 111.058 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.416 ' HB ' ' HG2' ' A' ' 73' ' ' GLN . 9.8 t -92.21 161.84 14.56 Favored 'General case' 0 N--CA 1.403 -2.787 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.0 m -74.32 6.54 3.54 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.713 0.768 . . . . 0.0 111.688 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.6 -8.2 57.69 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.09 -22.08 39.35 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.03 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 m -99.27 -175.62 3.07 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 120.648 0.261 . . . . 0.0 110.726 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -111.55 136.74 50.31 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.416 ' HG2' ' HB ' ' A' ' 67' ' ' THR . 22.6 pt20 -124.05 154.49 39.85 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.23 123.08 20.19 Favored 'General case' 0 C--O 1.246 0.909 0 O-C-N 124.172 0.92 . . . . 0.0 111.645 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.19 170.89 14.88 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.475 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.444 HD12 HG12 ' A' ' 62' ' ' ILE . 9.8 mm -113.96 143.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 58' ' ' ARG . 11.4 mm -66.77 125.62 24.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.5 p -107.44 -25.91 11.2 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.152 0.501 . . . . 0.0 110.914 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 21.8 tptm -163.09 165.27 24.87 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.99 129.61 18.05 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.672 0.789 . . . . 0.0 108.976 172.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.3 m . . . . . 0 C--N 1.297 -1.69 0 C-N-CA 123.412 0.685 . . . . 0.0 109.341 -176.832 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.443 -0.799 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.42 ' CD1' HD22 ' A' ' 32' ' ' LEU . 95.4 m95 -88.45 120.4 29.79 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.132 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 7' ' ' LEU . 90.6 m-85 -113.35 110.52 20.47 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 27.7 m -89.33 108.21 19.5 Favored 'General case' 0 N--CA 1.389 -3.497 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 26' ' ' ILE . 17.1 m -105.92 140.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.455 -176.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.21 139.98 29.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.597 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.422 ' CE2' ' HD3' ' A' ' 96' ' ' ARG . 65.3 m-85 -91.27 172.75 8.32 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.63 -12.26 57.32 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.485 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -75.75 -17.92 59.73 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.174 175.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.18 -10.66 67.63 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.831 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -97.21 161.8 13.64 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.409 ' C ' ' HD2' ' A' ' 96' ' ' ARG . 9.3 pt-20 -137.6 157.47 46.44 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -171.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 87' ' ' THR . 4.2 mpt_? -129.54 151.4 50.19 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.895 0.878 . . . . 0.0 110.061 173.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.9 m -102.27 113.95 27.7 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 3.7 mm? -113.86 168.31 9.9 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.673 0.789 . . . . 0.0 110.946 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -89.31 157.31 18.25 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 173.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.461 ' C ' ' HD3' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -50.22 -38.1 38.65 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.518 0.599 . . . . 0.0 111.513 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.5 m -79.04 -3.66 46.31 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.511 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 15.7 m -98.56 5.75 47.64 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 121.114 -0.991 . . . . 0.0 108.376 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.7 mp -112.9 145.13 41.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.467 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.516 ' SG ' ' HB2' ' A' ' 14' ' ' SER . 5.9 p . . . . . 0 C--N 1.281 -2.384 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.209 172.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.533 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 40.4 p90 . . . . . 0 N--CA 1.418 -2.062 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.587 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 21.3 mt -90.83 -176.0 4.54 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.656 0.597 . . . . 0.0 109.619 173.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -125.16 156.64 38.07 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.559 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -85.19 139.67 17.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -174.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.94 -5.65 83.17 Favored Glycine 0 CA--C 1.505 -0.586 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 96.8 m -79.68 133.89 36.39 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-O 121.491 0.662 . . . . 0.0 110.538 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -92.19 129.12 38.22 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.0 m -137.1 -178.88 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.763 0.792 . . . . 0.0 112.006 -173.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 m -125.69 135.79 52.49 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 172.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -127.65 135.35 50.12 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 19.6 pttp -93.06 143.21 26.47 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 118.62 -1.232 . . . . 0.0 113.599 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -134.78 124.93 25.94 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 58.11 25.47 12.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.552 1.141 . . . . 0.0 110.935 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.33 -9.42 76.17 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.327 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.74 131.43 50.93 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 76.6 m-85 -84.78 122.38 29.04 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.753 0.311 . . . . 0.0 110.704 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -106.98 149.0 27.98 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -80.5 143.38 33.36 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.32 148.51 16.63 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -115.49 132.52 56.6 Favored 'General case' 0 C--N 1.274 -2.709 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.712 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.443 ' HA ' HG12 ' A' ' 88' ' ' VAL . 63.2 mt -61.07 107.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.891 0.853 . . . . 0.0 111.681 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.531 ' HG2' ' OE1' ' A' ' 95' ' ' GLU . 24.0 tptm -83.85 -44.99 13.74 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 125.517 1.527 . . . . 0.0 109.662 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 m -138.9 144.91 39.33 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.39 118.09 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 123.645 0.778 . . . . 0.0 109.808 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -123.14 107.85 12.19 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.015 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -77.43 105.47 8.58 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -132.88 120.5 21.59 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.219 0.533 . . . . 0.0 110.658 -175.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.61 129.35 37.83 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 32.9 mmtp -83.02 104.93 13.6 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 37' ' ' VAL . 2.8 t -95.56 125.5 48.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.964 -174.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.411 ' HB2' HD13 ' A' ' 47' ' ' LEU . 49.0 tttm -99.74 105.73 17.56 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.527 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 23.8 m -117.07 156.1 18.47 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-O 121.151 0.501 . . . . 0.0 111.486 -175.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -113.93 114.67 26.53 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 173.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.8 mt -68.93 113.54 6.43 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.309 0.0 OUTLIER -72.98 -19.04 61.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -90.08 -27.02 19.95 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.909 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -112.22 -8.85 13.95 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.277 0.56 . . . . 0.0 111.804 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 p30 58.7 16.55 4.46 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.554 1.942 . . . . 0.0 113.986 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -98.6 150.72 21.45 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 121.994 -0.441 . . . . 0.0 111.107 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 m -99.56 144.77 28.26 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -142.89 142.3 31.72 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -174.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 36' ' ' LYS . 43.5 tp -125.42 102.62 7.49 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.16 178.73 4.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.921 -173.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.507 ' HG3' ' HB3' ' A' ' 51' ' ' ASP . 14.1 pt20 -92.02 154.53 18.71 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -174.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -54.63 -28.39 46.52 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 126.352 1.861 . . . . 0.0 111.515 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.507 ' HB3' ' HG3' ' A' ' 49' ' ' GLN . 8.2 t70 -63.38 -27.89 69.62 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.306 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -108.32 -9.54 15.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.985 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -100.38 127.29 53.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.233 0.54 . . . . 0.0 111.648 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -106.75 127.14 53.14 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.111 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.21 -173.28 17.93 Favored Glycine 0 C--N 1.296 -1.661 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.497 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -82.66 138.03 9.28 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.279 2.653 . . . . 0.0 112.311 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.7 83.03 4.79 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.79 0.805 . . . . 0.0 110.51 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.522 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 23.0 mtp180 -135.2 133.63 39.27 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.807 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.58 120.99 11.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.68 58.98 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.597 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.71 164.11 12.54 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 117.488 0.644 . . . . 0.0 111.46 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.6 mm -95.86 118.41 42.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.546 HG13 HD11 ' A' ' 77' ' ' ILE . 15.7 m -126.18 175.57 8.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -128.66 120.66 26.96 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.425 HG21 HG21 ' A' ' 37' ' ' VAL . 9.8 t -118.27 158.7 24.68 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.14 -174.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 67' ' ' THR . 37.2 ttm180 -76.87 139.48 40.28 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.334 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 16.9 p -94.1 171.82 8.61 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.8 m -55.7 -34.28 64.94 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -82.65 -4.92 58.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.96 3.93 56.83 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.483 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 58.1 m -87.53 168.75 12.79 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -121.7 139.85 53.05 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.111 0.482 . . . . 0.0 110.648 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -140.72 143.9 35.27 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.4 142.56 53.87 Favored 'General case' 0 C--O 1.254 1.326 0 CA-C-O 121.335 0.588 . . . . 0.0 110.946 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -148.97 164.66 33.9 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.87 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 5.4 mm -110.19 137.17 43.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.546 HD11 HG13 ' A' ' 63' ' ' VAL . 3.5 mp -72.84 122.9 26.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.5 m -103.82 -19.85 14.13 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.114 0.483 . . . . 0.0 109.825 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -168.68 156.46 7.85 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.18 139.67 37.6 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 172.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 85.6 m . . . . . 0 C--N 1.283 -2.305 0 CA-C-O 121.042 0.449 . . . . 0.0 110.475 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.409 -2.486 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -97.58 116.32 29.56 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-O 121.405 0.621 . . . . 0.0 110.621 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.587 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 53.3 m-85 -104.75 102.88 12.43 Favored 'General case' 0 N--CA 1.395 -3.205 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.4 m -79.91 105.61 11.32 Favored 'General case' 0 N--CA 1.384 -3.739 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 26' ' ' ILE . 16.4 m -105.42 140.39 23.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 p -111.52 130.27 65.37 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.045 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.511 -174.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -83.24 163.97 20.41 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.76 -7.56 45.83 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.365 0.602 . . . . 0.0 110.617 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -72.18 -17.56 61.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.978 173.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.4 -9.31 60.84 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.298 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.06 144.72 25.64 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.531 ' OE1' ' HG2' ' A' ' 27' ' ' LYS . 2.8 pt-20 -124.37 131.72 53.51 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.407 0.622 . . . . 0.0 110.542 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -115.78 151.16 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 m -103.11 108.58 19.82 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 120.738 0.304 . . . . 0.0 110.22 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.27 156.21 31.69 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.705 0.402 . . . . 0.0 111.188 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -99.55 169.92 8.96 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -56.54 -23.4 39.7 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.7 m -60.31 -39.55 87.42 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.771 0.829 . . . . 0.0 111.679 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 15.0 m -90.27 -6.88 54.67 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 mp -102.5 153.9 19.62 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.511 -175.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 72.8 m . . . . . 0 C--N 1.311 -1.083 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.066 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.47 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 18.9 p90 . . . . . 0 N--CA 1.433 -1.292 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.8 mt -93.78 -161.54 0.86 Allowed 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 p -131.54 162.43 30.3 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -171.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.3 t -64.91 142.18 17.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.902 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.92 -32.97 6.0 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.9 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.577 ' HB ' HD12 ' A' ' 26' ' ' ILE . 4.0 m -56.97 138.95 53.49 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.993 0.917 . . . . 0.0 110.564 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -111.3 113.67 26.31 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.9 m -135.43 -179.15 2.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 123.102 0.561 . . . . 0.0 109.708 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 m -105.24 142.81 34.36 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.475 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.81 119.3 29.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.46 ' HE2' ' HA2' ' A' ' 19' ' ' GLY . 13.7 tmtt? -88.43 107.22 18.74 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -129.12 139.53 51.92 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 59.6 25.07 13.91 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 122.018 0.913 . . . . 0.0 110.427 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . 91.0 1.73 72.5 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.28 -0.962 . . . . 0.0 114.325 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.51 145.54 43.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 117.916 0.858 . . . . 0.0 109.905 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -106.1 133.9 50.07 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.033 0.92 . . . . 0.0 113.473 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.6 t -122.75 158.25 30.57 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -72.92 147.42 45.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.67 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -149.82 142.33 24.4 Favored 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.57 -174.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 44.4 tttp -110.12 131.14 55.33 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.774 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.577 HD12 ' HB ' ' A' ' 11' ' ' THR . 36.6 mt -66.39 115.67 4.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -101.24 -36.24 8.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.136 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.2 m -140.14 144.73 36.84 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.1 t -116.57 120.18 64.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.444 ' HD3' ' N ' ' A' ' 31' ' ' ARG . 1.5 tmtp? -113.93 140.59 48.26 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.444 ' N ' ' HD3' ' A' ' 30' ' ' LYS . 10.9 mmt180 -75.03 118.36 17.9 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.728 0.775 . . . . 0.0 111.688 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.509 ' HB3' ' N ' ' A' ' 84' ' ' SER . 58.7 tp -91.51 164.5 13.77 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 127.01 2.124 . . . . 0.0 107.256 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.56 124.27 63.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 118.142 -1.423 . . . . 0.0 110.844 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -94.79 104.22 16.12 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 122.557 1.17 . . . . 0.0 108.202 172.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG12 HG13 ' A' ' 37' ' ' VAL . 15.8 t -87.35 128.69 39.72 Favored 'Isoleucine or valine' 1 C--N 1.244 -4.002 0 CA-C-N 112.753 -2.022 . . . . 0.0 109.648 -174.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 86.9 tttt -98.77 112.15 24.31 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 65' ' ' THR . 15.9 m -115.78 153.98 17.3 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 121.386 0.612 . . . . 0.0 111.727 -175.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -116.97 114.75 24.25 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.486 HD23 ' HB2' ' A' ' 75' ' ' ALA . 62.6 mt -75.35 120.52 20.93 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.3 ptpt -67.81 -30.24 69.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -79.53 -41.51 27.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.381 0.61 . . . . 0.0 111.725 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.85 -15.15 21.39 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.021 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.279 0.0 OUTLIER 63.21 16.93 9.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.664 1.985 . . . . 0.0 112.222 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -93.27 145.24 24.59 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.244 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -96.45 142.53 28.44 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -144.48 141.31 29.47 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.9 mt -100.87 113.25 26.02 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.78 179.72 2.84 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.033 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.528 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -117.08 165.09 13.78 Favored 'General case' 0 C--N 1.27 -2.866 0 O-C-N 122.29 -0.256 . . . . 0.0 110.527 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -59.35 -18.76 41.04 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.637 1.575 . . . . 0.0 111.86 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.54 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 12.0 t70 -70.93 -34.43 71.49 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.118 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 26.4 mt-30 -95.54 -10.54 29.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.181 -175.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.6 t -105.23 134.94 45.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.714 -177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.415 ' HE2' ' CD1' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -125.66 118.07 24.87 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.263 0.554 . . . . 0.0 110.73 168.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 142.77 -165.07 26.96 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.563 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.91 137.0 12.19 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.865 2.377 . . . . 0.0 113.131 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -96.51 81.57 3.25 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.55 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 42.5 ttp180 -140.85 139.49 34.47 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.109 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.3 t -67.21 122.39 18.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.55 4.18 59.43 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.753 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.08 161.65 14.19 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.947 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.6 mm -107.4 119.29 56.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.517 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.427 HG12 ' HA3' ' A' ' 55' ' ' GLY . 28.0 m -130.47 176.58 8.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -119.85 131.46 55.28 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.497 HG21 HG21 ' A' ' 37' ' ' VAL . 7.8 t -145.1 155.99 43.64 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.182 -171.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.622 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 46.7 ttt180 -89.26 122.42 32.5 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.483 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.8 t -84.62 168.02 15.72 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.2 p -70.78 -5.01 26.87 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.504 0.669 . . . . 0.0 111.611 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.66 -10.24 59.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.968 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.75 -22.2 36.25 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.98 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.5 p -87.75 144.81 26.43 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.622 ' CE1' ' HB2' ' A' ' 66' ' ' ARG . 87.1 m-85 -94.26 120.43 34.49 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -135.84 160.18 39.38 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 39.3 tt0 -76.72 132.04 39.1 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.486 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.03 173.68 11.25 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 122.153 -0.342 . . . . 0.0 111.591 -175.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.45 140.69 42.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.1 mp -79.52 128.44 38.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 120.658 0.266 . . . . 0.0 110.564 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 m -107.2 -17.25 14.2 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.992 0.517 . . . . 0.0 110.871 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 50.3 tptt -171.87 156.48 4.19 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.17 143.4 50.58 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.423 -1.812 0 C-N-CA 122.693 0.397 . . . . 0.0 110.485 178.733 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 1.3 p . . . . . 0 CA--C 1.552 1.035 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.443 ' HB2' ' HB3' ' A' ' 30' ' ' LYS 0.265 75.6 m95 -95.98 155.87 16.57 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 168.202 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.47 ' CD1' HD13 ' A' ' 26' ' ' ILE . 89.5 m-85 -134.58 117.85 16.6 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.558 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 17.8 m -84.03 104.37 14.04 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.67 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 22.8 m -109.92 141.62 24.71 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.837 0 CA-C-O 121.502 0.668 . . . . 0.0 110.462 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 6.3 t -97.9 116.72 41.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -72.89 159.92 32.96 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -57.2 -20.78 28.93 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.772 0.796 . . . . 0.0 111.072 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.65 -16.76 64.32 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.944 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.28 -6.88 59.77 Favored Glycine 0 C--O 1.241 0.555 0 CA-C-O 121.478 0.488 . . . . 0.0 112.402 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -96.8 141.34 30.13 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.56 128.29 54.81 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -136.32 147.5 47.46 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 18.6 m -99.38 107.43 19.68 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.24 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.85 170.41 8.16 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.54 ' HD3' ' OD1' ' A' ' 51' ' ' ASP . 2.2 mpt_? -94.9 175.2 6.74 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -72.6 -3.05 22.4 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.453 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 m -71.48 -41.29 69.52 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -109.82 22.63 15.43 Favored 'General case' 0 C--O 1.252 1.217 0 CA-C-O 121.761 0.791 . . . . 0.0 110.171 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.6 tp -112.67 142.72 44.94 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.478 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 15.4 t . . . . . 0 N--CA 1.431 -1.386 0 CA-C-O 121.695 0.759 . . . . 0.0 110.249 -177.338 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.756 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 45.2 p90 . . . . . 0 N--CA 1.413 -2.278 0 CA-C-O 121.14 0.495 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt -106.21 -175.68 2.86 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.645 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.9 p -131.33 158.53 40.43 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.33 130.59 28.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.66 38.19 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.043 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.531 ' HB ' HD12 ' A' ' 26' ' ' ILE . 33.2 m -81.23 139.47 35.47 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 120.821 0.343 . . . . 0.0 110.401 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.07 104.87 17.4 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.202 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.4 m -113.5 -179.28 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.836 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.532 ' OG ' ' HB3' ' A' ' 104' ' ' CYS . 3.0 p -131.14 135.34 47.38 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 21' ' ' PHE . . . -111.92 125.64 54.26 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 124.476 1.11 . . . . 0.0 109.672 -171.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -77.03 117.73 18.9 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.571 0.7 . . . . 0.0 109.569 173.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -129.62 135.95 49.17 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 59.4 25.65 14.41 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 121.521 0.677 . . . . 0.0 110.483 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.91 10.59 75.24 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.705 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.65 136.54 37.55 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 117.525 0.663 . . . . 0.0 110.437 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 35.4 p90 -98.79 129.59 45.21 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.47 -0.892 . . . . 0.0 113.127 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -129.26 157.39 42.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 10.5 pt-20 -74.01 146.25 43.92 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 121.779 0.8 . . . . 0.0 112.646 -174.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -151.99 145.8 25.1 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -105.07 133.75 49.32 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.673 -174.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.531 HD12 ' HB ' ' A' ' 11' ' ' THR . 39.3 mt -65.96 112.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.106 0.479 . . . . 0.0 110.451 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -94.72 -39.25 10.4 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.109 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 m -137.9 144.5 41.34 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 79.8 t -123.61 118.55 54.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 59.2 mtpt -112.22 96.95 6.32 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -83.27 108.38 16.45 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 84' ' ' SER . 2.4 pt? -144.05 107.61 4.62 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.048 0.928 . . . . 0.0 109.286 176.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 p -100.53 123.22 53.32 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.856 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 52.3 mtpt -85.12 100.64 11.85 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 122.066 0.936 . . . . 0.0 109.237 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 31.1 t -84.82 132.7 31.03 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 113.754 -1.566 . . . . 0.0 109.336 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 88.4 tttt -89.53 112.91 24.22 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.612 HG21 HG21 ' A' ' 65' ' ' THR . 3.7 m -123.64 153.46 29.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.216 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.323 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 8.2 tt -121.8 122.58 39.8 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.539 HD13 ' HB2' ' A' ' 75' ' ' ALA . 1.5 mm? -73.4 110.71 7.9 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.56 ' HB3' HD11 ' A' ' 76' ' ' ILE . 12.4 ptmm? -64.35 -20.19 65.96 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.228 0.537 . . . . 0.0 112.436 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -79.29 -46.66 17.3 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.817 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -98.51 -17.84 18.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.435 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 71.67 25.64 3.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.077 1.351 . . . . 0.0 111.593 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -104.68 155.74 18.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.751 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 38' ' ' LEU . 3.9 m -100.18 154.65 18.28 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -149.32 143.94 26.13 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 tp -128.11 102.15 6.59 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 10.6 m -137.66 168.12 21.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.297 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 29.7 pt20 -74.68 164.96 25.98 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.139 -174.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.47 ' OD1' ' HA ' ' A' ' 32' ' ' LEU . 7.7 p-10 -71.8 -5.6 35.38 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.849 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -73.85 -23.6 59.64 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 65' ' ' THR . 8.9 mm-40 -92.58 -34.45 14.02 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.048 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 89.3 t -79.24 111.05 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.198 0.999 . . . . 0.0 112.7 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -111.63 103.06 11.34 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.27 -159.85 28.16 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.1 128.59 6.5 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.901 1.734 . . . . 0.0 112.123 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 mp -88.8 81.6 6.94 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.521 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 22.6 mmt180 -139.17 135.8 34.39 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.695 -175.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.0 t -66.76 117.83 8.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.53 3.93 55.05 Favored Glycine 0 C--N 1.303 -1.261 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.532 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.19 164.01 12.67 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.027 0.414 . . . . 0.0 110.652 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.3 mm -105.48 124.89 60.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' A' ' 77' ' ' ILE . 19.7 m -130.15 -177.63 2.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 123.028 0.531 . . . . 0.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -118.25 136.1 53.88 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.066 -1.828 . . . . 0.0 106.066 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.612 HG21 HG21 ' A' ' 37' ' ' VAL . 13.4 t -140.11 156.63 46.48 Favored 'General case' 0 C--N 1.275 -2.643 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.794 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.476 ' H ' ' HB3' ' A' ' 52' ' ' GLN . 12.1 ttm180 -83.85 108.77 17.07 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 69' ' ' ASP . 12.7 t -81.09 178.86 8.15 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 m -64.23 -16.33 61.82 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.241 0.543 . . . . 0.0 112.051 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 67' ' ' THR . 20.7 t70 -73.82 -26.01 60.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.347 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.95 -18.83 36.32 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.49 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -84.32 154.69 22.77 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 65' ' ' THR . 90.1 m-85 -89.36 115.36 26.76 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.525 ' HB3' HD12 ' A' ' 39' ' ' LEU . 2.8 tp60 -108.84 143.86 37.48 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -174.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.78 136.85 38.18 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.423 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' ' 39' ' ' LEU . . . -145.23 168.1 21.22 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.428 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.56 HD11 ' HB3' ' A' ' 40' ' ' LYS . 1.6 mp -112.45 144.13 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.3 mp -83.5 129.38 37.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.2 m -110.97 -19.32 12.82 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 122.617 0.367 . . . . 0.0 110.885 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 54.0 tttm -168.52 159.54 10.32 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 4.1 mp -127.63 139.87 52.46 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 167.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.5 m . . . . . 0 C--N 1.29 -1.989 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.602 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.505 ' HA ' HD23 ' A' ' 32' ' ' LEU . 19.5 m . . . . . 0 N--CA 1.437 -1.102 0 CA-C-O 122.078 0.942 . . . . 0.0 112.5 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.516 ' HB3' ' OG1' ' A' ' 97' ' ' THR . 74.7 m95 -95.82 116.98 29.7 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.555 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.756 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 82.6 m-85 -105.56 105.06 14.92 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.2 m -84.37 104.13 14.13 Favored 'General case' 0 N--CA 1.398 -3.06 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 26' ' ' ILE . 28.5 m -108.59 142.12 22.04 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.575 -175.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.53 124.03 53.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.463 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -85.78 -179.89 6.93 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.814 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -68.57 -26.56 65.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.119 0.485 . . . . 0.0 110.78 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -68.87 -11.86 60.98 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.536 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.56 14.43 68.14 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -94.47 131.77 39.83 Favored 'General case' 0 CA--C 1.473 -2.01 0 CA-C-N 114.865 -0.668 . . . . 0.0 109.215 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.52 127.27 49.66 Favored 'General case' 0 C--N 1.268 -2.96 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.28 138.96 54.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.516 ' OG1' ' HB3' ' A' ' 85' ' ' TRP . 4.9 t -113.59 113.51 25.17 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.197 -1.401 . . . . 0.0 110.884 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.412 HD11 ' CB ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -127.49 172.2 10.91 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.618 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -98.7 173.21 7.01 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -60.15 -39.72 87.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.417 1.087 . . . . 0.0 111.283 -173.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.3 p -72.41 0.89 8.99 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.3 t -116.05 7.48 14.29 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.18 132.96 53.7 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.561 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.532 ' HB3' ' OG ' ' A' ' 14' ' ' SER . 22.3 t . . . . . 0 C--N 1.304 -1.373 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.038 -176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.3 p90 . . . . . 0 N--CA 1.446 -0.649 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.63 -172.47 3.58 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.4 p -128.36 156.63 42.8 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -169.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.65 126.65 29.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.011 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.55 -19.31 42.44 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 121.245 -0.503 . . . . 0.0 112.275 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.459 ' HB ' HD12 ' A' ' 26' ' ' ILE . 30.9 m -69.29 137.39 52.98 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.062 0.458 . . . . 0.0 110.669 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -86.44 131.83 34.09 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.406 HG21 HG11 ' A' ' 88' ' ' VAL . 30.8 m -137.22 -179.44 2.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-O 121.446 0.641 . . . . 0.0 111.494 -173.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.491 ' OG ' ' HB2' ' A' ' 104' ' ' CYS . 1.9 p -137.96 137.54 38.06 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.499 ' CB ' HD11 ' A' ' 98' ' ' LEU . . . -116.04 139.38 50.34 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -176.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -85.59 134.72 34.0 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.285 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -120.84 102.11 8.15 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 123.858 0.863 . . . . 0.0 109.146 172.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 58.77 28.09 16.87 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 170.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.51 9.71 57.5 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.777 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.05 151.39 41.99 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -106.73 137.12 45.36 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 119.031 0.832 . . . . 0.0 111.752 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.482 ' SG ' ' HD2' ' A' ' 90' ' ' PHE . 19.9 t -123.78 143.42 50.32 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.82 149.96 24.88 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.856 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' PHE . . . -149.89 173.2 14.04 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.312 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -137.64 132.21 32.64 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.671 ' HA ' HG12 ' A' ' 88' ' ' VAL . 60.5 mt -65.45 116.33 4.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 121.407 0.622 . . . . 0.0 111.166 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -95.03 -41.64 9.03 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.66 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.446 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 86.8 m -137.91 142.47 40.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.473 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -117.72 107.34 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.898 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 84' ' ' SER . 65.1 mttm -91.39 90.41 7.67 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 31' ' ' ARG . 18.7 ptt180 -94.77 106.07 18.04 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.496 HD23 ' HB3' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -139.38 144.0 37.98 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -175.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 11.4 p -118.41 124.34 72.98 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.718 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.267 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 97.9 mttt -82.65 100.7 10.36 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.716 0.769 . . . . 0.0 109.415 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.587 HG21 HD12 ' A' ' 57' ' ' LEU . 29.9 t -88.07 130.7 37.26 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.62 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.159 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 61.4 tttp -98.22 109.54 22.28 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.61 149.5 15.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 CA-C-O 121.38 0.609 . . . . 0.0 110.498 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.8 tp -111.69 118.11 34.73 Favored 'General case' 0 C--N 1.269 -2.934 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 75' ' ' ALA . 43.3 mt -70.35 126.12 28.73 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -72.82 -35.88 67.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.217 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -83.24 -36.15 24.82 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -107.42 -7.86 16.48 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.762 -0.775 . . . . 0.0 113.077 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.276 10.7 p30 59.76 21.06 9.85 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 125.679 1.592 . . . . 0.0 113.46 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.483 ' OG1' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -93.14 147.53 22.8 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.866 176.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -108.28 142.95 37.8 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.08 144.03 48.38 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -175.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.2 tp -126.88 101.76 6.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -142.27 162.89 18.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 5.2 pm0 -83.38 166.6 18.28 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.02 -12.31 2.0 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 125.967 1.707 . . . . 0.0 115.441 -173.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -89.19 -10.18 48.05 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 118.789 -1.165 . . . . 0.0 110.412 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -101.99 -7.82 22.04 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.9 t -103.16 118.46 50.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.407 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -98.03 97.31 8.8 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.67 -176.5 25.53 Favored Glycine 0 N--CA 1.427 -1.901 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.061 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -65.02 142.38 74.52 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.462 2.775 . . . . 0.0 112.696 176.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.587 HD12 HG21 ' A' ' 35' ' ' VAL . 1.5 mm? -96.75 84.16 3.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 7.0 tpt180 -137.98 126.37 23.29 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.773 -172.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.26 121.38 12.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.15 59.54 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.055 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.89 155.47 16.76 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.022 0.911 . . . . 0.0 110.937 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.7 mm -93.8 119.38 41.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.62 -179.12 2.48 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 122.768 0.427 . . . . 0.0 110.018 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -121.81 121.17 36.6 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.3 m -113.99 146.96 39.42 Favored 'General case' 0 N--CA 1.4 -2.974 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -83.57 127.23 33.58 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.7 p -92.17 175.28 6.91 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.9 m -68.63 -5.38 19.72 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.344 0.593 . . . . 0.0 111.919 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.04 -14.93 52.91 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 121.63 0.728 . . . . 0.0 109.302 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.01 -16.37 61.04 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 p -93.88 157.31 16.19 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 123.19 0.596 . . . . 0.0 110.561 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -94.95 146.89 23.93 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.455 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.446 ' HA ' HE21 ' A' ' 73' ' ' GLN . 0.1 OUTLIER -137.02 143.73 42.89 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -80.45 130.62 35.27 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.24 173.88 11.06 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.6 -169.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 mp -119.57 139.19 47.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.7 mp -73.55 127.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.95 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.3 m -108.41 -23.33 11.93 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 122.463 0.305 . . . . 0.0 111.415 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 51.7 tttp -163.98 154.81 15.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.434 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . 2.9 mp -130.45 133.62 46.46 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 3.4 m . . . . . 0 C--N 1.287 -2.117 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 4.2 p . . . . . 0 N--CA 1.426 -1.664 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.496 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 92.8 m95 -97.35 121.22 39.0 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.284 -175.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -105.1 110.73 23.23 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.446 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 24.5 m -79.72 108.74 13.51 Favored 'General case' 0 N--CA 1.401 -2.876 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 26' ' ' ILE . 28.9 m -113.54 145.16 19.8 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.447 -173.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 p -100.94 121.29 51.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.482 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 11.1 m-85 -88.76 -177.49 5.54 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.07 -172.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.75 -15.04 63.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.84 -17.4 63.99 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.529 173.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.42 -4.61 71.89 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -98.41 167.19 10.99 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 13.2 pt-20 -121.57 128.64 52.21 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.411 0.624 . . . . 0.0 111.304 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.461 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -125.62 150.92 47.15 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.496 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 44.5 m -105.21 118.11 35.72 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 120.824 0.345 . . . . 0.0 110.298 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.499 HD11 ' CB ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -141.97 152.49 43.52 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.106 0.562 . . . . 0.0 109.772 178.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -100.48 -173.76 2.49 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.055 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -53.97 -26.9 28.14 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.123 0.969 . . . . 0.0 112.836 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -58.02 -28.77 64.75 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 122.956 0.503 . . . . 0.0 112.306 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.4 p -125.96 10.51 7.61 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.336 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 103' ' ' LEU . 9.9 tp -111.86 128.05 56.01 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.491 ' HB2' ' OG ' ' A' ' 14' ' ' SER . 24.8 m . . . . . 0 C--N 1.312 -1.031 0 C-N-CA 122.691 0.396 . . . . 0.0 111.955 -172.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.435 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 21.4 p90 . . . . . 0 N--CA 1.425 -1.718 0 CA-C-O 122.247 1.022 . . . . 0.0 109.415 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.36 -167.51 1.87 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.965 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.9 p -130.55 173.73 10.59 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.46 141.84 16.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 123.936 0.895 . . . . 0.0 110.102 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.13 -11.32 58.64 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.291 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.631 ' HB ' HD12 ' A' ' 26' ' ' ILE . 6.6 m -74.49 141.27 44.93 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.418 ' OD2' ' HG3' ' A' ' 25' ' ' LYS . 10.7 t70 -107.01 117.5 34.24 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.7 m -121.96 -179.86 2.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 120.861 0.362 . . . . 0.0 110.182 -177.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.0 m -111.31 124.39 52.14 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.29 139.1 46.96 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' A' ' 16' ' ' LYS 0.264 0.0 OUTLIER -94.01 129.69 40.42 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -178.631 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.484 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 34.0 m-85 -98.6 101.82 13.37 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 170.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 10.0 ptm180 49.21 35.95 8.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 173.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.26 10.4 57.2 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.932 -0.576 . . . . 0.0 114.074 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.72 124.79 34.37 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 17.0 m-85 -91.91 141.95 28.09 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.465 0.65 . . . . 0.0 112.555 -172.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.9 t -127.53 145.32 50.89 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -71.73 143.43 49.62 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.4 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.517 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -141.44 139.63 33.43 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.192 -176.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.418 ' HG3' ' OD2' ' A' ' 12' ' ' ASP . 5.1 mttp -103.12 126.6 50.37 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.487 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.631 HD12 ' HB ' ' A' ' 11' ' ' THR . 25.1 mt -70.24 116.63 11.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.788 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.15 -45.09 6.67 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 109.424 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.422 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 7.6 m -128.6 143.63 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.635 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 81.6 t -126.59 119.29 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 57.0 mtpt -104.07 97.86 7.77 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -83.38 100.74 10.88 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 32' ' ' LEU . 2.1 pt? -133.22 161.32 34.76 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.443 ' H ' ' HB2' ' A' ' 50' ' ' ASP . 10.4 p -130.02 140.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.641 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 98.9 mttt -91.74 101.57 14.18 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.743 0.783 . . . . 0.0 109.682 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.412 HG12 HG13 ' A' ' 37' ' ' VAL . 21.7 t -90.49 121.48 40.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.182 -173.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 85.3 tttt -85.5 111.63 20.17 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 174.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.451 HG21 HG21 ' A' ' 65' ' ' THR . 1.9 m -112.61 146.44 17.35 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.269 0 CA-C-O 121.124 0.488 . . . . 0.0 110.606 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -112.96 114.1 26.43 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.584 HD11 ' HB3' ' A' ' 73' ' ' GLN . 31.9 tp -75.62 111.64 11.16 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -56.05 -43.1 77.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -170.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -76.69 -50.86 12.66 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.371 0.605 . . . . 0.0 111.875 -174.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.457 ' HB3' HD23 ' A' ' 39' ' ' LEU . 30.6 t70 -84.95 -9.22 58.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.568 -171.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.289 0.0 OUTLIER 56.33 24.06 7.91 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.377 2.271 . . . . 0.0 112.955 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.91 153.57 17.69 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.979 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.6 m -120.31 142.83 48.75 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.37 163.63 33.98 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.978 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 14.8 tp -128.02 104.31 7.72 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 -177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.2 m -121.05 174.36 5.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -173.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -87.4 162.34 17.37 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.488 0.661 . . . . 0.0 112.201 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 33' ' ' VAL . 7.7 t70 -44.16 -28.46 0.51 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 127.7 2.4 . . . . 0.0 113.275 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -85.97 -24.76 26.37 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.385 0.674 . . . . 0.0 110.886 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -84.14 -17.79 38.91 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.78 116.29 32.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.399 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -106.06 101.48 10.96 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.431 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.42 -162.85 27.92 Favored Glycine 0 C--N 1.309 -0.922 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.17 135.46 12.2 Favored 'Trans proline' 0 CA--C 1.517 -0.371 0 C-N-CA 122.477 2.118 . . . . 0.0 112.299 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.78 82.33 3.56 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 122.049 0.928 . . . . 0.0 109.619 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.555 ' HD3' ' N ' ' A' ' 59' ' ' VAL . 1.1 tmt_? -140.08 138.65 35.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.555 ' N ' ' HD3' ' A' ' 58' ' ' ARG . 22.2 t -61.74 119.1 5.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.44 6.31 57.56 Favored Glycine 0 C--N 1.298 -1.563 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.937 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.479 ' HB3' HD13 ' A' ' 77' ' ' ILE . . . -90.53 152.87 20.73 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 117.396 0.598 . . . . 0.0 110.844 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.429 HD13 HG13 ' A' ' 76' ' ' ILE . 45.1 mm -89.65 117.65 33.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.64 177.66 6.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -122.52 121.53 36.76 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 172.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.451 HG21 HG21 ' A' ' 37' ' ' VAL . 9.7 t -115.67 158.43 22.76 Favored 'General case' 0 C--N 1.263 -3.161 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -174.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 71' ' ' SER . 40.7 ttt180 -79.93 125.59 29.94 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p -84.12 177.34 8.27 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.9 m -75.78 -2.99 32.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.803 0.811 . . . . 0.0 110.296 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -93.83 -1.03 55.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.537 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.23 -5.63 83.78 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.521 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 17.7 t -94.76 172.49 8.13 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -177.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 65' ' ' THR . 93.4 m-85 -110.34 120.2 41.68 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.584 ' HB3' HD11 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -131.05 150.78 51.99 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -176.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.524 ' H ' ' NE2' ' A' ' 73' ' ' GLN . 32.8 tt0 -73.57 122.98 23.09 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.562 0.745 . . . . 0.0 111.56 -174.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.11 173.97 11.11 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.448 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.429 HG13 HD13 ' A' ' 62' ' ' ILE . 4.0 mp -122.31 141.47 42.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.479 HD13 ' HB3' ' A' ' 61' ' ' ALA . 3.2 mp -72.26 122.22 24.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.9 t -99.91 -18.28 17.19 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 86.8 tttt -175.89 143.8 0.59 Allowed 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.377 0.0 OUTLIER -117.57 118.93 33.48 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.471 0.653 . . . . 0.0 109.737 165.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.8 m . . . . . 0 C--N 1.298 -1.638 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.971 -171.327 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 CA--C 1.511 -0.521 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.577 ' HB3' ' OG1' ' A' ' 97' ' ' THR . 99.6 m95 -97.37 123.02 41.06 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.435 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 73.4 m-85 -111.41 106.79 15.81 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 5.6 m -82.42 104.02 12.4 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.517 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 15.8 m -106.46 154.49 7.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.578 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 11.9 p -104.31 135.46 42.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -100.86 -177.84 3.59 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.327 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.09 -26.88 68.53 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.502 1.121 . . . . 0.0 109.993 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.43 -16.87 64.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.827 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.14 14.17 72.53 Favored Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 26.5 t70 -97.43 137.26 36.66 Favored 'General case' 0 CA--C 1.469 -2.138 0 CA-C-N 113.953 -1.123 . . . . 0.0 108.407 -174.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.77 126.55 50.98 Favored 'General case' 0 C--N 1.269 -2.894 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -141.83 139.37 32.68 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 85' ' ' TRP . 10.9 t -100.16 122.45 43.01 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.083 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 20.0 mt -110.9 166.26 11.18 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.197 0.522 . . . . 0.0 110.065 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.98 164.06 24.71 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -68.19 -17.97 64.47 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.3 p -87.78 14.32 8.88 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.958 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 14.7 m -129.5 1.95 5.04 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.5 mt -128.33 147.31 50.61 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.486 -174.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 50.2 t . . . . . 0 C--N 1.294 -1.837 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.011 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.433 -1.29 0 N-CA-C 109.956 -0.386 . . . . 0.0 109.956 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.474 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 65.9 mt -70.39 -174.71 0.88 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.869 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 p -132.67 161.07 34.9 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.1 t -72.85 130.04 35.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.856 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.19 -24.11 4.52 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.25 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.6 m -83.49 142.26 31.05 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -99.91 135.2 41.7 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.0 m -127.01 161.21 34.45 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 C-N-CA 123.237 0.615 . . . . 0.0 109.516 -176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.7 m -100.61 123.97 45.56 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -107.05 121.24 44.09 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -175.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 83.5 tttt -81.0 105.99 12.65 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 22' ' ' CYS . 38.6 p90 -121.51 125.15 46.12 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.528 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 62.36 31.84 17.15 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.356 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.2 -3.25 69.4 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 115.16 0.824 . . . . 0.0 115.16 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.73 134.74 37.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.338 1.069 . . . . 0.0 110.27 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.588 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 28.5 p90 -91.17 136.17 33.28 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.558 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 52.3 t -134.96 163.03 30.78 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.95 147.11 45.54 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.59 0.709 . . . . 0.0 110.445 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.475 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -148.39 148.32 30.21 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.95 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -112.71 130.62 55.99 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.325 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.571 ' HA ' HG12 ' A' ' 88' ' ' VAL . 53.2 mt -64.84 119.58 9.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.952 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -95.85 -51.24 4.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.3 m -132.63 145.03 50.76 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.257 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG22 ' HD1' ' A' ' 86' ' ' TYR . 95.2 t -122.23 112.92 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.302 176.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' SER . 65.1 tttp -98.79 97.92 9.09 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -79.61 94.28 5.64 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.506 HD23 ' HE3' ' A' ' 30' ' ' LYS . 2.7 pp -103.14 160.63 14.48 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-O 121.127 0.489 . . . . 0.0 111.263 -178.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.21 118.36 57.24 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.064 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 47' ' ' LEU . 50.4 mtpt -82.85 100.96 10.66 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 21.4 t -84.98 117.34 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.841 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.953 -177.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.425 ' HA ' ' HG ' ' A' ' 47' ' ' LEU . 88.5 tttt -80.95 107.46 13.78 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' THR . 12.5 m -112.91 149.41 15.38 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.003 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.43 -175.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -117.53 111.13 18.82 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.524 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 44.9 mt -71.78 123.93 23.7 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 17.9 ptpt -62.54 -31.01 71.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -175.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HB3' ' CD ' ' A' ' 73' ' ' GLN . 44.9 tt0 -84.95 -55.72 3.93 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 120.897 0.379 . . . . 0.0 111.474 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.6 -22.51 40.57 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 64.45 32.29 11.97 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.47 0.708 . . . . 0.0 112.279 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -92.87 138.86 31.12 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.8 m -107.35 130.11 54.83 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -157.19 156.75 33.15 Favored 'General case' 0 C--N 1.257 -3.434 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.2 mp -113.14 107.88 16.54 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.9 m -114.31 166.87 7.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.89 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -86.73 165.38 16.11 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.639 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.22 -34.19 56.0 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 124.584 1.154 . . . . 0.0 110.532 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.12 -22.8 66.99 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.686 -173.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -99.79 -17.83 17.49 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.6 t -98.09 116.63 41.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.944 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -110.33 114.47 27.95 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.797 176.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.408 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 143.97 -163.83 27.63 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.02 137.36 7.39 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.072 2.515 . . . . 0.0 113.647 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.9 mt -95.03 82.89 3.84 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.345 0.593 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.429 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 3.0 mpt_? -139.14 142.25 38.04 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.75 112.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.26 6.99 35.81 Favored Glycine 0 N--CA 1.428 -1.883 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.435 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.19 152.95 18.31 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.4 mt -99.95 125.92 53.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-O 121.111 0.482 . . . . 0.0 110.124 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.408 HG12 ' HA3' ' A' ' 55' ' ' GLY . 25.2 m -127.96 -177.78 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 8.7 pt-20 -131.51 128.22 38.9 Favored 'General case' 0 C--N 1.272 -2.761 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.445 HG21 HG21 ' A' ' 37' ' ' VAL . 9.9 t -139.96 159.64 41.72 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.99 -168.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -69.02 132.01 45.97 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.66 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.405 HG23 ' HB3' ' A' ' 69' ' ' ASP . 7.0 t -90.51 168.97 11.43 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 m -64.53 -23.0 67.13 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.088 0.555 . . . . 0.0 110.987 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.405 ' HB3' HG23 ' A' ' 67' ' ' THR . 7.7 t70 -64.97 -26.19 68.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.288 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.8 -22.08 17.27 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.226 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.6 t -77.43 179.59 6.38 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.803 0.841 . . . . 0.0 109.504 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -119.19 136.13 54.34 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.524 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 30.3 tt0 -137.86 153.25 49.6 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 39.0 tt0 -77.44 137.19 38.54 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.426 0.631 . . . . 0.0 109.407 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.13 173.61 11.31 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.87 -174.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.19 143.74 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.43 HG13 ' CG1' ' A' ' 35' ' ' VAL . 3.0 mp -75.55 122.82 30.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 t -99.77 -24.2 14.76 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -169.22 151.55 4.68 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.3 OUTLIER -127.77 118.54 23.94 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 118.327 0.512 . . . . 0.0 110.805 172.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.306 -1.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.967 -174.758 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.5 p . . . . . 0 N--CA 1.425 -1.695 0 CA-C-O 121.14 0.495 . . . . 0.0 111.618 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.493 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 87.0 m95 -114.93 146.31 41.3 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 27.7 m-85 -124.03 112.96 17.79 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 m -85.49 107.15 17.31 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 26' ' ' ILE . 24.8 m -110.56 146.76 15.32 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.617 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.995 -175.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.11 121.5 53.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.427 ' HD1' ' HB2' ' A' ' 24' ' ' ALA . 29.4 m-85 -74.0 173.58 9.8 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.469 -176.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.98 -27.13 61.1 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.469 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.51 -15.92 61.79 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.241 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.89 75.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.807 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -98.26 141.87 30.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -104.42 127.93 52.2 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.41 ' HB2' ' CE2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -135.25 148.36 49.55 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.493 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 30.5 m -104.75 113.2 26.63 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.356 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.708 HD11 ' HB1' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -140.54 159.6 41.84 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.064 0.546 . . . . 0.0 111.404 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.547 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 95.8 mtt180 -99.75 -172.47 2.25 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 122.964 0.506 . . . . 0.0 109.987 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.447 ' HA ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.08 -14.57 63.07 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.107 0.48 . . . . 0.0 110.964 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 p -73.27 -2.39 21.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 123.872 0.869 . . . . 0.0 111.234 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 19.6 m -137.6 9.53 2.89 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 99' ' ' ARG . 93.1 mt -113.69 137.69 51.26 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.853 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.2 t . . . . . 0 C--N 1.295 -1.779 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.172 -177.651 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 47.9 p90 . . . . . 0 N--CA 1.416 -2.15 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.533 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 6.6 mp -78.26 177.38 8.46 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.231 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 p -131.47 152.26 50.85 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.62 112.5 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.209 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.02 -24.15 3.45 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.519 ' HB ' HD12 ' A' ' 26' ' ' ILE . 46.2 m -73.68 138.67 44.87 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 120.937 0.398 . . . . 0.0 109.93 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -99.02 126.11 44.66 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -136.37 -178.91 2.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 123.249 0.62 . . . . 0.0 109.906 -176.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 15.8 m -130.9 146.06 52.21 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 174.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -119.38 127.4 53.1 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -80.87 138.98 36.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.168 0.509 . . . . 0.0 111.582 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -125.69 101.17 6.75 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 123.871 0.868 . . . . 0.0 108.898 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 57.63 37.8 27.55 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.385 0.428 . . . . 0.0 111.174 171.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.27 -6.06 71.68 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.982 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.56 123.8 43.76 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . 0.258 0.5 OUTLIER -107.62 131.28 54.54 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -174.102 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.7 m -105.14 144.51 31.83 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.386 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -85.9 147.55 26.2 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' A' ' 90' ' ' PHE . . . -150.55 154.58 37.83 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.528 0.68 . . . . 0.0 110.672 -175.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.99 126.81 55.19 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.521 ' HA ' HG12 ' A' ' 88' ' ' VAL . 32.0 mt -61.26 120.44 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -95.4 -43.9 7.79 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.927 0.891 . . . . 0.0 110.08 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.1 m -140.63 146.12 37.52 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.8 t -121.6 114.99 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 O-C-N 123.603 0.564 . . . . 0.0 109.599 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -112.35 91.13 3.54 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.748 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -84.09 87.48 7.15 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 32' ' ' LEU . 2.4 pt? -91.15 111.23 22.62 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.564 -174.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.5 t -86.62 114.63 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.026 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 14.5 mmmm -80.05 99.49 7.71 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.8 t -89.38 129.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.071 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.286 -175.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 83.8 tttt -91.52 103.13 15.78 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 3.7 m -112.6 155.19 13.91 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.786 -177.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 44' ' ' THR . 8.4 tt -129.14 118.31 22.24 Favored 'General case' 0 N--CA 1.387 -3.625 0 CA-C-N 114.445 -1.252 . . . . 0.0 107.638 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.711 HD23 ' HB2' ' A' ' 75' ' ' ALA . 86.5 mt -68.79 122.56 18.84 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.95 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 21.7 ptmt -59.94 -29.54 68.47 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 120.903 0.382 . . . . 0.0 111.415 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -59.84 -55.17 37.51 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 124.606 1.162 . . . . 0.0 113.226 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -120.23 -0.08 10.54 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.442 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 68.35 23.73 7.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.167 0.987 . . . . 0.0 112.334 -176.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -78.73 133.3 37.16 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 m -106.37 148.18 28.37 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 2.6 pt20 -159.72 160.07 33.62 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 123.031 0.207 . . . . 0.0 110.444 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 mt -115.8 102.17 9.47 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 27.9 m -124.28 170.13 14.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -177.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 11.3 pt20 -91.26 170.78 9.71 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.956 -175.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -55.96 -21.08 18.93 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.097 1.759 . . . . 0.0 112.151 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -78.18 -35.39 48.78 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.307 0.575 . . . . 0.0 109.942 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -82.67 -15.14 53.12 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.081 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -109.17 135.17 48.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.162 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.451 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -125.46 139.75 53.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 172.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.94 -166.93 13.94 Favored Glycine 0 C--N 1.31 -0.867 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.57 132.34 10.97 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.77 2.313 . . . . 0.0 113.086 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.38 81.99 6.53 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.553 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 8.8 tpt180 -140.49 135.95 32.46 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.64 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.24 116.28 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.74 2.77 46.43 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.238 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.35 149.44 22.1 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.417 HG12 HG13 ' A' ' 76' ' ' ILE . 49.5 mt -95.69 117.12 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-O 121.882 0.849 . . . . 0.0 109.961 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 16.4 m -116.84 -172.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.273 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 72' ' ' PHE . 40.3 mt-10 -129.01 124.27 34.53 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.0 m -112.66 144.95 41.3 Favored 'General case' 0 N--CA 1.385 -3.678 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -74.05 117.69 16.14 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -89.06 -179.8 5.99 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 t -60.35 -29.86 69.17 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.218 1.007 . . . . 0.0 111.478 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.98 -25.18 67.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.845 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.56 -20.58 22.64 Favored Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.625 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 p -89.4 164.03 15.04 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.069 0.548 . . . . 0.0 111.052 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.479 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 96.5 m-85 -96.05 123.31 39.61 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 122.854 0.461 . . . . 0.0 110.746 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -114.03 150.86 33.3 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.508 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 45.6 mt-10 -68.87 127.73 34.15 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.113 0.959 . . . . 0.0 111.897 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.711 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -135.84 161.49 35.47 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.85 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.417 HG13 HG12 ' A' ' 62' ' ' ILE . 3.8 mp -116.89 139.49 43.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -73.05 124.45 30.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.9 176.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 t -103.9 -26.24 12.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.434 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 23.0 tptm -167.57 159.21 11.92 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mp -135.01 141.43 46.19 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 5.0 m . . . . . 0 C--N 1.278 -2.529 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.426 -1.646 0 CA-C-O 121.317 0.579 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.424 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 57.7 m95 -95.55 122.05 37.88 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.973 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 92.8 m-85 -109.35 109.43 20.31 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 73.0 m -85.17 104.18 14.81 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 174.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 26' ' ' ILE . 28.5 m -106.2 141.46 21.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.868 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.27 130.41 59.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.022 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' A' ' 24' ' ' ALA . 52.0 m-85 -91.02 167.89 12.06 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -62.18 -19.66 63.33 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.007 0.908 . . . . 0.0 109.993 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.16 -11.36 48.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.462 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.83 -3.78 82.23 Favored Glycine 0 C--O 1.227 -0.336 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -96.18 142.48 28.3 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -117.14 143.9 45.31 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 123.442 0.464 . . . . 0.0 110.994 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -129.61 143.8 50.99 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 85.7 m -104.16 113.05 26.33 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.0 OUTLIER -133.91 163.47 29.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.571 0.748 . . . . 0.0 112.109 -177.314 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -99.36 177.56 5.15 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 122.821 0.448 . . . . 0.0 110.013 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -60.9 -33.03 72.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.064 0.546 . . . . 0.0 111.428 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.4 m -57.86 -32.29 67.51 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.736 0.814 . . . . 0.0 110.921 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 17.5 m -91.45 7.4 41.39 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.019 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.7 170.48 7.91 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.554 0.692 . . . . 0.0 111.321 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 14' ' ' SER . 53.1 t . . . . . 0 C--N 1.292 -1.905 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.664 176.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.442 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 45.7 p90 . . . . . 0 N--CA 1.412 -2.374 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.438 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 90.2 mt -99.84 175.25 5.85 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.9 p -122.17 161.21 23.58 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 120.614 0.245 . . . . 0.0 111.521 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.57 144.05 14.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.521 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.35 -25.97 26.32 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.653 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.573 ' HB ' HD12 ' A' ' 26' ' ' ILE . 9.7 m -58.08 133.23 55.37 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 122.162 0.982 . . . . 0.0 112.65 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -84.49 113.91 21.55 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 113.491 -1.686 . . . . 0.0 109.165 177.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.48 -177.81 2.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.455 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -140.11 147.22 39.91 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 173.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -126.16 131.69 51.98 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 22.3 pttp -82.51 133.35 35.2 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -112.92 112.58 24.16 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 170.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 61.09 31.06 19.76 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.343 0.592 . . . . 0.0 110.897 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.33 -8.45 72.2 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.885 -0.598 . . . . 0.0 114.192 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.76 124.44 50.59 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.537 0.669 . . . . 0.0 110.126 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 73.7 m-85 -87.99 120.47 29.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -99.82 143.74 29.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 172.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -75.25 148.52 39.37 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.719 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -154.34 143.66 21.34 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.449 0.643 . . . . 0.0 111.227 -175.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -115.73 128.29 55.76 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.573 HD12 ' HB ' ' A' ' 11' ' ' THR . 17.6 mt -68.94 113.82 5.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 120.716 0.293 . . . . 0.0 111.554 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HD2' ' HB ' ' A' ' 89' ' ' VAL . 43.9 mtpt -88.17 -38.09 15.61 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.8 m -146.54 141.95 27.53 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.067 -175.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.37 131.06 73.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -123.79 97.82 5.54 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -78.63 86.52 4.61 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.684 1.23 . . . . 0.0 108.607 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.475 ' HA ' ' OD1' ' A' ' 50' ' ' ASP . 2.0 pt? -107.29 134.47 50.32 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.967 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.3 t -108.06 132.27 56.22 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.971 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -86.04 101.53 13.01 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.49 HG12 HG13 ' A' ' 37' ' ' VAL . 11.5 t -91.78 127.08 44.3 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.836 -174.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -92.21 106.94 18.84 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.498 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 2.4 m -114.79 143.71 23.93 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.96 0 CA-C-O 121.682 0.753 . . . . 0.0 112.022 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.1 tp -111.14 118.02 34.83 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.7 -1.591 . . . . 0.0 107.639 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.736 HD23 ' HB2' ' A' ' 75' ' ' ALA . 94.3 mt -67.29 111.37 3.96 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.428 ' HB3' HD11 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -73.25 -15.2 61.43 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.183 0.516 . . . . 0.0 112.214 -176.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -88.76 -51.09 5.84 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.654 0.74 . . . . 0.0 109.621 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 15.0 t70 -89.98 -33.12 16.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.445 -170.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 35.3 m-80 83.64 15.89 0.28 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.101 1.36 . . . . 0.0 113.402 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -95.85 150.52 20.33 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.91 0.386 . . . . 0.0 110.368 174.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -118.03 144.83 45.25 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -151.4 157.84 42.94 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.939 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.3 tp -119.36 101.48 7.99 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.1 m -126.62 175.53 8.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.48 -170.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -88.57 154.23 20.5 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.426 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 32' ' ' LEU . 6.4 p-10 -65.88 -12.98 58.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.061 0.944 . . . . 0.0 111.507 -176.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.83 -28.89 63.88 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.664 0.745 . . . . 0.0 109.68 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.43 ' OE1' ' HD3' ' A' ' 66' ' ' ARG . 43.3 mt-30 -108.24 8.94 28.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.979 0.895 . . . . 0.0 109.333 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 78.4 t -108.03 110.06 30.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.909 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.27 103.58 16.22 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.024 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.531 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 145.1 -171.36 26.25 Favored Glycine 0 C--N 1.292 -1.88 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.339 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.81 144.28 19.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.209 2.606 . . . . 0.0 113.194 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -93.22 82.36 4.52 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.49 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 50.6 mtm180 -139.5 131.89 28.49 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.771 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.53 117.95 7.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.06 10.75 51.3 Favored Glycine 0 C--N 1.299 -1.477 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.291 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB3' HD13 ' A' ' 77' ' ' ILE . . . -97.85 162.46 13.24 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 117.313 0.556 . . . . 0.0 110.062 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.8 mm -102.54 121.53 53.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 123.559 0.537 . . . . 0.0 110.113 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.531 HG12 ' HA3' ' A' ' 55' ' ' GLY . 29.9 m -130.12 177.2 7.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.039 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -126.22 121.68 33.42 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.9 t -122.21 154.67 37.19 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-O 121.151 0.5 . . . . 0.0 111.067 -173.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HD3' ' OE1' ' A' ' 52' ' ' GLN . 34.8 ttt180 -85.4 132.09 34.29 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.375 177.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.9 p -95.74 163.78 13.04 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.5 m -57.18 -23.68 49.23 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -80.5 -3.22 49.22 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 122.247 -0.283 . . . . 0.0 111.599 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.416 ' HA2' ' HE ' ' A' ' 66' ' ' ARG . . . 95.52 6.19 59.85 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.9 175.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.2 m -97.59 152.37 19.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 122.504 -0.409 . . . . 0.0 110.48 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' THR . 56.0 m-85 -110.88 121.01 44.28 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -128.39 153.7 46.78 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.918 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -73.52 127.88 33.95 Favored 'General case' 0 C--O 1.256 1.444 0 CA-C-O 121.716 0.769 . . . . 0.0 110.788 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.736 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -135.73 168.54 19.09 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.177 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.428 HD11 ' HB3' ' A' ' 40' ' ' LYS . 8.9 mt -118.01 145.84 23.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.2 mp -77.98 115.13 19.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 175.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 m -97.93 -17.31 19.3 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.025 0.44 . . . . 0.0 109.964 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -169.64 156.73 6.67 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.65 111.18 6.8 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.799 0.809 . . . . 0.0 110.588 173.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 C--N 1.297 -1.685 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.787 -178.132 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 CA--C 1.552 1.033 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -102.7 141.6 35.25 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.498 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.442 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 50.6 m-85 -127.79 106.83 9.39 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 54.1 m -87.15 107.81 18.63 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.675 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 23.6 m -112.06 147.56 15.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.096 -173.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.501 ' HB ' ' HD2' ' A' ' 27' ' ' LYS . 7.2 p -105.09 125.08 60.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 123.687 0.795 . . . . 0.0 109.887 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.457 ' CE1' HG23 ' A' ' 88' ' ' VAL . 57.3 m-85 -92.79 -176.86 4.36 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.295 -174.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -47.61 -41.59 22.2 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.145 1.378 . . . . 0.0 112.664 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.08 -16.72 60.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.099 0.476 . . . . 0.0 111.893 -175.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.58 5.74 56.67 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.643 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -96.61 149.92 21.24 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.5 144.12 43.86 Favored 'General case' 0 C--O 1.253 1.287 0 CA-C-O 121.474 0.655 . . . . 0.0 112.177 -175.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.4 mmt-85 -136.77 151.27 49.0 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.466 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 63.5 m -99.42 109.27 21.87 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.278 0.561 . . . . 0.0 109.604 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.25 159.4 17.95 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.691 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -99.66 161.72 13.44 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 ttp85 -61.57 -23.43 65.98 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 m -59.01 -25.08 63.35 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 123.556 0.742 . . . . 0.0 110.93 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 18.9 m -96.12 -8.24 33.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.041 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.9 mp -92.9 133.18 36.36 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -171.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.455 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 19.3 t . . . . . 0 C--N 1.289 -2.062 0 CA-C-N 112.682 -2.053 . . . . 0.0 110.324 178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.418 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.428 -1.564 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.522 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 48.6 mt -113.18 -174.92 2.55 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -131.17 160.63 34.23 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.81 144.84 10.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.49 -6.52 74.72 Favored Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.87 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.417 ' HB ' HD12 ' A' ' 26' ' ' ILE . 25.3 m -89.16 133.5 34.38 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 120.965 0.412 . . . . 0.0 110.19 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -96.88 124.18 40.79 Favored 'General case' 0 CA--C 1.476 -1.875 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.909 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 103' ' ' LEU . 28.2 m -131.59 160.77 42.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.216 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 104' ' ' CYS . 2.4 p -94.58 117.02 29.47 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.447 ' HB1' HD12 ' A' ' 98' ' ' LEU . . . -106.52 127.68 53.5 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.393 -173.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 22.6 pttp -84.76 134.9 34.31 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.453 0.644 . . . . 0.0 112.378 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.413 ' CZ ' ' HZ ' ' A' ' 90' ' ' PHE . 80.7 m-85 -132.98 136.23 45.95 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HD3' ' C ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 44.68 26.28 0.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.05 2.9 64.07 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.159 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.15 146.35 51.1 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 16' ' ' LYS 0.262 18.4 p90 -106.76 146.41 30.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 116.026 1.862 . . . . 0.0 116.026 -175.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 66.1 m -131.53 138.23 48.84 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.745 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 38.2 tt0 -79.92 137.35 36.86 Favored 'General case' 0 N--CA 1.406 -2.649 0 CA-C-O 121.225 0.536 . . . . 0.0 111.297 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -147.41 158.75 44.1 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.048 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -106.55 129.26 54.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.417 HD12 ' HB ' ' A' ' 11' ' ' THR . 72.1 mt -61.0 117.27 2.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.196 0.522 . . . . 0.0 110.311 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -99.41 -40.5 7.85 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.983 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 m -127.48 141.83 51.56 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.514 HG13 ' CE1' ' A' ' 86' ' ' TYR . 55.8 t -120.17 124.06 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 C-N-CA 123.179 0.592 . . . . 0.0 109.601 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 46.9 tptt -131.4 90.62 2.89 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -83.54 92.43 7.62 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 117.766 -1.574 . . . . 0.0 108.211 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 32' ' ' LEU . 2.3 pt? -112.33 133.97 54.13 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.278 0.561 . . . . 0.0 109.869 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.6 123.09 48.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -96.03 109.91 22.23 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 122.086 0.946 . . . . 0.0 109.225 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 37' ' ' VAL . 21.4 t -94.59 129.26 45.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.323 -172.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 83.6 tttt -88.89 105.84 18.01 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 175.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.537 HG21 HG21 ' A' ' 65' ' ' THR . 0.4 OUTLIER -113.27 143.93 21.95 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.279 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.359 -177.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.6 115.01 29.29 Favored 'General case' 0 C--N 1.266 -3.033 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.541 HD12 ' H ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -66.67 118.19 9.89 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -64.53 -43.43 94.02 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 124.65 1.18 . . . . 0.0 113.221 -171.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -88.42 -25.34 22.71 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.571 0.701 . . . . 0.0 111.717 -174.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.541 ' H ' HD12 ' A' ' 39' ' ' LEU . 18.0 t70 -98.55 -32.01 11.67 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.565 -175.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 76.78 21.87 1.18 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -102.45 149.61 24.21 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.449 HG21 ' HE2' ' A' ' 36' ' ' LYS . 2.2 m -101.58 138.68 38.26 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -140.16 144.86 36.87 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 36' ' ' LYS . 10.5 tt -124.92 106.67 10.16 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.9 m -135.68 -178.02 2.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.517 -173.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.415 ' HB2' ' HG2' ' A' ' 52' ' ' GLN . 3.0 mt-30 -64.51 150.59 46.4 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -18.29 63.25 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.275 171.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.48 -24.41 61.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.5 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 65' ' ' THR . 12.3 mm100 -85.54 -19.05 31.71 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.2 t -91.5 112.12 24.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.659 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -97.82 98.47 9.86 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.98 175.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.442 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 150.51 179.11 26.01 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.596 178.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.53 141.26 72.84 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.242 2.628 . . . . 0.0 114.246 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.96 81.97 7.36 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 97.5 mtt180 -139.57 132.98 30.11 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.02 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.9 t -72.69 110.31 5.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.543 0.687 . . . . 0.0 109.538 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.97 7.19 27.44 Favored Glycine 0 N--CA 1.428 -1.858 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.364 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.54 147.46 22.97 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.258 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.404 HD13 HG13 ' A' ' 76' ' ' ILE . 48.3 mm -86.07 117.0 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.442 HG12 ' HA3' ' A' ' 55' ' ' GLY . 27.5 m -130.76 179.04 4.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.23 125.92 48.31 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 HG21 ' A' ' 37' ' ' VAL . 14.5 t -132.48 159.6 38.88 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -76.05 114.19 14.41 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 123.606 0.566 . . . . 0.0 109.853 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 71' ' ' SER . 9.2 t -85.38 -179.47 6.96 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.357 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.7 m -64.9 -18.1 64.9 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.629 1.172 . . . . 0.0 111.038 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.419 ' H ' HG23 ' A' ' 67' ' ' THR . 31.4 t70 -75.69 -21.51 57.53 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.448 177.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.61 -14.85 58.99 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 67' ' ' THR . 21.3 m -90.88 159.77 16.06 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -92.33 127.42 37.81 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -140.24 165.21 28.0 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.41 ' O ' HD13 ' A' ' 39' ' ' LEU . 60.3 mt-10 -67.72 136.47 54.33 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.108 0.48 . . . . 0.0 111.91 -175.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -145.62 164.6 31.2 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.8 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.404 HG13 HD13 ' A' ' 62' ' ' ILE . 3.1 mp -118.51 136.45 55.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -69.71 122.61 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 m -111.14 -17.03 13.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.212 0.529 . . . . 0.0 110.68 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 65.1 tttp -166.55 143.43 4.91 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.78 111.58 13.81 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.502 0.668 . . . . 0.0 109.705 172.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 m . . . . . 0 C--N 1.288 -2.082 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.93 -169.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.419 ' HB3' ' CE2' ' A' ' 86' ' ' TYR . 44.0 m . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.536 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 34.5 m95 -90.04 132.62 35.29 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.799 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.588 ' HB2' HD11 ' A' ' 103' ' ' LEU . 97.6 m-85 -128.27 112.61 14.67 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.811 176.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 26.1 m -84.81 107.15 16.83 Favored 'General case' 0 N--CA 1.39 -3.469 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 17.2 m -105.63 141.43 20.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.195 -177.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.6 p -114.71 132.13 64.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.837 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 76.3 m-85 -86.35 166.32 15.69 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.24 -21.86 66.74 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 122.283 1.039 . . . . 0.0 108.588 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.67 -17.27 64.48 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.06 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.93 0.16 64.1 Favored Glycine 0 C--O 1.218 -0.876 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.156 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -96.88 144.61 26.66 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 9.3 pt-20 -122.27 133.31 54.69 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.066 0.46 . . . . 0.0 111.088 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -129.67 142.18 50.78 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 31.9 m -105.47 111.41 24.11 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 120.769 0.318 . . . . 0.0 110.913 -177.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.447 HD12 ' HB1' ' A' ' 15' ' ' ALA . 25.2 mt -118.62 171.77 7.96 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -79.73 162.54 25.11 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -56.73 -30.12 63.21 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.153 0.502 . . . . 0.0 111.209 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.6 p -81.27 -2.66 49.78 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.809 0.844 . . . . 0.0 112.641 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 27.6 t -107.34 9.66 29.85 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.588 HD11 ' HB2' ' A' ' 86' ' ' TYR . 70.8 mt -122.27 134.92 54.67 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.455 ' HB3' ' OG ' ' A' ' 14' ' ' SER . 47.0 t . . . . . 0 C--N 1.285 -2.218 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -175.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.642 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 24.2 p90 . . . . . 0 N--CA 1.407 -2.583 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 87.6 mt -98.44 178.41 5.04 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.738 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.7 p -134.96 169.27 17.66 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.379 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.55 123.26 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 122.776 0.43 . . . . 0.0 111.09 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.0 -33.64 3.01 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.447 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.576 ' HB ' HD12 ' A' ' 26' ' ' ILE . 15.6 m -59.41 138.64 57.59 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.176 0.59 . . . . 0.0 111.332 -177.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -100.53 116.83 33.39 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.5 m -128.43 -179.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 122.871 0.468 . . . . 0.0 110.396 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 16.8 m -129.23 137.28 51.01 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.486 ' CB ' HD11 ' A' ' 98' ' ' LEU . . . -107.27 128.53 54.52 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -85.72 120.14 26.82 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.85 0.357 . . . . 0.0 111.144 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -125.88 109.91 13.04 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 61.86 26.77 16.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.831 0.852 . . . . 0.0 112.557 172.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.73 25.39 42.12 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.921 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.52 144.78 50.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -106.61 120.1 41.06 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.353 0.597 . . . . 0.0 111.117 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.6 m -103.73 128.73 51.07 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 175.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 9.8 pt-20 -93.62 140.49 29.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.536 -1.265 . . . . 0.0 109.852 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -145.47 156.68 43.89 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.319 -173.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -112.23 132.78 54.73 Favored 'General case' 0 C--N 1.266 -3.029 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.576 HD12 ' HB ' ' A' ' 11' ' ' THR . 43.2 mt -59.41 121.81 7.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.332 0.587 . . . . 0.0 111.907 -176.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -97.31 -46.97 5.9 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 125.025 1.33 . . . . 0.0 109.994 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 16.6 m -137.77 146.18 43.3 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.412 HG12 ' HG3' ' A' ' 31' ' ' ARG . 98.4 t -131.16 124.24 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -110.75 91.07 3.52 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HG3' HG12 ' A' ' 29' ' ' VAL . 48.3 mtm180 -78.15 122.9 26.25 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 121.974 0.892 . . . . 0.0 111.515 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 84' ' ' SER . 1.8 pt? -155.7 148.56 24.26 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -135.75 143.91 35.09 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.943 0 N-CA-C 104.34 -2.467 . . . . 0.0 104.34 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 94.4 mttt -85.05 101.19 12.21 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.533 HG12 HG13 ' A' ' 37' ' ' VAL . 21.3 t -86.46 118.06 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.52 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.575 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -86.55 107.82 18.3 Favored 'General case' 0 N--CA 1.413 -2.286 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.567 HG21 HG21 ' A' ' 65' ' ' THR . 3.7 m -112.53 150.03 14.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -126.53 117.66 23.31 Favored 'General case' 0 C--N 1.26 -3.314 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 75' ' ' ALA . 20.3 mt -72.84 106.35 4.75 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -57.96 -34.36 69.85 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -72.13 -45.8 59.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 120.98 0.419 . . . . 0.0 111.403 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -91.84 -8.89 45.3 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.492 -175.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.2 p30 53.31 28.09 6.92 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.302 1.841 . . . . 0.0 113.256 -177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -104.14 145.74 29.75 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.309 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 m -97.7 154.44 17.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -151.15 138.93 19.8 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 mt -109.72 102.33 11.15 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.414 HG21 ' OG1' ' A' ' 65' ' ' THR . 27.4 m -116.58 176.43 2.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.29 -174.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -101.56 160.02 14.8 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.4 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -47.18 -33.9 5.75 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 126.405 1.882 . . . . 0.0 112.237 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -72.81 -28.76 62.76 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.29 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 85.6 mt-30 -92.72 -3.53 54.67 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.548 0.69 . . . . 0.0 109.222 -178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.8 t -99.37 123.02 51.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.076 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -103.46 95.83 6.34 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.424 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 148.59 -173.82 28.44 Favored Glycine 0 N--CA 1.423 -2.231 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.132 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.416 ' HD2' HG12 ' A' ' 63' ' ' VAL . 11.6 Cg_exo -73.14 148.35 44.24 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.096 2.531 . . . . 0.0 113.478 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.27 82.64 6.5 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 62.8 ttt180 -139.35 119.59 13.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.818 -174.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.66 115.69 6.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.11 0.481 . . . . 0.0 109.862 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.5 5.51 42.44 Favored Glycine 0 N--CA 1.418 -2.543 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.122 -177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.13 155.78 16.98 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.413 0.606 . . . . 0.0 110.393 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.2 mt -97.24 124.8 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.424 HG12 ' HA3' ' A' ' 55' ' ' GLY . 28.0 m -132.18 179.19 4.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -113.49 125.51 54.29 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.567 HG21 HG21 ' A' ' 37' ' ' VAL . 9.7 t -127.61 152.39 47.72 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-O 120.777 0.323 . . . . 0.0 110.17 -174.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . 58.2 ttt180 -83.25 123.9 30.05 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.041 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.2 p -85.6 177.13 7.83 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -71.33 -20.6 62.16 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.033 0.444 . . . . 0.0 109.815 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.91 -25.0 66.95 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.968 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.91 -20.27 24.47 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.077 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.2 p -92.2 159.43 15.64 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 120.942 0.401 . . . . 0.0 110.97 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 65' ' ' THR . 51.1 m-85 -92.73 138.89 31.1 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.013 0.435 . . . . 0.0 110.244 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -132.14 149.73 52.33 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.67 129.81 34.74 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.024 0.916 . . . . 0.0 109.741 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.514 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -142.86 173.38 11.59 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.403 -174.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 5.7 mm -110.92 143.94 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -79.75 111.26 16.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -90.65 -24.77 20.4 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 120.922 0.391 . . . . 0.0 109.963 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -165.17 146.16 7.39 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.0 111.23 17.64 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.854 0.835 . . . . 0.0 109.119 168.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 8.2 m . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -173.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.506 ' HA ' HD23 ' A' ' 32' ' ' LEU . 50.5 m . . . . . 0 CA--C 1.507 -0.698 0 CA-C-O 121.883 0.849 . . . . 0.0 111.726 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -99.65 134.06 43.08 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.161 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.642 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 82.2 m-85 -121.2 107.94 13.17 Favored 'General case' 0 N--CA 1.422 -1.872 0 O-C-N 123.753 0.658 . . . . 0.0 109.315 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 33.3 m -90.08 106.47 18.5 Favored 'General case' 0 N--CA 1.398 -3.073 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 26' ' ' ILE . 16.2 m -105.74 141.65 20.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.164 -176.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.5 137.95 42.03 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.366 -174.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 87.4 m-85 -94.23 163.74 13.32 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.46 -26.74 65.48 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.615 0.722 . . . . 0.0 111.52 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.84 -17.14 64.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.089 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.1 1.92 58.21 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.75 138.31 31.58 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -125.86 133.91 51.8 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.465 0.65 . . . . 0.0 111.048 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.62 142.3 50.26 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.039 -176.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 43.4 m -104.89 110.16 22.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.519 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.486 HD11 ' CB ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -132.9 170.39 15.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.322 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -98.97 170.6 8.61 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -58.06 -31.38 67.01 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 123.699 0.8 . . . . 0.0 111.93 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 m -70.91 -9.14 57.19 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 121.498 0.666 . . . . 0.0 111.465 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.477 ' HB2' HD12 ' A' ' 98' ' ' LEU . 21.5 m -109.01 1.22 20.43 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 14' ' ' SER . 89.6 mt -107.22 129.43 54.87 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.788 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 14.2 t . . . . . 0 C--N 1.306 -1.291 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.079 -177.198 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.4 p90 . . . . . 0 N--CA 1.404 -2.752 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 29.5 mt -88.49 173.52 8.63 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.9 p -123.51 162.1 23.58 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -173.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -65.61 133.27 30.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.671 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.94 -16.57 42.89 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.944 177.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.619 ' HB ' HD12 ' A' ' 26' ' ' ILE . 13.4 m -66.54 132.08 47.42 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.498 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -96.75 115.36 27.3 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.9 m -128.61 -179.56 3.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 121.435 0.636 . . . . 0.0 110.361 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 19.4 m -133.43 136.45 45.21 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -107.18 138.83 42.63 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -89.91 129.93 36.19 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.879 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -127.7 108.14 10.49 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.344 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.501 ' HD2' ' N ' ' A' ' 18' ' ' ARG . 2.9 mpt_? 59.57 32.82 21.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.67 0.788 . . . . 0.0 111.659 175.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.44 -2.63 68.0 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.787 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.36 147.97 36.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 117.184 0.492 . . . . 0.0 109.738 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -93.41 138.79 31.38 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.017 0.437 . . . . 0.0 110.833 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.0 m -125.36 128.03 47.53 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 170.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 6.8 pt-20 -90.08 138.38 31.56 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 118.417 -1.313 . . . . 0.0 110.771 -173.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.43 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -148.67 151.01 34.2 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.02 -174.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.6 tttp -108.92 128.98 55.4 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.619 HD12 ' HB ' ' A' ' 11' ' ' THR . 19.0 mt -66.63 118.67 10.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 120.646 0.26 . . . . 0.0 110.709 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -97.13 -46.85 6.0 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.259 0.552 . . . . 0.0 110.129 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 m -127.06 139.2 53.17 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.2 t -121.57 107.17 19.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.028 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 84' ' ' SER . 95.5 mttt -99.3 90.49 4.57 Favored 'General case' 0 C--N 1.264 -3.115 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -86.21 108.12 18.21 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.425 ' H ' HD23 ' A' ' 32' ' ' LEU . 1.9 pt? -132.78 129.46 38.61 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -175.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 8.5 p -97.39 116.38 39.63 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.826 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -88.92 100.56 13.28 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 57' ' ' LEU . 25.7 t -84.75 137.05 21.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.862 -174.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 39.8 ttmt -91.43 105.43 17.76 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 175.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 65' ' ' THR . 3.5 m -112.6 143.13 22.93 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.328 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.3 118.75 34.78 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 67' ' ' THR . 10.4 mp -69.4 122.59 19.25 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.851 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.74 -31.43 72.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.153 0.501 . . . . 0.0 111.017 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -89.4 -58.82 2.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.529 0.68 . . . . 0.0 110.982 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.37 -17.37 45.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.599 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 t30 71.68 7.12 5.87 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.069 0.937 . . . . 0.0 113.385 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -86.64 159.75 19.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 110.789 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.6 m -119.4 140.35 50.54 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -134.09 142.51 47.56 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.44 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.75 101.22 10.53 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.2 149.62 28.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.424 0.631 . . . . 0.0 111.764 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 15.1 pt20 -69.81 160.98 30.73 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.37 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -63.4 -7.2 6.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.611 0.764 . . . . 0.0 112.523 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 49' ' ' GLN . 5.4 m-20 -73.58 -34.63 65.2 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.523 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 25.7 mm-40 -86.33 -28.99 23.35 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.076 -177.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.7 t -91.06 121.74 41.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.474 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -105.74 108.73 20.4 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.01 -173.79 22.76 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.059 177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.9 139.2 46.7 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 123.139 2.559 . . . . 0.0 112.859 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.474 HD12 HG21 ' A' ' 35' ' ' VAL . 1.7 mm? -97.12 81.44 3.05 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.537 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 42.8 ttp85 -141.1 138.6 33.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.835 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.92 124.7 19.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.34 9.07 63.7 Favored Glycine 0 N--CA 1.427 -1.952 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.349 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.93 153.18 18.05 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.926 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -89.81 119.24 36.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.0 m -134.55 175.04 12.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.034 0.445 . . . . 0.0 110.807 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -126.3 128.19 46.74 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.56 HG21 HG21 ' A' ' 37' ' ' VAL . 11.8 t -131.13 157.92 41.85 Favored 'General case' 0 C--N 1.277 -2.55 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.042 -174.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.523 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 37.0 ttm-85 -82.54 128.59 34.45 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 105.221 -2.141 . . . . 0.0 105.221 170.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.477 HG21 HD21 ' A' ' 39' ' ' LEU . 34.2 p -84.98 176.79 8.23 Favored 'General case' 0 C--N 1.276 -2.615 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.199 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.1 m -66.17 -19.72 65.92 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.004 0.431 . . . . 0.0 110.044 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -75.55 -25.43 57.14 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.84 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.33 -17.33 16.71 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.702 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.6 m -90.09 151.97 21.36 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.648 0.261 . . . . 0.0 111.416 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 65' ' ' THR . 62.4 m-85 -87.46 126.76 35.09 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.87 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -140.96 145.54 36.15 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.363 1.065 . . . . 0.0 108.983 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -76.13 131.05 39.17 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 121.812 0.815 . . . . 0.0 111.253 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.8 170.12 16.29 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.382 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.1 mm -119.83 142.46 35.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -74.42 129.06 36.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.3 m -114.47 -17.11 11.82 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 121.227 0.537 . . . . 0.0 111.025 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 57.4 tttm -168.82 156.23 7.48 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.76 135.15 53.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 87.1 m . . . . . 0 C--N 1.278 -2.516 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.769 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.7 p . . . . . 0 N--CA 1.425 -1.692 0 CA-C-O 121.111 0.481 . . . . 0.0 109.877 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.542 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 87.6 m95 -107.75 113.87 27.43 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.108 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 94.5 m-85 -101.47 110.59 22.62 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.1 m -89.93 104.14 16.73 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.428 HG22 HD23 ' A' ' 98' ' ' LEU . 24.4 m -106.9 140.59 24.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.273 0.559 . . . . 0.0 111.301 -174.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 3.5 t -101.79 128.69 54.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 124.239 1.015 . . . . 0.0 109.979 -173.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 58.7 m-85 -87.71 174.02 8.65 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 174.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.31 -17.82 55.55 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.96 -17.81 62.04 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.045 0.538 . . . . 0.0 110.326 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.21 -0.48 68.85 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.96 131.48 40.85 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 123.325 0.65 . . . . 0.0 109.548 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.457 ' C ' ' HD2' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -111.74 137.25 49.92 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.354 0.597 . . . . 0.0 111.911 -179.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.457 ' HD2' ' C ' ' A' ' 95' ' ' GLU . 4.3 mpt_? -121.67 158.18 29.25 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.395 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.542 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 24.0 m -101.84 119.69 39.19 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.251 0.548 . . . . 0.0 110.771 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.428 HD23 HG22 ' A' ' 88' ' ' VAL . 4.0 mm? -122.09 174.5 6.9 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.484 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.405 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 22.5 mmt180 -98.86 166.58 11.23 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.89 -21.61 63.3 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.572 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.6 m -74.19 -9.78 58.96 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.521 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 5.3 m -98.95 -11.8 21.26 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 99' ' ' ARG . 70.1 mt -101.68 128.35 48.02 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.073 -171.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 30.3 t . . . . . 0 C--N 1.311 -1.082 0 C-N-CA 124.749 1.219 . . . . 0.0 110.75 -178.405 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.761 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 38.2 p90 . . . . . 0 N--CA 1.421 -1.885 0 CA-C-O 120.901 0.382 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.55 -173.58 3.07 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.716 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.5 p -128.61 157.91 39.96 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -171.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 m -74.35 148.96 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 CA-C-O 121.122 0.487 . . . . 0.0 111.834 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.15 -12.59 67.36 Favored Glycine 0 C--N 1.301 -1.378 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.071 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.479 ' HB ' HD12 ' A' ' 26' ' ' ILE . 13.6 m -79.59 135.92 36.71 Favored 'General case' 0 N--CA 1.403 -2.809 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -99.78 121.04 40.68 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 104' ' ' CYS . 17.4 m -135.37 -177.33 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 121.474 0.654 . . . . 0.0 110.307 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 m -123.07 141.62 51.76 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.54 139.76 41.57 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.344 0.0 OUTLIER -99.98 136.61 39.63 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -177.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -131.62 121.72 24.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.668 -1.605 . . . . 0.0 107.355 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 61.53 31.7 18.85 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.028 0.931 . . . . 0.0 110.428 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.89 28.8 70.04 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.5 -177.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.75 152.29 50.16 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -102.39 144.84 30.36 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.686 -173.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -127.58 139.73 52.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 172.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.53 152.38 26.04 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.482 -175.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -162.37 145.36 11.39 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -106.51 128.75 54.34 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.527 ' HA ' HG12 ' A' ' 88' ' ' VAL . 30.4 mt -63.75 114.42 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 121.185 0.517 . . . . 0.0 111.23 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.42 -42.39 6.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.757 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 5.8 m -130.05 137.35 50.18 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.1 t -116.61 116.4 52.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.279 0.562 . . . . 0.0 109.949 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.484 ' HB3' HD22 ' A' ' 32' ' ' LEU . 46.7 mmtt -109.57 91.03 3.48 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.185 174.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -83.25 87.69 6.94 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.549 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.629 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.3 pt? -135.07 116.53 14.69 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.291 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 62.8 t -108.5 115.23 48.74 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 171.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -82.64 108.35 15.95 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.244 1.021 . . . . 0.0 109.755 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.04 133.75 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.455 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.244 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -88.86 107.08 18.79 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 65' ' ' THR . 3.5 m -112.59 148.49 15.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.305 -176.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.75 117.87 30.51 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 75' ' ' ALA . 57.3 mt -73.92 106.55 5.68 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.41 -29.05 67.46 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -87.69 -24.47 23.86 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.765 -177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -115.53 -13.97 11.54 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.177 -173.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 68.33 15.98 9.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.508 1.523 . . . . 0.0 113.112 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -99.99 158.28 15.94 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.377 0.132 . . . . 0.0 111.088 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -125.57 140.4 52.78 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.1 160.61 42.7 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.359 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.56 100.88 7.39 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 m -128.28 163.88 31.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.434 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.629 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 17.1 pm0 -80.78 160.05 24.98 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.47 -25.11 2.38 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 127.076 2.15 . . . . 0.0 112.51 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.42 -29.1 67.69 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.718 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 65' ' ' THR . 71.7 mt-30 -100.21 -15.17 18.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.463 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.08 110.82 22.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 122.523 1.154 . . . . 0.0 111.586 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -99.19 106.13 18.26 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 113.974 -1.466 . . . . 0.0 108.001 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 139.68 -169.65 24.53 Favored Glycine 0 C--N 1.302 -1.325 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.172 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.56 134.86 11.34 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.884 2.39 . . . . 0.0 112.544 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -88.53 82.26 6.97 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.535 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 35.0 mtp180 -139.26 132.59 30.01 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.744 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.32 120.07 10.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.34 5.81 61.74 Favored Glycine 0 N--CA 1.433 -1.556 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.867 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -96.39 169.21 10.07 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.894 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.5 mm -99.02 115.74 40.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.113 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 77' ' ' ILE . 16.0 m -123.78 -173.05 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.8 135.87 35.07 Favored 'General case' 1 N--CA 1.374 -4.238 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 174.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.636 HG21 HG21 ' A' ' 37' ' ' VAL . 11.6 t -141.56 158.91 43.24 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.056 -175.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -80.49 126.39 31.16 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -99.09 179.7 4.53 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.135 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.7 t -66.82 -21.06 66.04 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.205 1.002 . . . . 0.0 110.242 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.18 -18.34 62.49 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.53 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.88 -13.44 60.67 Favored Glycine 0 C--O 1.241 0.584 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.976 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.9 p -91.68 165.06 13.5 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 123.136 0.574 . . . . 0.0 110.727 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -98.38 124.68 43.18 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.425 ' HB3' HD22 ' A' ' 39' ' ' LEU . 5.5 tp-100 -119.6 146.91 45.1 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -176.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -72.7 127.74 33.46 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.581 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -132.55 168.35 18.39 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 7.0 mm -115.45 149.23 17.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.561 HD11 HG13 ' A' ' 63' ' ' VAL . 3.7 mp -89.92 130.47 39.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.0 m -107.35 -16.96 14.26 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.002 0.429 . . . . 0.0 110.583 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -173.53 147.47 1.45 Allowed 'General case' 0 C--O 1.212 -0.888 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.321 0.0 OUTLIER -129.92 115.89 17.84 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.546 0.688 . . . . 0.0 110.781 171.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.4 m . . . . . 0 C--N 1.288 -2.108 0 CA-C-O 121.456 0.646 . . . . 0.0 109.341 -177.02 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.6 m . . . . . 0 N--CA 1.447 -0.616 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.517 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 78.8 m95 -100.97 129.98 46.9 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.526 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.761 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 74.6 m-85 -123.11 108.73 13.19 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 26.0 m -84.25 103.8 13.74 Favored 'General case' 0 N--CA 1.391 -3.38 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 26' ' ' ILE . 17.3 m -106.09 141.29 21.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.845 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.79 122.77 56.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.864 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -88.51 173.43 8.68 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.41 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -55.28 -33.45 63.25 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.262 1.025 . . . . 0.0 111.589 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.82 -17.84 62.75 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.987 0.422 . . . . 0.0 111.608 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.56 6.76 56.28 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -90.47 134.83 34.09 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -111.04 128.32 55.82 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-O 121.221 0.534 . . . . 0.0 109.937 177.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -123.45 140.97 52.47 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.517 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 32.3 m -103.66 108.82 20.26 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 120.725 0.298 . . . . 0.0 111.104 -176.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.8 mt -117.34 178.03 4.52 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -98.74 165.25 11.88 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -62.06 -25.38 67.65 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.13 0.49 . . . . 0.0 110.816 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.93 1.21 9.21 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.18 0.992 . . . . 0.0 112.213 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.5 t -127.61 11.24 6.74 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.9 mp -122.26 161.0 24.09 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.291 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.402 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 37.5 t . . . . . 0 N--CA 1.416 -2.156 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -178.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.6 p90 . . . . . 0 C--O 1.225 -0.197 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.42 ' O ' ' HE2' ' A' ' 86' ' ' TYR . 3.0 pp -151.43 166.47 30.96 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.464 ' HB ' ' OG1' ' A' ' 11' ' ' THR 0.539 54.2 p 115.17 71.88 0.0 OUTLIER 'General case' 0 C--O 1.193 -1.882 0 C-N-CA 130.201 3.401 . . . . 0.0 115.516 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.2 t -92.41 140.21 16.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.83 -13.57 58.68 Favored Glycine 0 C--N 1.313 -0.743 0 N-CA-C 112.238 -0.345 . . . . 0.0 112.238 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.5 ' HB ' HD12 ' A' ' 26' ' ' ILE . 3.6 m -68.8 133.18 47.97 Favored 'General case' 0 N--CA 1.411 -2.38 0 C-N-CA 123.501 0.72 . . . . 0.0 110.067 -177.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.79 110.32 22.94 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.32 173.49 13.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 122.305 0.242 . . . . 0.0 110.719 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.9 p -95.38 132.06 40.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.772 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -119.6 120.78 37.69 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 123.675 0.79 . . . . 0.0 109.802 -177.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 1.9 ttpm? -82.81 106.23 14.48 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.906 -177.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -138.41 145.87 41.5 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 62.99 25.19 14.93 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 122.762 1.268 . . . . 0.0 108.899 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.53 16.04 75.61 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.263 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.17 142.67 42.18 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 26.2 p90 -98.45 114.09 26.33 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.089 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -100.6 143.17 31.08 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -71.64 132.78 45.08 Favored 'General case' 0 N--CA 1.38 -3.963 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -146.27 164.48 32.17 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.175 -173.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -117.44 126.84 53.32 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.507 HG12 HG12 ' A' ' 88' ' ' VAL . 18.6 mt -69.58 109.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -87.49 -41.2 13.68 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.344 0.592 . . . . 0.0 110.174 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.8 m -137.95 141.53 40.55 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.775 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.6 t -118.94 108.54 24.27 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 84' ' ' SER . 31.2 mmmt -82.33 101.29 10.47 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -84.49 99.39 10.67 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.6 pt? -138.88 126.09 21.44 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.655 0.74 . . . . 0.0 111.031 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 60.1 t -104.07 124.83 58.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -84.36 104.42 14.36 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 57' ' ' LEU . 16.2 t -93.4 126.41 45.83 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.806 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.157 -177.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 81.5 tttt -95.6 110.5 22.59 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.417 HG13 HG12 ' A' ' 35' ' ' VAL . 3.6 m -117.51 154.53 19.34 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.952 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.338 -176.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tt -122.03 113.73 19.95 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 75' ' ' ALA . 43.2 mt -64.72 118.14 8.5 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.356 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.486 ' HB3' HD11 ' A' ' 76' ' ' ILE . 18.8 ptpt -75.51 -23.04 56.66 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.409 -176.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -85.46 -42.45 14.47 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.268 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -91.66 -22.84 20.05 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.383 0.611 . . . . 0.0 110.653 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 73.1 22.31 2.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.109 1.364 . . . . 0.0 113.614 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 p -104.81 150.73 24.56 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.744 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -97.96 144.48 27.45 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -142.57 142.82 32.24 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.7 tp -121.57 102.63 8.36 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.28 164.49 29.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.767 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 4.5 pm0 -84.29 168.05 16.02 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -46.39 -21.47 0.17 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 128.584 2.754 . . . . 0.0 114.306 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.26 -23.03 23.61 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 122.084 0.945 . . . . 0.0 110.446 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -91.16 -20.13 22.33 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.876 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.9 t -105.24 127.04 60.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.354 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -110.93 110.06 20.47 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.441 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 141.54 -164.04 26.73 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.506 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.07 136.18 16.1 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.824 2.349 . . . . 0.0 113.117 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.441 HD22 HG21 ' A' ' 35' ' ' VAL . 39.8 mt -93.2 83.0 4.56 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 28.5 tpt180 -140.38 131.01 25.59 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.4 t -63.64 119.66 8.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.8 3.58 55.99 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.401 -176.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . . . -97.44 168.76 10.19 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.471 0.635 . . . . 0.0 110.758 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.31 128.37 60.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.766 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.526 HG13 HD11 ' A' ' 77' ' ' ILE . 21.0 m -137.47 172.68 14.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.75 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -116.92 130.12 56.49 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.3 t -128.45 158.44 38.33 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.6 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -70.11 123.84 22.62 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.307 0.575 . . . . 0.0 111.023 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.482 HG23 ' H ' ' A' ' 69' ' ' ASP . 14.2 t -95.11 169.83 9.83 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 p -63.83 -20.52 65.86 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.683 0.793 . . . . 0.0 112.524 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.482 ' H ' HG23 ' A' ' 67' ' ' THR . 19.0 t70 -69.61 -25.73 64.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.511 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.5 -22.27 12.09 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.672 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 67' ' ' THR . 23.3 m -87.19 170.09 11.78 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.856 0.36 . . . . 0.0 110.642 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -100.69 137.27 39.31 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -133.29 155.85 48.66 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.412 ' OE1' ' HD2' ' A' ' 40' ' ' LYS . 38.1 tt0 -69.15 128.67 37.45 Favored 'General case' 0 C--O 1.253 1.237 0 O-C-N 124.227 0.954 . . . . 0.0 112.288 -177.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.519 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -139.7 171.03 14.82 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.211 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 40' ' ' LYS . 2.8 mp -120.86 141.87 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.526 HD11 HG13 ' A' ' 63' ' ' VAL . 3.3 mp -76.35 122.22 30.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -106.35 -18.93 13.85 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 86.7 tttt -163.78 150.0 11.52 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.3 OUTLIER -135.95 117.16 14.49 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.683 0.754 . . . . 0.0 110.838 171.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.3 m . . . . . 0 C--N 1.295 -1.781 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.072 -175.19 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 56.0 m . . . . . 0 C--O 1.237 0.398 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.49 ' CD1' HD21 ' A' ' 32' ' ' LEU . 99.4 m95 -103.37 108.31 19.49 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.583 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.42 ' HE2' ' O ' ' A' ' 7' ' ' LEU . 48.1 m-85 -90.39 111.56 22.84 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 m -87.98 105.19 17.29 Favored 'General case' 0 N--CA 1.405 -2.69 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.507 HG12 HG12 ' A' ' 26' ' ' ILE . 21.8 m -105.68 141.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.995 -176.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.88 125.72 59.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.92 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 42.9 m-85 -87.19 170.12 11.76 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -57.15 -24.62 55.56 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 123.39 0.432 . . . . 0.0 112.057 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -72.4 -16.88 61.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.267 0.556 . . . . 0.0 111.846 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.84 -1.75 63.7 Favored Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.984 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.54 150.16 20.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.97 154.4 50.52 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 118.313 0.506 . . . . 0.0 111.521 -175.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -149.14 147.6 28.65 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.271 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.37 113.17 23.7 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 123.544 0.738 . . . . 0.0 110.899 174.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.772 HD11 ' HB1' ' A' ' 15' ' ' ALA 0.315 0.2 OUTLIER -129.83 146.87 51.55 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.141 0.496 . . . . 0.0 111.858 174.229 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.1 158.84 34.05 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.171 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.05 -38.25 56.42 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.902 1.281 . . . . 0.0 110.54 -175.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.5 m -62.72 -10.12 11.59 Favored 'General case' 0 CA--C 1.576 1.944 0 C-N-CA 123.834 0.854 . . . . 0.0 112.875 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.0 m -111.49 6.38 20.15 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 120.937 -1.102 . . . . 0.0 111.448 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 mp -108.81 139.61 43.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.8 t . . . . . 0 C--N 1.298 -1.648 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -175.977 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.562 ' HA ' ' OH ' ' A' ' 86' ' ' TYR 0.29 28.4 p90 . . . . . 0 N--CA 1.463 0.189 0 N-CA-C 115.679 1.733 . . . . 0.0 115.679 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.51 173.67 7.95 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 173.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.4 p -127.74 169.04 14.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -172.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.6 t -72.49 134.69 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.306 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.91 -22.22 14.77 Favored Glycine 0 N--CA 1.432 -1.596 0 C-N-CA 119.816 -1.183 . . . . 0.0 113.419 175.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -93.43 167.74 11.51 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.719 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 5.0 p-10 -118.17 139.27 51.52 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 m -132.18 162.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.83 -177.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.477 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 14.4 m -101.13 127.95 47.44 Favored 'General case' 0 N--CA 1.405 -2.715 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.623 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -106.91 120.78 42.98 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 22.2 ptmt -93.59 138.07 32.22 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.721 -177.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HH ' ' HZ ' ' A' ' 90' ' ' PHE . 74.9 m-85 -134.81 130.9 36.78 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.7 mmt-85 61.21 25.2 15.22 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.85 1.26 . . . . 0.0 110.243 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.23 2.55 83.06 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.206 -0.521 . . . . 0.0 113.093 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.25 145.97 45.63 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 74.1 m-85 -95.1 132.92 39.48 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.982 -175.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.2 m -116.54 132.67 56.62 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -86.12 145.16 27.15 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.105 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.96 153.3 34.95 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 64.6 tttm -108.94 126.72 53.39 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -175.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.508 ' HA ' HG12 ' A' ' 88' ' ' VAL . 23.3 mt -65.31 114.14 2.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.936 0.398 . . . . 0.0 111.732 -175.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -97.18 -45.8 6.39 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.091 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.514 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 4.9 m -127.04 139.76 52.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -175.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.9 t -125.44 122.88 63.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 63.8 mttp -110.75 91.79 3.8 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 172.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.383 0.0 OUTLIER -85.71 86.94 7.34 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.06 177.362 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.5 pt? -116.46 105.27 12.3 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.449 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 7.3 p -91.45 127.23 43.92 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.529 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 68.4 mttm -79.78 105.11 10.83 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.314 0.578 . . . . 0.0 109.706 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.7 t -89.4 122.83 41.19 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.196 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.492 ' CB ' ' HB3' ' A' ' 79' ' ' LYS . 2.9 tmtm? -89.64 108.35 19.62 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.432 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 19.4 m -117.02 153.3 18.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 121.475 0.655 . . . . 0.0 112.472 -174.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -123.34 120.03 31.84 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.18 127.07 31.4 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.962 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.2 ptpt -64.28 -34.66 78.63 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -80.74 -58.77 2.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.001 0.429 . . . . 0.0 111.889 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.71 -4.42 55.11 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.7 p30 52.12 29.4 6.39 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.664 1.185 . . . . 0.0 112.595 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.3 145.77 24.22 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.734 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -113.27 147.73 37.0 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -158.7 164.46 35.9 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.918 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 31.5 tp -129.5 102.3 6.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.68 162.37 31.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 5.4 pm0 -90.99 166.73 12.86 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.32 -0.952 . . . . 0.0 113.538 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.408 ' HB2' HG12 ' A' ' 33' ' ' VAL . 4.9 t70 -42.68 -32.19 0.55 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 127.268 2.227 . . . . 0.0 113.253 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -68.25 -34.9 77.06 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 123.691 0.796 . . . . 0.0 111.238 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -90.39 -12.43 37.56 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.349 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 65' ' ' THR . 87.7 t -93.81 115.7 33.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.602 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -108.38 124.34 50.22 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.292 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.26 -161.38 22.07 Favored Glycine 0 C--N 1.288 -2.108 0 CA-C-O 119.445 -0.642 . . . . 0.0 111.921 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -86.13 133.23 4.02 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.848 2.365 . . . . 0.0 112.833 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.88 82.55 3.87 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 122.085 0.945 . . . . 0.0 110.808 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.583 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 25.6 mmt180 -140.02 141.11 36.34 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.371 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.05 126.34 22.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.23 3.85 67.06 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.308 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.55 157.5 15.99 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.422 HG12 ' CD1' ' A' ' 76' ' ' ILE . 56.8 mt -101.76 124.43 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 121.383 0.611 . . . . 0.0 110.796 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.489 HG13 HD11 ' A' ' 77' ' ' ILE . 14.6 m -125.64 -178.65 2.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.814 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 73' ' ' GLN . 39.0 mt-10 -126.69 120.89 30.55 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.513 HG22 HG22 ' A' ' 53' ' ' VAL . 33.9 p -116.37 150.28 37.99 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.725 -174.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -76.67 130.41 37.75 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.1 p -87.91 -177.16 5.71 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.0 t -78.35 -0.88 30.72 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 110.033 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -94.68 -14.45 24.83 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.3 5.61 60.44 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.455 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 m -97.15 160.86 14.1 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.34 119.31 37.86 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 121.05 0.452 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 46.7 mt-30 -119.19 153.54 34.76 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.083 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 44.9 mt-10 -69.09 122.75 19.38 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 124.056 0.847 . . . . 0.0 109.563 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.432 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -137.42 162.28 34.05 Favored 'General case' 0 C--N 1.267 -3.011 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.572 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.422 ' CD1' HG12 ' A' ' 62' ' ' ILE . 9.2 mm -107.48 137.52 38.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -70.89 120.02 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . 13.6 m -109.58 -15.77 14.11 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.301 -178.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HB3' ' CB ' ' A' ' 36' ' ' LYS . 15.3 tppt? -172.77 150.13 2.08 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.4 123.82 32.63 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 171.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 C--N 1.305 -1.365 0 C-N-CA 123.455 0.702 . . . . 0.0 109.954 -177.853 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.428 ' HA ' HD23 ' A' ' 32' ' ' LEU . 50.5 m . . . . . 0 C--O 1.245 0.843 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.576 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 89.5 m95 -101.37 136.73 40.74 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.836 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.562 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 56.0 m-85 -122.81 114.36 20.41 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.514 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 16.0 m -91.74 105.54 17.8 Favored 'General case' 0 N--CA 1.401 -2.908 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 26' ' ' ILE . 21.4 m -105.81 141.7 20.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.925 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.9 p -105.73 135.65 43.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.091 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.456 ' HZ ' ' HH ' ' A' ' 17' ' ' TYR . 44.8 m-85 -97.4 173.04 7.39 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.424 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -54.61 -42.64 71.4 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.674 1.189 . . . . 0.0 111.14 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.81 -14.02 62.61 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.925 0.89 . . . . 0.0 112.731 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.61 9.13 55.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.83 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -89.73 140.65 29.36 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -124.82 138.67 54.26 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -133.92 142.17 47.63 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.576 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 67.1 m -99.79 118.85 37.16 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.013 0.435 . . . . 0.0 110.872 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.623 HD11 ' HB1' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -136.54 162.97 31.63 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.361 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.418 ' O ' HD13 ' A' ' 103' ' ' LEU . 28.7 ptt180 -99.32 166.32 11.26 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.738 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.448 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 72.0 mtm180 -56.47 -25.57 51.39 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 m -57.67 -22.37 45.53 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.35 1.06 . . . . 0.0 111.798 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.5 m -118.72 12.98 13.19 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.086 0.47 . . . . 0.0 111.634 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 99' ' ' ARG . 8.6 mp -103.12 146.16 28.81 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.633 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . 0.41 ' CB ' ' HB2' ' A' ' 14' ' ' SER . 34.6 t . . . . . 0 C--N 1.296 -1.737 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.215 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.3 t80 . . . . . 0 N--CA 1.432 -1.348 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 7' ' ' LEU . 56.6 mt -127.54 -164.15 1.33 Allowed 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.037 173.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.9 p -87.86 133.48 33.89 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -160.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.6 t -92.1 135.47 27.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.181 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.85 -11.39 52.86 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.887 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.496 ' HB ' HD12 ' A' ' 26' ' ' ILE . 24.6 m -75.52 143.1 42.66 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 123.068 0.547 . . . . 0.0 110.805 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -96.8 131.68 43.28 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.3 m -141.05 -179.63 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.192 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 3.3 p -118.75 136.82 53.76 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.652 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -107.37 125.63 51.44 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 125.196 1.398 . . . . 0.0 107.57 -177.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HE3' ' HA ' ' A' ' 102' ' ' SER . 20.5 pttp -88.6 142.25 27.85 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.387 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -134.0 100.29 4.69 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 58.74 39.74 23.93 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.851 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.6 -11.36 70.13 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.534 -0.757 . . . . 0.0 114.243 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.78 131.05 54.34 Favored 'General case' 0 C--O 1.205 -1.238 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 1.6 m-85 -106.68 132.44 52.67 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.842 -174.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.4 m -110.76 148.97 31.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -84.18 143.24 29.77 Favored 'General case' 0 C--O 1.249 1.069 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.638 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.472 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -154.32 149.61 27.1 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.327 -177.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.449 ' O ' HG12 ' A' ' 89' ' ' VAL . 3.9 tmmm? -113.37 129.26 56.58 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.496 HD12 ' HB ' ' A' ' 11' ' ' THR . 53.8 mt -64.73 119.35 8.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 123.582 0.753 . . . . 0.0 112.657 -175.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -90.53 -49.21 6.63 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 122.154 0.978 . . . . 0.0 109.549 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.0 m -142.89 147.72 35.8 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.096 -175.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 86' ' ' TYR . 53.2 t -114.27 133.52 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 171.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 23.7 tptm -121.82 120.82 35.68 Favored 'General case' 0 C--N 1.263 -3.156 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -70.56 144.32 51.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.611 -1.236 . . . . 0.0 111.026 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.538 HD21 ' CD1' ' A' ' 85' ' ' TRP . 73.5 mt -123.7 157.7 33.3 Favored 'General case' 0 C--N 1.265 -3.106 0 CA-C-N 114.046 -1.433 . . . . 0.0 107.457 175.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.417 ' CG1' ' HB2' ' A' ' 80' ' ' LEU . 60.7 t -119.86 110.65 29.8 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.361 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 42.9 mtpt -85.53 108.1 17.78 Favored 'General case' 0 CA--C 1.471 -2.065 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.47 HG11 HG13 ' A' ' 77' ' ' ILE . 14.9 t -91.61 132.43 36.07 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.229 -173.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -90.4 111.91 23.32 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.448 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 2.7 m -112.96 144.33 20.85 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.103 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.056 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -112.76 115.36 28.4 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.9 122.03 17.81 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.385 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -66.74 -38.93 87.64 Favored 'General case' 0 N--CA 1.41 -2.464 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -170.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -86.31 -45.77 10.93 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.443 ' HB2' HE22 ' A' ' 73' ' ' GLN . 17.6 t70 -86.27 -25.12 25.68 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -173.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 74.02 19.65 2.97 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.07 150.8 24.19 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -112.06 145.02 40.46 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.447 HE22 HG22 ' A' ' 67' ' ' THR . 4.1 tt0 -151.4 147.8 27.33 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -174.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.4 tp -123.48 101.49 7.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.0 m -134.62 165.08 32.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.406 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 5.6 pm0 -85.66 161.03 19.42 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -173.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -43.49 -28.12 0.34 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 127.294 2.238 . . . . 0.0 113.977 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.87 -37.34 87.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.941 0.401 . . . . 0.0 110.789 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.487 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 88.1 mt-30 -100.53 -6.94 24.69 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.324 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.0 t -101.14 113.27 36.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.601 0.715 . . . . 0.0 110.035 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -98.63 100.28 11.49 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.041 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.515 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 152.33 -163.34 30.22 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.424 176.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -81.7 146.38 14.94 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.763 2.975 . . . . 0.0 113.903 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.93 82.09 6.21 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 49.1 mtm105 -139.89 123.75 17.51 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.674 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.3 t -61.08 118.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.525 0.679 . . . . 0.0 109.64 176.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.76 11.05 51.63 Favored Glycine 0 C--N 1.299 -1.515 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.532 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.459 ' HB3' HD13 ' A' ' 77' ' ' ILE . . . -97.11 168.9 10.17 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.414 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.8 mm -101.45 120.33 50.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 77' ' ' ILE . 27.4 m -131.32 176.96 7.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -122.82 123.09 40.22 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 8.5 t -114.96 154.36 28.91 Favored 'General case' 0 C--N 1.265 -3.08 0 CA-C-O 121.052 0.453 . . . . 0.0 110.402 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.487 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . 59.9 ttt-85 -85.69 147.62 26.27 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.447 HG22 HE22 ' A' ' 46' ' ' GLN . 59.2 p -99.94 172.68 7.07 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.9 t -67.84 -6.98 24.22 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.298 0.57 . . . . 0.0 109.801 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.31 -25.47 27.15 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.411 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.98 -11.77 34.45 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.357 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 m -87.48 158.12 19.03 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 122.184 0.193 . . . . 0.0 110.706 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 65' ' ' THR . 54.5 m-85 -111.13 145.26 38.92 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 122.538 0.335 . . . . 0.0 110.415 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.443 HE22 ' HB2' ' A' ' 42' ' ' ASP . 8.2 tt0 -147.69 151.72 36.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.95 126.52 30.04 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.804 0.841 . . . . 0.0 109.554 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.448 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -139.65 167.74 21.42 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.812 -176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.0 mm -115.81 144.71 22.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.547 HD11 HG13 ' A' ' 63' ' ' VAL . 3.5 mp -77.55 123.65 34.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -111.87 -16.71 13.08 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.546 0.689 . . . . 0.0 111.582 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -161.1 150.8 17.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.417 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -141.25 111.51 6.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.067 0.937 . . . . 0.0 110.654 175.39 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 C--N 1.317 -0.841 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.464 -170.718 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.8 p . . . . . 0 C--O 1.249 1.035 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.538 ' CD1' HD21 ' A' ' 32' ' ' LEU . 64.8 m95 -94.09 151.08 19.76 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 167.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.496 ' CD2' HG22 ' A' ' 29' ' ' VAL . 53.2 m-85 -127.37 116.9 21.21 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 42.5 m -86.29 105.85 16.95 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.472 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 22.3 m -109.06 141.47 24.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.345 -176.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 25' ' ' LYS . 14.8 p -107.78 134.22 50.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.436 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -80.27 169.71 17.4 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -63.33 -20.78 65.8 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.41 0.624 . . . . 0.0 109.905 175.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -68.74 -17.81 64.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.246 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.99 0.1 68.74 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.669 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.55 142.5 28.54 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 9.4 pt-20 -117.98 138.64 52.05 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.425 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 4.0 mmp_? -124.3 142.71 51.05 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.0 m -102.57 117.79 35.44 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.046 0.451 . . . . 0.0 111.222 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.652 HD11 ' HB1' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -139.54 173.4 11.58 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 123.168 0.587 . . . . 0.0 109.991 179.313 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.464 ' O ' HD13 ' A' ' 103' ' ' LEU . 3.7 ptm180 -95.38 173.8 7.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.569 0.622 . . . . 0.0 112.277 -173.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 53.8 ttp85 -58.37 -40.79 83.22 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.809 0.444 . . . . 0.0 111.535 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.13 12.06 7.06 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.496 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 10.7 p -115.75 5.65 14.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.587 1.184 . . . . 0.0 108.477 170.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 99' ' ' ARG . 9.5 mp -112.21 153.06 27.66 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.104 175.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 C--N 1.285 -2.222 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.211 179.357 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.639 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 25.6 p90 . . . . . 0 N--CA 1.438 -1.058 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.447 ' O ' ' HB ' ' A' ' 8' ' ' THR . 4.1 pp -145.23 134.87 23.38 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 9.2 t 176.41 25.3 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 O-C-N 124.13 0.894 . . . . 0.0 111.127 174.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 p -75.9 132.48 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 O-C-N 121.173 -0.954 . . . . 0.0 109.475 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.8 -3.77 74.61 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.403 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -91.76 153.45 19.6 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-O 121.093 0.473 . . . . 0.0 109.978 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -103.7 111.44 23.94 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -119.14 173.22 5.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.181 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 14.9 m -95.26 135.18 37.17 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.05 127.06 39.15 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 21.5 ptmt -88.75 117.35 27.67 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.742 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CE2' ' HB2' ' A' ' 22' ' ' CYS . 50.7 p90 -133.5 138.0 45.91 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 70.3 ttt180 64.2 25.77 13.68 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 122.326 1.06 . . . . 0.0 108.666 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.17 18.09 77.75 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.552 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.69 130.72 47.57 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.504 ' CD2' ' HB3' ' A' ' 16' ' ' LYS . 33.9 m-85 -86.53 110.38 19.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.573 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 73.1 m -126.64 155.37 42.68 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -78.82 149.4 32.57 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.246 -1.381 . . . . 0.0 111.756 -176.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.403 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -144.88 149.35 35.19 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.475 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -104.0 126.95 51.51 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.993 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.478 HG12 HG12 ' A' ' 88' ' ' VAL . 47.4 mt -69.27 121.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.954 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -111.56 -37.55 5.18 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.387 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 9.3 m -129.06 145.26 51.32 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.6 t -135.66 133.07 51.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 123.674 0.79 . . . . 0.0 108.955 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -122.92 111.09 16.22 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.639 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 46.1 mtm-85 -86.65 107.0 17.99 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.127 0.489 . . . . 0.0 109.891 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 32' ' ' LEU . 1.8 pt? -124.65 137.62 54.35 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 43.3 t -92.56 129.16 43.54 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.001 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.859 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -90.73 101.17 13.92 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.477 HG12 HG13 ' A' ' 37' ' ' VAL . 14.2 t -93.51 130.97 41.75 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.942 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.484 -170.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 88.0 tttt -98.36 106.26 18.52 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.52 HG21 HG21 ' A' ' 65' ' ' THR . 1.8 m -112.7 143.37 22.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 CA-C-O 121.396 0.617 . . . . 0.0 111.217 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.0 tp -111.09 120.85 43.71 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.032 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 75' ' ' ALA . 68.1 mt -73.13 116.81 14.11 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -68.47 -26.79 65.67 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.613 0.721 . . . . 0.0 110.083 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -70.83 -36.51 72.93 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.054 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -128.03 -19.6 3.95 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -171.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 78.43 15.19 1.3 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.274 1.03 . . . . 0.0 112.829 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.59 142.18 28.05 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -115.07 132.52 56.57 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.641 0.734 . . . . 0.0 109.434 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 2.2 mp0 -120.49 147.06 45.62 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.687 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.4 mt -122.29 101.65 7.64 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.72 -178.04 2.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -175.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -96.02 165.98 11.99 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.739 178.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.68 -4.66 3.2 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.103 0.961 . . . . 0.0 113.162 -177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.66 -30.59 41.27 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.424 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 79.7 mm-40 -82.46 -23.38 34.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.832 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.71 131.42 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.317 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -112.78 104.59 12.62 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.8 -176.0 21.16 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.597 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.23 144.39 99.49 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 123.742 2.961 . . . . 0.0 113.447 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.01 82.35 2.55 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.004 0.907 . . . . 0.0 108.587 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.537 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 79.3 ttt180 -139.86 133.61 30.51 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.627 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.01 119.36 12.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.23 4.0 53.76 Favored Glycine 0 C--N 1.292 -1.883 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.962 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.73 143.67 27.45 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.921 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.466 HG12 HG13 ' A' ' 76' ' ' ILE . 41.2 mt -93.74 124.05 46.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.489 0.662 . . . . 0.0 109.278 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.31 -172.54 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.881 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.71 148.27 44.17 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.52 HG21 HG21 ' A' ' 37' ' ' VAL . 8.8 t -145.38 152.88 40.56 Favored 'General case' 0 C--N 1.276 -2.61 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.939 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.424 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 40.3 ttm180 -78.73 126.88 31.32 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 174.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 71' ' ' SER . 7.2 t -98.87 159.05 15.23 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 174.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.2 m -66.05 -2.79 4.41 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.83 -22.43 61.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.75 -22.8 16.01 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.595 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 67' ' ' THR . 24.8 m -99.12 161.46 13.61 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.025 0.44 . . . . 0.0 111.964 -177.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 65' ' ' THR . 53.3 m-85 -93.09 124.11 36.83 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.039 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -122.26 162.08 22.1 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -78.05 128.1 33.33 Favored 'General case' 0 C--O 1.254 1.311 0 C-N-CA 123.387 0.675 . . . . 0.0 109.238 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.685 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -143.02 171.96 13.35 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.699 -175.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 62' ' ' ILE . 4.5 mp -123.59 139.01 51.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -70.63 122.13 21.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.3 m -102.22 -23.36 14.03 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.236 0.541 . . . . 0.0 110.109 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 87.0 tttt -163.7 144.41 8.8 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.404 ' HB2' ' CG1' ' A' ' 33' ' ' VAL 0.315 0.0 OUTLIER -120.9 116.06 24.41 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 167.957 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 N--CA 1.411 -2.385 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.506 -167.231 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.9 m . . . . . 0 N--CA 1.438 -1.065 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TRP . . . . . 0.486 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 46.9 m95 -99.09 131.42 45.14 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' THR . 33.4 m-85 -122.15 120.29 33.79 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 89.2 m -98.16 109.38 22.14 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.478 HG12 HG12 ' A' ' 26' ' ' ILE . 17.5 m -106.25 148.25 10.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.314 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.24 123.72 54.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.566 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -92.33 -175.33 3.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.521 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.5 -33.0 13.4 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.382 1.873 . . . . 0.0 112.643 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -78.74 -16.95 56.58 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.414 0.626 . . . . 0.0 111.648 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.09 16.05 59.95 Favored Glycine 0 C--N 1.31 -0.865 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -172.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.79 135.83 38.18 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 114.039 -1.08 . . . . 0.0 108.855 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 87' ' ' THR . 42.9 mt-10 -102.84 128.69 49.5 Favored 'General case' 0 C--N 1.277 -2.571 0 O-C-N 124.309 1.006 . . . . 0.0 110.144 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -136.29 140.64 43.55 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 26.7 m -89.68 111.92 23.03 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 122.524 0.33 . . . . 0.0 110.643 -177.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 17.0 mt -110.54 172.41 6.88 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.111 0.482 . . . . 0.0 110.973 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -99.27 169.04 9.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.783 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -68.19 -25.11 65.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.276 0.56 . . . . 0.0 110.521 178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.0 m -83.18 4.04 28.36 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.934 0.873 . . . . 0.0 109.81 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 7.4 m -120.56 -0.47 10.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.32 162.18 28.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.102 -174.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.3 t . . . . . 0 N--CA 1.42 -1.955 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.432 174.785 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.623 0 N-CA-C 111.671 0.249 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -83.03 34.98 0.47 Allowed 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 122.928 1.347 . . . . 0.0 108.629 -178.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -122.31 177.0 1.73 Allowed Pre-proline 0 C--N 1.287 -2.113 0 C-N-CA 124.875 1.27 . . . . 0.0 109.037 -171.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.662 ' HA ' ' O ' ' A' ' 7' ' ' LEU . 25.9 Cg_exo -66.91 88.19 0.29 Allowed 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.55 1.5 . . . . 0.0 109.689 168.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -98.44 -15.04 19.79 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.957 -177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.487 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 27.7 t80 -153.91 -58.07 0.12 Allowed 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 104.922 -2.251 . . . . 0.0 104.922 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.662 ' O ' ' HA ' ' A' ' 4' ' ' PRO . 95.9 mt -123.24 -160.26 0.89 Allowed 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.526 -2.027 . . . . 0.0 105.526 167.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.48 HG23 ' OG1' ' A' ' 11' ' ' THR . 1.4 t -122.45 150.96 41.77 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 118.189 0.45 . . . . 0.0 111.908 -169.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -91.59 145.39 7.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.289 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 94.34 -13.13 67.9 Favored Glycine 0 CA--C 1.51 -0.281 0 N-CA-C 111.827 -0.509 . . . . 0.0 111.827 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.48 ' OG1' HG23 ' A' ' 8' ' ' THR . 13.7 m -73.43 141.42 46.9 Favored 'General case' 0 N--CA 1.416 -2.165 0 C-N-CA 123.344 0.658 . . . . 0.0 111.174 -177.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -89.71 131.29 35.76 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 26.8 m -135.71 175.8 9.85 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.761 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.595 -177.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.423 ' HB2' ' HB2' ' A' ' 104' ' ' CYS . 51.5 m -117.08 144.82 44.23 Favored 'General case' 0 N--CA 1.417 -2.085 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 171.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -121.28 139.09 53.86 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.1 mtmt -75.87 136.11 40.15 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.329 0.585 . . . . 0.0 112.077 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -133.95 105.27 6.65 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.845 173.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 18' ' ' ARG . 2.9 mtp180 60.37 26.59 16.14 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 173.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 93.85 8.1 60.83 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.856 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.45 164.32 17.33 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -102.33 135.96 43.02 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 123.081 0.238 . . . . 0.0 111.003 -178.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 50.5 t -122.33 146.86 46.92 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 169.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -88.04 151.24 22.9 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 119.384 -0.927 . . . . 0.0 109.502 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.597 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -152.79 162.32 41.42 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.8 179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -126.61 126.29 43.37 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.584 ' HA ' HG12 ' A' ' 88' ' ' VAL . 52.3 mt -66.64 111.53 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -176.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -87.8 -44.43 11.12 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 124.858 1.263 . . . . 0.0 110.325 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 m -139.59 145.29 38.38 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 74.4 t -116.95 126.54 74.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 48.7 mttp -130.55 116.31 17.98 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.91 108.53 21.24 Favored 'General case' 0 C--N 1.276 -2.63 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -139.14 158.78 43.57 Favored 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.738 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 14.5 p -125.27 137.27 58.19 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.672 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 93.3 mttt -90.29 101.06 13.79 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 122.128 0.966 . . . . 0.0 108.852 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.602 HG12 HG13 ' A' ' 37' ' ' VAL . 20.8 t -83.8 120.95 35.73 Favored 'Isoleucine or valine' 0 C--N 1.26 -3.296 0 CA-C-N 114.137 -1.392 . . . . 0.0 110.122 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -85.34 107.86 17.54 Favored 'General case' 0 N--CA 1.428 -1.542 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 173.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.602 HG13 HG12 ' A' ' 35' ' ' VAL . 1.7 m -112.71 157.08 13.55 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.111 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.2 tt -135.41 121.57 20.18 Favored 'General case' 0 C--N 1.273 -2.76 0 N-CA-C 105.938 -1.875 . . . . 0.0 105.938 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.597 HD23 ' HB2' ' A' ' 75' ' ' ALA . 73.1 mt -69.8 129.33 39.26 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.005 -176.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.1 ptpt -68.71 -32.4 72.18 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.555 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 23.2 tt0 -81.1 -59.95 2.47 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 120.924 0.392 . . . . 0.0 110.956 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -85.57 -4.3 59.12 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.6 p30 56.38 18.62 3.53 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 125.729 1.612 . . . . 0.0 113.543 178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -88.53 137.51 32.25 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-O 120.965 0.412 . . . . 0.0 111.165 -179.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.5 m -101.11 148.16 25.39 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.443 ' OE1' HG23 ' A' ' 37' ' ' VAL . 0.2 OUTLIER -152.44 163.39 39.62 Favored 'General case' 0 C--N 1.285 -2.22 0 C-N-CA 123.133 0.573 . . . . 0.0 110.236 175.418 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.416 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 20.8 tp -128.99 103.13 6.83 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 -178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.3 m -135.53 162.52 37.27 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.518 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.593 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 16.9 pm0 -77.23 161.5 28.1 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -175.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -62.98 -6.02 3.48 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 124.618 1.167 . . . . 0.0 113.617 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -82.21 -27.63 32.45 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.776 0.798 . . . . 0.0 108.988 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -87.05 -22.51 25.41 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.223 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 97.4 t -103.8 117.21 48.95 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-N 114.913 -1.04 . . . . 0.0 111.47 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -102.8 105.37 15.77 Favored 'General case' 0 C--N 1.287 -2.137 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.315 177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.492 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 149.63 -179.39 26.45 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.638 177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -60.79 141.1 93.87 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.336 2.691 . . . . 0.0 113.562 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -95.27 83.45 3.87 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.542 ' HB3' ' HB2' ' A' ' 61' ' ' ALA . 47.2 ttp180 -139.13 135.9 34.56 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 60.5 t -66.57 122.79 18.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 176.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.87 12.18 59.46 Favored Glycine 0 N--CA 1.423 -2.214 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.422 -176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.542 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . . . -97.2 157.73 15.8 Favored 'General case' 0 CA--C 1.509 -0.601 0 CA-C-N 118.161 0.981 . . . . 0.0 110.789 178.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.9 mm -97.36 121.74 48.2 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -178.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.492 HG12 ' HA3' ' A' ' 55' ' ' GLY . 29.6 m -136.4 -173.91 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 C-N-CA 122.927 0.491 . . . . 0.0 109.893 -177.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -128.88 132.25 47.71 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 174.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.481 HG21 HG21 ' A' ' 37' ' ' VAL . 9.1 t -133.79 158.56 43.03 Favored 'General case' 0 C--N 1.279 -2.466 0 CA-C-O 120.792 0.329 . . . . 0.0 110.369 -174.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.4 ttm-85 -83.94 115.37 22.27 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.309 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 71' ' ' SER . 5.1 t -81.72 167.2 19.38 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 175.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.7 p -67.7 -2.35 6.81 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.927 0.87 . . . . 0.0 112.219 -177.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -85.93 -16.31 38.85 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.023 -0.99 . . . . 0.0 109.067 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 93.5 -2.94 71.23 Favored Glycine 0 C--O 1.227 -0.289 0 N-CA-C 111.541 -0.624 . . . . 0.0 111.541 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.454 ' O ' HG22 ' A' ' 67' ' ' THR . 8.2 m -92.26 159.97 15.37 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -109.74 115.73 30.4 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.594 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 7.2 tt0 -113.37 148.35 35.95 Favored 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 115.892 -0.594 . . . . 0.0 109.618 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 35.3 tt0 -70.4 125.17 26.05 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.597 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -136.91 173.92 11.18 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.358 -173.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.406 HD11 ' HB3' ' A' ' 40' ' ' LYS . 2.4 mp -123.67 139.99 48.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.411 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -75.5 126.2 35.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 176.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.2 m -108.33 -17.32 14.03 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-O 120.336 0.112 . . . . 0.0 110.892 177.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -166.65 151.69 7.8 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.274 -1.009 . . . . 0.0 108.274 177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 25.0 mt -124.36 112.87 17.46 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 106.8 -1.555 . . . . 0.0 106.8 169.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.8 m -95.52 122.18 37.99 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -59.72 142.04 53.95 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-O 120.96 0.41 . . . . 0.0 111.01 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -151.88 165.07 35.68 Favored 'General case' 0 N--CA 1.425 -1.718 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 179.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.547 ' O ' ' HA ' ' A' ' 99' ' ' ARG . 75.2 m -170.42 135.47 1.23 Allowed 'General case' 0 C--N 1.288 -2.078 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 176.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.494 ' CE3' ' HB ' ' A' ' 97' ' ' THR . 46.1 m95 -107.61 107.92 18.95 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.079 0.466 . . . . 0.0 110.05 177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.487 ' OH ' ' HB3' ' A' ' 6' ' ' TYR . 96.5 m-85 -101.64 103.45 14.25 Favored 'General case' 0 N--CA 1.404 -2.742 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.4 m -76.16 104.09 6.52 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.597 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 25.4 m -112.28 141.14 28.72 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.215 0 CA-C-O 121.261 0.553 . . . . 0.0 111.172 -175.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.425 HG22 ' HB3' ' A' ' 95' ' ' GLU . 9.7 t -97.36 118.16 43.33 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.404 -1.271 . . . . 0.0 108.095 -176.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 93.0 m-85 -84.44 168.47 15.49 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -61.36 -21.27 63.89 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.12 0.486 . . . . 0.0 111.218 -175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -70.1 -16.87 63.18 Favored 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 123.666 0.786 . . . . 0.0 111.113 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.62 1.94 58.79 Favored Glycine 0 CA--C 1.507 -0.468 0 N-CA-C 111.342 -0.703 . . . . 0.0 111.342 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.4 138.85 33.38 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 9.6 pt-20 -120.58 128.57 53.18 Favored 'General case' 0 C--N 1.284 -2.245 0 O-C-N 123.522 0.514 . . . . 0.0 110.413 179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -131.54 149.61 52.45 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.494 ' HB ' ' CE3' ' A' ' 85' ' ' TRP . 2.3 p -79.75 112.72 17.29 Favored 'General case' 0 C--N 1.308 -1.206 0 C-N-CA 122.383 0.273 . . . . 0.0 111.048 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -110.83 137.73 48.11 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-O 121.195 0.522 . . . . 0.0 110.682 177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.547 ' HA ' ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -76.34 143.62 40.66 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 105.134 -2.173 . . . . 0.0 105.134 175.272 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.472 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 2.5 tmm_? -44.07 -33.13 1.37 Allowed 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 124.619 1.167 . . . . 0.0 113.265 -176.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . 0.403 ' H ' ' HD2' ' A' ' 99' ' ' ARG . 24.3 m -55.31 -32.91 62.83 Favored 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 124.016 0.926 . . . . 0.0 112.047 178.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 35.1 m -82.69 -16.59 47.56 Favored 'General case' 0 N--CA 1.433 -1.306 0 O-C-N 122.063 -0.398 . . . . 0.0 110.849 -178.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.1 mp -86.87 128.97 35.06 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-O 121.79 0.805 . . . . 0.0 111.462 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.423 ' HB2' ' HB2' ' A' ' 14' ' ' SER . 20.0 m -105.16 1.19 28.08 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 114.497 -1.229 . . . . 0.0 110.902 -175.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.656 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 82.9 mt 59.46 -88.78 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.971 0.908 . . . . 0.0 112.602 -176.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.425 ' HB3' ' OE1' ' A' ' 108' ' ' GLU . 40.4 ttmt -88.44 -43.15 11.68 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 -178.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.43 21.99 4.58 Favored Glycine 0 N--CA 1.432 -1.596 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.829 177.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.425 ' OE1' ' HB3' ' A' ' 106' ' ' LYS . 0.4 OUTLIER -69.21 144.13 53.8 Favored 'General case' 0 C--O 1.25 1.082 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 178.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 44.4 mtm-85 -77.56 73.33 4.13 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -172.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -129.23 14.07 6.16 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 169.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -131.15 171.21 13.55 Favored 'General case' 0 C--O 1.247 0.928 0 CA-C-N 112.826 -1.988 . . . . 0.0 106.124 175.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 73.9 -53.56 0.69 Allowed 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 125.28 1.432 . . . . 0.0 111.357 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -99.37 -70.24 0.74 Allowed 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 174.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.7 m -73.34 150.32 41.94 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.636 -179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 170.93 109.28 0.01 OUTLIER 'General case' 0 CA--C 1.507 -0.685 0 C-N-CA 125.582 1.553 . . . . 0.0 108.336 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.6 p -108.81 11.38 26.26 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.183 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 8.2 mp 73.39 22.76 2.67 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.324 1.05 . . . . 0.0 110.302 -176.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 . . . . . 0 C--N 1.307 -1.263 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 176.482 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.645 0 CA-C-O 120.782 0.325 . . . . 0.0 110.293 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.495 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 27.9 t70 -95.38 -34.93 11.95 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.476 ' OE1' ' HA ' ' A' ' 83' ' ' ALA . 30.9 mt-10 -104.56 97.69 12.9 Favored Pre-proline 0 N--CA 1.442 -0.828 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 175.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 2' ' ' ASP . 12.8 Cg_exo -73.86 -9.29 22.25 Favored 'Trans proline' 0 C--N 1.356 0.925 0 C-N-CA 123.187 2.591 . . . . 0.0 112.046 -178.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.49 27.57 0.5 Allowed 'General case' 0 C--N 1.309 -1.164 0 C-N-CA 124.815 1.246 . . . . 0.0 111.324 -178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.694 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 39.6 p90 -76.81 99.45 5.15 Favored 'General case' 0 N--CA 1.409 -2.491 0 CA-C-O 122.605 1.193 . . . . 0.0 109.948 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.8 mt -76.88 177.32 7.78 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 112.82 -1.991 . . . . 0.0 109.801 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.472 ' HA ' HG21 ' A' ' 29' ' ' VAL . 10.6 p -133.4 166.57 22.22 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.374 -177.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.3 t -66.4 111.41 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.587 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 142.98 -26.52 2.2 Favored Glycine 0 N--CA 1.426 -2.0 0 N-CA-C 110.653 -0.979 . . . . 0.0 110.653 -177.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.483 ' HB ' HD12 ' A' ' 26' ' ' ILE . 5.6 m -71.64 137.93 48.27 Favored 'General case' 0 N--CA 1.417 -2.11 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -116.33 125.68 52.46 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.451 ' CG2' HD22 ' A' ' 103' ' ' LEU . 33.9 m -144.79 -178.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -174.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.513 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 9.4 t -99.26 147.46 25.14 Favored 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 106.962 -1.496 . . . . 0.0 106.962 175.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -137.75 128.8 27.42 Favored 'General case' 0 C--N 1.308 -1.239 0 C-N-CA 123.324 0.65 . . . . 0.0 109.396 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 51.1 mtpt -70.54 121.09 17.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.955 175.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.417 ' HE1' ' HB2' ' A' ' 22' ' ' CYS . 12.5 p90 -148.46 138.55 22.44 Favored 'General case' 0 N--CA 1.424 -1.772 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 60.65 26.13 15.87 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.167 0.587 . . . . 0.0 111.46 -178.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.55 3.05 72.1 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-N 115.82 -0.627 . . . . 0.0 114.184 175.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.06 145.53 44.1 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 117.652 0.726 . . . . 0.0 110.157 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 21.7 p90 -93.58 120.61 34.07 Favored 'General case' 0 C--N 1.31 -1.122 0 C-N-CA 120.153 -0.619 . . . . 0.0 110.987 175.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.417 ' HB2' ' HE1' ' A' ' 17' ' ' TYR . 83.7 m -123.63 173.63 7.96 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 -177.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -75.11 146.5 41.35 Favored 'General case' 0 C--O 1.253 1.242 0 C-N-CA 119.852 -0.739 . . . . 0.0 110.21 -178.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.572 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -152.12 147.78 26.86 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.416 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -116.6 128.36 55.32 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.541 ' HA ' HG12 ' A' ' 88' ' ' VAL . 28.4 mt -62.36 116.09 2.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.5 tppp? -90.37 -40.32 12.15 Favored 'General case' 0 C--N 1.317 -0.818 0 C-N-CA 124.601 1.16 . . . . 0.0 110.118 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 87.4 m -144.41 145.98 32.23 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.278 -177.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.472 HG21 ' HA ' ' A' ' 8' ' ' THR . 96.0 t -129.29 128.75 66.93 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.306 0 CA-C-N 115.146 -0.934 . . . . 0.0 109.086 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 84' ' ' SER . 21.8 mmmt -118.29 102.66 9.14 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.328 -0.851 . . . . 0.0 109.637 173.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 75.7 mtm180 -77.15 88.0 3.62 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 104.623 -2.362 . . . . 0.0 104.623 170.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 83' ' ' ALA . 3.5 pp -111.09 153.58 25.47 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.958 0.885 . . . . 0.0 112.437 -172.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.493 ' CG1' ' HB3' ' A' ' 80' ' ' LEU . 60.3 t -115.81 120.61 65.3 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.365 0 N-CA-C 106.705 -1.591 . . . . 0.0 106.705 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.621 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 26.4 mtpp -85.59 99.02 10.99 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.595 HG12 HG13 ' A' ' 37' ' ' VAL . 21.4 t -84.41 123.8 39.31 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.947 0 CA-C-N 113.471 -1.695 . . . . 0.0 110.928 -177.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 87.7 tttt -87.99 115.41 25.44 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 171.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.595 HG13 HG12 ' A' ' 35' ' ' VAL . 1.7 m -118.46 143.38 29.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.38 0 CA-C-O 121.427 0.632 . . . . 0.0 112.077 -178.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 44' ' ' THR . 1.9 tm? -107.21 116.89 32.72 Favored 'General case' 0 C--N 1.277 -2.544 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.501 HD23 ' HB2' ' A' ' 75' ' ' ALA . 44.8 mt -74.7 124.6 27.04 Favored 'General case' 0 C--O 1.21 -1.017 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 -177.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.486 ' HB3' HD11 ' A' ' 76' ' ' ILE . 22.2 pttp -72.82 -29.29 63.12 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -78.2 -38.92 42.11 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 120.947 0.403 . . . . 0.0 111.595 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.565 ' OD1' ' HB ' ' A' ' 44' ' ' THR . 14.6 t70 -93.33 -25.55 17.68 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.864 0.364 . . . . 0.0 110.948 -176.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 70.26 22.31 5.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 124.29 1.036 . . . . 0.0 111.24 -177.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.565 ' HB ' ' OD1' ' A' ' 42' ' ' ASP . 5.6 t -101.23 -174.8 2.69 Favored 'General case' 0 CA--C 1.484 -1.59 0 CA-C-O 121.475 0.655 . . . . 0.0 110.049 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.7 m -136.24 139.65 42.9 Favored 'General case' 0 C--N 1.258 -3.377 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.25 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -131.01 156.93 44.29 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.405 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 8.1 tt -140.96 103.8 4.55 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 174.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 25.6 m -126.03 -178.49 2.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.303 -1.317 . . . . 0.0 109.746 -172.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -100.7 173.06 6.7 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.456 ' HB2' ' H ' ' A' ' 33' ' ' VAL . 1.4 t70 -43.03 -29.86 0.38 Allowed 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 128.657 2.783 . . . . 0.0 114.754 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -82.35 -28.01 31.84 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.121 -174.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.494 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 8.0 mm-40 -90.19 -16.48 29.39 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.421 0.629 . . . . 0.0 109.443 -176.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 98.8 t -97.57 109.37 23.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 CA-C-N 114.882 -1.053 . . . . 0.0 111.509 -177.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -99.03 106.88 19.17 Favored 'General case' 0 C--N 1.286 -2.182 0 CA-C-N 114.434 -1.257 . . . . 0.0 108.525 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 139.18 -171.3 23.73 Favored Glycine 0 N--CA 1.433 -1.505 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.406 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.32 137.58 23.58 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.136 2.558 . . . . 0.0 113.495 -176.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 51.5 mt -90.03 81.98 6.17 Favored 'General case' 0 C--N 1.29 -2.004 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 38.7 ttm180 -139.61 128.63 23.64 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.892 -1.049 . . . . 0.0 108.629 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 35.5 t -65.97 116.27 5.03 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.37 6.19 51.16 Favored Glycine 0 N--CA 1.431 -1.699 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.836 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.39 165.2 12.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 117.391 0.596 . . . . 0.0 111.228 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.414 HD13 HG13 ' A' ' 76' ' ' ILE . 48.5 mm -96.14 124.27 48.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 O-C-N 123.6 0.563 . . . . 0.0 109.935 178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.421 ' CG1' HD11 ' A' ' 77' ' ' ILE . 19.7 m -131.61 178.08 6.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 176.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -121.6 121.4 37.32 Favored 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 173.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.442 HG21 HG21 ' A' ' 37' ' ' VAL . 8.4 t -116.37 158.04 24.1 Favored 'General case' 0 C--N 1.28 -2.454 0 CA-C-N 116.148 -0.478 . . . . 0.0 109.816 -175.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 23.1 mtt180 -79.15 143.55 35.34 Favored 'General case' 0 CA--C 1.479 -1.782 0 CA-C-N 115.754 -0.657 . . . . 0.0 112.037 176.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 75.1 p -97.92 175.25 6.2 Favored 'General case' 0 N--CA 1.404 -2.727 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.205 175.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 17.4 m -76.7 -17.92 58.82 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.252 0.549 . . . . 0.0 111.095 -179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -84.11 -21.12 31.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.819 176.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.8 6.01 23.37 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.368 -0.92 . . . . 0.0 114.424 174.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.9 p -99.3 177.27 5.25 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 117.619 0.71 . . . . 0.0 110.387 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.446 ' CE1' ' HG3' ' A' ' 66' ' ' ARG . 60.6 m-85 -108.46 137.26 46.71 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-O 121.119 0.485 . . . . 0.0 110.792 175.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 mm-40 -122.43 141.75 51.27 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.28 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 56.7 mt-10 -74.36 118.69 17.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-O 121.715 0.769 . . . . 0.0 109.004 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -134.25 166.82 21.91 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.322 -175.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 40' ' ' LYS . 3.5 mp -112.14 141.89 26.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.421 HD11 ' CG1' ' A' ' 63' ' ' VAL . 3.2 mp -74.26 122.57 27.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m -101.18 -27.3 13.3 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.264 0.554 . . . . 0.0 110.241 177.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 53.7 tptt -162.72 142.24 9.14 Favored 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.493 ' HB3' ' CG1' ' A' ' 33' ' ' VAL . 25.3 mt -119.0 127.09 53.13 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 171.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.621 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 3.7 m -106.49 104.3 13.96 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -67.59 120.26 13.71 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.477 ' HB3' HD12 ' A' ' 32' ' ' LEU . . . -143.73 -176.91 5.16 Favored 'General case' 0 N--CA 1.432 -1.331 0 O-C-N 123.852 0.72 . . . . 0.0 110.433 -174.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 49.2 m -163.22 135.95 5.45 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 176.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -118.59 145.25 45.54 Favored 'General case' 0 CA--C 1.485 -1.523 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 175.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.694 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 55.5 m-85 -124.69 121.9 35.97 Favored 'General case' 0 N--CA 1.423 -1.821 0 O-C-N 124.152 0.907 . . . . 0.0 109.115 -176.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.495 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 70.5 m -95.09 107.73 19.8 Favored 'General case' 0 N--CA 1.409 -2.524 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 173.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.572 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 30.3 m -109.64 147.16 14.25 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.446 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.884 -176.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -103.92 128.48 57.2 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -90.49 179.06 5.94 Favored 'General case' 0 C--N 1.294 -1.81 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.915 -172.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -52.0 -39.71 59.83 Favored 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 125.488 1.515 . . . . 0.0 112.809 178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -80.39 -13.73 58.91 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.421 0.629 . . . . 0.0 111.866 -176.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 104.49 -0.44 43.06 Favored Glycine 0 C--N 1.292 -1.884 0 C-N-CA 120.865 -0.683 . . . . 0.0 113.84 175.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -87.56 154.08 20.9 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 6.8 pt-20 -130.42 137.61 49.92 Favored 'General case' 0 N--CA 1.416 -2.131 0 CA-C-O 120.861 0.362 . . . . 0.0 110.084 -179.035 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.495 ' O ' ' HA ' ' A' ' 87' ' ' THR . 0.6 OUTLIER -139.21 158.64 43.8 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.886 -177.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.1 m -101.57 117.22 34.47 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 123.444 0.465 . . . . 0.0 110.235 -178.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.405 ' CD2' HD21 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -136.2 165.1 26.52 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.078 0.951 . . . . 0.0 111.909 -177.385 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -100.12 -171.3 2.01 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.407 HH21 ' HA ' ' A' ' 6' ' ' TYR . 3.6 mpt_? -75.93 -5.34 45.69 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.654 -177.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.2 p -71.27 -21.13 62.14 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.671 0.748 . . . . 0.0 110.11 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.533 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 23.3 m -106.64 -16.17 14.58 Favored 'General case' 0 N--CA 1.428 -1.573 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.053 176.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.513 ' HA ' ' O ' ' A' ' 14' ' ' SER . 87.6 mt -93.05 127.33 38.54 Favored 'General case' 0 CA--C 1.497 -1.074 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.612 -175.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 14' ' ' SER . 18.8 m -96.67 90.71 5.41 Favored 'General case' 0 C--N 1.29 -1.995 0 CA-C-O 121.168 0.508 . . . . 0.0 110.431 -176.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 61.1 mt -83.28 -26.2 30.89 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 171.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.61 -173.73 3.95 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 177.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 95.04 130.16 5.99 Favored Glycine 0 N--CA 1.438 -1.221 0 C-N-CA 120.223 -0.989 . . . . 0.0 111.981 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -142.32 147.61 36.63 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 72.88 -56.99 0.65 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 124.533 1.133 . . . . 0.0 110.699 -171.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 22.8 m-70 -135.88 155.65 49.99 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 176.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -124.78 125.92 44.81 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 120.693 -0.403 . . . . 0.0 110.528 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 115' ' ' GLU . . . 69.13 -51.58 0.59 Allowed 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 125.973 1.709 . . . . 0.0 111.839 177.148 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -74.13 6.34 3.57 Favored 'General case' 0 C--N 1.297 -1.713 0 C-N-CA 125.578 1.551 . . . . 0.0 110.692 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 18.6 m -64.18 -19.46 65.34 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 124.571 1.149 . . . . 0.0 109.032 173.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 112' ' ' ALA . 44.8 mt-10 -66.31 -23.95 66.46 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.975 175.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 49.7 m -99.46 97.52 8.53 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 177.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -151.0 -63.04 0.19 Allowed 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 34.6 t70 . . . . . 0 C--N 1.307 -1.265 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.218 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.499 -1.009 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -104.19 -30.68 10.04 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 173.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 29.3 mp0 -73.68 115.76 45.03 Favored Pre-proline 0 N--CA 1.423 -1.808 0 CA-C-N 112.72 -2.036 . . . . 0.0 109.766 -174.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -95.55 -4.7 1.94 Allowed 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.085 1.857 . . . . 0.0 113.438 179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -90.46 -19.53 23.77 Favored 'General case' 0 CA--C 1.508 -0.67 0 O-C-N 121.895 -0.503 . . . . 0.0 110.751 -178.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 44.2 p90 -167.96 136.97 2.49 Favored 'General case' 0 N--CA 1.42 -1.965 0 N-CA-C 103.461 -2.792 . . . . 0.0 103.461 177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.472 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 22.1 mt -85.88 178.71 7.2 Favored 'General case' 0 C--N 1.277 -2.571 0 C-N-CA 120.294 -0.562 . . . . 0.0 111.586 -175.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.5 p -133.0 168.34 18.65 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.264 -176.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.3 t -68.29 148.66 11.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 123.853 0.861 . . . . 0.0 111.562 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 91.23 -5.94 81.17 Favored Glycine 0 CA--C 1.505 -0.531 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.963 175.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.527 ' HB ' HD12 ' A' ' 26' ' ' ILE . 8.6 m -82.62 139.82 33.55 Favored 'General case' 0 N--CA 1.418 -2.037 0 C-N-CA 122.346 0.258 . . . . 0.0 110.532 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -104.93 111.06 23.69 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.559 -1.275 . . . . 0.0 107.559 175.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 104' ' ' CYS . 29.3 m -127.24 171.97 14.92 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.049 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.555 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 21.2 m -95.11 142.81 27.13 Favored 'General case' 0 C--N 1.285 -2.198 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.598 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -133.78 129.36 36.48 Favored 'General case' 0 C--N 1.311 -1.075 0 C-N-CA 123.027 0.531 . . . . 0.0 109.701 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HD2' ' HA ' ' A' ' 111' ' ' PHE . 21.1 ptmt -94.83 120.31 34.84 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.706 0.765 . . . . 0.0 110.379 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -119.97 120.97 37.9 Favored 'General case' 0 N--CA 1.406 -2.639 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 178.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.7 mpt_? 63.78 26.28 14.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.53 0.681 . . . . 0.0 110.729 -176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.85 -14.88 63.09 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.453 -0.794 . . . . 0.0 113.501 178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -104.31 130.17 52.15 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.428 ' HA ' ' HA ' ' A' ' 16' ' ' LYS 0.289 6.6 p90 -105.0 123.96 48.7 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 116.201 1.926 . . . . 0.0 116.201 -177.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.2 t -115.06 160.61 19.42 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.3 OUTLIER -90.69 148.94 22.28 Favored 'General case' 0 C--N 1.271 -2.814 0 CA-C-O 121.887 0.851 . . . . 0.0 110.08 178.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.539 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -144.54 149.34 35.71 Favored 'General case' 0 C--N 1.259 -3.334 0 CA-C-N 114.557 -1.201 . . . . 0.0 109.699 -175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.76 126.26 51.65 Favored 'General case' 0 C--N 1.274 -2.688 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.583 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.527 HD12 ' HB ' ' A' ' 11' ' ' THR . 30.8 mt -68.95 119.45 14.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 123.526 0.73 . . . . 0.0 112.268 -175.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -91.29 -53.38 4.37 Favored 'General case' 0 CA--C 1.49 -1.331 0 CA-C-O 122.057 0.932 . . . . 0.0 109.455 177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 m -129.71 143.41 50.8 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.463 -174.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.7 t -127.71 123.66 61.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.301 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.8 tttm -112.71 117.98 33.72 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 171.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -72.05 108.31 5.2 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 84' ' ' SER . 6.6 tt -129.34 136.76 50.43 Favored 'General case' 0 N--CA 1.409 -2.512 0 CA-C-O 121.544 0.688 . . . . 0.0 109.34 -174.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.4 t -115.59 132.97 63.41 Favored 'Isoleucine or valine' 0 C--N 1.264 -3.126 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.088 -176.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -84.69 101.54 12.27 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 170.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.402 HG12 HG13 ' A' ' 37' ' ' VAL . 14.3 t -91.8 118.27 36.86 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.07 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.779 -176.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 87.7 tttt -80.52 103.71 10.56 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.448 HG21 HG21 ' A' ' 65' ' ' THR . 3.9 m -111.55 143.52 21.21 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.448 0 CA-C-O 121.689 0.757 . . . . 0.0 111.21 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -111.04 117.13 32.46 Favored 'General case' 0 C--N 1.267 -3.018 0 CA-C-N 113.149 -1.841 . . . . 0.0 106.91 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.49 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 75.7 mt -73.72 108.5 6.59 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 179.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.2 pttt -62.25 -30.32 71.03 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 -175.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -80.22 -40.15 27.69 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.241 0.543 . . . . 0.0 111.697 -178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -95.05 -25.38 16.49 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-O 121.242 0.544 . . . . 0.0 111.384 -174.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 74.42 22.67 2.11 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.524 1.53 . . . . 0.0 113.12 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -103.97 150.17 24.47 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.655 176.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.9 m -119.03 151.87 37.44 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 0.1 OUTLIER -157.85 161.88 38.35 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 123.451 0.7 . . . . 0.0 109.619 177.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.6 mt -113.11 102.31 10.27 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 17.7 m -117.94 172.51 5.4 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.264 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.597 -177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -84.9 161.5 19.82 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 121.058 0.456 . . . . 0.0 111.963 -174.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -64.44 -20.15 65.99 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.271 1.029 . . . . 0.0 111.06 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -78.58 -21.92 47.88 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.783 0.801 . . . . 0.0 109.533 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.402 ' O ' ' HA ' ' A' ' 65' ' ' THR . 96.6 mt-30 -98.31 -11.57 22.41 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.656 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.88 111.51 27.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.569 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -98.4 103.75 15.72 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.227 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 140.71 178.87 17.63 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.505 177.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.53 140.32 80.98 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 123.346 2.697 . . . . 0.0 113.93 -178.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -89.35 82.27 6.51 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.523 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 73.5 mtp180 -140.11 134.47 31.32 Favored 'General case' 0 CA--C 1.488 -1.421 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.455 178.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.79 118.61 10.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.307 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.19 6.17 53.86 Favored Glycine 0 N--CA 1.432 -1.605 0 CA-C-N 115.498 -0.774 . . . . 0.0 112.43 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -96.33 155.84 16.59 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.704 0.752 . . . . 0.0 110.619 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.0 mm -96.09 116.92 39.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-O 121.426 0.632 . . . . 0.0 109.334 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.523 HG12 ' HA3' ' A' ' 55' ' ' GLY . 30.4 m -126.82 170.61 16.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.196 -0.911 . . . . 0.0 108.565 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -112.84 121.46 44.75 Favored 'General case' 0 C--N 1.268 -2.964 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.506 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 9.2 t -119.68 157.59 28.2 Favored 'General case' 0 C--N 1.269 -2.926 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.956 -174.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -81.93 126.17 31.61 Favored 'General case' 0 C--N 1.289 -2.045 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.759 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 67.7 p -90.31 -176.07 4.7 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 36.0 m -67.26 -26.31 66.5 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -79.85 -6.9 58.25 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.387 0.613 . . . . 0.0 110.56 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 94.27 -18.57 56.63 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.51 -179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.5 m -72.78 141.75 48.09 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 122.786 0.434 . . . . 0.0 110.081 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.506 ' HA ' ' O ' ' A' ' 65' ' ' THR . 45.0 m-85 -89.88 133.23 34.87 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.49 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 32.0 tt0 -124.09 146.52 48.55 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 179.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -78.05 117.31 19.24 Favored 'General case' 0 N--CA 1.434 -1.245 0 CA-C-O 122.484 1.135 . . . . 0.0 110.754 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.455 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -124.93 174.03 8.25 Favored 'General case' 0 C--N 1.282 -2.346 0 CA-C-N 113.494 -1.685 . . . . 0.0 110.987 -174.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.474 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 10.9 mt -117.15 144.34 25.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.523 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -77.88 125.85 37.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 109.273 -0.639 . . . . 0.0 109.273 175.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 t -102.64 -20.89 14.25 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 178.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -173.92 153.32 2.12 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.4 OUTLIER -129.77 115.39 17.22 Favored 'General case' 0 C--N 1.293 -1.881 0 CA-C-O 121.759 0.79 . . . . 0.0 111.437 172.609 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 38.9 m -105.53 124.42 49.52 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.083 -176.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -75.88 130.56 38.72 Favored 'General case' 0 C--N 1.317 -0.844 0 C-N-CA 119.914 -0.714 . . . . 0.0 109.422 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -120.7 -67.95 0.94 Allowed 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -178.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.48 ' HA ' ' HB3' ' A' ' 32' ' ' LEU . 31.2 m 67.87 145.35 0.04 OUTLIER 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 124.848 1.259 . . . . 0.0 113.37 -179.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 6.3 m95 -95.81 134.11 39.15 Favored 'General case' 0 CA--C 1.492 -1.256 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.155 176.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.472 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 91.0 m-85 -125.89 104.42 8.31 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 55.2 m -83.53 106.9 15.64 Favored 'General case' 0 N--CA 1.408 -2.553 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 176.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.453 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 26.8 m -113.45 142.74 24.92 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.758 -174.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.482 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 9.9 p -99.39 125.29 52.98 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.78 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 72.4 m-85 -88.24 178.72 6.53 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.183 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -54.44 -31.85 56.29 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.015 0.926 . . . . 0.0 111.66 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -65.74 -17.09 64.37 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 123.894 0.877 . . . . 0.0 111.503 179.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.46 6.9 83.13 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.651 -0.785 . . . . 0.0 111.335 -178.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -97.15 136.53 37.54 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 11.6 pt-20 -107.02 126.93 52.97 Favored 'General case' 0 C--N 1.286 -2.162 0 CA-C-O 121.585 0.707 . . . . 0.0 110.06 177.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -122.5 145.35 48.39 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 44.4 m -87.65 119.86 28.38 Favored 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 177.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -109.69 166.21 11.08 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.226 0.536 . . . . 0.0 111.389 -177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -94.47 152.03 18.9 Favored 'General case' 0 N--CA 1.428 -1.529 0 CA-C-N 114.519 -1.219 . . . . 0.0 107.968 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -50.79 -49.53 58.18 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 124.888 1.275 . . . . 0.0 111.759 -179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.4 p -79.83 11.16 3.43 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 114.968 -1.015 . . . . 0.0 112.289 -176.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 19.7 m -120.12 5.87 10.8 Favored 'General case' 0 N--CA 1.426 -1.643 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.7 tp -117.95 165.87 13.19 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 115.2 -0.909 . . . . 0.0 108.764 -175.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.453 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 43.5 t -133.76 108.61 8.6 Favored 'General case' 0 N--CA 1.433 -1.31 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -177.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.5 tt -169.51 -50.81 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 104.371 -2.455 . . . . 0.0 104.371 167.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 41.3 tttp -157.35 144.87 18.73 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 168.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.11 30.57 9.21 Favored Glycine 0 C--N 1.301 -1.375 0 N-CA-C 106.291 -2.724 . . . . 0.0 106.291 -166.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.57 -10.38 57.92 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 126.369 1.868 . . . . 0.0 112.188 -172.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.422 ' HA ' ' HD3' ' A' ' 109' ' ' ARG . 18.1 mmt180 -72.18 134.49 45.72 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.255 -179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 86.68 -37.74 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 125.939 1.695 . . . . 0.0 109.691 -171.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.607 ' HA ' ' HD2' ' A' ' 16' ' ' LYS . 59.5 t80 -64.33 -63.15 1.21 Allowed 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 171.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -98.42 89.49 4.45 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 172.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.25 105.35 2.49 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.76 -178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.2 t -101.56 -35.17 9.23 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -112.37 -9.86 13.82 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 171.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 65.1 m 77.54 -57.36 0.5 Allowed 'General case' 0 C--O 1.238 0.456 0 C-N-CA 125.157 1.383 . . . . 0.0 109.627 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.526 ' H ' HD23 ' A' ' 117' ' ' LEU . 2.3 pt? -96.32 47.31 1.08 Allowed 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 174.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.413 ' OD2' ' HD2' ' A' ' 109' ' ' ARG . 6.2 m-20 . . . . . 0 C--O 1.245 0.822 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.661 177.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.622 0 CA-C-O 120.658 0.266 . . . . 0.0 111.362 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -66.72 -34.98 79.04 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.974 0.892 . . . . 0.0 108.85 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.51 110.22 57.82 Favored Pre-proline 0 N--CA 1.428 -1.56 0 CA-C-N 114.179 -1.373 . . . . 0.0 109.334 172.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -88.42 -159.9 0.1 OUTLIER 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 122.346 2.031 . . . . 0.0 112.754 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.84 20.22 3.15 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.494 0.664 . . . . 0.0 110.724 -179.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -152.75 148.94 27.83 Favored 'General case' 0 N--CA 1.394 -3.267 0 N-CA-C 105.785 -1.932 . . . . 0.0 105.785 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.412 ' HB2' ' CE2' ' A' ' 86' ' ' TYR . 89.9 mt -94.03 174.82 6.96 Favored 'General case' 0 C--N 1.263 -3.193 0 N-CA-C 107.81 -1.182 . . . . 0.0 107.81 176.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 12.5 p -133.33 161.1 35.42 Favored 'General case' 0 C--N 1.294 -1.826 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.5 m -69.73 149.39 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-O 121.429 0.633 . . . . 0.0 111.998 179.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.81 -7.77 55.61 Favored Glycine 0 C--N 1.289 -2.058 0 CA-C-N 114.547 -1.206 . . . . 0.0 113.722 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 14.0 t -102.65 164.42 11.66 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.123 -1.031 . . . . 0.0 109.16 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.451 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 17.3 t70 -117.25 128.48 55.12 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -172.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.455 HG12 HD23 ' A' ' 105' ' ' LEU . 33.0 m -128.78 173.88 12.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 CA-C-O 121.844 0.83 . . . . 0.0 110.415 -175.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.516 ' HB2' ' SG ' ' A' ' 104' ' ' CYS . 13.6 m -110.04 121.89 46.3 Favored 'General case' 0 C--N 1.275 -2.641 0 N-CA-C 106.851 -1.536 . . . . 0.0 106.851 172.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.42 144.44 34.34 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.3 ttpm? -96.28 126.88 41.8 Favored 'General case' 0 C--N 1.311 -1.091 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.054 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -131.62 122.25 25.7 Favored 'General case' 0 C--N 1.309 -1.187 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? 59.44 26.67 15.64 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 121.224 0.535 . . . . 0.0 111.894 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.52 0.2 88.17 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.721 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.88 148.88 29.96 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -96.98 133.09 42.1 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.1 m -129.05 139.85 51.86 Favored 'General case' 0 C--N 1.286 -2.158 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -75.92 132.81 40.5 Favored 'General case' 0 N--CA 1.398 -3.056 0 C-N-CA 123.52 0.728 . . . . 0.0 109.341 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -154.53 144.36 21.68 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.52 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' HB2' ' NZ ' ' A' ' 25' ' ' LYS . 4.4 ttmp? -106.12 133.37 50.93 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -176.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.548 ' HA ' HG12 ' A' ' 88' ' ' VAL . 24.1 mt -64.95 110.4 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.301 0.572 . . . . 0.0 111.201 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -94.72 -40.72 9.64 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.298 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 20.8 m -133.24 143.24 48.98 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.866 0.365 . . . . 0.0 110.063 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 61.3 t -123.63 124.6 69.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.864 0.866 . . . . 0.0 109.159 179.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -118.22 112.47 20.15 Favored 'General case' 0 C--N 1.282 -2.368 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.089 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.435 ' HA ' ' HE ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -77.18 96.57 4.54 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.045 178.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.42 HD22 ' CD1' ' A' ' 85' ' ' TRP . 8.6 mp -122.59 114.74 21.04 Favored 'General case' 0 CA--C 1.462 -2.417 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.022 178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.8 t -115.73 114.57 46.64 Favored 'Isoleucine or valine' 0 C--N 1.258 -3.38 0 N-CA-C 105.869 -1.9 . . . . 0.0 105.869 170.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 94.2 mttt -79.25 106.01 10.98 Favored 'General case' 0 N--CA 1.421 -1.89 0 CA-C-O 121.978 0.894 . . . . 0.0 109.19 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 67.8 t -91.8 127.32 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.041 0 CA-C-N 113.667 -1.606 . . . . 0.0 108.099 -177.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 35.6 ttpt -97.36 127.73 43.57 Favored 'General case' 0 N--CA 1.406 -2.659 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 33.8 m -120.84 160.85 21.28 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.59 0 O-C-N 123.449 0.468 . . . . 0.0 109.764 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 31.6 tp -122.74 118.35 27.86 Favored 'General case' 0 C--N 1.274 -2.674 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 177.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.693 HD23 ' HB2' ' A' ' 75' ' ' ALA . 81.1 mt -68.75 121.94 17.55 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.734 -0.667 . . . . 0.0 110.477 178.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 mtpt -55.9 -44.27 78.08 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.396 -175.428 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -80.85 -61.27 2.01 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 114.734 -1.121 . . . . 0.0 112.024 -173.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -80.94 -22.31 39.71 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.25 -0.887 . . . . 0.0 112.878 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 74.26 19.21 2.91 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 123.329 0.652 . . . . 0.0 112.743 178.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.403 ' OG1' HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -82.7 142.22 31.82 Favored 'General case' 0 N--CA 1.415 -2.198 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 175.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.414 HG22 ' HG2' ' A' ' 36' ' ' LYS . 3.2 m -109.18 137.44 47.06 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.488 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 3.6 tp60 -136.03 140.81 44.13 Favored 'General case' 0 C--N 1.275 -2.659 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -172.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.455 HD13 ' HB2' ' A' ' 36' ' ' LYS . 41.4 tp -119.67 101.96 8.28 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.6 t -135.71 152.9 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -175.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.555 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 5.3 pm0 -71.57 153.45 42.13 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-O 121.516 0.674 . . . . 0.0 112.523 -178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -55.8 -11.83 1.12 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.899 2.079 . . . . 0.0 114.234 -175.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -77.82 -25.93 49.17 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.629 0.728 . . . . 0.0 110.557 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -106.97 -2.68 20.94 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.918 0.866 . . . . 0.0 110.144 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.423 HG22 HG23 ' A' ' 65' ' ' THR . 53.1 t -101.44 113.27 37.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 CA-C-N 114.524 -1.216 . . . . 0.0 107.953 174.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -94.1 97.99 10.68 Favored 'General case' 0 C--N 1.276 -2.605 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.278 -175.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.519 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 153.78 -166.48 31.89 Favored Glycine 0 N--CA 1.429 -1.797 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.042 176.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -79.46 146.49 19.41 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.971 2.447 . . . . 0.0 112.293 178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.495 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -98.25 82.21 2.89 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 122.847 1.308 . . . . 0.0 108.421 176.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.548 ' O ' HG13 ' A' ' 77' ' ' ILE . 19.4 tpt180 -140.78 117.97 11.3 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 112.723 -2.035 . . . . 0.0 107.26 -178.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.439 ' HA ' ' CG2' ' A' ' 77' ' ' ILE . 47.1 t -56.54 123.44 7.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.699 0 CA-C-N 118.439 0.563 . . . . 0.0 109.868 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.438 ' H ' ' HB ' ' A' ' 77' ' ' ILE . . . 98.43 7.83 55.45 Favored Glycine 0 N--CA 1.42 -2.406 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.84 -174.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.496 ' O ' HG12 ' A' ' 77' ' ' ILE . . . -96.21 153.11 17.98 Favored 'General case' 0 CA--C 1.506 -0.721 0 CA-C-N 118.743 1.271 . . . . 0.0 109.575 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.444 HG12 HD12 ' A' ' 76' ' ' ILE . 65.2 mt -94.74 119.53 42.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.519 HG12 ' HA3' ' A' ' 55' ' ' GLY . 27.5 m -133.13 169.68 21.52 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.0 -175.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -111.97 120.17 41.0 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.423 HG23 HG22 ' A' ' 53' ' ' VAL . 18.9 m -106.56 146.53 30.54 Favored 'General case' 0 N--CA 1.396 -3.17 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -176.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 38.3 ttt180 -68.68 119.61 13.36 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 121.55 0.691 . . . . 0.0 111.058 178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.416 ' HB ' ' HG2' ' A' ' 73' ' ' GLN . 9.8 t -92.21 161.84 14.56 Favored 'General case' 0 N--CA 1.403 -2.787 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 176.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 27.0 m -74.32 6.54 3.54 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 121.713 0.768 . . . . 0.0 111.688 -177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.6 -8.2 57.69 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 102.09 -22.08 39.35 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.536 -0.756 . . . . 0.0 113.03 177.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.8 m -99.27 -175.62 3.07 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 120.648 0.261 . . . . 0.0 110.726 -177.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -111.55 136.74 50.31 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 177.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.416 ' HG2' ' HB ' ' A' ' 67' ' ' THR . 22.6 pt20 -124.05 154.49 39.85 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 111.509 0.189 . . . . 0.0 111.509 177.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -69.23 123.08 20.19 Favored 'General case' 0 C--O 1.246 0.909 0 O-C-N 124.172 0.92 . . . . 0.0 111.645 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.693 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.19 170.89 14.88 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.475 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.444 HD12 HG12 ' A' ' 62' ' ' ILE . 9.8 mm -113.96 143.64 23.24 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 177.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.548 HG13 ' O ' ' A' ' 58' ' ' ARG . 11.4 mm -66.77 125.62 24.51 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.5 p -107.44 -25.91 11.2 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.152 0.501 . . . . 0.0 110.914 176.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 21.8 tptm -163.09 165.27 24.87 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -144.99 129.61 18.05 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 123.672 0.789 . . . . 0.0 108.976 172.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.3 m -127.77 125.65 40.29 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 123.412 0.685 . . . . 0.0 109.341 -176.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -81.05 135.33 35.82 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -175.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -117.39 -66.3 1.09 Allowed 'General case' 0 C--N 1.299 -1.621 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.1 m 53.33 104.92 0.01 OUTLIER 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 124.812 1.32 . . . . 0.0 113.998 179.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.42 ' CD1' HD22 ' A' ' 32' ' ' LEU . 95.4 m95 -88.45 120.4 29.79 Favored 'General case' 0 C--N 1.286 -2.172 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.132 -179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.412 ' CE2' ' HB2' ' A' ' 7' ' ' LEU . 90.6 m-85 -113.35 110.52 20.47 Favored 'General case' 0 N--CA 1.424 -1.734 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 96' ' ' ARG . 27.7 m -89.33 108.21 19.5 Favored 'General case' 0 N--CA 1.389 -3.497 0 N-CA-C 107.232 -1.396 . . . . 0.0 107.232 177.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.548 HG12 ' HA ' ' A' ' 26' ' ' ILE . 17.1 m -105.92 140.67 23.26 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.277 0 CA-C-N 114.431 -1.259 . . . . 0.0 109.455 -176.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.7 p -109.21 139.98 29.82 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.203 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.597 -174.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.422 ' CE2' ' HD3' ' A' ' 96' ' ' ARG . 65.3 m-85 -91.27 172.75 8.32 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.63 -12.26 57.32 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.485 174.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -75.75 -17.92 59.73 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.174 175.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 96.18 -10.66 67.63 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.831 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 50.2 t0 -97.21 161.8 13.64 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.409 ' C ' ' HD2' ' A' ' 96' ' ' ARG . 9.3 pt-20 -137.6 157.47 46.44 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -171.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 87' ' ' THR . 4.2 mpt_? -129.54 151.4 50.19 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.895 0.878 . . . . 0.0 110.061 173.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 66.9 m -102.27 113.95 27.7 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 3.7 mm? -113.86 168.31 9.9 Favored 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 123.673 0.789 . . . . 0.0 110.946 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 -89.31 157.31 18.25 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 173.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.461 ' C ' ' HD3' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -50.22 -38.1 38.65 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 118.518 0.599 . . . . 0.0 111.513 -179.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.5 m -79.04 -3.66 46.31 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.511 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 15.7 m -98.56 5.75 47.64 Favored 'General case' 0 N--CA 1.432 -1.326 0 O-C-N 121.114 -0.991 . . . . 0.0 108.376 178.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 10.7 mp -112.9 145.13 41.27 Favored 'General case' 0 N--CA 1.43 -1.439 0 CA-C-N 114.206 -1.361 . . . . 0.0 109.467 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 110' ' ' HIS . 5.9 p -133.57 97.15 3.86 Favored 'General case' 0 C--N 1.281 -2.384 0 CA-C-N 115.274 -0.876 . . . . 0.0 109.209 172.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.455 HD23 HG12 ' A' ' 13' ' ' VAL . 2.9 tm? -73.01 -64.22 1.01 Allowed 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.346 -178.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -159.41 -49.33 0.06 Allowed 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.386 -0.926 . . . . 0.0 111.573 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -71.24 -26.64 73.19 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 179.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -68.35 -31.72 71.32 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 76.6 mtm180 56.52 45.89 21.56 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.737 0.815 . . . . 0.0 112.024 175.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.579 ' HA ' ' SG ' ' A' ' 104' ' ' CYS . 47.6 m80 65.62 98.68 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.948 0 O-C-N 124.09 0.869 . . . . 0.0 109.506 -178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.451 ' CZ ' ' HA ' ' A' ' 102' ' ' SER . 15.1 p90 -75.09 121.19 21.66 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 113.935 1.087 . . . . 0.0 113.935 -170.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -140.51 45.46 1.83 Allowed 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 106.197 -1.779 . . . . 0.0 106.197 175.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -40.98 -62.47 0.81 Allowed 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 113.785 -1.552 . . . . 0.0 114.074 -172.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.7 t 64.17 -64.18 0.14 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.036 1.334 . . . . 0.0 111.537 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -129.62 -179.41 5.16 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.6 m 71.27 107.66 0.06 Allowed 'General case' 0 CA--C 1.544 0.738 0 O-C-N 124.133 0.895 . . . . 0.0 110.05 -179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -87.61 103.42 15.55 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -174.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 38.9 t70 . . . . . 0 C--N 1.3 -1.569 0 CA-C-O 118.27 -0.871 . . . . 0.0 109.511 172.915 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.578 0 CA-C-O 120.356 0.122 . . . . 0.0 110.718 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.574 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 33.1 t70 -74.2 -37.62 63.83 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.265 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.519 ' HB3' HD23 ' A' ' 7' ' ' LEU . 8.6 pt-20 -92.69 106.54 19.07 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.407 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 2' ' ' ASP . 5.6 Cg_exo -79.21 -76.43 0.01 OUTLIER 'Trans proline' 0 N--CA 1.431 -2.167 0 N-CA-C 108.343 -1.445 . . . . 0.0 108.343 172.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.83 7.77 11.03 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.533 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 40.4 p90 -159.26 149.08 18.83 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -174.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.587 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 21.3 mt -90.83 -176.0 4.54 Favored 'General case' 0 C--N 1.285 -2.228 0 O-C-N 123.656 0.597 . . . . 0.0 109.619 173.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -125.16 156.64 38.07 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.559 -170.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 p -85.19 139.67 17.11 Favored 'Isoleucine or valine' 0 C--O 1.242 0.691 0 CA-C-O 120.997 0.427 . . . . 0.0 111.67 -174.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.94 -5.65 83.17 Favored Glycine 0 CA--C 1.505 -0.586 0 N-CA-C 110.724 -0.95 . . . . 0.0 110.724 -178.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 96.8 m -79.68 133.89 36.39 Favored 'General case' 0 N--CA 1.398 -3.059 0 CA-C-O 121.491 0.662 . . . . 0.0 110.538 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -92.19 129.12 38.22 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 -176.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 105' ' ' LEU . 32.0 m -137.1 -178.88 2.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 121.763 0.792 . . . . 0.0 112.006 -173.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 m -125.69 135.79 52.49 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 172.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -127.65 135.35 50.12 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 -178.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 19.6 pttp -93.06 143.21 26.47 Favored 'General case' 0 C--N 1.314 -0.966 0 C-N-CA 118.62 -1.232 . . . . 0.0 113.599 -177.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -134.78 124.93 25.94 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? 58.11 25.47 12.48 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.552 1.141 . . . . 0.0 110.935 -176.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 92.33 -9.42 76.17 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 121.089 -0.577 . . . . 0.0 113.327 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -103.74 131.43 50.93 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 -179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.562 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 76.6 m-85 -84.78 122.38 29.04 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.753 0.311 . . . . 0.0 110.704 -177.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -106.98 149.0 27.98 Favored 'General case' 0 N--CA 1.422 -1.838 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -80.5 143.38 33.36 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.32 148.51 16.63 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.3 ttmp? -115.49 132.52 56.6 Favored 'General case' 0 C--N 1.274 -2.709 0 C-N-CA 120.209 -0.596 . . . . 0.0 109.712 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.443 ' HA ' HG12 ' A' ' 88' ' ' VAL . 63.2 mt -61.07 107.48 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.891 0.853 . . . . 0.0 111.681 -179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.531 ' HG2' ' OE1' ' A' ' 95' ' ' GLU . 24.0 tptm -83.85 -44.99 13.74 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 125.517 1.527 . . . . 0.0 109.662 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.3 m -138.9 144.91 39.33 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.9 t -126.39 118.09 50.22 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 C-N-CA 123.645 0.778 . . . . 0.0 109.808 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -123.14 107.85 12.19 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.015 174.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -77.43 105.47 8.58 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.49 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 1.3 pt? -132.88 120.5 21.59 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.219 0.533 . . . . 0.0 110.658 -175.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 42.9 t -84.61 129.35 37.83 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.63 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 32.9 mmtp -83.02 104.93 13.6 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 175.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.428 HG12 HG13 ' A' ' 37' ' ' VAL . 2.8 t -95.56 125.5 48.29 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.936 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.964 -174.405 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.411 ' HB2' HD13 ' A' ' 47' ' ' LEU . 49.0 tttm -99.74 105.73 17.56 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.574 -2.01 . . . . 0.0 105.574 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.527 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 23.8 m -117.07 156.1 18.47 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-O 121.151 0.501 . . . . 0.0 111.486 -175.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -113.93 114.67 26.53 Favored 'General case' 0 C--N 1.276 -2.61 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 173.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 24.8 mt -68.93 113.54 6.43 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 -177.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . 0.309 0.0 OUTLIER -72.98 -19.04 61.3 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 -175.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -90.08 -27.02 19.95 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.909 176.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -112.22 -8.85 13.95 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.277 0.56 . . . . 0.0 111.804 -173.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 p30 58.7 16.55 4.46 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 126.554 1.942 . . . . 0.0 113.986 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -98.6 150.72 21.45 Favored 'General case' 0 N--CA 1.439 -1.013 0 O-C-N 121.994 -0.441 . . . . 0.0 111.107 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.6 m -99.56 144.77 28.26 Favored 'General case' 0 N--CA 1.422 -1.847 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -142.89 142.3 31.72 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -174.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.411 HD13 ' HB2' ' A' ' 36' ' ' LYS . 43.5 tp -125.42 102.62 7.49 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 106.404 -1.702 . . . . 0.0 106.404 176.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.16 178.73 4.68 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.921 -173.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.507 ' HG3' ' HB3' ' A' ' 51' ' ' ASP . 14.1 pt20 -92.02 154.53 18.71 Favored 'General case' 0 C--N 1.295 -1.78 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -174.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -54.63 -28.39 46.52 Favored 'General case' 0 N--CA 1.502 2.128 0 C-N-CA 126.352 1.861 . . . . 0.0 111.515 178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.507 ' HB3' ' HG3' ' A' ' 49' ' ' GLN . 8.2 t70 -63.38 -27.89 69.62 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.27 -1.332 . . . . 0.0 109.306 -178.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 75.5 mt-30 -108.32 -9.54 15.46 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.985 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -100.38 127.29 53.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 CA-C-O 121.233 0.54 . . . . 0.0 111.648 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -106.75 127.14 53.14 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.111 178.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 126.21 -173.28 17.93 Favored Glycine 0 C--N 1.296 -1.661 0 CA-C-N 116.07 -0.514 . . . . 0.0 112.497 178.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -82.66 138.03 9.28 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 123.279 2.653 . . . . 0.0 112.311 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -92.7 83.03 4.79 Favored 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.79 0.805 . . . . 0.0 110.51 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.522 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 23.0 mtp180 -135.2 133.63 39.27 Favored 'General case' 0 CA--C 1.488 -1.434 0 CA-C-N 114.126 -1.397 . . . . 0.0 109.807 178.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.6 t -63.58 120.99 11.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.43 5.68 58.98 Favored Glycine 0 N--CA 1.433 -1.534 0 CA-C-N 115.379 -0.828 . . . . 0.0 112.597 -176.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.71 164.11 12.54 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-N 117.488 0.644 . . . . 0.0 111.46 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 41.6 mm -95.86 118.41 42.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.546 HG13 HD11 ' A' ' 77' ' ' ILE . 15.7 m -126.18 175.57 8.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 173.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -128.66 120.66 26.96 Favored 'General case' 0 C--N 1.284 -2.271 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.425 HG21 HG21 ' A' ' 37' ' ' VAL . 9.8 t -118.27 158.7 24.68 Favored 'General case' 0 C--N 1.268 -2.956 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.14 -174.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 67' ' ' THR . 37.2 ttm180 -76.87 139.48 40.28 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-N 114.836 -1.074 . . . . 0.0 110.334 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.482 ' O ' ' HG2' ' A' ' 66' ' ' ARG . 16.9 p -94.1 171.82 8.61 Favored 'General case' 0 N--CA 1.423 -1.823 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 172.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.8 m -55.7 -34.28 64.94 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -174.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -82.65 -4.92 58.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -175.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 98.96 3.93 56.83 Favored Glycine 0 C--N 1.309 -0.966 0 C-N-CA 119.887 -1.149 . . . . 0.0 113.483 177.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 58.1 m -87.53 168.75 12.79 Favored 'General case' 0 C--N 1.305 -1.333 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 176.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.3 m-85 -121.7 139.85 53.05 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.111 0.482 . . . . 0.0 110.648 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -140.72 143.9 35.27 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.4 142.56 53.87 Favored 'General case' 0 C--O 1.254 1.326 0 CA-C-O 121.335 0.588 . . . . 0.0 110.946 -176.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -148.97 164.66 33.9 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.87 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 5.4 mm -110.19 137.17 43.7 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 177.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.546 HD11 HG13 ' A' ' 63' ' ' VAL . 3.5 mp -72.84 122.9 26.47 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.162 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 175.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 16.5 m -103.82 -19.85 14.13 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.114 0.483 . . . . 0.0 109.825 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -168.68 156.46 7.85 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -139.18 139.67 37.6 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 172.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 85.6 m -124.58 127.09 46.86 Favored 'General case' 0 C--N 1.283 -2.305 0 CA-C-O 121.042 0.449 . . . . 0.0 110.475 -176.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -57.12 122.9 13.49 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 124.869 1.267 . . . . 0.0 110.604 178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.49 ' HB3' ' O ' ' A' ' 32' ' ' LEU . . . -149.81 146.85 27.38 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-O 121.502 0.667 . . . . 0.0 109.775 176.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.2 m -155.62 127.69 7.59 Favored 'General case' 0 C--N 1.269 -2.913 0 N-CA-C 105.241 -2.133 . . . . 0.0 105.241 171.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 12.1 m95 -97.58 116.32 29.56 Favored 'General case' 0 N--CA 1.404 -2.771 0 CA-C-O 121.405 0.621 . . . . 0.0 110.621 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.587 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 53.3 m-85 -104.75 102.88 12.43 Favored 'General case' 0 N--CA 1.395 -3.205 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 177.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.4 m -79.91 105.61 11.32 Favored 'General case' 0 N--CA 1.384 -3.739 0 N-CA-C 104.182 -2.525 . . . . 0.0 104.182 177.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.443 HG12 ' HA ' ' A' ' 26' ' ' ILE . 16.4 m -105.42 140.39 23.61 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -176.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 p -111.52 130.27 65.37 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.045 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.511 -174.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -83.24 163.97 20.41 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 177.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.76 -7.56 45.83 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.365 0.602 . . . . 0.0 110.617 177.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -72.18 -17.56 61.93 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.547 -0.752 . . . . 0.0 109.978 173.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.4 -9.31 60.84 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.298 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -90.06 144.72 25.64 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.531 ' OE1' ' HG2' ' A' ' 27' ' ' LYS . 2.8 pt-20 -124.37 131.72 53.51 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.407 0.622 . . . . 0.0 110.542 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 11.7 tpt180 -115.78 151.16 35.72 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -174.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.0 m -103.11 108.58 19.82 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 120.738 0.304 . . . . 0.0 110.22 -175.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -120.27 156.21 31.69 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 122.705 0.402 . . . . 0.0 111.188 -175.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 33.4 ttt180 -99.55 169.92 8.96 Favored 'General case' 0 CA--C 1.548 0.9 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -56.54 -23.4 39.7 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 5.7 m -60.31 -39.55 87.42 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.771 0.829 . . . . 0.0 111.679 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 15.0 m -90.27 -6.88 54.67 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -174.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.6 mp -102.5 153.9 19.62 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.511 -175.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 109' ' ' ARG . 72.8 m -135.26 18.44 3.4 Favored 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -178.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.424 ' HA ' HG12 ' A' ' 13' ' ' VAL . 44.1 tp 47.44 -90.78 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -119.02 -49.58 2.41 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.413 ' H ' ' H ' ' A' ' 108' ' ' GLU . . . 163.27 2.43 0.05 OUTLIER Glycine 0 C--N 1.303 -1.255 0 C-N-CA 119.951 -1.119 . . . . 0.0 112.855 -176.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.462 ' CD ' ' H ' ' A' ' 108' ' ' GLU . 0.8 OUTLIER -69.43 -34.87 75.08 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 176.258 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.454 ' HE ' ' CD ' ' A' ' 113' ' ' GLU . 1.9 ptm180 -121.88 138.45 54.39 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 105.172 -2.158 . . . . 0.0 105.172 173.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 5.1 t-160 -146.16 37.48 1.04 Allowed 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 119.272 -0.971 . . . . 0.0 110.71 -175.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 3.8 t80 62.4 81.11 0.21 Allowed 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 125.273 1.429 . . . . 0.0 111.593 178.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 179.44 -60.84 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 104.012 -2.588 . . . . 0.0 104.012 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.454 ' CD ' ' HE ' ' A' ' 109' ' ' ARG . 36.4 mt-10 41.61 -90.01 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 127.279 2.232 . . . . 0.0 117.014 168.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.3 t -152.14 -159.88 1.07 Allowed 'General case' 0 N--CA 1.415 -2.208 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -168.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -71.12 153.78 42.26 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 124.128 0.971 . . . . 0.0 110.053 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 21.4 p -89.78 160.46 16.51 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.406 HD13 ' N ' ' A' ' 118' ' ' ASP . 1.9 tm? -147.96 136.94 22.01 Favored 'General case' 0 C--N 1.307 -1.246 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.406 ' N ' HD13 ' A' ' 117' ' ' LEU . 11.9 m-20 . . . . . 0 C--O 1.256 1.436 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.404 ' HB2' ' HB2' ' A' ' 105' ' ' LEU . . . . . . . . 0 N--CA 1.469 0.497 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.514 ' O ' ' HD3' ' A' ' 4' ' ' PRO . 6.8 m-20 -86.18 1.81 49.28 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 -172.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -104.5 90.85 3.57 Favored Pre-proline 0 C--O 1.248 0.984 0 CA-C-O 121.799 0.809 . . . . 0.0 109.32 173.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.514 ' HD3' ' O ' ' A' ' 2' ' ' ASP . 10.1 Cg_endo -88.49 67.84 2.98 Favored 'Trans proline' 0 N--CA 1.423 -2.639 0 C-N-CA 121.945 1.764 . . . . 0.0 113.203 -174.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -106.08 -78.14 0.58 Allowed 'General case' 0 N--CA 1.428 -1.544 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 171.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.47 ' HA ' ' OG ' ' A' ' 84' ' ' SER . 18.9 p90 -178.94 131.98 0.12 Allowed 'General case' 0 N--CA 1.433 -1.292 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.8 mt -93.78 -161.54 0.86 Allowed 'General case' 0 C--N 1.281 -2.413 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 49.0 p -131.54 162.43 30.3 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -171.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.3 t -64.91 142.18 17.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 114.215 -1.357 . . . . 0.0 109.902 177.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.92 -32.97 6.0 Favored Glycine 0 N--CA 1.436 -1.317 0 C-N-CA 121.044 -0.598 . . . . 0.0 112.9 177.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.577 ' HB ' HD12 ' A' ' 26' ' ' ILE . 4.0 m -56.97 138.95 53.49 Favored 'General case' 0 C--O 1.247 0.929 0 C-N-CA 123.993 0.917 . . . . 0.0 110.564 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -111.3 113.67 26.31 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -176.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.569 HG11 HD23 ' A' ' 105' ' ' LEU . 31.9 m -135.43 -179.15 2.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 C-N-CA 123.102 0.561 . . . . 0.0 109.708 -176.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.4 m -105.24 142.81 34.36 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 120.112 -0.635 . . . . 0.0 109.475 178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -123.81 119.3 29.29 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.46 ' HE2' ' HA2' ' A' ' 19' ' ' GLY . 13.7 tmtt? -88.43 107.22 18.74 Favored 'General case' 0 N--CA 1.426 -1.648 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 176.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -129.12 139.53 51.92 Favored 'General case' 0 N--CA 1.421 -1.908 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 -176.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 69.3 ttt180 59.6 25.07 13.91 Favored 'General case' 0 CA--C 1.554 1.104 0 CA-C-O 122.018 0.913 . . . . 0.0 110.427 178.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.46 ' HA2' ' HE2' ' A' ' 16' ' ' LYS . . . 91.0 1.73 72.5 Favored Glycine 0 CA--C 1.531 1.06 0 C-N-CA 120.28 -0.962 . . . . 0.0 114.325 178.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.51 145.54 43.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 117.916 0.858 . . . . 0.0 109.905 -177.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -106.1 133.9 50.07 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.033 0.92 . . . . 0.0 113.473 179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 47.6 t -122.75 158.25 30.57 Favored 'General case' 0 C--N 1.283 -2.321 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 177.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -72.92 147.42 45.3 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.67 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -149.82 142.33 24.4 Favored 'General case' 0 C--N 1.267 -3.013 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.57 -174.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 88' ' ' VAL . 44.4 tttp -110.12 131.14 55.33 Favored 'General case' 0 C--N 1.275 -2.657 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.774 -176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.577 HD12 ' HB ' ' A' ' 11' ' ' THR . 36.6 mt -66.39 115.67 4.68 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -101.24 -36.24 8.98 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.136 178.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 25.2 m -140.14 144.73 36.84 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 87.1 t -116.57 120.18 64.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 173.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.444 ' HD3' ' N ' ' A' ' 31' ' ' ARG . 1.5 tmtp? -113.93 140.59 48.26 Favored 'General case' 0 C--N 1.277 -2.558 0 N-CA-C 106.206 -1.776 . . . . 0.0 106.206 -178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.444 ' N ' ' HD3' ' A' ' 30' ' ' LYS . 10.9 mmt180 -75.03 118.36 17.9 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.728 0.775 . . . . 0.0 111.688 -173.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.509 ' HB3' ' N ' ' A' ' 84' ' ' SER . 58.7 tp -91.51 164.5 13.77 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 127.01 2.124 . . . . 0.0 107.256 177.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 46.5 t -107.56 124.27 63.45 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 118.142 -1.423 . . . . 0.0 110.844 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HD3' ' HB2' ' A' ' 4' ' ' PRO . 6.6 ttpm? -94.79 104.22 16.12 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-O 122.557 1.17 . . . . 0.0 108.202 172.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG12 HG13 ' A' ' 37' ' ' VAL . 15.8 t -87.35 128.69 39.72 Favored 'Isoleucine or valine' 1 C--N 1.244 -4.002 0 CA-C-N 112.753 -2.022 . . . . 0.0 109.648 -174.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 86.9 tttt -98.77 112.15 24.31 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 175.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.497 HG21 HG21 ' A' ' 65' ' ' THR . 15.9 m -115.78 153.98 17.3 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 121.386 0.612 . . . . 0.0 111.727 -175.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -116.97 114.75 24.25 Favored 'General case' 0 C--N 1.272 -2.767 0 N-CA-C 105.295 -2.113 . . . . 0.0 105.295 173.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.486 HD23 ' HB2' ' A' ' 75' ' ' ALA . 62.6 mt -75.35 120.52 20.93 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 -178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.3 ptpt -67.81 -30.24 69.61 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 113.175 0.806 . . . . 0.0 113.175 -177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -79.53 -41.51 27.16 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.381 0.61 . . . . 0.0 111.725 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -96.85 -15.15 21.39 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.28 -0.418 . . . . 0.0 112.021 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.279 0.0 OUTLIER 63.21 16.93 9.81 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 126.664 1.985 . . . . 0.0 112.222 -177.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -93.27 145.24 24.59 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 115.927 -0.578 . . . . 0.0 111.244 -178.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -96.45 142.53 28.44 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 176.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -144.48 141.31 29.47 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -175.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.9 mt -100.87 113.25 26.02 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 172.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.5 m -124.78 179.72 2.84 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.033 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.528 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.5 pt20 -117.08 165.09 13.78 Favored 'General case' 0 C--N 1.27 -2.866 0 O-C-N 122.29 -0.256 . . . . 0.0 110.527 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -59.35 -18.76 41.04 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 125.637 1.575 . . . . 0.0 111.86 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.54 ' OD1' ' HD3' ' A' ' 99' ' ' ARG . 12.0 t70 -70.93 -34.43 71.49 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.118 176.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.461 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 26.4 mt-30 -95.54 -10.54 29.36 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.181 -175.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 96.6 t -105.23 134.94 45.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.714 -177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.415 ' HE2' ' CD1' ' A' ' 72' ' ' PHE . 0.2 OUTLIER -125.66 118.07 24.87 Favored 'General case' 0 N--CA 1.427 -1.586 0 CA-C-O 121.263 0.554 . . . . 0.0 110.73 168.79 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.427 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 142.77 -165.07 26.96 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 114.748 -1.115 . . . . 0.0 110.563 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.91 137.0 12.19 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 122.865 2.377 . . . . 0.0 113.131 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -96.51 81.57 3.25 Favored 'General case' 0 C--N 1.298 -1.667 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.55 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 42.5 ttp180 -140.85 139.49 34.47 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.109 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.3 t -67.21 122.39 18.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.55 4.18 59.43 Favored Glycine 0 N--CA 1.429 -1.83 0 CA-C-N 115.518 -0.765 . . . . 0.0 111.753 -176.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -94.08 161.65 14.19 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 120.51 -0.476 . . . . 0.0 109.947 -178.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.6 mm -107.4 119.29 56.75 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.517 -176.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.427 HG12 ' HA3' ' A' ' 55' ' ' GLY . 28.0 m -130.47 176.58 8.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -119.85 131.46 55.28 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 172.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.497 HG21 HG21 ' A' ' 37' ' ' VAL . 7.8 t -145.1 155.99 43.64 Favored 'General case' 0 C--N 1.284 -2.268 0 C-N-CA 120.011 -0.676 . . . . 0.0 112.182 -171.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.622 ' HB2' ' CE1' ' A' ' 72' ' ' PHE . 46.7 ttt180 -89.26 122.42 32.5 Favored 'General case' 0 C--N 1.302 -1.477 0 CA-C-N 114.888 -1.051 . . . . 0.0 109.483 178.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 6.8 t -84.62 168.02 15.72 Favored 'General case' 0 C--N 1.279 -2.473 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 173.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.2 p -70.78 -5.01 26.87 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.504 0.669 . . . . 0.0 111.611 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.66 -10.24 59.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.968 175.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 103.75 -22.2 36.25 Favored Glycine 0 N--CA 1.442 -0.902 0 CA-C-N 115.73 -0.668 . . . . 0.0 113.98 175.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.5 p -87.75 144.81 26.43 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -175.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.622 ' CE1' ' HB2' ' A' ' 66' ' ' ARG . 87.1 m-85 -94.26 120.43 34.49 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.7 mt-30 -135.84 160.18 39.38 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.409 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 39.3 tt0 -76.72 132.04 39.1 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.486 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.03 173.68 11.25 Favored 'General case' 0 C--N 1.295 -1.781 0 O-C-N 122.153 -0.342 . . . . 0.0 111.591 -175.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 3.1 mp -119.45 140.69 42.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.1 mp -79.52 128.44 38.56 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-O 120.658 0.266 . . . . 0.0 110.564 178.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 21.1 m -107.2 -17.25 14.2 Favored 'General case' 0 C--N 1.305 -1.342 0 C-N-CA 122.992 0.517 . . . . 0.0 110.871 177.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 50.3 tptt -171.87 156.48 4.19 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 -176.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -131.17 143.4 50.58 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 104.999 -2.223 . . . . 0.0 104.999 169.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.0 p -134.76 159.53 41.04 Favored 'General case' 0 N--CA 1.423 -1.812 0 C-N-CA 122.693 0.397 . . . . 0.0 110.485 178.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -67.04 115.93 7.29 Favored 'General case' 0 C--N 1.309 -1.161 0 C-N-CA 123.983 0.913 . . . . 0.0 111.168 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.424 ' HB2' ' HB2' ' A' ' 34' ' ' LYS . . . -118.94 -164.52 1.05 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 176.148 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.509 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 1.3 p -141.04 129.6 22.65 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -172.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.443 ' HB2' ' HB3' ' A' ' 30' ' ' LYS 0.265 75.6 m95 -95.98 155.87 16.57 Favored 'General case' 0 C--O 1.248 0.977 0 N-CA-C 103.939 -2.615 . . . . 0.0 103.939 168.202 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.47 ' CD1' HD13 ' A' ' 26' ' ' ILE . 89.5 m-85 -134.58 117.85 16.6 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.558 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 17.8 m -84.03 104.37 14.04 Favored 'General case' 0 N--CA 1.419 -2.008 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 174.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.67 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 22.8 m -109.92 141.62 24.71 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.837 0 CA-C-O 121.502 0.668 . . . . 0.0 110.462 -176.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 24' ' ' ALA . 6.3 t -97.9 116.72 41.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 -178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -72.89 159.92 32.96 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -57.2 -20.78 28.93 Favored 'General case' 0 N--CA 1.484 1.245 0 CA-C-O 121.772 0.796 . . . . 0.0 111.072 174.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -67.65 -16.76 64.32 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.051 -0.977 . . . . 0.0 110.944 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 99.28 -6.88 59.77 Favored Glycine 0 C--O 1.241 0.555 0 CA-C-O 121.478 0.488 . . . . 0.0 112.402 177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -96.8 141.34 30.13 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -117.56 128.29 54.81 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -136.32 147.5 47.46 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 -179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 18.6 m -99.38 107.43 19.68 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.24 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.85 170.41 8.16 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 175.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.54 ' HD3' ' OD1' ' A' ' 51' ' ' ASP . 2.2 mpt_? -94.9 175.2 6.74 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -72.6 -3.05 22.4 Favored 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.162 -0.926 . . . . 0.0 112.453 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.9 m -71.48 -41.29 69.52 Favored 'General case' 0 N--CA 1.435 -1.182 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 8.0 t -109.82 22.63 15.43 Favored 'General case' 0 C--O 1.252 1.217 0 CA-C-O 121.761 0.791 . . . . 0.0 110.171 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.6 tp -112.67 142.72 44.94 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 114.72 -1.127 . . . . 0.0 108.478 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 15.4 t -91.42 83.09 5.39 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 121.695 0.759 . . . . 0.0 110.249 -177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.569 HD23 HG11 ' A' ' 13' ' ' VAL . 92.1 mt -104.52 55.87 0.71 Allowed 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.814 175.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 88.2 tttt 74.24 98.5 0.07 Allowed 'General case' 0 C--O 1.238 0.487 0 C-N-CA 125.236 1.414 . . . . 0.0 111.021 -176.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -144.63 130.56 3.97 Favored Glycine 0 N--CA 1.422 -2.291 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.829 -179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.454 ' C ' ' H ' ' A' ' 110' ' ' HIS . 0.2 OUTLIER -90.11 101.86 14.57 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 177.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 70.8 -30.54 0.21 Allowed 'General case' 0 CA--C 1.561 1.386 0 C-N-CA 124.536 1.134 . . . . 0.0 111.484 -173.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.454 ' H ' ' C ' ' A' ' 108' ' ' GLU . 7.1 t-160 -65.9 89.02 0.11 Allowed 'General case' 0 C--N 1.319 -0.726 0 C-N-CA 125.771 1.628 . . . . 0.0 110.059 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 52.72 72.88 0.38 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.825 1.25 . . . . 0.0 111.724 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -163.89 -169.36 1.85 Allowed 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 114.435 -1.257 . . . . 0.0 107.637 -176.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -61.9 -19.36 62.6 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . 0.299 7.7 p 60.66 83.25 0.15 Allowed 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.488 1.137 . . . . 0.0 111.949 -175.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -55.0 146.97 16.58 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 112.926 -1.943 . . . . 0.0 113.417 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 3.4 m -59.32 -29.12 67.4 Favored 'General case' 0 C--N 1.316 -0.855 0 C-N-CA 124.912 1.285 . . . . 0.0 111.585 -177.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 94.8 mt -85.77 9.3 16.89 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 -175.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 14.6 t70 . . . . . 0 C--O 1.243 0.741 0 CA-C-O 117.783 -1.103 . . . . 0.0 108.593 175.073 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.638 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -80.13 -36.31 35.46 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.499 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 1.2 mp0 -68.64 134.52 90.47 Favored Pre-proline 0 N--CA 1.43 -1.455 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 173.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' O ' ' HD2' ' A' ' 100' ' ' ARG . 46.8 Cg_endo -71.05 84.72 0.85 Allowed 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.787 1.658 . . . . 0.0 111.467 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.84 -29.71 16.59 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.322 -0.853 . . . . 0.0 109.673 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.756 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 45.2 p90 -127.2 127.29 44.25 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.688 178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.4 mt -106.21 -175.68 2.86 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.645 -177.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.9 p -131.33 158.53 40.43 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -173.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.0 t -63.33 130.59 28.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.84 -11.66 38.19 Favored Glycine 0 N--CA 1.443 -0.884 0 C-N-CA 120.114 -1.041 . . . . 0.0 113.043 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.531 ' HB ' HD12 ' A' ' 26' ' ' ILE . 33.2 m -81.23 139.47 35.47 Favored 'General case' 0 N--CA 1.418 -2.065 0 CA-C-O 120.821 0.343 . . . . 0.0 110.401 179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.07 104.87 17.4 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.202 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.565 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 31.4 m -113.5 -179.28 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.285 -2.229 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.836 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.532 ' OG ' ' HB3' ' A' ' 104' ' ' CYS . 3.0 p -131.14 135.34 47.38 Favored 'General case' 0 C--N 1.273 -2.756 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 175.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' O ' ' HA ' ' A' ' 21' ' ' PHE . . . -111.92 125.64 54.26 Favored 'General case' 0 C--N 1.287 -2.132 0 O-C-N 124.476 1.11 . . . . 0.0 109.672 -171.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -77.03 117.73 18.9 Favored 'General case' 0 N--CA 1.432 -1.343 0 CA-C-O 121.571 0.7 . . . . 0.0 109.569 173.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -129.62 135.95 49.17 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 177.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.9 tpt180 59.4 25.65 14.41 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 121.521 0.677 . . . . 0.0 110.483 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.91 10.59 75.24 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 116.041 -0.527 . . . . 0.0 113.705 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.65 136.54 37.55 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-N 117.525 0.663 . . . . 0.0 110.437 -177.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 35.4 p90 -98.79 129.59 45.21 Favored 'General case' 0 C--N 1.308 -1.202 0 C-N-CA 119.47 -0.892 . . . . 0.0 113.127 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 44.3 t -129.26 157.39 42.0 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 10.5 pt-20 -74.01 146.25 43.92 Favored 'General case' 0 C--O 1.251 1.145 0 CA-C-O 121.779 0.8 . . . . 0.0 112.646 -174.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -151.99 145.8 25.1 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -105.07 133.75 49.32 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 119.424 -0.91 . . . . 0.0 110.673 -174.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.531 HD12 ' HB ' ' A' ' 11' ' ' THR . 39.3 mt -65.96 112.81 2.11 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.106 0.479 . . . . 0.0 110.451 -179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -94.72 -39.25 10.4 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.109 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.3 m -137.9 144.5 41.34 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 179.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 79.8 t -123.61 118.55 54.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 59.2 mtpt -112.22 96.95 6.32 Favored 'General case' 0 C--N 1.284 -2.264 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 174.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -83.27 108.38 16.45 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.505 HD23 ' HA ' ' A' ' 84' ' ' SER . 2.4 pt? -144.05 107.61 4.62 Favored 'General case' 0 C--N 1.288 -2.066 0 CA-C-O 122.048 0.928 . . . . 0.0 109.286 176.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.0 p -100.53 123.22 53.32 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.856 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 177.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 48' ' ' VAL . 52.3 mtpt -85.12 100.64 11.85 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-O 122.066 0.936 . . . . 0.0 109.237 -179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 31.1 t -84.82 132.7 31.03 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.686 0 CA-C-N 113.754 -1.566 . . . . 0.0 109.336 -178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 88.4 tttt -89.53 112.91 24.22 Favored 'General case' 0 CA--C 1.482 -1.654 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.612 HG21 HG21 ' A' ' 65' ' ' THR . 3.7 m -123.64 153.46 29.4 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.216 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.323 -177.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.408 ' HA ' ' HA ' ' A' ' 45' ' ' THR . 8.2 tt -121.8 122.58 39.8 Favored 'General case' 0 C--N 1.267 -3.002 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.539 HD13 ' HB2' ' A' ' 75' ' ' ALA . 1.5 mm? -73.4 110.71 7.9 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.56 ' HB3' HD11 ' A' ' 76' ' ' ILE . 12.4 ptmm? -64.35 -20.19 65.96 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.228 0.537 . . . . 0.0 112.436 -178.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -79.29 -46.66 17.3 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.817 179.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -98.51 -17.84 18.51 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.435 -174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 71.67 25.64 3.24 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.077 1.351 . . . . 0.0 111.593 -178.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -104.68 155.74 18.6 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.751 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 38' ' ' LEU . 3.9 m -100.18 154.65 18.28 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -149.32 143.94 26.13 Favored 'General case' 0 N--CA 1.421 -1.884 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 36.2 tp -128.11 102.15 6.59 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 10.6 m -137.66 168.12 21.36 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.297 -174.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 29.7 pt20 -74.68 164.96 25.98 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.139 -174.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.47 ' OD1' ' HA ' ' A' ' 32' ' ' LEU . 7.7 p-10 -71.8 -5.6 35.38 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.849 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -73.85 -23.6 59.64 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 174.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.503 ' O ' ' HA ' ' A' ' 65' ' ' THR . 8.9 mm-40 -92.58 -34.45 14.02 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.048 178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 89.3 t -79.24 111.05 15.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.198 0.999 . . . . 0.0 112.7 -176.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -111.63 103.06 11.34 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.426 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 148.27 -159.85 28.16 Favored Glycine 0 N--CA 1.433 -1.513 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -81.1 128.59 6.5 Favored 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 121.901 1.734 . . . . 0.0 112.123 178.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 mp -88.8 81.6 6.94 Favored 'General case' 0 C--N 1.282 -2.351 0 N-CA-C 107.6 -1.259 . . . . 0.0 107.6 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.521 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 22.6 mmt180 -139.17 135.8 34.39 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.695 -175.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.0 t -66.76 117.83 8.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.069 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.53 3.93 55.05 Favored Glycine 0 C--N 1.303 -1.261 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.532 -177.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.4 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -97.19 164.01 12.67 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-N 117.027 0.414 . . . . 0.0 110.652 -178.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 32.3 mm -105.48 124.89 60.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.841 -0.799 . . . . 0.0 108.841 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.414 ' CG1' HD11 ' A' ' 77' ' ' ILE . 19.7 m -130.15 -177.63 2.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 C-N-CA 123.028 0.531 . . . . 0.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -118.25 136.1 53.88 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 106.066 -1.828 . . . . 0.0 106.066 169.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.612 HG21 HG21 ' A' ' 37' ' ' VAL . 13.4 t -140.11 156.63 46.48 Favored 'General case' 0 C--N 1.275 -2.643 0 C-N-CA 119.705 -0.798 . . . . 0.0 109.794 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.476 ' H ' ' HB3' ' A' ' 52' ' ' GLN . 12.1 ttm180 -83.85 108.77 17.07 Favored 'General case' 0 C--N 1.283 -2.294 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.448 HG23 ' H ' ' A' ' 69' ' ' ASP . 12.7 t -81.09 178.86 8.15 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 8.8 m -64.23 -16.33 61.82 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.241 0.543 . . . . 0.0 112.051 -175.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.448 ' H ' HG23 ' A' ' 67' ' ' THR . 20.7 t70 -73.82 -26.01 60.39 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.347 177.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 106.95 -18.83 36.32 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.635 -0.793 . . . . 0.0 111.49 -177.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.8 m -84.32 154.69 22.77 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 110.332 -0.248 . . . . 0.0 110.332 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 65' ' ' THR . 90.1 m-85 -89.36 115.36 26.76 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 174.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.525 ' HB3' HD12 ' A' ' 39' ' ' LEU . 2.8 tp60 -108.84 143.86 37.48 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -174.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -77.78 136.85 38.18 Favored 'General case' 0 C--O 1.251 1.149 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.423 179.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.539 ' HB2' HD13 ' A' ' 39' ' ' LEU . . . -145.23 168.1 21.22 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.964 -0.562 . . . . 0.0 112.428 -172.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.56 HD11 ' HB3' ' A' ' 40' ' ' LYS . 1.6 mp -112.45 144.13 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 175.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.521 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.3 mp -83.5 129.38 37.61 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 176.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 38.2 m -110.97 -19.32 12.82 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 122.617 0.367 . . . . 0.0 110.885 175.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 54.0 tttm -168.52 159.54 10.32 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 35' ' ' VAL . 4.1 mp -127.63 139.87 52.46 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 167.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 86.5 m -126.0 116.5 21.55 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -69.07 126.42 29.74 Favored 'General case' 0 CA--C 1.505 -0.758 0 C-N-CA 120.688 -0.405 . . . . 0.0 111.109 -178.426 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.428 ' HA ' ' NE ' ' A' ' 99' ' ' ARG . . . -130.38 9.69 5.18 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.602 -179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.505 ' HA ' HD23 ' A' ' 32' ' ' LEU . 19.5 m -55.67 121.95 10.29 Favored 'General case' 0 N--CA 1.437 -1.102 0 O-C-N 124.406 1.066 . . . . 0.0 112.5 -176.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.516 ' HB3' ' OG1' ' A' ' 97' ' ' THR . 74.7 m95 -95.82 116.98 29.7 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 114.39 -1.277 . . . . 0.0 110.555 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.756 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 82.6 m-85 -105.56 105.06 14.92 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 175.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.2 m -84.37 104.13 14.13 Favored 'General case' 0 N--CA 1.398 -3.06 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.465 HG12 ' HA ' ' A' ' 26' ' ' ILE . 28.5 m -108.59 142.12 22.04 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.352 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.575 -175.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.2 p -100.53 124.03 53.83 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.463 -177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -85.78 -179.89 6.93 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.877 -1.056 . . . . 0.0 109.814 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -68.57 -26.56 65.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.119 0.485 . . . . 0.0 110.78 -175.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -68.87 -11.86 60.98 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.536 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 85.56 14.43 68.14 Favored Glycine 0 N--CA 1.439 -1.128 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -175.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -94.47 131.77 39.83 Favored 'General case' 0 CA--C 1.473 -2.01 0 CA-C-N 114.865 -0.668 . . . . 0.0 109.215 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -102.52 127.27 49.66 Favored 'General case' 0 C--N 1.268 -2.96 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.28 138.96 54.5 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 -176.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.516 ' OG1' ' HB3' ' A' ' 85' ' ' TRP . 4.9 t -113.59 113.51 25.17 Favored 'General case' 0 C--N 1.284 -2.277 0 C-N-CA 118.197 -1.401 . . . . 0.0 110.884 -178.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.412 HD11 ' CB ' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -127.49 172.2 10.91 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.618 -177.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.428 ' NE ' ' HA ' ' A' ' 83' ' ' ALA . 95.9 mtt180 -98.7 173.21 7.01 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 4' ' ' PRO . 0.0 OUTLIER -60.15 -39.72 87.37 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.417 1.087 . . . . 0.0 111.283 -173.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.3 p -72.41 0.89 8.99 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 30.3 t -116.05 7.48 14.29 Favored 'General case' 0 N--CA 1.425 -1.709 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.0 mt -110.18 132.96 53.7 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.561 -177.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.532 ' HB3' ' OG ' ' A' ' 14' ' ' SER . 22.3 t -96.55 -59.47 1.81 Allowed 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.038 -176.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 7.1 tt 95.88 137.6 0.02 OUTLIER 'General case' 0 C--O 1.241 0.621 0 C-N-CA 127.602 2.361 . . . . 0.0 109.814 -177.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 24.1 ttmm -40.01 111.1 0.17 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.381 1.473 . . . . 0.0 113.8 -174.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 165.14 174.08 34.43 Favored Glycine 0 N--CA 1.435 -1.399 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . 0.29 0.0 OUTLIER -67.65 -62.32 1.47 Allowed 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 -178.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.2 mtt180 -132.46 81.58 1.96 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.872 -0.518 . . . . 0.0 109.888 178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.494 ' HB2' ' SG ' ' A' ' 104' ' ' CYS . 21.9 m80 -91.93 -14.97 28.7 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 122.076 0.941 . . . . 0.0 109.149 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -107.29 45.49 0.99 Allowed 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 104.479 -2.415 . . . . 0.0 104.479 173.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.94 95.51 1.99 Allowed 'General case' 0 N--CA 1.427 -1.609 0 CA-C-N 114.043 -1.435 . . . . 0.0 110.43 -177.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -75.42 104.96 6.2 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 175.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 14.8 m -112.93 117.1 31.15 Favored 'General case' 0 N--CA 1.402 -2.843 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 -176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.57 136.28 57.96 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-O 121.366 0.603 . . . . 0.0 110.795 -176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.5 m -116.1 93.32 4.19 Favored 'General case' 0 N--CA 1.406 -2.657 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -87.37 -42.66 12.7 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 -176.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 C--N 1.303 -1.456 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 178.431 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.814 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -69.16 -23.94 64.01 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -103.03 124.61 37.9 Favored Pre-proline 0 C--N 1.31 -1.138 0 C-N-CA 119.32 -0.952 . . . . 0.0 111.127 179.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -84.01 14.73 2.33 Favored 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.936 2.424 . . . . 0.0 111.783 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.48 -57.77 9.16 Favored 'General case' 0 C--O 1.245 0.838 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -178.38 135.99 0.16 Allowed 'General case' 0 N--CA 1.446 -0.649 0 O-C-N 124.489 1.118 . . . . 0.0 109.736 174.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.2 mt -89.63 -172.47 3.58 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 172.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.4 p -128.36 156.63 42.8 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -169.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.6 t -68.65 126.65 29.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.011 -178.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.55 -19.31 42.44 Favored Glycine 0 N--CA 1.437 -1.252 0 C-N-CA 121.245 -0.503 . . . . 0.0 112.275 179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.459 ' HB ' HD12 ' A' ' 26' ' ' ILE . 30.9 m -69.29 137.39 52.98 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-O 121.062 0.458 . . . . 0.0 110.669 -177.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.47 ' O ' ' HG ' ' A' ' 105' ' ' LEU . 13.4 m-20 -86.44 131.83 34.09 Favored 'General case' 0 CA--C 1.493 -1.245 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 105' ' ' LEU . 30.8 m -137.22 -179.44 2.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-O 121.446 0.641 . . . . 0.0 111.494 -173.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.491 ' OG ' ' HB2' ' A' ' 104' ' ' CYS . 1.9 p -137.96 137.54 38.06 Favored 'General case' 0 N--CA 1.42 -1.951 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.499 ' CB ' HD11 ' A' ' 98' ' ' LEU . . . -116.04 139.38 50.34 Favored 'General case' 0 C--N 1.28 -2.454 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 -176.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.6 ttpt -85.59 134.72 34.0 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.874 -0.73 . . . . 0.0 110.285 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 36.6 m-85 -120.84 102.11 8.15 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 123.858 0.863 . . . . 0.0 109.146 172.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 91.5 mtt180 58.77 28.09 16.87 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 170.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.51 9.71 57.5 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 121.177 -0.535 . . . . 0.0 113.777 -179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -123.05 151.39 41.99 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -106.73 137.12 45.36 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 119.031 0.832 . . . . 0.0 111.752 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.482 ' SG ' ' HD2' ' A' ' 90' ' ' PHE . 19.9 t -123.78 143.42 50.32 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -85.82 149.96 24.88 Favored 'General case' 0 N--CA 1.44 -0.959 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.856 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.436 ' HA ' ' HA ' ' A' ' 90' ' ' PHE . . . -149.89 173.2 14.04 Favored 'General case' 0 N--CA 1.417 -2.099 0 CA-C-N 115.547 -0.751 . . . . 0.0 109.312 178.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -137.64 132.21 32.64 Favored 'General case' 0 C--N 1.277 -2.586 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.671 ' HA ' HG12 ' A' ' 88' ' ' VAL . 60.5 mt -65.45 116.33 4.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 CA-C-O 121.407 0.622 . . . . 0.0 111.166 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -95.03 -41.64 9.03 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.66 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.446 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 86.8 m -137.91 142.47 40.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.473 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -117.72 107.34 21.85 Favored 'Isoleucine or valine' 0 CA--C 1.476 -1.898 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 84' ' ' SER . 65.1 mttm -91.39 90.41 7.67 Favored 'General case' 0 C--N 1.263 -3.158 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 31' ' ' ARG . 18.7 ptt180 -94.77 106.07 18.04 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.548 ' O ' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -139.38 144.0 37.98 Favored 'General case' 0 C--N 1.277 -2.572 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -175.284 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 11.4 p -118.41 124.34 72.98 Favored 'Isoleucine or valine' 0 C--N 1.25 -3.718 0 C-N-CA 119.138 -1.025 . . . . 0.0 110.267 -177.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 97.9 mttt -82.65 100.7 10.36 Favored 'General case' 0 CA--C 1.502 -0.883 0 CA-C-O 121.716 0.769 . . . . 0.0 109.415 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.587 HG21 HD12 ' A' ' 57' ' ' LEU . 29.9 t -88.07 130.7 37.26 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.62 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.159 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 61.4 tttp -98.22 109.54 22.28 Favored 'General case' 0 N--CA 1.422 -1.869 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 31.3 m -112.61 149.5 15.1 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.455 0 CA-C-O 121.38 0.609 . . . . 0.0 110.498 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 20.8 tp -111.69 118.11 34.73 Favored 'General case' 0 C--N 1.269 -2.934 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 176.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.54 HD23 ' HB2' ' A' ' 75' ' ' ALA . 43.3 mt -70.35 126.12 28.73 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -178.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -72.82 -35.88 67.4 Favored 'General case' 0 C--N 1.307 -1.272 0 C-N-CA 120.01 -0.676 . . . . 0.0 111.217 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -83.24 -36.15 24.82 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -175.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -107.42 -7.86 16.48 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.762 -0.775 . . . . 0.0 113.077 -175.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.276 10.7 p30 59.76 21.06 9.85 Favored 'General case' 0 N--CA 1.504 2.262 0 C-N-CA 125.679 1.592 . . . . 0.0 113.46 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.483 ' OG1' HD12 ' A' ' 39' ' ' LEU . 0.1 OUTLIER -93.14 147.53 22.8 Favored 'General case' 0 N--CA 1.407 -2.624 0 CA-C-N 115.399 -0.819 . . . . 0.0 108.866 176.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.7 m -108.28 142.95 37.8 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.08 144.03 48.38 Favored 'General case' 0 C--N 1.278 -2.511 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -175.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.2 tp -126.88 101.76 6.72 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 178.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -142.27 162.89 18.98 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 5.2 pm0 -83.38 166.6 18.28 Favored 'General case' 0 N--CA 1.427 -1.6 0 N-CA-C 113.87 1.063 . . . . 0.0 113.87 -175.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -57.02 -12.31 2.0 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 125.967 1.707 . . . . 0.0 115.441 -173.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -89.19 -10.18 48.05 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 118.789 -1.165 . . . . 0.0 110.412 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -101.99 -7.82 22.04 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 86.9 t -103.16 118.46 50.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 114.341 -1.3 . . . . 0.0 109.407 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -98.03 97.31 8.8 Favored 'General case' 0 C--N 1.282 -2.362 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 146.67 -176.5 25.53 Favored Glycine 0 N--CA 1.427 -1.901 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.061 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -65.02 142.38 74.52 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.462 2.775 . . . . 0.0 112.696 176.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.587 HD12 HG21 ' A' ' 35' ' ' VAL . 1.5 mm? -96.75 84.16 3.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.516 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 7.0 tpt180 -137.98 126.37 23.29 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.416 -1.266 . . . . 0.0 108.773 -172.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 t -63.26 121.38 12.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.19 5.15 59.54 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 115.431 -0.804 . . . . 0.0 113.055 -178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.89 155.47 16.76 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 118.022 0.911 . . . . 0.0 110.937 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 43.7 mm -93.8 119.38 41.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.6 m -137.62 -179.12 2.48 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.886 0 C-N-CA 122.768 0.427 . . . . 0.0 110.018 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -121.81 121.17 36.6 Favored 'General case' 0 C--N 1.306 -1.284 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 175.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 24.3 m -113.99 146.96 39.42 Favored 'General case' 0 N--CA 1.4 -2.974 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 -176.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.5 ttt180 -83.57 127.23 33.58 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.7 p -92.17 175.28 6.91 Favored 'General case' 0 C--N 1.287 -2.127 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.9 m -68.63 -5.38 19.72 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-O 121.344 0.593 . . . . 0.0 111.919 179.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -83.04 -14.93 52.91 Favored 'General case' 0 C--O 1.216 -0.68 0 CA-C-O 121.63 0.728 . . . . 0.0 109.302 176.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 97.01 -16.37 61.04 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 p -93.88 157.31 16.19 Favored 'General case' 0 N--CA 1.421 -1.891 0 C-N-CA 123.19 0.596 . . . . 0.0 110.561 -178.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -94.95 146.89 23.93 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.455 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.446 ' HA ' HE21 ' A' ' 73' ' ' GLN . 0.1 OUTLIER -137.02 143.73 42.89 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 178.082 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -80.45 130.62 35.27 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.54 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.24 173.88 11.06 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.6 -169.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.1 mp -119.57 139.19 47.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.516 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.7 mp -73.55 127.34 35.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 C-N-CA 120.528 -0.469 . . . . 0.0 109.95 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 48.3 m -108.41 -23.33 11.93 Favored 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 122.463 0.305 . . . . 0.0 111.415 177.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 51.7 tttp -163.98 154.81 15.65 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -176.551 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.434 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . 2.9 mp -130.45 133.62 46.46 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 169.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 3.4 m -104.52 123.12 46.95 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -66.49 119.75 12.19 Favored 'General case' 0 CA--C 1.502 -0.88 0 O-C-N 123.541 0.526 . . . . 0.0 110.944 -176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.548 ' HB3' ' O ' ' A' ' 32' ' ' LEU . . . -138.78 145.85 40.66 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-O 121.438 0.637 . . . . 0.0 109.601 178.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 4.2 p -169.69 101.8 0.32 Allowed 'General case' 0 C--N 1.284 -2.244 0 C-N-CA 124.821 1.248 . . . . 0.0 107.992 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.496 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 92.8 m95 -97.35 121.22 39.0 Favored 'General case' 0 C--N 1.276 -2.602 0 CA-C-N 114.425 -1.261 . . . . 0.0 110.284 -175.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -105.1 110.73 23.23 Favored 'General case' 0 N--CA 1.412 -2.33 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -175.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.446 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 24.5 m -79.72 108.74 13.51 Favored 'General case' 0 N--CA 1.401 -2.876 0 N-CA-C 105.217 -2.142 . . . . 0.0 105.217 173.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 26' ' ' ILE . 28.9 m -113.54 145.16 19.8 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.627 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.447 -173.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.1 p -100.94 121.29 51.58 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.482 ' HD2' ' SG ' ' A' ' 22' ' ' CYS . 11.1 m-85 -88.76 -177.49 5.54 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.07 -172.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -68.75 -15.04 63.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.84 -17.4 63.99 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.529 173.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 81.42 -4.61 71.89 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.832 -0.507 . . . . 0.0 111.832 -178.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -98.41 167.19 10.99 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 13.2 pt-20 -121.57 128.64 52.21 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 121.411 0.624 . . . . 0.0 111.304 -175.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.461 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . 0.6 OUTLIER -125.62 150.92 47.15 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 175.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.496 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 44.5 m -105.21 118.11 35.72 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-O 120.824 0.345 . . . . 0.0 110.298 -179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.499 HD11 ' CB ' ' A' ' 15' ' ' ALA . 0.8 OUTLIER -141.97 152.49 43.52 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 123.106 0.562 . . . . 0.0 109.772 178.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -100.48 -173.76 2.49 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.055 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 30.8 tpt180 -53.97 -26.9 28.14 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 124.123 0.969 . . . . 0.0 112.836 -177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 13.7 m -58.02 -28.77 64.75 Favored 'General case' 0 CA--C 1.554 1.107 0 C-N-CA 122.956 0.503 . . . . 0.0 112.306 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 12.4 p -125.96 10.51 7.61 Favored 'General case' 0 N--CA 1.435 -1.223 0 C-N-CA 120.035 -0.666 . . . . 0.0 112.336 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 103' ' ' LEU . 9.9 tp -111.86 128.05 56.01 Favored 'General case' 0 N--CA 1.422 -1.829 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.491 ' HB2' ' OG ' ' A' ' 14' ' ' SER . 24.8 m -96.96 -63.25 1.15 Allowed 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 122.691 0.396 . . . . 0.0 111.955 -172.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 13' ' ' VAL . 5.5 tt 77.52 -66.14 0.24 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.706 1.203 . . . . 0.0 110.635 177.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 28.3 ttpp -94.77 -81.84 0.38 Allowed 'General case' 0 N--CA 1.434 -1.255 0 C-N-CA 120.954 -0.298 . . . . 0.0 111.199 -176.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 166.65 64.03 0.03 OUTLIER Glycine 0 CA--C 1.484 -1.864 0 C-N-CA 118.537 -1.792 . . . . 0.0 112.452 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.68 124.1 33.21 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 178.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 71.9 mtp180 -74.96 36.67 0.11 Allowed 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 -168.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.2 p80 -163.0 93.72 0.81 Allowed 'General case' 0 CA--C 1.54 0.575 0 CA-C-O 121.567 0.699 . . . . 0.0 111.527 176.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 104' ' ' CYS . 20.7 m-85 -126.45 21.47 7.19 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-N 115.255 -0.884 . . . . 0.0 109.805 173.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 69.22 71.47 0.26 Allowed 'General case' 0 C--O 1.243 0.719 0 C-N-CA 124.339 1.056 . . . . 0.0 109.691 -175.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 27.2 mp0 -77.27 153.76 33.63 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 113.784 -1.553 . . . . 0.0 110.518 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 19.2 m -92.16 -175.92 4.21 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 175.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -79.23 85.68 5.07 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-O 122.086 0.946 . . . . 0.0 110.569 178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.2 m -116.67 25.05 10.84 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.216 -179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 79.3 mt -73.5 -33.24 64.69 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.176 0.989 . . . . 0.0 108.678 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 20.7 t70 . . . . . 0 C--N 1.301 -1.519 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.641 175.307 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.455 0 CA-C-O 120.628 0.252 . . . . 0.0 110.956 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -118.34 -37.87 3.27 Favored 'General case' 0 CA--C 1.506 -0.732 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.436 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 0.7 OUTLIER -73.77 144.4 82.89 Favored Pre-proline 0 N--CA 1.429 -1.521 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.606 -179.179 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -87.46 36.54 0.45 Allowed 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.691 2.26 . . . . 0.0 111.873 177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.96 -58.99 5.08 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 122.655 0.382 . . . . 0.0 110.388 -177.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.435 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 21.4 p90 -145.51 96.99 2.91 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-O 122.247 1.022 . . . . 0.0 109.415 176.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.1 mt -85.36 -167.51 1.87 Allowed 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.965 -176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.9 p -130.55 173.73 10.59 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 74.4 t -69.46 141.84 16.78 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 C-N-CA 123.936 0.895 . . . . 0.0 110.102 178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.13 -11.32 58.64 Favored Glycine 0 N--CA 1.438 -1.231 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.291 177.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.631 ' HB ' HD12 ' A' ' 26' ' ' ILE . 6.6 m -74.49 141.27 44.93 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.418 ' OD2' ' HG3' ' A' ' 25' ' ' LYS . 10.7 t70 -107.01 117.5 34.24 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.585 HG12 HD23 ' A' ' 105' ' ' LEU . 34.7 m -121.96 -179.86 2.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 120.861 0.362 . . . . 0.0 110.182 -177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.0 m -111.31 124.39 52.14 Favored 'General case' 0 C--N 1.284 -2.261 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 175.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.29 139.1 46.96 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.554 ' HD2' ' O ' ' A' ' 16' ' ' LYS 0.264 0.0 OUTLIER -94.01 129.69 40.42 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 -178.631 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.484 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 34.0 m-85 -98.6 101.82 13.37 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 105.865 -1.902 . . . . 0.0 105.865 170.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 17' ' ' TYR . 10.0 ptm180 49.21 35.95 8.34 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 173.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.26 10.4 57.2 Favored Glycine 0 CA--C 1.527 0.785 0 CA-C-N 115.932 -0.576 . . . . 0.0 114.074 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.72 124.79 34.37 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 176.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.423 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 17.0 m-85 -91.91 141.95 28.09 Favored 'General case' 0 C--N 1.284 -2.263 0 CA-C-O 121.465 0.65 . . . . 0.0 112.555 -172.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 43.9 t -127.53 145.32 50.89 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 173.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -71.73 143.43 49.62 Favored 'General case' 0 N--CA 1.423 -1.808 0 C-N-CA 118.891 -1.124 . . . . 0.0 108.4 176.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.517 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -141.44 139.63 33.43 Favored 'General case' 0 C--N 1.271 -2.817 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.192 -176.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.418 ' HG3' ' OD2' ' A' ' 12' ' ' ASP . 5.1 mttp -103.12 126.6 50.37 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.487 -175.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.631 HD12 ' HB ' ' A' ' 11' ' ' THR . 25.1 mt -70.24 116.63 11.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.788 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -97.15 -45.09 6.67 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.488 1.115 . . . . 0.0 109.424 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.422 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 7.6 m -128.6 143.63 50.99 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.635 -178.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 81.6 t -126.59 119.29 53.24 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.486 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 57.0 mtpt -104.07 97.86 7.77 Favored 'General case' 0 C--N 1.279 -2.49 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -83.38 100.74 10.88 Favored 'General case' 0 C--N 1.309 -1.164 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 176.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.418 ' H ' HD23 ' A' ' 32' ' ' LEU . 2.1 pt? -133.22 161.32 34.76 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.443 ' H ' ' HB2' ' A' ' 50' ' ' ASP . 10.4 p -130.02 140.88 47.82 Favored 'Isoleucine or valine' 0 C--N 1.252 -3.641 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 175.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.432 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 98.9 mttt -91.74 101.57 14.18 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.743 0.783 . . . . 0.0 109.682 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.412 HG12 HG13 ' A' ' 37' ' ' VAL . 21.7 t -90.49 121.48 40.84 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 114.562 -1.199 . . . . 0.0 110.182 -173.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 85.3 tttt -85.5 111.63 20.17 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.739 -1.948 . . . . 0.0 105.739 174.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.451 HG21 HG21 ' A' ' 65' ' ' THR . 1.9 m -112.61 146.44 17.35 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.269 0 CA-C-O 121.124 0.488 . . . . 0.0 110.606 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -112.96 114.1 26.43 Favored 'General case' 0 C--N 1.278 -2.506 0 N-CA-C 105.686 -1.968 . . . . 0.0 105.686 175.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.584 HD11 ' HB3' ' A' ' 73' ' ' GLN . 31.9 tp -75.62 111.64 11.16 Favored 'General case' 0 C--N 1.285 -2.223 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.5 pttt -56.05 -43.1 77.56 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -170.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -76.69 -50.86 12.66 Favored 'General case' 0 N--CA 1.426 -1.625 0 CA-C-O 121.371 0.605 . . . . 0.0 111.875 -174.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.457 ' HB3' HD23 ' A' ' 39' ' ' LEU . 30.6 t70 -84.95 -9.22 58.29 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.298 -0.865 . . . . 0.0 111.568 -171.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . 0.289 0.0 OUTLIER 56.33 24.06 7.91 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 127.377 2.271 . . . . 0.0 112.955 179.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -95.91 153.57 17.69 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.979 179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.6 m -120.31 142.83 48.75 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -145.37 163.63 33.98 Favored 'General case' 0 C--N 1.265 -3.097 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.978 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.432 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 14.8 tp -128.02 104.31 7.72 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 105.833 -1.914 . . . . 0.0 105.833 -177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.2 m -121.05 174.36 5.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.813 -173.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -87.4 162.34 17.37 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.488 0.661 . . . . 0.0 112.201 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.443 ' HB2' ' H ' ' A' ' 33' ' ' VAL . 7.7 t70 -44.16 -28.46 0.51 Allowed 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 127.7 2.4 . . . . 0.0 113.275 176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -85.97 -24.76 26.37 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.385 0.674 . . . . 0.0 110.886 -173.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.8 mm-40 -84.14 -17.79 38.91 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.2 t -91.78 116.29 32.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.95 -1.023 . . . . 0.0 111.399 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -106.06 101.48 10.96 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.431 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.42 -162.85 27.92 Favored Glycine 0 C--N 1.309 -0.922 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -79.17 135.46 12.2 Favored 'Trans proline' 0 CA--C 1.517 -0.371 0 C-N-CA 122.477 2.118 . . . . 0.0 112.299 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.9 mp -95.78 82.33 3.56 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 122.049 0.928 . . . . 0.0 109.619 -178.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.555 ' HD3' ' N ' ' A' ' 59' ' ' VAL . 1.1 tmt_? -140.08 138.65 35.49 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 106.722 -1.584 . . . . 0.0 106.722 -178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.555 ' N ' ' HD3' ' A' ' 58' ' ' ARG . 22.2 t -61.74 119.1 5.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.44 6.31 57.56 Favored Glycine 0 C--N 1.298 -1.563 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.937 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.479 ' HB3' HD13 ' A' ' 77' ' ' ILE . . . -90.53 152.87 20.73 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 117.396 0.598 . . . . 0.0 110.844 -179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.429 HD13 HG13 ' A' ' 76' ' ' ILE . 45.1 mm -89.65 117.65 33.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.64 177.66 6.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 179.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -122.52 121.53 36.76 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 172.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.451 HG21 HG21 ' A' ' 37' ' ' VAL . 9.7 t -115.67 158.43 22.76 Favored 'General case' 0 C--N 1.263 -3.161 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -174.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 71' ' ' SER . 40.7 ttt180 -79.93 125.59 29.94 Favored 'General case' 0 N--CA 1.405 -2.719 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 65.2 p -84.12 177.34 8.27 Favored 'General case' 0 C--N 1.289 -2.058 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.9 m -75.78 -2.99 32.47 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.803 0.811 . . . . 0.0 110.296 178.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -93.83 -1.03 55.46 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.537 177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 86.23 -5.63 83.78 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.521 176.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 17.7 t -94.76 172.49 8.13 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -177.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.405 ' HA ' ' O ' ' A' ' 65' ' ' THR . 93.4 m-85 -110.34 120.2 41.68 Favored 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.584 ' HB3' HD11 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -131.05 150.78 51.99 Favored 'General case' 0 C--N 1.297 -1.676 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -176.235 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.524 ' H ' ' NE2' ' A' ' 73' ' ' GLN . 32.8 tt0 -73.57 122.98 23.09 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 123.562 0.745 . . . . 0.0 111.56 -174.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -137.11 173.97 11.11 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.448 -175.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.429 HG13 HD13 ' A' ' 62' ' ' ILE . 4.0 mp -122.31 141.47 42.57 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.479 HD13 ' HB3' ' A' ' 61' ' ' ALA . 3.2 mp -72.26 122.22 24.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 175.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 47.9 t -99.91 -18.28 17.19 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 86.8 tttt -175.89 143.8 0.59 Allowed 'General case' 0 C--O 1.206 -1.197 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.377 0.0 OUTLIER -117.57 118.93 33.48 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.471 0.653 . . . . 0.0 109.737 165.709 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 20.8 m -101.59 130.56 47.94 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.971 -171.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -57.01 122.34 12.09 Favored 'General case' 0 C--N 1.313 -0.985 0 O-C-N 124.375 1.047 . . . . 0.0 111.035 -178.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -146.85 154.05 40.87 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 107.564 -1.273 . . . . 0.0 107.564 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.3 m -176.64 121.62 0.14 Allowed 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 126.429 1.892 . . . . 0.0 107.513 174.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.577 ' HB3' ' OG1' ' A' ' 97' ' ' THR . 99.6 m95 -97.37 123.02 41.06 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.435 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 73.4 m-85 -111.41 106.79 15.81 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 5.6 m -82.42 104.02 12.4 Favored 'General case' 0 N--CA 1.408 -2.538 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.517 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 15.8 m -106.46 154.49 7.5 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.578 -176.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 94' ' ' ASP . 11.9 p -104.31 135.46 42.0 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.748 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -100.86 -177.84 3.59 Favored 'General case' 0 C--N 1.288 -2.085 0 CA-C-N 115.275 -0.875 . . . . 0.0 111.327 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -62.09 -26.88 68.53 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.502 1.121 . . . . 0.0 109.993 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.43 -16.87 64.06 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.827 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.14 14.17 72.53 Favored Glycine 0 CA--C 1.501 -0.782 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -175.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.418 ' O ' ' HA ' ' A' ' 89' ' ' VAL . 26.5 t70 -97.43 137.26 36.66 Favored 'General case' 0 CA--C 1.469 -2.138 0 CA-C-N 113.953 -1.123 . . . . 0.0 108.407 -174.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -103.77 126.55 50.98 Favored 'General case' 0 C--N 1.269 -2.894 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 176.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 13.9 tpp180 -141.83 139.37 32.68 Favored 'General case' 0 C--N 1.276 -2.591 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -174.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.577 ' OG1' ' HB3' ' A' ' 85' ' ' TRP . 10.9 t -100.16 122.45 43.01 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 119.513 -0.875 . . . . 0.0 109.083 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 20.0 mt -110.9 166.26 11.18 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-O 121.197 0.522 . . . . 0.0 110.065 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.98 164.06 24.71 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -68.19 -17.97 64.47 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 7.3 p -87.78 14.32 8.88 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.958 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.508 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 14.7 m -129.5 1.95 5.04 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 176.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.5 mt -128.33 147.31 50.61 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.486 -174.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 50.2 t -154.54 126.33 7.61 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.585 HD23 HG12 ' A' ' 13' ' ' VAL . 55.2 mt -49.62 -69.65 0.11 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 122.855 0.462 . . . . 0.0 109.812 173.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.545 ' HE3' ' HA ' ' A' ' 106' ' ' LYS . 1.3 tpmt? -167.27 103.72 0.53 Allowed 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -170.77 71.24 0.12 Allowed Glycine 0 C--N 1.301 -1.391 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 112' ' ' ALA . 11.9 pt-20 -73.82 -24.19 59.76 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -175.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -88.93 66.14 7.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.1 t60 170.81 -59.08 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 105.893 -1.891 . . . . 0.0 105.893 -179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -106.0 92.81 4.31 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.155 176.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 108' ' ' GLU . . . -133.93 -48.18 0.8 Allowed 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 64.88 22.6 12.52 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 122.542 1.163 . . . . 0.0 111.122 178.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 24.4 t -141.03 117.33 10.7 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 101.88 -3.378 . . . . 0.0 101.88 174.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 68.14 96.65 0.06 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 -167.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.1 m -89.09 1.49 55.51 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -170.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 57.9 tp -78.84 -87.38 0.06 Allowed 'General case' 0 C--N 1.316 -0.852 0 C-N-CA 120.143 -0.623 . . . . 0.0 110.814 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 15.7 t70 . . . . . 0 C--N 1.315 -0.897 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.315 -177.068 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.512 -0.516 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -97.15 -30.58 12.94 Favored 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.097 0.475 . . . . 0.0 110.054 179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -107.28 107.01 59.84 Favored Pre-proline 0 C--N 1.308 -1.201 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -80.9 -11.6 12.38 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 122.441 2.094 . . . . 0.0 114.308 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.91 -21.85 20.36 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.505 0.669 . . . . 0.0 110.234 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.63 105.6 2.44 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.956 -177.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.474 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 65.9 mt -70.39 -174.71 0.88 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.869 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 6.9 p -132.67 161.07 34.9 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 -172.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 62.1 t -72.85 130.04 35.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.856 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.19 -24.11 4.52 Favored Glycine 0 N--CA 1.438 -1.223 0 C-N-CA 120.442 -0.885 . . . . 0.0 112.25 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 20.6 m -83.49 142.26 31.05 Favored 'General case' 0 N--CA 1.418 -2.061 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -99.91 135.2 41.7 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 171.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 105' ' ' LEU . 18.0 m -127.01 161.21 34.45 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.537 0 C-N-CA 123.237 0.615 . . . . 0.0 109.516 -176.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.7 m -100.61 123.97 45.56 Favored 'General case' 0 N--CA 1.409 -2.496 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 175.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.708 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -107.05 121.24 44.09 Favored 'General case' 0 C--N 1.272 -2.774 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -175.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.588 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 83.5 tttt -81.0 105.99 12.65 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 176.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.558 ' CE2' ' HB3' ' A' ' 22' ' ' CYS . 38.6 p90 -121.51 125.15 46.12 Favored 'General case' 0 N--CA 1.413 -2.322 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.528 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 30.3 ttt180 62.36 31.84 17.15 Favored 'General case' 0 CA--C 1.549 0.931 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.356 178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.2 -3.25 69.4 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 115.16 0.824 . . . . 0.0 115.16 175.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.73 134.74 37.46 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 118.338 1.069 . . . . 0.0 110.27 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.588 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 28.5 p90 -91.17 136.17 33.28 Favored 'General case' 0 CA--C 1.495 -1.166 0 N-CA-C 112.832 0.679 . . . . 0.0 112.832 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.558 ' HB3' ' CE2' ' A' ' 17' ' ' TYR . 52.3 t -134.96 163.03 30.78 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -72.95 147.11 45.54 Favored 'General case' 0 C--O 1.251 1.137 0 CA-C-O 121.59 0.709 . . . . 0.0 110.445 -177.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.475 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -148.39 148.32 30.21 Favored 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 114.53 -1.214 . . . . 0.0 108.95 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -112.71 130.62 55.99 Favored 'General case' 0 C--N 1.282 -2.343 0 C-N-CA 120.383 -0.527 . . . . 0.0 110.325 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.571 ' HA ' HG12 ' A' ' 88' ' ' VAL . 53.2 mt -64.84 119.58 9.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.952 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -95.85 -51.24 4.56 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 50.3 m -132.63 145.03 50.76 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.257 -176.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG22 ' HD1' ' A' ' 86' ' ' TYR . 95.2 t -122.23 112.92 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.302 176.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 84' ' ' SER . 65.1 tttp -98.79 97.92 9.09 Favored 'General case' 0 C--N 1.279 -2.493 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 178.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 65.7 mtt180 -79.61 94.28 5.64 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.655 HD12 ' HB3' ' A' ' 83' ' ' ALA . 2.7 pp -103.14 160.63 14.48 Favored 'General case' 0 N--CA 1.426 -1.654 0 CA-C-O 121.127 0.489 . . . . 0.0 111.263 -178.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.21 118.36 57.24 Favored 'Isoleucine or valine' 0 C--N 1.266 -3.064 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HB3' ' HB3' ' A' ' 47' ' ' LEU . 50.4 mtpt -82.85 100.96 10.66 Favored 'General case' 0 N--CA 1.417 -2.115 0 N-CA-C 106.828 -1.545 . . . . 0.0 106.828 174.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 47' ' ' LEU . 21.4 t -84.98 117.34 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.841 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.953 -177.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.425 ' HA ' ' HG ' ' A' ' 47' ' ' LEU . 88.5 tttt -80.95 107.46 13.78 Favored 'General case' 0 N--CA 1.427 -1.589 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 176.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 45' ' ' THR . 12.5 m -112.91 149.41 15.38 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.003 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.43 -175.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -117.53 111.13 18.82 Favored 'General case' 0 C--N 1.263 -3.173 0 N-CA-C 105.034 -2.209 . . . . 0.0 105.034 174.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.524 ' HB3' ' OE1' ' A' ' 73' ' ' GLN . 44.9 mt -71.78 123.93 23.7 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 17.9 ptpt -62.54 -31.01 71.73 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -175.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.461 ' HB3' ' CD ' ' A' ' 73' ' ' GLN . 44.9 tt0 -84.95 -55.72 3.93 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 120.897 0.379 . . . . 0.0 111.474 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -80.6 -22.51 40.57 Favored 'General case' 0 CA--C 1.498 -1.032 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 64.45 32.29 11.97 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 123.47 0.708 . . . . 0.0 112.279 -179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.6 p -92.87 138.86 31.12 Favored 'General case' 0 N--CA 1.422 -1.857 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 174.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.8 m -107.35 130.11 54.83 Favored 'General case' 0 N--CA 1.4 -2.945 0 N-CA-C 106.081 -1.822 . . . . 0.0 106.081 175.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -157.19 156.75 33.15 Favored 'General case' 0 C--N 1.257 -3.434 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -176.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.446 ' HA ' ' O ' ' A' ' 35' ' ' VAL . 6.2 mp -113.14 107.88 16.54 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.9 m -114.31 166.87 7.61 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.89 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -86.73 165.38 16.11 Favored 'General case' 0 C--N 1.296 -1.753 0 C-N-CA 121.026 -0.27 . . . . 0.0 111.639 -174.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -53.22 -34.19 56.0 Favored 'General case' 0 N--CA 1.502 2.127 0 C-N-CA 124.584 1.154 . . . . 0.0 110.532 -176.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -65.12 -22.8 66.99 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-N 114.088 -1.415 . . . . 0.0 110.686 -173.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -99.79 -17.83 17.49 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 90.6 t -98.09 116.63 41.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.944 -175.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -110.33 114.47 27.95 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.797 176.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.408 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 143.97 -163.83 27.63 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.02 137.36 7.39 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 123.072 2.515 . . . . 0.0 113.647 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 43.9 mt -95.03 82.89 3.84 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.345 0.593 . . . . 0.0 110.924 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.429 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 3.0 mpt_? -139.14 142.25 38.04 Favored 'General case' 0 CA--C 1.479 -1.761 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 174.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 67.0 t -67.75 112.93 3.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 177.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.26 6.99 35.81 Favored Glycine 0 N--CA 1.428 -1.883 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.435 -176.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.19 152.95 18.31 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 61.4 mt -99.95 125.92 53.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.956 0 CA-C-O 121.111 0.482 . . . . 0.0 110.124 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.408 HG12 ' HA3' ' A' ' 55' ' ' GLY . 25.2 m -127.96 -177.78 2.03 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.68 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 74' ' ' GLU . 8.7 pt-20 -131.51 128.22 38.9 Favored 'General case' 0 C--N 1.272 -2.761 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 171.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.445 HG21 HG21 ' A' ' 37' ' ' VAL . 9.9 t -139.96 159.64 41.72 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.99 -168.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.4 ttt180 -69.02 132.01 45.97 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.832 -1.077 . . . . 0.0 109.66 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.405 HG23 ' HB3' ' A' ' 69' ' ' ASP . 7.0 t -90.51 168.97 11.43 Favored 'General case' 0 N--CA 1.419 -1.976 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 176.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.5 m -64.53 -23.0 67.13 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 123.088 0.555 . . . . 0.0 110.987 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.405 ' HB3' HG23 ' A' ' 67' ' ' THR . 7.7 t70 -64.97 -26.19 68.19 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.288 176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.8 -22.08 17.27 Favored Glycine 0 N--CA 1.435 -1.379 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.226 -177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 35.6 t -77.43 179.59 6.38 Favored 'General case' 0 C--N 1.314 -0.964 0 C-N-CA 123.803 0.841 . . . . 0.0 109.504 178.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -119.19 136.13 54.34 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.524 ' OE1' ' HB3' ' A' ' 39' ' ' LEU . 30.3 tt0 -137.86 153.25 49.6 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -177.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.531 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 39.0 tt0 -77.44 137.19 38.54 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.426 0.631 . . . . 0.0 109.407 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.462 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -141.13 173.61 11.31 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.87 -174.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 2.9 mp -125.19 143.74 37.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.43 HG13 ' CG1' ' A' ' 35' ' ' VAL . 3.0 mp -75.55 122.82 30.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 17.3 t -99.77 -24.2 14.76 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.3 tppt? -169.22 151.55 4.68 Favored 'General case' 0 C--O 1.213 -0.817 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 179.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.3 OUTLIER -127.77 118.54 23.94 Favored 'General case' 0 C--N 1.292 -1.902 0 CA-C-N 118.327 0.512 . . . . 0.0 110.805 172.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 17.0 m -107.86 125.42 51.44 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.993 -0.549 . . . . 0.0 109.967 -174.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.9 121.49 24.22 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.06 0.457 . . . . 0.0 109.839 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB3' HD12 ' A' ' 32' ' ' LEU . . . -128.36 -179.44 5.03 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.5 p -164.41 145.9 8.4 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.14 0.495 . . . . 0.0 111.618 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.493 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 87.0 m95 -114.93 146.31 41.3 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 174.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.474 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 27.7 m-85 -124.03 112.96 17.79 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -178.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 27.1 m -85.49 107.15 17.31 Favored 'General case' 0 N--CA 1.406 -2.644 0 N-CA-C 106.152 -1.795 . . . . 0.0 106.152 175.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 26' ' ' ILE . 24.8 m -110.56 146.76 15.32 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.617 0 CA-C-N 115.025 -0.989 . . . . 0.0 109.995 -175.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -102.11 121.5 53.21 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.427 ' HD1' ' HB2' ' A' ' 24' ' ' ALA . 29.4 m-85 -74.0 173.58 9.8 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.406 -0.815 . . . . 0.0 111.469 -176.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -56.98 -27.13 61.1 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.697 -1.138 . . . . 0.0 109.469 171.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.51 -15.92 61.79 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.241 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 84.82 11.89 75.88 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.807 -177.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -98.26 141.87 30.62 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -104.42 127.93 52.2 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.41 ' HB2' ' CE2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -135.25 148.36 49.55 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 177.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.493 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 30.5 m -104.75 113.2 26.63 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.356 -178.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.708 HD11 ' HB1' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -140.54 159.6 41.84 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 123.064 0.546 . . . . 0.0 111.404 -179.09 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.547 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 95.8 mtt180 -99.75 -172.47 2.25 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 122.964 0.506 . . . . 0.0 109.987 178.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.447 ' HA ' ' HB2' ' A' ' 103' ' ' LEU . 0.0 OUTLIER -68.08 -14.57 63.07 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 121.107 0.48 . . . . 0.0 110.964 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 3.1 p -73.27 -2.39 21.7 Favored 'General case' 0 N--CA 1.43 -1.457 0 C-N-CA 123.872 0.869 . . . . 0.0 111.234 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 19.6 m -137.6 9.53 2.89 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 173.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 99' ' ' ARG . 93.1 mt -113.69 137.69 51.26 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-N 116.186 -0.461 . . . . 0.0 109.853 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 42.2 t -110.28 6.59 22.62 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.172 -177.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.638 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 93.7 mt 62.95 -74.43 0.04 OUTLIER 'General case' 0 C--O 1.207 -1.154 0 C-N-CA 124.083 0.953 . . . . 0.0 110.644 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -138.6 132.75 31.52 Favored 'General case' 0 N--CA 1.411 -2.419 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -75.49 45.31 1.8 Allowed Glycine 0 C--N 1.315 -0.589 0 O-C-N 123.445 0.465 . . . . 0.0 114.176 -175.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.438 ' HB2' ' HD2' ' A' ' 109' ' ' ARG . 37.9 mm-40 -82.55 -33.55 28.1 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 175.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.438 ' HD2' ' HB2' ' A' ' 108' ' ' GLU . 5.7 mpt_? -108.53 170.96 7.69 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 176.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -84.72 168.03 15.59 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 174.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -85.85 -69.15 0.68 Allowed 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -142.59 22.22 1.99 Allowed 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.735 0.779 . . . . 0.0 109.423 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -82.89 177.6 8.57 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.573 -176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.8 t -77.46 164.19 25.67 Favored 'General case' 0 C--O 1.248 1.011 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -73.84 -64.82 0.92 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 97.0 m -146.34 131.42 18.3 Favored 'General case' 0 N--CA 1.431 -1.397 0 N-CA-C 107.634 -1.246 . . . . 0.0 107.634 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -76.88 132.48 39.14 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 22.5 t70 . . . . . 0 C--N 1.305 -1.361 0 CA-C-O 118.696 -0.668 . . . . 0.0 110.14 -177.531 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.592 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -71.94 -33.55 68.31 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -109.59 106.1 58.03 Favored Pre-proline 0 N--CA 1.434 -1.24 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 172.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HB2' ' O ' ' A' ' 6' ' ' TYR . 2.9 Cg_exo -78.96 169.84 18.79 Favored 'Trans proline' 0 N--CA 1.445 -1.35 0 C-N-CA 121.68 1.587 . . . . 0.0 110.278 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.32 -4.04 56.49 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.903 0.858 . . . . 0.0 109.525 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.409 ' O ' ' HB2' ' A' ' 4' ' ' PRO . 47.9 p90 -170.78 125.74 0.7 Allowed 'General case' 0 N--CA 1.416 -2.15 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 178.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.533 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 6.6 mp -78.26 177.38 8.46 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.231 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 9.6 p -131.47 152.26 50.85 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -173.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 99.4 t -62.62 112.5 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.43 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.209 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 135.02 -24.15 3.45 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.862 -0.895 . . . . 0.0 110.862 -178.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.519 ' HB ' HD12 ' A' ' 26' ' ' ILE . 46.2 m -73.68 138.67 44.87 Favored 'General case' 0 N--CA 1.415 -2.192 0 CA-C-O 120.937 0.398 . . . . 0.0 109.93 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -99.02 126.11 44.66 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.6 m -136.37 -178.91 2.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 C-N-CA 123.249 0.62 . . . . 0.0 109.906 -176.078 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 15.8 m -130.9 146.06 52.21 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 174.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -119.38 127.4 53.1 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.465 ' HD3' ' HA ' ' A' ' 102' ' ' SER . 0.0 OUTLIER -80.87 138.98 36.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.168 0.509 . . . . 0.0 111.582 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -125.69 101.17 6.75 Favored 'General case' 0 C--N 1.294 -1.81 0 C-N-CA 123.871 0.868 . . . . 0.0 108.898 173.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 50.7 mtt180 57.63 37.8 27.55 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 123.385 0.428 . . . . 0.0 111.174 171.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.27 -6.06 71.68 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 120.733 -0.746 . . . . 0.0 113.982 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.56 123.8 43.76 Favored 'General case' 0 CA--C 1.498 -1.049 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . 0.258 0.5 OUTLIER -107.62 131.28 54.54 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -174.102 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.7 m -105.14 144.51 31.83 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.386 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -85.9 147.55 26.2 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -178.884 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HB2' ' CE2' ' A' ' 90' ' ' PHE . . . -150.55 154.58 37.83 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-O 121.528 0.68 . . . . 0.0 110.672 -175.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -114.99 126.81 55.19 Favored 'General case' 0 C--N 1.272 -2.77 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -176.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.521 ' HA ' HG12 ' A' ' 88' ' ' VAL . 32.0 mt -61.26 120.44 7.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -176.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -95.4 -43.9 7.79 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 123.927 0.891 . . . . 0.0 110.08 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 31.1 m -140.63 146.12 37.52 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -178.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 93.8 t -121.6 114.99 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.391 0 O-C-N 123.603 0.564 . . . . 0.0 109.599 177.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 14.9 mmmt -112.35 91.13 3.54 Favored 'General case' 0 C--N 1.275 -2.659 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.748 175.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 12.1 ptt180 -84.09 87.48 7.15 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.52 ' H ' HD23 ' A' ' 32' ' ' LEU . 2.4 pt? -91.15 111.23 22.62 Favored 'General case' 0 N--CA 1.417 -2.088 0 CA-C-N 114.658 -1.155 . . . . 0.0 109.564 -174.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 43.5 t -86.62 114.63 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.026 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.467 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 14.5 mmmm -80.05 99.49 7.71 Favored 'General case' 0 N--CA 1.413 -2.304 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 176.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.8 t -89.38 129.35 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.071 0 CA-C-N 114.377 -1.283 . . . . 0.0 108.286 -175.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 83.8 tttt -91.52 103.13 15.78 Favored 'General case' 0 N--CA 1.413 -2.32 0 N-CA-C 105.87 -1.9 . . . . 0.0 105.87 176.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.424 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 3.7 m -112.6 155.19 13.91 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.846 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.786 -177.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.494 ' HA ' ' O ' ' A' ' 44' ' ' THR . 8.4 tt -129.14 118.31 22.24 Favored 'General case' 0 N--CA 1.387 -3.625 0 CA-C-N 114.445 -1.252 . . . . 0.0 107.638 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.711 HD23 ' HB2' ' A' ' 75' ' ' ALA . 86.5 mt -68.79 122.56 18.84 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.95 -177.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.508 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 21.7 ptmt -59.94 -29.54 68.47 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 120.903 0.382 . . . . 0.0 111.415 -178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -59.84 -55.17 37.51 Favored 'General case' 0 N--CA 1.435 -1.187 0 C-N-CA 124.606 1.162 . . . . 0.0 113.226 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -120.23 -0.08 10.54 Favored 'General case' 0 C--N 1.313 -1.021 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.442 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 68.35 23.73 7.54 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 124.167 0.987 . . . . 0.0 112.334 -176.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.494 ' O ' ' HA ' ' A' ' 38' ' ' LEU . 0.5 OUTLIER -78.73 133.3 37.16 Favored 'General case' 0 N--CA 1.423 -1.805 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.608 -179.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.4 m -106.37 148.18 28.37 Favored 'General case' 0 C--N 1.288 -2.077 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.489 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 2.6 pt20 -159.72 160.07 33.62 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 123.031 0.207 . . . . 0.0 110.444 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.4 mt -115.8 102.17 9.47 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 34' ' ' LYS . 27.9 m -124.28 170.13 14.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.088 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -177.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.459 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 11.3 pt20 -91.26 170.78 9.71 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 119.652 -0.819 . . . . 0.0 112.956 -175.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -55.96 -21.08 18.93 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 126.097 1.759 . . . . 0.0 112.151 -178.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -78.18 -35.39 48.78 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.307 0.575 . . . . 0.0 109.942 -177.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -82.67 -15.14 53.12 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.081 -176.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.9 t -109.17 135.17 48.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.162 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.451 ' HD2' ' HB2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -125.46 139.75 53.37 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 172.64 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.94 -166.93 13.94 Favored Glycine 0 C--N 1.31 -0.867 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.57 132.34 10.97 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.77 2.313 . . . . 0.0 113.086 -179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.38 81.99 6.53 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.553 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 8.8 tpt180 -140.49 135.95 32.46 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.64 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.6 t -63.24 116.28 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.74 2.77 46.43 Favored Glycine 0 N--CA 1.43 -1.705 0 CA-C-N 115.666 -0.697 . . . . 0.0 112.238 -179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.35 149.44 22.1 Favored 'General case' 0 CA--C 1.5 -0.948 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 179.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.417 HG12 HG13 ' A' ' 76' ' ' ILE . 49.5 mt -95.69 117.12 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.684 0 CA-C-O 121.882 0.849 . . . . 0.0 109.961 177.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.423 ' HB ' ' O ' ' A' ' 54' ' ' LYS . 16.4 m -116.84 -172.46 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.278 -2.523 0 CA-C-N 114.392 -1.276 . . . . 0.0 108.273 178.456 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 72' ' ' PHE . 40.3 mt-10 -129.01 124.27 34.53 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 174.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 38.0 m -112.66 144.95 41.3 Favored 'General case' 0 N--CA 1.385 -3.678 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -74.05 117.69 16.14 Favored 'General case' 0 C--N 1.292 -1.929 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 15.3 t -89.06 -179.8 5.99 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 21.1 t -60.35 -29.86 69.17 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.218 1.007 . . . . 0.0 111.478 -176.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -64.98 -25.18 67.76 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.845 178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 111.56 -20.58 22.64 Favored Glycine 0 CA--C 1.505 -0.552 0 C-N-CA 120.765 -0.731 . . . . 0.0 111.625 -179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.2 p -89.4 164.03 15.04 Favored 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 123.069 0.548 . . . . 0.0 111.052 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.479 ' HB3' ' HB3' ' A' ' 64' ' ' GLU . 96.5 m-85 -96.05 123.31 39.61 Favored 'General case' 0 C--N 1.311 -1.107 0 C-N-CA 122.854 0.461 . . . . 0.0 110.746 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -114.03 150.86 33.3 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.508 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 45.6 mt-10 -68.87 127.73 34.15 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-O 122.113 0.959 . . . . 0.0 111.897 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.711 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -135.84 161.49 35.47 Favored 'General case' 0 C--N 1.273 -2.722 0 CA-C-N 113.918 -1.492 . . . . 0.0 109.85 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.417 HG13 HG12 ' A' ' 62' ' ' ILE . 3.8 mp -116.89 139.49 43.57 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -73.05 124.45 30.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.9 176.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.7 t -103.9 -26.24 12.74 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.434 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.502 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 23.0 tptm -167.57 159.21 11.92 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 -177.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.3 mp -135.01 141.43 46.19 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 172.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.467 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 5.0 m -127.58 104.13 7.71 Favored 'General case' 0 C--N 1.278 -2.529 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -74.93 133.23 41.81 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.713 0.768 . . . . 0.0 111.591 -177.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -137.19 160.25 39.55 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 177.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 2.9 p -153.89 121.83 6.02 Favored 'General case' 0 C--N 1.289 -2.037 0 C-N-CA 119.896 -0.721 . . . . 0.0 112.465 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.424 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 57.7 m95 -95.55 122.05 37.88 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.973 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 92.8 m-85 -109.35 109.43 20.31 Favored 'General case' 0 N--CA 1.407 -2.599 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 176.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 73.0 m -85.17 104.18 14.81 Favored 'General case' 0 N--CA 1.406 -2.667 0 N-CA-C 105.962 -1.866 . . . . 0.0 105.962 174.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 26' ' ' ILE . 28.5 m -106.2 141.46 21.42 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 CA-C-N 114.784 -1.098 . . . . 0.0 108.868 -176.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.27 130.41 59.47 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.504 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.022 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.457 ' CE2' ' HB2' ' A' ' 24' ' ' ALA . 52.0 m-85 -91.02 167.89 12.06 Favored 'General case' 0 C--N 1.269 -2.915 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -62.18 -19.66 63.33 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-O 122.007 0.908 . . . . 0.0 109.993 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.16 -11.36 48.91 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.258 -1.337 . . . . 0.0 111.462 176.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 82.83 -3.78 82.23 Favored Glycine 0 C--O 1.227 -0.336 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -96.18 142.48 28.3 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -117.14 143.9 45.31 Favored 'General case' 0 C--N 1.285 -2.235 0 O-C-N 123.442 0.464 . . . . 0.0 110.994 -174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 12.1 tpp180 -129.61 143.8 50.99 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 108.083 -1.081 . . . . 0.0 108.083 -179.497 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.424 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 85.7 m -104.16 113.05 26.33 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 177.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 102' ' ' SER . 0.0 OUTLIER -133.91 163.47 29.45 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.571 0.748 . . . . 0.0 112.109 -177.314 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -99.36 177.56 5.15 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 122.821 0.448 . . . . 0.0 110.013 175.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 34.0 mtt180 -60.9 -33.03 72.5 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.064 0.546 . . . . 0.0 111.428 -175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 8.4 m -57.86 -32.29 67.51 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 123.736 0.814 . . . . 0.0 110.921 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 98' ' ' LEU . 17.5 m -91.45 7.4 41.39 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.019 -176.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 75.9 mt -103.7 170.48 7.91 Favored 'General case' 0 N--CA 1.425 -1.709 0 CA-C-O 121.554 0.692 . . . . 0.0 111.321 -175.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.464 ' HB3' ' HB2' ' A' ' 14' ' ' SER . 53.1 t -116.66 -19.62 9.9 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-N 114.123 -1.398 . . . . 0.0 109.664 176.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.1 tm? 62.7 -81.39 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 -173.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -148.69 138.9 22.4 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 125.557 1.543 . . . . 0.0 107.209 174.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 166.45 157.52 10.35 Favored Glycine 0 N--CA 1.423 -2.183 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -179.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -107.78 -54.45 2.49 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -118.6 -8.93 10.35 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 121.317 0.58 . . . . 0.0 110.259 174.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.518 ' CB ' ' HB3' ' A' ' 113' ' ' GLU . 33.2 m170 -102.26 153.25 20.15 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 177.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.45 ' CD2' ' HE3' ' A' ' 16' ' ' LYS . 48.7 m-85 -114.42 109.36 18.19 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 58.88 74.79 0.42 Allowed 'General case' 0 CA--C 1.503 -0.86 0 C-N-CA 124.374 1.07 . . . . 0.0 108.685 -174.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.518 ' HB3' ' CB ' ' A' ' 110' ' ' HIS . 15.0 pt-20 -83.14 120.12 25.37 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -171.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.4 m -114.63 136.53 52.94 Favored 'General case' 0 N--CA 1.418 -2.066 0 N-CA-C 105.598 -2.001 . . . . 0.0 105.598 173.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 70.21 178.93 0.25 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 121.554 0.693 . . . . 0.0 111.568 -178.772 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.2 p -108.63 24.97 12.29 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -80.24 117.13 20.75 Favored 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 120.458 -0.497 . . . . 0.0 111.708 -179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.6 t70 . . . . . 0 C--N 1.31 -1.151 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 175.407 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.659 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -73.28 -55.14 6.82 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -75.2 122.82 88.18 Favored Pre-proline 0 N--CA 1.434 -1.227 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.093 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -91.14 38.32 0.31 Allowed 'Trans proline' 0 N--CA 1.438 -1.766 0 C-N-CA 122.728 2.285 . . . . 0.0 108.939 172.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -60.02 -39.55 86.24 Favored 'General case' 0 CA--C 1.507 -0.683 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.704 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.442 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 45.7 p90 -153.22 150.1 28.66 Favored 'General case' 0 N--CA 1.412 -2.374 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 173.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.438 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 90.2 mt -99.84 175.25 5.85 Favored 'General case' 0 C--N 1.282 -2.347 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.9 p -122.17 161.21 23.58 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-O 120.614 0.245 . . . . 0.0 111.521 -175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.0 p -67.57 144.05 14.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.521 -176.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.35 -25.97 26.32 Favored Glycine 0 N--CA 1.441 -1.005 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.653 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.573 ' HB ' HD12 ' A' ' 26' ' ' ILE . 9.7 m -58.08 133.23 55.37 Favored 'General case' 0 N--CA 1.424 -1.761 0 CA-C-O 122.162 0.982 . . . . 0.0 112.65 -176.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.423 ' HB3' ' NZ ' ' A' ' 106' ' ' LYS . 18.8 t70 -84.49 113.91 21.55 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 113.491 -1.686 . . . . 0.0 109.165 177.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.1 m -133.48 -177.81 2.31 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.455 -174.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.3 m -140.11 147.22 39.91 Favored 'General case' 0 C--N 1.281 -2.383 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 173.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -126.16 131.69 51.98 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 -179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 22.3 pttp -82.51 133.35 35.2 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -112.92 112.58 24.16 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 170.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 61.09 31.06 19.76 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.343 0.592 . . . . 0.0 110.897 174.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.33 -8.45 72.2 Favored Glycine 0 CA--C 1.526 0.751 0 CA-C-N 115.885 -0.598 . . . . 0.0 114.192 179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -108.76 124.44 50.59 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 117.537 0.669 . . . . 0.0 110.126 -179.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.565 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 73.7 m-85 -87.99 120.47 29.37 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -174.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -99.82 143.74 29.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 172.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -75.25 148.52 39.37 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.719 -176.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.675 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -154.34 143.66 21.34 Favored 'General case' 0 N--CA 1.419 -2.01 0 CA-C-O 121.449 0.643 . . . . 0.0 111.227 -175.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -115.73 128.29 55.76 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.573 HD12 ' HB ' ' A' ' 11' ' ' THR . 17.6 mt -68.94 113.82 5.08 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 120.716 0.293 . . . . 0.0 111.554 -176.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HD2' ' HB ' ' A' ' 89' ' ' VAL . 43.9 mtpt -88.17 -38.09 15.61 Favored 'General case' 0 CA--C 1.491 -1.314 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 48.8 m -146.54 141.95 27.53 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.067 -175.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 92.7 t -122.37 131.06 73.97 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 176.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -123.79 97.82 5.54 Favored 'General case' 0 C--N 1.277 -2.578 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 174.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.3 ptp180 -78.63 86.52 4.61 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.684 1.23 . . . . 0.0 108.607 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.475 ' HA ' ' OD1' ' A' ' 50' ' ' ASP . 2.0 pt? -107.29 134.47 50.32 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.967 -177.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.3 t -108.06 132.27 56.22 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.971 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 178.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -86.04 101.53 13.01 Favored 'General case' 0 N--CA 1.428 -1.559 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 176.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.49 HG12 HG13 ' A' ' 37' ' ' VAL . 11.5 t -91.78 127.08 44.3 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.701 0 CA-C-N 114.759 -1.11 . . . . 0.0 108.836 -174.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -92.21 106.94 18.84 Favored 'General case' 0 N--CA 1.423 -1.794 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.498 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 2.4 m -114.79 143.71 23.93 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.96 0 CA-C-O 121.682 0.753 . . . . 0.0 112.022 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 30.1 tp -111.14 118.02 34.83 Favored 'General case' 0 C--N 1.276 -2.594 0 CA-C-N 113.7 -1.591 . . . . 0.0 107.639 176.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.736 HD23 ' HB2' ' A' ' 75' ' ' ALA . 94.3 mt -67.29 111.37 3.96 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 177.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.428 ' HB3' HD11 ' A' ' 76' ' ' ILE . 0.0 OUTLIER -73.25 -15.2 61.43 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.183 0.516 . . . . 0.0 112.214 -176.734 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -88.76 -51.09 5.84 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.654 0.74 . . . . 0.0 109.621 177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 43' ' ' ASN . 15.0 t70 -89.98 -33.12 16.5 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.617 -1.174 . . . . 0.0 112.445 -170.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 35.3 m-80 83.64 15.89 0.28 Allowed 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.101 1.36 . . . . 0.0 113.402 -179.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.56 ' OG1' HD12 ' A' ' 39' ' ' LEU . 1.0 OUTLIER -95.85 150.52 20.33 Favored 'General case' 0 C--N 1.306 -1.317 0 CA-C-O 120.91 0.386 . . . . 0.0 110.368 174.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -118.03 144.83 45.25 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -151.4 157.84 42.94 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.939 176.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.3 tp -119.36 101.48 7.99 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 -179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 29.1 m -126.62 175.53 8.5 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.48 -170.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -88.57 154.23 20.5 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.151 -0.619 . . . . 0.0 110.426 -177.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.475 ' OD1' ' HA ' ' A' ' 32' ' ' LEU . 6.4 p-10 -65.88 -12.98 58.68 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 124.061 0.944 . . . . 0.0 111.507 -176.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -71.83 -28.89 63.88 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.664 0.745 . . . . 0.0 109.68 -176.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.43 ' OE1' ' HD3' ' A' ' 66' ' ' ARG . 43.3 mt-30 -108.24 8.94 28.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.979 0.895 . . . . 0.0 109.333 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.444 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 78.4 t -108.03 110.06 30.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.909 176.09 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.27 103.58 16.22 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.024 -178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.531 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 145.1 -171.36 26.25 Favored Glycine 0 C--N 1.292 -1.88 0 CA-C-N 115.583 -0.735 . . . . 0.0 112.339 177.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -78.81 144.28 19.15 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 123.209 2.606 . . . . 0.0 113.194 -177.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -93.22 82.36 4.52 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.49 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 50.6 mtm180 -139.5 131.89 28.49 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.771 177.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.6 t -65.53 117.95 7.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.148 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 98.06 10.75 51.3 Favored Glycine 0 C--N 1.299 -1.477 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.291 -175.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.434 ' HB3' HD13 ' A' ' 77' ' ' ILE . . . -97.85 162.46 13.24 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-N 117.313 0.556 . . . . 0.0 110.062 177.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 50.8 mm -102.54 121.53 53.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 O-C-N 123.559 0.537 . . . . 0.0 110.113 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.531 HG12 ' HA3' ' A' ' 55' ' ' GLY . 29.9 m -130.12 177.2 7.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.039 -179.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -126.22 121.68 33.42 Favored 'General case' 0 C--N 1.292 -1.934 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.444 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 7.9 t -122.21 154.67 37.19 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-O 121.151 0.5 . . . . 0.0 111.067 -173.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.43 ' HD3' ' OE1' ' A' ' 52' ' ' GLN . 34.8 ttt180 -85.4 132.09 34.29 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.375 177.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 18.9 p -95.74 163.78 13.04 Favored 'General case' 0 N--CA 1.418 -2.06 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 171.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.5 m -57.18 -23.68 49.23 Favored 'General case' 0 CA--C 1.551 0.985 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -175.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -80.5 -3.22 49.22 Favored 'General case' 0 C--N 1.318 -0.78 0 O-C-N 122.247 -0.283 . . . . 0.0 111.599 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.416 ' HA2' ' HE ' ' A' ' 66' ' ' ARG . . . 95.52 6.19 59.85 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.471 -0.871 . . . . 0.0 113.9 175.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 21.2 m -97.59 152.37 19.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 122.504 -0.409 . . . . 0.0 110.48 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.444 ' HA ' ' O ' ' A' ' 65' ' ' THR . 56.0 m-85 -110.88 121.01 44.28 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -128.39 153.7 46.78 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 116.253 -0.43 . . . . 0.0 109.918 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -73.52 127.88 33.95 Favored 'General case' 0 C--O 1.256 1.444 0 CA-C-O 121.716 0.769 . . . . 0.0 110.788 -176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.736 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -135.73 168.54 19.09 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.851 -1.068 . . . . 0.0 112.177 -175.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.428 HD11 ' HB3' ' A' ' 40' ' ' LYS . 8.9 mt -118.01 145.84 23.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 175.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.49 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.2 mp -77.98 115.13 19.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 175.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 20.2 m -97.93 -17.31 19.3 Favored 'General case' 0 C--N 1.294 -1.839 0 CA-C-O 121.025 0.44 . . . . 0.0 109.964 177.669 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -169.64 156.73 6.67 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -140.65 111.18 6.8 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-O 121.799 0.809 . . . . 0.0 110.588 173.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.7 m -103.28 108.06 19.13 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.871 -1.058 . . . . 0.0 108.787 -178.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -67.67 135.09 52.26 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -175.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -113.4 -63.84 1.39 Allowed 'General case' 0 C--N 1.309 -1.18 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.8 m 58.49 112.3 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 21.2 m95 -102.7 141.6 35.25 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.009 -0.996 . . . . 0.0 110.498 179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.442 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 50.6 m-85 -127.79 106.83 9.39 Favored 'General case' 0 N--CA 1.434 -1.254 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -179.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 54.1 m -87.15 107.81 18.63 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 177.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.675 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 23.6 m -112.06 147.56 15.81 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.096 -173.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.501 ' HB ' ' HD2' ' A' ' 27' ' ' LYS . 7.2 p -105.09 125.08 60.16 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 123.687 0.795 . . . . 0.0 109.887 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.457 ' CE1' HG23 ' A' ' 88' ' ' VAL . 57.3 m-85 -92.79 -176.86 4.36 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.295 -174.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -47.61 -41.59 22.2 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 125.145 1.378 . . . . 0.0 112.664 -177.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -75.08 -16.72 60.55 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.099 0.476 . . . . 0.0 111.893 -175.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.58 5.74 56.67 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.643 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -96.61 149.92 21.24 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -114.5 144.12 43.86 Favored 'General case' 0 C--O 1.253 1.287 0 CA-C-O 121.474 0.655 . . . . 0.0 112.177 -175.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 50.4 mmt-85 -136.77 151.27 49.0 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.027 -0.988 . . . . 0.0 108.466 175.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 63.5 m -99.42 109.27 21.87 Favored 'General case' 0 N--CA 1.422 -1.862 0 CA-C-O 121.278 0.561 . . . . 0.0 109.604 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -111.25 159.4 17.95 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.691 -176.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -99.66 161.72 13.44 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 172.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 18.7 ttp85 -61.57 -23.43 65.98 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 112.192 0.442 . . . . 0.0 112.192 -174.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.2 m -59.01 -25.08 63.35 Favored 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 123.556 0.742 . . . . 0.0 110.93 179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.42 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 18.9 m -96.12 -8.24 33.81 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.041 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 9.9 mp -92.9 133.18 36.36 Favored 'General case' 0 CA--C 1.5 -0.978 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 -171.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.488 ' O ' ' HB3' ' A' ' 108' ' ' GLU . 19.3 t -77.1 -48.89 16.57 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-N 112.682 -2.053 . . . . 0.0 110.324 178.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 2.6 tm? 66.03 94.37 0.06 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.853 -1.067 . . . . 0.0 108.135 -172.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.423 ' NZ ' ' HB3' ' A' ' 12' ' ' ASP . 74.3 mmtt 63.24 -95.38 0.05 OUTLIER 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.025 -0.989 . . . . 0.0 112.995 -177.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -138.97 67.38 0.51 Allowed Glycine 0 CA--C 1.485 -1.784 0 C-N-CA 120.018 -1.086 . . . . 0.0 112.527 -176.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 104' ' ' CYS . 21.6 tp10 -127.64 56.43 1.57 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 65.5 mtt180 -75.94 82.37 2.83 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 176.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -130.49 9.41 5.1 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.254 -168.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -126.93 109.7 12.23 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.306 -174.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.59 -38.73 62.55 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 105.727 -1.953 . . . . 0.0 105.727 170.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -137.61 -62.04 0.62 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 105.909 -1.886 . . . . 0.0 105.909 170.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.8 t -179.76 147.73 0.3 Allowed 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 102.162 -3.273 . . . . 0.0 102.162 179.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -80.12 153.15 28.88 Favored 'General case' 0 C--N 1.308 -1.201 0 C-N-CA 119.254 -0.979 . . . . 0.0 110.634 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 73.8 m -61.75 109.31 1.19 Allowed 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 174.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.9 pp -126.1 135.15 51.38 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.069 -179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 . . . . . 0 C--N 1.31 -1.141 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 -179.062 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.193 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -90.71 6.97 41.87 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.438 0.637 . . . . 0.0 110.9 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -104.16 167.83 9.45 Favored Pre-proline 0 C--N 1.303 -1.441 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.565 ' HA ' HG11 ' A' ' 29' ' ' VAL . 52.4 Cg_exo -55.76 99.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.371 1.727 0 C-N-CA 122.817 2.345 . . . . 0.0 111.704 177.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -119.67 -70.23 0.8 Allowed 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.961 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.418 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -74.98 -63.92 1.16 Allowed 'General case' 0 N--CA 1.428 -1.564 0 C-N-CA 119.221 -0.992 . . . . 0.0 108.898 -176.309 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.522 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 48.6 mt -113.18 -174.92 2.55 Favored 'General case' 0 C--O 1.247 0.956 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 15.6 p -131.17 160.63 34.23 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 -171.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -78.81 144.84 10.47 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.49 -6.52 74.72 Favored Glycine 0 N--CA 1.435 -1.37 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.87 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.417 ' HB ' HD12 ' A' ' 26' ' ' ILE . 25.3 m -89.16 133.5 34.38 Favored 'General case' 0 N--CA 1.411 -2.422 0 CA-C-O 120.965 0.412 . . . . 0.0 110.19 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -96.88 124.18 40.79 Favored 'General case' 0 CA--C 1.476 -1.875 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.909 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.482 HG21 ' HB3' ' A' ' 103' ' ' LEU . 28.2 m -131.59 160.77 42.13 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.238 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.216 179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.455 ' OG ' ' HB3' ' A' ' 104' ' ' CYS . 2.4 p -94.58 117.02 29.47 Favored 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 175.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.447 ' HB1' HD12 ' A' ' 98' ' ' LEU . . . -106.52 127.68 53.5 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 115.313 -0.858 . . . . 0.0 109.393 -173.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 22.6 pttp -84.76 134.9 34.31 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-O 121.453 0.644 . . . . 0.0 112.378 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.413 ' CZ ' ' HZ ' ' A' ' 90' ' ' PHE . 80.7 m-85 -132.98 136.23 45.95 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 176.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.4 ' HD3' ' C ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 44.68 26.28 0.18 Allowed 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -176.021 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.05 2.9 64.07 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 120.959 -0.639 . . . . 0.0 114.159 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -129.15 146.35 51.1 Favored 'General case' 0 C--O 1.211 -0.973 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 16' ' ' LYS 0.262 18.4 p90 -106.76 146.41 30.89 Favored 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 116.026 1.862 . . . . 0.0 116.026 -175.467 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 66.1 m -131.53 138.23 48.84 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.973 -1.467 . . . . 0.0 107.745 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 38.2 tt0 -79.92 137.35 36.86 Favored 'General case' 0 N--CA 1.406 -2.649 0 CA-C-O 121.225 0.536 . . . . 0.0 111.297 -178.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.438 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -147.41 158.75 44.1 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.048 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 4.7 ttmp? -106.55 129.26 54.52 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.417 HD12 ' HB ' ' A' ' 11' ' ' THR . 72.1 mt -61.0 117.27 2.49 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-O 121.196 0.522 . . . . 0.0 110.311 179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -99.41 -40.5 7.85 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.983 179.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 3.6 m -127.48 141.83 51.56 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -176.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 4' ' ' PRO . 55.8 t -120.17 124.06 71.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.896 0 C-N-CA 123.179 0.592 . . . . 0.0 109.601 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.46 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 46.9 tptt -131.4 90.62 2.89 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 63.9 ttt180 -83.54 92.43 7.62 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 117.766 -1.574 . . . . 0.0 108.211 177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.542 ' H ' HD23 ' A' ' 32' ' ' LEU . 2.3 pt? -112.33 133.97 54.13 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.278 0.561 . . . . 0.0 109.869 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.7 t -96.6 123.09 48.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.429 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 81.1 mttt -96.03 109.91 22.23 Favored 'General case' 0 N--CA 1.423 -1.824 0 CA-C-O 122.086 0.946 . . . . 0.0 109.225 176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.487 HG12 HG13 ' A' ' 37' ' ' VAL . 21.4 t -94.59 129.26 45.05 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.752 0 CA-C-N 113.964 -1.471 . . . . 0.0 110.323 -172.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 83.6 tttt -88.89 105.84 18.01 Favored 'General case' 0 N--CA 1.424 -1.767 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 175.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.537 HG21 HG21 ' A' ' 65' ' ' THR . 0.4 OUTLIER -113.27 143.93 21.95 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.279 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.359 -177.821 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 4.7 tt -108.6 115.01 29.29 Favored 'General case' 0 C--N 1.266 -3.033 0 N-CA-C 105.099 -2.186 . . . . 0.0 105.099 177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.541 HD12 ' H ' ' A' ' 42' ' ' ASP . 0.4 OUTLIER -66.67 118.19 9.89 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 -174.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -64.53 -43.43 94.02 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 124.65 1.18 . . . . 0.0 113.221 -171.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -88.42 -25.34 22.71 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-O 121.571 0.701 . . . . 0.0 111.717 -174.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.541 ' H ' HD12 ' A' ' 39' ' ' LEU . 18.0 t70 -98.55 -32.01 11.67 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.565 -175.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 76.78 21.87 1.18 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.7 p -102.45 149.61 24.21 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 173.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.449 HG21 ' HE2' ' A' ' 36' ' ' LYS . 2.2 m -101.58 138.68 38.26 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 176.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -140.16 144.86 36.87 Favored 'General case' 0 C--N 1.275 -2.667 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.487 HD12 ' HB2' ' A' ' 36' ' ' LYS . 10.5 tt -124.92 106.67 10.16 Favored 'General case' 0 C--N 1.285 -2.2 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 12.9 m -135.68 -178.02 2.26 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.336 0 CA-C-N 114.839 -1.073 . . . . 0.0 110.517 -173.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.415 ' HB2' ' HG2' ' A' ' 52' ' ' GLN . 3.0 mt-30 -64.51 150.59 46.4 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.09 -18.29 63.25 Favored 'General case' 0 C--O 1.204 -1.295 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.275 171.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.48 -24.41 61.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.5 175.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.416 ' O ' ' HA ' ' A' ' 65' ' ' THR . 12.3 mm100 -85.54 -19.05 31.71 Favored 'General case' 0 CA--C 1.51 -0.571 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 176.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.2 t -91.5 112.12 24.96 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.228 0 CA-C-N 114.59 -1.186 . . . . 0.0 111.659 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -97.82 98.47 9.86 Favored 'General case' 0 C--N 1.27 -2.862 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.98 175.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.442 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 150.51 179.11 26.01 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-N 114.885 -1.052 . . . . 0.0 111.596 178.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.53 141.26 72.84 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 123.242 2.628 . . . . 0.0 114.246 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 69.5 mt -87.96 81.97 7.36 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.473 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 97.5 mtt180 -139.57 132.98 30.11 Favored 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 114.748 -1.114 . . . . 0.0 109.02 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 37.9 t -72.69 110.31 5.71 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 CA-C-O 121.543 0.687 . . . . 0.0 109.538 -176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 109.97 7.19 27.44 Favored Glycine 0 N--CA 1.428 -1.858 0 CA-C-N 114.863 -1.062 . . . . 0.0 112.364 -176.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -93.54 147.46 22.97 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 119.426 -0.91 . . . . 0.0 111.258 -178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.404 HD13 HG13 ' A' ' 76' ' ' ILE . 48.3 mm -86.07 117.0 29.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.442 HG12 ' HA3' ' A' ' 55' ' ' GLY . 27.5 m -130.76 179.04 4.63 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.939 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -121.23 125.92 48.31 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.537 HG21 HG21 ' A' ' 37' ' ' VAL . 14.5 t -132.48 159.6 38.88 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -76.05 114.19 14.41 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 123.606 0.566 . . . . 0.0 109.853 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.525 HG22 ' O ' ' A' ' 71' ' ' SER . 9.2 t -85.38 -179.47 6.96 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.357 -178.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.7 m -64.9 -18.1 64.9 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 124.629 1.172 . . . . 0.0 111.038 -178.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.419 ' H ' HG23 ' A' ' 67' ' ' THR . 31.4 t70 -75.69 -21.51 57.53 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.448 177.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 100.61 -14.85 58.99 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.459 -0.656 . . . . 0.0 111.459 -178.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 67' ' ' THR . 21.3 m -90.88 159.77 16.06 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -92.33 127.42 37.81 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -140.24 165.21 28.0 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.41 ' O ' HD13 ' A' ' 39' ' ' LEU . 60.3 mt-10 -67.72 136.47 54.33 Favored 'General case' 0 CA--C 1.503 -0.84 0 CA-C-O 121.108 0.48 . . . . 0.0 111.91 -175.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.498 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -145.62 164.6 31.2 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.199 -0.91 . . . . 0.0 109.8 177.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.404 HG13 HD13 ' A' ' 62' ' ' ILE . 3.1 mp -118.51 136.45 55.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 177.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.473 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -69.71 122.61 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 176.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 23.2 m -111.14 -17.03 13.32 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.212 0.529 . . . . 0.0 110.68 177.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 65.1 tttp -166.55 143.43 4.91 Favored 'General case' 0 C--O 1.211 -0.954 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 178.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.78 111.58 13.81 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.502 0.668 . . . . 0.0 109.705 172.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.4 m -103.56 127.8 50.91 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 115.178 -0.919 . . . . 0.0 110.93 -169.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -78.75 103.22 8.55 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 175.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.53 -64.06 1.22 Allowed 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 178.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.419 ' HB3' ' CE2' ' A' ' 86' ' ' TYR . 44.0 m 55.81 100.86 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.408 -1.269 . . . . 0.0 113.302 -178.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.536 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 34.5 m95 -90.04 132.62 35.29 Favored 'General case' 0 CA--C 1.498 -1.03 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.799 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.588 ' HB2' HD11 ' A' ' 103' ' ' LEU . 97.6 m-85 -128.27 112.61 14.67 Favored 'General case' 0 C--N 1.289 -2.065 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.811 176.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 97' ' ' THR . 26.1 m -84.81 107.15 16.83 Favored 'General case' 0 N--CA 1.39 -3.469 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 95' ' ' GLU . 17.2 m -105.63 141.43 20.97 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.466 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.195 -177.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.6 p -114.71 132.13 64.8 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.837 -176.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.438 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 76.3 m-85 -86.35 166.32 15.69 Favored 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -64.24 -21.86 66.74 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 122.283 1.039 . . . . 0.0 108.588 174.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -65.67 -17.27 64.48 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 113.765 -1.561 . . . . 0.0 111.06 175.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 94.93 0.16 64.1 Favored Glycine 0 C--O 1.218 -0.876 0 C-N-CA 121.254 -0.498 . . . . 0.0 113.156 176.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -96.88 144.61 26.66 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 9.3 pt-20 -122.27 133.31 54.69 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.066 0.46 . . . . 0.0 111.088 -179.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -129.67 142.18 50.78 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 31.9 m -105.47 111.41 24.11 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-O 120.769 0.318 . . . . 0.0 110.913 -177.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.447 HD12 ' HB1' ' A' ' 15' ' ' ALA . 25.2 mt -118.62 171.77 7.96 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 -178.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -79.73 162.54 25.11 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 174.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 13.6 ptt180 -56.73 -30.12 63.21 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-O 121.153 0.502 . . . . 0.0 111.209 177.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.6 p -81.27 -2.66 49.78 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 123.809 0.844 . . . . 0.0 112.641 -175.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 98' ' ' LEU . 27.6 t -107.34 9.66 29.85 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.588 HD11 ' HB2' ' A' ' 86' ' ' TYR . 70.8 mt -122.27 134.92 54.67 Favored 'General case' 0 N--CA 1.423 -1.801 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.455 ' HB3' ' OG ' ' A' ' 14' ' ' SER . 47.0 t -86.52 82.6 7.87 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -175.158 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 67.8 mt -115.52 -64.87 1.25 Allowed 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 162.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.6 mttp -118.59 138.52 52.51 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.325 176.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 160.18 -41.77 0.45 Allowed Glycine 0 C--N 1.307 -1.051 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 67.39 -68.91 0.14 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 125.374 1.47 . . . . 0.0 114.713 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 31.3 ptt180 -53.66 96.62 0.01 OUTLIER 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 114.382 1.253 . . . . 0.0 114.382 -173.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 12.1 t-80 73.51 19.72 3.3 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 124.991 1.317 . . . . 0.0 111.101 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.434 ' HB3' ' SG ' ' A' ' 104' ' ' CYS . 95.5 m-85 -106.16 164.38 12.04 Favored 'General case' 0 C--N 1.311 -1.104 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 175.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . 71.49 -71.73 0.13 Allowed 'General case' 0 C--O 1.245 0.824 0 C-N-CA 125.774 1.63 . . . . 0.0 113.729 175.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -137.21 153.99 50.29 Favored 'General case' 0 N--CA 1.418 -2.032 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -173.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 28.4 t 74.01 102.48 0.07 Allowed 'General case' 0 C--O 1.242 0.686 0 C-N-CA 125.004 1.322 . . . . 0.0 110.627 -178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 116' ' ' THR . 0.2 OUTLIER -158.12 -179.54 8.22 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 102.349 -3.204 . . . . 0.0 102.349 -178.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.454 ' H ' ' CD ' ' A' ' 115' ' ' GLU . 10.7 m -56.94 113.81 1.84 Allowed 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -67.68 -57.26 6.68 Favored 'General case' 0 C--O 1.242 0.686 0 CA-C-O 120.671 0.272 . . . . 0.0 110.485 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 27.3 t70 . . . . . 0 C--N 1.312 -1.035 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.965 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 120.943 0.401 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -90.87 34.54 0.91 Allowed 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 -179.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -51.7 114.14 4.86 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 125.937 1.695 . . . . 0.0 112.733 -173.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -77.26 29.35 0.42 Allowed 'Trans proline' 0 N--CA 1.48 0.705 0 C-N-CA 123.683 2.922 . . . . 0.0 112.908 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -72.27 -33.49 67.5 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 177.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.642 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 24.2 p90 -122.8 113.26 18.92 Favored 'General case' 0 N--CA 1.407 -2.583 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 87.6 mt -98.44 178.41 5.04 Favored 'General case' 0 C--N 1.287 -2.15 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.738 -178.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 17.7 p -134.96 169.27 17.66 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.379 -176.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 85.0 t -64.55 123.26 17.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 C-N-CA 122.776 0.43 . . . . 0.0 111.09 -177.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.0 -33.64 3.01 Favored Glycine 0 N--CA 1.436 -1.348 0 C-N-CA 120.606 -0.807 . . . . 0.0 112.447 179.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.576 ' HB ' HD12 ' A' ' 26' ' ' ILE . 15.6 m -59.41 138.64 57.59 Favored 'General case' 0 N--CA 1.438 -1.07 0 C-N-CA 123.176 0.59 . . . . 0.0 111.332 -177.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -100.53 116.83 33.39 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.5 m -128.43 -179.46 3.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.609 0 C-N-CA 122.871 0.468 . . . . 0.0 110.396 -175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.455 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 16.8 m -129.23 137.28 51.01 Favored 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.486 ' CB ' HD11 ' A' ' 98' ' ' LEU . . . -107.27 128.53 54.52 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -85.72 120.14 26.82 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 120.85 0.357 . . . . 0.0 111.144 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -125.88 109.91 13.04 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 176.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 72.1 mtp180 61.86 26.77 16.25 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.831 0.852 . . . . 0.0 112.557 172.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.73 25.39 42.12 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.36 -0.924 . . . . 0.0 111.921 -177.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -132.52 144.78 50.66 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 175.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -106.61 120.1 41.06 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-O 121.353 0.597 . . . . 0.0 111.117 -179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 62.6 m -103.73 128.73 51.07 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 175.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 9.8 pt-20 -93.62 140.49 29.56 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 118.536 -1.265 . . . . 0.0 109.852 -177.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.513 ' HB2' ' CE1' ' A' ' 90' ' ' PHE . . . -145.47 156.68 43.89 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.319 -173.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -112.23 132.78 54.73 Favored 'General case' 0 C--N 1.266 -3.029 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.576 HD12 ' HB ' ' A' ' 11' ' ' THR . 43.2 mt -59.41 121.81 7.98 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.332 0.587 . . . . 0.0 111.907 -176.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -97.31 -46.97 5.9 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 125.025 1.33 . . . . 0.0 109.994 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 16.6 m -137.77 146.18 43.3 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.412 HG12 ' HG3' ' A' ' 31' ' ' ARG . 98.4 t -131.16 124.24 55.15 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.262 0 N-CA-C 109.346 -0.613 . . . . 0.0 109.346 176.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -110.75 91.07 3.52 Favored 'General case' 0 C--N 1.271 -2.824 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 173.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.412 ' HG3' HG12 ' A' ' 29' ' ' VAL . 48.3 mtm180 -78.15 122.9 26.25 Favored 'General case' 0 CA--C 1.484 -1.575 0 CA-C-O 121.974 0.892 . . . . 0.0 111.515 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.506 HD23 ' HA ' ' A' ' 84' ' ' SER . 1.8 pt? -155.7 148.56 24.26 Favored 'General case' 0 N--CA 1.402 -2.862 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 175.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 p -135.75 143.91 35.09 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.943 0 N-CA-C 104.34 -2.467 . . . . 0.0 104.34 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.584 ' HB2' ' HB ' ' A' ' 81' ' ' THR . 94.4 mttt -85.05 101.19 12.21 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.533 HG12 HG13 ' A' ' 37' ' ' VAL . 21.3 t -86.46 118.06 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.52 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.575 -176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -86.55 107.82 18.3 Favored 'General case' 0 N--CA 1.413 -2.286 0 N-CA-C 106.024 -1.843 . . . . 0.0 106.024 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.567 HG21 HG21 ' A' ' 65' ' ' THR . 3.7 m -112.53 150.03 14.86 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.199 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 6.5 tt -126.53 117.66 23.31 Favored 'General case' 0 C--N 1.26 -3.314 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 176.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.514 HD23 ' HB2' ' A' ' 75' ' ' ALA . 20.3 mt -72.84 106.35 4.75 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -57.96 -34.36 69.85 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 -175.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -72.13 -45.8 59.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-O 120.98 0.419 . . . . 0.0 111.403 -178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -91.84 -8.89 45.3 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.492 -175.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.2 p30 53.31 28.09 6.92 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.302 1.841 . . . . 0.0 113.256 -177.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -104.14 145.74 29.75 Favored 'General case' 0 N--CA 1.434 -1.274 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.309 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.6 m -97.7 154.44 17.58 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -151.15 138.93 19.8 Favored 'General case' 0 N--CA 1.426 -1.631 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 mt -109.72 102.33 11.15 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 174.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.414 HG21 ' OG1' ' A' ' 65' ' ' THR . 27.4 m -116.58 176.43 2.57 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.449 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.29 -174.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -101.56 160.02 14.8 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.4 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -47.18 -33.9 5.75 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 126.405 1.882 . . . . 0.0 112.237 -178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -72.81 -28.76 62.76 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.29 -174.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.431 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 85.6 mt-30 -92.72 -3.53 54.67 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-O 121.548 0.69 . . . . 0.0 109.222 -178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 93.8 t -99.37 123.02 51.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.317 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.076 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -103.46 95.83 6.34 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 175.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.424 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 148.59 -173.82 28.44 Favored Glycine 0 N--CA 1.423 -2.231 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.132 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.416 ' HD2' HG12 ' A' ' 63' ' ' VAL . 11.6 Cg_exo -73.14 148.35 44.24 Favored 'Trans proline' 0 N--CA 1.462 -0.328 0 C-N-CA 123.096 2.531 . . . . 0.0 113.478 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.27 82.64 6.5 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 173.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.445 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 62.8 ttt180 -139.35 119.59 13.72 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 114.731 -1.122 . . . . 0.0 108.818 -174.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 62.1 t -67.66 115.69 6.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 CA-C-O 121.11 0.481 . . . . 0.0 109.862 -178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 104.5 5.51 42.44 Favored Glycine 0 N--CA 1.418 -2.543 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.122 -177.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -98.13 155.78 16.98 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-N 117.413 0.606 . . . . 0.0 110.393 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 48.2 mt -97.24 124.8 50.31 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.961 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.424 HG12 ' HA3' ' A' ' 55' ' ' GLY . 28.0 m -132.18 179.19 4.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -113.49 125.51 54.29 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 173.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.567 HG21 HG21 ' A' ' 37' ' ' VAL . 9.7 t -127.61 152.39 47.72 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-O 120.777 0.323 . . . . 0.0 110.17 -174.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.431 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . 58.2 ttt180 -83.25 123.9 30.05 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.041 -178.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 82.2 p -85.6 177.13 7.83 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -71.33 -20.6 62.16 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-O 121.033 0.444 . . . . 0.0 109.815 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -65.91 -25.0 66.95 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.968 175.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 110.91 -20.27 24.47 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.077 177.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.2 p -92.2 159.43 15.64 Favored 'General case' 0 N--CA 1.427 -1.579 0 CA-C-O 120.942 0.401 . . . . 0.0 110.97 -178.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 65' ' ' THR . 51.1 m-85 -92.73 138.89 31.1 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.013 0.435 . . . . 0.0 110.244 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -132.14 149.73 52.33 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -80.67 129.81 34.74 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.024 0.916 . . . . 0.0 109.741 178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.514 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -142.86 173.38 11.59 Favored 'General case' 0 C--N 1.277 -2.573 0 CA-C-N 114.72 -1.127 . . . . 0.0 111.403 -174.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 37' ' ' VAL . 5.7 mm -110.92 143.94 19.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -79.75 111.26 16.32 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.046 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 173.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.1 m -90.65 -24.77 20.4 Favored 'General case' 0 C--N 1.283 -2.284 0 CA-C-O 120.922 0.391 . . . . 0.0 109.963 179.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -165.17 146.16 7.39 Favored 'General case' 0 C--O 1.211 -0.96 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -120.0 111.23 17.64 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 121.854 0.835 . . . . 0.0 109.119 168.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.584 ' HB ' ' HB2' ' A' ' 34' ' ' LYS . 8.2 m -96.09 126.62 41.45 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -173.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -56.84 141.59 44.1 Favored 'General case' 0 C--N 1.311 -1.096 0 O-C-N 124.323 1.014 . . . . 0.0 112.679 -171.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 32' ' ' LEU . . . -159.82 -144.32 0.11 Allowed 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 178.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.506 ' HA ' HD23 ' A' ' 32' ' ' LEU . 50.5 m 87.63 121.83 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.698 0 C-N-CA 125.396 1.478 . . . . 0.0 111.726 -178.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -99.65 134.06 43.08 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.161 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.642 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 82.2 m-85 -121.2 107.94 13.17 Favored 'General case' 0 N--CA 1.422 -1.872 0 O-C-N 123.753 0.658 . . . . 0.0 109.315 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.454 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 33.3 m -90.08 106.47 18.5 Favored 'General case' 0 N--CA 1.398 -3.073 0 N-CA-C 106.674 -1.602 . . . . 0.0 106.674 176.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.488 HG12 ' HA ' ' A' ' 26' ' ' ILE . 16.2 m -105.74 141.65 20.58 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.292 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.164 -176.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.2 p -111.5 137.95 42.03 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.366 -174.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.513 ' CE1' ' HB2' ' A' ' 24' ' ' ALA . 87.4 m-85 -94.23 163.74 13.32 Favored 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -59.46 -26.74 65.48 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-O 121.615 0.722 . . . . 0.0 111.52 -179.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -65.84 -17.14 64.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.089 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.1 1.92 58.21 Favored Glycine 0 N--CA 1.439 -1.163 0 N-CA-C 111.638 -0.585 . . . . 0.0 111.638 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -87.75 138.31 31.58 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -125.86 133.91 51.8 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.465 0.65 . . . . 0.0 111.048 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.62 142.3 50.26 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.039 -176.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 87' ' ' THR . 43.4 m -104.89 110.16 22.42 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-O 120.846 0.355 . . . . 0.0 110.519 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.486 HD11 ' CB ' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -132.9 170.39 15.4 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.322 -179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 35.4 ptt-85 -98.97 170.6 8.61 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 -58.06 -31.38 67.01 Favored 'General case' 0 C--O 1.216 -0.699 0 C-N-CA 123.699 0.8 . . . . 0.0 111.93 -178.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.3 m -70.91 -9.14 57.19 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 121.498 0.666 . . . . 0.0 111.465 -178.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.477 ' HB2' HD12 ' A' ' 98' ' ' LEU . 21.5 m -109.01 1.22 20.43 Favored 'General case' 0 N--CA 1.42 -1.973 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 177.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.447 ' HA ' ' O ' ' A' ' 14' ' ' SER . 89.6 mt -107.22 129.43 54.87 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.788 -177.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 14.2 t -71.24 -55.73 7.49 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.079 -177.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 53.2 tp 67.95 173.62 0.27 Allowed 'General case' 0 CA--C 1.562 1.409 0 C-N-CA 123.847 0.859 . . . . 0.0 111.797 175.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 27.7 tptp 75.31 -20.74 0.33 Allowed 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.603 1.561 . . . . 0.0 112.94 175.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.13 1.89 59.4 Favored Glycine 0 C--N 1.307 -1.069 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -175.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -86.74 153.73 21.48 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 104.911 -2.255 . . . . 0.0 104.911 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 110' ' ' HIS . 53.0 ttp180 -134.22 87.48 2.37 Favored 'General case' 0 N--CA 1.426 -1.631 0 CA-C-O 120.925 0.393 . . . . 0.0 111.063 -179.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.43 ' HB3' ' O ' ' A' ' 109' ' ' ARG . 4.5 p-80 174.93 -28.59 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.788 0 C-N-CA 125.684 1.594 . . . . 0.0 107.319 172.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER 73.97 -74.74 0.08 Allowed 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.674 1.189 . . . . 0.0 109.42 173.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.83 -62.31 0.1 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -103.33 128.72 50.32 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.558 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 6.0 m -132.57 -52.62 0.94 Allowed 'General case' 0 C--N 1.293 -1.866 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -124.06 -170.62 2.17 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.2 t -77.42 104.61 8.04 Favored 'General case' 0 N--CA 1.433 -1.304 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.1 mp 66.08 -174.23 0.18 Allowed 'General case' 0 C--O 1.243 0.753 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.642 -174.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 . . . . . 0 CA--C 1.485 -1.544 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 -179.166 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.5 0 N-CA-C 110.296 -0.261 . . . . 0.0 110.296 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -76.04 -36.53 59.03 Favored 'General case' 0 CA--C 1.496 -1.098 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -114.5 142.68 28.56 Favored Pre-proline 0 C--N 1.296 -1.738 0 N-CA-C 106.231 -1.766 . . . . 0.0 106.231 173.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.68 106.04 0.3 Allowed 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.463 2.109 . . . . 0.0 111.894 178.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.63 -8.25 54.96 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.956 0.884 . . . . 0.0 109.781 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -154.8 156.69 36.71 Favored 'General case' 0 N--CA 1.404 -2.752 0 N-CA-C 103.884 -2.635 . . . . 0.0 103.884 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 86' ' ' TYR . 29.5 mt -88.49 173.52 8.63 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 32.9 p -123.51 162.1 23.58 Favored 'General case' 0 C--N 1.289 -2.031 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -173.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.2 t -65.61 133.27 30.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.671 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.94 -16.57 42.89 Favored Glycine 0 N--CA 1.428 -1.834 0 C-N-CA 120.346 -0.931 . . . . 0.0 112.944 177.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.619 ' HB ' HD12 ' A' ' 26' ' ' ILE . 13.4 m -66.54 132.08 47.42 Favored 'General case' 0 N--CA 1.431 -1.399 0 CA-C-O 121.02 0.438 . . . . 0.0 110.498 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -96.75 115.36 27.3 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.9 m -128.61 -179.56 3.11 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.079 0 CA-C-O 121.435 0.636 . . . . 0.0 110.361 -174.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 19.4 m -133.43 136.45 45.21 Favored 'General case' 0 C--N 1.281 -2.372 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 175.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 102' ' ' SER . . . -107.18 138.83 42.63 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.7 mtpt -89.91 129.93 36.19 Favored 'General case' 0 N--CA 1.434 -1.246 0 C-N-CA 119.937 -0.705 . . . . 0.0 111.879 179.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -127.7 108.14 10.49 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.344 175.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.501 ' HD2' ' N ' ' A' ' 18' ' ' ARG . 2.9 mpt_? 59.57 32.82 21.84 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 123.67 0.788 . . . . 0.0 111.659 175.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.44 -2.63 68.0 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.557 -0.747 . . . . 0.0 113.787 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.36 147.97 36.66 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 117.184 0.492 . . . . 0.0 109.738 -178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -93.41 138.79 31.38 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-O 121.017 0.437 . . . . 0.0 110.833 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 81.0 m -125.36 128.03 47.53 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 106.051 -1.833 . . . . 0.0 106.051 170.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 6.8 pt-20 -90.08 138.38 31.56 Favored 'General case' 0 C--N 1.317 -0.84 0 C-N-CA 118.417 -1.313 . . . . 0.0 110.771 -173.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.43 ' HB2' ' CD1' ' A' ' 90' ' ' PHE . . . -148.67 151.01 34.2 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.02 -174.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.6 tttp -108.92 128.98 55.4 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.619 HD12 ' HB ' ' A' ' 11' ' ' THR . 19.0 mt -66.63 118.67 10.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-O 120.646 0.26 . . . . 0.0 110.709 -178.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -97.13 -46.85 6.0 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.259 0.552 . . . . 0.0 110.129 177.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.9 m -127.06 139.2 53.17 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -175.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 83.2 t -121.57 107.17 19.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 CA-C-N 114.955 -1.021 . . . . 0.0 109.028 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 84' ' ' SER . 95.5 mttt -99.3 90.49 4.57 Favored 'General case' 0 C--N 1.264 -3.115 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -86.21 108.12 18.21 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.425 ' H ' HD23 ' A' ' 32' ' ' LEU . 1.9 pt? -132.78 129.46 38.61 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 -175.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.542 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 8.5 p -97.39 116.38 39.63 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 C-N-CA 119.179 -1.008 . . . . 0.0 109.826 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 46.6 mtpt -88.92 100.56 13.28 Favored 'General case' 0 N--CA 1.425 -1.702 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.474 HG21 HD12 ' A' ' 57' ' ' LEU . 25.7 t -84.75 137.05 21.52 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.21 0 CA-C-N 113.713 -1.585 . . . . 0.0 109.862 -174.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 39.8 ttmt -91.43 105.43 17.76 Favored 'General case' 0 N--CA 1.423 -1.796 0 N-CA-C 107.159 -1.423 . . . . 0.0 107.159 175.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.56 HG21 HG21 ' A' ' 65' ' ' THR . 3.5 m -112.6 143.13 22.93 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.584 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.328 179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -114.3 118.75 34.78 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.477 HD21 HG21 ' A' ' 67' ' ' THR . 10.4 mp -69.4 122.59 19.25 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.851 -179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.74 -31.43 72.42 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.153 0.501 . . . . 0.0 111.017 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -89.4 -58.82 2.39 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.529 0.68 . . . . 0.0 110.982 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -82.37 -17.37 45.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.599 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 2.5 t30 71.68 7.12 5.87 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-O 122.069 0.937 . . . . 0.0 113.385 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.3 p -86.64 159.75 19.11 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.241 -0.912 . . . . 0.0 110.789 178.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 37' ' ' VAL . 2.6 m -119.4 140.35 50.54 Favored 'General case' 0 N--CA 1.423 -1.824 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.477 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 0.9 OUTLIER -134.09 142.51 47.56 Favored 'General case' 0 C--N 1.281 -2.371 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.44 -179.438 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.4 mt -107.75 101.22 10.53 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.209 -1.774 . . . . 0.0 106.209 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 5.3 m -135.2 149.62 28.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.424 0.631 . . . . 0.0 111.764 -175.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 15.1 pt20 -69.81 160.98 30.73 Favored 'General case' 0 C--N 1.284 -2.273 0 CA-C-N 114.726 -1.125 . . . . 0.0 111.37 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -63.4 -7.2 6.01 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.611 0.764 . . . . 0.0 112.523 -178.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.413 ' HB2' ' HG3' ' A' ' 49' ' ' GLN . 5.4 m-20 -73.58 -34.63 65.2 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 174.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.523 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 25.7 mm-40 -86.33 -28.99 23.35 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.076 -177.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 81.7 t -91.06 121.74 41.74 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.013 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.474 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -105.74 108.73 20.4 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 178.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 140.01 -173.79 22.76 Favored Glycine 0 N--CA 1.43 -1.721 0 C-N-CA 120.571 -0.823 . . . . 0.0 112.059 177.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.9 139.2 46.7 Favored 'Trans proline' 0 N--CA 1.475 0.431 0 C-N-CA 123.139 2.559 . . . . 0.0 112.859 179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.474 HD12 HG21 ' A' ' 35' ' ' VAL . 1.7 mm? -97.12 81.44 3.05 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 -179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.537 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 42.8 ttp85 -141.1 138.6 33.65 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.835 -179.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 46.9 t -63.92 124.7 19.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.34 9.07 63.7 Favored Glycine 0 N--CA 1.427 -1.952 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.349 -177.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.93 153.18 18.05 Favored 'General case' 0 C--O 1.241 0.657 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.926 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -89.81 119.24 36.6 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -178.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 30.0 m -134.55 175.04 12.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-O 121.034 0.445 . . . . 0.0 110.807 179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -126.3 128.19 46.74 Favored 'General case' 0 C--N 1.289 -2.055 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 175.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.56 HG21 HG21 ' A' ' 37' ' ' VAL . 11.8 t -131.13 157.92 41.85 Favored 'General case' 0 C--N 1.277 -2.55 0 C-N-CA 119.461 -0.896 . . . . 0.0 111.042 -174.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.523 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 37.0 ttm-85 -82.54 128.59 34.45 Favored 'General case' 0 N--CA 1.414 -2.235 0 N-CA-C 105.221 -2.141 . . . . 0.0 105.221 170.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.477 HG21 HD21 ' A' ' 39' ' ' LEU . 34.2 p -84.98 176.79 8.23 Favored 'General case' 0 C--N 1.276 -2.615 0 C-N-CA 120.398 -0.521 . . . . 0.0 110.199 178.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.1 m -66.17 -19.72 65.92 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-O 121.004 0.431 . . . . 0.0 110.044 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -75.55 -25.43 57.14 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.84 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.33 -17.33 16.71 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.702 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.6 m -90.09 151.97 21.36 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-O 120.648 0.261 . . . . 0.0 111.416 -178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 65' ' ' THR . 62.4 m-85 -87.46 126.76 35.09 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.87 174.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -140.96 145.54 36.15 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 124.363 1.065 . . . . 0.0 108.983 -176.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -76.13 131.05 39.17 Favored 'General case' 0 C--O 1.252 1.204 0 CA-C-O 121.812 0.815 . . . . 0.0 111.253 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -142.8 170.12 16.29 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.382 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 10.1 mm -119.83 142.46 35.25 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 107.886 -1.154 . . . . 0.0 107.886 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.6 mp -74.42 129.06 36.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 178.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 15.3 m -114.47 -17.11 11.82 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 121.227 0.537 . . . . 0.0 111.025 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 57.4 tttm -168.82 156.23 7.48 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.1 mp -123.76 135.15 53.65 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 169.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 87.1 m -114.37 111.71 21.89 Favored 'General case' 0 C--N 1.278 -2.516 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -65.39 122.74 17.85 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.107 -179.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -125.55 153.34 43.79 Favored 'General case' 0 N--CA 1.423 -1.81 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 175.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.7 p -161.78 122.38 2.64 Favored 'General case' 0 C--N 1.287 -2.133 0 CA-C-O 121.111 0.481 . . . . 0.0 109.877 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.542 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 87.6 m95 -107.75 113.87 27.43 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.108 179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.57 ' CE1' ' HB2' ' A' ' 7' ' ' LEU . 94.5 m-85 -101.47 110.59 22.62 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 4.1 m -89.93 104.14 16.73 Favored 'General case' 0 N--CA 1.414 -2.228 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.428 HG22 HD23 ' A' ' 98' ' ' LEU . 24.4 m -106.9 140.59 24.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 CA-C-O 121.273 0.559 . . . . 0.0 111.301 -174.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.413 ' HA ' ' HA ' ' A' ' 95' ' ' GLU . 3.5 t -101.79 128.69 54.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 C-N-CA 124.239 1.015 . . . . 0.0 109.979 -173.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 58.7 m-85 -87.71 174.02 8.65 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 174.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.31 -17.82 55.55 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -71.96 -17.81 62.04 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 123.045 0.538 . . . . 0.0 110.326 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 93.21 -0.48 68.85 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.869 -0.892 . . . . 0.0 110.869 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -94.96 131.48 40.85 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 123.325 0.65 . . . . 0.0 109.548 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.457 ' C ' ' HD2' ' A' ' 96' ' ' ARG . 0.3 OUTLIER -111.74 137.25 49.92 Favored 'General case' 0 C--N 1.293 -1.859 0 CA-C-O 121.354 0.597 . . . . 0.0 111.911 -179.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.457 ' HD2' ' C ' ' A' ' 95' ' ' GLU . 4.3 mpt_? -121.67 158.18 29.25 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.395 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.542 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 24.0 m -101.84 119.69 39.19 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-O 121.251 0.548 . . . . 0.0 110.771 -174.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.428 HD23 HG22 ' A' ' 88' ' ' VAL . 4.0 mm? -122.09 174.5 6.9 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.484 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.405 ' O ' ' HG ' ' A' ' 103' ' ' LEU . 22.5 mmt180 -98.86 166.58 11.23 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 173.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.89 -21.61 63.3 Favored 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.572 176.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.6 m -74.19 -9.78 58.96 Favored 'General case' 0 CA--C 1.557 1.233 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.521 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.559 ' O ' ' HA ' ' A' ' 15' ' ' ALA . 5.3 m -98.95 -11.8 21.26 Favored 'General case' 0 N--CA 1.418 -2.048 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 99' ' ' ARG . 70.1 mt -101.68 128.35 48.02 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.073 -171.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.718 ' SG ' ' HA ' ' A' ' 110' ' ' HIS . 30.3 t -61.11 -41.93 97.59 Favored 'General case' 0 C--N 1.311 -1.082 0 C-N-CA 124.749 1.219 . . . . 0.0 110.75 -178.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 94.9 mt 68.86 127.77 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 176.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 63.8 tttm 71.39 -28.89 0.19 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 125.428 1.491 . . . . 0.0 113.04 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 93.52 -38.03 3.25 Favored Glycine 0 CA--C 1.502 -0.766 0 N-CA-C 110.594 -1.002 . . . . 0.0 110.594 177.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -66.86 -43.9 82.35 Favored 'General case' 0 C--N 1.312 -1.064 0 C-N-CA 123.94 0.896 . . . . 0.0 109.043 175.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -86.9 136.79 32.83 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.187 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.718 ' HA ' ' SG ' ' A' ' 104' ' ' CYS . 8.6 m170 -116.1 137.94 51.68 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.153 0.502 . . . . 0.0 110.628 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -86.53 130.48 34.48 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.018 177.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -133.03 134.4 44.35 Favored 'General case' 0 N--CA 1.418 -2.038 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -84.05 -0.82 53.27 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.598 0.713 . . . . 0.0 110.081 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.3 p -153.84 85.75 1.17 Allowed 'General case' 0 N--CA 1.422 -1.84 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 173.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -74.21 -25.63 59.79 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.006 0.431 . . . . 0.0 111.381 -177.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.7 m -82.57 118.09 23.03 Favored 'General case' 0 N--CA 1.427 -1.619 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 175.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 82.7 mt -82.12 -31.41 30.66 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.094 0.474 . . . . 0.0 110.462 -177.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.4 t70 . . . . . 0 C--N 1.305 -1.367 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.373 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.178 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -134.58 -34.02 0.94 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.434 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 27.9 mt-10 -72.07 114.8 32.28 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.046 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 10.6 Cg_endo -88.57 -175.34 1.25 Allowed 'Trans proline' 0 N--CA 1.447 -1.212 0 C-N-CA 122.291 1.994 . . . . 0.0 112.826 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.22 -22.1 63.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.373 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.761 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . 38.2 p90 -131.37 129.89 41.93 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-O 120.901 0.382 . . . . 0.0 110.353 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.55 -173.58 3.07 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.716 178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 41.5 p -128.61 157.91 39.96 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.018 0.748 . . . . 0.0 113.018 -171.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.1 m -74.35 148.96 7.76 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.164 0 CA-C-O 121.122 0.487 . . . . 0.0 111.834 177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.15 -12.59 67.36 Favored Glycine 0 C--N 1.301 -1.378 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.071 179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.479 ' HB ' HD12 ' A' ' 26' ' ' ILE . 13.6 m -79.59 135.92 36.71 Favored 'General case' 0 N--CA 1.403 -2.809 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 -179.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.512 ' O ' ' HB2' ' A' ' 106' ' ' LYS . 15.9 t70 -99.78 121.04 40.68 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -178.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 104' ' ' CYS . 17.4 m -135.37 -177.33 1.94 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-O 121.474 0.654 . . . . 0.0 110.307 -174.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.7 m -123.07 141.62 51.76 Favored 'General case' 0 C--N 1.278 -2.505 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 176.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.54 139.76 41.57 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . 0.344 0.0 OUTLIER -99.98 136.61 39.63 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 115.459 1.651 . . . . 0.0 115.459 -177.815 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -131.62 121.72 24.81 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 113.668 -1.605 . . . . 0.0 107.355 178.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 61.53 31.7 18.85 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 124.028 0.931 . . . . 0.0 110.428 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.89 28.8 70.04 Favored Glycine 0 CA--C 1.524 0.633 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.5 -177.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -136.75 152.29 50.16 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -102.39 144.84 30.36 Favored 'General case' 0 C--N 1.293 -1.886 0 C-N-CA 120.007 -0.677 . . . . 0.0 112.686 -173.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 46.0 t -127.58 139.73 52.57 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 172.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.53 152.38 26.04 Favored 'General case' 0 C--N 1.322 -0.615 0 C-N-CA 118.371 -1.332 . . . . 0.0 111.482 -175.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -162.37 145.36 11.39 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -106.51 128.75 54.34 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -175.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.527 ' HA ' HG12 ' A' ' 88' ' ' VAL . 30.4 mt -63.75 114.42 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.241 0 CA-C-O 121.185 0.517 . . . . 0.0 111.23 -178.151 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -100.42 -42.39 6.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.117 -0.947 . . . . 0.0 110.757 -177.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 5.8 m -130.05 137.35 50.18 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 178.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 50.1 t -116.61 116.4 52.08 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-O 121.279 0.562 . . . . 0.0 109.949 177.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.484 ' HB3' HD22 ' A' ' 32' ' ' LEU . 46.7 mmtt -109.57 91.03 3.48 Favored 'General case' 0 C--N 1.276 -2.62 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.185 174.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -83.25 87.69 6.94 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 114.724 -1.125 . . . . 0.0 109.549 178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.629 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.3 pt? -135.07 116.53 14.69 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 119.194 -1.002 . . . . 0.0 111.291 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 62.8 t -108.5 115.23 48.74 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.492 0 N-CA-C 105.282 -2.118 . . . . 0.0 105.282 171.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -82.64 108.35 15.95 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.244 1.021 . . . . 0.0 109.755 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.04 133.75 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.455 0 CA-C-N 113.793 -1.549 . . . . 0.0 109.244 -175.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -88.86 107.08 18.79 Favored 'General case' 0 CA--C 1.484 -1.567 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 176.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.636 HG21 HG21 ' A' ' 65' ' ' THR . 3.5 m -112.59 148.49 15.59 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.192 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.305 -176.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -117.75 117.87 30.51 Favored 'General case' 0 C--N 1.276 -2.604 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 75' ' ' ALA . 57.3 mt -73.92 106.55 5.68 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -59.41 -29.05 67.46 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -177.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.4 tp60 -87.69 -24.47 23.86 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.765 -177.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -115.53 -13.97 11.54 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 120.321 -0.552 . . . . 0.0 112.177 -173.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 68.33 15.98 9.28 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.508 1.523 . . . . 0.0 113.112 178.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.3 p -99.99 158.28 15.94 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.377 0.132 . . . . 0.0 111.088 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.9 m -125.57 140.4 52.78 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -179.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -148.1 160.61 42.7 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.359 177.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 21.4 tp -120.56 100.88 7.39 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 105.653 -1.98 . . . . 0.0 105.653 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 m -128.28 163.88 31.38 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.434 -175.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.629 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 17.1 pm0 -80.78 160.05 24.98 Favored 'General case' 0 C--N 1.285 -2.219 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.47 -25.11 2.38 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 127.076 2.15 . . . . 0.0 112.51 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -68.42 -29.1 67.69 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.718 -178.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.464 ' O ' ' HA ' ' A' ' 65' ' ' THR . 71.7 mt-30 -100.21 -15.17 18.2 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.899 -0.592 . . . . 0.0 109.463 179.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.8 t -91.08 110.82 22.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-O 122.523 1.154 . . . . 0.0 111.586 -178.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -99.19 106.13 18.26 Favored 'General case' 0 C--N 1.276 -2.59 0 CA-C-N 113.974 -1.466 . . . . 0.0 108.001 179.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 139.68 -169.65 24.53 Favored Glycine 0 C--N 1.302 -1.325 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.172 177.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.56 134.86 11.34 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 122.884 2.39 . . . . 0.0 112.544 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mp -88.53 82.26 6.97 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.535 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 35.0 mtp180 -139.26 132.59 30.01 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.859 -1.064 . . . . 0.0 109.744 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 26.1 t -64.32 120.07 10.18 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.34 5.81 61.74 Favored Glycine 0 N--CA 1.433 -1.556 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.867 -178.37 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 76' ' ' ILE . . . -96.39 169.21 10.07 Favored 'General case' 0 CA--C 1.504 -0.796 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.894 -177.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.5 mm -99.02 115.74 40.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.266 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.113 -177.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.561 HG13 HD11 ' A' ' 77' ' ' ILE . 16.0 m -123.78 -173.05 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 174.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -138.8 135.87 35.07 Favored 'General case' 1 N--CA 1.374 -4.238 0 N-CA-C 105.108 -2.182 . . . . 0.0 105.108 174.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.636 HG21 HG21 ' A' ' 37' ' ' VAL . 11.6 t -141.56 158.91 43.24 Favored 'General case' 0 C--N 1.272 -2.769 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.056 -175.156 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -80.49 126.39 31.16 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 9.8 t -99.09 179.7 4.53 Favored 'General case' 0 C--N 1.285 -2.222 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.135 -179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 32.7 t -66.82 -21.06 66.04 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 124.205 1.002 . . . . 0.0 110.242 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -71.18 -18.34 62.49 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.53 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 99.88 -13.44 60.67 Favored Glycine 0 C--O 1.241 0.584 0 C-N-CA 121.172 -0.537 . . . . 0.0 111.976 179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.9 p -91.68 165.06 13.5 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 123.136 0.574 . . . . 0.0 110.727 -179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -98.38 124.68 43.18 Favored 'General case' 0 N--CA 1.427 -1.601 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 173.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.425 ' HB3' HD22 ' A' ' 39' ' ' LEU . 5.5 tp-100 -119.6 146.91 45.1 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -176.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -72.7 127.74 33.46 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.581 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -132.55 168.35 18.39 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -174.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 61' ' ' ALA . 7.0 mm -115.45 149.23 17.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 177.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.561 HD11 HG13 ' A' ' 63' ' ' VAL . 3.7 mp -89.92 130.47 39.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 176.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 55.0 m -107.35 -16.96 14.26 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 121.002 0.429 . . . . 0.0 110.583 175.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -173.53 147.47 1.45 Allowed 'General case' 0 C--O 1.212 -0.888 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.321 0.0 OUTLIER -129.92 115.89 17.84 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 121.546 0.688 . . . . 0.0 110.781 171.61 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 85.4 m -112.14 103.88 12.07 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-O 121.456 0.646 . . . . 0.0 109.341 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 33' ' ' VAL . 1.9 p30 -75.4 141.77 43.18 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.108 -176.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -107.14 -60.25 1.71 Allowed 'General case' 0 N--CA 1.416 -2.174 0 N-CA-C 107.222 -1.399 . . . . 0.0 107.222 176.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.6 m 45.05 90.41 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.282 1.433 . . . . 0.0 113.546 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.517 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 78.8 m95 -100.97 129.98 46.9 Favored 'General case' 0 C--N 1.289 -2.052 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.526 -177.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.761 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 74.6 m-85 -123.11 108.73 13.19 Favored 'General case' 0 CA--C 1.482 -1.662 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.485 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 26.0 m -84.25 103.8 13.74 Favored 'General case' 0 N--CA 1.391 -3.38 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 177.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.527 HG12 ' HA ' ' A' ' 26' ' ' ILE . 17.3 m -106.09 141.29 21.71 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.444 0 CA-C-N 115.606 -0.724 . . . . 0.0 109.845 -177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.79 122.77 56.9 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.454 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.864 -176.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -88.51 173.43 8.68 Favored 'General case' 0 C--N 1.291 -1.964 0 CA-C-N 114.887 -1.051 . . . . 0.0 110.41 -177.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -55.28 -33.45 63.25 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 124.262 1.025 . . . . 0.0 111.589 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.82 -17.84 62.75 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 120.987 0.422 . . . . 0.0 111.608 -178.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 98.56 6.76 56.28 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -90.47 134.83 34.09 Favored 'General case' 0 CA--C 1.474 -1.958 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 88' ' ' VAL . 0.3 OUTLIER -111.04 128.32 55.82 Favored 'General case' 0 C--N 1.267 -3.01 0 CA-C-O 121.221 0.534 . . . . 0.0 109.937 177.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -123.45 140.97 52.47 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.517 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 32.3 m -103.66 108.82 20.26 Favored 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 120.725 0.298 . . . . 0.0 111.104 -176.051 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 19.8 mt -117.34 178.03 4.52 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 71.1 mtp180 -98.74 165.25 11.88 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 31.2 ptt-85 -62.06 -25.38 67.65 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-O 121.13 0.49 . . . . 0.0 110.816 -178.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -72.93 1.21 9.21 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 124.18 0.992 . . . . 0.0 112.213 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 28.5 t -127.61 11.24 6.74 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 8.9 mp -122.26 161.0 24.09 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.291 -177.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.402 ' O ' ' HB ' ' A' ' 13' ' ' VAL . 37.5 t -135.35 -143.94 0.2 Allowed 'General case' 0 N--CA 1.416 -2.156 0 N-CA-C 106.735 -1.58 . . . . 0.0 106.735 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 96.9 mt -141.11 164.16 31.03 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.512 ' HB2' ' O ' ' A' ' 12' ' ' ASP . 6.5 tmtt? -67.03 132.77 48.58 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.2 -15.82 8.17 Favored Glycine 0 N--CA 1.432 -1.571 0 N-CA-C 110.236 -1.146 . . . . 0.0 110.236 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 65.33 96.62 0.05 OUTLIER 'General case' 0 C--O 1.242 0.704 0 C-N-CA 124.59 1.156 . . . . 0.0 109.827 -178.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 46.1 mtp180 -104.68 167.81 9.48 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -178.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -80.32 79.71 6.87 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.907 0.861 . . . . 0.0 111.082 -177.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 50.4 t80 -111.14 13.76 21.85 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 175.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -80.42 -171.25 2.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 113.695 -1.593 . . . . 0.0 109.821 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 56.98 77.43 0.26 Allowed 'General case' 0 C--O 1.237 0.422 0 CA-C-O 122.683 1.23 . . . . 0.0 112.056 -173.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 75.7 m -157.16 -173.83 4.63 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 69.12 97.15 0.06 Allowed 'General case' 0 C--O 1.245 0.863 0 O-C-N 124.139 0.899 . . . . 0.0 109.74 -175.057 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.9 m -48.8 -50.16 35.56 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 125.594 1.558 . . . . 0.0 111.621 -176.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.74 100.42 13.23 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 175.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 C--N 1.298 -1.673 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.036 -179.589 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.569 0 CA-C-O 121.366 0.603 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -114.23 -37.88 4.28 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.483 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.424 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 1.4 mp0 -36.22 96.45 0.11 Allowed Pre-proline 0 N--CA 1.475 0.776 0 C-N-CA 127.452 2.301 . . . . 0.0 115.605 -172.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -110.66 39.26 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 124.736 3.624 . . . . 0.0 107.069 172.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.54 14.49 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 118.467 2.766 . . . . 0.0 118.467 -165.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 42.6 p90 -160.26 21.23 0.15 Allowed 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 118.845 0.748 . . . . 0.0 112.085 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.42 ' O ' ' HE2' ' A' ' 86' ' ' TYR . 3.0 pp -151.43 166.47 30.96 Favored 'General case' 0 C--O 1.212 -0.877 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.464 ' HB ' ' OG1' ' A' ' 11' ' ' THR 0.539 54.2 p 115.17 71.88 0.0 OUTLIER 'General case' 0 C--O 1.193 -1.882 0 C-N-CA 130.201 3.401 . . . . 0.0 115.516 176.268 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.2 t -92.41 140.21 16.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 174.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.83 -13.57 58.68 Favored Glycine 0 C--N 1.313 -0.743 0 N-CA-C 112.238 -0.345 . . . . 0.0 112.238 177.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.5 ' HB ' HD12 ' A' ' 26' ' ' ILE . 3.6 m -68.8 133.18 47.97 Favored 'General case' 0 N--CA 1.411 -2.38 0 C-N-CA 123.501 0.72 . . . . 0.0 110.067 -177.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -98.79 110.32 22.94 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 -178.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.7 m -137.32 173.49 13.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 122.305 0.242 . . . . 0.0 110.719 -176.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.9 p -95.38 132.06 40.83 Favored 'General case' 0 N--CA 1.42 -1.929 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 172.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.772 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -119.6 120.78 37.69 Favored 'General case' 0 C--N 1.308 -1.205 0 C-N-CA 123.675 0.79 . . . . 0.0 109.802 -177.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 21' ' ' PHE . 1.9 ttpm? -82.81 106.23 14.48 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.906 -177.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.5 p90 -138.41 145.87 41.5 Favored 'General case' 0 C--N 1.288 -2.101 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 62.99 25.19 14.93 Favored 'General case' 0 CA--C 1.567 1.626 0 CA-C-O 122.762 1.268 . . . . 0.0 108.899 -178.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.53 16.04 75.61 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 114.872 -1.058 . . . . 0.0 113.263 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.17 142.67 42.18 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 26.2 p90 -98.45 114.09 26.33 Favored 'General case' 0 C--N 1.29 -2.004 0 C-N-CA 118.978 -1.089 . . . . 0.0 112.089 177.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 53.8 t -100.6 143.17 31.08 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -71.64 132.78 45.08 Favored 'General case' 0 N--CA 1.38 -3.963 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 177.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.5 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -146.27 164.48 32.17 Favored 'General case' 0 C--N 1.266 -3.057 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.175 -173.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.5 tttp -117.44 126.84 53.32 Favored 'General case' 0 C--N 1.279 -2.492 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.507 HG12 HG12 ' A' ' 88' ' ' VAL . 18.6 mt -69.58 109.29 2.29 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -87.49 -41.2 13.68 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.344 0.592 . . . . 0.0 110.174 -178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.8 m -137.95 141.53 40.55 Favored 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.775 -176.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 84.6 t -118.94 108.54 24.27 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.671 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 175.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 84' ' ' SER . 31.2 mmmt -82.33 101.29 10.47 Favored 'General case' 0 C--N 1.276 -2.611 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 32.2 mtm180 -84.49 99.39 10.67 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.518 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.6 pt? -138.88 126.09 21.44 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-O 121.655 0.74 . . . . 0.0 111.031 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 60.1 t -104.07 124.83 58.73 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 106.334 -1.728 . . . . 0.0 106.334 175.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -84.36 104.42 14.36 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.441 HG21 HD22 ' A' ' 57' ' ' LEU . 16.2 t -93.4 126.41 45.83 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.806 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.157 -177.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 79' ' ' LYS . 81.5 tttt -95.6 110.5 22.59 Favored 'General case' 0 N--CA 1.419 -2.002 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 178.445 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.417 HG13 HG12 ' A' ' 35' ' ' VAL . 3.6 m -117.51 154.53 19.34 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.952 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.338 -176.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 5.5 tt -122.03 113.73 19.95 Favored 'General case' 0 C--N 1.267 -3.008 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 176.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 75' ' ' ALA . 43.2 mt -64.72 118.14 8.5 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.356 179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.486 ' HB3' HD11 ' A' ' 76' ' ' ILE . 18.8 ptpt -75.51 -23.04 56.66 Favored 'General case' 0 C--N 1.309 -1.195 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.409 -176.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -85.46 -42.45 14.47 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.268 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -91.66 -22.84 20.05 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.383 0.611 . . . . 0.0 110.653 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 73.1 22.31 2.94 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 125.109 1.364 . . . . 0.0 113.614 177.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.5 p -104.81 150.73 24.56 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.744 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -97.96 144.48 27.45 Favored 'General case' 0 N--CA 1.422 -1.825 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 174.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -142.57 142.82 32.24 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 -175.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.7 tp -121.57 102.63 8.36 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 106.963 -1.495 . . . . 0.0 106.963 176.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.28 164.49 29.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.767 -174.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.518 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 4.5 pm0 -84.29 168.05 16.02 Favored 'General case' 0 C--N 1.291 -1.941 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.298 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -46.39 -21.47 0.17 Allowed 'General case' 0 N--CA 1.494 1.741 0 C-N-CA 128.584 2.754 . . . . 0.0 114.306 179.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -88.26 -23.03 23.61 Favored 'General case' 0 C--N 1.309 -1.194 0 CA-C-O 122.084 0.945 . . . . 0.0 110.446 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -91.16 -20.13 22.33 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.876 -177.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.9 t -105.24 127.04 60.24 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.904 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.354 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -110.93 110.06 20.47 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.441 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 141.54 -164.04 26.73 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.506 176.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.07 136.18 16.1 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.824 2.349 . . . . 0.0 113.117 -178.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.441 HD22 HG21 ' A' ' 35' ' ' VAL . 39.8 mt -93.2 83.0 4.56 Favored 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.488 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 28.5 tpt180 -140.38 131.01 25.59 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 56.4 t -63.64 119.66 8.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.8 3.58 55.99 Favored Glycine 0 N--CA 1.427 -1.907 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.401 -176.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 58' ' ' ARG . . . -97.44 168.76 10.19 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.471 0.635 . . . . 0.0 110.758 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 49.3 mm -106.31 128.37 60.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.766 -176.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.526 HG13 HD11 ' A' ' 77' ' ' ILE . 21.0 m -137.47 172.68 14.28 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.75 179.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -116.92 130.12 56.49 Favored 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 172.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 15.3 t -128.45 158.44 38.33 Favored 'General case' 0 C--N 1.281 -2.398 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.6 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -70.11 123.84 22.62 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.307 0.575 . . . . 0.0 111.023 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.482 HG23 ' H ' ' A' ' 69' ' ' ASP . 14.2 t -95.11 169.83 9.83 Favored 'General case' 0 N--CA 1.42 -1.953 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 177.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.2 p -63.83 -20.52 65.86 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.683 0.793 . . . . 0.0 112.524 -176.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.482 ' H ' HG23 ' A' ' 67' ' ' THR . 19.0 t70 -69.61 -25.73 64.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.511 179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 115.5 -22.27 12.09 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.672 -178.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.464 ' O ' HG22 ' A' ' 67' ' ' THR . 23.3 m -87.19 170.09 11.78 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-O 120.856 0.36 . . . . 0.0 110.642 178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.8 m-85 -100.69 137.27 39.31 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 174.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -133.29 155.85 48.66 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 110.532 -0.173 . . . . 0.0 110.532 -177.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.412 ' OE1' ' HD2' ' A' ' 40' ' ' LYS . 38.1 tt0 -69.15 128.67 37.45 Favored 'General case' 0 C--O 1.253 1.237 0 O-C-N 124.227 0.954 . . . . 0.0 112.288 -177.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.519 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -139.7 171.03 14.82 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.68 -1.146 . . . . 0.0 110.211 -178.229 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.486 HD11 ' HB3' ' A' ' 40' ' ' LYS . 2.8 mp -120.86 141.87 39.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 177.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.526 HD11 HG13 ' A' ' 63' ' ' VAL . 3.3 mp -76.35 122.22 30.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 8.7 t -106.35 -18.93 13.85 Favored 'General case' 0 C--N 1.29 -1.978 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.518 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 86.7 tttt -163.78 150.0 11.52 Favored 'General case' 0 C--O 1.219 -0.518 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . 0.26 0.3 OUTLIER -135.95 117.16 14.49 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 121.683 0.754 . . . . 0.0 110.838 171.811 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.3 m -112.16 104.85 13.08 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.072 -175.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -67.38 109.77 3.3 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -94.03 -73.17 0.58 Allowed 'General case' 0 C--N 1.312 -1.043 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.35 -177.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 56.0 m 57.71 115.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -177.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.49 ' CD1' HD21 ' A' ' 32' ' ' LEU . 99.4 m95 -103.37 108.31 19.49 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-N 114.088 -1.414 . . . . 0.0 110.583 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.42 ' HE2' ' O ' ' A' ' 7' ' ' LEU . 48.1 m-85 -90.39 111.56 22.84 Favored 'General case' 0 C--N 1.289 -2.059 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 3.1 m -87.98 105.19 17.29 Favored 'General case' 0 N--CA 1.405 -2.69 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.507 HG12 HG12 ' A' ' 26' ' ' ILE . 21.8 m -105.68 141.09 21.79 Favored 'Isoleucine or valine' 0 C--N 1.272 -2.803 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.995 -176.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.3 p -104.88 125.72 59.83 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 CA-C-N 115.092 -0.958 . . . . 0.0 108.92 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.439 ' CD1' ' HB2' ' A' ' 24' ' ' ALA . 42.9 m-85 -87.19 170.12 11.76 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -176.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -57.15 -24.62 55.56 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 123.39 0.432 . . . . 0.0 112.057 -179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -72.4 -16.88 61.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-O 121.267 0.556 . . . . 0.0 111.846 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 95.84 -1.75 63.7 Favored Glycine 0 CA--C 1.503 -0.658 0 C-N-CA 121.041 -0.6 . . . . 0.0 111.984 -178.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -92.54 150.16 20.92 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -132.97 154.4 50.52 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 118.313 0.506 . . . . 0.0 111.521 -175.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 30.3 tpt180 -149.14 147.6 28.65 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.271 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -88.37 113.17 23.7 Favored 'General case' 0 N--CA 1.426 -1.629 0 C-N-CA 123.544 0.738 . . . . 0.0 110.899 174.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.772 HD11 ' HB1' ' A' ' 15' ' ' ALA 0.315 0.2 OUTLIER -129.83 146.87 51.55 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-O 121.141 0.496 . . . . 0.0 111.858 174.229 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.0 ptm180 -69.1 158.84 34.05 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.843 -1.071 . . . . 0.0 111.171 -178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.05 -38.25 56.42 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.902 1.281 . . . . 0.0 110.54 -175.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 6.5 m -62.72 -10.12 11.59 Favored 'General case' 0 CA--C 1.576 1.944 0 C-N-CA 123.834 0.854 . . . . 0.0 112.875 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 62.0 m -111.49 6.38 20.15 Favored 'General case' 0 N--CA 1.441 -0.918 0 O-C-N 120.937 -1.102 . . . . 0.0 111.448 175.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 11.2 mp -108.81 139.61 43.39 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 110' ' ' HIS . 49.8 t -75.8 -48.83 20.04 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -175.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 52.3 tp 69.01 -70.66 0.13 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.394 1.078 . . . . 0.0 112.39 -179.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 38.4 mtmm -106.09 108.33 19.79 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.007 0.432 . . . . 0.0 110.163 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 97.69 -177.78 32.02 Favored Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 6.3 mp0 -121.59 -40.16 2.58 Favored 'General case' 0 C--N 1.305 -1.353 0 CA-C-N 117.805 0.803 . . . . 0.0 110.144 179.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -90.58 77.9 6.35 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.815 -173.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.45 ' HB2' ' SG ' ' A' ' 104' ' ' CYS . 69.0 m-70 -137.63 159.07 42.99 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.231 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 74.65 7.18 4.46 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 125.251 1.42 . . . . 0.0 113.258 179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -156.18 156.02 33.46 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 174.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 70.64 13.28 7.3 Favored 'General case' 0 CA--C 1.553 1.063 0 CA-C-O 122.375 1.084 . . . . 0.0 110.448 179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 11.2 t -178.91 105.59 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 66.45 178.45 0.22 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.844 1.307 . . . . 0.0 113.596 177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 22.1 m -135.79 167.94 20.23 Favored 'General case' 0 C--N 1.275 -2.664 0 N-CA-C 103.278 -2.86 . . . . 0.0 103.278 174.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.401 ' H ' HD13 ' A' ' 117' ' ' LEU 0.259 0.0 OUTLIER -122.38 138.17 54.62 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 119.912 1.233 . . . . 0.0 113.034 -177.769 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 29.2 t70 . . . . . 0 C--N 1.307 -1.278 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.157 178.296 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.218 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -113.08 -5.66 13.73 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.031 0.443 . . . . 0.0 110.25 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -106.17 151.11 40.07 Favored Pre-proline 0 C--N 1.304 -1.387 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.889 179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -82.42 76.53 4.13 Favored 'Trans proline' 0 N--CA 1.448 -1.199 0 C-N-CA 122.086 1.857 . . . . 0.0 110.287 174.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -69.23 -41.34 77.13 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.858 -179.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.562 ' HA ' ' OH ' ' A' ' 86' ' ' TYR 0.29 28.4 p90 60.95 134.26 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 126.759 2.024 . . . . 0.0 115.679 178.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 94.5 mt -90.51 173.67 7.95 Favored 'General case' 0 C--N 1.298 -1.665 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 173.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 22.4 p -127.74 169.04 14.28 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -172.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.6 t -72.49 134.69 29.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.306 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.91 -22.22 14.77 Favored Glycine 0 N--CA 1.432 -1.596 0 C-N-CA 119.816 -1.183 . . . . 0.0 113.419 175.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.8 t -93.43 167.74 11.51 Favored 'General case' 0 N--CA 1.43 -1.475 0 C-N-CA 119.252 -0.979 . . . . 0.0 108.719 -178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 25' ' ' LYS . 5.0 p-10 -118.17 139.27 51.52 Favored 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.3 m -132.18 162.23 40.03 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.337 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.83 -177.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.477 ' HB3' ' HB3' ' A' ' 21' ' ' PHE . 14.4 m -101.13 127.95 47.44 Favored 'General case' 0 N--CA 1.405 -2.715 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.149 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.623 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -106.91 120.78 42.98 Favored 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 105.709 -1.959 . . . . 0.0 105.709 179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 22.2 ptmt -93.59 138.07 32.22 Favored 'General case' 0 C--N 1.292 -1.926 0 C-N-CA 118.8 -1.16 . . . . 0.0 112.721 -177.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' HH ' ' HZ ' ' A' ' 90' ' ' PHE . 74.9 m-85 -134.81 130.9 36.78 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.7 mmt-85 61.21 25.2 15.22 Favored 'General case' 0 C--N 1.31 -1.142 0 C-N-CA 124.85 1.26 . . . . 0.0 110.243 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.23 2.55 83.06 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.206 -0.521 . . . . 0.0 113.093 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.25 145.97 45.63 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 -177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.477 ' HB3' ' HB3' ' A' ' 14' ' ' SER . 74.1 m-85 -95.1 132.92 39.48 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.107 -0.637 . . . . 0.0 111.982 -175.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 69.2 m -116.54 132.67 56.62 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 174.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -86.12 145.16 27.15 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.105 -175.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -150.96 153.3 34.95 Favored 'General case' 0 C--N 1.286 -2.152 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 12' ' ' ASP . 64.6 tttm -108.94 126.72 53.39 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -175.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.508 ' HA ' HG12 ' A' ' 88' ' ' VAL . 23.3 mt -65.31 114.14 2.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 120.936 0.398 . . . . 0.0 111.732 -175.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -97.18 -45.8 6.39 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.091 178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.514 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 4.9 m -127.04 139.76 52.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -175.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 76.9 t -125.44 122.88 63.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 177.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.404 ' HB2' ' HB2' ' A' ' 85' ' ' TRP . 63.8 mttp -110.75 91.79 3.8 Favored 'General case' 0 C--N 1.282 -2.341 0 N-CA-C 106.471 -1.678 . . . . 0.0 106.471 172.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . 0.383 0.0 OUTLIER -85.71 86.94 7.34 Favored 'General case' 0 N--CA 1.422 -1.85 0 C-N-CA 118.407 -1.317 . . . . 0.0 112.06 177.362 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.523 ' HB2' ' HB2' ' A' ' 49' ' ' GLN . 2.5 pt? -116.46 105.27 12.3 Favored 'General case' 0 N--CA 1.413 -2.305 0 CA-C-N 114.616 -1.175 . . . . 0.0 110.449 -175.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 7.3 p -91.45 127.23 43.92 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.396 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.529 ' HB3' ' HG ' ' A' ' 47' ' ' LEU . 68.4 mttm -79.78 105.11 10.83 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.314 0.578 . . . . 0.0 109.706 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 28.7 t -89.4 122.83 41.19 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.864 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.196 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.492 ' CB ' ' HB3' ' A' ' 79' ' ' LYS . 2.9 tmtm? -89.64 108.35 19.62 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 105.251 -2.129 . . . . 0.0 105.251 -179.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.432 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 19.4 m -117.02 153.3 18.74 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 121.475 0.655 . . . . 0.0 112.472 -174.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -123.34 120.03 31.84 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 176.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 9.8 mp -72.18 127.07 31.4 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.962 -179.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 18.2 ptpt -64.28 -34.66 78.63 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 -177.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -80.74 -58.77 2.95 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-O 121.001 0.429 . . . . 0.0 111.889 -177.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.71 -4.42 55.11 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -172.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.7 p30 52.12 29.4 6.39 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.664 1.185 . . . . 0.0 112.595 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.3 145.77 24.22 Favored 'General case' 0 N--CA 1.419 -2.022 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.734 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.0 m -113.27 147.73 37.0 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -177.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -158.7 164.46 35.9 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-N 115.992 -0.549 . . . . 0.0 109.918 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 34' ' ' LYS . 31.5 tp -129.5 102.3 6.33 Favored 'General case' 0 C--N 1.294 -1.834 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.6 m -126.68 162.37 31.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -176.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.523 ' HB2' ' HB2' ' A' ' 32' ' ' LEU . 5.4 pm0 -90.99 166.73 12.86 Favored 'General case' 0 C--N 1.281 -2.381 0 C-N-CA 119.32 -0.952 . . . . 0.0 113.538 -173.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.408 ' HB2' HG12 ' A' ' 33' ' ' VAL . 4.9 t70 -42.68 -32.19 0.55 Allowed 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 127.268 2.227 . . . . 0.0 113.253 179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -68.25 -34.9 77.06 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 123.691 0.796 . . . . 0.0 111.238 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -90.39 -12.43 37.56 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.349 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 65' ' ' THR . 87.7 t -93.81 115.7 33.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 CA-C-N 114.606 -1.179 . . . . 0.0 111.602 -177.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -108.38 124.34 50.22 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.292 175.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.26 -161.38 22.07 Favored Glycine 0 C--N 1.288 -2.108 0 CA-C-O 119.445 -0.642 . . . . 0.0 111.921 -178.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -86.13 133.23 4.02 Favored 'Trans proline' 0 C--N 1.354 0.83 0 C-N-CA 122.848 2.365 . . . . 0.0 112.833 178.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.3 mp -94.88 82.55 3.87 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-O 122.085 0.945 . . . . 0.0 110.808 -178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.583 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 25.6 mmt180 -140.02 141.11 36.34 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.371 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 47.3 t -64.05 126.34 22.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 177.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.23 3.85 67.06 Favored Glycine 0 N--CA 1.435 -1.387 0 CA-C-N 115.903 -0.589 . . . . 0.0 112.308 -177.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -97.55 157.5 15.99 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.422 HG12 ' CD1' ' A' ' 76' ' ' ILE . 56.8 mt -101.76 124.43 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.133 0 CA-C-O 121.383 0.611 . . . . 0.0 110.796 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.489 HG13 HD11 ' A' ' 77' ' ' ILE . 14.6 m -125.64 -178.65 2.09 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.814 177.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 73' ' ' GLN . 39.0 mt-10 -126.69 120.89 30.55 Favored 'General case' 0 C--N 1.287 -2.118 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 174.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.513 HG22 HG22 ' A' ' 53' ' ' VAL . 33.9 p -116.37 150.28 37.99 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.725 -174.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.8 ttp180 -76.67 130.41 37.75 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 60.1 p -87.91 -177.16 5.71 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 176.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.0 t -78.35 -0.88 30.72 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.153 0.501 . . . . 0.0 110.033 178.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -94.68 -14.45 24.83 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 175.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 95.3 5.61 60.44 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.455 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 m -97.15 160.86 14.1 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -112.34 119.31 37.86 Favored 'General case' 0 C--O 1.246 0.885 0 CA-C-O 121.05 0.452 . . . . 0.0 111.214 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 46.7 mt-30 -119.19 153.54 34.76 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.083 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.428 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 44.9 mt-10 -69.09 122.75 19.38 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 124.056 0.847 . . . . 0.0 109.563 177.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.432 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -137.42 162.28 34.05 Favored 'General case' 0 C--N 1.267 -3.011 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.572 178.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.422 ' CD1' HG12 ' A' ' 62' ' ' ILE . 9.2 mm -107.48 137.52 38.2 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.101 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 -177.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.583 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -70.89 120.02 18.14 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.565 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 175.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 36' ' ' LYS . 13.6 m -109.58 -15.77 14.11 Favored 'General case' 0 C--N 1.287 -2.144 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.301 -178.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.492 ' HB3' ' CB ' ' A' ' 36' ' ' LYS . 15.3 tppt? -172.77 150.13 2.08 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.4 123.82 32.63 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 171.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 24.4 m -118.77 115.5 24.59 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 123.455 0.702 . . . . 0.0 109.954 -177.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -63.4 136.53 57.69 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.15 0.5 . . . . 0.0 111.798 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -139.02 13.34 2.65 Favored 'General case' 0 N--CA 1.427 -1.575 0 CA-C-N 115.551 -0.75 . . . . 0.0 109.994 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.428 ' HA ' HD23 ' A' ' 32' ' ' LEU . 50.5 m -49.3 123.74 7.96 Favored 'General case' 0 C--O 1.245 0.843 0 O-C-N 124.231 0.957 . . . . 0.0 113.57 -175.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.576 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 89.5 m95 -101.37 136.73 40.74 Favored 'General case' 0 N--CA 1.438 -1.069 0 CA-C-N 114.588 -1.187 . . . . 0.0 109.836 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.562 ' OH ' ' HA ' ' A' ' 6' ' ' TYR . 56.0 m-85 -122.81 114.36 20.41 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.514 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 16.0 m -91.74 105.54 17.8 Favored 'General case' 0 N--CA 1.401 -2.908 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' A' ' 26' ' ' ILE . 21.4 m -105.81 141.7 20.53 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.925 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 14.9 p -105.73 135.65 43.06 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.016 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.091 -176.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.456 ' HZ ' ' HH ' ' A' ' 17' ' ' TYR . 44.8 m-85 -97.4 173.04 7.39 Favored 'General case' 0 C--N 1.288 -2.099 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.424 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -54.61 -42.64 71.4 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.674 1.189 . . . . 0.0 111.14 -174.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -67.81 -14.02 62.61 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.925 0.89 . . . . 0.0 112.731 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 97.61 9.13 55.33 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.071 -1.061 . . . . 0.0 111.83 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -89.73 140.65 29.36 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -124.82 138.67 54.26 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 15.1 tpp180 -133.92 142.17 47.63 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.576 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 67.1 m -99.79 118.85 37.16 Favored 'General case' 0 C--N 1.288 -2.067 0 CA-C-O 121.013 0.435 . . . . 0.0 110.872 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.623 HD11 ' HB1' ' A' ' 15' ' ' ALA . 0.3 OUTLIER -136.54 162.97 31.63 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.361 177.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.418 ' O ' HD13 ' A' ' 103' ' ' LEU . 28.7 ptt180 -99.32 166.32 11.26 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.738 -176.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.448 ' HG3' ' CE1' ' A' ' 86' ' ' TYR . 72.0 mtm180 -56.47 -25.57 51.39 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -178.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 2.5 m -57.67 -22.37 45.53 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.35 1.06 . . . . 0.0 111.798 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 34.5 m -118.72 12.98 13.19 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 121.086 0.47 . . . . 0.0 111.634 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 99' ' ' ARG . 8.6 mp -103.12 146.16 28.81 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.633 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 111' ' ' PHE . 34.6 t -79.75 -55.5 4.95 Favored 'General case' 0 C--N 1.296 -1.737 0 CA-C-N 114.729 -1.123 . . . . 0.0 113.215 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.501 ' O ' ' HG3' ' A' ' 106' ' ' LYS . 6.4 tt -64.1 101.33 0.39 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 114.111 1.152 . . . . 0.0 114.111 -167.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 105' ' ' LEU . 1.9 mptt -174.14 -50.1 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 104.508 -2.405 . . . . 0.0 104.508 169.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 109.9 69.81 0.63 Allowed Glycine 0 N--CA 1.435 -1.423 0 CA-C-N 113.436 -1.711 . . . . 0.0 110.147 -176.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 60.0 mt-10 -133.16 138.46 46.61 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -176.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 74.9 mtm180 48.85 -100.08 0.07 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 114.921 1.452 . . . . 0.0 114.921 165.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -130.78 18.86 5.11 Favored 'General case' 0 CA--C 1.502 -0.887 0 CA-C-O 121.732 0.777 . . . . 0.0 109.94 177.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.423 ' HB3' ' HA ' ' A' ' 104' ' ' CYS . 98.9 m-85 -85.71 -22.98 27.56 Favored 'General case' 0 CA--C 1.504 -0.798 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 173.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -144.95 171.61 14.22 Favored 'General case' 0 N--CA 1.412 -2.37 0 N-CA-C 104.437 -2.431 . . . . 0.0 104.437 176.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 68.0 89.48 0.1 Allowed 'General case' 0 C--O 1.243 0.758 0 CA-C-O 122.475 1.131 . . . . 0.0 109.827 -177.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.0 t -78.56 87.54 4.52 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-N 114.495 -1.23 . . . . 0.0 112.342 -172.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -80.74 -43.15 20.69 Favored 'General case' 0 C--N 1.308 -1.2 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 168.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.8 p -118.58 173.63 6.73 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 113.957 -1.474 . . . . 0.0 108.043 177.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 71.2 mt -108.75 -66.78 1.02 Allowed 'General case' 0 C--N 1.289 -2.048 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 177.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 . . . . . 0 C--N 1.3 -1.57 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 174.814 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.417 0 CA-C-O 121.36 0.6 . . . . 0.0 110.746 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -113.04 20.39 16.37 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -62.66 119.49 51.34 Favored Pre-proline 0 C--N 1.311 -1.099 0 CA-C-N 113.513 -1.676 . . . . 0.0 112.61 -173.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -65.87 143.31 72.81 Favored 'Trans proline' 0 N--CA 1.441 -1.607 0 N-CA-C 106.691 -2.08 . . . . 0.0 106.691 167.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.465 ' HB3' ' HB ' ' A' ' 29' ' ' VAL . . . -53.63 -43.35 68.64 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -175.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -151.07 -52.51 0.13 Allowed 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 7' ' ' LEU . 56.6 mt -127.54 -164.15 1.33 Allowed 'General case' 0 N--CA 1.425 -1.676 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.037 173.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 42.9 p -87.86 133.48 33.89 Favored 'General case' 0 C--N 1.28 -2.424 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 -160.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.6 t -92.1 135.47 27.23 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 114.808 -1.087 . . . . 0.0 108.181 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.85 -11.39 52.86 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.887 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.496 ' HB ' HD12 ' A' ' 26' ' ' ILE . 24.6 m -75.52 143.1 42.66 Favored 'General case' 0 N--CA 1.423 -1.819 0 C-N-CA 123.068 0.547 . . . . 0.0 110.805 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -96.8 131.68 43.28 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 105' ' ' LEU . 31.3 m -141.05 -179.63 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.192 -176.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 103' ' ' LEU . 3.3 p -118.75 136.82 53.76 Favored 'General case' 0 N--CA 1.401 -2.918 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 172.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.652 ' HB1' HD11 ' A' ' 98' ' ' LEU . . . -107.37 125.63 51.44 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 125.196 1.398 . . . . 0.0 107.57 -177.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HE3' ' HA ' ' A' ' 102' ' ' SER . 20.5 pttp -88.6 142.25 27.85 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.387 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -134.0 100.29 4.69 Favored 'General case' 0 C--N 1.291 -1.978 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 174.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.0 mtp180 58.74 39.74 23.93 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.851 175.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.6 -11.36 70.13 Favored Glycine 0 CA--C 1.521 0.429 0 CA-C-N 115.534 -0.757 . . . . 0.0 114.243 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -106.78 131.05 54.34 Favored 'General case' 0 C--O 1.205 -1.238 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -178.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.406 ' HA ' ' HA ' ' A' ' 16' ' ' LYS . 1.6 m-85 -106.68 132.44 52.67 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.427 -0.909 . . . . 0.0 110.842 -174.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.4 m -110.76 148.97 31.22 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -84.18 143.24 29.77 Favored 'General case' 0 C--O 1.249 1.069 0 C-N-CA 119.116 -1.034 . . . . 0.0 108.638 179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.472 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -154.32 149.61 27.1 Favored 'General case' 0 C--N 1.291 -1.942 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.327 -177.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.449 ' O ' HG12 ' A' ' 89' ' ' VAL . 3.9 tmmm? -113.37 129.26 56.58 Favored 'General case' 0 C--N 1.288 -2.089 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.496 HD12 ' HB ' ' A' ' 11' ' ' THR . 53.8 mt -64.73 119.35 8.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 C-N-CA 123.582 0.753 . . . . 0.0 112.657 -175.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.0 mmtp -90.53 -49.21 6.63 Favored 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 122.154 0.978 . . . . 0.0 109.549 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 55.0 m -142.89 147.72 35.8 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-N 114.177 -1.374 . . . . 0.0 111.096 -175.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.496 HG22 ' CD2' ' A' ' 86' ' ' TYR . 53.2 t -114.27 133.52 60.07 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.014 0 N-CA-C 105.506 -2.035 . . . . 0.0 105.506 171.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.487 ' HB3' ' HB2' ' A' ' 85' ' ' TRP . 23.7 tptm -121.82 120.82 35.68 Favored 'General case' 0 C--N 1.263 -3.156 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -176.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -70.56 144.32 51.3 Favored 'General case' 0 CA--C 1.494 -1.183 0 C-N-CA 118.611 -1.236 . . . . 0.0 111.026 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.538 HD21 ' CD1' ' A' ' 85' ' ' TRP . 73.5 mt -123.7 157.7 33.3 Favored 'General case' 0 C--N 1.265 -3.106 0 CA-C-N 114.046 -1.433 . . . . 0.0 107.457 175.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.417 ' CG1' ' HB2' ' A' ' 80' ' ' LEU . 60.7 t -119.86 110.65 29.8 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.361 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 173.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 49' ' ' GLN . 42.9 mtpt -85.53 108.1 17.78 Favored 'General case' 0 CA--C 1.471 -2.065 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 174.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.47 HG11 HG13 ' A' ' 77' ' ' ILE . 14.9 t -91.61 132.43 36.07 Favored 'Isoleucine or valine' 0 C--N 1.263 -3.188 0 CA-C-N 113.662 -1.608 . . . . 0.0 109.229 -173.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -90.4 111.91 23.32 Favored 'General case' 0 N--CA 1.41 -2.431 0 N-CA-C 104.124 -2.547 . . . . 0.0 104.124 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.448 ' HB ' ' HB1' ' A' ' 75' ' ' ALA . 2.7 m -112.96 144.33 20.85 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.103 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.056 -177.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -112.76 115.36 28.4 Favored 'General case' 0 C--N 1.271 -2.806 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 174.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 7.4 mp -68.9 122.03 17.81 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.385 -177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 37.3 tttm -66.74 -38.93 87.64 Favored 'General case' 0 N--CA 1.41 -2.464 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -170.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -86.31 -45.77 10.93 Favored 'General case' 0 C--N 1.312 -1.024 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.443 ' HB2' HE22 ' A' ' 73' ' ' GLN . 17.6 t70 -86.27 -25.12 25.68 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 112.459 0.541 . . . . 0.0 112.459 -173.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 74.02 19.65 2.97 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.515 0.932 . . . . 0.0 113.515 178.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.07 150.8 24.19 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 110.086 -0.338 . . . . 0.0 110.086 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -112.06 145.02 40.46 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 176.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.447 HE22 HG22 ' A' ' 67' ' ' THR . 4.1 tt0 -151.4 147.8 27.33 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -174.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.4 tp -123.48 101.49 7.36 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 10.0 m -134.62 165.08 32.36 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.406 -176.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 34' ' ' LYS . 5.6 pm0 -85.66 161.03 19.42 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -173.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -43.49 -28.12 0.34 Allowed 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 127.294 2.238 . . . . 0.0 113.977 178.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -64.87 -37.34 87.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 120.941 0.401 . . . . 0.0 110.789 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.487 ' HB3' ' HB3' ' A' ' 66' ' ' ARG . 88.1 mt-30 -100.53 -6.94 24.69 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.324 -177.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.0 t -101.14 113.27 36.73 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-O 121.601 0.715 . . . . 0.0 110.035 177.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -98.63 100.28 11.49 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.041 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.515 ' HA3' HG12 ' A' ' 63' ' ' VAL . . . 152.33 -163.34 30.22 Favored Glycine 0 N--CA 1.437 -1.242 0 CA-C-N 115.938 -0.573 . . . . 0.0 112.424 176.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -81.7 146.38 14.94 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 123.763 2.975 . . . . 0.0 113.903 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.93 82.09 6.21 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 176.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 49.1 mtm105 -139.89 123.75 17.51 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.674 177.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.3 t -61.08 118.03 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.525 0.679 . . . . 0.0 109.64 176.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.76 11.05 51.63 Favored Glycine 0 C--N 1.299 -1.515 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.532 -177.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.459 ' HB3' HD13 ' A' ' 77' ' ' ILE . . . -97.11 168.9 10.17 Favored 'General case' 0 CA--C 1.51 -0.566 0 C-N-CA 119.919 -0.712 . . . . 0.0 110.414 178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 23.8 mm -101.45 120.33 50.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.547 HG13 HD11 ' A' ' 77' ' ' ILE . 27.4 m -131.32 176.96 7.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 177.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -122.82 123.09 40.22 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 171.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 72' ' ' PHE . 8.5 t -114.96 154.36 28.91 Favored 'General case' 0 C--N 1.265 -3.08 0 CA-C-O 121.052 0.453 . . . . 0.0 110.402 -175.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.487 ' HB3' ' HB3' ' A' ' 52' ' ' GLN . 59.9 ttt-85 -85.69 147.62 26.27 Favored 'General case' 0 C--N 1.286 -2.194 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 175.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.447 HG22 HE22 ' A' ' 46' ' ' GLN . 59.2 p -99.94 172.68 7.07 Favored 'General case' 0 C--N 1.284 -2.279 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 173.661 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 25.9 t -67.84 -6.98 24.22 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-O 121.298 0.57 . . . . 0.0 109.801 175.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -85.31 -25.47 27.15 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.411 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 108.98 -11.77 34.45 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 121.079 -0.582 . . . . 0.0 112.357 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.1 m -87.48 158.12 19.03 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 122.184 0.193 . . . . 0.0 110.706 -178.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.472 ' HA ' ' O ' ' A' ' 65' ' ' THR . 54.5 m-85 -111.13 145.26 38.92 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 122.538 0.335 . . . . 0.0 110.415 178.396 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.443 HE22 ' HB2' ' A' ' 42' ' ' ASP . 8.2 tt0 -147.69 151.72 36.61 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 178.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -68.95 126.52 30.04 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.804 0.841 . . . . 0.0 109.554 178.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.448 ' HB1' ' HB ' ' A' ' 37' ' ' VAL . . . -139.65 167.74 21.42 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.812 -176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 8.0 mm -115.81 144.71 22.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.547 HD11 HG13 ' A' ' 63' ' ' VAL . 3.5 mp -77.55 123.65 34.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 175.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.4 p -111.87 -16.71 13.08 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-O 121.546 0.689 . . . . 0.0 111.582 176.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -161.1 150.8 17.07 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 176.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.417 ' HB2' ' CG1' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -141.25 111.51 6.8 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 122.067 0.937 . . . . 0.0 110.654 175.39 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.2 m -105.01 140.61 37.94 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 114.66 -1.154 . . . . 0.0 111.464 -170.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -74.49 127.03 32.04 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.322 0.582 . . . . 0.0 110.761 177.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.466 ' HB3' ' HB2' ' A' ' 32' ' ' LEU . . . -130.29 -170.05 2.25 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 176.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.8 p -166.1 142.53 5.06 Favored 'General case' 0 C--O 1.249 1.035 0 N-CA-C 114.793 1.405 . . . . 0.0 114.793 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.538 ' CD1' HD21 ' A' ' 32' ' ' LEU . 64.8 m95 -94.09 151.08 19.76 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 167.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.496 ' CD2' HG22 ' A' ' 29' ' ' VAL . 53.2 m-85 -127.37 116.9 21.21 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 42.5 m -86.29 105.85 16.95 Favored 'General case' 0 N--CA 1.401 -2.9 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 175.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.472 ' HB ' ' HB1' ' A' ' 24' ' ' ALA . 22.3 m -109.06 141.47 24.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.041 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.345 -176.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.449 HG12 ' O ' ' A' ' 25' ' ' LYS . 14.8 p -107.78 134.22 50.23 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.885 0 CA-C-N 115.393 -0.822 . . . . 0.0 110.436 -176.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -80.27 169.71 17.4 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -63.33 -20.78 65.8 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.41 0.624 . . . . 0.0 109.905 175.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -68.74 -17.81 64.12 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.246 175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 92.99 0.1 68.74 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.669 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -96.55 142.5 28.54 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 89' ' ' VAL . 9.4 pt-20 -117.98 138.64 52.05 Favored 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -176.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.425 ' HA ' ' NE ' ' A' ' 96' ' ' ARG . 4.0 mmp_? -124.3 142.71 51.05 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 55.0 m -102.57 117.79 35.44 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.046 0.451 . . . . 0.0 111.222 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.652 HD11 ' HB1' ' A' ' 15' ' ' ALA . 0.4 OUTLIER -139.54 173.4 11.58 Favored 'General case' 0 C--O 1.208 -1.094 0 C-N-CA 123.168 0.587 . . . . 0.0 109.991 179.313 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.464 ' O ' HD13 ' A' ' 103' ' ' LEU . 3.7 ptm180 -95.38 173.8 7.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 118.569 0.622 . . . . 0.0 112.277 -173.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 53.8 ttp85 -58.37 -40.79 83.22 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 122.809 0.444 . . . . 0.0 111.535 -175.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.13 12.06 7.06 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -177.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.496 ' HA ' ' HE3' ' A' ' 16' ' ' LYS . 10.7 p -115.75 5.65 14.24 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 122.587 1.184 . . . . 0.0 108.477 170.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 99' ' ' ARG . 9.5 mp -112.21 153.06 27.66 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.051 -1.886 . . . . 0.0 106.104 175.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 55.7 m -89.91 -29.29 18.63 Favored 'General case' 0 C--N 1.285 -2.222 0 C-N-CA 119.504 -0.878 . . . . 0.0 111.211 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.413 ' HA ' HG12 ' A' ' 13' ' ' VAL . 75.3 mt 62.76 -71.48 0.05 Allowed 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.993 0.917 . . . . 0.0 111.386 -174.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 14.0 tppt? 175.22 -53.6 0.01 OUTLIER 'General case' 0 C--O 1.243 0.738 0 C-N-CA 124.495 1.118 . . . . 0.0 109.693 176.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -103.47 -3.4 47.15 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.776 -0.647 . . . . 0.0 113.38 -176.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -89.04 135.12 33.72 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.4 ttm-85 -139.98 68.11 1.37 Allowed 'General case' 0 C--N 1.291 -1.958 0 CA-C-O 122.328 1.061 . . . . 0.0 109.319 176.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -136.86 119.78 16.39 Favored 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 113.677 -1.601 . . . . 0.0 107.204 176.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -115.48 -169.35 1.56 Allowed 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.438 ' H ' ' HE2' ' A' ' 16' ' ' LYS . . . -164.34 82.35 0.41 Allowed 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -173.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -102.07 108.5 19.94 Favored 'General case' 0 C--N 1.284 -2.254 0 CA-C-N 115.01 -0.996 . . . . 0.0 110.703 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.5 p -100.41 -171.66 2.07 Favored 'General case' 0 C--N 1.281 -2.396 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -81.74 -57.05 3.61 Favored 'General case' 0 N--CA 1.425 -1.693 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 178.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 39.2 p -96.77 130.0 44.1 Favored 'General case' 0 N--CA 1.422 -1.832 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 174.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -89.74 104.63 17.17 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 106.482 -1.674 . . . . 0.0 106.482 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 . . . . . 0 C--N 1.306 -1.297 0 CA-C-O 118.698 -0.668 . . . . 0.0 109.848 -176.402 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.36 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -123.37 -5.68 8.25 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.8 mp0 -65.33 129.18 94.34 Favored Pre-proline 0 C--O 1.252 1.197 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.016 179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 3' ' ' GLU . 22.0 Cg_exo -66.62 126.01 14.75 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.608 2.205 . . . . 0.0 110.657 177.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.448 ' HB1' ' NH1' ' A' ' 100' ' ' ARG . . . -112.83 -41.54 3.76 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-O 121.366 0.603 . . . . 0.0 110.688 -178.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.639 ' O ' ' HD3' ' A' ' 31' ' ' ARG . 25.6 p90 -99.42 9.67 42.85 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -176.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.447 ' O ' ' HB ' ' A' ' 8' ' ' THR . 4.1 pp -145.23 134.87 23.38 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 175.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 7' ' ' LEU . 9.2 t 176.41 25.3 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.12 0 O-C-N 124.13 0.894 . . . . 0.0 111.127 174.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.6 p -75.9 132.48 33.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 O-C-N 121.173 -0.954 . . . . 0.0 109.475 178.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.8 -3.77 74.61 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.403 -178.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.3 m -91.76 153.45 19.6 Favored 'General case' 0 N--CA 1.411 -2.413 0 CA-C-O 121.093 0.473 . . . . 0.0 109.978 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -103.7 111.44 23.94 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -178.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 34.5 m -119.14 173.22 5.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.854 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.181 -175.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 23' ' ' GLU . 14.9 m -95.26 135.18 37.17 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -130.05 127.06 39.15 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HB3' ' CD2' ' A' ' 21' ' ' PHE . 21.5 ptmt -88.75 117.35 27.67 Favored 'General case' 0 C--N 1.291 -1.975 0 C-N-CA 119.45 -0.9 . . . . 0.0 109.742 178.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.573 ' CE2' ' HB2' ' A' ' 22' ' ' CYS . 50.7 p90 -133.5 138.0 45.91 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 177.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.409 ' O ' ' HG2' ' A' ' 18' ' ' ARG . 70.3 ttt180 64.2 25.77 13.68 Favored 'General case' 0 CA--C 1.562 1.43 0 CA-C-O 122.326 1.06 . . . . 0.0 108.666 -176.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.17 18.09 77.75 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.552 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.69 130.72 47.57 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.504 ' CD2' ' HB3' ' A' ' 16' ' ' LYS . 33.9 m-85 -86.53 110.38 19.74 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 -176.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.573 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 73.1 m -126.64 155.37 42.68 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 177.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 14' ' ' SER . 0.1 OUTLIER -78.82 149.4 32.57 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 118.246 -1.381 . . . . 0.0 111.756 -176.749 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.403 ' HB1' ' HB ' ' A' ' 88' ' ' VAL . . . -144.88 149.35 35.19 Favored 'General case' 0 C--N 1.28 -2.446 0 CA-C-N 114.159 -1.382 . . . . 0.0 108.475 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -104.0 126.95 51.51 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 119.279 -0.968 . . . . 0.0 109.993 -177.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.478 HG12 HG12 ' A' ' 88' ' ' VAL . 47.4 mt -69.27 121.8 19.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.954 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.3 tttm -111.56 -37.55 5.18 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.387 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 87' ' ' THR . 9.3 m -129.06 145.26 51.32 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.6 t -135.66 133.07 51.67 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 123.674 0.79 . . . . 0.0 108.955 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 ttmm -122.92 111.09 16.22 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.639 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 46.1 mtm-85 -86.65 107.0 17.99 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-O 121.127 0.489 . . . . 0.0 109.891 178.074 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 32' ' ' LEU . 1.8 pt? -124.65 137.62 54.35 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 49' ' ' GLN . 43.3 t -92.56 129.16 43.54 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.001 0 C-N-CA 118.954 -1.098 . . . . 0.0 108.859 -178.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -90.73 101.17 13.92 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.477 HG12 HG13 ' A' ' 37' ' ' VAL . 14.2 t -93.51 130.97 41.75 Favored 'Isoleucine or valine' 0 C--N 1.245 -3.942 0 CA-C-N 113.757 -1.565 . . . . 0.0 110.484 -170.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.5 ' HA ' ' O ' ' A' ' 46' ' ' GLN . 88.0 tttt -98.36 106.26 18.52 Favored 'General case' 0 N--CA 1.42 -1.927 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.52 HG21 HG21 ' A' ' 65' ' ' THR . 1.8 m -112.7 143.37 22.54 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.756 0 CA-C-O 121.396 0.617 . . . . 0.0 111.217 179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 44.0 tp -111.09 120.85 43.71 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 114.482 -1.235 . . . . 0.0 108.032 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.685 HD23 ' HB2' ' A' ' 75' ' ' ALA . 68.1 mt -73.13 116.81 14.11 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -68.47 -26.79 65.67 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-O 121.613 0.721 . . . . 0.0 110.083 177.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.2 tt0 -70.83 -36.51 72.93 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 114.468 -1.242 . . . . 0.0 112.054 -179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -128.03 -19.6 3.95 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 -171.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 78.43 15.19 1.3 Allowed 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 124.274 1.03 . . . . 0.0 112.829 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.59 142.18 28.05 Favored 'General case' 0 N--CA 1.422 -1.868 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 175.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 2.4 m -115.07 132.52 56.57 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-O 121.641 0.734 . . . . 0.0 109.434 -176.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 36' ' ' LYS . 2.2 mp0 -120.49 147.06 45.62 Favored 'General case' 0 C--N 1.272 -2.775 0 CA-C-N 114.935 -1.029 . . . . 0.0 110.687 -174.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.4 mt -122.29 101.65 7.64 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 172.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 16.7 m -133.72 -178.04 2.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 -175.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -96.02 165.98 11.99 Favored 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.739 178.366 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.68 -4.66 3.2 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 124.103 0.961 . . . . 0.0 113.162 -177.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -79.66 -30.59 41.27 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 176.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.424 ' OE1' ' HD2' ' A' ' 66' ' ' ARG . 79.7 mm-40 -82.46 -23.38 34.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.832 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 91.8 t -89.71 131.42 37.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.147 0 CA-C-N 114.821 -1.081 . . . . 0.0 110.317 -178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -112.78 104.59 12.62 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 138.8 -176.0 21.16 Favored Glycine 0 N--CA 1.43 -1.747 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.597 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -60.23 144.39 99.49 Favored 'Trans proline' 0 N--CA 1.484 0.956 0 C-N-CA 123.742 2.961 . . . . 0.0 113.447 177.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.01 82.35 2.55 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-O 122.004 0.907 . . . . 0.0 108.587 176.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.537 ' O ' ' HB ' ' A' ' 77' ' ' ILE . 79.3 ttt180 -139.86 133.61 30.51 Favored 'General case' 0 C--N 1.292 -1.924 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.627 -177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.01 119.36 12.44 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.23 4.0 53.76 Favored Glycine 0 C--N 1.292 -1.883 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.962 -177.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.73 143.67 27.45 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 119.975 -0.69 . . . . 0.0 109.921 -179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.466 HG12 HG13 ' A' ' 76' ' ' ILE . 41.2 mt -93.74 124.05 46.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.489 0.662 . . . . 0.0 109.278 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 27.5 m -137.31 -172.54 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.286 -2.163 0 CA-C-N 115.164 -0.926 . . . . 0.0 108.881 -175.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -120.71 148.27 44.17 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.52 HG21 HG21 ' A' ' 37' ' ' VAL . 8.8 t -145.38 152.88 40.56 Favored 'General case' 0 C--N 1.276 -2.61 0 C-N-CA 120.384 -0.526 . . . . 0.0 109.939 -179.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.424 ' HD2' ' OE1' ' A' ' 52' ' ' GLN . 40.3 ttm180 -78.73 126.88 31.32 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 174.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . 0.433 HG22 ' O ' ' A' ' 71' ' ' SER . 7.2 t -98.87 159.05 15.23 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 174.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 24.2 m -66.05 -2.79 4.41 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 112.802 0.668 . . . . 0.0 112.802 -177.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.83 -22.43 61.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 172.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 112.75 -22.8 16.01 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.291 -0.868 . . . . 0.0 113.595 175.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.433 ' O ' HG22 ' A' ' 67' ' ' THR . 24.8 m -99.12 161.46 13.61 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.025 0.44 . . . . 0.0 111.964 -177.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.421 ' HA ' ' O ' ' A' ' 65' ' ' THR . 53.3 m-85 -93.09 124.11 36.83 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.039 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -122.26 162.08 22.1 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -178.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -78.05 128.1 33.33 Favored 'General case' 0 C--O 1.254 1.311 0 C-N-CA 123.387 0.675 . . . . 0.0 109.238 -178.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.685 ' HB2' HD23 ' A' ' 39' ' ' LEU . . . -143.02 171.96 13.35 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.699 -175.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.466 HG13 HG12 ' A' ' 62' ' ' ILE . 4.5 mp -123.59 139.01 51.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.537 ' HB ' ' O ' ' A' ' 58' ' ' ARG . 3.4 mp -70.63 122.13 21.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 175.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.3 m -102.22 -23.36 14.03 Favored 'General case' 0 C--N 1.299 -1.63 0 CA-C-O 121.236 0.541 . . . . 0.0 110.109 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.466 ' HB3' ' HB3' ' A' ' 36' ' ' LYS . 87.0 tttt -163.7 144.41 8.8 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.404 ' HB2' ' CG1' ' A' ' 33' ' ' VAL 0.315 0.0 OUTLIER -120.9 116.06 24.41 Favored 'General case' 0 N--CA 1.422 -1.853 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 167.957 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 8.5 m -101.59 144.4 30.37 Favored 'General case' 0 N--CA 1.411 -2.385 0 CA-C-N 114.212 -1.358 . . . . 0.0 109.506 -167.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.601 ' HB3' ' NH1' ' A' ' 100' ' ' ARG . 1.7 m-20 -63.18 122.31 15.81 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.362 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -145.97 147.23 31.47 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 174.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 68.9 m -165.03 139.67 5.1 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 174.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TRP . . . . . 0.486 ' HB3' ' CG2' ' A' ' 97' ' ' THR . 46.9 m95 -99.09 131.42 45.14 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 175.239 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' THR . 33.4 m-85 -122.15 120.29 33.79 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . 0.481 ' HB ' ' HB ' ' A' ' 28' ' ' THR . 89.2 m -98.16 109.38 22.14 Favored 'General case' 0 N--CA 1.395 -3.212 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.478 HG12 HG12 ' A' ' 26' ' ' ILE . 17.5 m -106.25 148.25 10.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 CA-C-N 114.629 -1.169 . . . . 0.0 110.314 -176.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.4 p -101.24 123.72 54.48 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.566 179.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -92.33 -175.33 3.99 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.521 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -49.5 -33.0 13.4 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 126.382 1.873 . . . . 0.0 112.643 179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -78.74 -16.95 56.58 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.414 0.626 . . . . 0.0 111.648 -176.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . 88.09 16.05 59.95 Favored Glycine 0 C--N 1.31 -0.865 0 N-CA-C 108.595 -1.802 . . . . 0.0 108.595 -172.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -96.79 135.83 38.18 Favored 'General case' 0 CA--C 1.484 -1.581 0 CA-C-N 114.039 -1.08 . . . . 0.0 108.855 -177.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 87' ' ' THR . 42.9 mt-10 -102.84 128.69 49.5 Favored 'General case' 0 C--N 1.277 -2.571 0 O-C-N 124.309 1.006 . . . . 0.0 110.144 -178.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -136.29 140.64 43.55 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.486 ' CG2' ' HB3' ' A' ' 85' ' ' TRP . 26.7 m -89.68 111.92 23.03 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 122.524 0.33 . . . . 0.0 110.643 -177.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.447 ' HB3' ' HB2' ' A' ' 102' ' ' SER . 17.0 mt -110.54 172.41 6.88 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-O 121.111 0.482 . . . . 0.0 110.973 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 43.6 mtm180 -99.27 169.04 9.64 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.907 -1.042 . . . . 0.0 108.783 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.601 ' NH1' ' HB3' ' A' ' 82' ' ' ASP . 97.4 mtt180 -68.19 -25.11 65.07 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-O 121.276 0.56 . . . . 0.0 110.521 178.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' THR . . . . . . . . . . . . . 4.0 m -83.18 4.04 28.36 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 121.934 0.873 . . . . 0.0 109.81 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 7.4 m -120.56 -0.47 10.27 Favored 'General case' 0 C--N 1.312 -1.056 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 95.6 mt -129.32 162.18 28.54 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.102 -174.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 49.3 t -138.58 104.54 5.15 Favored 'General case' 0 N--CA 1.42 -1.955 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.432 174.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 58.6 tp -98.44 -82.82 0.42 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 170.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 34.7 mtmm 46.31 -83.43 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.1 1.76 . . . . 0.0 113.945 178.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -160.79 -48.69 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.466 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.411 ' HG3' ' H ' ' A' ' 110' ' ' HIS . 10.4 pt-20 -120.77 -178.87 3.83 Favored 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 77.9 mtt180 -87.06 17.61 4.09 Favored 'General case' 0 C--O 1.251 1.14 0 N-CA-C 112.13 0.418 . . . . 0.0 112.13 -178.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.411 ' H ' ' HG3' ' A' ' 108' ' ' GLU . 14.9 t-80 -69.85 100.4 1.54 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 122.013 0.911 . . . . 0.0 109.074 -179.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -178.81 -35.71 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 103.605 -2.739 . . . . 0.0 103.605 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -86.04 171.91 11.04 Favored 'General case' 0 C--O 1.252 1.196 0 CA-C-N 113.884 -1.507 . . . . 0.0 107.478 171.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -81.44 104.66 12.03 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 68.7 m -155.73 102.63 2.22 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 105.377 -2.083 . . . . 0.0 105.377 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -80.27 109.1 14.43 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.626 0.727 . . . . 0.0 111.195 -171.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.6 p -92.38 160.65 15.0 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.735 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 7.2 mp 68.79 91.08 0.09 Allowed 'General case' 0 C--O 1.241 0.648 0 C-N-CA 124.061 0.945 . . . . 0.0 111.716 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 . . . . . 0 C--N 1.303 -1.451 0 CA-C-N 115.089 -0.959 . . . . 0.0 108.712 179.615 . . . . . . . . 0 0 . 1 stop_ save_